data_2lz0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lz0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo . . . . . 0 N--CA 1.45 -1.05 0 N-CA-C 109.47 -1.011 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.28 155.51 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 120.732 -1.23 . . . . 0.0 112.179 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.59 88.47 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.731 1.612 . . . . 0.0 109.846 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 96.41 0.2 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt 58.51 17.72 5.14 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.393 1.477 . . . . 0.0 114.455 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.17 175.37 11.82 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 31' ' ' ILE . 15.4 mttm -138.27 -0.59 2.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.154 2.181 . . . . 0.0 114.507 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -81.63 -29.36 33.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.606 1.094 . . . . 0.0 112.048 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.59 73.64 10.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.276 1.031 . . . . 0.0 110.893 -160.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -147.16 -49.45 0.18 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.289 0.636 . . . . 0.0 110.458 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.81 71.84 1.05 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.564 1.146 . . . . 0.0 110.702 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.4 -45.55 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -82.4 104.23 12.55 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -60.94 -5.2 1.25 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.546 1.539 . . . . 0.0 114.46 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.29 30.51 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.85 1.204 . . . . 0.0 110.601 -152.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -104.79 88.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 124.497 1.119 . . . . 0.0 109.018 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -70.83 -11.97 61.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.758 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -140.64 135.99 32.25 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 119.855 1.207 . . . . 0.0 108.078 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.18 102.62 7.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -73.66 145.38 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.92 149.75 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.687 1.995 . . . . 0.0 107.98 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -103.14 165.11 14.18 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 125.586 1.554 . . . . 0.0 111.253 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.59 161.49 45.68 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.998 2.465 . . . . 0.0 111.309 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 53.63 23.66 3.73 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.125 2.57 . . . . 0.0 115.432 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.443 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 tt -117.17 63.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.655 1.182 . . . . 0.0 111.4 -171.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.426 ' CA ' ' HE2' ' A' ' 13' ' ' LYS . . . 95.82 164.2 34.03 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 128.407 2.908 . . . . 0.0 112.718 174.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.17 124.1 31.44 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 173.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.34 76.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.692 1.997 . . . . 0.0 108.099 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.22 -165.24 0.17 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.272 -167.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.44 165.21 19.37 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.47 -1.394 . . . . 0.0 111.356 165.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.79 11.26 35.77 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 117.689 1.835 . . . . 0.0 117.689 168.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -43.27 78.39 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 121.53 2.665 . . . . 0.0 111.326 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -116.84 5.96 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.314 1.046 . . . . 0.0 112.382 -155.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -46.69 124.74 6.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.649 1.58 . . . . 0.0 112.852 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.32 20.71 61.87 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.374 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.4 p -71.33 75.1 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.524 -0.986 . . . . 0.0 111.556 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.0 p -59.76 -16.51 28.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.52 1.128 . . . . 0.0 112.929 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.69 71.54 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.323 0.965 . . . . 0.0 110.888 162.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.5 tp -115.79 115.07 25.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.421 1.089 . . . . 0.0 110.095 159.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -139.12 24.26 2.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.086 0.554 . . . . 0.0 111.662 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -159.44 152.02 21.44 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 120.751 -1.218 . . . . 0.0 109.922 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 tp -141.69 138.32 32.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.97 137.88 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 119.704 1.138 . . . . 0.0 108.024 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -114.7 117.27 30.34 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.107 0.963 . . . . 0.0 109.849 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -88.9 30.09 0.97 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.428 1.091 . . . . 0.0 111.735 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 164.43 18.24 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -113.18 2.81 15.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.35 144.56 31.52 Favored Pre-proline 0 N--CA 1.447 -0.621 0 O-C-N 120.636 -1.29 . . . . 0.0 110.892 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -73.85 -32.37 7.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.294 2.663 . . . . 0.0 114.238 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -66.46 -25.9 66.94 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.146 0.43 . . . . 0.0 111.455 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.17 4.88 1.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 113.071 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.17 149.05 52.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.559 1.072 . . . . 0.0 108.505 167.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.9 m -142.64 135.32 27.99 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.658 0.783 . . . . 0.0 109.046 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.26 2.6 0.88 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.56 -67.24 1.28 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.729 2.585 . . . . 0.0 113.916 163.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 174.85 -32.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 131.596 3.958 . . . . 0.0 107.734 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.47 4.17 74.44 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.407 -1.218 . . . . 0.0 115.507 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.2 tp -43.73 -54.03 5.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.69 1.596 . . . . 0.0 112.57 -158.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.6 33.51 5.61 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.54 132.66 53.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.437 1.017 . . . . 0.0 109.911 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 20.97 79.5 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.742 0.686 . . . . 0.0 113.943 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.01 178.61 7.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.43 1.492 . . . . 0.0 110.816 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.97 101.22 0.99 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.829 1.651 . . . . 0.0 108.432 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -146.05 169.08 19.4 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.631 -0.668 . . . . 0.0 112.266 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt -90.04 155.45 19.07 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 128.112 2.565 . . . . 0.0 110.82 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 mt -117.37 94.87 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.183 2.193 . . . . 0.0 108.222 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.82 129.7 38.45 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 121.037 -1.039 . . . . 0.0 110.125 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -130.89 160.1 68.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.52 1.528 . . . . 0.0 108.544 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -67.7 151.74 78.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.729 1.62 . . . . 0.0 110.939 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.72 -36.9 72.65 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.471 0.578 . . . . 0.0 111.594 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -72.61 -6.57 45.11 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.858 -0.527 . . . . 0.0 111.967 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.05 -8.17 20.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.087 1.355 . . . . 0.0 113.776 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tp -63.01 -50.79 69.34 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.639 1.108 . . . . 0.0 111.359 -165.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -63.03 -44.73 95.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -51.74 -53.93 34.1 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.786 1.234 . . . . 0.0 111.029 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -60.25 -38.44 83.5 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.53 0.519 . . . . 0.0 110.61 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -68.96 -25.17 64.41 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.332 -0.855 . . . . 0.0 113.091 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -87.63 -2.38 58.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.346 1.43 . . . . 0.0 112.508 173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -71.04 157.74 37.69 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.064 0.847 . . . . 0.0 112.376 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 19.92 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.336 1.054 . . . . 0.0 113.812 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.92 -68.42 0.4 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 126.989 2.115 . . . . 0.0 108.012 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -57.53 -14.78 5.62 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.254 1.822 . . . . 0.0 114.676 -165.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -44.65 -47.0 10.49 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.506 1.048 . . . . 0.0 113.097 161.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 t -62.72 -16.4 57.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.79 0.836 . . . . 0.0 111.943 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -108.35 10.97 27.47 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.039 -1.663 . . . . 0.0 111.335 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.15 -8.13 35.92 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 119.949 -1.719 . . . . 0.0 112.421 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.98 -6.17 57.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.901 0.881 . . . . 0.0 112.84 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -130.65 -14.85 3.59 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 124.06 0.944 . . . . 0.0 112.536 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.13 144.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 120.833 -1.167 . . . . 0.0 108.616 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -149.01 164.35 21.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.885 0.874 . . . . 0.0 110.882 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.73 149.92 73.71 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.98 2.453 . . . . 0.0 113.835 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 mtm . . . . . 0 C--O 1.239 0.503 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.752 165.488 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.446 -1.281 0 N-CA-C 109.539 -0.985 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.34 160.26 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.108 -1.62 . . . . 0.0 110.782 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.26 99.05 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.53 1.532 . . . . 0.0 108.411 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.16 121.68 1.08 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.73 -11.33 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.92 2.888 . . . . 0.0 117.429 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -135.16 153.5 51.95 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 121.122 1.783 . . . . 0.0 108.523 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -135.35 51.61 2.07 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.229 1.811 . . . . 0.0 109.939 170.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -127.26 -17.95 4.63 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.7 75.92 0.95 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.066 1.303 . . . . 0.0 109.57 -167.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -130.51 -55.47 1.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.284 1.034 . . . . 0.0 110.71 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.68 30.52 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.806 2.043 . . . . 0.0 113.372 -165.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.05 -36.09 1.55 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.018 1.771 . . . . 0.0 113.07 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -89.26 102.53 15.2 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.283 2.042 . . . . 0.0 112.065 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.3 p -65.66 6.48 0.33 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.265 1.826 . . . . 0.0 114.21 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.82 -1.46 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.834 1.254 . . . . 0.0 109.96 -167.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.1 tt -69.54 111.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -91.05 -14.23 31.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.766 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -146.44 139.98 25.94 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.605 0.762 . . . . 0.0 110.402 -168.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.2 mt -137.4 101.41 2.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.1 132.96 45.86 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 162.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.02 133.79 67.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 126.058 1.743 . . . . 0.0 108.193 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -94.48 162.98 24.21 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 122.889 0.476 . . . . 0.0 110.969 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.79 151.9 78.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.291 1.994 . . . . 0.0 109.635 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 52.73 38.22 25.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.207 1.803 . . . . 0.0 113.471 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 tp -119.88 0.78 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.499 1.12 . . . . 0.0 113.192 -164.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.38 169.3 11.7 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.247 1.404 . . . . 0.0 112.445 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 132.49 37.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 112.028 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.96 77.98 9.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.147 1.779 . . . . 0.0 107.189 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -69.63 164.17 23.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.994 0.902 . . . . 0.0 110.342 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -66.99 110.83 3.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.311 1.445 . . . . 0.0 110.102 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.43 11.05 32.21 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.283 0.944 . . . . 0.0 114.546 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.5 mtp -52.93 -23.83 8.0 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -127.28 20.03 6.85 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 110.736 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 t -63.59 94.16 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.857 1.263 . . . . 0.0 110.671 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.21 -7.74 6.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.939 1.733 . . . . 0.0 112.859 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.97 70.37 9.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.127 1.963 . . . . 0.0 109.501 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.9 p -67.05 -25.32 66.2 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.161 -0.962 . . . . 0.0 113.338 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.0 -2.11 57.58 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.605 -1.309 . . . . 0.0 113.119 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.84 119.9 24.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.051 0.94 . . . . 0.0 110.207 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -141.11 2.75 1.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.518 0.727 . . . . 0.0 112.239 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -126.97 153.95 45.2 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.183 -1.573 . . . . 0.0 111.186 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 tp -146.14 100.96 3.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.434 3.494 . . . . 0.0 104.143 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.15 124.35 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 120.89 -1.132 . . . . 0.0 108.084 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mp -101.72 107.86 19.21 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 107.878 -168.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.8 p -77.15 19.72 0.3 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.53 161.09 20.05 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 120.076 1.307 . . . . 0.0 112.445 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -97.31 -4.22 39.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.501 1.52 . . . . 0.0 112.976 -167.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.85 148.4 42.36 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 119.935 1.243 . . . . 0.0 110.4 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.28 -36.45 7.07 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.113 2.542 . . . . 0.0 112.45 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -25.39 63.82 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.484 0.584 . . . . 0.0 112.441 -172.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -1.4 31.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.688 1.595 . . . . 0.0 113.434 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -127.9 126.8 42.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.16 171.86 11.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.701 1.6 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.3 146.85 3.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.496 1.118 . . . . 0.0 109.624 159.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.27 -173.06 34.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 164.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.3 -48.55 81.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.131 0.972 . . . . 0.0 109.061 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.94 36.58 3.02 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 117.536 -1.702 . . . . 0.0 112.315 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tt -44.56 -56.4 4.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.114 1.457 . . . . 0.0 107.526 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 25.31 10.33 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 125.462 1.505 . . . . 0.0 113.241 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.27 130.1 41.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.49 1.041 . . . . 0.0 111.619 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.36 79.35 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.438 1.018 . . . . 0.0 114.641 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.73 -170.47 2.63 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.04 93.65 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.424 -0.798 . . . . 0.0 109.406 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -125.04 165.12 18.74 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -98.36 158.25 15.7 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 128.168 2.587 . . . . 0.0 110.145 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.4 mt -116.05 90.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.278 1.831 . . . . 0.0 108.744 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.6 136.65 36.28 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.843 -1.161 . . . . 0.0 108.872 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.09 160.83 67.12 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 126.708 2.003 . . . . 0.0 108.379 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.49 153.58 60.55 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.555 1.504 . . . . 0.0 109.267 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.78 -35.63 64.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.071 0.548 . . . . 0.0 112.232 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.26 -42.48 73.59 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.936 1.294 . . . . 0.0 110.885 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.83 57.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.948 0.899 . . . . 0.0 112.318 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.2 tp -51.68 -61.57 2.17 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.099 1.318 . . . . 0.0 112.078 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.81 -28.38 61.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.533 1.133 . . . . 0.0 110.175 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -59.96 -46.16 90.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.469 1.508 . . . . 0.0 110.195 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -64.65 -41.48 96.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.03 0.832 . . . . 0.0 110.215 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -65.41 -12.64 54.25 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 116.921 -1.514 . . . . 0.0 114.361 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -96.38 2.73 52.94 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 121.685 2.039 . . . . 0.0 112.919 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.32 143.9 36.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.709 1.141 . . . . 0.0 111.994 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.72 10.45 1.39 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.044 1.338 . . . . 0.0 113.746 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -137.24 -64.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.123 1.769 . . . . 0.0 111.029 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -54.21 -20.82 7.54 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.776 1.171 . . . . 0.0 113.649 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -43.81 -47.66 8.13 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.852 1.261 . . . . 0.0 113.91 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 t -64.09 -24.16 67.6 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.665 0.666 . . . . 0.0 111.86 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -96.77 14.55 24.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.361 1.064 . . . . 0.0 111.137 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.14 -18.21 33.77 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 120.288 -1.508 . . . . 0.0 111.04 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.13 -22.36 28.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 113.084 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -119.45 -8.48 10.02 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.527 1.131 . . . . 0.0 112.983 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.11 115.65 29.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -149.27 165.46 17.62 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.269 1.028 . . . . 0.0 111.277 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.71 158.75 40.48 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.412 2.075 . . . . 0.0 114.441 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 13.4 mtm . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 126.169 1.787 . . . . 0.0 109.979 161.448 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 CA-C-O 121.783 0.659 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.9 165.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.714 2.006 . . . . 0.0 107.518 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 p -113.33 157.19 14.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 109.199 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 -75.49 0.2 Allowed Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.5 mmt -123.69 3.17 8.9 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -167.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -136.94 156.09 48.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.5 1.046 . . . . 0.0 108.901 169.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -139.17 82.52 1.9 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.131 1.373 . . . . 0.0 110.167 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -150.01 -44.49 0.13 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.815 1.646 . . . . 0.0 111.689 162.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.85 10.48 0.05 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 -168.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -82.05 -12.64 58.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 119.801 -1.812 . . . . 0.0 113.618 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.02 79.74 1.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.61 -13.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.761 -1.577 . . . . 0.0 116.169 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -112.91 91.73 3.76 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 120.295 2.047 . . . . 0.0 109.345 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -66.35 31.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.755 3.622 . . . . 0.0 113.98 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.88 -7.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.371 1.869 . . . . 0.0 111.736 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.94 89.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.025 0.83 . . . . 0.0 110.511 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -72.1 -13.86 61.69 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.501 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -144.68 137.38 26.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -168.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -136.6 120.01 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.548 1.539 . . . . 0.0 106.963 170.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 m -84.42 143.75 29.22 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.949 -1.095 . . . . 0.0 108.162 158.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.42 139.79 44.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -101.71 165.07 14.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.705 1.202 . . . . 0.0 111.573 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -66.71 144.95 73.85 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.631 1.554 . . . . 0.0 109.625 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 47.8 74.29 0.17 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.819 1.647 . . . . 0.0 112.282 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.268 4.8 tp -143.0 33.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 121.619 0.724 . . . . 0.0 112.153 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.48 170.88 16.89 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.84 1.686 . . . . 0.0 111.49 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.3 tp -83.92 127.38 33.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.115 0.958 . . . . 0.0 109.713 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.6 mt -73.02 90.11 1.48 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 162.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 38' ' ' MET . 54.5 p90 -70.44 -164.61 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.91 0.884 . . . . 0.0 112.175 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -158.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.846 -0.597 . . . . 0.0 112.032 160.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.15 76.89 0.0 OUTLIER Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.57 2.033 . . . . 0.0 117.407 -165.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.433 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 30.9 mtp -67.62 -22.06 65.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.317 1.847 . . . . 0.0 111.125 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.72 10.06 4.67 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.129 0.972 . . . . 0.0 110.675 -161.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -62.38 118.16 7.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.33 52.32 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.709 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.1 p -68.39 73.79 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.131 1.965 . . . . 0.0 111.577 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 p -63.7 2.07 0.52 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.955 1.302 . . . . 0.0 113.627 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.91 39.88 0.87 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.229 -1.367 . . . . 0.0 112.272 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.77 120.64 42.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.477 1.944 . . . . 0.0 110.582 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.07 -13.3 5.12 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -117.86 162.98 17.23 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.662 1.119 . . . . 0.0 111.851 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 tp -148.67 145.76 27.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.014 2.126 . . . . 0.0 106.96 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -128.61 134.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -111.57 112.4 24.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -74.58 -14.6 60.8 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.94 -176.44 50.75 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.36 0.981 . . . . 0.0 110.81 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.57 3.64 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.92 143.56 25.76 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 118.243 0.474 . . . . 0.0 110.169 -174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.63 -27.63 32.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.677 2.918 . . . . 0.0 112.373 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.9 m -75.62 9.88 2.02 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.276 -0.89 . . . . 0.0 112.553 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.04 7.43 36.47 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.255 -0.903 . . . . 0.0 112.433 162.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -138.38 111.64 7.99 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.234 1.413 . . . . 0.0 110.052 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.18 177.55 7.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.183 1.793 . . . . 0.0 110.848 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.65 160.96 15.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.395 3.078 . . . . 0.0 105.389 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.52 -101.63 2.73 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.04 -57.49 1.78 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.187 1.795 . . . . 0.0 108.017 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.1 74.58 0.22 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 124.486 1.041 . . . . 0.0 111.928 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tp -43.74 -41.78 5.08 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.972 2.109 . . . . 0.0 110.259 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.85 56.08 1.87 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.786 2.034 . . . . 0.0 107.985 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.46 129.86 41.5 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 164.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.29 87.13 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.069 0.842 . . . . 0.0 115.17 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.71 170.8 14.72 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.297 1.439 . . . . 0.0 110.61 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.65 101.82 2.01 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.856 1.662 . . . . 0.0 107.765 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.11 169.06 18.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.104 0.562 . . . . 0.0 111.409 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.31 146.19 26.03 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.007 1.323 . . . . 0.0 110.609 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.5 mt -112.01 96.49 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 128.363 2.665 . . . . 0.0 109.92 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.7 m -83.68 134.54 34.77 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.002 -1.061 . . . . 0.0 112.06 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.8 157.87 74.08 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 126.09 1.756 . . . . 0.0 109.443 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.96 148.86 64.73 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 CA-C-N 121.878 1.706 . . . . 0.0 111.15 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.99 -35.95 64.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.971 0.909 . . . . 0.0 112.014 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -67.8 -20.81 65.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.253 1.821 . . . . 0.0 111.852 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -112.41 -0.28 15.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.118 1.367 . . . . 0.0 112.4 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.23 -34.63 76.86 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.111 -0.993 . . . . 0.0 111.852 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -83.25 -33.05 26.13 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.187 0.995 . . . . 0.0 109.847 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.52 -63.31 1.16 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.235 2.214 . . . . 0.0 111.282 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -64.92 -37.13 86.62 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.848 0.459 . . . . 0.0 110.355 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.08 -24.79 67.83 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.445 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -85.72 -4.55 59.19 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.895 1.225 . . . . 0.0 113.067 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.01 150.05 47.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.108 1.322 . . . . 0.0 110.878 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.37 -44.57 90.95 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.455 -0.778 . . . . 0.0 110.281 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -83.28 -65.33 1.02 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.075 0.95 . . . . 0.0 109.271 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -58.0 -15.7 9.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -164.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -45.02 -43.79 9.52 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.567 1.076 . . . . 0.0 112.858 165.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -63.39 -14.57 51.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -113.56 14.97 19.05 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.377 -1.452 . . . . 0.0 111.663 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.1 3.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.423 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.58 -12.07 59.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.115 166.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -130.26 0.64 4.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.835 1.198 . . . . 0.0 112.805 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.9 mt -89.85 113.24 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -135.42 164.64 42.22 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 126.249 1.819 . . . . 0.0 110.444 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.56 164.24 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.026 1.817 . . . . 0.0 113.407 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 mtm . . . . . 0 N--CA 1.453 -0.286 0 C-N-CA 126.188 1.795 . . . . 0.0 109.261 161.809 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 CA--C 1.547 1.126 0 N-CA-C 107.954 -1.595 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.16 130.46 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 120.554 -1.341 . . . . 0.0 107.479 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.55 122.48 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 122.913 0.485 . . . . 0.0 110.301 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.12 81.33 0.21 Allowed Glycine 0 C--O 1.223 -0.559 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 68.0 mtp 58.82 -60.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.896 2.478 . . . . 0.0 114.351 -168.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.91 91.43 2.47 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.417 1.008 . . . . 0.0 108.351 -171.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -72.71 88.55 1.3 Allowed 'General case' 0 CA--C 1.519 -0.221 0 O-C-N 120.915 -1.116 . . . . 0.0 108.02 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -173.21 54.13 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.922 2.089 . . . . 0.0 109.686 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.15 61.51 0.45 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.814 1.246 . . . . 0.0 110.58 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -131.44 -44.47 1.01 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.223 0.609 . . . . 0.0 111.413 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.34 77.25 1.01 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.154 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.06 -28.0 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.612 -1.66 . . . . 0.0 113.859 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -117.98 87.88 2.8 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.224 2.012 . . . . 0.0 112.769 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.0 9.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 132.223 4.209 . . . . 0.0 118.108 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.87 19.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.72 1.608 . . . . 0.0 109.546 -166.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.04 113.44 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 166.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -95.86 -17.62 20.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.453 1.101 . . . . 0.0 111.444 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -148.31 134.0 18.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.93 0.769 . . . . 0.0 111.02 -160.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 mt -141.29 90.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.36 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.3 m -86.16 87.71 7.47 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.558 0.743 . . . . 0.0 109.087 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.09 164.26 3.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 O-C-N 121.003 -1.061 . . . . 0.0 108.852 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -126.23 165.54 27.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.959 1.303 . . . . 0.0 109.919 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.8 149.76 60.79 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.074 1.849 . . . . 0.0 111.026 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 48.48 66.03 1.18 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.191 2.996 . . . . 0.0 111.374 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.93 55.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 110.685 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.21 144.45 15.31 Favored Glycine 0 C--O 1.241 0.561 0 O-C-N 121.018 -1.051 . . . . 0.0 112.603 170.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.83 141.38 58.67 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.319 1.048 . . . . 0.0 108.445 171.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.43 77.83 2.99 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.495 1.118 . . . . 0.0 108.316 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -70.46 162.7 28.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.081 0.943 . . . . 0.0 111.12 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -70.23 113.57 7.53 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.582 1.953 . . . . 0.0 110.312 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.89 4.85 36.12 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.456 1.027 . . . . 0.0 114.156 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.7 mmm -48.2 -41.36 26.99 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.835 1.317 . . . . 0.0 112.824 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -112.27 18.75 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.789 1.236 . . . . 0.0 111.787 -165.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -60.22 121.2 11.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.89 12.9 65.47 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.204 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.4 m -80.03 63.52 4.58 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.855 1.327 . . . . 0.0 110.296 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.5 p -63.47 -13.74 43.64 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -164.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.14 -1.35 29.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.47 -1.393 . . . . 0.0 113.029 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.78 108.74 14.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 110.313 -171.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -126.46 -10.12 6.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -135.9 143.15 44.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.949 1.299 . . . . 0.0 111.837 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.46 140.31 35.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.237 2.215 . . . . 0.0 107.112 173.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -131.57 150.48 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -133.39 106.55 7.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.832 1.253 . . . . 0.0 109.627 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.2 p -82.27 45.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.886 0.766 . . . . 0.0 111.373 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -143.35 129.86 3.89 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.749 -1.219 . . . . 0.0 111.08 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.45 3.3 47.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.469 2.307 . . . . 0.0 112.753 -163.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.04 144.22 34.25 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 120.531 -1.356 . . . . 0.0 108.477 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -67.03 -33.48 31.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.735 1.623 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -62.24 -20.67 64.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.033 0.933 . . . . 0.0 112.541 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 9.82 0.43 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.956 1.702 . . . . 0.0 113.568 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.54 -177.07 5.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 109.46 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 t -145.65 -177.04 5.37 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.334 1.454 . . . . 0.0 108.847 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.82 6.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 128.492 2.717 . . . . 0.0 107.947 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.23 -171.21 24.92 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 151.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.4 -51.52 43.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.21 58.37 5.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.507 1.051 . . . . 0.0 112.095 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.8 tp -44.94 -35.01 2.64 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.398 1.879 . . . . 0.0 112.048 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 29.86 4.22 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 119.821 -1.799 . . . . 0.0 112.087 178.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.87 135.36 15.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.666 0.666 . . . . 0.0 111.101 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.06 -18.7 52.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.267 0.937 . . . . 0.0 112.889 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.0 -178.51 4.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.81 1.644 . . . . 0.0 109.461 173.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -160.91 104.58 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -133.52 168.12 19.22 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.801 0.84 . . . . 0.0 111.603 -169.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -85.61 145.42 27.35 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.994 0.918 . . . . 0.0 112.092 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -105.8 143.51 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.872 2.469 . . . . 0.0 108.986 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -127.87 138.59 52.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.044 1.338 . . . . 0.0 108.986 171.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.22 164.51 42.4 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.951 2.101 . . . . 0.0 108.376 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.62 147.74 82.23 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.816 1.684 . . . . 0.0 109.446 171.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -51.28 -33.48 28.78 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.63 -26.41 67.81 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.336 1.454 . . . . 0.0 110.689 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.78 -4.88 25.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.581 1.552 . . . . 0.0 112.21 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.75 -54.32 45.77 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.878 1.217 . . . . 0.0 112.081 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.72 -33.78 76.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.447 0.699 . . . . 0.0 110.068 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -59.83 -52.75 64.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.534 1.534 . . . . 0.0 111.816 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -58.85 -40.73 85.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.502 0.721 . . . . 0.0 110.027 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 -70.9 -16.91 62.71 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.89 5.38 45.35 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.95 1.25 . . . . 0.0 112.713 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.47 178.15 0.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.701 1.6 . . . . 0.0 113.039 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.4 -20.25 17.93 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.6 -1.313 . . . . 0.0 112.33 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -113.03 -53.94 2.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.684 1.129 . . . . 0.0 110.656 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -58.53 -15.64 12.07 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -46.07 -43.82 14.94 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 115.443 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -44.91 75.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.033 1.288 . . . . 0.0 108.564 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.1 5.74 6.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 112.823 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.51 -21.22 66.2 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.949 1.249 . . . . 0.0 111.769 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -10.58 19.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -119.48 4.55 11.16 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 124.623 1.169 . . . . 0.0 111.563 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.7 mt -97.13 100.97 11.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -119.23 165.14 18.01 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.18 0.992 . . . . 0.0 112.571 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.29 169.1 22.41 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.508 2.805 . . . . 0.0 112.534 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.2 mtm . . . . . 0 CA--C 1.54 0.581 0 C-N-CA 127.162 2.185 . . . . 0.0 111.758 171.432 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 CA--C 1.541 0.831 0 N-CA-C 109.685 -0.929 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.65 153.15 27.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.639 -1.288 . . . . 0.0 109.548 -168.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -92.81 61.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.77 -83.93 0.09 OUTLIER Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.4 mtp -140.18 -35.58 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.89 130.82 44.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.024 1.284 . . . . 0.0 111.939 -172.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -91.98 95.38 9.77 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.92 -52.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 108.334 173.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 8.41 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.589 2.356 . . . . 0.0 117.339 -171.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -89.26 -0.59 57.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.916 1.235 . . . . 0.0 113.736 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.55 86.5 2.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.474 1.034 . . . . 0.0 109.741 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.41 -26.98 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 117.608 -1.662 . . . . 0.0 114.741 167.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -95.65 99.21 11.1 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.806 2.303 . . . . 0.0 110.116 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 p -65.57 19.61 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.051 2.941 . . . . 0.0 115.155 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.81 4.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 120.594 -1.316 . . . . 0.0 111.786 -159.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 tt -90.94 104.38 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 O-C-N 120.103 -1.623 . . . . 0.0 107.155 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -84.08 -15.9 45.72 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 117.667 -1.159 . . . . 0.0 111.835 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -138.83 129.75 26.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.249 0.931 . . . . 0.0 110.194 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.9 mt -129.89 97.87 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -79.4 115.18 18.88 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.411 -0.806 . . . . 0.0 109.118 171.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.49 125.33 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.145 1.778 . . . . 0.0 110.598 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.76 164.77 51.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 170.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.43 162.03 36.61 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.321 2.014 . . . . 0.0 108.738 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 46.79 53.08 10.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.191 1.396 . . . . 0.0 111.932 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.25 22.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.095 -1.003 . . . . 0.0 113.023 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.63 160.36 9.11 Favored Glycine 0 CA--C 1.521 0.437 0 O-C-N 120.843 -1.161 . . . . 0.0 111.028 165.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.9 tp -72.25 129.09 37.6 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.963 -1.316 . . . . 0.0 108.418 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -85.52 87.83 7.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.69 -166.62 0.58 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.302 0.641 . . . . 0.0 109.375 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.93 148.26 36.47 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 2.59 90.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.1 -1.389 . . . . 0.0 116.312 164.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -34.93 70.34 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.483 2.142 . . . . 0.0 110.107 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.06 17.51 22.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.685 1.594 . . . . 0.0 111.196 -172.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 t -57.16 109.78 0.72 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.55 0.99 46.73 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.631 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -79.02 66.63 4.51 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.538 2.169 . . . . 0.0 110.203 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.0 p -66.04 -6.61 13.48 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.652 1.981 . . . . 0.0 113.695 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.82 25.81 3.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.829 1.252 . . . . 0.0 110.887 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.8 135.19 47.98 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 171.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.6 -25.09 1.03 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.256 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.05 154.92 43.73 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.554 1.941 . . . . 0.0 110.88 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.45 147.7 27.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.32 2.248 . . . . 0.0 105.311 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.29 142.81 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.5 mt -121.12 116.19 24.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.858 0.863 . . . . 0.0 110.212 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.7 p -86.25 3.22 44.12 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.628 0.974 . . . . 0.0 113.628 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.93 162.17 23.92 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 120.802 -1.186 . . . . 0.0 110.931 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -110.61 3.25 19.21 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -164.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -152.6 144.66 16.7 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.119 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.53 -23.25 64.52 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.397 2.731 . . . . 0.0 112.87 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -60.95 -23.75 65.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.395 0.998 . . . . 0.0 112.143 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.84 4.87 17.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.134 0.973 . . . . 0.0 113.151 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -134.9 170.58 15.65 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 126.8 2.04 . . . . 0.0 110.027 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 m -122.16 -176.56 3.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.147 1.379 . . . . 0.0 109.027 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 174.72 -17.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.884 1.674 . . . . 0.0 113.02 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 47.35 -97.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 128.24 2.829 . . . . 0.0 111.349 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.27 14.78 1.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.233 1.413 . . . . 0.0 109.896 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.05 14.09 3.31 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 117.474 -1.736 . . . . 0.0 115.251 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 tt -44.22 -51.62 8.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.822 2.311 . . . . 0.0 111.874 -165.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -86.09 -7.36 58.65 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 116.975 -1.488 . . . . 0.0 114.823 -171.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.2 118.3 4.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.967 0.803 . . . . 0.0 111.11 -152.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.51 -9.28 38.14 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.823 1.677 . . . . 0.0 114.266 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.57 -174.38 3.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.147 1.474 . . . . 0.0 114.064 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -151.0 115.66 5.18 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 131.453 3.901 . . . . 0.0 103.749 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -147.91 -175.11 4.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.392 1.077 . . . . 0.0 109.972 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.7 tp -127.64 148.4 50.38 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.346 -1.471 . . . . 0.0 110.035 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -110.72 136.87 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.036 2.134 . . . . 0.0 107.77 -173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 33.7 m -123.43 122.62 38.73 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.994 2.117 . . . . 0.0 110.813 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.88 158.79 58.86 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 107.29 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -69.77 153.57 68.72 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.32 -32.54 73.31 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -27.03 66.65 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.39 0.541 . . . . 0.0 110.445 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -92.74 -7.82 45.55 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.167 -0.958 . . . . 0.0 111.857 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 tp -62.04 -55.94 24.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.104 1.775 . . . . 0.0 111.517 -162.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.72 -30.03 70.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.737 -0.602 . . . . 0.0 110.691 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -59.21 -31.58 69.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.178 1.391 . . . . 0.0 112.475 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -77.69 -41.5 37.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.342 0.974 . . . . 0.0 110.497 166.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -65.98 -27.06 67.86 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 0.0 113.506 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -77.12 -3.07 37.49 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.157 -0.965 . . . . 0.0 111.819 173.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 130.45 35.04 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 121.026 1.739 . . . . 0.0 107.902 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.67 -38.15 90.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.09 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.42 -61.77 1.65 Allowed 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.601 0.637 . . . . 0.0 110.378 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -58.52 -9.1 1.45 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.32 -47.78 6.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.083 0.953 . . . . 0.0 111.908 163.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 t -61.11 -17.92 55.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.576 0.751 . . . . 0.0 111.272 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -113.14 5.61 17.14 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.614 1.966 . . . . 0.0 113.755 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.46 -24.95 65.64 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.946 1.248 . . . . 0.0 111.548 -171.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.09 -13.98 62.63 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -123.33 17.03 9.81 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.632 1.106 . . . . 0.0 111.546 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -103.73 123.07 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.01 166.04 29.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.553 1.941 . . . . 0.0 110.917 173.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.22 174.19 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.317 2.678 . . . . 0.0 112.006 169.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 mtm . . . . . 0 N--CA 1.463 0.185 0 C-N-CA 125.74 1.616 . . . . 0.0 111.562 170.006 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 N-CA-C 108.793 -1.272 . . . . 0.0 108.793 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.97 154.84 19.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 120.687 -1.258 . . . . 0.0 108.013 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.45 155.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 123.932 0.77 . . . . 0.0 109.189 165.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.4 -70.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 36.2 mtp -146.54 -51.98 0.22 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.245 1.418 . . . . 0.0 109.499 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -84.67 113.96 21.67 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.505 0.722 . . . . 0.0 109.695 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 27.2 mmtp -75.28 6.93 3.87 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -85.94 5.11 34.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -104.18 4.9 34.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -159.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -85.85 -57.28 3.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.364 0.984 . . . . 0.0 110.506 -165.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.47 85.21 0.28 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.019 2.528 . . . . 0.0 110.643 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.2 -17.72 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.934 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.04 114.9 28.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.378 1.589 . . . . 0.0 110.797 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 p -73.2 -0.66 14.95 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.597 -1.314 . . . . 0.0 114.173 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.84 -8.89 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 120.305 1.411 . . . . 0.0 110.8 -152.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 tt -65.16 99.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 127.637 2.375 . . . . 0.0 108.103 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -85.95 -10.0 55.91 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.739 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -141.43 134.98 29.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.286 0.948 . . . . 0.0 108.839 -172.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.03 122.55 49.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -83.09 141.17 32.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 160.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.7 143.31 32.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 124.147 0.979 . . . . 0.0 108.367 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -92.78 164.28 22.69 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 110.226 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.81 171.25 14.85 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.634 2.223 . . . . 0.0 110.007 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 48.68 35.39 6.19 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.601 1.96 . . . . 0.0 113.91 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.506 ' O ' ' HE3' ' A' ' 13' ' ' LYS 0.255 5.4 tt -131.53 63.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 122.634 1.207 . . . . 0.0 112.432 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.64 159.56 32.05 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.153 1.358 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.1 168.54 8.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.8 1.24 . . . . 0.0 111.671 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.1 mt -133.2 84.78 2.16 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -84.43 162.05 20.09 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.061 0.391 . . . . 0.0 110.726 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.18 126.03 26.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.371 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.49 11.44 64.21 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.692 -1.06 . . . . 0.0 114.693 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -62.38 -32.94 73.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.22 2.01 . . . . 0.0 112.415 172.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -107.02 29.3 7.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.027 1.731 . . . . 0.0 110.996 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 t -66.12 102.83 0.87 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.78 48.32 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.828 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.09 63.37 1.8 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.78 1.79 . . . . 0.0 109.618 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 p -73.62 -12.51 60.77 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -158.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.42 13.8 19.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.857 1.208 . . . . 0.0 112.131 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.32 117.59 8.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -126.94 -8.65 6.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -148.33 148.55 30.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.18 0.992 . . . . 0.0 112.282 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tp -151.39 100.49 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.88 138.15 21.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 mt -123.48 129.85 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.051 0.94 . . . . 0.0 108.976 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 p -113.67 35.58 3.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.173 0.989 . . . . 0.0 111.409 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.62 139.9 11.35 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.1 4.13 21.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -163.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -151.75 144.49 16.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 120.64 -1.288 . . . . 0.0 109.423 -164.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -37.97 3.05 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.152 2.568 . . . . 0.0 113.241 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -74.95 -7.04 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.012 0.824 . . . . 0.0 112.095 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.08 -10.93 59.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.031 0.932 . . . . 0.0 112.237 165.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -97.71 173.11 7.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 123.263 1.506 . . . . 0.0 110.709 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -164.39 1.08 Allowed 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 129.111 2.964 . . . . 0.0 106.869 169.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 77.05 142.64 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 130.223 3.409 . . . . 0.0 110.567 -169.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.91 -31.63 0.02 OUTLIER Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.214 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.5 -45.33 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.276 2.231 . . . . 0.0 110.235 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.44 71.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.554 -1.137 . . . . 0.0 112.248 -162.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.1 tp -44.63 -63.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.276 1.038 . . . . 0.0 110.766 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.6 -9.74 59.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 116.916 -1.516 . . . . 0.0 112.311 -164.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -45.29 112.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.954 1.302 . . . . 0.0 110.497 -157.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.08 -6.06 28.89 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.606 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.31 173.26 13.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.223 1.809 . . . . 0.0 110.73 168.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -140.48 81.91 1.83 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.167 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -95.26 -176.79 3.91 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.197 1.399 . . . . 0.0 109.023 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.85 157.86 28.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 107.515 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.5 139.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.637 1.175 . . . . 0.0 108.814 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.26 135.36 54.21 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.533 1.133 . . . . 0.0 110.126 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -136.74 155.29 76.7 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 126.166 1.786 . . . . 0.0 107.036 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 153.71 71.22 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 121.536 1.584 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.09 -30.2 66.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.1 -29.69 69.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.322 1.049 . . . . 0.0 111.326 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.09 -11.63 22.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.33 1.052 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 tp -57.68 -52.06 66.97 Favored 'General case' 0 C--O 1.228 -0.055 0 O-C-N 121.108 -0.995 . . . . 0.0 110.45 -170.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -27.38 68.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -59.11 5.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.442 1.497 . . . . 0.0 109.551 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -63.01 -26.62 68.94 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.556 1.071 . . . . 0.0 111.414 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -17.17 61.45 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -103.26 -9.43 19.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.637 1.108 . . . . 0.0 113.612 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.97 151.27 26.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.489 1.116 . . . . 0.0 111.831 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.64 -50.74 72.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.014 -0.429 . . . . 0.0 111.679 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -82.94 -60.68 2.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 108.936 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -60.06 -15.63 24.63 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -43.96 -49.5 8.51 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 120.105 1.32 . . . . 0.0 112.98 164.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 t -57.19 -31.3 65.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -93.8 15.86 15.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.806 1.242 . . . . 0.0 112.658 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.71 65.69 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.016 -1.677 . . . . 0.0 112.18 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.44 38.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.112 0.965 . . . . 0.0 112.979 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -127.43 21.07 6.66 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.87 106.95 21.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 119.898 1.226 . . . . 0.0 108.739 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.62 164.86 26.03 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.088 1.755 . . . . 0.0 111.161 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.55 163.0 36.62 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.66 2.24 . . . . 0.0 112.211 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.7 mtt . . . . . 0 N--CA 1.454 -0.254 0 C-N-CA 124.859 1.264 . . . . 0.0 109.581 163.325 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 CA--C 1.542 0.898 0 N-CA-C 109.816 -0.879 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.54 146.79 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 108.062 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -86.03 99.54 7.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.06 86.82 0.18 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 167.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.3 mtp 57.89 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 129.309 3.044 . . . . 0.0 118.241 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -110.44 97.07 6.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 121.69 2.041 . . . . 0.0 111.034 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -73.16 28.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.921 1.288 . . . . 0.0 113.221 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.71 28.47 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.626 1.103 . . . . 0.0 111.671 -168.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -125.1 1.94 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.11 1.364 . . . . 0.0 113.562 -171.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.504 ' C ' ' H ' ' A' ' 18' ' ' GLY . 26.4 m-85 -91.67 -36.3 13.7 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.321 -0.862 . . . . 0.0 111.418 -162.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.53 14.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.458 2.303 . . . . 0.0 114.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -114.58 -13.54 9.51 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.328 1.918 . . . . 0.0 113.848 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -120.86 107.13 12.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.215 2.007 . . . . 0.0 111.894 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.4 p -79.09 9.62 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.013 1.725 . . . . 0.0 114.355 -168.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.7 -4.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.146 -170.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.35 104.32 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -81.74 -15.62 53.75 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 117.954 -1.022 . . . . 0.0 111.13 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -143.44 126.03 15.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.002 0.921 . . . . 0.0 109.452 -162.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 88.0 mt -133.15 103.98 6.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.4 m -75.03 139.77 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 166.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.02 165.45 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.57 1.948 . . . . 0.0 108.024 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.08 165.87 23.57 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 108.992 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.65 162.52 41.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.928 1.752 . . . . 0.0 110.167 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 48.51 19.43 0.23 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.141 2.177 . . . . 0.0 114.549 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 tp -95.06 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 119.895 -1.753 . . . . 0.0 110.758 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.76 151.23 21.33 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 121.14 -0.975 . . . . 0.0 111.728 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.3 tp -70.44 138.47 51.24 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 121.769 0.795 . . . . 0.0 110.293 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.27 99.9 11.9 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 164.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -75.02 165.14 25.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.0 134.62 35.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.833 -1.167 . . . . 0.0 108.352 173.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.17 -0.07 71.58 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.928 1.252 . . . . 0.0 113.204 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -48.75 -44.03 38.23 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.457 2.303 . . . . 0.0 112.676 173.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -95.64 9.83 38.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.598 0.759 . . . . 0.0 112.668 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -58.24 113.65 2.04 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.651 1.114 . . . . 0.0 109.861 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.54 -0.29 53.1 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.004 -1.442 . . . . 0.0 113.721 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.5 m -74.74 67.64 1.61 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.916 1.858 . . . . 0.0 109.284 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -75.17 10.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.389 1.876 . . . . 0.0 113.66 -168.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.32 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.113 0.965 . . . . 0.0 112.943 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.48 118.9 10.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.673 1.579 . . . . 0.0 109.68 -175.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -126.08 -11.59 6.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.313 0.645 . . . . 0.0 111.785 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.81 146.6 25.19 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.168 1.349 . . . . 0.0 111.322 -173.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.33 141.28 25.9 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.542 1.937 . . . . 0.0 106.417 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.25 141.27 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.1 mt -122.74 103.87 8.94 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 109.369 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.8 p -77.53 39.24 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.456 1.502 . . . . 0.0 113.216 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.83 153.52 25.36 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 119.824 -1.798 . . . . 0.0 110.495 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -108.32 4.38 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -158.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.44 144.6 40.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.219 1.008 . . . . 0.0 111.37 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.28 -22.27 5.93 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.3 2.667 . . . . 0.0 115.383 -172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 m -64.95 -36.83 85.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.057 1.299 . . . . 0.0 109.822 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.81 7.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -126.54 128.42 46.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.373 1.069 . . . . 0.0 109.575 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 167.04 13.41 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.221 1.009 . . . . 0.0 110.817 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.88 167.67 16.56 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.117 2.167 . . . . 0.0 108.537 153.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.84 -177.45 40.97 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 158.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -51.76 -44.86 63.51 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.3 1.44 . . . . 0.0 109.847 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.26 82.09 0.3 Allowed Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 127.233 2.349 . . . . 0.0 109.738 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.8 tp -51.53 -63.47 1.12 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.16 0.984 . . . . 0.0 109.623 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.47 17.12 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.121 1.368 . . . . 0.0 112.165 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.26 127.18 28.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.797 0.726 . . . . 0.0 109.244 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.33 81.48 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.249 0.928 . . . . 0.0 113.762 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.54 -164.41 1.82 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.72 2.008 . . . . 0.0 107.402 170.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -167.73 99.37 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 167.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -131.52 168.81 17.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.022 1.329 . . . . 0.0 109.486 -168.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -98.18 152.82 18.96 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.147 1.379 . . . . 0.0 109.653 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.88 138.63 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 0.0 109.458 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -127.52 145.13 50.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.221 1.008 . . . . 0.0 110.014 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.12 158.77 74.95 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 108.58 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -67.17 148.85 81.53 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 CA-C-N 120.938 1.371 . . . . 0.0 110.229 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.4 -22.54 63.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -81.07 -22.85 38.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.022 1.329 . . . . 0.0 112.128 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.71 -1.58 32.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.151 1.38 . . . . 0.0 111.889 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.02 -47.39 83.19 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.769 -0.582 . . . . 0.0 112.019 -165.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.91 -43.67 78.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.443 0.297 . . . . 0.0 110.783 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -46.86 -55.0 8.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.19 1.396 . . . . 0.0 111.61 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -63.44 -41.47 98.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.012 0.824 . . . . 0.0 110.584 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -64.78 -16.09 62.55 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.312 -0.868 . . . . 0.0 112.475 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -101.11 15.55 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.262 1.825 . . . . 0.0 112.817 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 28.7 t70 -76.3 179.29 5.88 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.62 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.405 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 8.8 t80 -106.71 -29.33 9.64 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.609 1.964 . . . . 0.0 112.859 175.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.01 -56.2 2.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.772 0.829 . . . . 0.0 108.764 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -61.57 -10.71 8.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.743 -172.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.308 0.3 OUTLIER -43.89 -57.63 3.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.765 1.226 . . . . 0.0 113.373 168.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.6 t -69.86 -9.87 56.42 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.688 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -104.73 1.32 29.19 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.645 -1.285 . . . . 0.0 111.927 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.45 -3.86 12.85 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 119.671 -1.893 . . . . 0.0 112.585 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.82 -14.05 60.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.169 1.387 . . . . 0.0 112.375 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -127.78 34.96 4.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.203 1.401 . . . . 0.0 109.845 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -109.45 139.0 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.65 163.86 43.84 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.851 1.66 . . . . 0.0 110.127 166.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.92 149.04 91.49 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.86 1.707 . . . . 0.0 110.148 167.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ptp . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 124.641 1.177 . . . . 0.0 108.729 173.208 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 N-CA-C 107.298 -1.847 . . . . 0.0 107.298 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -150.1 147.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 120.448 -1.407 . . . . 0.0 107.92 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 t -78.8 101.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.43 -75.52 0.58 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -51.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.379 1.872 . . . . 0.0 111.365 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -87.36 172.44 9.84 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -126.31 3.98 7.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.533 1.133 . . . . 0.0 113.939 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -83.38 -28.77 28.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.02 23.65 0.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.887 1.275 . . . . 0.0 113.733 -157.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.98 -47.34 5.57 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.088 -1.008 . . . . 0.0 110.57 -171.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.31 1.444 . . . . 0.0 108.054 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.61 -23.44 0.09 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.821 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -108.64 105.22 14.74 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.748 2.274 . . . . 0.0 111.56 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -68.81 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.908 2.483 . . . . 0.0 113.055 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.96 -9.28 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.884 1.274 . . . . 0.0 111.538 -163.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.2 tt -77.48 96.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 120.897 -1.127 . . . . 0.0 108.8 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -75.07 -16.12 60.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.18 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -149.19 134.81 18.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.601 0.761 . . . . 0.0 109.53 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.4 114.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.0 m -89.82 137.72 32.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 t -130.77 121.37 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.935 1.694 . . . . 0.0 108.268 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -77.09 160.85 75.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.401 0.546 . . . . 0.0 110.798 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -75.49 159.9 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.723 2.282 . . . . 0.0 110.83 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 54.9 37.13 28.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.883 1.673 . . . . 0.0 113.007 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.292 3.7 tt -133.4 25.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.675 1.19 . . . . 0.0 112.205 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.61 159.3 8.15 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 127.132 2.301 . . . . 0.0 111.529 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.8 tp -71.96 126.15 29.03 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 124.306 1.042 . . . . 0.0 110.065 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.95 78.42 7.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -68.89 168.18 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.083 0.944 . . . . 0.0 111.548 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -75.54 137.42 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.59 -1.944 . . . . 0.0 108.667 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.34 3.4 90.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.101 0.858 . . . . 0.0 113.937 -174.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.1 ttp -59.77 -25.15 64.66 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 120.158 1.979 . . . . 0.0 113.364 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -114.4 15.69 17.9 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.848 1.259 . . . . 0.0 111.594 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 58.6 m -48.33 119.28 2.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 111.371 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.56 6.95 85.27 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.297 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.96 73.77 0.61 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.609 2.204 . . . . 0.0 107.092 163.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.6 p -65.31 -51.99 56.97 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.43 1.092 . . . . 0.0 111.532 -167.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.62 3.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.921 1.289 . . . . 0.0 113.957 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.2 tp -76.85 108.28 9.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.279 1.032 . . . . 0.0 110.129 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.62 -12.45 9.74 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.551 169.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -119.14 142.54 47.85 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.522 1.055 . . . . 0.0 113.236 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -146.53 136.57 23.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.94 137.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.2 113.75 22.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 p -83.97 0.38 48.2 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.33 179.05 41.96 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.216 0.912 . . . . 0.0 110.992 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.96 6.26 4.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.017 0.927 . . . . 0.0 112.63 -169.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -141.99 143.82 29.75 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.658 1.583 . . . . 0.0 107.721 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.53 -30.73 4.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.317 2.011 . . . . 0.0 112.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -77.07 -15.84 59.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 111.824 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.64 12.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.441 1.496 . . . . 0.0 112.804 165.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -124.33 168.55 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.252 1.021 . . . . 0.0 110.07 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -141.78 133.68 27.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.61 172.69 9.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.322 2.249 . . . . 0.0 106.388 172.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.73 -145.04 8.1 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.342 1.925 . . . . 0.0 109.361 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.01 -8.86 58.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.782 -0.834 . . . . 0.0 113.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.98 68.23 0.27 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -170.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 tp -46.14 -44.02 15.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.204 1.402 . . . . 0.0 111.022 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -113.7 16.75 18.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.016 0.926 . . . . 0.0 111.419 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.67 146.24 52.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.861 0.755 . . . . 0.0 110.808 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 76.47 -1.02 62.56 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.753 1.168 . . . . 0.0 113.825 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.27 -175.46 4.18 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 128.921 2.888 . . . . 0.0 107.456 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -156.56 94.49 1.48 Allowed 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.812 -1.18 . . . . 0.0 110.737 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -125.21 163.4 22.57 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.112 0.965 . . . . 0.0 111.134 -171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.68 152.39 18.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 108.113 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.4 mt -122.08 101.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -167.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.2 m -87.78 138.05 31.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.365 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.16 155.28 72.62 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.42 1.888 . . . . 0.0 109.7 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.84 144.54 53.91 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 CA-C-N 121.432 1.547 . . . . 0.0 109.46 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -55.24 -32.78 62.57 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -67.33 -18.24 65.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.224 3.01 . . . . 0.0 112.159 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.46 -0.19 19.01 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.83 -1.168 . . . . 0.0 113.135 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 tp -62.7 -50.27 71.8 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.172 0.896 . . . . 0.0 111.351 -168.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.61 -43.21 99.28 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.8 -56.28 9.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.525 1.93 . . . . 0.0 111.795 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -70.61 -40.22 73.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.292 0.496 . . . . 0.0 109.744 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -62.7 -25.41 68.15 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 121.208 -0.933 . . . . 0.0 112.565 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -85.14 -13.69 49.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.275 1.43 . . . . 0.0 112.679 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 87' ' ' PHE . 29.1 t70 -66.73 143.1 57.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.443 0.565 . . . . 0.0 111.553 -160.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.89 24.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.133 2.573 . . . . 0.0 113.439 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -153.23 -67.32 0.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.983 2.513 . . . . 0.0 107.207 173.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -58.6 -16.96 18.19 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -167.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -44.08 -45.01 7.88 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.499 1.52 . . . . 0.0 113.775 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -69.36 -6.15 28.03 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.77 15.81 14.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.04 1.291 . . . . 0.0 111.567 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.66 66.55 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.48 -1.388 . . . . 0.0 110.707 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.28 3.28 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -127.29 4.74 6.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.878 1.217 . . . . 0.0 111.889 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.85 123.65 46.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -136.06 162.42 56.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.771 0.828 . . . . 0.0 111.508 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.75 149.16 91.43 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.315 2.677 . . . . 0.0 114.208 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.557 166.127 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 CA--C 1.541 0.858 0 CA-C-O 121.63 0.596 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.34 165.42 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 108.791 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.268 7.0 p -110.57 68.23 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.28 1.038 . . . . 0.0 109.826 -161.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.75 79.62 0.26 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 125.766 1.651 . . . . 0.0 109.791 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.2 10.07 1.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.786 2.034 . . . . 0.0 114.388 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.59 122.68 15.67 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.878 1.217 . . . . 0.0 110.225 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -105.29 90.94 3.58 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.391 1.476 . . . . 0.0 107.066 168.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.46 10.43 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 175.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -131.67 1.28 4.02 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.782 -1.199 . . . . 0.0 113.053 -160.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.24 -36.66 16.61 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.664 -0.647 . . . . 0.0 111.573 -163.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 43.87 0.09 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.905 2.082 . . . . 0.0 112.255 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.82 -27.46 0.37 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.381 -1.233 . . . . 0.0 113.352 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -106.78 94.15 4.96 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.438 1.619 . . . . 0.0 110.63 -173.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.5 p -64.24 22.04 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 129.537 3.135 . . . . 0.0 115.107 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.29 7.56 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 O-C-N 119.861 -1.774 . . . . 0.0 110.074 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.94 98.55 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.241 -1.537 . . . . 0.0 107.147 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -71.29 -26.36 62.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.744 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -136.79 120.72 17.57 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.432 0.56 . . . . 0.0 111.218 -160.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mt -122.29 89.96 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 m -66.82 130.93 44.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 161.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.1 155.4 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.328 1.851 . . . . 0.0 107.047 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -119.59 159.66 45.21 Favored Pre-proline 0 N--CA 1.452 -0.368 0 C-N-CA 124.809 1.243 . . . . 0.0 107.864 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.1 152.98 51.68 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.733 1.622 . . . . 0.0 111.196 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 59.85 21.38 10.29 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.524 1.93 . . . . 0.0 113.849 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.25 93.86 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 124.505 2.097 . . . . 0.0 107.198 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.49 138.62 5.21 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 127.27 2.367 . . . . 0.0 113.28 161.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -58.47 130.23 45.77 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mt -88.07 123.37 32.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -133.99 176.56 8.46 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.57 1.148 . . . . 0.0 109.407 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -72.42 152.07 42.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.545 1.164 . . . . 0.0 111.512 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 66.13 -3.67 3.07 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.085 1.326 . . . . 0.0 114.425 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 39' ' ' PHE . 3.6 tmm? -57.74 -32.56 67.56 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.805 . . . . 0.0 112.094 -170.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 38' ' ' MET . 59.7 m-85 -102.49 -5.92 23.48 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.406 1.482 . . . . 0.0 113.468 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 t -54.23 124.78 16.83 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.342 0.974 . . . . 0.0 110.974 -164.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.31 9.24 48.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.764 1.173 . . . . 0.0 112.784 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.7 p -69.85 74.19 0.43 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.951 1.7 . . . . 0.0 111.93 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -58.16 -7.83 0.93 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.49 0.23 5.6 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.609 -1.186 . . . . 0.0 113.5 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.35 123.34 24.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.5 1.955 . . . . 0.0 112.383 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.08 8.66 0.95 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -146.09 126.24 13.81 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.347 -1.471 . . . . 0.0 109.374 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -120.68 139.78 52.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.23 146.75 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -121.86 136.33 54.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.384 1.474 . . . . 0.0 107.154 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 p -111.37 33.69 4.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.122 0.963 . . . . 0.0 111.246 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.85 161.66 20.22 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -113.75 4.17 15.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -157.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.99 147.81 19.46 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.466 1.03 . . . . 0.0 109.64 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.52 -27.51 70.04 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.042 3.161 . . . . 0.0 113.695 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m -72.58 -13.24 61.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.36 7.17 4.6 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.061 -1.024 . . . . 0.0 112.125 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -139.89 179.45 6.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.162 2.185 . . . . 0.0 109.336 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -139.25 179.4 6.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.977 2.111 . . . . 0.0 108.625 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -161.06 1.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.21 -108.14 0.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -150.69 38.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.747 1.619 . . . . 0.0 109.568 163.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.09 28.38 0.2 Allowed Glycine 0 C--O 1.225 -0.415 0 CA-C-O 118.043 -1.421 . . . . 0.0 114.285 -165.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tt -45.29 -41.97 9.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.55 1.675 . . . . 0.0 112.175 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -117.89 26.15 9.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.856 1.262 . . . . 0.0 112.071 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -58.55 141.64 51.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 110.151 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 -29.95 3.03 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.341 0.972 . . . . 0.0 112.389 -173.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.17 -179.82 4.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.269 1.828 . . . . 0.0 110.25 -175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -161.02 106.87 1.4 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.58 1.152 . . . . 0.0 107.973 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -139.13 167.27 22.43 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.245 1.418 . . . . 0.0 109.76 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.9 mt -89.92 141.93 28.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.949 1.299 . . . . 0.0 108.986 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 mt -90.19 138.12 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.627 1.971 . . . . 0.0 105.823 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.2 m -120.81 136.0 55.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.31 161.11 62.36 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 124.615 1.166 . . . . 0.0 107.997 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.04 147.7 84.68 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.997 1.035 . . . . 0.0 110.425 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -50.34 -37.2 35.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.236 1.014 . . . . 0.0 112.6 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -31.93 59.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.797 -0.565 . . . . 0.0 110.482 -170.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.23 -5.84 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.926 1.29 . . . . 0.0 112.302 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.4 tp -56.14 -38.04 70.28 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 112.12 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -69.8 -47.4 62.98 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.57 -0.706 . . . . 0.0 111.409 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -49.03 -53.28 20.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.136 1.774 . . . . 0.0 111.955 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -66.12 -42.6 88.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.288 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -57.1 -48.67 78.04 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.936 0.789 . . . . 0.0 111.657 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -68.87 -11.54 60.64 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.34 137.85 48.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.308 0.958 . . . . 0.0 111.218 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -61.4 -38.08 85.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.384 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.59 -66.73 0.66 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.369 1.068 . . . . 0.0 108.46 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -58.68 -23.17 58.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.563 -1.208 . . . . 0.0 112.232 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -44.7 -35.18 2.54 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -56.27 -41.1 75.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.085 0.402 . . . . 0.0 110.153 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -89.43 9.91 24.58 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 112.432 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.27 -22.06 66.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.083 -1.635 . . . . 0.0 112.393 -167.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.1 -19.16 64.17 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -113.43 5.27 16.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.891 0.769 . . . . 0.0 112.007 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.9 mt -86.98 134.05 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.471 1.508 . . . . 0.0 109.271 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.42 166.44 19.94 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.694 1.998 . . . . 0.0 111.51 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.7 175.83 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.002 2.468 . . . . 0.0 112.599 169.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 126.134 1.774 . . . . 0.0 109.39 174.491 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.543 0.928 0 N-CA-C 109.704 -0.922 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.56 165.57 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 126.379 1.871 . . . . 0.0 107.948 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.455 HG23 ' CE ' ' A' ' 13' ' ' LYS . 2.1 p -93.48 95.79 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.12 -84.99 1.5 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.8 mtp -128.38 -56.79 1.23 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.197 1.799 . . . . 0.0 109.954 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 115.93 23.42 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.34 -0.85 . . . . 0.0 110.49 -163.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -72.6 4.02 4.37 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -164.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.5 m -114.27 62.61 0.66 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.846 2.112 . . . . 0.0 112.33 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -133.9 4.47 3.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.402 1.081 . . . . 0.0 112.529 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.03 -55.96 3.25 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.443 1.497 . . . . 0.0 111.145 -167.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.28 92.57 0.04 OUTLIER 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.47 -6.04 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.199 -1.334 . . . . 0.0 112.988 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -139.34 144.85 38.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.056 1.928 . . . . 0.0 112.525 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.1 p -115.65 16.34 16.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.44 2.296 . . . . 0.0 113.264 -159.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.72 14.02 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 127.81 2.444 . . . . 0.0 111.254 -168.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tt -95.43 85.22 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 O-C-N 119.887 -1.758 . . . . 0.0 108.464 -165.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -87.51 18.14 4.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.032 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.95 145.92 26.75 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -137.19 104.25 3.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -70.13 144.26 52.1 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 162.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.6 123.01 35.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.19 161.82 66.52 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.809 -0.557 . . . . 0.0 109.909 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.79 167.2 26.76 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.583 2.189 . . . . 0.0 111.285 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 45.09 42.68 6.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.365 2.266 . . . . 0.0 114.411 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 tt -141.42 2.17 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.407 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . 178.16 130.47 1.41 Allowed Glycine 0 C--N 1.336 0.561 0 O-C-N 120.056 -1.653 . . . . 0.0 112.546 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 tp -59.09 136.67 58.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 164.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 5.5 mt -100.64 75.08 1.71 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.205 1.002 . . . . 0.0 109.408 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -75.03 163.22 27.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.96 0.504 . . . . 0.0 111.63 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -69.32 114.62 7.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.563 1.545 . . . . 0.0 110.517 175.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.54 -5.75 24.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.297 1.427 . . . . 0.0 112.761 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' A' ' 34' ' ' LEU . 16.6 mtp -50.17 -54.0 23.84 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.952 1.301 . . . . 0.0 111.796 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -98.29 9.9 41.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.624 1.17 . . . . 0.0 111.497 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.6 t -66.76 112.28 4.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.34 -4.38 37.79 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.838 0.732 . . . . 0.0 112.598 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -76.58 72.63 3.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.331 1.565 . . . . 0.0 108.508 168.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 p -72.87 4.05 4.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.266 2.226 . . . . 0.0 113.189 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 49.89 1.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.215 1.806 . . . . 0.0 107.667 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.3 tp -122.67 105.34 10.0 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.32 -11.43 7.93 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.583 1.177 . . . . 0.0 114.159 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -129.98 124.2 32.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -117.89 140.53 49.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.26 132.18 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -110.92 113.85 26.73 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.481 0.713 . . . . 0.0 109.263 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.69 12.8 6.54 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.45 177.22 27.04 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -136.48 29.9 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 109.261 -170.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.69 147.3 9.4 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.314 -0.866 . . . . 0.0 111.35 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.33 -42.84 9.35 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.706 2.938 . . . . 0.0 112.592 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -74.67 -15.31 60.81 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.377 -0.827 . . . . 0.0 112.759 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.79 -7.92 43.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.889 0.768 . . . . 0.0 113.06 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.41 -168.63 1.34 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.27 1.428 . . . . 0.0 109.579 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.9 m -145.62 172.69 12.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.552 1.541 . . . . 0.0 107.052 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.87 137.85 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.09 -165.39 11.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 156.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.57 -59.89 4.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.283 0.563 . . . . 0.0 109.536 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.72 65.75 3.49 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 125.021 1.296 . . . . 0.0 111.45 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.8 tp -45.07 -48.42 11.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.299 1.04 . . . . 0.0 110.719 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.94 36.69 2.78 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.567 -0.708 . . . . 0.0 111.108 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.66 121.2 12.2 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.445 -1.41 . . . . 0.0 110.029 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.73 10.18 81.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.08 171.89 13.45 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.674 1.237 . . . . 0.0 108.485 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -140.08 94.23 2.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 122.218 1.008 . . . . 0.0 108.299 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.59 165.04 16.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.272 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.8 mt -105.12 158.14 16.78 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.088 1.355 . . . . 0.0 109.051 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.78 101.39 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 127.089 2.155 . . . . 0.0 106.548 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.9 m -75.27 127.11 32.43 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.88 156.18 80.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 125.309 1.444 . . . . 0.0 107.116 172.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.59 143.16 67.48 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -51.61 -43.03 62.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.05 1.74 . . . . 0.0 110.568 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.91 -10.11 12.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.71 -4.66 12.16 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 125.139 1.376 . . . . 0.0 112.434 168.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.64 -59.1 5.93 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 121.286 1.857 . . . . 0.0 110.841 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.48 -18.05 61.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.457 0.646 . . . . 0.0 112.222 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -66.24 -45.06 81.96 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.462 2.305 . . . . 0.0 110.0 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -64.05 -49.91 70.47 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -56.27 -32.25 64.36 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.732 1.151 . . . . 0.0 113.947 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -80.69 2.27 26.65 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -64.13 167.04 6.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.393 1.092 . . . . 0.0 111.554 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.03 -45.61 60.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.746 0.818 . . . . 0.0 110.702 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -104.0 -47.93 4.04 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.048 0.939 . . . . 0.0 111.091 -162.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -55.03 -21.15 11.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.893 0.769 . . . . 0.0 112.188 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -46.15 -45.19 16.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.265 1.826 . . . . 0.0 113.099 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 t -64.56 -25.5 68.0 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.338 0.517 . . . . 0.0 110.297 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.28 9.34 38.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.24 1.816 . . . . 0.0 112.62 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -8.94 32.58 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.36 -1.463 . . . . 0.0 112.168 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.12 -18.62 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.471 1.032 . . . . 0.0 113.488 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -112.48 -4.3 14.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 112.629 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.44 134.23 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.62 160.08 55.1 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.153 0.981 . . . . 0.0 111.031 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.17 164.12 26.48 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 111.963 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 CA--C 1.533 0.3 0 C-N-CA 126.389 1.876 . . . . 0.0 111.645 176.305 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 N--CA 1.458 -0.611 0 N-CA-C 107.483 -1.776 . . . . 0.0 107.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.96 140.75 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.534 1.134 . . . . 0.0 108.163 -164.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -76.43 77.79 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.04 72.32 0.46 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.365 1.46 . . . . 0.0 110.086 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.39 9.49 2.02 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.467 1.907 . . . . 0.0 115.895 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -132.23 159.14 39.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.284 1.402 . . . . 0.0 109.374 158.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -138.46 31.92 2.32 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.392 1.477 . . . . 0.0 112.22 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.0 t -133.67 29.0 3.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.799 1.24 . . . . 0.0 110.882 175.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -115.4 2.72 13.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.161 1.785 . . . . 0.0 112.42 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.27 -41.07 11.77 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.967 -1.083 . . . . 0.0 110.926 -163.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.59 84.79 1.15 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.311 1.044 . . . . 0.0 109.759 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.06 -41.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -87.34 91.16 8.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.015 0.912 . . . . 0.0 112.37 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.2 p -70.94 33.48 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 128.425 2.69 . . . . 0.0 114.589 -171.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.0 1.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 120.352 -1.468 . . . . 0.0 112.319 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -71.9 83.89 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-O 121.975 0.893 . . . . 0.0 111.473 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -79.37 4.31 15.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.797 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -153.29 138.28 17.23 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.1 1.36 . . . . 0.0 108.427 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -134.66 126.0 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 167.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.5 m -102.49 122.15 43.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.12 112.49 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.96 1.304 . . . . 0.0 107.962 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -65.15 164.02 26.3 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.329 0.652 . . . . 0.0 110.491 167.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.24 154.97 68.98 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.216 1.944 . . . . 0.0 110.627 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.69 51.85 8.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.784 2.034 . . . . 0.0 113.109 171.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 tt -136.95 84.0 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 124.227 1.965 . . . . 0.0 107.808 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.82 149.48 0.11 Allowed Glycine 0 CA--C 1.525 0.682 1 C-N-CA 131.168 4.223 . . . . 0.0 113.014 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.334 0.0 OUTLIER -64.81 155.33 34.29 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.792 -0.828 . . . . 0.0 110.195 170.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.46 ' H ' ' HB2' ' A' ' 59' ' ' SER . 5.0 mt -102.15 123.09 45.4 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 168.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -122.53 175.51 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 111.306 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.9 126.4 27.88 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.419 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.45 46.81 93.6 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 mtp -70.64 -34.24 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.815 1.246 . . . . 0.0 110.805 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -114.84 29.85 7.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.088 1.355 . . . . 0.0 110.655 -167.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.3 t -61.73 109.69 1.3 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.891 0.876 . . . . 0.0 110.53 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.79 12.88 55.03 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.978 -0.901 . . . . 0.0 113.462 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -78.2 73.82 4.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.392 1.596 . . . . 0.0 109.441 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 p -68.06 -3.17 9.36 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.971 2.508 . . . . 0.0 113.5 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.68 53.43 1.85 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.486 1.514 . . . . 0.0 107.889 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 tp -129.63 111.78 13.03 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.607 1.563 . . . . 0.0 107.882 174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.77 8.95 3.06 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -137.3 152.7 50.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 O-C-N 120.878 -1.139 . . . . 0.0 110.503 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.8 tp -146.1 94.03 2.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.86 1.664 . . . . 0.0 107.169 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -82.71 141.52 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -128.18 118.05 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 p -88.48 -4.53 58.6 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -167.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.8 154.31 20.56 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 119.064 0.847 . . . . 0.0 112.111 -167.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.31 -2.82 58.49 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.37 148.1 39.42 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 120.288 1.403 . . . . 0.0 111.868 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.91 -23.61 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.23 2.62 . . . . 0.0 113.803 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 t -73.69 -21.18 60.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.698 1.599 . . . . 0.0 110.869 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.26 6.27 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.263 1.825 . . . . 0.0 113.031 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -141.72 175.36 9.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.261 1.824 . . . . 0.0 111.001 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.46 ' HB2' ' H ' ' A' ' 34' ' ' LEU . 3.8 m -135.12 -171.95 2.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.42 2.688 . . . . 0.0 108.584 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 177.1 -13.56 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.393 1.477 . . . . 0.0 113.425 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.22 -100.24 0.51 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.588 1.566 . . . . 0.0 110.134 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -140.39 -13.16 1.02 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.372 1.069 . . . . 0.0 111.299 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.08 42.8 0.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 124.007 0.813 . . . . 0.0 111.343 -159.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -44.47 -55.56 4.97 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.216 1.406 . . . . 0.0 111.569 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -98.33 12.38 35.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.931 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -64.32 158.28 23.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.266 0.939 . . . . 0.0 110.17 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.8 6.52 51.71 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.894 1.235 . . . . 0.0 114.695 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.26 -163.84 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.318 2.247 . . . . 0.0 107.499 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -155.74 112.29 3.16 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 120.456 -1.403 . . . . 0.0 110.051 164.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 175.42 8.02 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.56 1.144 . . . . 0.0 112.774 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.2 tp -111.04 155.75 22.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.954 2.502 . . . . 0.0 108.553 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.9 mt -117.76 138.9 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.462 1.105 . . . . 0.0 108.206 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.93 130.7 50.62 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.556 1.542 . . . . 0.0 107.686 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.74 160.18 68.66 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.18 144.54 69.33 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.44 -29.99 27.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.53 0.732 . . . . 0.0 111.477 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.05 -33.08 73.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.022 1.329 . . . . 0.0 112.29 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.53 -3.82 19.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.584 1.154 . . . . 0.0 112.391 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.88 -46.4 74.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.47 -36.93 60.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.04 -52.5 42.53 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 109.799 172.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.91 -42.03 97.51 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.868 0.867 . . . . 0.0 109.817 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -67.01 -11.61 57.51 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -110.12 18.13 20.3 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.027 1.731 . . . . 0.0 110.707 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -79.53 159.43 26.9 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.757 -1.214 . . . . 0.0 112.036 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -81.71 -35.47 29.74 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.124 -0.985 . . . . 0.0 112.103 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -90.96 -54.21 4.06 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.606 -0.684 . . . . 0.0 109.225 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -69.54 -12.51 61.71 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -47.43 -35.5 8.55 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 121.27 1.85 . . . . 0.0 115.158 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -63.15 -41.41 99.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.116 0.871 . . . . 0.0 111.181 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -75.94 3.77 9.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.221 1.008 . . . . 0.0 112.35 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.85 -19.87 65.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.678 -1.263 . . . . 0.0 112.024 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.5 -5.94 6.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.742 -1.123 . . . . 0.0 113.626 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -133.41 12.61 4.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.369 1.44 . . . . 0.0 112.474 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.3 mt -89.54 130.78 38.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -138.08 165.39 33.79 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 111.284 165.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 176.37 2.48 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.446 2.097 . . . . 0.0 111.36 168.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 125.731 1.613 . . . . 0.0 107.311 175.044 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 N-CA-C 110.397 -0.655 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -134.67 165.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -169.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.06 70.07 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.381 -0.824 . . . . 0.0 108.796 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.99 69.51 0.51 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.1 mtp 58.42 13.8 2.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.679 1.992 . . . . 0.0 115.61 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.27 172.07 13.38 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.301 1.41 . . . . 0.0 109.899 157.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.45 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 mmpt? -118.2 4.6 11.95 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.254 1.422 . . . . 0.0 113.422 -175.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -82.43 -23.93 34.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.395 1.452 . . . . 0.0 113.301 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.88 62.27 4.06 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.531 . . . . 0.0 111.999 -165.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -142.24 -49.06 0.36 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.686 -1.259 . . . . 0.0 112.13 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.77 66.06 2.0 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.476 1.11 . . . . 0.0 110.57 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 -34.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.587 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -94.9 80.58 3.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.413 1.606 . . . . 0.0 112.297 -168.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.5 p -62.34 24.21 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 130.869 3.668 . . . . 0.0 116.511 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.36 -14.48 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 128.552 2.741 . . . . 0.0 110.947 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -62.51 99.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 119.348 0.976 . . . . 0.0 110.099 -174.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -4.11 52.96 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.736 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -152.56 134.1 14.53 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 119.033 0.833 . . . . 0.0 112.163 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.5 108.88 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -81.0 146.53 30.63 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -139.65 115.0 8.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -66.5 164.2 34.06 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 118.202 0.455 . . . . 0.0 110.172 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.32 162.38 36.49 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.849 1.699 . . . . 0.0 110.848 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 44.7 56.47 5.17 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.187 2.595 . . . . 0.0 112.693 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.5 tt -144.69 71.12 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 124.282 1.992 . . . . 0.0 109.37 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.46 170.81 42.4 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 126.988 2.232 . . . . 0.0 112.416 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.4 tp -83.84 133.71 34.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.901 1.28 . . . . 0.0 110.638 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.42 122.1 28.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 159.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -126.75 175.51 7.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.817 1.247 . . . . 0.0 109.35 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.42 156.14 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.829 0.851 . . . . 0.0 110.237 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 63.75 -1.01 2.69 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.737 2.113 . . . . 0.0 115.307 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -29.65 60.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.013 1.725 . . . . 0.0 112.643 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -110.56 18.45 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.795 1.238 . . . . 0.0 113.373 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 t -56.91 105.54 0.23 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.776 0.831 . . . . 0.0 111.577 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.43 23.47 39.95 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.128 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -72.37 76.96 1.02 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.743 1.772 . . . . 0.0 109.182 164.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -71.79 15.68 0.14 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.816 2.446 . . . . 0.0 114.243 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.41 4.39 1.98 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 119.85 13.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.394 0.997 . . . . 0.0 110.631 -169.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -122.25 -35.21 3.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.31 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -121.06 141.91 50.32 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 122.021 2.192 . . . . 0.0 113.178 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.7 tp -119.74 138.99 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.916 2.487 . . . . 0.0 104.561 161.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.05 140.59 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -115.44 151.38 34.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -119.47 5.14 11.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 112.395 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.12 169.03 30.37 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 118.971 0.805 . . . . 0.0 111.828 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.39 15.69 8.96 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.59 152.7 42.2 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 120.641 -1.287 . . . . 0.0 108.632 163.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -3.32 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 124.526 3.484 . . . . 0.0 113.896 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 m -91.48 14.64 14.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.865 1.212 . . . . 0.0 112.495 161.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.59 -4.49 55.26 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.181 1.355 . . . . 0.0 113.497 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -129.07 174.74 9.27 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.987 1.715 . . . . 0.0 109.72 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -119.35 172.4 7.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.807 1.643 . . . . 0.0 108.316 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -174.06 118.81 0.25 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 127.977 2.511 . . . . 0.0 105.948 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.66 -178.91 5.27 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 125.817 1.675 . . . . 0.0 109.425 161.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.51 -38.82 88.74 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.452 1.101 . . . . 0.0 111.779 -162.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.21 81.79 0.29 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 126.892 2.187 . . . . 0.0 107.832 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 tt -51.81 -47.06 64.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.544 1.172 . . . . 0.0 109.106 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -85.99 -7.0 58.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 117.573 -1.203 . . . . 0.0 114.157 -165.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -54.64 112.66 1.06 Allowed 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.684 0.615 . . . . 0.0 110.007 -159.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.38 -13.31 12.27 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.313 -1.271 . . . . 0.0 115.755 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.5 -172.43 4.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.014 1.407 . . . . 0.0 109.503 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -151.0 97.79 2.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.135 -0.978 . . . . 0.0 111.646 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -122.73 164.9 17.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 109.685 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.5 149.0 21.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.375 1.87 . . . . 0.0 110.689 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.26 126.34 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 m -112.78 140.15 47.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -133.39 160.21 69.53 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.075 1.35 . . . . 0.0 107.431 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.82 147.73 81.35 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.292 -1.465 . . . . 0.0 108.292 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.91 -30.21 32.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.964 0.506 . . . . 0.0 112.182 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -71.38 -25.58 62.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.871 1.268 . . . . 0.0 112.343 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.71 -3.28 46.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 113.049 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 tp -62.2 -50.09 73.19 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.358 -0.839 . . . . 0.0 113.216 -163.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -74.54 -37.85 62.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.805 0.842 . . . . 0.0 109.917 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -49.34 -52.81 25.69 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.529 1.132 . . . . 0.0 109.086 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -70.29 -30.22 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.09 0.556 . . . . 0.0 110.762 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -22.91 62.21 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.379 -0.826 . . . . 0.0 112.763 169.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -91.22 6.66 44.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.001 1.32 . . . . 0.0 112.175 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.98 159.73 24.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 120.807 1.64 . . . . 0.0 112.14 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -72.04 -43.73 64.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 120.768 -1.208 . . . . 0.0 110.978 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -95.36 -53.12 3.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.933 0.893 . . . . 0.0 110.22 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.86 -13.18 22.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.404 1.002 . . . . 0.0 113.415 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -48.64 -48.26 39.72 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.503 1.521 . . . . 0.0 114.743 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 t -52.04 -43.81 63.94 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.022 1.283 . . . . 0.0 110.171 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -80.38 6.7 11.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.435 1.094 . . . . 0.0 113.665 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.7 70.24 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.066 1.303 . . . . 0.0 111.533 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.1 -3.07 0.73 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 114.239 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -135.89 12.49 3.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.194 1.398 . . . . 0.0 112.271 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.9 mt -98.02 131.09 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.676 1.125 . . . . 0.0 108.949 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.58 166.14 26.35 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.771 2.028 . . . . 0.0 111.737 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.2 154.16 69.47 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.134 1.89 . . . . 0.0 113.214 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.3 ptp . . . . . 0 CA--C 1.536 0.433 0 C-N-CA 126.604 1.961 . . . . 0.0 109.515 173.05 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 N-CA-C 110.416 -0.648 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.29 165.78 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.242 1.417 . . . . 0.0 109.042 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -109.3 127.02 66.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.328 1.051 . . . . 0.0 111.806 -172.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.18 76.01 0.2 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.011 1.291 . . . . 0.0 110.018 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.4 mtm 63.19 -31.68 0.1 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.822 2.849 . . . . 0.0 115.99 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -44.39 43.39 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.746 1 C-N-CA 136.928 6.091 . . . . 0.0 118.52 169.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -73.22 72.11 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 119.372 -2.08 . . . . 0.0 111.029 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.61 4.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.055 2.142 . . . . 0.0 112.266 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.06 -13.92 14.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.721 1.6 . . . . 0.0 113.096 -174.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CD1' ' SD ' ' A' ' 38' ' ' MET . 21.4 m-85 -69.4 -35.0 75.35 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.708 0.803 . . . . 0.0 111.777 -160.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 33.27 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.896 2.078 . . . . 0.0 112.827 168.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -108.62 -40.8 1.55 Allowed Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.5 -1.375 . . . . 0.0 112.37 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -102.37 157.28 17.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.924 1.362 . . . . 0.0 109.997 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 p -123.21 22.65 9.36 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.534 1.534 . . . . 0.0 110.671 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.05 16.79 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.13 1.772 . . . . 0.0 108.78 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -87.62 104.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -107.65 9.59 29.23 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.168 1.787 . . . . 0.0 111.646 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -154.13 148.35 25.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 156.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.45 118.25 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -82.38 125.02 30.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 166.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.24 164.45 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 171.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -131.24 157.86 76.9 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -167.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.7 157.07 59.59 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m120 46.73 37.72 5.01 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.179 1.791 . . . . 0.0 114.855 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.265 4.7 tt -117.12 18.65 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.242 . . . . 0.0 113.168 -174.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.62 149.56 5.68 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.59 1.566 . . . . 0.0 110.465 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.82 130.23 42.54 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mt -79.44 78.01 5.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.66 1.184 . . . . 0.0 107.904 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -75.36 168.63 19.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.833 0.825 . . . . 0.0 111.432 -162.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -74.56 98.08 3.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.512 0.725 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.77 -1.72 11.02 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.833 1.682 . . . . 0.0 113.815 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.465 ' SD ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 tmm? -59.24 -37.61 77.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.723 2.009 . . . . 0.0 113.431 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -103.68 11.88 35.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.042 1.337 . . . . 0.0 112.492 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 t -69.89 94.41 0.84 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -171.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.69 -6.65 6.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.157 -1.357 . . . . 0.0 113.478 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.2 m -74.63 70.54 1.84 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.652 2.226 . . . . 0.0 109.957 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p -67.83 -11.05 57.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.807 1.243 . . . . 0.0 114.326 -168.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.6 18.44 17.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.853 1.261 . . . . 0.0 111.714 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tt -79.86 119.48 22.8 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 120.458 -1.401 . . . . 0.0 108.477 -173.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.82 -17.53 5.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.505 1.522 . . . . 0.0 112.447 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -152.02 150.15 29.65 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.175 2.19 . . . . 0.0 110.859 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.79 145.43 25.73 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 128.45 2.7 . . . . 0.0 104.451 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.29 141.38 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 HD23 ' CE2' ' A' ' 58' ' ' TYR . 94.9 mt -126.97 115.03 18.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.242 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.7 p -82.17 12.32 4.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.87 175.36 32.46 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.456 -1.402 . . . . 0.0 109.893 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -132.85 19.57 4.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.76 0.824 . . . . 0.0 110.982 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -160.88 144.81 10.12 Favored Pre-proline 0 N--CA 1.467 0.411 0 C-N-CA 125.029 1.332 . . . . 0.0 109.224 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.98 -25.03 44.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.01 2.473 . . . . 0.0 113.423 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 m -65.34 -11.67 44.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.346 0.658 . . . . 0.0 112.139 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.52 -1.01 35.74 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.728 1.149 . . . . 0.0 112.869 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.415 ' CE2' HD23 ' A' ' 50' ' ' LEU . 83.9 m-85 -137.78 170.51 15.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 110.468 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.7 m -156.8 149.06 23.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.928 1.291 . . . . 0.0 109.59 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.21 158.3 44.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.231 2.213 . . . . 0.0 110.106 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.3 -166.23 42.0 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.67 -24.4 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.298 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.34 73.81 0.44 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.888 1.709 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.2 -40.75 5.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.642 1.577 . . . . 0.0 110.808 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.66 24.06 7.25 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 0.0 111.415 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -51.53 121.93 7.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.144 0.884 . . . . 0.0 110.941 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.54 13.39 82.98 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.855 -0.969 . . . . 0.0 114.231 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.52 176.03 8.9 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.604 1.962 . . . . 0.0 108.178 162.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.61 76.27 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.08 -1.012 . . . . 0.0 110.159 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -119.83 171.06 8.68 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.391 1.076 . . . . 0.0 111.979 -165.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.03 160.79 17.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.254 1.822 . . . . 0.0 110.303 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -131.08 104.78 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.028 2.131 . . . . 0.0 110.016 -163.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.2 m -95.25 105.25 17.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.574 1.95 . . . . 0.0 113.334 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -113.22 156.14 43.45 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.702 1.201 . . . . 0.0 109.254 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.51 151.81 82.17 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.585 1.602 . . . . 0.0 109.158 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.62 -31.24 66.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.781 0.832 . . . . 0.0 112.226 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -59.51 -33.17 71.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.333 1.453 . . . . 0.0 112.093 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.08 -6.52 38.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.499 -0.751 . . . . 0.0 111.978 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -61.9 -50.66 71.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.298 0.954 . . . . 0.0 111.663 -164.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.57 -30.65 46.88 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.688 -0.633 . . . . 0.0 111.078 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -50.32 -55.17 16.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.21 1.404 . . . . 0.0 109.242 168.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.25 -37.98 85.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.235 0.614 . . . . 0.0 111.054 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -68.12 -28.16 67.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 118.463 -0.78 . . . . 0.0 112.863 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.11 3.95 47.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.02 1.282 . . . . 0.0 113.291 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.36 148.36 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.738 0.815 . . . . 0.0 112.029 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -58.64 -42.77 89.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 112.815 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -102.88 -52.94 2.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.154 0.981 . . . . 0.0 109.731 -171.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -60.39 -12.25 8.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -44.28 -44.62 8.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 164.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.4 t -64.03 -46.35 84.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.358 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.98 6.37 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.111 -0.993 . . . . 0.0 112.812 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.11 68.3 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.663 -1.273 . . . . 0.0 111.181 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -19.04 15.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.008 0.923 . . . . 0.0 113.315 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -117.62 4.87 12.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.614 1.166 . . . . 0.0 112.673 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.5 mt -99.26 95.41 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.45 163.13 22.31 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.8 0.84 . . . . 0.0 109.245 173.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.48 166.57 26.79 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 168.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.6 mtm . . . . . 0 C--O 1.236 0.347 0 C-N-CA 125.127 1.371 . . . . 0.0 109.511 166.451 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 CA--C 1.543 0.972 0 CA-C-O 121.91 0.712 . . . . 0.0 113.498 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -134.48 144.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 O-C-N 120.433 -1.417 . . . . 0.0 109.341 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.489 ' CG1' ' HE3' ' A' ' 13' ' ' LYS . 16.6 t -77.71 94.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.66 84.25 0.22 Allowed Glycine 0 C--O 1.223 -0.554 0 N-CA-C 106.561 -2.616 . . . . 0.0 106.561 165.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 ttt 56.4 4.13 0.13 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 166.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -132.14 85.22 2.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.905 1.23 . . . . 0.0 111.51 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HE3' ' CG1' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -74.81 73.49 2.09 Favored 'General case' 0 C--N 1.339 0.114 0 O-C-N 120.118 -1.614 . . . . 0.0 109.316 174.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -145.14 -16.98 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.558 1.143 . . . . 0.0 113.229 172.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.76 86.09 2.46 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 126.98 2.112 . . . . 0.0 107.817 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.411 ' CD1' ' HE3' ' A' ' 38' ' ' MET . 59.1 m-85 -142.01 -52.0 0.41 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.18 0.992 . . . . 0.0 112.047 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.92 87.17 1.01 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.22 1.808 . . . . 0.0 108.275 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 -41.59 0.05 OUTLIER Glycine 0 C--N 1.33 0.238 0 CA-C-O 118.488 -1.174 . . . . 0.0 112.535 -171.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -110.0 133.28 53.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.971 0.885 . . . . 0.0 109.909 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 p -101.28 6.3 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 114.054 -155.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.76 17.81 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 110.666 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tt -97.92 90.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.86 -17.98 62.09 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.15 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -138.99 120.06 14.55 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.675 1.125 . . . . 0.0 108.786 -165.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.92 135.57 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.6 m -117.72 133.06 56.33 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.37 122.41 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.897 1.679 . . . . 0.0 109.195 -173.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -79.14 165.06 51.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -75.36 168.71 23.99 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.967 2.445 . . . . 0.0 111.922 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 50.0 34.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.964 2.106 . . . . 0.0 114.002 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.275 4.9 tt -138.47 27.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.58 162.59 9.17 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.43 0.538 . . . . 0.0 113.791 152.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.6 tp -80.77 121.13 25.54 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 109.564 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -78.95 83.34 5.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -69.37 167.03 17.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.678 0.751 . . . . 0.0 111.447 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.2 124.91 25.55 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.817 1.247 . . . . 0.0 110.094 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.16 28.54 66.12 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.659 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.411 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 3.7 mtp -54.29 -35.04 62.17 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.2 1.5 . . . . 0.0 110.128 161.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.3 22.09 16.27 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.191 1.796 . . . . 0.0 111.807 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.34 121.22 15.26 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.22 11.06 70.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.949 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.95 91.13 1.52 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.47 1.635 . . . . 0.0 108.485 171.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -3.68 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.933 2.093 . . . . 0.0 113.677 -166.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.16 68.0 1.3 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 161.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.6 tp -121.17 109.93 15.57 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.634 1.173 . . . . 0.0 109.978 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -139.98 30.66 2.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.816 0.446 . . . . 0.0 112.103 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -157.02 147.54 21.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 119.874 -1.766 . . . . 0.0 110.196 169.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.41 150.22 50.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.195 1.798 . . . . 0.0 107.157 172.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -137.62 145.4 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.7 mt -128.6 108.56 10.61 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.323 0.965 . . . . 0.0 111.775 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.284 9.5 t -93.44 57.43 2.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.082 1.353 . . . . 0.0 109.51 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.34 175.54 20.11 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.687 2.565 . . . . 0.0 107.95 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -132.17 6.39 4.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.616 0.766 . . . . 0.0 111.956 -165.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.1 144.11 19.27 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 119.658 1.117 . . . . 0.0 109.974 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -70.43 -30.06 19.76 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.899 2.399 . . . . 0.0 113.25 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 m -74.29 -18.29 60.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.711 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.5 15.12 0.19 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.373 1.469 . . . . 0.0 114.018 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -139.7 170.14 16.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.558 1.943 . . . . 0.0 108.077 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.0 m -138.0 165.49 26.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.391 1.077 . . . . 0.0 108.427 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.7 163.47 37.23 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.986 1.714 . . . . 0.0 106.931 162.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -154.06 27.17 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 164.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -23.04 65.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.582 0.753 . . . . 0.0 112.013 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 76.97 0.25 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -169.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.9 tp -45.58 -61.07 1.85 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.405 1.482 . . . . 0.0 110.824 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -90.46 16.81 8.21 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.979 1.312 . . . . 0.0 111.265 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -56.91 140.53 48.2 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.635 1.107 . . . . 0.0 109.348 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.15 -10.15 69.84 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.315 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.95 -174.31 3.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.212 1.805 . . . . 0.0 109.704 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -155.58 100.78 2.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.411 1.484 . . . . 0.0 108.283 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -138.1 171.32 14.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.43 1.492 . . . . 0.0 110.47 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -101.81 151.71 21.74 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.203 1.401 . . . . 0.0 110.697 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -106.79 104.4 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 126.53 1.932 . . . . 0.0 109.363 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.8 m -80.55 131.64 35.56 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.87 159.16 71.27 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 126.059 1.743 . . . . 0.0 108.311 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.35 157.7 49.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 121.459 1.557 . . . . 0.0 110.781 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -66.31 -24.72 66.59 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.15 -43.29 82.68 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.37 1.468 . . . . 0.0 110.396 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.09 -8.62 59.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.698 0.399 . . . . 0.0 111.269 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.41 -46.78 84.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.077 0.951 . . . . 0.0 111.24 -167.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.47 -29.81 59.71 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.548 -1.345 . . . . 0.0 110.495 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -59.07 5.83 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.615 1.566 . . . . 0.0 110.502 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -60.97 -39.65 90.41 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.92 0.782 . . . . 0.0 110.335 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.495 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 3.0 mtm180 -60.05 -39.27 85.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.896 -0.503 . . . . 0.0 110.121 -174.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -76.66 0.19 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.382 1.473 . . . . 0.0 113.685 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.57 173.02 8.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.993 1.27 . . . . 0.0 112.13 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -91.81 -21.25 20.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.837 1.655 . . . . 0.0 112.963 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 -56.53 2.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.915 1.286 . . . . 0.0 110.735 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -59.22 -11.42 3.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.324 1.9 pt20 -44.43 -62.31 1.22 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.683 2.393 . . . . 0.0 114.629 168.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -46.4 80.87 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -67.8 -6.6 22.1 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.093 -1.004 . . . . 0.0 113.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.54 61.46 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 119.973 -1.704 . . . . 0.0 112.171 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.5 57.57 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -124.33 -1.43 8.14 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.2 1.0 . . . . 0.0 112.465 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.8 mt -85.14 134.31 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.52 164.91 33.68 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 126.282 1.833 . . . . 0.0 109.674 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.98 171.07 7.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.334 2.023 . . . . 0.0 112.814 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtt . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 123.172 1.463 . . . . 0.0 109.897 168.485 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.54 0.802 0 N-CA-C 111.024 -0.414 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -144.6 143.07 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.26 165.98 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.561 1.544 . . . . 0.0 111.331 165.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.16 -95.98 0.1 Allowed Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 104.002 -3.639 . . . . 0.0 104.002 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtt -141.41 27.08 1.92 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.246 1.023 . . . . 0.0 112.434 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -146.57 164.56 32.21 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.354 -0.841 . . . . 0.0 109.342 161.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -129.36 11.93 5.92 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -163.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.39 -16.82 30.08 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 122.403 2.365 . . . . 0.0 113.287 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' CD2' ' H ' ' A' ' 15' ' ' LEU . 2.3 mm? -70.61 23.03 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.454 2.702 . . . . 0.0 114.877 -161.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.53 -33.71 4.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.4 -1.437 . . . . 0.0 111.298 -165.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.77 56.94 2.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.603 0.761 . . . . 0.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.97 -18.12 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 CA-C-O 117.77 -1.572 . . . . 0.0 115.974 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -119.95 147.73 44.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.808 . . . . 0.0 111.486 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -126.9 16.57 7.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 111.559 -155.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.81 29.41 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 126.104 1.762 . . . . 0.0 109.583 -166.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tt -113.87 98.5 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 126.706 2.002 . . . . 0.0 106.987 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 mtt85 -89.27 -9.62 49.94 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.071 -1.442 . . . . 0.0 111.144 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.97 135.75 36.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.626 1.557 . . . . 0.0 109.097 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 mt -138.94 102.76 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.2 m -90.78 94.55 9.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.44 127.37 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 120.209 -1.557 . . . . 0.0 110.223 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -79.6 162.67 62.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.656 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.83 164.83 31.19 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.922 2.415 . . . . 0.0 111.085 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 45.15 49.89 9.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.994 2.118 . . . . 0.0 112.015 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.91 -5.02 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.31 158.42 11.04 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 120.636 -1.29 . . . . 0.0 111.384 157.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.5 tp -57.17 158.39 5.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 mt -124.87 81.62 1.97 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.125 1.37 . . . . 0.0 109.494 172.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -70.19 174.68 5.25 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.616 -0.678 . . . . 0.0 112.189 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -73.24 131.1 41.57 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 120.631 -1.293 . . . . 0.0 109.736 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.19 8.3 87.44 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.612 -1.105 . . . . 0.0 113.222 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -12.55 2.01 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.81 2.305 . . . . 0.0 113.038 175.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -122.05 11.5 10.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.36 1.464 . . . . 0.0 111.518 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.5 p -66.31 98.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.068 -1.02 . . . . 0.0 110.555 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.15 -6.35 6.8 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.107 1.337 . . . . 0.0 112.6 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.8 m -73.57 61.53 0.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.376 1.588 . . . . 0.0 111.381 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 p -72.19 25.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.998 1.719 . . . . 0.0 114.592 -171.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.92 17.02 2.3 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.528 -1.358 . . . . 0.0 111.796 161.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.23 120.92 16.63 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.899 1.227 . . . . 0.0 109.193 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.16 -17.46 4.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.133 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.881 1.673 . . . . 0.0 112.908 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.39 103.83 4.16 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 128.256 2.622 . . . . 0.0 104.39 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.29 142.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.11 146.38 43.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -119.6 28.12 8.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.602 0.761 . . . . 0.0 110.684 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.18 17.21 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.85 5.8 22.85 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.65 144.03 21.46 Favored Pre-proline 0 C--O 1.232 0.182 0 C-N-CA 124.83 1.252 . . . . 0.0 107.93 171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.06 -11.57 30.7 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.121 2.547 . . . . 0.0 113.691 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -59.55 -30.08 68.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.323 1.449 . . . . 0.0 111.057 167.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.76 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.881 1.272 . . . . 0.0 113.538 -166.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -139.68 -175.93 4.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.271 1.829 . . . . 0.0 110.134 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -144.42 172.74 12.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.881 2.072 . . . . 0.0 107.916 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.07 168.63 24.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.708 1.203 . . . . 0.0 108.295 161.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.0 -107.03 2.71 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -105.14 -21.41 13.27 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.186 0.594 . . . . 0.0 111.367 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.63 -136.36 3.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 105.408 -3.077 . . . . 0.0 105.408 152.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -160.37 -47.69 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.281 1.032 . . . . 0.0 110.971 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 12.42 28.79 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.249 -0.907 . . . . 0.0 112.526 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.97 145.93 39.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.473 1.109 . . . . 0.0 111.8 -165.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.03 -30.39 1.82 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.488 1.518 . . . . 0.0 112.778 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.67 -175.17 2.72 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 110.318 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -164.6 91.61 0.59 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.921 2.488 . . . . 0.0 106.371 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -134.09 172.65 12.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.595 1.958 . . . . 0.0 109.317 -172.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.15 157.46 16.98 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.809 -1.182 . . . . 0.0 110.887 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.15 102.5 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.629 1.972 . . . . 0.0 106.358 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 m -99.35 110.41 22.92 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.86 1.664 . . . . 0.0 111.195 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.8 157.8 40.76 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.18 1.354 . . . . 0.0 110.34 -166.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -65.35 147.27 87.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 CA-C-N 120.385 1.173 . . . . 0.0 110.016 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.73 -37.49 71.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.899 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -38.86 89.47 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.606 -0.684 . . . . 0.0 110.138 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.2 -18.54 49.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.7 0.8 . . . . 0.0 112.475 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.0 tp -47.26 -53.49 13.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.451 . . . . 0.0 112.576 -166.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.1 -28.37 60.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.908 1.283 . . . . 0.0 109.629 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.98 -38.58 91.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.273 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -67.89 -31.93 72.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -84.25 9.83 11.94 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.65 163.47 21.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.518 1.054 . . . . 0.0 112.773 -169.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -88.12 -36.7 16.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.477 -0.764 . . . . 0.0 111.176 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -82.77 -66.55 0.88 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -68.6 -2.79 9.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.698 1.199 . . . . 0.0 114.172 -163.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.276 1.0 OUTLIER -43.76 -56.04 4.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.651 2.38 . . . . 0.0 112.666 174.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 t -52.75 -40.98 63.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.412 1.085 . . . . 0.0 111.183 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.69 4.3 5.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.339 -0.851 . . . . 0.0 113.073 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.17 -26.48 64.82 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 119.71 -1.869 . . . . 0.0 112.097 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.55 -12.3 14.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -125.92 16.22 7.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.273 0.942 . . . . 0.0 110.188 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.27 122.03 50.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -132.73 165.61 35.2 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.59 1.556 . . . . 0.0 109.239 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.99 175.02 5.05 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.167 1.912 . . . . 0.0 112.072 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 CA--C 1.537 0.445 0 C-N-CA 125.842 1.657 . . . . 0.0 110.541 175.844 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 CA--C 1.546 1.107 0 CA-C-O 121.27 0.446 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.64 158.28 31.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.58 1.952 . . . . 0.0 110.634 -165.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.7 t -80.9 67.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.977 1.311 . . . . 0.0 109.911 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.6 59.53 0.91 Allowed Glycine 0 C--N 1.332 0.353 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 69.82 -55.74 0.59 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.934 2.094 . . . . 0.0 114.016 -176.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 106.9 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.548 1.539 . . . . 0.0 111.024 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mmtm -94.36 81.27 3.97 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 119.612 -1.93 . . . . 0.0 108.169 166.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 p -168.19 -16.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.545 -162.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.14 8.23 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.073 0.851 . . . . 0.0 112.79 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.32 -64.21 0.92 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.945 1.298 . . . . 0.0 109.453 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.67 95.32 0.01 OUTLIER 'General case' 0 C--N 1.34 0.171 0 C-N-CA 127.203 2.201 . . . . 0.0 110.62 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.77 -42.82 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -81.51 112.7 18.98 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.279 0.54 . . . . 0.0 111.348 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.1 p -84.89 14.69 4.58 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.391 1.876 . . . . 0.0 112.559 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.62 46.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.687 1.595 . . . . 0.0 109.733 -170.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.28 86.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 O-C-N 120.922 -1.111 . . . . 0.0 108.88 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -68.82 -19.8 64.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.892 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -138.95 126.84 22.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.69 90.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 m -64.69 141.37 58.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.74 159.55 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 128.079 2.552 . . . . 0.0 105.964 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -118.36 163.8 23.46 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.15 173.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.65 172.06 16.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.791 1.66 . . . . 0.0 110.883 171.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 51.42 27.39 3.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.33 1.852 . . . . 0.0 114.519 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 tt -124.35 5.09 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 112.164 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.84 171.4 18.27 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.083 0.849 . . . . 0.0 112.692 164.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.4 tp -91.21 124.77 35.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.575 1.55 . . . . 0.0 107.402 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.21 104.64 11.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 168.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -107.97 175.49 5.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.756 1.222 . . . . 0.0 110.463 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.59 117.45 8.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.162 1.385 . . . . 0.0 111.168 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.74 40.76 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.217 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.4 mtp -61.23 -52.69 63.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.405 1.603 . . . . 0.0 108.557 156.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -90.11 22.46 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -47.77 123.91 6.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.46 10.58 86.15 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.339 -1.256 . . . . 0.0 114.358 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.9 m -75.91 67.74 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.904 2.352 . . . . 0.0 109.153 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -66.58 -26.23 67.01 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.115 2.166 . . . . 0.0 112.865 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.96 61.95 1.01 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.332 1.453 . . . . 0.0 108.455 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.29 129.69 55.51 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 165.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.97 -15.57 5.83 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.047 166.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -135.52 148.48 49.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 122.543 2.429 . . . . 0.0 114.122 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 tp -137.77 92.17 2.65 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.788 2.835 . . . . 0.0 106.717 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.44 145.95 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -129.58 112.19 13.47 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.151 0.98 . . . . 0.0 108.634 -167.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.8 p -72.16 -6.18 40.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.606 1.093 . . . . 0.0 113.891 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 134.79 12.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.869 1.213 . . . . 0.0 110.583 -163.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.58 -14.64 60.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.926 1.29 . . . . 0.0 113.486 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.87 143.6 40.69 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 108.225 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.68 -36.45 41.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.531 2.154 . . . . 0.0 111.689 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.8 p -66.26 -12.8 58.54 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.57 -6.75 51.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.37 1.068 . . . . 0.0 112.218 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.95 177.59 4.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.748 2.019 . . . . 0.0 111.646 -174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -161.17 124.25 3.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.067 1.347 . . . . 0.0 109.383 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.37 1.62 2.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -164.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 45.4 -103.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 127.394 2.425 . . . . 0.0 113.321 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.96 -7.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.394 2.278 . . . . 0.0 111.275 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.2 25.92 3.8 Favored Glycine 0 C--N 1.336 0.572 0 O-C-N 121.127 -0.983 . . . . 0.0 112.889 -163.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.1 tp -47.18 -54.47 10.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.481 1.112 . . . . 0.0 110.704 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 74.79 0.95 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.13 125.4 44.41 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.94 -12.89 68.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.404 -170.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.21 172.02 17.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.139 2.176 . . . . 0.0 108.95 170.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -141.98 111.24 6.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -124.36 -178.79 4.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 128.308 2.643 . . . . 0.0 108.369 -173.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.24 154.03 27.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.569 -1.332 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -116.89 131.4 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m -128.05 127.09 42.52 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 156.88 72.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 123.87 0.868 . . . . 0.0 108.851 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.1 153.28 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.856 1.037 . . . . 0.0 109.502 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.87 -33.15 70.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.03 -37.37 84.67 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.989 0.813 . . . . 0.0 110.316 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.94 -6.78 55.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.251 1.02 . . . . 0.0 111.527 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.5 -60.96 2.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.945 1.248 . . . . 0.0 112.386 -164.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.71 -36.0 79.68 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.447 0.699 . . . . 0.0 110.254 174.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.22 -57.52 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.984 1.714 . . . . 0.0 111.58 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -64.06 -42.76 96.9 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 124.912 1.285 . . . . 0.0 109.866 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -54.54 -39.39 67.63 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.149 -0.345 . . . . 0.0 110.791 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -81.02 8.07 9.34 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.419 1.487 . . . . 0.0 114.231 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 26.6 t0 -64.38 174.91 1.49 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 120.434 1.47 . . . . 0.0 110.989 173.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.407 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 51.9 t80 -75.96 -60.5 2.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.322 1.449 . . . . 0.0 111.455 163.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.92 -57.08 3.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.717 1.207 . . . . 0.0 109.774 -171.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -56.59 -17.17 7.66 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -44.59 -46.65 10.13 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 113.8 165.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 t -66.26 -31.83 72.89 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.676 -0.64 . . . . 0.0 110.518 -176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -83.35 4.72 26.13 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.389 -1.444 . . . . 0.0 112.283 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.58 5.03 2.63 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 120.219 -1.551 . . . . 0.0 112.466 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.81 -8.58 58.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.311 0.959 . . . . 0.0 112.524 167.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -138.65 14.1 2.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.665 1.12 . . . . 0.0 113.516 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.0 mt -91.7 138.97 18.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.51 164.52 39.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.183 -0.948 . . . . 0.0 109.681 165.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.91 164.4 27.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.131 1.887 . . . . 0.0 110.25 165.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.2 ptp . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 124.052 0.941 . . . . 0.0 109.873 -176.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 CA--C 1.543 0.954 0 N-CA-C 107.369 -1.82 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -152.68 164.57 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 122.183 0.992 . . . . 0.0 109.305 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' HE3' ' A' ' 13' ' ' LYS . 37.8 t -74.15 78.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 161.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.0 -167.27 32.81 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 152.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.22 39.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.639 2.22 . . . . 0.0 113.308 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.425 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 20.6 t70 -89.71 114.33 25.97 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.787 -1.821 . . . . 0.0 109.297 -159.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HE3' ' CG1' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -80.75 89.1 5.77 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.365 -1.459 . . . . 0.0 108.551 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 t -156.15 -2.45 0.13 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -125.96 25.62 6.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.693 1.133 . . . . 0.0 112.363 -151.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -103.37 -36.98 7.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.591 1.156 . . . . 0.0 111.872 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 28.89 0.05 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.744 1.618 . . . . 0.0 113.038 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.35 -21.7 4.7 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.027 -1.985 . . . . 0.0 113.41 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -126.73 118.17 24.17 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 121.409 2.605 . . . . 0.0 111.615 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.0 p -74.71 18.29 0.18 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.234 2.213 . . . . 0.0 113.72 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.45 6.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.322 1.419 . . . . 0.0 111.476 -158.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -92.62 94.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.555 -1.34 . . . . 0.0 107.541 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -75.81 -13.97 60.29 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.533 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -140.41 135.89 32.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.649 1.113 . . . . 0.0 109.995 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.38 90.49 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.498 1.119 . . . . 0.0 108.767 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.9 m -65.75 141.92 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 165.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.34 167.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.016 1.327 . . . . 0.0 110.505 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -114.34 163.99 17.58 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.279 1.432 . . . . 0.0 110.486 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.7 153.78 72.58 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.691 2.261 . . . . 0.0 109.878 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.39 64.12 1.43 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.79 2.036 . . . . 0.0 111.679 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.273 0.2 OUTLIER -140.71 55.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 123.708 1.718 . . . . 0.0 109.558 -176.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.72 49.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 125.706 1.622 . . . . 0.0 112.543 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.6 tp -105.69 131.74 52.69 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 123.212 1.482 . . . . 0.0 112.745 -157.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -84.37 67.11 9.73 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.674 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -65.47 162.52 17.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.214 1.007 . . . . 0.0 110.058 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.75 109.8 12.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.681 1.192 . . . . 0.0 109.249 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.73 6.78 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.024 1.773 . . . . 0.0 112.803 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.1 -33.51 26.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.372 1.869 . . . . 0.0 113.105 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -114.89 7.94 15.81 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.875 1.67 . . . . 0.0 113.558 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -62.75 101.84 0.29 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.657 1.117 . . . . 0.0 108.616 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.86 -2.85 10.89 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.162 0.887 . . . . 0.0 113.835 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.4 m -77.54 78.7 4.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.489 2.144 . . . . 0.0 109.474 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.5 p -69.97 -23.67 63.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 112.923 -172.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.39 45.15 2.36 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.728 1.211 . . . . 0.0 108.829 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tt -98.6 109.41 22.18 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -110.66 -22.37 11.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.26 150.45 39.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.472 1.033 . . . . 0.0 111.942 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.52 142.45 24.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.958 2.503 . . . . 0.0 105.602 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.24 155.09 29.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -128.08 127.84 43.82 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.5 172.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 p -88.52 38.27 0.86 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 110.076 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.83 159.52 24.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 125.102 1.335 . . . . 0.0 109.898 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -124.5 6.73 8.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.499 0.72 . . . . 0.0 112.482 -157.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -153.24 144.45 16.23 Favored Pre-proline 0 CA--C 1.535 0.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.64 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -66.49 -31.1 42.7 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.189 2.593 . . . . 0.0 113.059 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 m -76.22 -5.93 49.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.183 0.593 . . . . 0.0 112.044 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.99 3.16 27.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.171 0.896 . . . . 0.0 111.93 166.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -133.7 165.62 24.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.87 1.319 . . . . 0.0 110.816 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -134.04 170.79 15.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.225 1.81 . . . . 0.0 108.818 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.03 -177.56 1.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.997 3.719 . . . . 0.0 104.178 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.28 -145.91 5.34 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 0.2 21.89 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.803 -0.822 . . . . 0.0 113.015 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.99 74.47 0.11 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.832 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 tt -44.44 -41.19 6.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.355 1.462 . . . . 0.0 109.098 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' NH1' ' H ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -125.33 34.75 4.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 126.009 1.724 . . . . 0.0 111.871 -173.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -52.26 121.14 6.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.966 0.803 . . . . 0.0 109.027 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.82 12.41 84.57 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.685 -1.064 . . . . 0.0 115.245 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 173.35 11.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.405 1.603 . . . . 0.0 109.85 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -157.43 95.16 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.425 ' H ' ' NH1' ' A' ' 65' ' ' ARG . 37.8 p90 -131.62 168.9 16.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.157 1.383 . . . . 0.0 111.51 -173.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.27 146.08 29.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.21 1.004 . . . . 0.0 111.398 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.68 128.44 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 127.717 2.407 . . . . 0.0 108.688 -172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.72 109.55 14.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.159 1.784 . . . . 0.0 112.208 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.72 160.87 26.37 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.448 1.099 . . . . 0.0 108.896 -175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.2 138.19 65.39 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 108.01 -1.573 . . . . 0.0 108.01 171.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.6 -31.18 56.57 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.26 -33.2 75.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 -175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.81 -2.73 58.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.238 1.415 . . . . 0.0 112.273 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.97 -50.84 70.48 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 119.882 -1.761 . . . . 0.0 112.204 -166.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -65.28 -32.27 73.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.696 0.76 . . . . 0.0 111.039 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -57.27 -56.09 26.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.093 2.157 . . . . 0.0 110.419 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -60.87 -46.12 91.85 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.587 0.755 . . . . 0.0 110.587 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -58.54 -38.76 78.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.59 -0.96 22.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.911 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.56 164.88 6.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.212 1.369 . . . . 0.0 111.683 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.24 13.92 25.87 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.993 1.317 . . . . 0.0 113.162 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -146.22 -59.25 0.31 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.843 2.057 . . . . 0.0 110.923 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -61.42 -9.05 4.74 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.931 1.241 . . . . 0.0 112.964 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.261 0.5 OUTLIER -43.38 -60.52 1.68 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.6 2.36 . . . . 0.0 114.177 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -50.85 37.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 109.849 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -71.02 -2.91 16.97 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.476 1.511 . . . . 0.0 113.285 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.93 -23.61 66.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.658 -1.276 . . . . 0.0 111.969 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.0 -22.67 64.74 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 -116.41 10.45 14.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.296 1.438 . . . . 0.0 111.685 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.06 115.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.15 163.41 23.31 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.773 1.229 . . . . 0.0 109.872 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 164.34 34.37 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.171 1.914 . . . . 0.0 110.415 168.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.2 mtm . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 127.251 2.22 . . . . 0.0 111.647 174.226 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo . . . . . 0 CA--C 1.543 0.948 0 N-CA-C 113.637 0.591 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.86 139.74 47.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.52 123.6 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.165 0.586 . . . . 0.0 110.135 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.34 66.49 0.34 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 mmt 61.05 -55.43 0.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.425 2.69 . . . . 0.0 114.03 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -57.66 114.94 2.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 164.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 30.0 mmtp -104.02 88.55 3.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.38 1.072 . . . . 0.0 108.745 170.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -153.24 -14.94 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.176 0.99 . . . . 0.0 113.604 153.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.453 ' CD2' ' H ' ' A' ' 15' ' ' LEU . 1.7 mm? -65.55 -4.1 5.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -165.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.482 ' C ' ' H ' ' A' ' 18' ' ' GLY . 9.8 m-85 -71.07 -51.29 26.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.571 1.148 . . . . 0.0 109.864 -174.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.36 13.77 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -109.78 4.83 30.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 127.256 2.36 . . . . 0.0 112.708 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -132.4 161.29 34.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.125 1.463 . . . . 0.0 109.683 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 -3.73 10.4 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.155 1.782 . . . . 0.0 112.175 -163.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.0 0.66 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.39 . . . . 0.0 110.474 -160.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.9 tt -71.81 98.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.349 1.86 . . . . 0.0 109.138 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -78.79 -3.47 44.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 117.026 -1.464 . . . . 0.0 112.077 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -152.26 137.69 17.64 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 120.513 1.506 . . . . 0.0 111.344 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -143.72 102.32 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 108.28 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.1 m -85.59 95.75 9.43 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.11 147.79 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -108.99 163.85 16.04 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 124.838 1.255 . . . . 0.0 107.796 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.61 168.08 17.5 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.372 2.048 . . . . 0.0 109.004 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 62.93 -7.13 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 167.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.455 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 5.9 tt -99.83 54.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 121.082 1.765 . . . . 0.0 112.803 -171.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.01 166.55 39.67 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.479 -1.388 . . . . 0.0 111.722 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.6 tp -76.12 165.88 24.28 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.527 1.931 . . . . 0.0 112.033 -171.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.9 73.94 0.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.029 0.831 . . . . 0.0 108.804 169.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.45 170.41 13.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.883 -169.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 150.77 41.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.343 1.068 . . . . 0.0 110.924 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.4 -2.55 37.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.268 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ptm -62.64 -11.25 15.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.833 . . . . 0.0 114.09 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.74 13.41 11.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 111.829 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -66.96 96.88 0.45 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.456 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.93 19.02 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.391 0.996 . . . . 0.0 112.901 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.9 m -73.66 68.8 1.24 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.026 1.413 . . . . 0.0 107.245 164.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -62.63 -55.08 30.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.51 58.01 3.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.377 -0.827 . . . . 0.0 109.002 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -114.84 121.14 42.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.233 1.813 . . . . 0.0 108.025 160.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -135.79 -5.24 2.2 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -124.87 153.12 43.1 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.636 -1.29 . . . . 0.0 110.821 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.46 131.02 11.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.66 144.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.6 mt -121.45 91.39 3.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 108.198 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 t -83.04 64.42 7.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.254 1.422 . . . . 0.0 110.213 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.3 150.49 18.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.059 1.314 . . . . 0.0 110.966 166.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -89.36 -20.41 24.05 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.988 1.315 . . . . 0.0 113.324 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 159.43 54.45 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 126.896 2.078 . . . . 0.0 107.155 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -74.1 -45.65 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.154 3.236 . . . . 0.0 111.851 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -61.7 -25.33 67.34 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -159.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.58 2.47 6.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 113.084 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -105.78 156.02 18.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.339 1.456 . . . . 0.0 108.373 169.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -134.06 142.83 47.72 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 107.386 169.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.56 154.3 34.02 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.778 3.231 . . . . 0.0 106.849 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.98 -160.84 23.68 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 122.073 0.818 . . . . 0.0 111.797 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.04 2.15 4.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.006 1.322 . . . . 0.0 112.87 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.02 74.59 0.17 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.716 1.627 . . . . 0.0 109.726 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.98 -46.22 64.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.583 1.192 . . . . 0.0 109.484 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -106.07 37.8 2.18 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.776 1.63 . . . . 0.0 110.663 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 117.65 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.75 -11.68 38.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.262 0.934 . . . . 0.0 114.398 168.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 -178.3 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.785 1.634 . . . . 0.0 108.587 166.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -142.62 90.42 2.22 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -173.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -135.27 163.88 28.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.3 160.02 14.74 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.321 1.448 . . . . 0.0 109.664 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.45 89.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -171.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -78.79 155.9 29.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.407 -0.808 . . . . 0.0 111.031 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.78 160.83 37.19 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 125.479 1.512 . . . . 0.0 109.457 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.32 141.24 51.04 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -53.81 -31.76 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.416 1.086 . . . . 0.0 112.54 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -46.42 76.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.942 1.697 . . . . 0.0 110.475 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.3 0.14 42.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 112.248 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.5 -45.22 85.18 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.58 1.082 . . . . 0.0 112.419 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.7 -44.44 90.25 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.686 0.795 . . . . 0.0 110.852 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.84 -53.18 27.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.97 1.308 . . . . 0.0 110.815 -171.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -66.53 -38.08 86.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.09 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -61.9 -18.0 58.65 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.437 1.017 . . . . 0.0 111.694 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -87.85 -15.26 37.26 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.65 130.21 40.61 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.319 1.872 . . . . 0.0 109.27 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -47.25 -39.25 13.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.656 1.182 . . . . 0.0 110.885 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -69.04 -74.21 0.13 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.4 1.08 . . . . 0.0 109.95 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -55.77 -22.96 26.95 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -44.67 -48.14 10.57 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -60.14 -43.59 95.6 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.691 0.678 . . . . 0.0 109.682 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.14 7.08 5.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.888 -1.133 . . . . 0.0 112.73 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.68 -19.73 64.15 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 120.043 -1.661 . . . . 0.0 111.996 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.75 37.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -121.01 7.94 10.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.234 1.013 . . . . 0.0 111.813 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 92.3 mt -83.99 148.03 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.122 0.969 . . . . 0.0 108.995 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.33 165.3 17.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.982 1.713 . . . . 0.0 109.654 164.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 163.88 31.61 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.979 1.786 . . . . 0.0 112.299 174.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.2 ptp . . . . . 0 CA--C 1.54 0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 110.812 178.427 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 CA--C 1.536 0.598 0 N-CA-C 111.168 -0.359 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.04 146.56 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 120.764 -1.21 . . . . 0.0 109.701 -169.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.12 132.56 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.241 0.616 . . . . 0.0 110.261 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.79 82.54 0.15 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.438 ' H ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER 48.2 28.88 1.68 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.805 1.642 . . . . 0.0 111.914 -175.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -147.9 122.42 9.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 32.9 mmtp -106.32 94.98 5.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 162.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.68 19.73 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.943 1.697 . . . . 0.0 110.598 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.52 64.91 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.225 -1.547 . . . . 0.0 111.362 -167.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.0 -10.44 1.15 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.69 17.36 21.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.139 1.336 . . . . 0.0 112.483 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.6 -6.94 20.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.626 -168.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -138.43 105.17 5.36 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 120.354 2.077 . . . . 0.0 109.677 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -72.16 9.43 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -168.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.56 39.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 128.049 2.54 . . . . 0.0 109.442 -159.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.58 96.71 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 128.274 2.63 . . . . 0.0 106.557 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -78.83 -13.3 59.88 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.213 1.005 . . . . 0.0 111.557 -170.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.07 121.27 11.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.184 1.794 . . . . 0.0 107.143 -173.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.7 mt -111.39 103.41 15.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.0 m -72.71 143.41 48.05 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.77 159.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 127.308 2.243 . . . . 0.0 106.313 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.96 163.96 46.42 Favored Pre-proline 0 N--CA 1.451 -0.375 0 C-N-CA 124.033 0.933 . . . . 0.0 110.796 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.61 146.81 55.97 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 -171.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 51.31 66.08 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.09 2.156 . . . . 0.0 110.589 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.438 HD13 ' H ' ' A' ' 11' ' ' MET . 8.6 tp -133.88 40.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.877 1.271 . . . . 0.0 111.086 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.08 156.95 24.83 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.194 -1.566 . . . . 0.0 113.386 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.5 127.19 30.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 127.828 2.451 . . . . 0.0 111.015 -171.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.17 77.17 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -67.57 165.0 17.8 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.81 0.814 . . . . 0.0 110.302 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.96 144.26 33.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.963 -1.086 . . . . 0.0 110.333 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 85.84 5.62 83.59 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.718 0.675 . . . . 0.0 112.883 -178.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 mtp -54.81 -27.2 40.1 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.808 1.243 . . . . 0.0 112.849 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.67 20.53 4.24 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.627 1.171 . . . . 0.0 111.338 -162.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 t -65.44 115.86 6.13 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.88 56.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 76.0 m -68.02 74.81 0.21 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.971 1.385 . . . . 0.0 112.813 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.6 p -63.74 -31.23 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.289 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.57 63.87 0.71 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.178 1.354 . . . . 0.0 107.918 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.14 120.97 34.81 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.194 2.198 . . . . 0.0 106.804 162.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . 0.307 1.2 pt-20 -131.44 -4.07 3.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.018 1.327 . . . . 0.0 114.382 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -144.63 157.99 43.97 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 122.491 1.139 . . . . 0.0 113.3 170.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -140.65 141.04 35.09 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.378 3.071 . . . . 0.0 104.289 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.28 142.33 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -128.07 104.69 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.687 1.195 . . . . 0.0 108.694 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -79.28 37.22 0.32 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.577 0.751 . . . . 0.0 111.003 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.83 146.69 18.69 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -97.37 16.25 20.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.991 0.516 . . . . 0.0 111.434 -165.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.75 147.5 17.88 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 110.157 -164.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.22 -41.62 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.647 2.898 . . . . 0.0 110.663 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -67.06 -22.21 65.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.575 1.55 . . . . 0.0 114.229 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.37 4.79 10.0 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 112.158 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -122.62 172.7 8.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.708 1.242 . . . . 0.0 108.995 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.78 126.51 18.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.49 35.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.226 1.41 . . . . 0.0 107.478 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.3 -127.17 5.1 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.4 14.38 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.379 1.072 . . . . 0.0 111.859 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.45 82.86 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 tt -52.43 -50.96 61.54 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.52 40.95 1.28 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.473 1.109 . . . . 0.0 110.694 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 21.2 t70 -65.89 136.3 55.95 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 120.82 -1.175 . . . . 0.0 107.91 169.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.85 60.55 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.776 -1.569 . . . . 0.0 114.865 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 -172.62 4.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.923 1.861 . . . . 0.0 109.444 175.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -134.76 80.18 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -94.38 167.88 11.24 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.48 149.95 28.84 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.281 1.033 . . . . 0.0 109.457 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -109.53 149.63 12.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.15 1.38 . . . . 0.0 107.926 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.1 m -129.87 130.61 45.44 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.343 1.457 . . . . 0.0 107.514 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.21 160.55 67.49 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.944 1.698 . . . . 0.0 108.395 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.55 147.75 90.35 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 120.377 1.17 . . . . 0.0 109.962 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.26 -28.12 67.8 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 -5.99 49.11 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.635 0.774 . . . . 0.0 112.053 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.15 -3.46 31.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.011 -1.055 . . . . 0.0 112.829 167.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.57 -36.59 81.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.359 0.982 . . . . 0.0 113.427 -161.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.57 -30.81 32.9 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.001 -1.062 . . . . 0.0 109.173 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.8 ttm105 -56.38 -60.27 3.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.729 1.211 . . . . 0.0 110.618 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.2 p90 -54.87 -40.64 69.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.505 0.593 . . . . 0.0 110.939 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 1.3 mtp-105 -65.49 -19.85 66.1 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.883 -0.511 . . . . 0.0 111.433 -174.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -100.45 5.28 44.2 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.831 1.252 . . . . 0.0 111.655 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.02 162.7 21.53 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.707 1.139 . . . . 0.0 110.858 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.82 -43.83 64.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.306 -0.871 . . . . 0.0 111.346 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -95.42 -60.38 1.68 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.706 1.203 . . . . 0.0 109.926 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.78 -18.61 13.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.163 1.785 . . . . 0.0 113.936 -170.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -44.98 -42.97 8.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.316 1.446 . . . . 0.0 114.265 167.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -58.71 -37.96 77.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -85.59 10.92 11.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.395 1.478 . . . . 0.0 112.847 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.78 -0.69 7.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.497 -2.002 . . . . 0.0 112.729 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.82 -15.66 53.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.314 0.961 . . . . 0.0 113.451 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -118.11 0.35 11.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.4 92.87 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -168.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -99.35 163.14 19.19 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.371 1.068 . . . . 0.0 112.659 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.75 151.89 58.06 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.212 2.608 . . . . 0.0 112.067 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 mtm . . . . . 0 C--O 1.235 0.297 0 C-N-CA 125.855 1.662 . . . . 0.0 110.784 165.028 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.447 -1.23 0 N-CA-C 108.554 -1.364 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -133.24 165.78 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.423 1.889 . . . . 0.0 108.359 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.1 66.87 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.049 1.74 . . . . 0.0 108.309 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.86 82.87 0.32 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.7 mmt 57.98 -58.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 130.229 3.411 . . . . 0.0 115.747 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -62.59 101.53 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.243 1.817 . . . . 0.0 111.413 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -94.21 76.41 4.0 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 119.518 -1.989 . . . . 0.0 108.545 171.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.79 -9.02 0.72 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.434 1.094 . . . . 0.0 113.243 168.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 6.66 15.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -165.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -68.48 -43.89 75.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.139 1.336 . . . . 0.0 111.761 -174.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.68 47.62 0.18 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.256 2.223 . . . . 0.0 112.973 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -133.16 -39.03 0.21 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-O 119.219 -0.767 . . . . 0.0 111.238 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -85.09 100.95 12.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.481 1.141 . . . . 0.0 110.878 -172.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -70.99 9.92 0.62 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.282 2.633 . . . . 0.0 113.88 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.19 55.02 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.892 1.277 . . . . 0.0 109.223 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -129.94 92.36 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.214 -0.928 . . . . 0.0 110.325 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 1.9 mmt85 -76.17 -15.26 60.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.019 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -137.36 135.62 37.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.569 1.077 . . . . 0.0 108.843 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -133.55 113.14 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.5 m -93.16 107.67 19.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -103.14 105.46 18.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.455 1.502 . . . . 0.0 108.386 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -65.02 165.07 17.45 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.798 167.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.5 168.68 24.16 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.503 2.136 . . . . 0.0 110.15 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 46.67 39.21 6.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.91 1.684 . . . . 0.0 112.981 171.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.304 5.2 tt -130.25 22.6 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 120.233 1.379 . . . . 0.0 112.386 -174.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.53 164.33 11.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.007 0.813 . . . . 0.0 113.206 155.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.94 117.49 9.88 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 126.314 1.845 . . . . 0.0 111.54 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -74.55 95.56 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 164.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -76.29 173.79 10.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.147 0.979 . . . . 0.0 111.447 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.0 129.15 39.55 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.423 1.089 . . . . 0.0 113.004 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.62 25.18 74.01 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -45.17 -36.62 3.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.708 2.003 . . . . 0.0 113.321 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.22 13.62 20.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.07 1.748 . . . . 0.0 111.72 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -49.79 119.35 3.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.849 0.859 . . . . 0.0 111.935 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.5 20.99 79.41 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.598 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -71.91 78.67 0.89 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -76.02 -6.37 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.381 1.872 . . . . 0.0 112.305 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.48 72.9 1.45 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 162.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 39.4 tp -134.85 123.6 23.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 130.785 3.634 . . . . 0.0 109.036 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -143.03 -20.48 0.64 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -100.86 145.79 28.13 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.795 2.088 . . . . 0.0 111.163 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.35 150.38 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.65 138.18 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -111.8 155.0 24.26 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -126.2 7.49 7.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.819 0.848 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.06 179.45 41.01 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -125.97 3.76 7.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.259 0.624 . . . . 0.0 111.768 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -147.65 144.17 18.91 Favored Pre-proline 0 N--CA 1.466 0.371 0 C-N-CA 124.6 1.16 . . . . 0.0 108.963 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.2 -27.3 16.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.768 2.312 . . . . 0.0 113.43 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.4 -14.67 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.827 1.251 . . . . 0.0 111.163 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.24 -2.96 23.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.699 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.93 165.33 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.76 1.624 . . . . 0.0 109.833 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 m -139.83 123.65 17.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.93 -0.63 6.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.195 1.398 . . . . 0.0 113.0 -168.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.73 -97.81 0.23 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 126.831 2.158 . . . . 0.0 109.029 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -147.56 -9.6 0.42 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.007 1.723 . . . . 0.0 111.375 160.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.73 24.22 9.71 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.771 1.177 . . . . 0.0 114.04 -163.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.0 tp -44.46 -44.59 8.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.367 1.867 . . . . 0.0 114.092 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.83 58.57 1.64 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -164.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.05 153.15 26.03 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.29 -11.13 51.69 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 117.88 -1.511 . . . . 0.0 114.566 170.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.5 165.32 31.54 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.733 2.013 . . . . 0.0 107.946 162.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.93 86.47 2.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.32 1.048 . . . . 0.0 109.595 -168.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -112.18 174.82 5.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.892 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.67 154.09 39.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.092 2.957 . . . . 0.0 107.929 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -117.03 107.92 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 126.207 1.803 . . . . 0.0 108.354 -163.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.12 151.63 36.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.728 161.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.07 161.72 51.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.236 1.814 . . . . 0.0 107.64 164.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.07 149.61 76.97 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 108.098 -1.539 . . . . 0.0 108.098 167.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.37 -33.09 41.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.832 0.853 . . . . 0.0 111.913 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -59.28 -42.82 92.13 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.714 1.605 . . . . 0.0 111.012 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 -7.22 56.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.688 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.97 -55.18 37.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.822 1.192 . . . . 0.0 112.985 -164.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.53 -33.24 60.7 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.465 -0.772 . . . . 0.0 111.466 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -45.43 -51.62 11.21 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.791 2.036 . . . . 0.0 109.422 167.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.06 -43.43 92.3 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.233 1.013 . . . . 0.0 111.433 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.01 -19.71 65.75 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.255 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -103.09 18.8 20.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.174 1.352 . . . . 0.0 112.993 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.53 166.32 19.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.603 1.561 . . . . 0.0 111.775 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.37 -34.65 16.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.827 0.851 . . . . 0.0 111.514 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -92.04 -59.38 2.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -65.04 -12.42 50.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -170.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -44.15 -45.5 8.31 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -60.67 -43.95 97.06 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 125.623 1.569 . . . . 0.0 110.37 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -71.96 0.59 8.92 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.327 1.451 . . . . 0.0 112.811 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.32 71.06 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 119.864 -1.773 . . . . 0.0 111.479 -172.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.65 5.07 1.56 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -125.1 7.77 7.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.907 1.683 . . . . 0.0 111.937 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.5 mt -102.89 116.2 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.933 1.242 . . . . 0.0 109.391 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.91 155.93 63.03 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 126.057 1.743 . . . . 0.0 111.037 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.37 146.71 40.4 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.978 3.119 . . . . 0.0 111.861 172.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 39.7 mtm . . . . . 0 C--O 1.24 0.566 0 C-N-CA 125.307 1.443 . . . . 0.0 112.151 177.339 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -123.35 157.17 33.89 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 167.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -145.63 74.5 1.39 Allowed 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 165.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -167.1 161.52 14.75 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.352 -164.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.3 -2.66 1.76 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.15 -1.361 . . . . 0.0 114.279 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -111.88 86.86 7.79 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 120.089 1.945 . . . . 0.0 110.064 -172.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.5 79.79 1.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.469 2.113 . . . . 0.0 109.47 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.28 155.51 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 120.732 -1.23 . . . . 0.0 112.179 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.59 88.47 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.731 1.612 . . . . 0.0 109.846 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 96.41 0.2 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt 58.51 17.72 5.14 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.393 1.477 . . . . 0.0 114.455 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.17 175.37 11.82 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 31' ' ' ILE . 15.4 mttm -138.27 -0.59 2.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.154 2.181 . . . . 0.0 114.507 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -81.63 -29.36 33.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.606 1.094 . . . . 0.0 112.048 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.59 73.64 10.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.276 1.031 . . . . 0.0 110.893 -160.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -147.16 -49.45 0.18 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.289 0.636 . . . . 0.0 110.458 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.81 71.84 1.05 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.564 1.146 . . . . 0.0 110.702 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.4 -45.55 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -82.4 104.23 12.55 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -60.94 -5.2 1.25 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.546 1.539 . . . . 0.0 114.46 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.29 30.51 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.85 1.204 . . . . 0.0 110.601 -152.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -104.79 88.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 124.497 1.119 . . . . 0.0 109.018 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -70.83 -11.97 61.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.758 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -140.64 135.99 32.25 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 119.855 1.207 . . . . 0.0 108.078 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.18 102.62 7.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -73.66 145.38 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.92 149.75 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.687 1.995 . . . . 0.0 107.98 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -103.14 165.11 14.18 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 125.586 1.554 . . . . 0.0 111.253 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.59 161.49 45.68 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.998 2.465 . . . . 0.0 111.309 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 53.63 23.66 3.73 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.125 2.57 . . . . 0.0 115.432 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.443 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 tt -117.17 63.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.655 1.182 . . . . 0.0 111.4 -171.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.426 ' CA ' ' HE2' ' A' ' 13' ' ' LYS . . . 95.82 164.2 34.03 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 128.407 2.908 . . . . 0.0 112.718 174.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.17 124.1 31.44 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 173.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.34 76.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.692 1.997 . . . . 0.0 108.099 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.22 -165.24 0.17 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.272 -167.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.44 165.21 19.37 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.47 -1.394 . . . . 0.0 111.356 165.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.79 11.26 35.77 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 117.689 1.835 . . . . 0.0 117.689 168.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -43.27 78.39 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 121.53 2.665 . . . . 0.0 111.326 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -116.84 5.96 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.314 1.046 . . . . 0.0 112.382 -155.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -46.69 124.74 6.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.649 1.58 . . . . 0.0 112.852 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.32 20.71 61.87 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.374 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.4 p -71.33 75.1 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.524 -0.986 . . . . 0.0 111.556 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.0 p -59.76 -16.51 28.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.52 1.128 . . . . 0.0 112.929 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.69 71.54 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.323 0.965 . . . . 0.0 110.888 162.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.5 tp -115.79 115.07 25.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.421 1.089 . . . . 0.0 110.095 159.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -139.12 24.26 2.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.086 0.554 . . . . 0.0 111.662 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -159.44 152.02 21.44 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 120.751 -1.218 . . . . 0.0 109.922 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 tp -141.69 138.32 32.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.97 137.88 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 119.704 1.138 . . . . 0.0 108.024 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -114.7 117.27 30.34 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.107 0.963 . . . . 0.0 109.849 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -88.9 30.09 0.97 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.428 1.091 . . . . 0.0 111.735 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 164.43 18.24 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -113.18 2.81 15.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.35 144.56 31.52 Favored Pre-proline 0 N--CA 1.447 -0.621 0 O-C-N 120.636 -1.29 . . . . 0.0 110.892 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -73.85 -32.37 7.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.294 2.663 . . . . 0.0 114.238 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -66.46 -25.9 66.94 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.146 0.43 . . . . 0.0 111.455 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.17 4.88 1.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 113.071 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.17 149.05 52.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.559 1.072 . . . . 0.0 108.505 167.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.9 m -142.64 135.32 27.99 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.658 0.783 . . . . 0.0 109.046 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.26 2.6 0.88 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.56 -67.24 1.28 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.729 2.585 . . . . 0.0 113.916 163.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 174.85 -32.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 131.596 3.958 . . . . 0.0 107.734 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.47 4.17 74.44 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.407 -1.218 . . . . 0.0 115.507 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.2 tp -43.73 -54.03 5.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.69 1.596 . . . . 0.0 112.57 -158.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.6 33.51 5.61 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.54 132.66 53.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.437 1.017 . . . . 0.0 109.911 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 20.97 79.5 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.742 0.686 . . . . 0.0 113.943 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.01 178.61 7.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.43 1.492 . . . . 0.0 110.816 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.97 101.22 0.99 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.829 1.651 . . . . 0.0 108.432 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -146.05 169.08 19.4 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.631 -0.668 . . . . 0.0 112.266 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt -90.04 155.45 19.07 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 128.112 2.565 . . . . 0.0 110.82 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 mt -117.37 94.87 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.183 2.193 . . . . 0.0 108.222 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.82 129.7 38.45 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 121.037 -1.039 . . . . 0.0 110.125 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -130.89 160.1 68.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.52 1.528 . . . . 0.0 108.544 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -67.7 151.74 78.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.729 1.62 . . . . 0.0 110.939 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.72 -36.9 72.65 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.471 0.578 . . . . 0.0 111.594 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -72.61 -6.57 45.11 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.858 -0.527 . . . . 0.0 111.967 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.05 -8.17 20.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.087 1.355 . . . . 0.0 113.776 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tp -63.01 -50.79 69.34 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.639 1.108 . . . . 0.0 111.359 -165.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -63.03 -44.73 95.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -51.74 -53.93 34.1 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.786 1.234 . . . . 0.0 111.029 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -60.25 -38.44 83.5 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.53 0.519 . . . . 0.0 110.61 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -68.96 -25.17 64.41 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.332 -0.855 . . . . 0.0 113.091 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -87.63 -2.38 58.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.346 1.43 . . . . 0.0 112.508 173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -71.04 157.74 37.69 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.064 0.847 . . . . 0.0 112.376 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 19.92 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.336 1.054 . . . . 0.0 113.812 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.92 -68.42 0.4 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 126.989 2.115 . . . . 0.0 108.012 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -57.53 -14.78 5.62 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.254 1.822 . . . . 0.0 114.676 -165.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -44.65 -47.0 10.49 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.506 1.048 . . . . 0.0 113.097 161.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 t -62.72 -16.4 57.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.79 0.836 . . . . 0.0 111.943 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -108.35 10.97 27.47 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.039 -1.663 . . . . 0.0 111.335 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.15 -8.13 35.92 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 119.949 -1.719 . . . . 0.0 112.421 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.98 -6.17 57.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.901 0.881 . . . . 0.0 112.84 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -130.65 -14.85 3.59 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 124.06 0.944 . . . . 0.0 112.536 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.13 144.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 120.833 -1.167 . . . . 0.0 108.616 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -149.01 164.35 21.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.885 0.874 . . . . 0.0 110.882 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.73 149.92 73.71 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.98 2.453 . . . . 0.0 113.835 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 mtm -69.43 175.12 4.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.752 165.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -144.24 -176.62 5.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.703 2.801 . . . . 0.0 107.044 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--O 1.252 1.226 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 154.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m -89.94 121.38 31.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 156.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -130.16 56.26 1.76 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 170.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.68 165.01 33.63 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 128.412 2.685 . . . . 0.0 105.912 166.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.18 57.53 0.12 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 124.377 0.989 . . . . 0.0 111.097 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -68.01 162.35 60.12 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 117.848 0.824 . . . . 0.0 109.324 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -81.79 76.85 4.12 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.94 1.76 . . . . 0.0 109.539 -169.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.34 160.26 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.108 -1.62 . . . . 0.0 110.782 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.26 99.05 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.53 1.532 . . . . 0.0 108.411 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.16 121.68 1.08 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.73 -11.33 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.92 2.888 . . . . 0.0 117.429 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -135.16 153.5 51.95 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 121.122 1.783 . . . . 0.0 108.523 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -135.35 51.61 2.07 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.229 1.811 . . . . 0.0 109.939 170.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -127.26 -17.95 4.63 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.7 75.92 0.95 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.066 1.303 . . . . 0.0 109.57 -167.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -130.51 -55.47 1.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.284 1.034 . . . . 0.0 110.71 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.68 30.52 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.806 2.043 . . . . 0.0 113.372 -165.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.05 -36.09 1.55 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.018 1.771 . . . . 0.0 113.07 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -89.26 102.53 15.2 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.283 2.042 . . . . 0.0 112.065 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.3 p -65.66 6.48 0.33 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.265 1.826 . . . . 0.0 114.21 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.82 -1.46 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.834 1.254 . . . . 0.0 109.96 -167.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.1 tt -69.54 111.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -91.05 -14.23 31.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.766 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -146.44 139.98 25.94 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.605 0.762 . . . . 0.0 110.402 -168.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.2 mt -137.4 101.41 2.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.1 132.96 45.86 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 162.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.02 133.79 67.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 126.058 1.743 . . . . 0.0 108.193 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -94.48 162.98 24.21 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 122.889 0.476 . . . . 0.0 110.969 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.79 151.9 78.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.291 1.994 . . . . 0.0 109.635 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 52.73 38.22 25.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.207 1.803 . . . . 0.0 113.471 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 tp -119.88 0.78 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.499 1.12 . . . . 0.0 113.192 -164.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.38 169.3 11.7 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.247 1.404 . . . . 0.0 112.445 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 132.49 37.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 112.028 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.96 77.98 9.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.147 1.779 . . . . 0.0 107.189 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -69.63 164.17 23.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.994 0.902 . . . . 0.0 110.342 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -66.99 110.83 3.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.311 1.445 . . . . 0.0 110.102 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.43 11.05 32.21 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.283 0.944 . . . . 0.0 114.546 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.5 mtp -52.93 -23.83 8.0 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -127.28 20.03 6.85 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 110.736 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 t -63.59 94.16 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.857 1.263 . . . . 0.0 110.671 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.21 -7.74 6.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.939 1.733 . . . . 0.0 112.859 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.97 70.37 9.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.127 1.963 . . . . 0.0 109.501 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.9 p -67.05 -25.32 66.2 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.161 -0.962 . . . . 0.0 113.338 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.0 -2.11 57.58 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.605 -1.309 . . . . 0.0 113.119 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.84 119.9 24.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.051 0.94 . . . . 0.0 110.207 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -141.11 2.75 1.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.518 0.727 . . . . 0.0 112.239 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -126.97 153.95 45.2 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.183 -1.573 . . . . 0.0 111.186 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 tp -146.14 100.96 3.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.434 3.494 . . . . 0.0 104.143 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.15 124.35 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 120.89 -1.132 . . . . 0.0 108.084 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mp -101.72 107.86 19.21 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 107.878 -168.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.8 p -77.15 19.72 0.3 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.53 161.09 20.05 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 120.076 1.307 . . . . 0.0 112.445 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -97.31 -4.22 39.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.501 1.52 . . . . 0.0 112.976 -167.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.85 148.4 42.36 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 119.935 1.243 . . . . 0.0 110.4 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.28 -36.45 7.07 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.113 2.542 . . . . 0.0 112.45 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -25.39 63.82 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.484 0.584 . . . . 0.0 112.441 -172.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -1.4 31.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.688 1.595 . . . . 0.0 113.434 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -127.9 126.8 42.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.16 171.86 11.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.701 1.6 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.3 146.85 3.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.496 1.118 . . . . 0.0 109.624 159.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.27 -173.06 34.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 164.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.3 -48.55 81.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.131 0.972 . . . . 0.0 109.061 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.94 36.58 3.02 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 117.536 -1.702 . . . . 0.0 112.315 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tt -44.56 -56.4 4.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.114 1.457 . . . . 0.0 107.526 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 25.31 10.33 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 125.462 1.505 . . . . 0.0 113.241 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.27 130.1 41.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.49 1.041 . . . . 0.0 111.619 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.36 79.35 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.438 1.018 . . . . 0.0 114.641 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.73 -170.47 2.63 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.04 93.65 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.424 -0.798 . . . . 0.0 109.406 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -125.04 165.12 18.74 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -98.36 158.25 15.7 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 128.168 2.587 . . . . 0.0 110.145 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.4 mt -116.05 90.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.278 1.831 . . . . 0.0 108.744 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.6 136.65 36.28 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.843 -1.161 . . . . 0.0 108.872 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.09 160.83 67.12 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 126.708 2.003 . . . . 0.0 108.379 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.49 153.58 60.55 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.555 1.504 . . . . 0.0 109.267 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.78 -35.63 64.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.071 0.548 . . . . 0.0 112.232 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.26 -42.48 73.59 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.936 1.294 . . . . 0.0 110.885 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.83 57.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.948 0.899 . . . . 0.0 112.318 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.2 tp -51.68 -61.57 2.17 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.099 1.318 . . . . 0.0 112.078 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.81 -28.38 61.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.533 1.133 . . . . 0.0 110.175 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -59.96 -46.16 90.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.469 1.508 . . . . 0.0 110.195 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -64.65 -41.48 96.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.03 0.832 . . . . 0.0 110.215 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -65.41 -12.64 54.25 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 116.921 -1.514 . . . . 0.0 114.361 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -96.38 2.73 52.94 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 121.685 2.039 . . . . 0.0 112.919 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.32 143.9 36.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.709 1.141 . . . . 0.0 111.994 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.72 10.45 1.39 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.044 1.338 . . . . 0.0 113.746 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -137.24 -64.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.123 1.769 . . . . 0.0 111.029 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -54.21 -20.82 7.54 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.776 1.171 . . . . 0.0 113.649 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -43.81 -47.66 8.13 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.852 1.261 . . . . 0.0 113.91 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 t -64.09 -24.16 67.6 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.665 0.666 . . . . 0.0 111.86 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -96.77 14.55 24.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.361 1.064 . . . . 0.0 111.137 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.14 -18.21 33.77 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 120.288 -1.508 . . . . 0.0 111.04 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.13 -22.36 28.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 113.084 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -119.45 -8.48 10.02 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.527 1.131 . . . . 0.0 112.983 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.11 115.65 29.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -149.27 165.46 17.62 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.269 1.028 . . . . 0.0 111.277 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.71 158.75 40.48 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.412 2.075 . . . . 0.0 114.441 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 13.4 mtm -78.15 176.34 9.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.169 1.787 . . . . 0.0 109.979 161.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -98.73 -177.45 3.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.124 0.97 . . . . 0.0 109.005 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.252 1.234 0 C-N-CA 124.925 1.29 . . . . 0.0 109.792 -179.297 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.394 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -78.74 91.76 4.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -174.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -124.76 150.42 46.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.586 1.554 . . . . 0.0 108.4 -169.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -61.77 125.09 22.59 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.162 0.985 . . . . 0.0 108.466 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.44 66.14 0.04 OUTLIER Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -115.21 160.36 34.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 125.208 1.403 . . . . 0.0 109.902 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.94 72.25 6.59 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.873 3.049 . . . . 0.0 110.48 -167.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.9 165.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.714 2.006 . . . . 0.0 107.518 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 p -113.33 157.19 14.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 109.199 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 -75.49 0.2 Allowed Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.5 mmt -123.69 3.17 8.9 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -167.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -136.94 156.09 48.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.5 1.046 . . . . 0.0 108.901 169.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -139.17 82.52 1.9 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.131 1.373 . . . . 0.0 110.167 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -150.01 -44.49 0.13 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.815 1.646 . . . . 0.0 111.689 162.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.85 10.48 0.05 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 -168.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -82.05 -12.64 58.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 119.801 -1.812 . . . . 0.0 113.618 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.02 79.74 1.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.61 -13.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.761 -1.577 . . . . 0.0 116.169 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -112.91 91.73 3.76 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 120.295 2.047 . . . . 0.0 109.345 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -66.35 31.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.755 3.622 . . . . 0.0 113.98 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.88 -7.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.371 1.869 . . . . 0.0 111.736 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.94 89.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.025 0.83 . . . . 0.0 110.511 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -72.1 -13.86 61.69 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.501 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -144.68 137.38 26.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -168.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -136.6 120.01 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.548 1.539 . . . . 0.0 106.963 170.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 m -84.42 143.75 29.22 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.949 -1.095 . . . . 0.0 108.162 158.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.42 139.79 44.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -101.71 165.07 14.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.705 1.202 . . . . 0.0 111.573 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -66.71 144.95 73.85 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.631 1.554 . . . . 0.0 109.625 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 47.8 74.29 0.17 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.819 1.647 . . . . 0.0 112.282 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.268 4.8 tp -143.0 33.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 121.619 0.724 . . . . 0.0 112.153 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.48 170.88 16.89 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.84 1.686 . . . . 0.0 111.49 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.3 tp -83.92 127.38 33.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.115 0.958 . . . . 0.0 109.713 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.6 mt -73.02 90.11 1.48 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 162.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 38' ' ' MET . 54.5 p90 -70.44 -164.61 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.91 0.884 . . . . 0.0 112.175 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -158.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.846 -0.597 . . . . 0.0 112.032 160.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.15 76.89 0.0 OUTLIER Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.57 2.033 . . . . 0.0 117.407 -165.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.433 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 30.9 mtp -67.62 -22.06 65.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.317 1.847 . . . . 0.0 111.125 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.72 10.06 4.67 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.129 0.972 . . . . 0.0 110.675 -161.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -62.38 118.16 7.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.33 52.32 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.709 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.1 p -68.39 73.79 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.131 1.965 . . . . 0.0 111.577 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 p -63.7 2.07 0.52 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.955 1.302 . . . . 0.0 113.627 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.91 39.88 0.87 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.229 -1.367 . . . . 0.0 112.272 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.77 120.64 42.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.477 1.944 . . . . 0.0 110.582 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.07 -13.3 5.12 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -117.86 162.98 17.23 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.662 1.119 . . . . 0.0 111.851 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 tp -148.67 145.76 27.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.014 2.126 . . . . 0.0 106.96 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -128.61 134.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -111.57 112.4 24.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -74.58 -14.6 60.8 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.94 -176.44 50.75 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.36 0.981 . . . . 0.0 110.81 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.57 3.64 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.92 143.56 25.76 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 118.243 0.474 . . . . 0.0 110.169 -174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.63 -27.63 32.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.677 2.918 . . . . 0.0 112.373 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.9 m -75.62 9.88 2.02 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.276 -0.89 . . . . 0.0 112.553 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.04 7.43 36.47 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.255 -0.903 . . . . 0.0 112.433 162.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -138.38 111.64 7.99 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.234 1.413 . . . . 0.0 110.052 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.18 177.55 7.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.183 1.793 . . . . 0.0 110.848 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.65 160.96 15.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.395 3.078 . . . . 0.0 105.389 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.52 -101.63 2.73 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.04 -57.49 1.78 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.187 1.795 . . . . 0.0 108.017 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.1 74.58 0.22 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 124.486 1.041 . . . . 0.0 111.928 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tp -43.74 -41.78 5.08 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.972 2.109 . . . . 0.0 110.259 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.85 56.08 1.87 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.786 2.034 . . . . 0.0 107.985 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.46 129.86 41.5 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 164.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.29 87.13 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.069 0.842 . . . . 0.0 115.17 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.71 170.8 14.72 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.297 1.439 . . . . 0.0 110.61 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.65 101.82 2.01 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.856 1.662 . . . . 0.0 107.765 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.11 169.06 18.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.104 0.562 . . . . 0.0 111.409 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.31 146.19 26.03 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.007 1.323 . . . . 0.0 110.609 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.5 mt -112.01 96.49 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 128.363 2.665 . . . . 0.0 109.92 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.7 m -83.68 134.54 34.77 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.002 -1.061 . . . . 0.0 112.06 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.8 157.87 74.08 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 126.09 1.756 . . . . 0.0 109.443 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.96 148.86 64.73 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 CA-C-N 121.878 1.706 . . . . 0.0 111.15 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.99 -35.95 64.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.971 0.909 . . . . 0.0 112.014 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -67.8 -20.81 65.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.253 1.821 . . . . 0.0 111.852 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -112.41 -0.28 15.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.118 1.367 . . . . 0.0 112.4 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.23 -34.63 76.86 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.111 -0.993 . . . . 0.0 111.852 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -83.25 -33.05 26.13 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.187 0.995 . . . . 0.0 109.847 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.52 -63.31 1.16 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.235 2.214 . . . . 0.0 111.282 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -64.92 -37.13 86.62 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.848 0.459 . . . . 0.0 110.355 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.08 -24.79 67.83 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.445 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -85.72 -4.55 59.19 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.895 1.225 . . . . 0.0 113.067 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.01 150.05 47.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.108 1.322 . . . . 0.0 110.878 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.37 -44.57 90.95 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.455 -0.778 . . . . 0.0 110.281 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -83.28 -65.33 1.02 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.075 0.95 . . . . 0.0 109.271 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -58.0 -15.7 9.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -164.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -45.02 -43.79 9.52 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.567 1.076 . . . . 0.0 112.858 165.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -63.39 -14.57 51.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -113.56 14.97 19.05 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.377 -1.452 . . . . 0.0 111.663 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.1 3.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.423 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.58 -12.07 59.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.115 166.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -130.26 0.64 4.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.835 1.198 . . . . 0.0 112.805 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.9 mt -89.85 113.24 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -135.42 164.64 42.22 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 126.249 1.819 . . . . 0.0 110.444 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.56 164.24 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.026 1.817 . . . . 0.0 113.407 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 mtm -82.58 172.44 12.97 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.188 1.795 . . . . 0.0 109.261 161.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -126.13 -173.15 2.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.655 1.182 . . . . 0.0 109.758 171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.608 1.963 . . . . 0.0 106.343 168.356 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.42 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.2 85.29 1.27 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.778 1.231 . . . . 0.0 107.725 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.7 m170 66.31 169.92 0.23 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.406 2.682 . . . . 0.0 111.981 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -66.41 152.44 45.09 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.263 0.625 . . . . 0.0 110.2 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.61 73.56 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -53.21 157.93 2.87 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 148.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.18 91.02 0.46 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.863 2.375 . . . . 0.0 107.954 167.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.16 130.46 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 120.554 -1.341 . . . . 0.0 107.479 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.55 122.48 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 122.913 0.485 . . . . 0.0 110.301 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.12 81.33 0.21 Allowed Glycine 0 C--O 1.223 -0.559 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 68.0 mtp 58.82 -60.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.896 2.478 . . . . 0.0 114.351 -168.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.91 91.43 2.47 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.417 1.008 . . . . 0.0 108.351 -171.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -72.71 88.55 1.3 Allowed 'General case' 0 CA--C 1.519 -0.221 0 O-C-N 120.915 -1.116 . . . . 0.0 108.02 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -173.21 54.13 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.922 2.089 . . . . 0.0 109.686 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.15 61.51 0.45 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.814 1.246 . . . . 0.0 110.58 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -131.44 -44.47 1.01 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.223 0.609 . . . . 0.0 111.413 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.34 77.25 1.01 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.154 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.06 -28.0 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.612 -1.66 . . . . 0.0 113.859 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -117.98 87.88 2.8 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.224 2.012 . . . . 0.0 112.769 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.0 9.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 132.223 4.209 . . . . 0.0 118.108 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.87 19.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.72 1.608 . . . . 0.0 109.546 -166.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.04 113.44 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 166.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -95.86 -17.62 20.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.453 1.101 . . . . 0.0 111.444 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -148.31 134.0 18.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.93 0.769 . . . . 0.0 111.02 -160.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 mt -141.29 90.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.36 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.3 m -86.16 87.71 7.47 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.558 0.743 . . . . 0.0 109.087 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.09 164.26 3.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 O-C-N 121.003 -1.061 . . . . 0.0 108.852 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -126.23 165.54 27.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.959 1.303 . . . . 0.0 109.919 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.8 149.76 60.79 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.074 1.849 . . . . 0.0 111.026 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 48.48 66.03 1.18 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.191 2.996 . . . . 0.0 111.374 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.93 55.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 110.685 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.21 144.45 15.31 Favored Glycine 0 C--O 1.241 0.561 0 O-C-N 121.018 -1.051 . . . . 0.0 112.603 170.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.83 141.38 58.67 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.319 1.048 . . . . 0.0 108.445 171.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.43 77.83 2.99 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.495 1.118 . . . . 0.0 108.316 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -70.46 162.7 28.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.081 0.943 . . . . 0.0 111.12 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -70.23 113.57 7.53 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.582 1.953 . . . . 0.0 110.312 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.89 4.85 36.12 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.456 1.027 . . . . 0.0 114.156 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.7 mmm -48.2 -41.36 26.99 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.835 1.317 . . . . 0.0 112.824 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -112.27 18.75 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.789 1.236 . . . . 0.0 111.787 -165.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -60.22 121.2 11.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.89 12.9 65.47 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.204 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.4 m -80.03 63.52 4.58 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.855 1.327 . . . . 0.0 110.296 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.5 p -63.47 -13.74 43.64 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -164.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.14 -1.35 29.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.47 -1.393 . . . . 0.0 113.029 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.78 108.74 14.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 110.313 -171.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -126.46 -10.12 6.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -135.9 143.15 44.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.949 1.299 . . . . 0.0 111.837 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.46 140.31 35.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.237 2.215 . . . . 0.0 107.112 173.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -131.57 150.48 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.8 mt -133.39 106.55 7.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.832 1.253 . . . . 0.0 109.627 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.2 p -82.27 45.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.886 0.766 . . . . 0.0 111.373 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -143.35 129.86 3.89 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.749 -1.219 . . . . 0.0 111.08 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.45 3.3 47.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.469 2.307 . . . . 0.0 112.753 -163.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.04 144.22 34.25 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 120.531 -1.356 . . . . 0.0 108.477 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -67.03 -33.48 31.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.735 1.623 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -62.24 -20.67 64.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.033 0.933 . . . . 0.0 112.541 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 9.82 0.43 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.956 1.702 . . . . 0.0 113.568 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.54 -177.07 5.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 109.46 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 t -145.65 -177.04 5.37 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.334 1.454 . . . . 0.0 108.847 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.82 6.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 128.492 2.717 . . . . 0.0 107.947 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.23 -171.21 24.92 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 151.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.4 -51.52 43.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.21 58.37 5.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.507 1.051 . . . . 0.0 112.095 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.8 tp -44.94 -35.01 2.64 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.398 1.879 . . . . 0.0 112.048 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 29.86 4.22 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 119.821 -1.799 . . . . 0.0 112.087 178.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.87 135.36 15.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.666 0.666 . . . . 0.0 111.101 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.06 -18.7 52.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.267 0.937 . . . . 0.0 112.889 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.0 -178.51 4.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.81 1.644 . . . . 0.0 109.461 173.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -160.91 104.58 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -133.52 168.12 19.22 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.801 0.84 . . . . 0.0 111.603 -169.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -85.61 145.42 27.35 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.994 0.918 . . . . 0.0 112.092 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -105.8 143.51 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.872 2.469 . . . . 0.0 108.986 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -127.87 138.59 52.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.044 1.338 . . . . 0.0 108.986 171.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.22 164.51 42.4 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.951 2.101 . . . . 0.0 108.376 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.62 147.74 82.23 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.816 1.684 . . . . 0.0 109.446 171.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -51.28 -33.48 28.78 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.63 -26.41 67.81 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.336 1.454 . . . . 0.0 110.689 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.78 -4.88 25.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.581 1.552 . . . . 0.0 112.21 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.75 -54.32 45.77 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.878 1.217 . . . . 0.0 112.081 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.72 -33.78 76.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.447 0.699 . . . . 0.0 110.068 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -59.83 -52.75 64.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.534 1.534 . . . . 0.0 111.816 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -58.85 -40.73 85.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.502 0.721 . . . . 0.0 110.027 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 -70.9 -16.91 62.71 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.89 5.38 45.35 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.95 1.25 . . . . 0.0 112.713 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.47 178.15 0.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.701 1.6 . . . . 0.0 113.039 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.4 -20.25 17.93 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.6 -1.313 . . . . 0.0 112.33 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -113.03 -53.94 2.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.684 1.129 . . . . 0.0 110.656 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -58.53 -15.64 12.07 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -46.07 -43.82 14.94 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 115.443 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -44.91 75.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.033 1.288 . . . . 0.0 108.564 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.1 5.74 6.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 112.823 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.51 -21.22 66.2 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.949 1.249 . . . . 0.0 111.769 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -10.58 19.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -119.48 4.55 11.16 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 124.623 1.169 . . . . 0.0 111.563 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.7 mt -97.13 100.97 11.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -119.23 165.14 18.01 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.18 0.992 . . . . 0.0 112.571 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.29 169.1 22.41 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.508 2.805 . . . . 0.0 112.534 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.2 mtm -84.76 169.21 14.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.162 2.185 . . . . 0.0 111.758 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.73 172.7 10.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.578 1.951 . . . . 0.0 108.336 164.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.202 0 CA-C-O 116.285 -1.817 . . . . 0.0 111.986 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.9 t -158.04 145.29 18.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.966 1.307 . . . . 0.0 108.152 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 44.23 81.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.02 2.128 . . . . 0.0 111.955 -171.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -148.78 -165.51 2.3 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.77 22.53 15.71 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-O 118.435 -1.203 . . . . 0.0 113.667 168.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.67 82.3 1.32 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 163.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.43 64.64 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.026 3.151 . . . . 0.0 109.685 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.65 153.15 27.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.639 -1.288 . . . . 0.0 109.548 -168.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -92.81 61.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.77 -83.93 0.09 OUTLIER Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.4 mtp -140.18 -35.58 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.89 130.82 44.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.024 1.284 . . . . 0.0 111.939 -172.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -91.98 95.38 9.77 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.92 -52.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 108.334 173.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 8.41 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.589 2.356 . . . . 0.0 117.339 -171.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -89.26 -0.59 57.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.916 1.235 . . . . 0.0 113.736 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.55 86.5 2.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.474 1.034 . . . . 0.0 109.741 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.41 -26.98 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 117.608 -1.662 . . . . 0.0 114.741 167.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -95.65 99.21 11.1 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.806 2.303 . . . . 0.0 110.116 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 p -65.57 19.61 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.051 2.941 . . . . 0.0 115.155 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.81 4.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 120.594 -1.316 . . . . 0.0 111.786 -159.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 tt -90.94 104.38 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 O-C-N 120.103 -1.623 . . . . 0.0 107.155 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -84.08 -15.9 45.72 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 117.667 -1.159 . . . . 0.0 111.835 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -138.83 129.75 26.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.249 0.931 . . . . 0.0 110.194 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.9 mt -129.89 97.87 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -79.4 115.18 18.88 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.411 -0.806 . . . . 0.0 109.118 171.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.49 125.33 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.145 1.778 . . . . 0.0 110.598 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.76 164.77 51.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 170.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.43 162.03 36.61 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.321 2.014 . . . . 0.0 108.738 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 46.79 53.08 10.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.191 1.396 . . . . 0.0 111.932 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.25 22.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.095 -1.003 . . . . 0.0 113.023 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.63 160.36 9.11 Favored Glycine 0 CA--C 1.521 0.437 0 O-C-N 120.843 -1.161 . . . . 0.0 111.028 165.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.9 tp -72.25 129.09 37.6 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.963 -1.316 . . . . 0.0 108.418 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -85.52 87.83 7.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.69 -166.62 0.58 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.302 0.641 . . . . 0.0 109.375 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.93 148.26 36.47 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 2.59 90.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.1 -1.389 . . . . 0.0 116.312 164.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -34.93 70.34 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.483 2.142 . . . . 0.0 110.107 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.06 17.51 22.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.685 1.594 . . . . 0.0 111.196 -172.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 t -57.16 109.78 0.72 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.55 0.99 46.73 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.631 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -79.02 66.63 4.51 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.538 2.169 . . . . 0.0 110.203 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.0 p -66.04 -6.61 13.48 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.652 1.981 . . . . 0.0 113.695 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.82 25.81 3.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.829 1.252 . . . . 0.0 110.887 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.8 135.19 47.98 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 171.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.6 -25.09 1.03 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.256 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.05 154.92 43.73 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.554 1.941 . . . . 0.0 110.88 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.45 147.7 27.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.32 2.248 . . . . 0.0 105.311 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.29 142.81 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.5 mt -121.12 116.19 24.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.858 0.863 . . . . 0.0 110.212 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.7 p -86.25 3.22 44.12 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.628 0.974 . . . . 0.0 113.628 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.93 162.17 23.92 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 120.802 -1.186 . . . . 0.0 110.931 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -110.61 3.25 19.21 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -164.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -152.6 144.66 16.7 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.119 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.53 -23.25 64.52 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.397 2.731 . . . . 0.0 112.87 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -60.95 -23.75 65.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.395 0.998 . . . . 0.0 112.143 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.84 4.87 17.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.134 0.973 . . . . 0.0 113.151 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -134.9 170.58 15.65 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 126.8 2.04 . . . . 0.0 110.027 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 m -122.16 -176.56 3.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.147 1.379 . . . . 0.0 109.027 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 174.72 -17.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.884 1.674 . . . . 0.0 113.02 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 47.35 -97.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 128.24 2.829 . . . . 0.0 111.349 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.27 14.78 1.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.233 1.413 . . . . 0.0 109.896 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.05 14.09 3.31 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 117.474 -1.736 . . . . 0.0 115.251 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 tt -44.22 -51.62 8.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.822 2.311 . . . . 0.0 111.874 -165.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -86.09 -7.36 58.65 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 116.975 -1.488 . . . . 0.0 114.823 -171.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.2 118.3 4.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.967 0.803 . . . . 0.0 111.11 -152.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.51 -9.28 38.14 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.823 1.677 . . . . 0.0 114.266 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.57 -174.38 3.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.147 1.474 . . . . 0.0 114.064 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -151.0 115.66 5.18 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 131.453 3.901 . . . . 0.0 103.749 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -147.91 -175.11 4.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.392 1.077 . . . . 0.0 109.972 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.7 tp -127.64 148.4 50.38 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.346 -1.471 . . . . 0.0 110.035 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -110.72 136.87 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.036 2.134 . . . . 0.0 107.77 -173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 33.7 m -123.43 122.62 38.73 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.994 2.117 . . . . 0.0 110.813 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.88 158.79 58.86 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 107.29 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -69.77 153.57 68.72 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.32 -32.54 73.31 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -27.03 66.65 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.39 0.541 . . . . 0.0 110.445 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -92.74 -7.82 45.55 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.167 -0.958 . . . . 0.0 111.857 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 tp -62.04 -55.94 24.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.104 1.775 . . . . 0.0 111.517 -162.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.72 -30.03 70.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.737 -0.602 . . . . 0.0 110.691 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -59.21 -31.58 69.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.178 1.391 . . . . 0.0 112.475 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -77.69 -41.5 37.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.342 0.974 . . . . 0.0 110.497 166.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -65.98 -27.06 67.86 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 0.0 113.506 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -77.12 -3.07 37.49 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.157 -0.965 . . . . 0.0 111.819 173.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 130.45 35.04 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 121.026 1.739 . . . . 0.0 107.902 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.67 -38.15 90.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.09 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.42 -61.77 1.65 Allowed 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.601 0.637 . . . . 0.0 110.378 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -58.52 -9.1 1.45 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.32 -47.78 6.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.083 0.953 . . . . 0.0 111.908 163.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 t -61.11 -17.92 55.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.576 0.751 . . . . 0.0 111.272 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -113.14 5.61 17.14 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.614 1.966 . . . . 0.0 113.755 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.46 -24.95 65.64 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.946 1.248 . . . . 0.0 111.548 -171.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.09 -13.98 62.63 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -123.33 17.03 9.81 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.632 1.106 . . . . 0.0 111.546 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -103.73 123.07 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -130.01 166.04 29.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.553 1.941 . . . . 0.0 110.917 173.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.22 174.19 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.317 2.678 . . . . 0.0 112.006 169.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 mtm -96.3 170.7 9.06 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.74 1.616 . . . . 0.0 111.562 170.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -91.17 175.29 6.99 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.4 1.08 . . . . 0.0 110.279 162.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 130.047 3.339 . . . . 0.0 108.107 -160.256 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.912 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -57.93 148.76 24.7 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 118.843 1.321 . . . . 0.0 111.776 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 176.5 159.82 0.33 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 128.325 2.65 . . . . 0.0 108.312 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -92.34 163.92 13.7 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.604 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -113.55 16.92 21.36 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 117.575 -1.681 . . . . 0.0 113.989 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.8 86.01 0.55 Allowed Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 119.762 1.781 . . . . 0.0 108.872 173.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.11 78.95 2.13 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.78 2.986 . . . . 0.0 108.793 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.97 154.84 19.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 120.687 -1.258 . . . . 0.0 108.013 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.45 155.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 123.932 0.77 . . . . 0.0 109.189 165.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.4 -70.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 36.2 mtp -146.54 -51.98 0.22 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.245 1.418 . . . . 0.0 109.499 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -84.67 113.96 21.67 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.505 0.722 . . . . 0.0 109.695 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 27.2 mmtp -75.28 6.93 3.87 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -85.94 5.11 34.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -104.18 4.9 34.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -159.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -85.85 -57.28 3.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.364 0.984 . . . . 0.0 110.506 -165.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.47 85.21 0.28 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.019 2.528 . . . . 0.0 110.643 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.2 -17.72 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.934 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.04 114.9 28.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.378 1.589 . . . . 0.0 110.797 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 p -73.2 -0.66 14.95 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.597 -1.314 . . . . 0.0 114.173 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.84 -8.89 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 120.305 1.411 . . . . 0.0 110.8 -152.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 tt -65.16 99.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 127.637 2.375 . . . . 0.0 108.103 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -85.95 -10.0 55.91 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.739 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -141.43 134.98 29.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.286 0.948 . . . . 0.0 108.839 -172.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.03 122.55 49.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -83.09 141.17 32.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 160.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.7 143.31 32.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 124.147 0.979 . . . . 0.0 108.367 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -92.78 164.28 22.69 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 110.226 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.81 171.25 14.85 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.634 2.223 . . . . 0.0 110.007 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 48.68 35.39 6.19 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.601 1.96 . . . . 0.0 113.91 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.506 ' O ' ' HE3' ' A' ' 13' ' ' LYS 0.255 5.4 tt -131.53 63.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 122.634 1.207 . . . . 0.0 112.432 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.64 159.56 32.05 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.153 1.358 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.1 168.54 8.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.8 1.24 . . . . 0.0 111.671 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.1 mt -133.2 84.78 2.16 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -84.43 162.05 20.09 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.061 0.391 . . . . 0.0 110.726 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.18 126.03 26.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.371 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.49 11.44 64.21 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.692 -1.06 . . . . 0.0 114.693 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -62.38 -32.94 73.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.22 2.01 . . . . 0.0 112.415 172.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -107.02 29.3 7.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.027 1.731 . . . . 0.0 110.996 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 t -66.12 102.83 0.87 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.78 48.32 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.828 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.09 63.37 1.8 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.78 1.79 . . . . 0.0 109.618 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 p -73.62 -12.51 60.77 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -158.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.42 13.8 19.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.857 1.208 . . . . 0.0 112.131 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.32 117.59 8.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -126.94 -8.65 6.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -148.33 148.55 30.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.18 0.992 . . . . 0.0 112.282 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tp -151.39 100.49 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.88 138.15 21.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 mt -123.48 129.85 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.051 0.94 . . . . 0.0 108.976 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 p -113.67 35.58 3.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.173 0.989 . . . . 0.0 111.409 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.62 139.9 11.35 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.1 4.13 21.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -163.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -151.75 144.49 16.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 120.64 -1.288 . . . . 0.0 109.423 -164.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -37.97 3.05 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.152 2.568 . . . . 0.0 113.241 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -74.95 -7.04 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.012 0.824 . . . . 0.0 112.095 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.08 -10.93 59.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.031 0.932 . . . . 0.0 112.237 165.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -97.71 173.11 7.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 123.263 1.506 . . . . 0.0 110.709 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -164.39 1.08 Allowed 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 129.111 2.964 . . . . 0.0 106.869 169.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 77.05 142.64 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 130.223 3.409 . . . . 0.0 110.567 -169.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.91 -31.63 0.02 OUTLIER Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.214 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.5 -45.33 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.276 2.231 . . . . 0.0 110.235 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.44 71.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.554 -1.137 . . . . 0.0 112.248 -162.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.1 tp -44.63 -63.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.276 1.038 . . . . 0.0 110.766 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.6 -9.74 59.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 116.916 -1.516 . . . . 0.0 112.311 -164.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -45.29 112.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.954 1.302 . . . . 0.0 110.497 -157.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.08 -6.06 28.89 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.606 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.31 173.26 13.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.223 1.809 . . . . 0.0 110.73 168.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -140.48 81.91 1.83 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.167 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -95.26 -176.79 3.91 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.197 1.399 . . . . 0.0 109.023 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.85 157.86 28.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 107.515 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.5 139.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.637 1.175 . . . . 0.0 108.814 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.26 135.36 54.21 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.533 1.133 . . . . 0.0 110.126 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -136.74 155.29 76.7 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 126.166 1.786 . . . . 0.0 107.036 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 153.71 71.22 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 121.536 1.584 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.09 -30.2 66.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.1 -29.69 69.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.322 1.049 . . . . 0.0 111.326 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.09 -11.63 22.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.33 1.052 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 tp -57.68 -52.06 66.97 Favored 'General case' 0 C--O 1.228 -0.055 0 O-C-N 121.108 -0.995 . . . . 0.0 110.45 -170.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -27.38 68.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -59.11 5.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.442 1.497 . . . . 0.0 109.551 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -63.01 -26.62 68.94 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.556 1.071 . . . . 0.0 111.414 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -17.17 61.45 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -103.26 -9.43 19.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.637 1.108 . . . . 0.0 113.612 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.97 151.27 26.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.489 1.116 . . . . 0.0 111.831 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.64 -50.74 72.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.014 -0.429 . . . . 0.0 111.679 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -82.94 -60.68 2.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 108.936 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -60.06 -15.63 24.63 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -43.96 -49.5 8.51 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 120.105 1.32 . . . . 0.0 112.98 164.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 t -57.19 -31.3 65.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -93.8 15.86 15.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.806 1.242 . . . . 0.0 112.658 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.71 65.69 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.016 -1.677 . . . . 0.0 112.18 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.44 38.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.112 0.965 . . . . 0.0 112.979 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -127.43 21.07 6.66 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.87 106.95 21.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 119.898 1.226 . . . . 0.0 108.739 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.62 164.86 26.03 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.088 1.755 . . . . 0.0 111.161 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.55 163.0 36.62 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.66 2.24 . . . . 0.0 112.211 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.7 mtt -75.78 176.82 7.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.859 1.264 . . . . 0.0 109.581 163.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -103.2 -166.66 1.29 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.133 1.373 . . . . 0.0 110.059 167.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.858 1.663 . . . . 0.0 107.999 -170.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.7 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 m -62.57 144.42 56.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.051 0.426 . . . . 0.0 110.796 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -147.14 36.93 0.93 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.612 1.165 . . . . 0.0 109.881 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -139.71 145.24 38.1 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.732 1.213 . . . . 0.0 108.541 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.29 74.66 0.16 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -66.64 165.28 25.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.239 0.615 . . . . 0.0 110.494 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.34 68.39 5.17 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.112 3.208 . . . . 0.0 109.816 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.54 146.79 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 108.062 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -86.03 99.54 7.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.06 86.82 0.18 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 167.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.3 mtp 57.89 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 129.309 3.044 . . . . 0.0 118.241 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -110.44 97.07 6.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 121.69 2.041 . . . . 0.0 111.034 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -73.16 28.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.921 1.288 . . . . 0.0 113.221 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.71 28.47 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.626 1.103 . . . . 0.0 111.671 -168.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -125.1 1.94 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.11 1.364 . . . . 0.0 113.562 -171.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.504 ' C ' ' H ' ' A' ' 18' ' ' GLY . 26.4 m-85 -91.67 -36.3 13.7 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.321 -0.862 . . . . 0.0 111.418 -162.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.53 14.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.458 2.303 . . . . 0.0 114.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -114.58 -13.54 9.51 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.328 1.918 . . . . 0.0 113.848 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -120.86 107.13 12.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.215 2.007 . . . . 0.0 111.894 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.4 p -79.09 9.62 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.013 1.725 . . . . 0.0 114.355 -168.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.7 -4.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.146 -170.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.35 104.32 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -81.74 -15.62 53.75 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 117.954 -1.022 . . . . 0.0 111.13 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -143.44 126.03 15.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.002 0.921 . . . . 0.0 109.452 -162.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 88.0 mt -133.15 103.98 6.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.4 m -75.03 139.77 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 166.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.02 165.45 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.57 1.948 . . . . 0.0 108.024 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.08 165.87 23.57 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 108.992 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.65 162.52 41.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.928 1.752 . . . . 0.0 110.167 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 48.51 19.43 0.23 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.141 2.177 . . . . 0.0 114.549 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 tp -95.06 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 119.895 -1.753 . . . . 0.0 110.758 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.76 151.23 21.33 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 121.14 -0.975 . . . . 0.0 111.728 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.3 tp -70.44 138.47 51.24 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 121.769 0.795 . . . . 0.0 110.293 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.27 99.9 11.9 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 164.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -75.02 165.14 25.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.0 134.62 35.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.833 -1.167 . . . . 0.0 108.352 173.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.17 -0.07 71.58 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.928 1.252 . . . . 0.0 113.204 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -48.75 -44.03 38.23 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.457 2.303 . . . . 0.0 112.676 173.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -95.64 9.83 38.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.598 0.759 . . . . 0.0 112.668 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -58.24 113.65 2.04 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.651 1.114 . . . . 0.0 109.861 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.54 -0.29 53.1 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.004 -1.442 . . . . 0.0 113.721 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.5 m -74.74 67.64 1.61 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.916 1.858 . . . . 0.0 109.284 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -75.17 10.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.389 1.876 . . . . 0.0 113.66 -168.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.32 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.113 0.965 . . . . 0.0 112.943 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.48 118.9 10.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.673 1.579 . . . . 0.0 109.68 -175.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -126.08 -11.59 6.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.313 0.645 . . . . 0.0 111.785 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.81 146.6 25.19 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.168 1.349 . . . . 0.0 111.322 -173.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.33 141.28 25.9 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.542 1.937 . . . . 0.0 106.417 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.25 141.27 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.1 mt -122.74 103.87 8.94 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 109.369 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.8 p -77.53 39.24 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.456 1.502 . . . . 0.0 113.216 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.83 153.52 25.36 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 119.824 -1.798 . . . . 0.0 110.495 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -108.32 4.38 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -158.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.44 144.6 40.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.219 1.008 . . . . 0.0 111.37 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.28 -22.27 5.93 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.3 2.667 . . . . 0.0 115.383 -172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 m -64.95 -36.83 85.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.057 1.299 . . . . 0.0 109.822 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.81 7.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -126.54 128.42 46.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.373 1.069 . . . . 0.0 109.575 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 167.04 13.41 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.221 1.009 . . . . 0.0 110.817 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.88 167.67 16.56 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.117 2.167 . . . . 0.0 108.537 153.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.84 -177.45 40.97 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 158.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -51.76 -44.86 63.51 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.3 1.44 . . . . 0.0 109.847 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.26 82.09 0.3 Allowed Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 127.233 2.349 . . . . 0.0 109.738 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.8 tp -51.53 -63.47 1.12 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.16 0.984 . . . . 0.0 109.623 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.47 17.12 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.121 1.368 . . . . 0.0 112.165 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.26 127.18 28.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.797 0.726 . . . . 0.0 109.244 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.33 81.48 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.249 0.928 . . . . 0.0 113.762 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.54 -164.41 1.82 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.72 2.008 . . . . 0.0 107.402 170.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -167.73 99.37 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 167.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -131.52 168.81 17.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.022 1.329 . . . . 0.0 109.486 -168.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -98.18 152.82 18.96 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.147 1.379 . . . . 0.0 109.653 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.88 138.63 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 0.0 109.458 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -127.52 145.13 50.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.221 1.008 . . . . 0.0 110.014 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.12 158.77 74.95 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 108.58 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -67.17 148.85 81.53 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 CA-C-N 120.938 1.371 . . . . 0.0 110.229 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.4 -22.54 63.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -81.07 -22.85 38.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.022 1.329 . . . . 0.0 112.128 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.71 -1.58 32.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.151 1.38 . . . . 0.0 111.889 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.02 -47.39 83.19 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.769 -0.582 . . . . 0.0 112.019 -165.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.91 -43.67 78.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.443 0.297 . . . . 0.0 110.783 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -46.86 -55.0 8.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.19 1.396 . . . . 0.0 111.61 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -63.44 -41.47 98.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.012 0.824 . . . . 0.0 110.584 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -64.78 -16.09 62.55 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.312 -0.868 . . . . 0.0 112.475 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -101.11 15.55 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.262 1.825 . . . . 0.0 112.817 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 28.7 t70 -76.3 179.29 5.88 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.62 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.405 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 8.8 t80 -106.71 -29.33 9.64 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.609 1.964 . . . . 0.0 112.859 175.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.01 -56.2 2.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.772 0.829 . . . . 0.0 108.764 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -61.57 -10.71 8.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.743 -172.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.308 0.3 OUTLIER -43.89 -57.63 3.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.765 1.226 . . . . 0.0 113.373 168.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.6 t -69.86 -9.87 56.42 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.688 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -104.73 1.32 29.19 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.645 -1.285 . . . . 0.0 111.927 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.45 -3.86 12.85 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 119.671 -1.893 . . . . 0.0 112.585 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.82 -14.05 60.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.169 1.387 . . . . 0.0 112.375 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -127.78 34.96 4.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.203 1.401 . . . . 0.0 109.845 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -109.45 139.0 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.65 163.86 43.84 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.851 1.66 . . . . 0.0 110.127 166.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.92 149.04 91.49 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.86 1.707 . . . . 0.0 110.148 167.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ptp -77.96 160.05 28.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.641 1.177 . . . . 0.0 108.729 173.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.67 -168.55 2.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.876 1.67 . . . . 0.0 107.752 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 C--O 1.246 0.897 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.595 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -71.69 166.16 22.51 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.027 1.331 . . . . 0.0 108.472 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -154.47 39.38 0.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.111 0.964 . . . . 0.0 110.077 163.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.07 -179.24 7.94 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.727 1.611 . . . . 0.0 111.065 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.53 -88.32 0.07 OUTLIER Glycine 0 CA--C 1.521 0.464 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 168.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -133.25 156.2 80.1 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.976 1.311 . . . . 0.0 108.947 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.96 85.52 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.732 3.622 . . . . 0.0 107.298 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -150.1 147.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 120.448 -1.407 . . . . 0.0 107.92 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 t -78.8 101.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.43 -75.52 0.58 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -51.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.379 1.872 . . . . 0.0 111.365 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -87.36 172.44 9.84 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -126.31 3.98 7.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.533 1.133 . . . . 0.0 113.939 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -83.38 -28.77 28.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.02 23.65 0.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.887 1.275 . . . . 0.0 113.733 -157.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.98 -47.34 5.57 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.088 -1.008 . . . . 0.0 110.57 -171.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.31 1.444 . . . . 0.0 108.054 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.61 -23.44 0.09 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.821 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -108.64 105.22 14.74 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.748 2.274 . . . . 0.0 111.56 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -68.81 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.908 2.483 . . . . 0.0 113.055 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.96 -9.28 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.884 1.274 . . . . 0.0 111.538 -163.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.2 tt -77.48 96.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 120.897 -1.127 . . . . 0.0 108.8 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -75.07 -16.12 60.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.18 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -149.19 134.81 18.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.601 0.761 . . . . 0.0 109.53 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.4 114.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.0 m -89.82 137.72 32.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 t -130.77 121.37 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.935 1.694 . . . . 0.0 108.268 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -77.09 160.85 75.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.401 0.546 . . . . 0.0 110.798 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -75.49 159.9 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.723 2.282 . . . . 0.0 110.83 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 54.9 37.13 28.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.883 1.673 . . . . 0.0 113.007 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.292 3.7 tt -133.4 25.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.675 1.19 . . . . 0.0 112.205 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.61 159.3 8.15 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 127.132 2.301 . . . . 0.0 111.529 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.8 tp -71.96 126.15 29.03 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 124.306 1.042 . . . . 0.0 110.065 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.95 78.42 7.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -68.89 168.18 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.083 0.944 . . . . 0.0 111.548 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -75.54 137.42 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.59 -1.944 . . . . 0.0 108.667 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.34 3.4 90.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.101 0.858 . . . . 0.0 113.937 -174.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.1 ttp -59.77 -25.15 64.66 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 120.158 1.979 . . . . 0.0 113.364 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -114.4 15.69 17.9 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.848 1.259 . . . . 0.0 111.594 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 58.6 m -48.33 119.28 2.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 111.371 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.56 6.95 85.27 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.297 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.96 73.77 0.61 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.609 2.204 . . . . 0.0 107.092 163.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.6 p -65.31 -51.99 56.97 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.43 1.092 . . . . 0.0 111.532 -167.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.62 3.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.921 1.289 . . . . 0.0 113.957 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.2 tp -76.85 108.28 9.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.279 1.032 . . . . 0.0 110.129 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.62 -12.45 9.74 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.551 169.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -119.14 142.54 47.85 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.522 1.055 . . . . 0.0 113.236 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -146.53 136.57 23.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.94 137.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.2 113.75 22.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 p -83.97 0.38 48.2 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.33 179.05 41.96 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.216 0.912 . . . . 0.0 110.992 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.96 6.26 4.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.017 0.927 . . . . 0.0 112.63 -169.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -141.99 143.82 29.75 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.658 1.583 . . . . 0.0 107.721 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.53 -30.73 4.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.317 2.011 . . . . 0.0 112.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -77.07 -15.84 59.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 111.824 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.64 12.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.441 1.496 . . . . 0.0 112.804 165.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -124.33 168.55 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.252 1.021 . . . . 0.0 110.07 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -141.78 133.68 27.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.61 172.69 9.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.322 2.249 . . . . 0.0 106.388 172.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.73 -145.04 8.1 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.342 1.925 . . . . 0.0 109.361 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.01 -8.86 58.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.782 -0.834 . . . . 0.0 113.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.98 68.23 0.27 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -170.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 tp -46.14 -44.02 15.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.204 1.402 . . . . 0.0 111.022 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -113.7 16.75 18.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.016 0.926 . . . . 0.0 111.419 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.67 146.24 52.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.861 0.755 . . . . 0.0 110.808 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 76.47 -1.02 62.56 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.753 1.168 . . . . 0.0 113.825 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.27 -175.46 4.18 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 128.921 2.888 . . . . 0.0 107.456 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -156.56 94.49 1.48 Allowed 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.812 -1.18 . . . . 0.0 110.737 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -125.21 163.4 22.57 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.112 0.965 . . . . 0.0 111.134 -171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.68 152.39 18.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 108.113 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.4 mt -122.08 101.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -167.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.2 m -87.78 138.05 31.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.365 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.16 155.28 72.62 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.42 1.888 . . . . 0.0 109.7 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.84 144.54 53.91 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 CA-C-N 121.432 1.547 . . . . 0.0 109.46 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -55.24 -32.78 62.57 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -67.33 -18.24 65.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.224 3.01 . . . . 0.0 112.159 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.46 -0.19 19.01 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.83 -1.168 . . . . 0.0 113.135 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 tp -62.7 -50.27 71.8 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.172 0.896 . . . . 0.0 111.351 -168.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.61 -43.21 99.28 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.8 -56.28 9.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.525 1.93 . . . . 0.0 111.795 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -70.61 -40.22 73.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.292 0.496 . . . . 0.0 109.744 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -62.7 -25.41 68.15 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 121.208 -0.933 . . . . 0.0 112.565 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -85.14 -13.69 49.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.275 1.43 . . . . 0.0 112.679 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 87' ' ' PHE . 29.1 t70 -66.73 143.1 57.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.443 0.565 . . . . 0.0 111.553 -160.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.89 24.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.133 2.573 . . . . 0.0 113.439 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -153.23 -67.32 0.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.983 2.513 . . . . 0.0 107.207 173.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -58.6 -16.96 18.19 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -167.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -44.08 -45.01 7.88 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.499 1.52 . . . . 0.0 113.775 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -69.36 -6.15 28.03 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.77 15.81 14.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.04 1.291 . . . . 0.0 111.567 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.66 66.55 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.48 -1.388 . . . . 0.0 110.707 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.28 3.28 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -127.29 4.74 6.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.878 1.217 . . . . 0.0 111.889 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.85 123.65 46.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -136.06 162.42 56.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.771 0.828 . . . . 0.0 111.508 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.75 149.16 91.43 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.315 2.677 . . . . 0.0 114.208 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.5 mtm -73.51 156.37 38.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.557 166.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -98.64 -178.02 3.85 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.061 2.144 . . . . 0.0 109.865 171.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.453 HE21 ' C ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 154.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -84.23 120.18 25.91 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.249 1.42 . . . . 0.0 110.238 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 47.45 51.91 13.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.29 1.036 . . . . 0.0 112.052 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -145.9 -174.22 4.36 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.157 1.783 . . . . 0.0 107.523 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.22 80.03 0.25 Allowed Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -116.94 85.75 18.33 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.558 1.543 . . . . 0.0 109.635 -175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -76.22 64.64 7.11 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.373 3.382 . . . . 0.0 110.639 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.34 165.42 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 108.791 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.268 7.0 p -110.57 68.23 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.28 1.038 . . . . 0.0 109.826 -161.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.75 79.62 0.26 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 125.766 1.651 . . . . 0.0 109.791 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.2 10.07 1.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.786 2.034 . . . . 0.0 114.388 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.59 122.68 15.67 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.878 1.217 . . . . 0.0 110.225 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -105.29 90.94 3.58 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.391 1.476 . . . . 0.0 107.066 168.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.46 10.43 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 175.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mp -131.67 1.28 4.02 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.782 -1.199 . . . . 0.0 113.053 -160.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.24 -36.66 16.61 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.664 -0.647 . . . . 0.0 111.573 -163.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 43.87 0.09 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.905 2.082 . . . . 0.0 112.255 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.82 -27.46 0.37 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.381 -1.233 . . . . 0.0 113.352 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -106.78 94.15 4.96 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.438 1.619 . . . . 0.0 110.63 -173.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.5 p -64.24 22.04 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 129.537 3.135 . . . . 0.0 115.107 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.29 7.56 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 O-C-N 119.861 -1.774 . . . . 0.0 110.074 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.94 98.55 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.241 -1.537 . . . . 0.0 107.147 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -71.29 -26.36 62.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.744 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -136.79 120.72 17.57 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.432 0.56 . . . . 0.0 111.218 -160.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mt -122.29 89.96 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 m -66.82 130.93 44.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 161.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.1 155.4 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.328 1.851 . . . . 0.0 107.047 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -119.59 159.66 45.21 Favored Pre-proline 0 N--CA 1.452 -0.368 0 C-N-CA 124.809 1.243 . . . . 0.0 107.864 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.1 152.98 51.68 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.733 1.622 . . . . 0.0 111.196 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 59.85 21.38 10.29 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.524 1.93 . . . . 0.0 113.849 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.25 93.86 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 124.505 2.097 . . . . 0.0 107.198 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.49 138.62 5.21 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 127.27 2.367 . . . . 0.0 113.28 161.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -58.47 130.23 45.77 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mt -88.07 123.37 32.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -133.99 176.56 8.46 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.57 1.148 . . . . 0.0 109.407 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -72.42 152.07 42.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.545 1.164 . . . . 0.0 111.512 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 66.13 -3.67 3.07 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.085 1.326 . . . . 0.0 114.425 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 39' ' ' PHE . 3.6 tmm? -57.74 -32.56 67.56 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.805 . . . . 0.0 112.094 -170.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 38' ' ' MET . 59.7 m-85 -102.49 -5.92 23.48 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.406 1.482 . . . . 0.0 113.468 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 t -54.23 124.78 16.83 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.342 0.974 . . . . 0.0 110.974 -164.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.31 9.24 48.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.764 1.173 . . . . 0.0 112.784 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.7 p -69.85 74.19 0.43 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.951 1.7 . . . . 0.0 111.93 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -58.16 -7.83 0.93 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.49 0.23 5.6 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.609 -1.186 . . . . 0.0 113.5 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.35 123.34 24.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.5 1.955 . . . . 0.0 112.383 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.08 8.66 0.95 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -146.09 126.24 13.81 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.347 -1.471 . . . . 0.0 109.374 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -120.68 139.78 52.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.23 146.75 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -121.86 136.33 54.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.384 1.474 . . . . 0.0 107.154 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 p -111.37 33.69 4.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.122 0.963 . . . . 0.0 111.246 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.85 161.66 20.22 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -113.75 4.17 15.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -157.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.99 147.81 19.46 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.466 1.03 . . . . 0.0 109.64 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.52 -27.51 70.04 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.042 3.161 . . . . 0.0 113.695 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m -72.58 -13.24 61.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.36 7.17 4.6 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.061 -1.024 . . . . 0.0 112.125 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -139.89 179.45 6.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.162 2.185 . . . . 0.0 109.336 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -139.25 179.4 6.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.977 2.111 . . . . 0.0 108.625 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -161.06 1.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.21 -108.14 0.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -150.69 38.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.747 1.619 . . . . 0.0 109.568 163.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.09 28.38 0.2 Allowed Glycine 0 C--O 1.225 -0.415 0 CA-C-O 118.043 -1.421 . . . . 0.0 114.285 -165.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tt -45.29 -41.97 9.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.55 1.675 . . . . 0.0 112.175 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -117.89 26.15 9.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.856 1.262 . . . . 0.0 112.071 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -58.55 141.64 51.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 110.151 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 -29.95 3.03 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.341 0.972 . . . . 0.0 112.389 -173.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.17 -179.82 4.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.269 1.828 . . . . 0.0 110.25 -175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -161.02 106.87 1.4 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.58 1.152 . . . . 0.0 107.973 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -139.13 167.27 22.43 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.245 1.418 . . . . 0.0 109.76 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.9 mt -89.92 141.93 28.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.949 1.299 . . . . 0.0 108.986 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 mt -90.19 138.12 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.627 1.971 . . . . 0.0 105.823 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.2 m -120.81 136.0 55.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.31 161.11 62.36 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 124.615 1.166 . . . . 0.0 107.997 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.04 147.7 84.68 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.997 1.035 . . . . 0.0 110.425 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -50.34 -37.2 35.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.236 1.014 . . . . 0.0 112.6 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -31.93 59.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.797 -0.565 . . . . 0.0 110.482 -170.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.23 -5.84 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.926 1.29 . . . . 0.0 112.302 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.4 tp -56.14 -38.04 70.28 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 112.12 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -69.8 -47.4 62.98 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.57 -0.706 . . . . 0.0 111.409 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -49.03 -53.28 20.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.136 1.774 . . . . 0.0 111.955 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -66.12 -42.6 88.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.288 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -57.1 -48.67 78.04 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.936 0.789 . . . . 0.0 111.657 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -68.87 -11.54 60.64 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.34 137.85 48.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.308 0.958 . . . . 0.0 111.218 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -61.4 -38.08 85.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.384 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.59 -66.73 0.66 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.369 1.068 . . . . 0.0 108.46 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -58.68 -23.17 58.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.563 -1.208 . . . . 0.0 112.232 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -44.7 -35.18 2.54 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -56.27 -41.1 75.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.085 0.402 . . . . 0.0 110.153 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -89.43 9.91 24.58 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 112.432 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.27 -22.06 66.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.083 -1.635 . . . . 0.0 112.393 -167.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.1 -19.16 64.17 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -113.43 5.27 16.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.891 0.769 . . . . 0.0 112.007 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.9 mt -86.98 134.05 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.471 1.508 . . . . 0.0 109.271 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.42 166.44 19.94 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.694 1.998 . . . . 0.0 111.51 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.7 175.83 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.002 2.468 . . . . 0.0 112.599 169.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp -102.22 170.88 7.81 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.134 1.774 . . . . 0.0 109.39 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.47 -177.55 3.43 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.488 0.715 . . . . 0.0 110.678 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 . . . . . 0 C--O 1.246 0.885 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 161.553 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.632 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.8 m -153.1 88.64 1.32 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -120.34 51.47 1.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 127.446 2.299 . . . . 0.0 107.144 -170.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -167.69 100.37 0.48 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.52 90.64 0.08 OUTLIER Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -107.86 164.12 15.48 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.865 1.266 . . . . 0.0 110.71 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.44 67.65 7.72 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.979 3.119 . . . . 0.0 109.704 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.56 165.57 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 126.379 1.871 . . . . 0.0 107.948 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.455 HG23 ' CE ' ' A' ' 13' ' ' LYS . 2.1 p -93.48 95.79 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.12 -84.99 1.5 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.8 mtp -128.38 -56.79 1.23 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.197 1.799 . . . . 0.0 109.954 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 115.93 23.42 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.34 -0.85 . . . . 0.0 110.49 -163.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -72.6 4.02 4.37 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -164.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.5 m -114.27 62.61 0.66 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.846 2.112 . . . . 0.0 112.33 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -133.9 4.47 3.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.402 1.081 . . . . 0.0 112.529 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.03 -55.96 3.25 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.443 1.497 . . . . 0.0 111.145 -167.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.28 92.57 0.04 OUTLIER 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.47 -6.04 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.199 -1.334 . . . . 0.0 112.988 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -139.34 144.85 38.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.056 1.928 . . . . 0.0 112.525 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.1 p -115.65 16.34 16.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.44 2.296 . . . . 0.0 113.264 -159.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.72 14.02 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 127.81 2.444 . . . . 0.0 111.254 -168.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tt -95.43 85.22 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 O-C-N 119.887 -1.758 . . . . 0.0 108.464 -165.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -87.51 18.14 4.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.032 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.95 145.92 26.75 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -137.19 104.25 3.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -70.13 144.26 52.1 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 162.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.6 123.01 35.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.19 161.82 66.52 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.809 -0.557 . . . . 0.0 109.909 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.79 167.2 26.76 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.583 2.189 . . . . 0.0 111.285 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 45.09 42.68 6.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.365 2.266 . . . . 0.0 114.411 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 tt -141.42 2.17 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.407 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . 178.16 130.47 1.41 Allowed Glycine 0 C--N 1.336 0.561 0 O-C-N 120.056 -1.653 . . . . 0.0 112.546 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 tp -59.09 136.67 58.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 164.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 5.5 mt -100.64 75.08 1.71 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.205 1.002 . . . . 0.0 109.408 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -75.03 163.22 27.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.96 0.504 . . . . 0.0 111.63 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -69.32 114.62 7.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.563 1.545 . . . . 0.0 110.517 175.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.54 -5.75 24.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.297 1.427 . . . . 0.0 112.761 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' A' ' 34' ' ' LEU . 16.6 mtp -50.17 -54.0 23.84 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.952 1.301 . . . . 0.0 111.796 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -98.29 9.9 41.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.624 1.17 . . . . 0.0 111.497 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.6 t -66.76 112.28 4.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.34 -4.38 37.79 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.838 0.732 . . . . 0.0 112.598 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -76.58 72.63 3.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.331 1.565 . . . . 0.0 108.508 168.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 p -72.87 4.05 4.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.266 2.226 . . . . 0.0 113.189 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 49.89 1.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.215 1.806 . . . . 0.0 107.667 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.3 tp -122.67 105.34 10.0 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.32 -11.43 7.93 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.583 1.177 . . . . 0.0 114.159 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -129.98 124.2 32.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -117.89 140.53 49.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.26 132.18 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -110.92 113.85 26.73 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.481 0.713 . . . . 0.0 109.263 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.69 12.8 6.54 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.45 177.22 27.04 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -136.48 29.9 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 109.261 -170.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.69 147.3 9.4 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.314 -0.866 . . . . 0.0 111.35 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.33 -42.84 9.35 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.706 2.938 . . . . 0.0 112.592 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -74.67 -15.31 60.81 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.377 -0.827 . . . . 0.0 112.759 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.79 -7.92 43.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.889 0.768 . . . . 0.0 113.06 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.41 -168.63 1.34 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.27 1.428 . . . . 0.0 109.579 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.9 m -145.62 172.69 12.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.552 1.541 . . . . 0.0 107.052 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.87 137.85 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.09 -165.39 11.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 156.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.57 -59.89 4.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.283 0.563 . . . . 0.0 109.536 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.72 65.75 3.49 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 125.021 1.296 . . . . 0.0 111.45 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.8 tp -45.07 -48.42 11.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.299 1.04 . . . . 0.0 110.719 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.94 36.69 2.78 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.567 -0.708 . . . . 0.0 111.108 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.66 121.2 12.2 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.445 -1.41 . . . . 0.0 110.029 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.73 10.18 81.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.08 171.89 13.45 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.674 1.237 . . . . 0.0 108.485 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -140.08 94.23 2.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 122.218 1.008 . . . . 0.0 108.299 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.59 165.04 16.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.272 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.8 mt -105.12 158.14 16.78 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.088 1.355 . . . . 0.0 109.051 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.78 101.39 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 127.089 2.155 . . . . 0.0 106.548 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.9 m -75.27 127.11 32.43 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.88 156.18 80.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 125.309 1.444 . . . . 0.0 107.116 172.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.59 143.16 67.48 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -51.61 -43.03 62.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.05 1.74 . . . . 0.0 110.568 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.91 -10.11 12.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.71 -4.66 12.16 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 125.139 1.376 . . . . 0.0 112.434 168.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.64 -59.1 5.93 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 121.286 1.857 . . . . 0.0 110.841 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.48 -18.05 61.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.457 0.646 . . . . 0.0 112.222 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -66.24 -45.06 81.96 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.462 2.305 . . . . 0.0 110.0 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -64.05 -49.91 70.47 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -56.27 -32.25 64.36 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.732 1.151 . . . . 0.0 113.947 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -80.69 2.27 26.65 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -64.13 167.04 6.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.393 1.092 . . . . 0.0 111.554 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.03 -45.61 60.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.746 0.818 . . . . 0.0 110.702 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -104.0 -47.93 4.04 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.048 0.939 . . . . 0.0 111.091 -162.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -55.03 -21.15 11.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.893 0.769 . . . . 0.0 112.188 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -46.15 -45.19 16.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.265 1.826 . . . . 0.0 113.099 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 t -64.56 -25.5 68.0 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.338 0.517 . . . . 0.0 110.297 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.28 9.34 38.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.24 1.816 . . . . 0.0 112.62 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -8.94 32.58 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.36 -1.463 . . . . 0.0 112.168 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.12 -18.62 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.471 1.032 . . . . 0.0 113.488 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -112.48 -4.3 14.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 112.629 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.44 134.23 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.62 160.08 55.1 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.153 0.981 . . . . 0.0 111.031 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.17 164.12 26.48 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 111.963 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.1 mtt -83.71 -173.47 4.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.389 1.876 . . . . 0.0 111.645 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -137.8 179.92 6.14 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.203 2.601 . . . . 0.0 109.026 165.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 . . . . . 0 C--O 1.248 0.986 0 C-N-CA 125.928 1.691 . . . . 0.0 107.046 169.668 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.867 0 CA-C-O 120.122 -0.266 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -141.85 142.72 33.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.715 1.206 . . . . 0.0 110.456 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 45.59 45.5 10.79 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.79 1.636 . . . . 0.0 112.051 -166.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -147.29 147.77 30.73 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.516 -0.74 . . . . 0.0 109.517 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.16 71.67 0.32 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -170.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -130.49 78.0 74.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.003 2.121 . . . . 0.0 106.584 171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.25 64.03 8.27 Favored 'Trans proline' 0 N--CA 1.458 -0.611 1 C-N-CA 126.484 4.789 . . . . 0.0 107.483 -171.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.96 140.75 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.534 1.134 . . . . 0.0 108.163 -164.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -76.43 77.79 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.04 72.32 0.46 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.365 1.46 . . . . 0.0 110.086 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.39 9.49 2.02 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.467 1.907 . . . . 0.0 115.895 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -132.23 159.14 39.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.284 1.402 . . . . 0.0 109.374 158.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -138.46 31.92 2.32 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.392 1.477 . . . . 0.0 112.22 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.0 t -133.67 29.0 3.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.799 1.24 . . . . 0.0 110.882 175.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -115.4 2.72 13.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.161 1.785 . . . . 0.0 112.42 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.27 -41.07 11.77 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.967 -1.083 . . . . 0.0 110.926 -163.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.59 84.79 1.15 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.311 1.044 . . . . 0.0 109.759 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.06 -41.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -87.34 91.16 8.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.015 0.912 . . . . 0.0 112.37 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.2 p -70.94 33.48 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 128.425 2.69 . . . . 0.0 114.589 -171.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.0 1.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 120.352 -1.468 . . . . 0.0 112.319 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -71.9 83.89 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-O 121.975 0.893 . . . . 0.0 111.473 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -79.37 4.31 15.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.797 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -153.29 138.28 17.23 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.1 1.36 . . . . 0.0 108.427 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -134.66 126.0 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 167.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.5 m -102.49 122.15 43.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.12 112.49 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.96 1.304 . . . . 0.0 107.962 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -65.15 164.02 26.3 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.329 0.652 . . . . 0.0 110.491 167.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.24 154.97 68.98 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.216 1.944 . . . . 0.0 110.627 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.69 51.85 8.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.784 2.034 . . . . 0.0 113.109 171.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 tt -136.95 84.0 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 124.227 1.965 . . . . 0.0 107.808 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.82 149.48 0.11 Allowed Glycine 0 CA--C 1.525 0.682 1 C-N-CA 131.168 4.223 . . . . 0.0 113.014 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.334 0.0 OUTLIER -64.81 155.33 34.29 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.792 -0.828 . . . . 0.0 110.195 170.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.46 ' H ' ' HB2' ' A' ' 59' ' ' SER . 5.0 mt -102.15 123.09 45.4 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 168.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -122.53 175.51 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 111.306 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.9 126.4 27.88 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.419 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.45 46.81 93.6 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 mtp -70.64 -34.24 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.815 1.246 . . . . 0.0 110.805 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -114.84 29.85 7.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.088 1.355 . . . . 0.0 110.655 -167.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.3 t -61.73 109.69 1.3 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.891 0.876 . . . . 0.0 110.53 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.79 12.88 55.03 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.978 -0.901 . . . . 0.0 113.462 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -78.2 73.82 4.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.392 1.596 . . . . 0.0 109.441 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 p -68.06 -3.17 9.36 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.971 2.508 . . . . 0.0 113.5 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.68 53.43 1.85 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.486 1.514 . . . . 0.0 107.889 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 tp -129.63 111.78 13.03 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.607 1.563 . . . . 0.0 107.882 174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.77 8.95 3.06 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -137.3 152.7 50.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 O-C-N 120.878 -1.139 . . . . 0.0 110.503 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.8 tp -146.1 94.03 2.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.86 1.664 . . . . 0.0 107.169 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -82.71 141.52 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -128.18 118.05 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 p -88.48 -4.53 58.6 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -167.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.8 154.31 20.56 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 119.064 0.847 . . . . 0.0 112.111 -167.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.31 -2.82 58.49 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.37 148.1 39.42 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 120.288 1.403 . . . . 0.0 111.868 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.91 -23.61 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.23 2.62 . . . . 0.0 113.803 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 t -73.69 -21.18 60.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.698 1.599 . . . . 0.0 110.869 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.26 6.27 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.263 1.825 . . . . 0.0 113.031 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -141.72 175.36 9.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.261 1.824 . . . . 0.0 111.001 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.46 ' HB2' ' H ' ' A' ' 34' ' ' LEU . 3.8 m -135.12 -171.95 2.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.42 2.688 . . . . 0.0 108.584 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 177.1 -13.56 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.393 1.477 . . . . 0.0 113.425 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.22 -100.24 0.51 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.588 1.566 . . . . 0.0 110.134 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -140.39 -13.16 1.02 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.372 1.069 . . . . 0.0 111.299 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.08 42.8 0.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 124.007 0.813 . . . . 0.0 111.343 -159.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -44.47 -55.56 4.97 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.216 1.406 . . . . 0.0 111.569 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -98.33 12.38 35.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.931 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -64.32 158.28 23.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.266 0.939 . . . . 0.0 110.17 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.8 6.52 51.71 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.894 1.235 . . . . 0.0 114.695 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.26 -163.84 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.318 2.247 . . . . 0.0 107.499 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -155.74 112.29 3.16 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 120.456 -1.403 . . . . 0.0 110.051 164.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 175.42 8.02 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.56 1.144 . . . . 0.0 112.774 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.2 tp -111.04 155.75 22.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.954 2.502 . . . . 0.0 108.553 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.9 mt -117.76 138.9 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.462 1.105 . . . . 0.0 108.206 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.93 130.7 50.62 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.556 1.542 . . . . 0.0 107.686 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.74 160.18 68.66 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.18 144.54 69.33 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.44 -29.99 27.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.53 0.732 . . . . 0.0 111.477 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.05 -33.08 73.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.022 1.329 . . . . 0.0 112.29 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.53 -3.82 19.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.584 1.154 . . . . 0.0 112.391 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.88 -46.4 74.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.47 -36.93 60.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.04 -52.5 42.53 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 109.799 172.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.91 -42.03 97.51 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.868 0.867 . . . . 0.0 109.817 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -67.01 -11.61 57.51 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -110.12 18.13 20.3 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.027 1.731 . . . . 0.0 110.707 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -79.53 159.43 26.9 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.757 -1.214 . . . . 0.0 112.036 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -81.71 -35.47 29.74 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.124 -0.985 . . . . 0.0 112.103 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -90.96 -54.21 4.06 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.606 -0.684 . . . . 0.0 109.225 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -69.54 -12.51 61.71 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -47.43 -35.5 8.55 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 121.27 1.85 . . . . 0.0 115.158 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -63.15 -41.41 99.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.116 0.871 . . . . 0.0 111.181 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -75.94 3.77 9.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.221 1.008 . . . . 0.0 112.35 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.85 -19.87 65.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.678 -1.263 . . . . 0.0 112.024 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.5 -5.94 6.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.742 -1.123 . . . . 0.0 113.626 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -133.41 12.61 4.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.369 1.44 . . . . 0.0 112.474 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.3 mt -89.54 130.78 38.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -138.08 165.39 33.79 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 111.284 165.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 176.37 2.48 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.446 2.097 . . . . 0.0 111.36 168.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.3 ptp -109.36 154.15 22.95 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.731 1.613 . . . . 0.0 107.311 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.28 177.11 8.22 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.7 1.2 . . . . 0.0 109.698 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 115.977 -1.963 . . . . 0.0 111.344 -177.64 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.428 0 CA-C-O 121.403 0.446 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 p -152.38 177.12 10.92 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 129.416 3.086 . . . . 0.0 104.804 162.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -124.25 156.33 37.04 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.541 1.064 . . . . 0.0 111.341 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.39 168.36 12.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.977 1.711 . . . . 0.0 110.081 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.89 10.46 72.15 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.833 -0.982 . . . . 0.0 112.796 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -113.61 85.18 8.86 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.343 1.457 . . . . 0.0 110.65 -170.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.96 64.44 8.27 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.742 2.294 . . . . 0.0 110.397 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -134.67 165.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -169.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.06 70.07 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.381 -0.824 . . . . 0.0 108.796 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.99 69.51 0.51 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.1 mtp 58.42 13.8 2.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.679 1.992 . . . . 0.0 115.61 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.27 172.07 13.38 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.301 1.41 . . . . 0.0 109.899 157.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.45 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 mmpt? -118.2 4.6 11.95 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.254 1.422 . . . . 0.0 113.422 -175.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -82.43 -23.93 34.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.395 1.452 . . . . 0.0 113.301 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.88 62.27 4.06 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.531 . . . . 0.0 111.999 -165.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -142.24 -49.06 0.36 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.686 -1.259 . . . . 0.0 112.13 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.77 66.06 2.0 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.476 1.11 . . . . 0.0 110.57 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 -34.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.587 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -94.9 80.58 3.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.413 1.606 . . . . 0.0 112.297 -168.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.5 p -62.34 24.21 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 130.869 3.668 . . . . 0.0 116.511 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.36 -14.48 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 128.552 2.741 . . . . 0.0 110.947 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -62.51 99.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 119.348 0.976 . . . . 0.0 110.099 -174.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -4.11 52.96 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.736 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -152.56 134.1 14.53 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 119.033 0.833 . . . . 0.0 112.163 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.5 108.88 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -81.0 146.53 30.63 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -139.65 115.0 8.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -66.5 164.2 34.06 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 118.202 0.455 . . . . 0.0 110.172 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.32 162.38 36.49 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.849 1.699 . . . . 0.0 110.848 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 44.7 56.47 5.17 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.187 2.595 . . . . 0.0 112.693 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.5 tt -144.69 71.12 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 124.282 1.992 . . . . 0.0 109.37 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.46 170.81 42.4 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 126.988 2.232 . . . . 0.0 112.416 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.4 tp -83.84 133.71 34.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.901 1.28 . . . . 0.0 110.638 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.42 122.1 28.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 159.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -126.75 175.51 7.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.817 1.247 . . . . 0.0 109.35 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.42 156.14 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.829 0.851 . . . . 0.0 110.237 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 63.75 -1.01 2.69 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.737 2.113 . . . . 0.0 115.307 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -29.65 60.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.013 1.725 . . . . 0.0 112.643 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -110.56 18.45 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.795 1.238 . . . . 0.0 113.373 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 t -56.91 105.54 0.23 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.776 0.831 . . . . 0.0 111.577 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.43 23.47 39.95 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.128 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -72.37 76.96 1.02 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.743 1.772 . . . . 0.0 109.182 164.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -71.79 15.68 0.14 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.816 2.446 . . . . 0.0 114.243 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.41 4.39 1.98 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 119.85 13.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.394 0.997 . . . . 0.0 110.631 -169.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -122.25 -35.21 3.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.31 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -121.06 141.91 50.32 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 122.021 2.192 . . . . 0.0 113.178 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.7 tp -119.74 138.99 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.916 2.487 . . . . 0.0 104.561 161.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.05 140.59 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -115.44 151.38 34.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -119.47 5.14 11.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 112.395 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.12 169.03 30.37 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 118.971 0.805 . . . . 0.0 111.828 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.39 15.69 8.96 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.59 152.7 42.2 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 120.641 -1.287 . . . . 0.0 108.632 163.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -3.32 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 124.526 3.484 . . . . 0.0 113.896 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 m -91.48 14.64 14.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.865 1.212 . . . . 0.0 112.495 161.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.59 -4.49 55.26 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.181 1.355 . . . . 0.0 113.497 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -129.07 174.74 9.27 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.987 1.715 . . . . 0.0 109.72 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -119.35 172.4 7.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.807 1.643 . . . . 0.0 108.316 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -174.06 118.81 0.25 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 127.977 2.511 . . . . 0.0 105.948 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.66 -178.91 5.27 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 125.817 1.675 . . . . 0.0 109.425 161.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.51 -38.82 88.74 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.452 1.101 . . . . 0.0 111.779 -162.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.21 81.79 0.29 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 126.892 2.187 . . . . 0.0 107.832 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 tt -51.81 -47.06 64.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.544 1.172 . . . . 0.0 109.106 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -85.99 -7.0 58.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 117.573 -1.203 . . . . 0.0 114.157 -165.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -54.64 112.66 1.06 Allowed 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.684 0.615 . . . . 0.0 110.007 -159.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.38 -13.31 12.27 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.313 -1.271 . . . . 0.0 115.755 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.5 -172.43 4.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.014 1.407 . . . . 0.0 109.503 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -151.0 97.79 2.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.135 -0.978 . . . . 0.0 111.646 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -122.73 164.9 17.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 109.685 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.5 149.0 21.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.375 1.87 . . . . 0.0 110.689 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.26 126.34 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 m -112.78 140.15 47.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -133.39 160.21 69.53 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.075 1.35 . . . . 0.0 107.431 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.82 147.73 81.35 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.292 -1.465 . . . . 0.0 108.292 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.91 -30.21 32.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.964 0.506 . . . . 0.0 112.182 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -71.38 -25.58 62.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.871 1.268 . . . . 0.0 112.343 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.71 -3.28 46.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 113.049 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 tp -62.2 -50.09 73.19 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.358 -0.839 . . . . 0.0 113.216 -163.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -74.54 -37.85 62.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.805 0.842 . . . . 0.0 109.917 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -49.34 -52.81 25.69 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.529 1.132 . . . . 0.0 109.086 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -70.29 -30.22 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.09 0.556 . . . . 0.0 110.762 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -22.91 62.21 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.379 -0.826 . . . . 0.0 112.763 169.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -91.22 6.66 44.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.001 1.32 . . . . 0.0 112.175 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.98 159.73 24.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 120.807 1.64 . . . . 0.0 112.14 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -72.04 -43.73 64.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 120.768 -1.208 . . . . 0.0 110.978 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -95.36 -53.12 3.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.933 0.893 . . . . 0.0 110.22 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.86 -13.18 22.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.404 1.002 . . . . 0.0 113.415 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -48.64 -48.26 39.72 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.503 1.521 . . . . 0.0 114.743 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 t -52.04 -43.81 63.94 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.022 1.283 . . . . 0.0 110.171 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -80.38 6.7 11.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.435 1.094 . . . . 0.0 113.665 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.7 70.24 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.066 1.303 . . . . 0.0 111.533 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.1 -3.07 0.73 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 114.239 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -135.89 12.49 3.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.194 1.398 . . . . 0.0 112.271 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.9 mt -98.02 131.09 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.676 1.125 . . . . 0.0 108.949 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.58 166.14 26.35 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.771 2.028 . . . . 0.0 111.737 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.2 154.16 69.47 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.134 1.89 . . . . 0.0 113.214 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.3 ptp -78.68 162.85 25.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.604 1.961 . . . . 0.0 109.515 173.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . 0.255 1.3 pt-20 -100.98 -167.96 1.5 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.832 0.853 . . . . 0.0 110.823 169.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 117.289 -1.338 . . . . 0.0 111.064 -166.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 CA-C-O 118.438 -1.201 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.85 123.49 7.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.164 1.386 . . . . 0.0 108.669 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -171.92 152.86 3.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.169 1.787 . . . . 0.0 108.336 176.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -88.08 40.77 0.96 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 122.415 1.102 . . . . 0.0 111.395 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.03 -41.44 2.76 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.687 1.613 . . . . 0.0 112.632 171.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.58 159.4 38.62 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 125.942 1.697 . . . . 0.0 108.59 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.19 100.83 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.385 2.057 . . . . 0.0 110.416 -171.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.29 165.78 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.242 1.417 . . . . 0.0 109.042 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -109.3 127.02 66.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.328 1.051 . . . . 0.0 111.806 -172.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.18 76.01 0.2 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.011 1.291 . . . . 0.0 110.018 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.4 mtm 63.19 -31.68 0.1 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.822 2.849 . . . . 0.0 115.99 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -44.39 43.39 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.746 1 C-N-CA 136.928 6.091 . . . . 0.0 118.52 169.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -73.22 72.11 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 119.372 -2.08 . . . . 0.0 111.029 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.61 4.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.055 2.142 . . . . 0.0 112.266 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.06 -13.92 14.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.721 1.6 . . . . 0.0 113.096 -174.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CD1' ' SD ' ' A' ' 38' ' ' MET . 21.4 m-85 -69.4 -35.0 75.35 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.708 0.803 . . . . 0.0 111.777 -160.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 33.27 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.896 2.078 . . . . 0.0 112.827 168.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -108.62 -40.8 1.55 Allowed Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.5 -1.375 . . . . 0.0 112.37 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -102.37 157.28 17.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.924 1.362 . . . . 0.0 109.997 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 p -123.21 22.65 9.36 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.534 1.534 . . . . 0.0 110.671 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.05 16.79 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.13 1.772 . . . . 0.0 108.78 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -87.62 104.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -107.65 9.59 29.23 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.168 1.787 . . . . 0.0 111.646 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -154.13 148.35 25.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 156.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.45 118.25 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -82.38 125.02 30.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 166.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.24 164.45 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 171.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -131.24 157.86 76.9 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -167.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.7 157.07 59.59 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m120 46.73 37.72 5.01 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.179 1.791 . . . . 0.0 114.855 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.265 4.7 tt -117.12 18.65 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.242 . . . . 0.0 113.168 -174.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.62 149.56 5.68 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.59 1.566 . . . . 0.0 110.465 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.82 130.23 42.54 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mt -79.44 78.01 5.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.66 1.184 . . . . 0.0 107.904 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -75.36 168.63 19.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.833 0.825 . . . . 0.0 111.432 -162.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -74.56 98.08 3.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.512 0.725 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.77 -1.72 11.02 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.833 1.682 . . . . 0.0 113.815 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.465 ' SD ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 tmm? -59.24 -37.61 77.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.723 2.009 . . . . 0.0 113.431 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -103.68 11.88 35.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.042 1.337 . . . . 0.0 112.492 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 t -69.89 94.41 0.84 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -171.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.69 -6.65 6.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.157 -1.357 . . . . 0.0 113.478 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.2 m -74.63 70.54 1.84 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.652 2.226 . . . . 0.0 109.957 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p -67.83 -11.05 57.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.807 1.243 . . . . 0.0 114.326 -168.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.6 18.44 17.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.853 1.261 . . . . 0.0 111.714 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tt -79.86 119.48 22.8 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 120.458 -1.401 . . . . 0.0 108.477 -173.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.82 -17.53 5.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.505 1.522 . . . . 0.0 112.447 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -152.02 150.15 29.65 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.175 2.19 . . . . 0.0 110.859 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.79 145.43 25.73 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 128.45 2.7 . . . . 0.0 104.451 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.29 141.38 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 HD23 ' CE2' ' A' ' 58' ' ' TYR . 94.9 mt -126.97 115.03 18.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.242 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.7 p -82.17 12.32 4.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.87 175.36 32.46 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.456 -1.402 . . . . 0.0 109.893 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -132.85 19.57 4.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.76 0.824 . . . . 0.0 110.982 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -160.88 144.81 10.12 Favored Pre-proline 0 N--CA 1.467 0.411 0 C-N-CA 125.029 1.332 . . . . 0.0 109.224 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.98 -25.03 44.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.01 2.473 . . . . 0.0 113.423 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 m -65.34 -11.67 44.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.346 0.658 . . . . 0.0 112.139 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.52 -1.01 35.74 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.728 1.149 . . . . 0.0 112.869 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.415 ' CE2' HD23 ' A' ' 50' ' ' LEU . 83.9 m-85 -137.78 170.51 15.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 110.468 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.7 m -156.8 149.06 23.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.928 1.291 . . . . 0.0 109.59 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.21 158.3 44.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.231 2.213 . . . . 0.0 110.106 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.3 -166.23 42.0 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.67 -24.4 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.298 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.34 73.81 0.44 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.888 1.709 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.2 -40.75 5.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.642 1.577 . . . . 0.0 110.808 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.66 24.06 7.25 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 0.0 111.415 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -51.53 121.93 7.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.144 0.884 . . . . 0.0 110.941 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.54 13.39 82.98 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.855 -0.969 . . . . 0.0 114.231 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.52 176.03 8.9 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.604 1.962 . . . . 0.0 108.178 162.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.61 76.27 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.08 -1.012 . . . . 0.0 110.159 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -119.83 171.06 8.68 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.391 1.076 . . . . 0.0 111.979 -165.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.03 160.79 17.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.254 1.822 . . . . 0.0 110.303 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -131.08 104.78 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.028 2.131 . . . . 0.0 110.016 -163.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.2 m -95.25 105.25 17.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.574 1.95 . . . . 0.0 113.334 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -113.22 156.14 43.45 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.702 1.201 . . . . 0.0 109.254 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.51 151.81 82.17 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.585 1.602 . . . . 0.0 109.158 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.62 -31.24 66.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.781 0.832 . . . . 0.0 112.226 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -59.51 -33.17 71.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.333 1.453 . . . . 0.0 112.093 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.08 -6.52 38.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.499 -0.751 . . . . 0.0 111.978 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -61.9 -50.66 71.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.298 0.954 . . . . 0.0 111.663 -164.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.57 -30.65 46.88 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.688 -0.633 . . . . 0.0 111.078 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -50.32 -55.17 16.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.21 1.404 . . . . 0.0 109.242 168.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.25 -37.98 85.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.235 0.614 . . . . 0.0 111.054 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -68.12 -28.16 67.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 118.463 -0.78 . . . . 0.0 112.863 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.11 3.95 47.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.02 1.282 . . . . 0.0 113.291 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.36 148.36 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.738 0.815 . . . . 0.0 112.029 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -58.64 -42.77 89.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 112.815 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -102.88 -52.94 2.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.154 0.981 . . . . 0.0 109.731 -171.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -60.39 -12.25 8.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -44.28 -44.62 8.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 164.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.4 t -64.03 -46.35 84.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.358 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.98 6.37 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.111 -0.993 . . . . 0.0 112.812 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.11 68.3 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.663 -1.273 . . . . 0.0 111.181 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -19.04 15.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.008 0.923 . . . . 0.0 113.315 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -117.62 4.87 12.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.614 1.166 . . . . 0.0 112.673 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.5 mt -99.26 95.41 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.45 163.13 22.31 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.8 0.84 . . . . 0.0 109.245 173.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.48 166.57 26.79 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 168.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.6 mtm -86.82 172.96 9.72 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.127 1.371 . . . . 0.0 109.511 166.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -111.81 -164.96 0.95 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.283 2.233 . . . . 0.0 106.984 167.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.246 0.894 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 171.335 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.28 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 m -150.55 -166.85 2.65 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.39 2.676 . . . . 0.0 105.134 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.1 m170 57.81 37.93 27.15 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.962 0.905 . . . . 0.0 110.76 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.47 156.5 36.83 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.34 1.456 . . . . 0.0 108.297 170.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.96 81.94 0.44 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.011 1.291 . . . . 0.0 110.654 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -81.14 144.05 53.76 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.896 1.679 . . . . 0.0 108.491 172.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.27 64.57 8.45 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 124.211 3.274 . . . . 0.0 113.498 -171.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -134.48 144.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 O-C-N 120.433 -1.417 . . . . 0.0 109.341 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.489 ' CG1' ' HE3' ' A' ' 13' ' ' LYS . 16.6 t -77.71 94.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.66 84.25 0.22 Allowed Glycine 0 C--O 1.223 -0.554 0 N-CA-C 106.561 -2.616 . . . . 0.0 106.561 165.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 ttt 56.4 4.13 0.13 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 166.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -132.14 85.22 2.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.905 1.23 . . . . 0.0 111.51 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HE3' ' CG1' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -74.81 73.49 2.09 Favored 'General case' 0 C--N 1.339 0.114 0 O-C-N 120.118 -1.614 . . . . 0.0 109.316 174.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -145.14 -16.98 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.558 1.143 . . . . 0.0 113.229 172.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.76 86.09 2.46 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 126.98 2.112 . . . . 0.0 107.817 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.411 ' CD1' ' HE3' ' A' ' 38' ' ' MET . 59.1 m-85 -142.01 -52.0 0.41 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.18 0.992 . . . . 0.0 112.047 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.92 87.17 1.01 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.22 1.808 . . . . 0.0 108.275 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 -41.59 0.05 OUTLIER Glycine 0 C--N 1.33 0.238 0 CA-C-O 118.488 -1.174 . . . . 0.0 112.535 -171.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -110.0 133.28 53.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.971 0.885 . . . . 0.0 109.909 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 p -101.28 6.3 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 114.054 -155.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.76 17.81 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 110.666 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tt -97.92 90.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.86 -17.98 62.09 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.15 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -138.99 120.06 14.55 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.675 1.125 . . . . 0.0 108.786 -165.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.92 135.57 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.6 m -117.72 133.06 56.33 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.37 122.41 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.897 1.679 . . . . 0.0 109.195 -173.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -79.14 165.06 51.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -75.36 168.71 23.99 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.967 2.445 . . . . 0.0 111.922 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 50.0 34.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.964 2.106 . . . . 0.0 114.002 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.275 4.9 tt -138.47 27.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.58 162.59 9.17 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.43 0.538 . . . . 0.0 113.791 152.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.6 tp -80.77 121.13 25.54 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 109.564 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -78.95 83.34 5.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -69.37 167.03 17.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.678 0.751 . . . . 0.0 111.447 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.2 124.91 25.55 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.817 1.247 . . . . 0.0 110.094 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.16 28.54 66.12 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.659 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.411 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 3.7 mtp -54.29 -35.04 62.17 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.2 1.5 . . . . 0.0 110.128 161.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.3 22.09 16.27 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.191 1.796 . . . . 0.0 111.807 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.34 121.22 15.26 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.22 11.06 70.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.949 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.95 91.13 1.52 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.47 1.635 . . . . 0.0 108.485 171.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -3.68 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.933 2.093 . . . . 0.0 113.677 -166.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.16 68.0 1.3 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 161.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.6 tp -121.17 109.93 15.57 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.634 1.173 . . . . 0.0 109.978 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -139.98 30.66 2.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.816 0.446 . . . . 0.0 112.103 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -157.02 147.54 21.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 119.874 -1.766 . . . . 0.0 110.196 169.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.41 150.22 50.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.195 1.798 . . . . 0.0 107.157 172.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -137.62 145.4 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.7 mt -128.6 108.56 10.61 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.323 0.965 . . . . 0.0 111.775 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.284 9.5 t -93.44 57.43 2.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.082 1.353 . . . . 0.0 109.51 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.34 175.54 20.11 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.687 2.565 . . . . 0.0 107.95 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -132.17 6.39 4.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.616 0.766 . . . . 0.0 111.956 -165.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.1 144.11 19.27 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 119.658 1.117 . . . . 0.0 109.974 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -70.43 -30.06 19.76 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.899 2.399 . . . . 0.0 113.25 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 m -74.29 -18.29 60.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.711 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.5 15.12 0.19 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.373 1.469 . . . . 0.0 114.018 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -139.7 170.14 16.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.558 1.943 . . . . 0.0 108.077 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.0 m -138.0 165.49 26.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.391 1.077 . . . . 0.0 108.427 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.7 163.47 37.23 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.986 1.714 . . . . 0.0 106.931 162.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -154.06 27.17 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 164.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -23.04 65.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.582 0.753 . . . . 0.0 112.013 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 76.97 0.25 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -169.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.9 tp -45.58 -61.07 1.85 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.405 1.482 . . . . 0.0 110.824 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -90.46 16.81 8.21 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.979 1.312 . . . . 0.0 111.265 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -56.91 140.53 48.2 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.635 1.107 . . . . 0.0 109.348 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.15 -10.15 69.84 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.315 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.95 -174.31 3.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.212 1.805 . . . . 0.0 109.704 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -155.58 100.78 2.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.411 1.484 . . . . 0.0 108.283 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -138.1 171.32 14.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.43 1.492 . . . . 0.0 110.47 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -101.81 151.71 21.74 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.203 1.401 . . . . 0.0 110.697 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -106.79 104.4 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 126.53 1.932 . . . . 0.0 109.363 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.8 m -80.55 131.64 35.56 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.87 159.16 71.27 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 126.059 1.743 . . . . 0.0 108.311 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.35 157.7 49.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 121.459 1.557 . . . . 0.0 110.781 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -66.31 -24.72 66.59 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.15 -43.29 82.68 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.37 1.468 . . . . 0.0 110.396 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.09 -8.62 59.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.698 0.399 . . . . 0.0 111.269 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.41 -46.78 84.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.077 0.951 . . . . 0.0 111.24 -167.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.47 -29.81 59.71 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.548 -1.345 . . . . 0.0 110.495 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -59.07 5.83 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.615 1.566 . . . . 0.0 110.502 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -60.97 -39.65 90.41 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.92 0.782 . . . . 0.0 110.335 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.495 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 3.0 mtm180 -60.05 -39.27 85.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.896 -0.503 . . . . 0.0 110.121 -174.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -76.66 0.19 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.382 1.473 . . . . 0.0 113.685 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.57 173.02 8.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.993 1.27 . . . . 0.0 112.13 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -91.81 -21.25 20.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.837 1.655 . . . . 0.0 112.963 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 -56.53 2.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.915 1.286 . . . . 0.0 110.735 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -59.22 -11.42 3.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.324 1.9 pt20 -44.43 -62.31 1.22 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.683 2.393 . . . . 0.0 114.629 168.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -46.4 80.87 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -67.8 -6.6 22.1 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.093 -1.004 . . . . 0.0 113.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.54 61.46 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 119.973 -1.704 . . . . 0.0 112.171 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.5 57.57 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -124.33 -1.43 8.14 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.2 1.0 . . . . 0.0 112.465 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.8 mt -85.14 134.31 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.52 164.91 33.68 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 126.282 1.833 . . . . 0.0 109.674 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.98 171.07 7.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.334 2.023 . . . . 0.0 112.814 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtt -88.7 175.79 7.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 123.172 1.463 . . . . 0.0 109.897 168.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -123.19 170.19 10.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 156.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 127.602 2.361 . . . . 0.0 113.114 163.679 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 p -153.89 72.21 0.89 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -152.58 170.56 19.89 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.697 1.599 . . . . 0.0 109.116 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -85.16 109.97 18.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.61 51.49 0.03 OUTLIER Glycine 0 C--N 1.334 0.45 0 O-C-N 121.304 -0.872 . . . . 0.0 111.958 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -65.75 162.9 39.95 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.581 1.152 . . . . 0.0 111.577 170.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.33 72.0 4.33 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.369 3.379 . . . . 0.0 111.024 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -144.6 143.07 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.26 165.98 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.561 1.544 . . . . 0.0 111.331 165.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.16 -95.98 0.1 Allowed Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 104.002 -3.639 . . . . 0.0 104.002 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtt -141.41 27.08 1.92 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.246 1.023 . . . . 0.0 112.434 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -146.57 164.56 32.21 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.354 -0.841 . . . . 0.0 109.342 161.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -129.36 11.93 5.92 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -163.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.39 -16.82 30.08 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 122.403 2.365 . . . . 0.0 113.287 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' CD2' ' H ' ' A' ' 15' ' ' LEU . 2.3 mm? -70.61 23.03 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.454 2.702 . . . . 0.0 114.877 -161.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.53 -33.71 4.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.4 -1.437 . . . . 0.0 111.298 -165.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.77 56.94 2.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.603 0.761 . . . . 0.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.97 -18.12 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 CA-C-O 117.77 -1.572 . . . . 0.0 115.974 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -119.95 147.73 44.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.808 . . . . 0.0 111.486 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -126.9 16.57 7.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 111.559 -155.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.81 29.41 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 126.104 1.762 . . . . 0.0 109.583 -166.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tt -113.87 98.5 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 126.706 2.002 . . . . 0.0 106.987 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 mtt85 -89.27 -9.62 49.94 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.071 -1.442 . . . . 0.0 111.144 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.97 135.75 36.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.626 1.557 . . . . 0.0 109.097 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 mt -138.94 102.76 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.2 m -90.78 94.55 9.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.44 127.37 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 120.209 -1.557 . . . . 0.0 110.223 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -79.6 162.67 62.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.656 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.83 164.83 31.19 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.922 2.415 . . . . 0.0 111.085 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 45.15 49.89 9.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.994 2.118 . . . . 0.0 112.015 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.91 -5.02 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.31 158.42 11.04 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 120.636 -1.29 . . . . 0.0 111.384 157.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.5 tp -57.17 158.39 5.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 mt -124.87 81.62 1.97 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.125 1.37 . . . . 0.0 109.494 172.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -70.19 174.68 5.25 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.616 -0.678 . . . . 0.0 112.189 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -73.24 131.1 41.57 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 120.631 -1.293 . . . . 0.0 109.736 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.19 8.3 87.44 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.612 -1.105 . . . . 0.0 113.222 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -12.55 2.01 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.81 2.305 . . . . 0.0 113.038 175.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -122.05 11.5 10.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.36 1.464 . . . . 0.0 111.518 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.5 p -66.31 98.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.068 -1.02 . . . . 0.0 110.555 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.15 -6.35 6.8 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.107 1.337 . . . . 0.0 112.6 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.8 m -73.57 61.53 0.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.376 1.588 . . . . 0.0 111.381 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 p -72.19 25.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.998 1.719 . . . . 0.0 114.592 -171.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.92 17.02 2.3 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.528 -1.358 . . . . 0.0 111.796 161.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.23 120.92 16.63 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.899 1.227 . . . . 0.0 109.193 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.16 -17.46 4.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.133 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.881 1.673 . . . . 0.0 112.908 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.39 103.83 4.16 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 128.256 2.622 . . . . 0.0 104.39 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.29 142.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.11 146.38 43.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -119.6 28.12 8.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.602 0.761 . . . . 0.0 110.684 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.18 17.21 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.85 5.8 22.85 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.65 144.03 21.46 Favored Pre-proline 0 C--O 1.232 0.182 0 C-N-CA 124.83 1.252 . . . . 0.0 107.93 171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.06 -11.57 30.7 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.121 2.547 . . . . 0.0 113.691 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -59.55 -30.08 68.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.323 1.449 . . . . 0.0 111.057 167.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.76 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.881 1.272 . . . . 0.0 113.538 -166.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -139.68 -175.93 4.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.271 1.829 . . . . 0.0 110.134 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -144.42 172.74 12.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.881 2.072 . . . . 0.0 107.916 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.07 168.63 24.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.708 1.203 . . . . 0.0 108.295 161.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.0 -107.03 2.71 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -105.14 -21.41 13.27 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.186 0.594 . . . . 0.0 111.367 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.63 -136.36 3.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 105.408 -3.077 . . . . 0.0 105.408 152.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -160.37 -47.69 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.281 1.032 . . . . 0.0 110.971 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 12.42 28.79 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.249 -0.907 . . . . 0.0 112.526 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.97 145.93 39.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.473 1.109 . . . . 0.0 111.8 -165.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.03 -30.39 1.82 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.488 1.518 . . . . 0.0 112.778 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.67 -175.17 2.72 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 110.318 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -164.6 91.61 0.59 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.921 2.488 . . . . 0.0 106.371 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -134.09 172.65 12.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.595 1.958 . . . . 0.0 109.317 -172.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.15 157.46 16.98 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.809 -1.182 . . . . 0.0 110.887 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.15 102.5 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.629 1.972 . . . . 0.0 106.358 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 m -99.35 110.41 22.92 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.86 1.664 . . . . 0.0 111.195 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.8 157.8 40.76 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.18 1.354 . . . . 0.0 110.34 -166.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -65.35 147.27 87.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 CA-C-N 120.385 1.173 . . . . 0.0 110.016 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.73 -37.49 71.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.899 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -38.86 89.47 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.606 -0.684 . . . . 0.0 110.138 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.2 -18.54 49.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.7 0.8 . . . . 0.0 112.475 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.0 tp -47.26 -53.49 13.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.451 . . . . 0.0 112.576 -166.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.1 -28.37 60.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.908 1.283 . . . . 0.0 109.629 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.98 -38.58 91.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.273 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -67.89 -31.93 72.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -84.25 9.83 11.94 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.65 163.47 21.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.518 1.054 . . . . 0.0 112.773 -169.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -88.12 -36.7 16.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.477 -0.764 . . . . 0.0 111.176 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -82.77 -66.55 0.88 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -68.6 -2.79 9.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.698 1.199 . . . . 0.0 114.172 -163.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.276 1.0 OUTLIER -43.76 -56.04 4.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.651 2.38 . . . . 0.0 112.666 174.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 t -52.75 -40.98 63.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.412 1.085 . . . . 0.0 111.183 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.69 4.3 5.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.339 -0.851 . . . . 0.0 113.073 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.17 -26.48 64.82 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 119.71 -1.869 . . . . 0.0 112.097 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.55 -12.3 14.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -125.92 16.22 7.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.273 0.942 . . . . 0.0 110.188 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.27 122.03 50.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -132.73 165.61 35.2 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.59 1.556 . . . . 0.0 109.239 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.99 175.02 5.05 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.167 1.912 . . . . 0.0 112.072 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptp -101.22 165.23 11.39 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.842 1.657 . . . . 0.0 110.541 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.47 -174.44 4.04 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.206 1.403 . . . . 0.0 110.8 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 . . . . . 0 C--O 1.255 1.394 0 C-N-CA 129.019 2.928 . . . . 0.0 105.007 163.691 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.51 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.58 156.14 45.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.578 1.551 . . . . 0.0 108.25 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -163.3 175.31 11.02 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.299 1.84 . . . . 0.0 107.695 163.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -96.71 68.0 2.39 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -173.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -117.66 100.9 0.89 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 126.088 1.804 . . . . 0.0 109.441 -171.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.31 158.97 39.95 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.941 1.696 . . . . 0.0 108.919 170.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -80.86 64.78 8.93 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.955 3.77 . . . . 0.0 112.181 -163.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.64 158.28 31.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.58 1.952 . . . . 0.0 110.634 -165.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.7 t -80.9 67.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.977 1.311 . . . . 0.0 109.911 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.6 59.53 0.91 Allowed Glycine 0 C--N 1.332 0.353 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 69.82 -55.74 0.59 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.934 2.094 . . . . 0.0 114.016 -176.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 106.9 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.548 1.539 . . . . 0.0 111.024 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mmtm -94.36 81.27 3.97 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 119.612 -1.93 . . . . 0.0 108.169 166.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 p -168.19 -16.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.545 -162.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.14 8.23 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.073 0.851 . . . . 0.0 112.79 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.32 -64.21 0.92 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.945 1.298 . . . . 0.0 109.453 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.67 95.32 0.01 OUTLIER 'General case' 0 C--N 1.34 0.171 0 C-N-CA 127.203 2.201 . . . . 0.0 110.62 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.77 -42.82 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -81.51 112.7 18.98 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.279 0.54 . . . . 0.0 111.348 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.1 p -84.89 14.69 4.58 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.391 1.876 . . . . 0.0 112.559 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.62 46.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.687 1.595 . . . . 0.0 109.733 -170.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.28 86.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 O-C-N 120.922 -1.111 . . . . 0.0 108.88 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -68.82 -19.8 64.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.892 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -138.95 126.84 22.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.69 90.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 m -64.69 141.37 58.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.74 159.55 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 128.079 2.552 . . . . 0.0 105.964 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -118.36 163.8 23.46 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.15 173.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.65 172.06 16.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.791 1.66 . . . . 0.0 110.883 171.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 51.42 27.39 3.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.33 1.852 . . . . 0.0 114.519 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 tt -124.35 5.09 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 112.164 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.84 171.4 18.27 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.083 0.849 . . . . 0.0 112.692 164.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.4 tp -91.21 124.77 35.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.575 1.55 . . . . 0.0 107.402 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.21 104.64 11.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 168.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -107.97 175.49 5.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.756 1.222 . . . . 0.0 110.463 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.59 117.45 8.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.162 1.385 . . . . 0.0 111.168 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.74 40.76 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.217 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.4 mtp -61.23 -52.69 63.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.405 1.603 . . . . 0.0 108.557 156.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -90.11 22.46 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -47.77 123.91 6.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.46 10.58 86.15 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.339 -1.256 . . . . 0.0 114.358 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.9 m -75.91 67.74 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.904 2.352 . . . . 0.0 109.153 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -66.58 -26.23 67.01 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.115 2.166 . . . . 0.0 112.865 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.96 61.95 1.01 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.332 1.453 . . . . 0.0 108.455 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.29 129.69 55.51 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 165.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.97 -15.57 5.83 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.047 166.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -135.52 148.48 49.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 122.543 2.429 . . . . 0.0 114.122 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 tp -137.77 92.17 2.65 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.788 2.835 . . . . 0.0 106.717 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.44 145.95 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -129.58 112.19 13.47 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.151 0.98 . . . . 0.0 108.634 -167.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.8 p -72.16 -6.18 40.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.606 1.093 . . . . 0.0 113.891 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 134.79 12.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.869 1.213 . . . . 0.0 110.583 -163.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.58 -14.64 60.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.926 1.29 . . . . 0.0 113.486 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.87 143.6 40.69 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 108.225 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.68 -36.45 41.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.531 2.154 . . . . 0.0 111.689 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.8 p -66.26 -12.8 58.54 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.57 -6.75 51.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.37 1.068 . . . . 0.0 112.218 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.95 177.59 4.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.748 2.019 . . . . 0.0 111.646 -174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -161.17 124.25 3.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.067 1.347 . . . . 0.0 109.383 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.37 1.62 2.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -164.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 45.4 -103.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 127.394 2.425 . . . . 0.0 113.321 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.96 -7.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.394 2.278 . . . . 0.0 111.275 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.2 25.92 3.8 Favored Glycine 0 C--N 1.336 0.572 0 O-C-N 121.127 -0.983 . . . . 0.0 112.889 -163.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.1 tp -47.18 -54.47 10.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.481 1.112 . . . . 0.0 110.704 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 74.79 0.95 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.13 125.4 44.41 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.94 -12.89 68.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.404 -170.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.21 172.02 17.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.139 2.176 . . . . 0.0 108.95 170.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -141.98 111.24 6.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -124.36 -178.79 4.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 128.308 2.643 . . . . 0.0 108.369 -173.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.24 154.03 27.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.569 -1.332 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -116.89 131.4 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m -128.05 127.09 42.52 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 156.88 72.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 123.87 0.868 . . . . 0.0 108.851 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.1 153.28 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.856 1.037 . . . . 0.0 109.502 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.87 -33.15 70.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.03 -37.37 84.67 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.989 0.813 . . . . 0.0 110.316 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.94 -6.78 55.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.251 1.02 . . . . 0.0 111.527 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.5 -60.96 2.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.945 1.248 . . . . 0.0 112.386 -164.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.71 -36.0 79.68 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.447 0.699 . . . . 0.0 110.254 174.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.22 -57.52 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.984 1.714 . . . . 0.0 111.58 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -64.06 -42.76 96.9 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 124.912 1.285 . . . . 0.0 109.866 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -54.54 -39.39 67.63 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.149 -0.345 . . . . 0.0 110.791 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -81.02 8.07 9.34 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.419 1.487 . . . . 0.0 114.231 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 86' ' ' TYR . 26.6 t0 -64.38 174.91 1.49 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 120.434 1.47 . . . . 0.0 110.989 173.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.407 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 51.9 t80 -75.96 -60.5 2.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.322 1.449 . . . . 0.0 111.455 163.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.92 -57.08 3.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.717 1.207 . . . . 0.0 109.774 -171.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -56.59 -17.17 7.66 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -44.59 -46.65 10.13 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 113.8 165.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 t -66.26 -31.83 72.89 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.676 -0.64 . . . . 0.0 110.518 -176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -83.35 4.72 26.13 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.389 -1.444 . . . . 0.0 112.283 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.58 5.03 2.63 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 120.219 -1.551 . . . . 0.0 112.466 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.81 -8.58 58.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.311 0.959 . . . . 0.0 112.524 167.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -138.65 14.1 2.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.665 1.12 . . . . 0.0 113.516 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.0 mt -91.7 138.97 18.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.51 164.52 39.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.183 -0.948 . . . . 0.0 109.681 165.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.91 164.4 27.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.131 1.887 . . . . 0.0 110.25 165.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.2 ptp -89.66 164.41 14.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.052 0.941 . . . . 0.0 109.873 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -153.29 172.89 16.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.707 1.203 . . . . 0.0 110.71 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.501 159.033 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.629 0 CA-C-O 119.167 -0.796 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.85 168.52 19.74 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 162.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -106.35 38.5 2.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.28 1.032 . . . . 0.0 110.945 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.4 164.13 39.14 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.509 -0.744 . . . . 0.0 109.854 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.06 78.37 1.41 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.13 0.871 . . . . 0.0 111.712 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.35 164.9 51.85 Favored Pre-proline 0 C--O 1.238 0.476 0 O-C-N 121.406 -1.055 . . . . 0.0 110.672 171.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -63.7 107.97 0.81 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.46 2.773 . . . . 0.0 107.369 161.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -152.68 164.57 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 122.183 0.992 . . . . 0.0 109.305 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' HE3' ' A' ' 13' ' ' LYS . 37.8 t -74.15 78.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 161.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.0 -167.27 32.81 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 152.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.22 39.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.639 2.22 . . . . 0.0 113.308 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.425 ' C ' ' HZ1' ' A' ' 13' ' ' LYS . 20.6 t70 -89.71 114.33 25.97 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.787 -1.821 . . . . 0.0 109.297 -159.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HE3' ' CG1' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -80.75 89.1 5.77 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.365 -1.459 . . . . 0.0 108.551 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 t -156.15 -2.45 0.13 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -125.96 25.62 6.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.693 1.133 . . . . 0.0 112.363 -151.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -103.37 -36.98 7.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.591 1.156 . . . . 0.0 111.872 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 28.89 0.05 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.744 1.618 . . . . 0.0 113.038 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.35 -21.7 4.7 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.027 -1.985 . . . . 0.0 113.41 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -126.73 118.17 24.17 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 121.409 2.605 . . . . 0.0 111.615 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.0 p -74.71 18.29 0.18 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.234 2.213 . . . . 0.0 113.72 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.45 6.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.322 1.419 . . . . 0.0 111.476 -158.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -92.62 94.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.555 -1.34 . . . . 0.0 107.541 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -75.81 -13.97 60.29 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.533 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -140.41 135.89 32.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.649 1.113 . . . . 0.0 109.995 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.38 90.49 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.498 1.119 . . . . 0.0 108.767 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.9 m -65.75 141.92 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 165.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.34 167.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.016 1.327 . . . . 0.0 110.505 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -114.34 163.99 17.58 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.279 1.432 . . . . 0.0 110.486 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.7 153.78 72.58 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.691 2.261 . . . . 0.0 109.878 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.39 64.12 1.43 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.79 2.036 . . . . 0.0 111.679 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.273 0.2 OUTLIER -140.71 55.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 123.708 1.718 . . . . 0.0 109.558 -176.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.72 49.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 125.706 1.622 . . . . 0.0 112.543 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.6 tp -105.69 131.74 52.69 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 123.212 1.482 . . . . 0.0 112.745 -157.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -84.37 67.11 9.73 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.674 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -65.47 162.52 17.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.214 1.007 . . . . 0.0 110.058 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.75 109.8 12.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.681 1.192 . . . . 0.0 109.249 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.73 6.78 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.024 1.773 . . . . 0.0 112.803 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.1 -33.51 26.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.372 1.869 . . . . 0.0 113.105 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -114.89 7.94 15.81 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.875 1.67 . . . . 0.0 113.558 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -62.75 101.84 0.29 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.657 1.117 . . . . 0.0 108.616 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.86 -2.85 10.89 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.162 0.887 . . . . 0.0 113.835 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.4 m -77.54 78.7 4.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.489 2.144 . . . . 0.0 109.474 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.5 p -69.97 -23.67 63.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 112.923 -172.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.39 45.15 2.36 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.728 1.211 . . . . 0.0 108.829 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tt -98.6 109.41 22.18 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -110.66 -22.37 11.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.26 150.45 39.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.472 1.033 . . . . 0.0 111.942 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.52 142.45 24.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.958 2.503 . . . . 0.0 105.602 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.24 155.09 29.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -128.08 127.84 43.82 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.5 172.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 p -88.52 38.27 0.86 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 110.076 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.83 159.52 24.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 125.102 1.335 . . . . 0.0 109.898 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -124.5 6.73 8.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.499 0.72 . . . . 0.0 112.482 -157.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -153.24 144.45 16.23 Favored Pre-proline 0 CA--C 1.535 0.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.64 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -66.49 -31.1 42.7 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.189 2.593 . . . . 0.0 113.059 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 m -76.22 -5.93 49.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.183 0.593 . . . . 0.0 112.044 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.99 3.16 27.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.171 0.896 . . . . 0.0 111.93 166.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -133.7 165.62 24.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.87 1.319 . . . . 0.0 110.816 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -134.04 170.79 15.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.225 1.81 . . . . 0.0 108.818 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.03 -177.56 1.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.997 3.719 . . . . 0.0 104.178 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.28 -145.91 5.34 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 0.2 21.89 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.803 -0.822 . . . . 0.0 113.015 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.99 74.47 0.11 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.832 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 tt -44.44 -41.19 6.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.355 1.462 . . . . 0.0 109.098 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' NH1' ' H ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -125.33 34.75 4.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 126.009 1.724 . . . . 0.0 111.871 -173.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -52.26 121.14 6.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.966 0.803 . . . . 0.0 109.027 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.82 12.41 84.57 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.685 -1.064 . . . . 0.0 115.245 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 173.35 11.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.405 1.603 . . . . 0.0 109.85 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -157.43 95.16 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.425 ' H ' ' NH1' ' A' ' 65' ' ' ARG . 37.8 p90 -131.62 168.9 16.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.157 1.383 . . . . 0.0 111.51 -173.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.27 146.08 29.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.21 1.004 . . . . 0.0 111.398 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.68 128.44 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 127.717 2.407 . . . . 0.0 108.688 -172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.72 109.55 14.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.159 1.784 . . . . 0.0 112.208 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.72 160.87 26.37 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.448 1.099 . . . . 0.0 108.896 -175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.2 138.19 65.39 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 108.01 -1.573 . . . . 0.0 108.01 171.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.6 -31.18 56.57 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.26 -33.2 75.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 -175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.81 -2.73 58.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.238 1.415 . . . . 0.0 112.273 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.97 -50.84 70.48 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 119.882 -1.761 . . . . 0.0 112.204 -166.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -65.28 -32.27 73.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.696 0.76 . . . . 0.0 111.039 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -57.27 -56.09 26.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.093 2.157 . . . . 0.0 110.419 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -60.87 -46.12 91.85 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.587 0.755 . . . . 0.0 110.587 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -58.54 -38.76 78.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.59 -0.96 22.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.911 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.56 164.88 6.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.212 1.369 . . . . 0.0 111.683 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.24 13.92 25.87 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.993 1.317 . . . . 0.0 113.162 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -146.22 -59.25 0.31 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.843 2.057 . . . . 0.0 110.923 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -61.42 -9.05 4.74 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.931 1.241 . . . . 0.0 112.964 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.261 0.5 OUTLIER -43.38 -60.52 1.68 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.6 2.36 . . . . 0.0 114.177 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -50.85 37.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 109.849 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -71.02 -2.91 16.97 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.476 1.511 . . . . 0.0 113.285 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.93 -23.61 66.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.658 -1.276 . . . . 0.0 111.969 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.0 -22.67 64.74 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 -116.41 10.45 14.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.296 1.438 . . . . 0.0 111.685 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.06 115.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.15 163.41 23.31 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.773 1.229 . . . . 0.0 109.872 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 164.34 34.37 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.171 1.914 . . . . 0.0 110.415 168.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.2 mtm -76.38 -171.44 1.79 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.251 2.22 . . . . 0.0 111.647 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -99.95 -177.01 3.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.708 2.003 . . . . 0.0 109.512 166.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 . . . . . 0 C--O 1.246 0.882 0 C-N-CA 128.093 2.557 . . . . 0.0 106.121 171.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.558 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -146.97 -167.96 2.91 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.769 0.827 . . . . 0.0 109.418 -170.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -135.86 48.62 2.18 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.025 1.73 . . . . 0.0 108.276 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -151.33 153.2 34.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.633 0.773 . . . . 0.0 109.439 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.59 4.24 0.18 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.926 1.25 . . . . 0.0 113.449 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -61.27 143.47 92.67 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 119.799 1.799 . . . . 0.0 107.815 168.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.41 66.49 8.44 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.781 3.654 . . . . 0.0 113.637 -171.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.86 139.74 47.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.52 123.6 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.165 0.586 . . . . 0.0 110.135 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.34 66.49 0.34 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 mmt 61.05 -55.43 0.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.425 2.69 . . . . 0.0 114.03 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -57.66 114.94 2.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 164.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 30.0 mmtp -104.02 88.55 3.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.38 1.072 . . . . 0.0 108.745 170.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -153.24 -14.94 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.176 0.99 . . . . 0.0 113.604 153.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.453 ' CD2' ' H ' ' A' ' 15' ' ' LEU . 1.7 mm? -65.55 -4.1 5.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -165.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.482 ' C ' ' H ' ' A' ' 18' ' ' GLY . 9.8 m-85 -71.07 -51.29 26.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.571 1.148 . . . . 0.0 109.864 -174.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.36 13.77 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -109.78 4.83 30.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 127.256 2.36 . . . . 0.0 112.708 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -132.4 161.29 34.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.125 1.463 . . . . 0.0 109.683 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 -3.73 10.4 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.155 1.782 . . . . 0.0 112.175 -163.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.0 0.66 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.39 . . . . 0.0 110.474 -160.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.9 tt -71.81 98.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.349 1.86 . . . . 0.0 109.138 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -78.79 -3.47 44.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 117.026 -1.464 . . . . 0.0 112.077 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -152.26 137.69 17.64 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 120.513 1.506 . . . . 0.0 111.344 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -143.72 102.32 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 108.28 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.1 m -85.59 95.75 9.43 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.11 147.79 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -108.99 163.85 16.04 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 124.838 1.255 . . . . 0.0 107.796 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.61 168.08 17.5 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.372 2.048 . . . . 0.0 109.004 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 62.93 -7.13 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 167.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.455 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 5.9 tt -99.83 54.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 121.082 1.765 . . . . 0.0 112.803 -171.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.01 166.55 39.67 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.479 -1.388 . . . . 0.0 111.722 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.6 tp -76.12 165.88 24.28 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.527 1.931 . . . . 0.0 112.033 -171.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.9 73.94 0.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.029 0.831 . . . . 0.0 108.804 169.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.45 170.41 13.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.883 -169.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 150.77 41.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.343 1.068 . . . . 0.0 110.924 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.4 -2.55 37.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.268 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ptm -62.64 -11.25 15.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.833 . . . . 0.0 114.09 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.74 13.41 11.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 111.829 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -66.96 96.88 0.45 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.456 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.93 19.02 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.391 0.996 . . . . 0.0 112.901 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.9 m -73.66 68.8 1.24 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.026 1.413 . . . . 0.0 107.245 164.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -62.63 -55.08 30.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.51 58.01 3.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.377 -0.827 . . . . 0.0 109.002 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -114.84 121.14 42.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.233 1.813 . . . . 0.0 108.025 160.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -135.79 -5.24 2.2 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -124.87 153.12 43.1 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.636 -1.29 . . . . 0.0 110.821 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.46 131.02 11.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.66 144.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.6 mt -121.45 91.39 3.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 108.198 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 t -83.04 64.42 7.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.254 1.422 . . . . 0.0 110.213 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.3 150.49 18.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.059 1.314 . . . . 0.0 110.966 166.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -89.36 -20.41 24.05 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.988 1.315 . . . . 0.0 113.324 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 159.43 54.45 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 126.896 2.078 . . . . 0.0 107.155 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -74.1 -45.65 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.154 3.236 . . . . 0.0 111.851 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -61.7 -25.33 67.34 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -159.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.58 2.47 6.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 113.084 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -105.78 156.02 18.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.339 1.456 . . . . 0.0 108.373 169.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -134.06 142.83 47.72 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 107.386 169.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.56 154.3 34.02 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.778 3.231 . . . . 0.0 106.849 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.98 -160.84 23.68 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 122.073 0.818 . . . . 0.0 111.797 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.04 2.15 4.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.006 1.322 . . . . 0.0 112.87 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.02 74.59 0.17 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.716 1.627 . . . . 0.0 109.726 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.98 -46.22 64.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.583 1.192 . . . . 0.0 109.484 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -106.07 37.8 2.18 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.776 1.63 . . . . 0.0 110.663 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 117.65 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.75 -11.68 38.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.262 0.934 . . . . 0.0 114.398 168.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 -178.3 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.785 1.634 . . . . 0.0 108.587 166.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -142.62 90.42 2.22 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -173.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -135.27 163.88 28.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.3 160.02 14.74 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.321 1.448 . . . . 0.0 109.664 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.45 89.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -171.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -78.79 155.9 29.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.407 -0.808 . . . . 0.0 111.031 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.78 160.83 37.19 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 125.479 1.512 . . . . 0.0 109.457 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.32 141.24 51.04 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -53.81 -31.76 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.416 1.086 . . . . 0.0 112.54 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -46.42 76.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.942 1.697 . . . . 0.0 110.475 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.3 0.14 42.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 112.248 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.5 -45.22 85.18 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.58 1.082 . . . . 0.0 112.419 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.7 -44.44 90.25 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.686 0.795 . . . . 0.0 110.852 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.84 -53.18 27.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.97 1.308 . . . . 0.0 110.815 -171.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -66.53 -38.08 86.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.09 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -61.9 -18.0 58.65 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.437 1.017 . . . . 0.0 111.694 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -87.85 -15.26 37.26 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.65 130.21 40.61 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.319 1.872 . . . . 0.0 109.27 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -47.25 -39.25 13.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.656 1.182 . . . . 0.0 110.885 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -69.04 -74.21 0.13 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.4 1.08 . . . . 0.0 109.95 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -55.77 -22.96 26.95 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -44.67 -48.14 10.57 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -60.14 -43.59 95.6 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.691 0.678 . . . . 0.0 109.682 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.14 7.08 5.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.888 -1.133 . . . . 0.0 112.73 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.68 -19.73 64.15 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 120.043 -1.661 . . . . 0.0 111.996 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.75 37.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -121.01 7.94 10.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.234 1.013 . . . . 0.0 111.813 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 92.3 mt -83.99 148.03 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.122 0.969 . . . . 0.0 108.995 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.33 165.3 17.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.982 1.713 . . . . 0.0 109.654 164.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 163.88 31.61 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.979 1.786 . . . . 0.0 112.299 174.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.2 ptp -82.17 -174.55 5.17 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 110.812 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.61 -170.0 2.15 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.258 2.223 . . . . 0.0 108.42 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 124.69 1.196 . . . . 0.0 107.773 176.474 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.29 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -168.57 1.15 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.394 1.092 . . . . 0.0 110.713 173.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -141.03 80.2 1.73 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.445 2.698 . . . . 0.0 105.205 173.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -166.9 166.67 15.37 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.312 0.645 . . . . 0.0 110.373 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.46 84.45 1.62 Allowed Glycine 0 C--N 1.331 0.291 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 163.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.82 161.15 80.75 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 160.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.38 70.99 5.39 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.648 3.565 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.04 146.56 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 120.764 -1.21 . . . . 0.0 109.701 -169.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.12 132.56 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.241 0.616 . . . . 0.0 110.261 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.79 82.54 0.15 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.438 ' H ' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER 48.2 28.88 1.68 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.805 1.642 . . . . 0.0 111.914 -175.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -147.9 122.42 9.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 32.9 mmtp -106.32 94.98 5.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 162.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.68 19.73 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.943 1.697 . . . . 0.0 110.598 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.52 64.91 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.225 -1.547 . . . . 0.0 111.362 -167.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.0 -10.44 1.15 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.69 17.36 21.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.139 1.336 . . . . 0.0 112.483 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.6 -6.94 20.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.626 -168.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -138.43 105.17 5.36 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 120.354 2.077 . . . . 0.0 109.677 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -72.16 9.43 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -168.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.56 39.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 128.049 2.54 . . . . 0.0 109.442 -159.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.58 96.71 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 128.274 2.63 . . . . 0.0 106.557 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -78.83 -13.3 59.88 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.213 1.005 . . . . 0.0 111.557 -170.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.07 121.27 11.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.184 1.794 . . . . 0.0 107.143 -173.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.7 mt -111.39 103.41 15.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.0 m -72.71 143.41 48.05 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.77 159.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 127.308 2.243 . . . . 0.0 106.313 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.96 163.96 46.42 Favored Pre-proline 0 N--CA 1.451 -0.375 0 C-N-CA 124.033 0.933 . . . . 0.0 110.796 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.61 146.81 55.97 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 -171.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 51.31 66.08 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.09 2.156 . . . . 0.0 110.589 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.438 HD13 ' H ' ' A' ' 11' ' ' MET . 8.6 tp -133.88 40.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.877 1.271 . . . . 0.0 111.086 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.08 156.95 24.83 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.194 -1.566 . . . . 0.0 113.386 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.5 127.19 30.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 127.828 2.451 . . . . 0.0 111.015 -171.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.17 77.17 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -67.57 165.0 17.8 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.81 0.814 . . . . 0.0 110.302 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.96 144.26 33.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.963 -1.086 . . . . 0.0 110.333 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 85.84 5.62 83.59 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.718 0.675 . . . . 0.0 112.883 -178.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 mtp -54.81 -27.2 40.1 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.808 1.243 . . . . 0.0 112.849 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.67 20.53 4.24 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.627 1.171 . . . . 0.0 111.338 -162.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 t -65.44 115.86 6.13 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.88 56.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 76.0 m -68.02 74.81 0.21 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.971 1.385 . . . . 0.0 112.813 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.6 p -63.74 -31.23 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.289 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.57 63.87 0.71 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.178 1.354 . . . . 0.0 107.918 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.14 120.97 34.81 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.194 2.198 . . . . 0.0 106.804 162.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . 0.307 1.2 pt-20 -131.44 -4.07 3.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.018 1.327 . . . . 0.0 114.382 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -144.63 157.99 43.97 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 122.491 1.139 . . . . 0.0 113.3 170.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -140.65 141.04 35.09 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.378 3.071 . . . . 0.0 104.289 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -135.28 142.33 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -128.07 104.69 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.687 1.195 . . . . 0.0 108.694 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -79.28 37.22 0.32 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.577 0.751 . . . . 0.0 111.003 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.83 146.69 18.69 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -97.37 16.25 20.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.991 0.516 . . . . 0.0 111.434 -165.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.75 147.5 17.88 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 110.157 -164.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.22 -41.62 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.647 2.898 . . . . 0.0 110.663 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -67.06 -22.21 65.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.575 1.55 . . . . 0.0 114.229 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.37 4.79 10.0 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 112.158 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -122.62 172.7 8.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.708 1.242 . . . . 0.0 108.995 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.78 126.51 18.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.49 35.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.226 1.41 . . . . 0.0 107.478 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.3 -127.17 5.1 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.4 14.38 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.379 1.072 . . . . 0.0 111.859 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.45 82.86 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 tt -52.43 -50.96 61.54 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.52 40.95 1.28 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.473 1.109 . . . . 0.0 110.694 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 21.2 t70 -65.89 136.3 55.95 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 120.82 -1.175 . . . . 0.0 107.91 169.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.85 60.55 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.776 -1.569 . . . . 0.0 114.865 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 -172.62 4.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.923 1.861 . . . . 0.0 109.444 175.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -134.76 80.18 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -94.38 167.88 11.24 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.48 149.95 28.84 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.281 1.033 . . . . 0.0 109.457 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -109.53 149.63 12.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.15 1.38 . . . . 0.0 107.926 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.1 m -129.87 130.61 45.44 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.343 1.457 . . . . 0.0 107.514 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.21 160.55 67.49 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.944 1.698 . . . . 0.0 108.395 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.55 147.75 90.35 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 120.377 1.17 . . . . 0.0 109.962 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.26 -28.12 67.8 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 -5.99 49.11 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.635 0.774 . . . . 0.0 112.053 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.15 -3.46 31.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.011 -1.055 . . . . 0.0 112.829 167.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.57 -36.59 81.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.359 0.982 . . . . 0.0 113.427 -161.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.57 -30.81 32.9 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.001 -1.062 . . . . 0.0 109.173 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.8 ttm105 -56.38 -60.27 3.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.729 1.211 . . . . 0.0 110.618 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.2 p90 -54.87 -40.64 69.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.505 0.593 . . . . 0.0 110.939 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 1.3 mtp-105 -65.49 -19.85 66.1 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.883 -0.511 . . . . 0.0 111.433 -174.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -100.45 5.28 44.2 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.831 1.252 . . . . 0.0 111.655 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.02 162.7 21.53 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.707 1.139 . . . . 0.0 110.858 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.82 -43.83 64.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.306 -0.871 . . . . 0.0 111.346 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -95.42 -60.38 1.68 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.706 1.203 . . . . 0.0 109.926 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.78 -18.61 13.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.163 1.785 . . . . 0.0 113.936 -170.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -44.98 -42.97 8.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.316 1.446 . . . . 0.0 114.265 167.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -58.71 -37.96 77.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -85.59 10.92 11.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.395 1.478 . . . . 0.0 112.847 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.78 -0.69 7.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.497 -2.002 . . . . 0.0 112.729 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.82 -15.66 53.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.314 0.961 . . . . 0.0 113.451 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -118.11 0.35 11.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.4 92.87 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -168.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -99.35 163.14 19.19 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.371 1.068 . . . . 0.0 112.659 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.75 151.89 58.06 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.212 2.608 . . . . 0.0 112.067 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 mtm -71.15 179.84 2.66 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.855 1.662 . . . . 0.0 110.784 165.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.4 -177.2 3.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.167 1.387 . . . . 0.0 111.758 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 . . . . . 0 C--O 1.253 1.277 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 156.125 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.754 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.55 178.17 8.15 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.609 1.164 . . . . 0.0 110.351 -170.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -144.02 47.32 1.43 Allowed 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.527 0.731 . . . . 0.0 111.743 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -151.06 139.86 20.83 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -127.32 17.81 6.17 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.495 -1.169 . . . . 0.0 114.471 -169.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.3 85.46 0.74 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 119.692 1.746 . . . . 0.0 110.853 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.36 73.5 2.72 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 123.097 2.532 . . . . 0.0 108.554 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -133.24 165.78 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.423 1.889 . . . . 0.0 108.359 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.1 66.87 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.049 1.74 . . . . 0.0 108.309 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.86 82.87 0.32 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.7 mmt 57.98 -58.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 130.229 3.411 . . . . 0.0 115.747 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -62.59 101.53 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.243 1.817 . . . . 0.0 111.413 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -94.21 76.41 4.0 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 119.518 -1.989 . . . . 0.0 108.545 171.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.79 -9.02 0.72 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.434 1.094 . . . . 0.0 113.243 168.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 6.66 15.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -165.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -68.48 -43.89 75.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.139 1.336 . . . . 0.0 111.761 -174.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.68 47.62 0.18 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.256 2.223 . . . . 0.0 112.973 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -133.16 -39.03 0.21 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-O 119.219 -0.767 . . . . 0.0 111.238 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -85.09 100.95 12.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.481 1.141 . . . . 0.0 110.878 -172.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -70.99 9.92 0.62 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.282 2.633 . . . . 0.0 113.88 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.19 55.02 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.892 1.277 . . . . 0.0 109.223 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -129.94 92.36 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.214 -0.928 . . . . 0.0 110.325 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 1.9 mmt85 -76.17 -15.26 60.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.019 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -137.36 135.62 37.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.569 1.077 . . . . 0.0 108.843 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -133.55 113.14 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.5 m -93.16 107.67 19.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -103.14 105.46 18.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.455 1.502 . . . . 0.0 108.386 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -65.02 165.07 17.45 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.798 167.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.5 168.68 24.16 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.503 2.136 . . . . 0.0 110.15 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 46.67 39.21 6.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.91 1.684 . . . . 0.0 112.981 171.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.304 5.2 tt -130.25 22.6 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 120.233 1.379 . . . . 0.0 112.386 -174.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.53 164.33 11.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.007 0.813 . . . . 0.0 113.206 155.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.94 117.49 9.88 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 126.314 1.845 . . . . 0.0 111.54 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -74.55 95.56 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 164.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -76.29 173.79 10.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.147 0.979 . . . . 0.0 111.447 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.0 129.15 39.55 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.423 1.089 . . . . 0.0 113.004 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.62 25.18 74.01 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -45.17 -36.62 3.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.708 2.003 . . . . 0.0 113.321 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.22 13.62 20.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.07 1.748 . . . . 0.0 111.72 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -49.79 119.35 3.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.849 0.859 . . . . 0.0 111.935 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.5 20.99 79.41 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.598 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -71.91 78.67 0.89 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -76.02 -6.37 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.381 1.872 . . . . 0.0 112.305 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.48 72.9 1.45 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 162.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 39.4 tp -134.85 123.6 23.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 130.785 3.634 . . . . 0.0 109.036 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -143.03 -20.48 0.64 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -100.86 145.79 28.13 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.795 2.088 . . . . 0.0 111.163 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.35 150.38 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.65 138.18 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -111.8 155.0 24.26 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -126.2 7.49 7.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.819 0.848 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.06 179.45 41.01 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -125.97 3.76 7.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.259 0.624 . . . . 0.0 111.768 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -147.65 144.17 18.91 Favored Pre-proline 0 N--CA 1.466 0.371 0 C-N-CA 124.6 1.16 . . . . 0.0 108.963 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.2 -27.3 16.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.768 2.312 . . . . 0.0 113.43 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.4 -14.67 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.827 1.251 . . . . 0.0 111.163 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.24 -2.96 23.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.699 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.93 165.33 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.76 1.624 . . . . 0.0 109.833 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 m -139.83 123.65 17.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.93 -0.63 6.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.195 1.398 . . . . 0.0 113.0 -168.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.73 -97.81 0.23 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 126.831 2.158 . . . . 0.0 109.029 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -147.56 -9.6 0.42 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.007 1.723 . . . . 0.0 111.375 160.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.73 24.22 9.71 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.771 1.177 . . . . 0.0 114.04 -163.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.0 tp -44.46 -44.59 8.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.367 1.867 . . . . 0.0 114.092 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.83 58.57 1.64 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -164.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.05 153.15 26.03 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.29 -11.13 51.69 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 117.88 -1.511 . . . . 0.0 114.566 170.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.5 165.32 31.54 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.733 2.013 . . . . 0.0 107.946 162.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.93 86.47 2.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.32 1.048 . . . . 0.0 109.595 -168.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -112.18 174.82 5.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.892 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.67 154.09 39.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.092 2.957 . . . . 0.0 107.929 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -117.03 107.92 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 126.207 1.803 . . . . 0.0 108.354 -163.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.12 151.63 36.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.728 161.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.07 161.72 51.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.236 1.814 . . . . 0.0 107.64 164.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.07 149.61 76.97 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 108.098 -1.539 . . . . 0.0 108.098 167.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.37 -33.09 41.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.832 0.853 . . . . 0.0 111.913 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -59.28 -42.82 92.13 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.714 1.605 . . . . 0.0 111.012 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 -7.22 56.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.688 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.97 -55.18 37.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.822 1.192 . . . . 0.0 112.985 -164.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.53 -33.24 60.7 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.465 -0.772 . . . . 0.0 111.466 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -45.43 -51.62 11.21 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.791 2.036 . . . . 0.0 109.422 167.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.06 -43.43 92.3 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.233 1.013 . . . . 0.0 111.433 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.01 -19.71 65.75 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.255 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -103.09 18.8 20.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.174 1.352 . . . . 0.0 112.993 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.53 166.32 19.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.603 1.561 . . . . 0.0 111.775 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.37 -34.65 16.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.827 0.851 . . . . 0.0 111.514 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -92.04 -59.38 2.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -65.04 -12.42 50.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -170.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -44.15 -45.5 8.31 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -60.67 -43.95 97.06 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 125.623 1.569 . . . . 0.0 110.37 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -71.96 0.59 8.92 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.327 1.451 . . . . 0.0 112.811 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.32 71.06 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 119.864 -1.773 . . . . 0.0 111.479 -172.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.65 5.07 1.56 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -125.1 7.77 7.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.907 1.683 . . . . 0.0 111.937 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.5 mt -102.89 116.2 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.933 1.242 . . . . 0.0 109.391 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.91 155.93 63.03 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 126.057 1.743 . . . . 0.0 111.037 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.37 146.71 40.4 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.978 3.119 . . . . 0.0 111.861 172.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 39.7 mtm -65.65 165.19 12.91 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.307 1.443 . . . . 0.0 112.151 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.08 -177.6 1.09 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.132 1.773 . . . . 0.0 110.375 160.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 . . . . . 0 C--O 1.245 0.842 0 C-N-CA 126.636 1.974 . . . . 0.0 105.871 178.106 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 84.8 Cg_endo . . . . . 0 N--CA 1.45 -1.05 0 N-CA-C 109.47 -1.011 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.28 155.51 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 120.732 -1.23 . . . . 0.0 112.179 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.59 88.47 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.731 1.612 . . . . 0.0 109.846 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 96.41 0.2 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt 58.51 17.72 5.14 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.393 1.477 . . . . 0.0 114.455 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.17 175.37 11.82 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 31' ' ' ILE . 15.4 mttm -138.27 -0.59 2.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.154 2.181 . . . . 0.0 114.507 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -81.63 -29.36 33.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.606 1.094 . . . . 0.0 112.048 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 1.2 mm? -83.59 73.64 10.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.276 1.031 . . . . 0.0 110.893 -160.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -147.16 -49.45 0.18 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.289 0.636 . . . . 0.0 110.458 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.81 71.84 1.05 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.564 1.146 . . . . 0.0 110.702 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.4 -45.55 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -82.4 104.23 12.55 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -60.94 -5.2 1.25 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.546 1.539 . . . . 0.0 114.46 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.29 30.51 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.85 1.204 . . . . 0.0 110.601 -152.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -104.79 88.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 124.497 1.119 . . . . 0.0 109.018 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -70.83 -11.97 61.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.758 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -140.64 135.99 32.25 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 119.855 1.207 . . . . 0.0 108.078 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.18 102.62 7.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -73.66 145.38 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.92 149.75 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.687 1.995 . . . . 0.0 107.98 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -103.14 165.11 14.18 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 125.586 1.554 . . . . 0.0 111.253 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.59 161.49 45.68 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.998 2.465 . . . . 0.0 111.309 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 53.63 23.66 3.73 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.125 2.57 . . . . 0.0 115.432 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.433 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 tt -117.17 63.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.655 1.182 . . . . 0.0 111.4 -171.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' CA ' ' HE2' ' A' ' 13' ' ' LYS . . . 95.82 164.2 34.03 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 128.407 2.908 . . . . 0.0 112.718 174.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -85.17 124.1 31.44 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 173.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 33' ' ' LEU . 1.4 mt -72.34 76.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.692 1.997 . . . . 0.0 108.099 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.22 -165.24 0.17 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.272 -167.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.44 165.21 19.37 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.47 -1.394 . . . . 0.0 111.356 165.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.79 11.26 35.77 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 117.689 1.835 . . . . 0.0 117.689 168.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -43.27 78.39 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 121.53 2.665 . . . . 0.0 111.326 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -116.84 5.96 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.314 1.046 . . . . 0.0 112.382 -155.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -46.69 124.74 6.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.649 1.58 . . . . 0.0 112.852 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.32 20.71 61.87 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.374 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 45' ' ' LEU . 8.4 p -71.33 75.1 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.524 -0.986 . . . . 0.0 111.556 175.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.0 p -59.76 -16.51 28.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.52 1.128 . . . . 0.0 112.929 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.69 71.54 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.323 0.965 . . . . 0.0 110.888 162.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 42' ' ' CYS . 52.5 tp -115.79 115.07 25.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.421 1.089 . . . . 0.0 110.095 159.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -139.12 24.26 2.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.086 0.554 . . . . 0.0 111.662 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -159.44 152.02 21.44 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 120.751 -1.218 . . . . 0.0 109.922 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 tp -141.69 138.32 32.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.97 137.88 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 119.704 1.138 . . . . 0.0 108.024 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -114.7 117.27 30.34 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.107 0.963 . . . . 0.0 109.849 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -88.9 30.09 0.97 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.428 1.091 . . . . 0.0 111.735 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 164.43 18.24 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -113.18 2.81 15.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.35 144.56 31.52 Favored Pre-proline 0 N--CA 1.447 -0.621 0 O-C-N 120.636 -1.29 . . . . 0.0 110.892 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -73.85 -32.37 7.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.294 2.663 . . . . 0.0 114.238 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -66.46 -25.9 66.94 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.146 0.43 . . . . 0.0 111.455 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.17 4.88 1.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 113.071 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.17 149.05 52.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.559 1.072 . . . . 0.0 108.505 167.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.9 m -142.64 135.32 27.99 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.658 0.783 . . . . 0.0 109.046 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -146.26 2.6 0.88 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.56 -67.24 1.28 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.729 2.585 . . . . 0.0 113.916 163.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 174.85 -32.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 131.596 3.958 . . . . 0.0 107.734 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.47 4.17 74.44 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.407 -1.218 . . . . 0.0 115.507 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.516 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 14.2 tp -43.73 -54.03 5.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.69 1.596 . . . . 0.0 112.57 -158.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.6 33.51 5.61 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.54 132.66 53.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.437 1.017 . . . . 0.0 109.911 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 20.97 79.5 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.742 0.686 . . . . 0.0 113.943 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.01 178.61 7.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.43 1.492 . . . . 0.0 110.816 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.97 101.22 0.99 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.829 1.651 . . . . 0.0 108.432 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -146.05 169.08 19.4 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.631 -0.668 . . . . 0.0 112.266 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt -90.04 155.45 19.07 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 128.112 2.565 . . . . 0.0 110.82 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 mt -117.37 94.87 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.183 2.193 . . . . 0.0 108.222 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.82 129.7 38.45 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 121.037 -1.039 . . . . 0.0 110.125 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -130.89 160.1 68.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.52 1.528 . . . . 0.0 108.544 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -67.7 151.74 78.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.729 1.62 . . . . 0.0 110.939 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.72 -36.9 72.65 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.471 0.578 . . . . 0.0 111.594 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -72.61 -6.57 45.11 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.858 -0.527 . . . . 0.0 111.967 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.05 -8.17 20.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.087 1.355 . . . . 0.0 113.776 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tp -63.01 -50.79 69.34 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.639 1.108 . . . . 0.0 111.359 -165.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -63.03 -44.73 95.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -51.74 -53.93 34.1 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.786 1.234 . . . . 0.0 111.029 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -60.25 -38.44 83.5 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.53 0.519 . . . . 0.0 110.61 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -68.96 -25.17 64.41 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.332 -0.855 . . . . 0.0 113.091 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -87.63 -2.38 58.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.346 1.43 . . . . 0.0 112.508 173.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -71.04 157.74 37.69 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.064 0.847 . . . . 0.0 112.376 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 19.92 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.336 1.054 . . . . 0.0 113.812 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.92 -68.42 0.4 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 126.989 2.115 . . . . 0.0 108.012 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -57.53 -14.78 5.62 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.254 1.822 . . . . 0.0 114.676 -165.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -44.65 -47.0 10.49 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.506 1.048 . . . . 0.0 113.097 161.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.404 HG23 ' CD2' ' A' ' 91' ' ' TYR . 2.9 t -62.72 -16.4 57.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.79 0.836 . . . . 0.0 111.943 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CD2' HG23 ' A' ' 90' ' ' THR . 96.3 m-85 -108.35 10.97 27.47 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.039 -1.663 . . . . 0.0 111.335 175.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.15 -8.13 35.92 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 119.949 -1.719 . . . . 0.0 112.421 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.98 -6.17 57.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.901 0.881 . . . . 0.0 112.84 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -130.65 -14.85 3.59 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 124.06 0.944 . . . . 0.0 112.536 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.13 144.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 120.833 -1.167 . . . . 0.0 108.616 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -149.01 164.35 21.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.885 0.874 . . . . 0.0 110.882 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.73 149.92 73.71 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.98 2.453 . . . . 0.0 113.835 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 mtm . . . . . 0 C--O 1.239 0.503 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.752 165.488 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.446 -1.281 0 N-CA-C 109.539 -0.985 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.34 160.26 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.108 -1.62 . . . . 0.0 110.782 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.26 99.05 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.53 1.532 . . . . 0.0 108.411 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.16 121.68 1.08 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.73 -11.33 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.92 2.888 . . . . 0.0 117.429 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -135.16 153.5 51.95 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 121.122 1.783 . . . . 0.0 108.523 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HE3' HG23 ' A' ' 31' ' ' ILE . 40.9 mttt -135.35 51.61 2.07 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.229 1.811 . . . . 0.0 109.939 170.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -127.26 -17.95 4.63 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.7 75.92 0.95 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.066 1.303 . . . . 0.0 109.57 -167.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -130.51 -55.47 1.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.284 1.034 . . . . 0.0 110.71 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.68 30.52 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.806 2.043 . . . . 0.0 113.372 -165.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.05 -36.09 1.55 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.018 1.771 . . . . 0.0 113.07 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -89.26 102.53 15.2 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.283 2.042 . . . . 0.0 112.065 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.3 p -65.66 6.48 0.33 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.265 1.826 . . . . 0.0 114.21 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.82 -1.46 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.834 1.254 . . . . 0.0 109.96 -167.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.1 tt -69.54 111.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -91.05 -14.23 31.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.766 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -146.44 139.98 25.94 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.605 0.762 . . . . 0.0 110.402 -168.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.2 mt -137.4 101.41 2.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.1 132.96 45.86 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 162.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.02 133.79 67.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 126.058 1.743 . . . . 0.0 108.193 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -94.48 162.98 24.21 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 122.889 0.476 . . . . 0.0 110.969 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.79 151.9 78.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.291 1.994 . . . . 0.0 109.635 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 52.73 38.22 25.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.207 1.803 . . . . 0.0 113.471 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.42 HG23 ' HE3' ' A' ' 13' ' ' LYS . 5.0 tp -119.88 0.78 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.499 1.12 . . . . 0.0 113.192 -164.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.38 169.3 11.7 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.247 1.404 . . . . 0.0 112.445 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 132.49 37.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 112.028 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.96 77.98 9.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.147 1.779 . . . . 0.0 107.189 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -69.63 164.17 23.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.994 0.902 . . . . 0.0 110.342 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -66.99 110.83 3.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.311 1.445 . . . . 0.0 110.102 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.43 11.05 32.21 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.283 0.944 . . . . 0.0 114.546 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.5 mtp -52.93 -23.83 8.0 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -127.28 20.03 6.85 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 110.736 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 t -63.59 94.16 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.857 1.263 . . . . 0.0 110.671 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.21 -7.74 6.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.939 1.733 . . . . 0.0 112.859 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.97 70.37 9.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.127 1.963 . . . . 0.0 109.501 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.9 p -67.05 -25.32 66.2 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.161 -0.962 . . . . 0.0 113.338 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.0 -2.11 57.58 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.605 -1.309 . . . . 0.0 113.119 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.84 119.9 24.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.051 0.94 . . . . 0.0 110.207 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -141.11 2.75 1.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.518 0.727 . . . . 0.0 112.239 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -126.97 153.95 45.2 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.183 -1.573 . . . . 0.0 111.186 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 tp -146.14 100.96 3.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.434 3.494 . . . . 0.0 104.143 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.15 124.35 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 120.89 -1.132 . . . . 0.0 108.084 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 72' ' ' ILE . 3.5 mp -101.72 107.86 19.21 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 107.878 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.8 p -77.15 19.72 0.3 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.53 161.09 20.05 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 120.076 1.307 . . . . 0.0 112.445 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -97.31 -4.22 39.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.501 1.52 . . . . 0.0 112.976 -167.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.85 148.4 42.36 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 119.935 1.243 . . . . 0.0 110.4 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.28 -36.45 7.07 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.113 2.542 . . . . 0.0 112.45 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -25.39 63.82 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.484 0.584 . . . . 0.0 112.441 -172.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -1.4 31.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.688 1.595 . . . . 0.0 113.434 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -127.9 126.8 42.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.16 171.86 11.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.701 1.6 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.3 146.85 3.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.496 1.118 . . . . 0.0 109.624 159.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.27 -173.06 34.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 164.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.3 -48.55 81.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.131 0.972 . . . . 0.0 109.061 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.94 36.58 3.02 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 117.536 -1.702 . . . . 0.0 112.315 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tt -44.56 -56.4 4.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.114 1.457 . . . . 0.0 107.526 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 25.31 10.33 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 125.462 1.505 . . . . 0.0 113.241 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.27 130.1 41.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.49 1.041 . . . . 0.0 111.619 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.36 79.35 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.438 1.018 . . . . 0.0 114.641 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.73 -170.47 2.63 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.04 93.65 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.424 -0.798 . . . . 0.0 109.406 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -125.04 165.12 18.74 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -98.36 158.25 15.7 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 128.168 2.587 . . . . 0.0 110.145 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 50' ' ' LEU . 24.4 mt -116.05 90.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.278 1.831 . . . . 0.0 108.744 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.6 136.65 36.28 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.843 -1.161 . . . . 0.0 108.872 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.09 160.83 67.12 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 126.708 2.003 . . . . 0.0 108.379 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.49 153.58 60.55 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.555 1.504 . . . . 0.0 109.267 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.78 -35.63 64.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.071 0.548 . . . . 0.0 112.232 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.26 -42.48 73.59 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.936 1.294 . . . . 0.0 110.885 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.83 57.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.948 0.899 . . . . 0.0 112.318 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.2 tp -51.68 -61.57 2.17 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.099 1.318 . . . . 0.0 112.078 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.81 -28.38 61.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.533 1.133 . . . . 0.0 110.175 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -59.96 -46.16 90.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.469 1.508 . . . . 0.0 110.195 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -64.65 -41.48 96.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.03 0.832 . . . . 0.0 110.215 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -65.41 -12.64 54.25 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 116.921 -1.514 . . . . 0.0 114.361 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -96.38 2.73 52.94 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 121.685 2.039 . . . . 0.0 112.919 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.32 143.9 36.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.709 1.141 . . . . 0.0 111.994 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.72 10.45 1.39 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.044 1.338 . . . . 0.0 113.746 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -137.24 -64.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.123 1.769 . . . . 0.0 111.029 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -54.21 -20.82 7.54 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.776 1.171 . . . . 0.0 113.649 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -43.81 -47.66 8.13 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.852 1.261 . . . . 0.0 113.91 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.432 HG23 ' CD1' ' A' ' 91' ' ' TYR . 4.9 t -64.09 -24.16 67.6 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.665 0.666 . . . . 0.0 111.86 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CD1' HG23 ' A' ' 90' ' ' THR . 76.8 m-85 -96.77 14.55 24.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.361 1.064 . . . . 0.0 111.137 175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.14 -18.21 33.77 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 120.288 -1.508 . . . . 0.0 111.04 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.13 -22.36 28.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 113.084 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -119.45 -8.48 10.02 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.527 1.131 . . . . 0.0 112.983 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.11 115.65 29.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -149.27 165.46 17.62 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.269 1.028 . . . . 0.0 111.277 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.71 158.75 40.48 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.412 2.075 . . . . 0.0 114.441 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 13.4 mtm . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 126.169 1.787 . . . . 0.0 109.979 161.448 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 CA-C-O 121.783 0.659 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.9 165.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.714 2.006 . . . . 0.0 107.518 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 p -113.33 157.19 14.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 109.199 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 -75.49 0.2 Allowed Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.5 mmt -123.69 3.17 8.9 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -167.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -136.94 156.09 48.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.5 1.046 . . . . 0.0 108.901 169.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -139.17 82.52 1.9 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.131 1.373 . . . . 0.0 110.167 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -150.01 -44.49 0.13 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.815 1.646 . . . . 0.0 111.689 162.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.61 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.85 10.48 0.05 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 -168.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -82.05 -12.64 58.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 119.801 -1.812 . . . . 0.0 113.618 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.02 79.74 1.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.61 -13.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.761 -1.577 . . . . 0.0 116.169 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -112.91 91.73 3.76 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 120.295 2.047 . . . . 0.0 109.345 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -66.35 31.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.755 3.622 . . . . 0.0 113.98 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.88 -7.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.371 1.869 . . . . 0.0 111.736 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.94 89.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.025 0.83 . . . . 0.0 110.511 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -72.1 -13.86 61.69 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.501 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -144.68 137.38 26.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -168.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -136.6 120.01 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.548 1.539 . . . . 0.0 106.963 170.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 m -84.42 143.75 29.22 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.949 -1.095 . . . . 0.0 108.162 158.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.42 139.79 44.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' HB2' ' HD2' ' A' ' 29' ' ' PRO . 6.0 pt20 -101.71 165.07 14.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.705 1.202 . . . . 0.0 111.573 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 28' ' ' GLN . 22.3 Cg_endo -66.71 144.95 73.85 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.631 1.554 . . . . 0.0 109.625 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 47.8 74.29 0.17 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.819 1.647 . . . . 0.0 112.282 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.268 4.8 tp -143.0 33.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 121.619 0.724 . . . . 0.0 112.153 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.48 170.88 16.89 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.84 1.686 . . . . 0.0 111.49 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.3 tp -83.92 127.38 33.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.115 0.958 . . . . 0.0 109.713 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 64' ' ' LEU . 46.6 mt -73.02 90.11 1.48 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 162.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 38' ' ' MET . 54.5 p90 -70.44 -164.61 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.91 0.884 . . . . 0.0 112.175 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -158.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.846 -0.597 . . . . 0.0 112.032 160.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.15 76.89 0.0 OUTLIER Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.57 2.033 . . . . 0.0 117.407 -165.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.464 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 30.9 mtp -67.62 -22.06 65.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.317 1.847 . . . . 0.0 111.125 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.72 10.06 4.67 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.129 0.972 . . . . 0.0 110.675 -161.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -62.38 118.16 7.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.33 52.32 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.709 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.1 p -68.39 73.79 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.131 1.965 . . . . 0.0 111.577 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 p -63.7 2.07 0.52 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.955 1.302 . . . . 0.0 113.627 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.91 39.88 0.87 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.229 -1.367 . . . . 0.0 112.272 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.77 120.64 42.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.477 1.944 . . . . 0.0 110.582 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.07 -13.3 5.12 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -117.86 162.98 17.23 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.662 1.119 . . . . 0.0 111.851 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.671 HD21 HD21 ' A' ' 50' ' ' LEU . 13.6 tp -148.67 145.76 27.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.014 2.126 . . . . 0.0 106.96 165.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -128.61 134.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.671 HD21 HD21 ' A' ' 48' ' ' LEU . 21.6 mt -111.57 112.4 24.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -74.58 -14.6 60.8 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.94 -176.44 50.75 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.36 0.981 . . . . 0.0 110.81 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.57 3.64 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.92 143.56 25.76 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 118.243 0.474 . . . . 0.0 110.169 -174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.63 -27.63 32.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.677 2.918 . . . . 0.0 112.373 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.9 m -75.62 9.88 2.02 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.276 -0.89 . . . . 0.0 112.553 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.04 7.43 36.47 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.255 -0.903 . . . . 0.0 112.433 162.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -138.38 111.64 7.99 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.234 1.413 . . . . 0.0 110.052 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -76.18 177.55 7.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.183 1.793 . . . . 0.0 110.848 175.123 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.65 160.96 15.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.395 3.078 . . . . 0.0 105.389 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.52 -101.63 2.73 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.04 -57.49 1.78 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.187 1.795 . . . . 0.0 108.017 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.1 74.58 0.22 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 124.486 1.041 . . . . 0.0 111.928 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 34' ' ' LEU . 2.0 tp -43.74 -41.78 5.08 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.972 2.109 . . . . 0.0 110.259 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.85 56.08 1.87 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.786 2.034 . . . . 0.0 107.985 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.46 129.86 41.5 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 164.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.29 87.13 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.069 0.842 . . . . 0.0 115.17 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.71 170.8 14.72 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.297 1.439 . . . . 0.0 110.61 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.65 101.82 2.01 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.856 1.662 . . . . 0.0 107.765 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.11 169.06 18.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.104 0.562 . . . . 0.0 111.409 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.61 HD13 ' N ' ' A' ' 72' ' ' ILE . 2.4 tm? -87.31 146.19 26.03 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.007 1.323 . . . . 0.0 110.609 -175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 71' ' ' LEU . 33.5 mt -112.01 96.49 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 128.363 2.665 . . . . 0.0 109.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.7 m -83.68 134.54 34.77 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.002 -1.061 . . . . 0.0 112.06 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.8 157.87 74.08 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 126.09 1.756 . . . . 0.0 109.443 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.96 148.86 64.73 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 CA-C-N 121.878 1.706 . . . . 0.0 111.15 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.99 -35.95 64.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.971 0.909 . . . . 0.0 112.014 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -67.8 -20.81 65.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.253 1.821 . . . . 0.0 111.852 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -112.41 -0.28 15.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.118 1.367 . . . . 0.0 112.4 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.23 -34.63 76.86 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.111 -0.993 . . . . 0.0 111.852 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -83.25 -33.05 26.13 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.187 0.995 . . . . 0.0 109.847 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.52 -63.31 1.16 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.235 2.214 . . . . 0.0 111.282 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -64.92 -37.13 86.62 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.848 0.459 . . . . 0.0 110.355 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.08 -24.79 67.83 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.445 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -85.72 -4.55 59.19 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.895 1.225 . . . . 0.0 113.067 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.01 150.05 47.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.108 1.322 . . . . 0.0 110.878 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.37 -44.57 90.95 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.455 -0.778 . . . . 0.0 110.281 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -83.28 -65.33 1.02 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.075 0.95 . . . . 0.0 109.271 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -58.0 -15.7 9.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -164.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -45.02 -43.79 9.52 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.567 1.076 . . . . 0.0 112.858 165.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 91' ' ' TYR . 6.8 t -63.39 -14.57 51.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CD1' HG23 ' A' ' 90' ' ' THR . 71.6 m-85 -113.56 14.97 19.05 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.377 -1.452 . . . . 0.0 111.663 173.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.1 3.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.423 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.58 -12.07 59.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.115 166.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -130.26 0.64 4.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.835 1.198 . . . . 0.0 112.805 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.9 mt -89.85 113.24 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.553 ' CG ' HD11 ' A' ' 71' ' ' LEU . 2.6 pt20 -135.42 164.64 42.22 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 126.249 1.819 . . . . 0.0 110.444 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.56 164.24 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.026 1.817 . . . . 0.0 113.407 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 mtm . . . . . 0 N--CA 1.453 -0.286 0 C-N-CA 126.188 1.795 . . . . 0.0 109.261 161.809 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 CA--C 1.547 1.126 0 N-CA-C 107.954 -1.595 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.16 130.46 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 120.554 -1.341 . . . . 0.0 107.479 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.55 122.48 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 122.913 0.485 . . . . 0.0 110.301 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.12 81.33 0.21 Allowed Glycine 0 C--O 1.223 -0.559 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 68.0 mtp 58.82 -60.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.896 2.478 . . . . 0.0 114.351 -168.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.91 91.43 2.47 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.417 1.008 . . . . 0.0 108.351 -171.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -72.71 88.55 1.3 Allowed 'General case' 0 CA--C 1.519 -0.221 0 O-C-N 120.915 -1.116 . . . . 0.0 108.02 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -173.21 54.13 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.922 2.089 . . . . 0.0 109.686 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.15 61.51 0.45 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.814 1.246 . . . . 0.0 110.58 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -131.44 -44.47 1.01 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.223 0.609 . . . . 0.0 111.413 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.34 77.25 1.01 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.154 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.06 -28.0 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.612 -1.66 . . . . 0.0 113.859 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.509 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.7 t30 -117.98 87.88 2.8 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.224 2.012 . . . . 0.0 112.769 -171.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.0 9.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 132.223 4.209 . . . . 0.0 118.108 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.87 19.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.72 1.608 . . . . 0.0 109.546 -166.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 19' ' ' ASN . 13.3 tt -89.04 113.44 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 166.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -95.86 -17.62 20.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.453 1.101 . . . . 0.0 111.444 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -148.31 134.0 18.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.93 0.769 . . . . 0.0 111.02 -160.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.431 HG12 HD11 ' A' ' 22' ' ' ILE . 7.5 mt -141.29 90.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.36 -166.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.3 m -86.16 87.71 7.47 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.558 0.743 . . . . 0.0 109.087 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.09 164.26 3.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 O-C-N 121.003 -1.061 . . . . 0.0 108.852 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' HG22 ' A' ' 31' ' ' ILE . 16.4 mt-30 -126.23 165.54 27.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.959 1.303 . . . . 0.0 109.919 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.8 149.76 60.79 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.074 1.849 . . . . 0.0 111.026 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 48.48 66.03 1.18 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.191 2.996 . . . . 0.0 111.374 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 28' ' ' GLN . 0.7 OUTLIER -144.93 55.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 110.685 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.21 144.45 15.31 Favored Glycine 0 C--O 1.241 0.561 0 O-C-N 121.018 -1.051 . . . . 0.0 112.603 170.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.83 141.38 58.67 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.319 1.048 . . . . 0.0 108.445 171.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.43 77.83 2.99 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.495 1.118 . . . . 0.0 108.316 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -70.46 162.7 28.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.081 0.943 . . . . 0.0 111.12 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -70.23 113.57 7.53 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.582 1.953 . . . . 0.0 110.312 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.89 4.85 36.12 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.456 1.027 . . . . 0.0 114.156 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.7 mmm -48.2 -41.36 26.99 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.835 1.317 . . . . 0.0 112.824 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -112.27 18.75 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.789 1.236 . . . . 0.0 111.787 -165.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -60.22 121.2 11.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.89 12.9 65.47 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.204 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.4 m -80.03 63.52 4.58 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.855 1.327 . . . . 0.0 110.296 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.5 p -63.47 -13.74 43.64 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -164.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.14 -1.35 29.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.47 -1.393 . . . . 0.0 113.029 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.78 108.74 14.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 110.313 -171.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -126.46 -10.12 6.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -135.9 143.15 44.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.949 1.299 . . . . 0.0 111.837 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.463 HD21 HD21 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -140.46 140.31 35.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.237 2.215 . . . . 0.0 107.112 173.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -131.57 150.48 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.463 HD21 HD21 ' A' ' 48' ' ' LEU . 74.8 mt -133.39 106.55 7.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.832 1.253 . . . . 0.0 109.627 -169.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.2 p -82.27 45.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.886 0.766 . . . . 0.0 111.373 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -143.35 129.86 3.89 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.749 -1.219 . . . . 0.0 111.08 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.45 3.3 47.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.469 2.307 . . . . 0.0 112.753 -163.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.04 144.22 34.25 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 120.531 -1.356 . . . . 0.0 108.477 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -67.03 -33.48 31.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.735 1.623 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -62.24 -20.67 64.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.033 0.933 . . . . 0.0 112.541 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 9.82 0.43 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.956 1.702 . . . . 0.0 113.568 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.54 -177.07 5.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 109.46 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 t -145.65 -177.04 5.37 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.334 1.454 . . . . 0.0 108.847 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.82 6.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 128.492 2.717 . . . . 0.0 107.947 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.23 -171.21 24.92 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 151.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.4 -51.52 43.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.21 58.37 5.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.507 1.051 . . . . 0.0 112.095 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD23 HH22 ' A' ' 65' ' ' ARG . 17.8 tp -44.94 -35.01 2.64 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.398 1.879 . . . . 0.0 112.048 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.476 HH22 HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -132.42 29.86 4.22 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 119.821 -1.799 . . . . 0.0 112.087 178.169 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.87 135.36 15.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.666 0.666 . . . . 0.0 111.101 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.06 -18.7 52.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.267 0.937 . . . . 0.0 112.889 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.0 -178.51 4.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.81 1.644 . . . . 0.0 109.461 173.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -160.91 104.58 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -133.52 168.12 19.22 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.801 0.84 . . . . 0.0 111.603 -169.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -85.61 145.42 27.35 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.994 0.918 . . . . 0.0 112.092 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -105.8 143.51 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.872 2.469 . . . . 0.0 108.986 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -127.87 138.59 52.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.044 1.338 . . . . 0.0 108.986 171.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.22 164.51 42.4 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.951 2.101 . . . . 0.0 108.376 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.62 147.74 82.23 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.816 1.684 . . . . 0.0 109.446 171.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -51.28 -33.48 28.78 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.63 -26.41 67.81 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.336 1.454 . . . . 0.0 110.689 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.78 -4.88 25.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.581 1.552 . . . . 0.0 112.21 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.75 -54.32 45.77 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.878 1.217 . . . . 0.0 112.081 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.72 -33.78 76.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.447 0.699 . . . . 0.0 110.068 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -59.83 -52.75 64.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.534 1.534 . . . . 0.0 111.816 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -58.85 -40.73 85.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.502 0.721 . . . . 0.0 110.027 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 -70.9 -16.91 62.71 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.89 5.38 45.35 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.95 1.25 . . . . 0.0 112.713 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.47 178.15 0.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.701 1.6 . . . . 0.0 113.039 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.4 -20.25 17.93 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.6 -1.313 . . . . 0.0 112.33 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -113.03 -53.94 2.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.684 1.129 . . . . 0.0 110.656 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -58.53 -15.64 12.07 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -46.07 -43.82 14.94 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 115.443 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -44.91 75.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.033 1.288 . . . . 0.0 108.564 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.1 5.74 6.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 112.823 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.461 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -63.51 -21.22 66.2 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.949 1.249 . . . . 0.0 111.769 -174.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -10.58 19.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -119.48 4.55 11.16 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 124.623 1.169 . . . . 0.0 111.563 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 92' ' ' ALA . 80.7 mt -97.13 100.97 11.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -172.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -119.23 165.14 18.01 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.18 0.992 . . . . 0.0 112.571 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.29 169.1 22.41 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.508 2.805 . . . . 0.0 112.534 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.2 mtm . . . . . 0 CA--C 1.54 0.581 0 C-N-CA 127.162 2.185 . . . . 0.0 111.758 171.432 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 CA--C 1.541 0.831 0 N-CA-C 109.685 -0.929 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.65 153.15 27.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.639 -1.288 . . . . 0.0 109.548 -168.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG11 HG13 ' A' ' 27' ' ' VAL . 3.2 t -92.81 61.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.77 -83.93 0.09 OUTLIER Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.4 mtp -140.18 -35.58 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.89 130.82 44.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.024 1.284 . . . . 0.0 111.939 -172.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -91.98 95.38 9.77 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.92 -52.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 108.334 173.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 8.41 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.589 2.356 . . . . 0.0 117.339 -171.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -89.26 -0.59 57.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.916 1.235 . . . . 0.0 113.736 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.55 86.5 2.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.474 1.034 . . . . 0.0 109.741 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.41 -26.98 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 117.608 -1.662 . . . . 0.0 114.741 167.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -95.65 99.21 11.1 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.806 2.303 . . . . 0.0 110.116 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 p -65.57 19.61 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.051 2.941 . . . . 0.0 115.155 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.81 4.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 120.594 -1.316 . . . . 0.0 111.786 -159.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 tt -90.94 104.38 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 O-C-N 120.103 -1.623 . . . . 0.0 107.155 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -84.08 -15.9 45.72 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 117.667 -1.159 . . . . 0.0 111.835 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -138.83 129.75 26.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.249 0.931 . . . . 0.0 110.194 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.449 HD12 HD11 ' A' ' 45' ' ' LEU . 73.9 mt -129.89 97.87 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -79.4 115.18 18.88 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.411 -0.806 . . . . 0.0 109.118 171.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG13 HG11 ' A' ' 9' ' ' VAL . 2.7 t -114.49 125.33 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.145 1.778 . . . . 0.0 110.598 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.76 164.77 51.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 170.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.43 162.03 36.61 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.321 2.014 . . . . 0.0 108.738 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 46.79 53.08 10.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.191 1.396 . . . . 0.0 111.932 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.25 22.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.095 -1.003 . . . . 0.0 113.023 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.63 160.36 9.11 Favored Glycine 0 CA--C 1.521 0.437 0 O-C-N 120.843 -1.161 . . . . 0.0 111.028 165.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 35' ' ' TYR . 9.9 tp -72.25 129.09 37.6 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.963 -1.316 . . . . 0.0 108.418 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -85.52 87.83 7.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.413 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -75.69 -166.62 0.58 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.302 0.641 . . . . 0.0 109.375 176.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.93 148.26 36.47 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 2.59 90.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.1 -1.389 . . . . 0.0 116.312 164.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -34.93 70.34 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.483 2.142 . . . . 0.0 110.107 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.06 17.51 22.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.685 1.594 . . . . 0.0 111.196 -172.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 t -57.16 109.78 0.72 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.55 0.99 46.73 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.631 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -79.02 66.63 4.51 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.538 2.169 . . . . 0.0 110.203 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.0 p -66.04 -6.61 13.48 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.652 1.981 . . . . 0.0 113.695 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.82 25.81 3.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.829 1.252 . . . . 0.0 110.887 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.734 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -70.8 135.19 47.98 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 171.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.6 -25.09 1.03 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.256 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.05 154.92 43.73 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.554 1.941 . . . . 0.0 110.88 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.45 147.7 27.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.32 2.248 . . . . 0.0 105.311 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.29 142.81 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' A' ' 58' ' ' TYR . 37.5 mt -121.12 116.19 24.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.858 0.863 . . . . 0.0 110.212 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.7 p -86.25 3.22 44.12 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.628 0.974 . . . . 0.0 113.628 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.93 162.17 23.92 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 120.802 -1.186 . . . . 0.0 110.931 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -110.61 3.25 19.21 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -164.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -152.6 144.66 16.7 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.119 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.53 -23.25 64.52 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.397 2.731 . . . . 0.0 112.87 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -60.95 -23.75 65.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.395 0.998 . . . . 0.0 112.143 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.84 4.87 17.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.134 0.973 . . . . 0.0 113.151 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.444 ' CE1' HD22 ' A' ' 50' ' ' LEU . 59.7 m-85 -134.9 170.58 15.65 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 126.8 2.04 . . . . 0.0 110.027 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 m -122.16 -176.56 3.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.147 1.379 . . . . 0.0 109.027 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . 174.72 -17.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.884 1.674 . . . . 0.0 113.02 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 47.35 -97.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 128.24 2.829 . . . . 0.0 111.349 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.27 14.78 1.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.233 1.413 . . . . 0.0 109.896 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.05 14.09 3.31 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 117.474 -1.736 . . . . 0.0 115.251 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.588 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 5.4 tt -44.22 -51.62 8.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.822 2.311 . . . . 0.0 111.874 -165.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -86.09 -7.36 58.65 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 116.975 -1.488 . . . . 0.0 114.823 -171.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.2 118.3 4.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.967 0.803 . . . . 0.0 111.11 -152.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.51 -9.28 38.14 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.823 1.677 . . . . 0.0 114.266 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.57 -174.38 3.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.147 1.474 . . . . 0.0 114.064 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -151.0 115.66 5.18 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 131.453 3.901 . . . . 0.0 103.749 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.734 ' HB2' HD22 ' A' ' 45' ' ' LEU . 46.8 p90 -147.91 -175.11 4.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.392 1.077 . . . . 0.0 109.972 174.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.7 tp -127.64 148.4 50.38 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.346 -1.471 . . . . 0.0 110.035 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -110.72 136.87 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.036 2.134 . . . . 0.0 107.77 -173.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 33.7 m -123.43 122.62 38.73 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.994 2.117 . . . . 0.0 110.813 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.88 158.79 58.86 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 107.29 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -69.77 153.57 68.72 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.32 -32.54 73.31 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -27.03 66.65 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.39 0.541 . . . . 0.0 110.445 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -92.74 -7.82 45.55 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.167 -0.958 . . . . 0.0 111.857 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 tp -62.04 -55.94 24.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.104 1.775 . . . . 0.0 111.517 -162.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.72 -30.03 70.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.737 -0.602 . . . . 0.0 110.691 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -59.21 -31.58 69.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.178 1.391 . . . . 0.0 112.475 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -77.69 -41.5 37.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.342 0.974 . . . . 0.0 110.497 166.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -65.98 -27.06 67.86 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 0.0 113.506 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -77.12 -3.07 37.49 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.157 -0.965 . . . . 0.0 111.819 173.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 130.45 35.04 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 121.026 1.739 . . . . 0.0 107.902 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.67 -38.15 90.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.09 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 60' ' ' ALA . 1.5 t80 -71.42 -61.77 1.65 Allowed 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.601 0.637 . . . . 0.0 110.378 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -58.52 -9.1 1.45 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.32 -47.78 6.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.083 0.953 . . . . 0.0 111.908 163.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 t -61.11 -17.92 55.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.576 0.751 . . . . 0.0 111.272 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -113.14 5.61 17.14 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.614 1.966 . . . . 0.0 113.755 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.46 -24.95 65.64 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.946 1.248 . . . . 0.0 111.548 -171.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.09 -13.98 62.63 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -123.33 17.03 9.81 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.632 1.106 . . . . 0.0 111.546 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -103.73 123.07 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 5.0 pt20 -130.01 166.04 29.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.553 1.941 . . . . 0.0 110.917 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 96' ' ' GLN . 55.4 Cg_endo -64.22 174.19 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.317 2.678 . . . . 0.0 112.006 169.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 mtm . . . . . 0 N--CA 1.463 0.185 0 C-N-CA 125.74 1.616 . . . . 0.0 111.562 170.006 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 N-CA-C 108.793 -1.272 . . . . 0.0 108.793 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.97 154.84 19.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 120.687 -1.258 . . . . 0.0 108.013 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.45 155.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 123.932 0.77 . . . . 0.0 109.189 165.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.4 -70.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 36.2 mtp -146.54 -51.98 0.22 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.245 1.418 . . . . 0.0 109.499 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -84.67 113.96 21.67 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.505 0.722 . . . . 0.0 109.695 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 27.2 mmtp -75.28 6.93 3.87 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -85.94 5.11 34.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -104.18 4.9 34.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -159.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -85.85 -57.28 3.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.364 0.984 . . . . 0.0 110.506 -165.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.47 85.21 0.28 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.019 2.528 . . . . 0.0 110.643 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.2 -17.72 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.934 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.04 114.9 28.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.378 1.589 . . . . 0.0 110.797 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 p -73.2 -0.66 14.95 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.597 -1.314 . . . . 0.0 114.173 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.84 -8.89 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 120.305 1.411 . . . . 0.0 110.8 -152.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 tt -65.16 99.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 127.637 2.375 . . . . 0.0 108.103 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -85.95 -10.0 55.91 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.739 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -141.43 134.98 29.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.286 0.948 . . . . 0.0 108.839 -172.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.03 122.55 49.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -83.09 141.17 32.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 160.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.7 143.31 32.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 124.147 0.979 . . . . 0.0 108.367 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -92.78 164.28 22.69 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 110.226 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.81 171.25 14.85 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.634 2.223 . . . . 0.0 110.007 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 48.68 35.39 6.19 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.601 1.96 . . . . 0.0 113.91 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.533 ' O ' ' HE3' ' A' ' 13' ' ' LYS 0.255 5.4 tt -131.53 63.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 122.634 1.207 . . . . 0.0 112.432 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.64 159.56 32.05 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.153 1.358 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.1 168.54 8.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.8 1.24 . . . . 0.0 111.671 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.45 HD13 HD13 ' A' ' 64' ' ' LEU . 37.1 mt -133.2 84.78 2.16 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 170.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -84.43 162.05 20.09 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.061 0.391 . . . . 0.0 110.726 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.18 126.03 26.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.371 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.49 11.44 64.21 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.692 -1.06 . . . . 0.0 114.693 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -62.38 -32.94 73.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.22 2.01 . . . . 0.0 112.415 172.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -107.02 29.3 7.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.027 1.731 . . . . 0.0 110.996 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 t -66.12 102.83 0.87 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.78 48.32 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.828 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.09 63.37 1.8 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.78 1.79 . . . . 0.0 109.618 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 p -73.62 -12.51 60.77 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -158.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.42 13.8 19.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.857 1.208 . . . . 0.0 112.131 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.721 HD22 ' CB ' ' A' ' 70' ' ' PHE . 2.7 tt -65.32 117.59 8.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -126.94 -8.65 6.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -148.33 148.55 30.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.18 0.992 . . . . 0.0 112.282 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tp -151.39 100.49 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.88 138.15 21.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 mt -123.48 129.85 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.051 0.94 . . . . 0.0 108.976 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 p -113.67 35.58 3.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.173 0.989 . . . . 0.0 111.409 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.62 139.9 11.35 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.1 4.13 21.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -163.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -151.75 144.49 16.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 120.64 -1.288 . . . . 0.0 109.423 -164.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -37.97 3.05 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.152 2.568 . . . . 0.0 113.241 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -74.95 -7.04 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.012 0.824 . . . . 0.0 112.095 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.08 -10.93 59.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.031 0.932 . . . . 0.0 112.237 165.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -97.71 173.11 7.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 123.263 1.506 . . . . 0.0 110.709 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -164.39 1.08 Allowed 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 129.111 2.964 . . . . 0.0 106.869 169.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 77.05 142.64 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 130.223 3.409 . . . . 0.0 110.567 -169.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.91 -31.63 0.02 OUTLIER Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.214 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.5 -45.33 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.276 2.231 . . . . 0.0 110.235 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.44 71.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.554 -1.137 . . . . 0.0 112.248 -162.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.45 HD13 HD13 ' A' ' 34' ' ' LEU . 42.1 tp -44.63 -63.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.276 1.038 . . . . 0.0 110.766 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.6 -9.74 59.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 116.916 -1.516 . . . . 0.0 112.311 -164.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -45.29 112.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.954 1.302 . . . . 0.0 110.497 -157.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.08 -6.06 28.89 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.606 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.31 173.26 13.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.223 1.809 . . . . 0.0 110.73 168.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -140.48 81.91 1.83 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.167 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.721 ' CB ' HD22 ' A' ' 45' ' ' LEU . 24.8 p90 -95.26 -176.79 3.91 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.197 1.399 . . . . 0.0 109.023 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.85 157.86 28.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 107.515 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.5 139.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.637 1.175 . . . . 0.0 108.814 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.26 135.36 54.21 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.533 1.133 . . . . 0.0 110.126 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -136.74 155.29 76.7 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 126.166 1.786 . . . . 0.0 107.036 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 153.71 71.22 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 121.536 1.584 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.09 -30.2 66.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.1 -29.69 69.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.322 1.049 . . . . 0.0 111.326 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.09 -11.63 22.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.33 1.052 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 tp -57.68 -52.06 66.97 Favored 'General case' 0 C--O 1.228 -0.055 0 O-C-N 121.108 -0.995 . . . . 0.0 110.45 -170.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -27.38 68.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -59.11 5.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.442 1.497 . . . . 0.0 109.551 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -63.01 -26.62 68.94 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.556 1.071 . . . . 0.0 111.414 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -17.17 61.45 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -103.26 -9.43 19.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.637 1.108 . . . . 0.0 113.612 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.97 151.27 26.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.489 1.116 . . . . 0.0 111.831 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.64 -50.74 72.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.014 -0.429 . . . . 0.0 111.679 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -82.94 -60.68 2.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 108.936 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -60.06 -15.63 24.63 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -43.96 -49.5 8.51 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 120.105 1.32 . . . . 0.0 112.98 164.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 t -57.19 -31.3 65.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -93.8 15.86 15.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.806 1.242 . . . . 0.0 112.658 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.71 65.69 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.016 -1.677 . . . . 0.0 112.18 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.44 38.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.112 0.965 . . . . 0.0 112.979 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -127.43 21.07 6.66 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.87 106.95 21.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 119.898 1.226 . . . . 0.0 108.739 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.62 164.86 26.03 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.088 1.755 . . . . 0.0 111.161 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.55 163.0 36.62 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.66 2.24 . . . . 0.0 112.211 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.7 mtt . . . . . 0 N--CA 1.454 -0.254 0 C-N-CA 124.859 1.264 . . . . 0.0 109.581 163.325 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 CA--C 1.542 0.898 0 N-CA-C 109.816 -0.879 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.54 146.79 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 108.062 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.415 HG11 HG13 ' A' ' 27' ' ' VAL . 21.8 t -86.03 99.54 7.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.06 86.82 0.18 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 167.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.3 mtp 57.89 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 129.309 3.044 . . . . 0.0 118.241 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -110.44 97.07 6.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 121.69 2.041 . . . . 0.0 111.034 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -73.16 28.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.921 1.288 . . . . 0.0 113.221 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.71 28.47 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.626 1.103 . . . . 0.0 111.671 -168.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -125.1 1.94 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.11 1.364 . . . . 0.0 113.562 -171.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 18' ' ' GLY . 26.4 m-85 -91.67 -36.3 13.7 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.321 -0.862 . . . . 0.0 111.418 -162.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.53 14.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.458 2.303 . . . . 0.0 114.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -114.58 -13.54 9.51 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.328 1.918 . . . . 0.0 113.848 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -120.86 107.13 12.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.215 2.007 . . . . 0.0 111.894 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.4 p -79.09 9.62 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.013 1.725 . . . . 0.0 114.355 -168.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.7 -4.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.146 -170.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.35 104.32 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -81.74 -15.62 53.75 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 117.954 -1.022 . . . . 0.0 111.13 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -143.44 126.03 15.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.002 0.921 . . . . 0.0 109.452 -162.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 45' ' ' LEU . 88.0 mt -133.15 103.98 6.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -175.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.4 m -75.03 139.77 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 166.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 9' ' ' VAL . 1.9 t -135.02 165.45 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.57 1.948 . . . . 0.0 108.024 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' HG22 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -125.08 165.87 23.57 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 108.992 176.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.65 162.52 41.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.928 1.752 . . . . 0.0 110.167 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 48.51 19.43 0.23 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.141 2.177 . . . . 0.0 114.549 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 28' ' ' GLN . 4.9 tp -95.06 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 119.895 -1.753 . . . . 0.0 110.758 -170.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.76 151.23 21.33 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 121.14 -0.975 . . . . 0.0 111.728 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.3 tp -70.44 138.47 51.24 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 121.769 0.795 . . . . 0.0 110.293 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.27 99.9 11.9 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 164.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -75.02 165.14 25.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.0 134.62 35.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.833 -1.167 . . . . 0.0 108.352 173.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.17 -0.07 71.58 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.928 1.252 . . . . 0.0 113.204 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -48.75 -44.03 38.23 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.457 2.303 . . . . 0.0 112.676 173.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -95.64 9.83 38.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.598 0.759 . . . . 0.0 112.668 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -58.24 113.65 2.04 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.651 1.114 . . . . 0.0 109.861 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.54 -0.29 53.1 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.004 -1.442 . . . . 0.0 113.721 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.5 m -74.74 67.64 1.61 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.916 1.858 . . . . 0.0 109.284 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -75.17 10.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.389 1.876 . . . . 0.0 113.66 -168.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.32 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.113 0.965 . . . . 0.0 112.943 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.737 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -66.48 118.9 10.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.673 1.579 . . . . 0.0 109.68 -175.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -126.08 -11.59 6.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.313 0.645 . . . . 0.0 111.785 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.81 146.6 25.19 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.168 1.349 . . . . 0.0 111.322 -173.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -147.33 141.28 25.9 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.542 1.937 . . . . 0.0 106.417 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.25 141.27 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 48' ' ' LEU . 43.1 mt -122.74 103.87 8.94 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 109.369 -170.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.8 p -77.53 39.24 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.456 1.502 . . . . 0.0 113.216 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.83 153.52 25.36 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 119.824 -1.798 . . . . 0.0 110.495 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -108.32 4.38 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -158.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.44 144.6 40.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.219 1.008 . . . . 0.0 111.37 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.28 -22.27 5.93 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.3 2.667 . . . . 0.0 115.383 -172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 m -64.95 -36.83 85.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.057 1.299 . . . . 0.0 109.822 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.81 7.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -126.54 128.42 46.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.373 1.069 . . . . 0.0 109.575 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 167.04 13.41 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.221 1.009 . . . . 0.0 110.817 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.88 167.67 16.56 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.117 2.167 . . . . 0.0 108.537 153.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.84 -177.45 40.97 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 158.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -51.76 -44.86 63.51 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.3 1.44 . . . . 0.0 109.847 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.26 82.09 0.3 Allowed Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 127.233 2.349 . . . . 0.0 109.738 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.8 tp -51.53 -63.47 1.12 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.16 0.984 . . . . 0.0 109.623 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.47 17.12 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.121 1.368 . . . . 0.0 112.165 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.26 127.18 28.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.797 0.726 . . . . 0.0 109.244 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.33 81.48 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.249 0.928 . . . . 0.0 113.762 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.54 -164.41 1.82 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.72 2.008 . . . . 0.0 107.402 170.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -167.73 99.37 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 167.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.737 ' CB ' HD22 ' A' ' 45' ' ' LEU . 19.6 p90 -131.52 168.81 17.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.022 1.329 . . . . 0.0 109.486 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -98.18 152.82 18.96 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.147 1.379 . . . . 0.0 109.653 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.88 138.63 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 0.0 109.458 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -127.52 145.13 50.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.221 1.008 . . . . 0.0 110.014 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.12 158.77 74.95 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 108.58 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -67.17 148.85 81.53 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 CA-C-N 120.938 1.371 . . . . 0.0 110.229 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.4 -22.54 63.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -81.07 -22.85 38.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.022 1.329 . . . . 0.0 112.128 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.71 -1.58 32.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.151 1.38 . . . . 0.0 111.889 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.02 -47.39 83.19 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.769 -0.582 . . . . 0.0 112.019 -165.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.91 -43.67 78.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.443 0.297 . . . . 0.0 110.783 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -46.86 -55.0 8.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.19 1.396 . . . . 0.0 111.61 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -63.44 -41.47 98.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.012 0.824 . . . . 0.0 110.584 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -64.78 -16.09 62.55 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.312 -0.868 . . . . 0.0 112.475 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -101.11 15.55 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.262 1.825 . . . . 0.0 112.817 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.3 179.29 5.88 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.62 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -106.71 -29.33 9.64 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.609 1.964 . . . . 0.0 112.859 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.01 -56.2 2.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.772 0.829 . . . . 0.0 108.764 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -61.57 -10.71 8.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.743 -172.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.308 0.3 OUTLIER -43.89 -57.63 3.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.765 1.226 . . . . 0.0 113.373 168.154 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.6 t -69.86 -9.87 56.42 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.688 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -104.73 1.32 29.19 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.645 -1.285 . . . . 0.0 111.927 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -68.45 -3.86 12.85 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 119.671 -1.893 . . . . 0.0 112.585 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.82 -14.05 60.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.169 1.387 . . . . 0.0 112.375 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -127.78 34.96 4.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.203 1.401 . . . . 0.0 109.845 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 92' ' ' ALA . 63.2 mt -109.45 139.0 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.65 163.86 43.84 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.851 1.66 . . . . 0.0 110.127 166.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.92 149.04 91.49 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.86 1.707 . . . . 0.0 110.148 167.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ptp . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 124.641 1.177 . . . . 0.0 108.729 173.208 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 N-CA-C 107.298 -1.847 . . . . 0.0 107.298 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -150.1 147.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 120.448 -1.407 . . . . 0.0 107.92 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 t -78.8 101.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.43 -75.52 0.58 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -51.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.379 1.872 . . . . 0.0 111.365 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -87.36 172.44 9.84 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -126.31 3.98 7.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.533 1.133 . . . . 0.0 113.939 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -83.38 -28.77 28.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.02 23.65 0.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.887 1.275 . . . . 0.0 113.733 -157.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.98 -47.34 5.57 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.088 -1.008 . . . . 0.0 110.57 -171.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.31 1.444 . . . . 0.0 108.054 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.61 -23.44 0.09 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.821 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -108.64 105.22 14.74 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.748 2.274 . . . . 0.0 111.56 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -68.81 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.908 2.483 . . . . 0.0 113.055 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.96 -9.28 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.884 1.274 . . . . 0.0 111.538 -163.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.2 tt -77.48 96.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 120.897 -1.127 . . . . 0.0 108.8 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -75.07 -16.12 60.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.18 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -149.19 134.81 18.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.601 0.761 . . . . 0.0 109.53 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.4 114.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.0 m -89.82 137.72 32.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 t -130.77 121.37 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.935 1.694 . . . . 0.0 108.268 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -77.09 160.85 75.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.401 0.546 . . . . 0.0 110.798 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -75.49 159.9 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.723 2.282 . . . . 0.0 110.83 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 54.9 37.13 28.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.883 1.673 . . . . 0.0 113.007 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.292 3.7 tt -133.4 25.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.675 1.19 . . . . 0.0 112.205 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.61 159.3 8.15 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 127.132 2.301 . . . . 0.0 111.529 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.8 tp -71.96 126.15 29.03 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 124.306 1.042 . . . . 0.0 110.065 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.95 78.42 7.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -68.89 168.18 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.083 0.944 . . . . 0.0 111.548 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -75.54 137.42 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.59 -1.944 . . . . 0.0 108.667 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.34 3.4 90.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.101 0.858 . . . . 0.0 113.937 -174.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.1 ttp -59.77 -25.15 64.66 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 120.158 1.979 . . . . 0.0 113.364 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -114.4 15.69 17.9 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.848 1.259 . . . . 0.0 111.594 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.429 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 58.6 m -48.33 119.28 2.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 111.371 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.56 6.95 85.27 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.297 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.96 73.77 0.61 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.609 2.204 . . . . 0.0 107.092 163.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.6 p -65.31 -51.99 56.97 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.43 1.092 . . . . 0.0 111.532 -167.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.62 3.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.921 1.289 . . . . 0.0 113.957 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.2 tp -76.85 108.28 9.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.279 1.032 . . . . 0.0 110.129 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.62 -12.45 9.74 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.551 169.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -119.14 142.54 47.85 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.522 1.055 . . . . 0.0 113.236 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 49' ' ' ILE . 2.0 tm? -146.53 136.57 23.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.541 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.4 mp -133.94 137.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.2 113.75 22.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 p -83.97 0.38 48.2 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.33 179.05 41.96 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.216 0.912 . . . . 0.0 110.992 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.96 6.26 4.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.017 0.927 . . . . 0.0 112.63 -169.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -141.99 143.82 29.75 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.658 1.583 . . . . 0.0 107.721 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.53 -30.73 4.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.317 2.011 . . . . 0.0 112.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -77.07 -15.84 59.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 111.824 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.64 12.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.441 1.496 . . . . 0.0 112.804 165.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -124.33 168.55 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.252 1.021 . . . . 0.0 110.07 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -141.78 133.68 27.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.61 172.69 9.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.322 2.249 . . . . 0.0 106.388 172.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.73 -145.04 8.1 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.342 1.925 . . . . 0.0 109.361 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.01 -8.86 58.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.782 -0.834 . . . . 0.0 113.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.98 68.23 0.27 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -170.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 tp -46.14 -44.02 15.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.204 1.402 . . . . 0.0 111.022 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -113.7 16.75 18.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.016 0.926 . . . . 0.0 111.419 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.67 146.24 52.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.861 0.755 . . . . 0.0 110.808 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 76.47 -1.02 62.56 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.753 1.168 . . . . 0.0 113.825 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.27 -175.46 4.18 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 128.921 2.888 . . . . 0.0 107.456 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -156.56 94.49 1.48 Allowed 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.812 -1.18 . . . . 0.0 110.737 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -125.21 163.4 22.57 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.112 0.965 . . . . 0.0 111.134 -171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.68 152.39 18.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 108.113 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.4 mt -122.08 101.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -167.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.2 m -87.78 138.05 31.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.365 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.16 155.28 72.62 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.42 1.888 . . . . 0.0 109.7 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.84 144.54 53.91 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 CA-C-N 121.432 1.547 . . . . 0.0 109.46 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -55.24 -32.78 62.57 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -67.33 -18.24 65.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.224 3.01 . . . . 0.0 112.159 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.46 -0.19 19.01 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.83 -1.168 . . . . 0.0 113.135 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 tp -62.7 -50.27 71.8 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.172 0.896 . . . . 0.0 111.351 -168.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.61 -43.21 99.28 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.8 -56.28 9.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.525 1.93 . . . . 0.0 111.795 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -70.61 -40.22 73.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.292 0.496 . . . . 0.0 109.744 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -62.7 -25.41 68.15 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 121.208 -0.933 . . . . 0.0 112.565 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -85.14 -13.69 49.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.275 1.43 . . . . 0.0 112.679 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.73 143.1 57.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.443 0.565 . . . . 0.0 111.553 -160.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.89 24.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.133 2.573 . . . . 0.0 113.439 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -67.32 0.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.983 2.513 . . . . 0.0 107.207 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -58.6 -16.96 18.19 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -167.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -44.08 -45.01 7.88 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.499 1.52 . . . . 0.0 113.775 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -69.36 -6.15 28.03 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.77 15.81 14.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.04 1.291 . . . . 0.0 111.567 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.66 66.55 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.48 -1.388 . . . . 0.0 110.707 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.28 3.28 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -127.29 4.74 6.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.878 1.217 . . . . 0.0 111.889 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.85 123.65 46.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -136.06 162.42 56.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.771 0.828 . . . . 0.0 111.508 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.75 149.16 91.43 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.315 2.677 . . . . 0.0 114.208 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.557 166.127 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 CA--C 1.541 0.858 0 CA-C-O 121.63 0.596 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.34 165.42 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 108.791 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.503 HG22 HD12 ' A' ' 31' ' ' ILE 0.268 7.0 p -110.57 68.23 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.28 1.038 . . . . 0.0 109.826 -161.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.75 79.62 0.26 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 125.766 1.651 . . . . 0.0 109.791 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.2 10.07 1.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.786 2.034 . . . . 0.0 114.388 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.59 122.68 15.67 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.878 1.217 . . . . 0.0 110.225 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -105.29 90.94 3.58 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.391 1.476 . . . . 0.0 107.066 168.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -162.46 10.43 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 14' ' ' SER . 1.3 mp -131.67 1.28 4.02 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.782 -1.199 . . . . 0.0 113.053 -160.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.24 -36.66 16.61 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.664 -0.647 . . . . 0.0 111.573 -163.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 43.87 0.09 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.905 2.082 . . . . 0.0 112.255 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.82 -27.46 0.37 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.381 -1.233 . . . . 0.0 113.352 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -106.78 94.15 4.96 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.438 1.619 . . . . 0.0 110.63 -173.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.5 p -64.24 22.04 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 129.537 3.135 . . . . 0.0 115.107 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.29 7.56 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 O-C-N 119.861 -1.774 . . . . 0.0 110.074 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.94 98.55 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.241 -1.537 . . . . 0.0 107.147 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -71.29 -26.36 62.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.744 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -136.79 120.72 17.57 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.432 0.56 . . . . 0.0 111.218 -160.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mt -122.29 89.96 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 m -66.82 130.93 44.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 161.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.1 155.4 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.328 1.851 . . . . 0.0 107.047 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -119.59 159.66 45.21 Favored Pre-proline 0 N--CA 1.452 -0.368 0 C-N-CA 124.809 1.243 . . . . 0.0 107.864 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.1 152.98 51.68 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.733 1.622 . . . . 0.0 111.196 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 59.85 21.38 10.29 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.524 1.93 . . . . 0.0 113.849 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.503 HD12 HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -118.25 93.86 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 124.505 2.097 . . . . 0.0 107.198 176.036 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.49 138.62 5.21 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 127.27 2.367 . . . . 0.0 113.28 161.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -58.47 130.23 45.77 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mt -88.07 123.37 32.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -133.99 176.56 8.46 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.57 1.148 . . . . 0.0 109.407 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -72.42 152.07 42.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.545 1.164 . . . . 0.0 111.512 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.477 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 66.13 -3.67 3.07 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.085 1.326 . . . . 0.0 114.425 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.469 ' HE3' ' CZ ' ' A' ' 39' ' ' PHE . 3.6 tmm? -57.74 -32.56 67.56 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.805 . . . . 0.0 112.094 -170.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.469 ' CZ ' ' HE3' ' A' ' 38' ' ' MET . 59.7 m-85 -102.49 -5.92 23.48 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.406 1.482 . . . . 0.0 113.468 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 t -54.23 124.78 16.83 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.342 0.974 . . . . 0.0 110.974 -164.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.31 9.24 48.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.764 1.173 . . . . 0.0 112.784 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.7 p -69.85 74.19 0.43 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.951 1.7 . . . . 0.0 111.93 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -58.16 -7.83 0.93 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.49 0.23 5.6 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.609 -1.186 . . . . 0.0 113.5 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.35 123.34 24.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.5 1.955 . . . . 0.0 112.383 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.08 8.66 0.95 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -146.09 126.24 13.81 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.347 -1.471 . . . . 0.0 109.374 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 72' ' ' ILE . 2.3 tp -120.68 139.78 52.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.23 146.75 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -121.86 136.33 54.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.384 1.474 . . . . 0.0 107.154 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 p -111.37 33.69 4.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.122 0.963 . . . . 0.0 111.246 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.85 161.66 20.22 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -113.75 4.17 15.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -157.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.99 147.81 19.46 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.466 1.03 . . . . 0.0 109.64 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.52 -27.51 70.04 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.042 3.161 . . . . 0.0 113.695 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m -72.58 -13.24 61.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.36 7.17 4.6 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.061 -1.024 . . . . 0.0 112.125 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -139.89 179.45 6.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.162 2.185 . . . . 0.0 109.336 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -139.25 179.4 6.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.977 2.111 . . . . 0.0 108.625 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -161.06 1.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.21 -108.14 0.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -150.69 38.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.747 1.619 . . . . 0.0 109.568 163.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.09 28.38 0.2 Allowed Glycine 0 C--O 1.225 -0.415 0 CA-C-O 118.043 -1.421 . . . . 0.0 114.285 -165.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 64' ' ' LEU . 7.2 tt -45.29 -41.97 9.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.55 1.675 . . . . 0.0 112.175 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -117.89 26.15 9.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.856 1.262 . . . . 0.0 112.071 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -58.55 141.64 51.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 110.151 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 -29.95 3.03 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.341 0.972 . . . . 0.0 112.389 -173.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.17 -179.82 4.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.269 1.828 . . . . 0.0 110.25 -175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -161.02 106.87 1.4 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.58 1.152 . . . . 0.0 107.973 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -139.13 167.27 22.43 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.245 1.418 . . . . 0.0 109.76 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.9 mt -89.92 141.93 28.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.949 1.299 . . . . 0.0 108.986 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.412 HG23 HD23 ' A' ' 48' ' ' LEU . 9.9 mt -90.19 138.12 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.627 1.971 . . . . 0.0 105.823 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.2 m -120.81 136.0 55.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.31 161.11 62.36 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 124.615 1.166 . . . . 0.0 107.997 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.04 147.7 84.68 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.997 1.035 . . . . 0.0 110.425 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -50.34 -37.2 35.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.236 1.014 . . . . 0.0 112.6 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -31.93 59.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.797 -0.565 . . . . 0.0 110.482 -170.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.23 -5.84 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.926 1.29 . . . . 0.0 112.302 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.4 tp -56.14 -38.04 70.28 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 112.12 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -69.8 -47.4 62.98 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.57 -0.706 . . . . 0.0 111.409 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -49.03 -53.28 20.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.136 1.774 . . . . 0.0 111.955 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -66.12 -42.6 88.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.288 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -57.1 -48.67 78.04 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.936 0.789 . . . . 0.0 111.657 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -68.87 -11.54 60.64 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.34 137.85 48.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.308 0.958 . . . . 0.0 111.218 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -61.4 -38.08 85.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.384 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.59 -66.73 0.66 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.369 1.068 . . . . 0.0 108.46 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -58.68 -23.17 58.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.563 -1.208 . . . . 0.0 112.232 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -44.7 -35.18 2.54 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -56.27 -41.1 75.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.085 0.402 . . . . 0.0 110.153 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -89.43 9.91 24.58 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 112.432 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -65.27 -22.06 66.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.083 -1.635 . . . . 0.0 112.393 -167.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.1 -19.16 64.17 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -113.43 5.27 16.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.891 0.769 . . . . 0.0 112.007 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 92' ' ' ALA . 29.9 mt -86.98 134.05 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.471 1.508 . . . . 0.0 109.271 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.42 166.44 19.94 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.694 1.998 . . . . 0.0 111.51 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.7 175.83 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.002 2.468 . . . . 0.0 112.599 169.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 126.134 1.774 . . . . 0.0 109.39 174.491 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.543 0.928 0 N-CA-C 109.704 -0.922 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.56 165.57 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 126.379 1.871 . . . . 0.0 107.948 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.676 HG23 ' CE ' ' A' ' 13' ' ' LYS . 2.1 p -93.48 95.79 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.12 -84.99 1.5 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.8 mtp -128.38 -56.79 1.23 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.197 1.799 . . . . 0.0 109.954 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 115.93 23.42 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.34 -0.85 . . . . 0.0 110.49 -163.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.676 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -72.6 4.02 4.37 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -164.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.5 m -114.27 62.61 0.66 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.846 2.112 . . . . 0.0 112.33 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -133.9 4.47 3.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.402 1.081 . . . . 0.0 112.529 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.03 -55.96 3.25 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.443 1.497 . . . . 0.0 111.145 -167.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.28 92.57 0.04 OUTLIER 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.47 -6.04 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.199 -1.334 . . . . 0.0 112.988 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -139.34 144.85 38.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.056 1.928 . . . . 0.0 112.525 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.1 p -115.65 16.34 16.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.44 2.296 . . . . 0.0 113.264 -159.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.72 14.02 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 127.81 2.444 . . . . 0.0 111.254 -168.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tt -95.43 85.22 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 O-C-N 119.887 -1.758 . . . . 0.0 108.464 -165.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -87.51 18.14 4.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.032 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.95 145.92 26.75 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -137.19 104.25 3.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -70.13 144.26 52.1 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 162.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.6 123.01 35.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.19 161.82 66.52 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.809 -0.557 . . . . 0.0 109.909 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.79 167.2 26.76 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.583 2.189 . . . . 0.0 111.285 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 45.09 42.68 6.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.365 2.266 . . . . 0.0 114.411 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 tt -141.42 2.17 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.417 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . 178.16 130.47 1.41 Allowed Glycine 0 C--N 1.336 0.561 0 O-C-N 120.056 -1.653 . . . . 0.0 112.546 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 tp -59.09 136.67 58.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 164.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.5 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 5.5 mt -100.64 75.08 1.71 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.205 1.002 . . . . 0.0 109.408 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -75.03 163.22 27.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.96 0.504 . . . . 0.0 111.63 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 10.6 p-10 -69.32 114.62 7.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.563 1.545 . . . . 0.0 110.517 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.54 -5.75 24.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.297 1.427 . . . . 0.0 112.761 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' A' ' 34' ' ' LEU . 16.6 mtp -50.17 -54.0 23.84 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.952 1.301 . . . . 0.0 111.796 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -98.29 9.9 41.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.624 1.17 . . . . 0.0 111.497 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.403 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 11.6 t -66.76 112.28 4.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.34 -4.38 37.79 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.838 0.732 . . . . 0.0 112.598 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -76.58 72.63 3.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.331 1.565 . . . . 0.0 108.508 168.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 p -72.87 4.05 4.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.266 2.226 . . . . 0.0 113.189 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 49.89 1.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.215 1.806 . . . . 0.0 107.667 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.3 tp -122.67 105.34 10.0 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.32 -11.43 7.93 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.583 1.177 . . . . 0.0 114.159 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -129.98 124.2 32.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.537 HD21 HD21 ' A' ' 50' ' ' LEU . 2.4 tp -117.89 140.53 49.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.26 132.18 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.537 HD21 HD21 ' A' ' 48' ' ' LEU . 25.3 mt -110.92 113.85 26.73 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.481 0.713 . . . . 0.0 109.263 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.69 12.8 6.54 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.45 177.22 27.04 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -136.48 29.9 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 109.261 -170.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.69 147.3 9.4 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.314 -0.866 . . . . 0.0 111.35 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.33 -42.84 9.35 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.706 2.938 . . . . 0.0 112.592 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -74.67 -15.31 60.81 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.377 -0.827 . . . . 0.0 112.759 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.79 -7.92 43.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.889 0.768 . . . . 0.0 113.06 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.41 -168.63 1.34 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.27 1.428 . . . . 0.0 109.579 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.9 m -145.62 172.69 12.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.552 1.541 . . . . 0.0 107.052 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.87 137.85 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.09 -165.39 11.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 156.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.57 -59.89 4.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.283 0.563 . . . . 0.0 109.536 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 36' ' ' ASP . . . -87.72 65.75 3.49 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 125.021 1.296 . . . . 0.0 111.45 -170.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.8 tp -45.07 -48.42 11.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.299 1.04 . . . . 0.0 110.719 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.94 36.69 2.78 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.567 -0.708 . . . . 0.0 111.108 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.66 121.2 12.2 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.445 -1.41 . . . . 0.0 110.029 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 83.73 10.18 81.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.08 171.89 13.45 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.674 1.237 . . . . 0.0 108.485 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -140.08 94.23 2.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 122.218 1.008 . . . . 0.0 108.299 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.59 165.04 16.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.272 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.8 mt -105.12 158.14 16.78 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.088 1.355 . . . . 0.0 109.051 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.78 101.39 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 127.089 2.155 . . . . 0.0 106.548 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.9 m -75.27 127.11 32.43 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.88 156.18 80.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 125.309 1.444 . . . . 0.0 107.116 172.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.59 143.16 67.48 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -51.61 -43.03 62.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.05 1.74 . . . . 0.0 110.568 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.91 -10.11 12.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.71 -4.66 12.16 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 125.139 1.376 . . . . 0.0 112.434 168.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.64 -59.1 5.93 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 121.286 1.857 . . . . 0.0 110.841 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.48 -18.05 61.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.457 0.646 . . . . 0.0 112.222 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -66.24 -45.06 81.96 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.462 2.305 . . . . 0.0 110.0 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -64.05 -49.91 70.47 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -56.27 -32.25 64.36 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.732 1.151 . . . . 0.0 113.947 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -80.69 2.27 26.65 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -64.13 167.04 6.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.393 1.092 . . . . 0.0 111.554 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.03 -45.61 60.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.746 0.818 . . . . 0.0 110.702 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -104.0 -47.93 4.04 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.048 0.939 . . . . 0.0 111.091 -162.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -55.03 -21.15 11.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.893 0.769 . . . . 0.0 112.188 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -46.15 -45.19 16.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.265 1.826 . . . . 0.0 113.099 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 t -64.56 -25.5 68.0 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.338 0.517 . . . . 0.0 110.297 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.28 9.34 38.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.24 1.816 . . . . 0.0 112.62 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -8.94 32.58 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.36 -1.463 . . . . 0.0 112.168 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.12 -18.62 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.471 1.032 . . . . 0.0 113.488 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -112.48 -4.3 14.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 112.629 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.44 134.23 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.62 160.08 55.1 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.153 0.981 . . . . 0.0 111.031 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.17 164.12 26.48 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 111.963 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 CA--C 1.533 0.3 0 C-N-CA 126.389 1.876 . . . . 0.0 111.645 176.305 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 N--CA 1.458 -0.611 0 N-CA-C 107.483 -1.776 . . . . 0.0 107.483 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.96 140.75 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.534 1.134 . . . . 0.0 108.163 -164.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 27' ' ' VAL . 41.8 t -76.43 77.79 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.04 72.32 0.46 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.365 1.46 . . . . 0.0 110.086 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.39 9.49 2.02 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.467 1.907 . . . . 0.0 115.895 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -132.23 159.14 39.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.284 1.402 . . . . 0.0 109.374 158.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -138.46 31.92 2.32 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.392 1.477 . . . . 0.0 112.22 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.0 t -133.67 29.0 3.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.799 1.24 . . . . 0.0 110.882 175.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -115.4 2.72 13.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.161 1.785 . . . . 0.0 112.42 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.27 -41.07 11.77 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.967 -1.083 . . . . 0.0 110.926 -163.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.59 84.79 1.15 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.311 1.044 . . . . 0.0 109.759 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.06 -41.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -87.34 91.16 8.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.015 0.912 . . . . 0.0 112.37 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.2 p -70.94 33.48 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 128.425 2.69 . . . . 0.0 114.589 -171.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.0 1.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 120.352 -1.468 . . . . 0.0 112.319 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -71.9 83.89 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-O 121.975 0.893 . . . . 0.0 111.473 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -79.37 4.31 15.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.797 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -153.29 138.28 17.23 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.1 1.36 . . . . 0.0 108.427 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -134.66 126.0 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 167.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.5 m -102.49 122.15 43.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 9' ' ' VAL . 2.3 t -112.12 112.49 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.96 1.304 . . . . 0.0 107.962 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -65.15 164.02 26.3 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.329 0.652 . . . . 0.0 110.491 167.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.24 154.97 68.98 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.216 1.944 . . . . 0.0 110.627 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.69 51.85 8.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.784 2.034 . . . . 0.0 113.109 171.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 tt -136.95 84.0 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 124.227 1.965 . . . . 0.0 107.808 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.82 149.48 0.11 Allowed Glycine 0 CA--C 1.525 0.682 1 C-N-CA 131.168 4.223 . . . . 0.0 113.014 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.86 HD21 ' HB3' ' A' ' 35' ' ' TYR 0.334 0.0 OUTLIER -64.81 155.33 34.29 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.792 -0.828 . . . . 0.0 110.195 170.789 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.534 ' H ' ' HB2' ' A' ' 59' ' ' SER . 5.0 mt -102.15 123.09 45.4 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 168.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.86 ' HB3' HD21 ' A' ' 33' ' ' LEU . 23.7 p90 -122.53 175.51 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 111.306 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.9 126.4 27.88 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.419 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.45 46.81 93.6 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 mtp -70.64 -34.24 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.815 1.246 . . . . 0.0 110.805 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -114.84 29.85 7.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.088 1.355 . . . . 0.0 110.655 -167.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.3 t -61.73 109.69 1.3 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.891 0.876 . . . . 0.0 110.53 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.79 12.88 55.03 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.978 -0.901 . . . . 0.0 113.462 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -78.2 73.82 4.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.392 1.596 . . . . 0.0 109.441 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 p -68.06 -3.17 9.36 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.971 2.508 . . . . 0.0 113.5 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.68 53.43 1.85 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.486 1.514 . . . . 0.0 107.889 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 tp -129.63 111.78 13.03 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.607 1.563 . . . . 0.0 107.882 174.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.77 8.95 3.06 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -137.3 152.7 50.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 O-C-N 120.878 -1.139 . . . . 0.0 110.503 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.8 tp -146.1 94.03 2.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.86 1.664 . . . . 0.0 107.169 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -82.71 141.52 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -128.18 118.05 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 p -88.48 -4.53 58.6 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -167.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.8 154.31 20.56 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 119.064 0.847 . . . . 0.0 112.111 -167.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.31 -2.82 58.49 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.37 148.1 39.42 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 120.288 1.403 . . . . 0.0 111.868 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.91 -23.61 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.23 2.62 . . . . 0.0 113.803 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 t -73.69 -21.18 60.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.698 1.599 . . . . 0.0 110.869 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.26 6.27 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.263 1.825 . . . . 0.0 113.031 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -141.72 175.36 9.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.261 1.824 . . . . 0.0 111.001 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.534 ' HB2' ' H ' ' A' ' 34' ' ' LEU . 3.8 m -135.12 -171.95 2.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.42 2.688 . . . . 0.0 108.584 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 177.1 -13.56 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.393 1.477 . . . . 0.0 113.425 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.22 -100.24 0.51 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.588 1.566 . . . . 0.0 110.134 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -140.39 -13.16 1.02 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.372 1.069 . . . . 0.0 111.299 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.08 42.8 0.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 124.007 0.813 . . . . 0.0 111.343 -159.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -44.47 -55.56 4.97 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.216 1.406 . . . . 0.0 111.569 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -98.33 12.38 35.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.931 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -64.32 158.28 23.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.266 0.939 . . . . 0.0 110.17 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.8 6.52 51.71 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.894 1.235 . . . . 0.0 114.695 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.26 -163.84 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.318 2.247 . . . . 0.0 107.499 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -155.74 112.29 3.16 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 120.456 -1.403 . . . . 0.0 110.051 164.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 175.42 8.02 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.56 1.144 . . . . 0.0 112.774 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.2 tp -111.04 155.75 22.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.954 2.502 . . . . 0.0 108.553 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.9 mt -117.76 138.9 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.462 1.105 . . . . 0.0 108.206 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.93 130.7 50.62 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.556 1.542 . . . . 0.0 107.686 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 82' ' ' TYR . 34.6 m -131.74 160.18 68.66 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.18 144.54 69.33 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.44 -29.99 27.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.53 0.732 . . . . 0.0 111.477 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.05 -33.08 73.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.022 1.329 . . . . 0.0 112.29 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.53 -3.82 19.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.584 1.154 . . . . 0.0 112.391 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.88 -46.4 74.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.47 -36.93 60.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.04 -52.5 42.53 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 109.799 172.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.476 ' CD2' HG11 ' A' ' 74' ' ' VAL . 3.2 m-85 -63.91 -42.03 97.51 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.868 0.867 . . . . 0.0 109.817 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -67.01 -11.61 57.51 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -110.12 18.13 20.3 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.027 1.731 . . . . 0.0 110.707 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -79.53 159.43 26.9 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.757 -1.214 . . . . 0.0 112.036 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -81.71 -35.47 29.74 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.124 -0.985 . . . . 0.0 112.103 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -90.96 -54.21 4.06 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.606 -0.684 . . . . 0.0 109.225 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -69.54 -12.51 61.71 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -47.43 -35.5 8.55 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 121.27 1.85 . . . . 0.0 115.158 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -63.15 -41.41 99.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.116 0.871 . . . . 0.0 111.181 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -75.94 3.77 9.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.221 1.008 . . . . 0.0 112.35 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -63.85 -19.87 65.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.678 -1.263 . . . . 0.0 112.024 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.5 -5.94 6.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.742 -1.123 . . . . 0.0 113.626 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -133.41 12.61 4.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.369 1.44 . . . . 0.0 112.474 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 92' ' ' ALA . 54.3 mt -89.54 130.78 38.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -138.08 165.39 33.79 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 111.284 165.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 176.37 2.48 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.446 2.097 . . . . 0.0 111.36 168.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 125.731 1.613 . . . . 0.0 107.311 175.044 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 N-CA-C 110.397 -0.655 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -134.67 165.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -169.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.06 70.07 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.381 -0.824 . . . . 0.0 108.796 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.99 69.51 0.51 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.1 mtp 58.42 13.8 2.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.679 1.992 . . . . 0.0 115.61 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.27 172.07 13.38 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.301 1.41 . . . . 0.0 109.899 157.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 mmpt? -118.2 4.6 11.95 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.254 1.422 . . . . 0.0 113.422 -175.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -82.43 -23.93 34.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.395 1.452 . . . . 0.0 113.301 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.88 62.27 4.06 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.531 . . . . 0.0 111.999 -165.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -142.24 -49.06 0.36 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.686 -1.259 . . . . 0.0 112.13 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.77 66.06 2.0 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.476 1.11 . . . . 0.0 110.57 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 -34.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.587 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' O ' HG22 ' A' ' 22' ' ' ILE . 55.4 t30 -94.9 80.58 3.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.413 1.606 . . . . 0.0 112.297 -168.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.5 p -62.34 24.21 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 130.869 3.668 . . . . 0.0 116.511 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.36 -14.48 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 128.552 2.741 . . . . 0.0 110.947 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 19' ' ' ASN . 16.4 tt -62.51 99.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 119.348 0.976 . . . . 0.0 110.099 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -4.11 52.96 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.736 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -152.56 134.1 14.53 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 119.033 0.833 . . . . 0.0 112.163 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.5 108.88 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -81.0 146.53 30.63 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -139.65 115.0 8.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -66.5 164.2 34.06 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 118.202 0.455 . . . . 0.0 110.172 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.32 162.38 36.49 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.849 1.699 . . . . 0.0 110.848 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 44.7 56.47 5.17 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.187 2.595 . . . . 0.0 112.693 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.5 tt -144.69 71.12 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 124.282 1.992 . . . . 0.0 109.37 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.46 170.81 42.4 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 126.988 2.232 . . . . 0.0 112.416 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.4 tp -83.84 133.71 34.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.901 1.28 . . . . 0.0 110.638 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.42 122.1 28.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 159.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -126.75 175.51 7.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.817 1.247 . . . . 0.0 109.35 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.42 156.14 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.829 0.851 . . . . 0.0 110.237 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 63.75 -1.01 2.69 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.737 2.113 . . . . 0.0 115.307 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -29.65 60.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.013 1.725 . . . . 0.0 112.643 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -110.56 18.45 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.795 1.238 . . . . 0.0 113.373 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 t -56.91 105.54 0.23 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.776 0.831 . . . . 0.0 111.577 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.43 23.47 39.95 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.128 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -72.37 76.96 1.02 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.743 1.772 . . . . 0.0 109.182 164.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -71.79 15.68 0.14 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.816 2.446 . . . . 0.0 114.243 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.41 4.39 1.98 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.759 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -68.37 119.85 13.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.394 0.997 . . . . 0.0 110.631 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -122.25 -35.21 3.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.31 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -121.06 141.91 50.32 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 122.021 2.192 . . . . 0.0 113.178 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.7 tp -119.74 138.99 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.916 2.487 . . . . 0.0 104.561 161.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.05 140.59 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -115.44 151.38 34.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -119.47 5.14 11.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 112.395 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.12 169.03 30.37 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 118.971 0.805 . . . . 0.0 111.828 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.39 15.69 8.96 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.59 152.7 42.2 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 120.641 -1.287 . . . . 0.0 108.632 163.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -3.32 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 124.526 3.484 . . . . 0.0 113.896 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 m -91.48 14.64 14.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.865 1.212 . . . . 0.0 112.495 161.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.59 -4.49 55.26 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.181 1.355 . . . . 0.0 113.497 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -129.07 174.74 9.27 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.987 1.715 . . . . 0.0 109.72 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -119.35 172.4 7.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.807 1.643 . . . . 0.0 108.316 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -174.06 118.81 0.25 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 127.977 2.511 . . . . 0.0 105.948 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.66 -178.91 5.27 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 125.817 1.675 . . . . 0.0 109.425 161.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.51 -38.82 88.74 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.452 1.101 . . . . 0.0 111.779 -162.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.21 81.79 0.29 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 126.892 2.187 . . . . 0.0 107.832 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 tt -51.81 -47.06 64.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.544 1.172 . . . . 0.0 109.106 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -85.99 -7.0 58.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 117.573 -1.203 . . . . 0.0 114.157 -165.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -54.64 112.66 1.06 Allowed 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.684 0.615 . . . . 0.0 110.007 -159.566 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.38 -13.31 12.27 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.313 -1.271 . . . . 0.0 115.755 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.5 -172.43 4.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.014 1.407 . . . . 0.0 109.503 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -151.0 97.79 2.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.135 -0.978 . . . . 0.0 111.646 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.759 ' CB ' HD22 ' A' ' 45' ' ' LEU . 13.8 p90 -122.73 164.9 17.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 109.685 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.5 149.0 21.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.375 1.87 . . . . 0.0 110.689 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.26 126.34 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 m -112.78 140.15 47.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -133.39 160.21 69.53 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.075 1.35 . . . . 0.0 107.431 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.82 147.73 81.35 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.292 -1.465 . . . . 0.0 108.292 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.91 -30.21 32.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.964 0.506 . . . . 0.0 112.182 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -71.38 -25.58 62.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.871 1.268 . . . . 0.0 112.343 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.71 -3.28 46.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 113.049 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 tp -62.2 -50.09 73.19 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.358 -0.839 . . . . 0.0 113.216 -163.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -74.54 -37.85 62.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.805 0.842 . . . . 0.0 109.917 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -49.34 -52.81 25.69 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.529 1.132 . . . . 0.0 109.086 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -70.29 -30.22 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.09 0.556 . . . . 0.0 110.762 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -22.91 62.21 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.379 -0.826 . . . . 0.0 112.763 169.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -91.22 6.66 44.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.001 1.32 . . . . 0.0 112.175 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.98 159.73 24.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 120.807 1.64 . . . . 0.0 112.14 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -72.04 -43.73 64.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 120.768 -1.208 . . . . 0.0 110.978 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -95.36 -53.12 3.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.933 0.893 . . . . 0.0 110.22 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.86 -13.18 22.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.404 1.002 . . . . 0.0 113.415 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -48.64 -48.26 39.72 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.503 1.521 . . . . 0.0 114.743 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 t -52.04 -43.81 63.94 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.022 1.283 . . . . 0.0 110.171 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -80.38 6.7 11.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.435 1.094 . . . . 0.0 113.665 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.7 70.24 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.066 1.303 . . . . 0.0 111.533 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.1 -3.07 0.73 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 114.239 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -135.89 12.49 3.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.194 1.398 . . . . 0.0 112.271 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.9 mt -98.02 131.09 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.676 1.125 . . . . 0.0 108.949 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.58 166.14 26.35 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.771 2.028 . . . . 0.0 111.737 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.2 154.16 69.47 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.134 1.89 . . . . 0.0 113.214 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.3 ptp . . . . . 0 CA--C 1.536 0.433 0 C-N-CA 126.604 1.961 . . . . 0.0 109.515 173.05 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 N-CA-C 110.416 -0.648 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.29 165.78 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.242 1.417 . . . . 0.0 109.042 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 ' CE ' ' A' ' 13' ' ' LYS . 4.0 p -109.3 127.02 66.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.328 1.051 . . . . 0.0 111.806 -172.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.18 76.01 0.2 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.011 1.291 . . . . 0.0 110.018 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.4 mtm 63.19 -31.68 0.1 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.822 2.849 . . . . 0.0 115.99 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -44.39 43.39 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.746 1 C-N-CA 136.928 6.091 . . . . 0.0 118.52 169.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.629 ' CE ' HG23 ' A' ' 9' ' ' VAL . 3.1 mmtm -73.22 72.11 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 119.372 -2.08 . . . . 0.0 111.029 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.61 4.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.055 2.142 . . . . 0.0 112.266 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.06 -13.92 14.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.721 1.6 . . . . 0.0 113.096 -174.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CD1' ' SD ' ' A' ' 38' ' ' MET . 21.4 m-85 -69.4 -35.0 75.35 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.708 0.803 . . . . 0.0 111.777 -160.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 33.27 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.896 2.078 . . . . 0.0 112.827 168.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.62 -40.8 1.55 Allowed Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.5 -1.375 . . . . 0.0 112.37 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -102.37 157.28 17.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.924 1.362 . . . . 0.0 109.997 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 p -123.21 22.65 9.36 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.534 1.534 . . . . 0.0 110.671 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.05 16.79 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.13 1.772 . . . . 0.0 108.78 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -87.62 104.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -107.65 9.59 29.23 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.168 1.787 . . . . 0.0 111.646 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -154.13 148.35 25.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 156.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.45 118.25 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -82.38 125.02 30.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 166.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 28' ' ' GLN . 1.8 t -119.24 164.45 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.442 ' H ' HG12 ' A' ' 27' ' ' VAL . 36.4 mt-30 -131.24 157.86 76.9 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -167.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 59.2 Cg_endo -70.7 157.07 59.59 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -177.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m120 46.73 37.72 5.01 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.179 1.791 . . . . 0.0 114.855 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.265 4.7 tt -117.12 18.65 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.242 . . . . 0.0 113.168 -174.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.62 149.56 5.68 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.59 1.566 . . . . 0.0 110.465 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 34' ' ' LEU . 1.4 tm? -65.82 130.23 42.54 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.574 ' N ' HD13 ' A' ' 33' ' ' LEU . 2.6 mt -79.44 78.01 5.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.66 1.184 . . . . 0.0 107.904 173.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HA ' HD12 ' A' ' 33' ' ' LEU . 3.3 p90 -75.36 168.63 19.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.833 0.825 . . . . 0.0 111.432 -162.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -74.56 98.08 3.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.512 0.725 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.77 -1.72 11.02 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.833 1.682 . . . . 0.0 113.815 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.465 ' SD ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 tmm? -59.24 -37.61 77.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.723 2.009 . . . . 0.0 113.431 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -103.68 11.88 35.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.042 1.337 . . . . 0.0 112.492 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 t -69.89 94.41 0.84 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -171.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.69 -6.65 6.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.157 -1.357 . . . . 0.0 113.478 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.2 m -74.63 70.54 1.84 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.652 2.226 . . . . 0.0 109.957 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p -67.83 -11.05 57.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.807 1.243 . . . . 0.0 114.326 -168.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.6 18.44 17.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.853 1.261 . . . . 0.0 111.714 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.756 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.2 tt -79.86 119.48 22.8 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 120.458 -1.401 . . . . 0.0 108.477 -173.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.82 -17.53 5.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.505 1.522 . . . . 0.0 112.447 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -152.02 150.15 29.65 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.175 2.19 . . . . 0.0 110.859 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.443 HD21 HD21 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -150.79 145.43 25.73 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 128.45 2.7 . . . . 0.0 104.451 178.209 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.29 141.38 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' A' ' 58' ' ' TYR . 94.9 mt -126.97 115.03 18.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.242 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.7 p -82.17 12.32 4.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.87 175.36 32.46 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.456 -1.402 . . . . 0.0 109.893 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -132.85 19.57 4.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.76 0.824 . . . . 0.0 110.982 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -160.88 144.81 10.12 Favored Pre-proline 0 N--CA 1.467 0.411 0 C-N-CA 125.029 1.332 . . . . 0.0 109.224 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.98 -25.03 44.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.01 2.473 . . . . 0.0 113.423 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 m -65.34 -11.67 44.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.346 0.658 . . . . 0.0 112.139 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 29' ' ' PRO . . . -79.52 -1.01 35.74 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.728 1.149 . . . . 0.0 112.869 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.47 ' CE2' HD22 ' A' ' 50' ' ' LEU . 83.9 m-85 -137.78 170.51 15.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 110.468 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.7 m -156.8 149.06 23.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.928 1.291 . . . . 0.0 109.59 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.21 158.3 44.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.231 2.213 . . . . 0.0 110.106 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.3 -166.23 42.0 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.67 -24.4 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.298 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.34 73.81 0.44 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.888 1.709 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.2 -40.75 5.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.642 1.577 . . . . 0.0 110.808 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.66 24.06 7.25 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 0.0 111.415 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -51.53 121.93 7.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.144 0.884 . . . . 0.0 110.941 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.54 13.39 82.98 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.855 -0.969 . . . . 0.0 114.231 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.52 176.03 8.9 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.604 1.962 . . . . 0.0 108.178 162.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.61 76.27 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.08 -1.012 . . . . 0.0 110.159 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.756 ' HB2' HD22 ' A' ' 45' ' ' LEU . 18.8 p90 -119.83 171.06 8.68 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.391 1.076 . . . . 0.0 111.979 -165.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.03 160.79 17.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.254 1.822 . . . . 0.0 110.303 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -131.08 104.78 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.028 2.131 . . . . 0.0 110.016 -163.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.2 m -95.25 105.25 17.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.574 1.95 . . . . 0.0 113.334 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -113.22 156.14 43.45 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.702 1.201 . . . . 0.0 109.254 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.51 151.81 82.17 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.585 1.602 . . . . 0.0 109.158 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.62 -31.24 66.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.781 0.832 . . . . 0.0 112.226 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -59.51 -33.17 71.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.333 1.453 . . . . 0.0 112.093 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.08 -6.52 38.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.499 -0.751 . . . . 0.0 111.978 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -61.9 -50.66 71.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.298 0.954 . . . . 0.0 111.663 -164.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.57 -30.65 46.88 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.688 -0.633 . . . . 0.0 111.078 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -50.32 -55.17 16.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.21 1.404 . . . . 0.0 109.242 168.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.25 -37.98 85.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.235 0.614 . . . . 0.0 111.054 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -68.12 -28.16 67.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 118.463 -0.78 . . . . 0.0 112.863 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.11 3.95 47.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.02 1.282 . . . . 0.0 113.291 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.36 148.36 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.738 0.815 . . . . 0.0 112.029 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -58.64 -42.77 89.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 112.815 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -102.88 -52.94 2.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.154 0.981 . . . . 0.0 109.731 -171.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -60.39 -12.25 8.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -44.28 -44.62 8.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 164.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.4 t -64.03 -46.35 84.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.358 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.98 6.37 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.111 -0.993 . . . . 0.0 112.812 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.11 68.3 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.663 -1.273 . . . . 0.0 111.181 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -19.04 15.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.008 0.923 . . . . 0.0 113.315 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -117.62 4.87 12.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.614 1.166 . . . . 0.0 112.673 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.5 mt -99.26 95.41 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -95.45 163.13 22.31 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.8 0.84 . . . . 0.0 109.245 173.365 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 96' ' ' GLN . 86.2 Cg_endo -69.48 166.57 26.79 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 168.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.6 mtm . . . . . 0 C--O 1.236 0.347 0 C-N-CA 125.127 1.371 . . . . 0.0 109.511 166.451 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 CA--C 1.543 0.972 0 CA-C-O 121.91 0.712 . . . . 0.0 113.498 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -134.48 144.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 O-C-N 120.433 -1.417 . . . . 0.0 109.341 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.927 HG13 ' HE3' ' A' ' 13' ' ' LYS . 16.6 t -77.71 94.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.66 84.25 0.22 Allowed Glycine 0 C--O 1.223 -0.554 0 N-CA-C 106.561 -2.616 . . . . 0.0 106.561 165.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 ttt 56.4 4.13 0.13 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 166.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -132.14 85.22 2.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.905 1.23 . . . . 0.0 111.51 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.927 ' HE3' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -74.81 73.49 2.09 Favored 'General case' 0 C--N 1.339 0.114 0 O-C-N 120.118 -1.614 . . . . 0.0 109.316 174.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -145.14 -16.98 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.558 1.143 . . . . 0.0 113.229 172.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.76 86.09 2.46 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 126.98 2.112 . . . . 0.0 107.817 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -142.01 -52.0 0.41 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.18 0.992 . . . . 0.0 112.047 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.92 87.17 1.01 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.22 1.808 . . . . 0.0 108.275 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 -41.59 0.05 OUTLIER Glycine 0 C--N 1.33 0.238 0 CA-C-O 118.488 -1.174 . . . . 0.0 112.535 -171.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -110.0 133.28 53.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.971 0.885 . . . . 0.0 109.909 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 p -101.28 6.3 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 114.054 -155.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.76 17.81 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 110.666 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tt -97.92 90.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.86 -17.98 62.09 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.15 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -138.99 120.06 14.55 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.675 1.125 . . . . 0.0 108.786 -165.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.92 135.57 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.6 m -117.72 133.06 56.33 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG13 HG11 ' A' ' 9' ' ' VAL . 2.2 t -132.37 122.41 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.897 1.679 . . . . 0.0 109.195 -173.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 28' ' ' GLN . 6.4 mp0 -79.14 165.06 51.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -75.36 168.71 23.99 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.967 2.445 . . . . 0.0 111.922 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 50.0 34.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.964 2.106 . . . . 0.0 114.002 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.275 4.9 tt -138.47 27.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.58 162.59 9.17 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.43 0.538 . . . . 0.0 113.791 152.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.6 tp -80.77 121.13 25.54 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 109.564 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -78.95 83.34 5.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -69.37 167.03 17.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.678 0.751 . . . . 0.0 111.447 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.2 124.91 25.55 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.817 1.247 . . . . 0.0 110.094 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.16 28.54 66.12 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.659 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.7 mtp -54.29 -35.04 62.17 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.2 1.5 . . . . 0.0 110.128 161.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.3 22.09 16.27 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.191 1.796 . . . . 0.0 111.807 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.419 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -67.34 121.22 15.26 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.22 11.06 70.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.949 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.95 91.13 1.52 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.47 1.635 . . . . 0.0 108.485 171.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -3.68 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.933 2.093 . . . . 0.0 113.677 -166.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.16 68.0 1.3 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 161.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.6 tp -121.17 109.93 15.57 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.634 1.173 . . . . 0.0 109.978 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -139.98 30.66 2.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.816 0.446 . . . . 0.0 112.103 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -157.02 147.54 21.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 119.874 -1.766 . . . . 0.0 110.196 169.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.657 HD12 HG23 ' A' ' 72' ' ' ILE . 2.1 tm? -134.41 150.22 50.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.195 1.798 . . . . 0.0 107.157 172.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.1 mp -137.62 145.4 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.7 mt -128.6 108.56 10.61 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.323 0.965 . . . . 0.0 111.775 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.284 9.5 t -93.44 57.43 2.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.082 1.353 . . . . 0.0 109.51 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.34 175.54 20.11 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.687 2.565 . . . . 0.0 107.95 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -132.17 6.39 4.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.616 0.766 . . . . 0.0 111.956 -165.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.1 144.11 19.27 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 119.658 1.117 . . . . 0.0 109.974 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -70.43 -30.06 19.76 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.899 2.399 . . . . 0.0 113.25 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 m -74.29 -18.29 60.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.711 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.5 15.12 0.19 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.373 1.469 . . . . 0.0 114.018 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -139.7 170.14 16.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.558 1.943 . . . . 0.0 108.077 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.0 m -138.0 165.49 26.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.391 1.077 . . . . 0.0 108.427 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.7 163.47 37.23 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.986 1.714 . . . . 0.0 106.931 162.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -154.06 27.17 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 164.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -23.04 65.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.582 0.753 . . . . 0.0 112.013 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 76.97 0.25 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -169.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.9 tp -45.58 -61.07 1.85 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.405 1.482 . . . . 0.0 110.824 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -90.46 16.81 8.21 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.979 1.312 . . . . 0.0 111.265 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -56.91 140.53 48.2 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.635 1.107 . . . . 0.0 109.348 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 87.15 -10.15 69.84 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.315 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.95 -174.31 3.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.212 1.805 . . . . 0.0 109.704 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -155.58 100.78 2.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.411 1.484 . . . . 0.0 108.283 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -138.1 171.32 14.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.43 1.492 . . . . 0.0 110.47 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -101.81 151.71 21.74 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.203 1.401 . . . . 0.0 110.697 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.657 HG23 HD12 ' A' ' 48' ' ' LEU . 44.4 mt -106.79 104.4 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 126.53 1.932 . . . . 0.0 109.363 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.8 m -80.55 131.64 35.56 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.87 159.16 71.27 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 126.059 1.743 . . . . 0.0 108.311 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.35 157.7 49.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 121.459 1.557 . . . . 0.0 110.781 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -66.31 -24.72 66.59 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.15 -43.29 82.68 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.37 1.468 . . . . 0.0 110.396 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.09 -8.62 59.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.698 0.399 . . . . 0.0 111.269 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.41 -46.78 84.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.077 0.951 . . . . 0.0 111.24 -167.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.47 -29.81 59.71 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.548 -1.345 . . . . 0.0 110.495 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -59.07 5.83 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.615 1.566 . . . . 0.0 110.502 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -60.97 -39.65 90.41 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.92 0.782 . . . . 0.0 110.335 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 3.0 mtm180 -60.05 -39.27 85.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.896 -0.503 . . . . 0.0 110.121 -174.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -76.66 0.19 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.382 1.473 . . . . 0.0 113.685 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.57 173.02 8.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.993 1.27 . . . . 0.0 112.13 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -91.81 -21.25 20.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.837 1.655 . . . . 0.0 112.963 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 -56.53 2.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.915 1.286 . . . . 0.0 110.735 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -59.22 -11.42 3.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.324 1.9 pt20 -44.43 -62.31 1.22 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.683 2.393 . . . . 0.0 114.629 168.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -46.4 80.87 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -67.8 -6.6 22.1 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.093 -1.004 . . . . 0.0 113.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.54 61.46 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 119.973 -1.704 . . . . 0.0 112.171 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.5 57.57 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -124.33 -1.43 8.14 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.2 1.0 . . . . 0.0 112.465 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 82' ' ' TYR . 64.8 mt -85.14 134.31 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.52 164.91 33.68 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 126.282 1.833 . . . . 0.0 109.674 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.98 171.07 7.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.334 2.023 . . . . 0.0 112.814 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtt . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 123.172 1.463 . . . . 0.0 109.897 168.485 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.54 0.802 0 N-CA-C 111.024 -0.414 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -144.6 143.07 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.26 165.98 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.561 1.544 . . . . 0.0 111.331 165.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.16 -95.98 0.1 Allowed Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 104.002 -3.639 . . . . 0.0 104.002 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtt -141.41 27.08 1.92 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.246 1.023 . . . . 0.0 112.434 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -146.57 164.56 32.21 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.354 -0.841 . . . . 0.0 109.342 161.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -129.36 11.93 5.92 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -163.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.39 -16.82 30.08 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 122.403 2.365 . . . . 0.0 113.287 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.61 23.03 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.454 2.702 . . . . 0.0 114.877 -161.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.53 -33.71 4.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.4 -1.437 . . . . 0.0 111.298 -165.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.77 56.94 2.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.603 0.761 . . . . 0.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.97 -18.12 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 CA-C-O 117.77 -1.572 . . . . 0.0 115.974 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -119.95 147.73 44.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.808 . . . . 0.0 111.486 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -126.9 16.57 7.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 111.559 -155.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.81 29.41 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 126.104 1.762 . . . . 0.0 109.583 -166.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tt -113.87 98.5 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 126.706 2.002 . . . . 0.0 106.987 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 mtt85 -89.27 -9.62 49.94 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.071 -1.442 . . . . 0.0 111.144 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.97 135.75 36.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.626 1.557 . . . . 0.0 109.097 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 mt -138.94 102.76 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.2 m -90.78 94.55 9.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.44 127.37 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 120.209 -1.557 . . . . 0.0 110.223 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -79.6 162.67 62.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.656 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.83 164.83 31.19 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.922 2.415 . . . . 0.0 111.085 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 45.15 49.89 9.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.994 2.118 . . . . 0.0 112.015 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.91 -5.02 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.31 158.42 11.04 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 120.636 -1.29 . . . . 0.0 111.384 157.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' H ' ' A' ' 34' ' ' LEU . 36.5 tp -57.17 158.39 5.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.9 mt -124.87 81.62 1.97 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.125 1.37 . . . . 0.0 109.494 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -70.19 174.68 5.25 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.616 -0.678 . . . . 0.0 112.189 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -73.24 131.1 41.57 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 120.631 -1.293 . . . . 0.0 109.736 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 66' ' ' ASP . . . 81.19 8.3 87.44 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.612 -1.105 . . . . 0.0 113.222 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -12.55 2.01 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.81 2.305 . . . . 0.0 113.038 175.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -122.05 11.5 10.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.36 1.464 . . . . 0.0 111.518 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.5 p -66.31 98.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.068 -1.02 . . . . 0.0 110.555 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.15 -6.35 6.8 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.107 1.337 . . . . 0.0 112.6 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.8 m -73.57 61.53 0.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.376 1.588 . . . . 0.0 111.381 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 p -72.19 25.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.998 1.719 . . . . 0.0 114.592 -171.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.92 17.02 2.3 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.528 -1.358 . . . . 0.0 111.796 161.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.773 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.3 tt -70.23 120.92 16.63 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.899 1.227 . . . . 0.0 109.193 -177.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.16 -17.46 4.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.133 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.881 1.673 . . . . 0.0 112.908 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.39 103.83 4.16 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 128.256 2.622 . . . . 0.0 104.39 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.29 142.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 58' ' ' TYR . 59.9 mt -117.11 146.38 43.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -119.6 28.12 8.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.602 0.761 . . . . 0.0 110.684 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.18 17.21 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.85 5.8 22.85 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.65 144.03 21.46 Favored Pre-proline 0 C--O 1.232 0.182 0 C-N-CA 124.83 1.252 . . . . 0.0 107.93 171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.06 -11.57 30.7 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.121 2.547 . . . . 0.0 113.691 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -59.55 -30.08 68.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.323 1.449 . . . . 0.0 111.057 167.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.76 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.881 1.272 . . . . 0.0 113.538 -166.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.477 ' CE2' HD22 ' A' ' 50' ' ' LEU . 86.0 m-85 -139.68 -175.93 4.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.271 1.829 . . . . 0.0 110.134 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 34' ' ' LEU . 8.3 t -144.42 172.74 12.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.881 2.072 . . . . 0.0 107.916 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.07 168.63 24.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.708 1.203 . . . . 0.0 108.295 161.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.0 -107.03 2.71 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -105.14 -21.41 13.27 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.186 0.594 . . . . 0.0 111.367 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.63 -136.36 3.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 105.408 -3.077 . . . . 0.0 105.408 152.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -160.37 -47.69 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.281 1.032 . . . . 0.0 110.971 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 12.42 28.79 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.249 -0.907 . . . . 0.0 112.526 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -58.97 145.93 39.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.473 1.109 . . . . 0.0 111.8 -165.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.03 -30.39 1.82 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.488 1.518 . . . . 0.0 112.778 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.67 -175.17 2.72 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 110.318 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -164.6 91.61 0.59 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.921 2.488 . . . . 0.0 106.371 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.773 ' HB2' HD22 ' A' ' 45' ' ' LEU . 24.4 p90 -134.09 172.65 12.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.595 1.958 . . . . 0.0 109.317 -172.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.15 157.46 16.98 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.809 -1.182 . . . . 0.0 110.887 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.15 102.5 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.629 1.972 . . . . 0.0 106.358 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 m -99.35 110.41 22.92 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.86 1.664 . . . . 0.0 111.195 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.8 157.8 40.76 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.18 1.354 . . . . 0.0 110.34 -166.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -65.35 147.27 87.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 CA-C-N 120.385 1.173 . . . . 0.0 110.016 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.73 -37.49 71.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.899 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -38.86 89.47 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.606 -0.684 . . . . 0.0 110.138 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.2 -18.54 49.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.7 0.8 . . . . 0.0 112.475 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.0 tp -47.26 -53.49 13.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.451 . . . . 0.0 112.576 -166.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.1 -28.37 60.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.908 1.283 . . . . 0.0 109.629 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.98 -38.58 91.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.273 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -67.89 -31.93 72.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -84.25 9.83 11.94 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.65 163.47 21.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.518 1.054 . . . . 0.0 112.773 -169.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -88.12 -36.7 16.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.477 -0.764 . . . . 0.0 111.176 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -82.77 -66.55 0.88 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -68.6 -2.79 9.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.698 1.199 . . . . 0.0 114.172 -163.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.276 1.0 OUTLIER -43.76 -56.04 4.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.651 2.38 . . . . 0.0 112.666 174.324 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.447 HG23 ' CD2' ' A' ' 91' ' ' TYR . 5.9 t -52.75 -40.98 63.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.412 1.085 . . . . 0.0 111.183 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CD2' HG23 ' A' ' 90' ' ' THR . 97.2 m-85 -73.69 4.3 5.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.339 -0.851 . . . . 0.0 113.073 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -59.17 -26.48 64.82 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 119.71 -1.869 . . . . 0.0 112.097 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.55 -12.3 14.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -125.92 16.22 7.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.273 0.942 . . . . 0.0 110.188 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 92' ' ' ALA . 84.8 mt -99.27 122.03 50.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -132.73 165.61 35.2 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.59 1.556 . . . . 0.0 109.239 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.99 175.02 5.05 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.167 1.912 . . . . 0.0 112.072 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 CA--C 1.537 0.445 0 C-N-CA 125.842 1.657 . . . . 0.0 110.541 175.844 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 CA--C 1.546 1.107 0 CA-C-O 121.27 0.446 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.64 158.28 31.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.58 1.952 . . . . 0.0 110.634 -165.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.672 HG13 ' CE ' ' A' ' 13' ' ' LYS . 36.7 t -80.9 67.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.977 1.311 . . . . 0.0 109.911 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.6 59.53 0.91 Allowed Glycine 0 C--N 1.332 0.353 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 69.82 -55.74 0.59 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.934 2.094 . . . . 0.0 114.016 -176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 106.9 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.548 1.539 . . . . 0.0 111.024 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.672 ' CE ' HG13 ' A' ' 9' ' ' VAL . 2.6 mmtm -94.36 81.27 3.97 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 119.612 -1.93 . . . . 0.0 108.169 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 p -168.19 -16.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.545 -162.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.14 8.23 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.073 0.851 . . . . 0.0 112.79 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.32 -64.21 0.92 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.945 1.298 . . . . 0.0 109.453 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.67 95.32 0.01 OUTLIER 'General case' 0 C--N 1.34 0.171 0 C-N-CA 127.203 2.201 . . . . 0.0 110.62 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.77 -42.82 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -81.51 112.7 18.98 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.279 0.54 . . . . 0.0 111.348 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.1 p -84.89 14.69 4.58 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.391 1.876 . . . . 0.0 112.559 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.62 46.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.687 1.595 . . . . 0.0 109.733 -170.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.28 86.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 O-C-N 120.922 -1.111 . . . . 0.0 108.88 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -68.82 -19.8 64.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.892 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -138.95 126.84 22.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.69 90.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 m -64.69 141.37 58.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.74 159.55 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 128.079 2.552 . . . . 0.0 105.964 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.401 ' O ' HG22 ' A' ' 31' ' ' ILE . 3.1 mp0 -118.36 163.8 23.46 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.15 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.442 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 61.5 Cg_endo -73.65 172.06 16.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.791 1.66 . . . . 0.0 110.883 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 51.42 27.39 3.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.33 1.852 . . . . 0.0 114.519 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 28' ' ' GLN . 5.2 tt -124.35 5.09 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 112.164 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.84 171.4 18.27 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.083 0.849 . . . . 0.0 112.692 164.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.4 tp -91.21 124.77 35.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.575 1.55 . . . . 0.0 107.402 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.21 104.64 11.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 168.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -107.97 175.49 5.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.756 1.222 . . . . 0.0 110.463 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.59 117.45 8.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.162 1.385 . . . . 0.0 111.168 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.74 40.76 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.217 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.4 mtp -61.23 -52.69 63.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.405 1.603 . . . . 0.0 108.557 156.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -90.11 22.46 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -47.77 123.91 6.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.46 10.58 86.15 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.339 -1.256 . . . . 0.0 114.358 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.9 m -75.91 67.74 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.904 2.352 . . . . 0.0 109.153 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -66.58 -26.23 67.01 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.115 2.166 . . . . 0.0 112.865 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.96 61.95 1.01 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.332 1.453 . . . . 0.0 108.455 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -109.29 129.69 55.51 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 165.447 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.97 -15.57 5.83 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.047 166.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -135.52 148.48 49.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 122.543 2.429 . . . . 0.0 114.122 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 70' ' ' PHE . 5.7 tp -137.77 92.17 2.65 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.788 2.835 . . . . 0.0 106.717 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.44 145.95 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -129.58 112.19 13.47 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.151 0.98 . . . . 0.0 108.634 -167.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.8 p -72.16 -6.18 40.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.606 1.093 . . . . 0.0 113.891 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 134.79 12.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.869 1.213 . . . . 0.0 110.583 -163.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.58 -14.64 60.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.926 1.29 . . . . 0.0 113.486 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.87 143.6 40.69 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 108.225 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.68 -36.45 41.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.531 2.154 . . . . 0.0 111.689 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.8 p -66.26 -12.8 58.54 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 29' ' ' PRO . . . -75.57 -6.75 51.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.37 1.068 . . . . 0.0 112.218 176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.95 177.59 4.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.748 2.019 . . . . 0.0 111.646 -174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -161.17 124.25 3.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.067 1.347 . . . . 0.0 109.383 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.37 1.62 2.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -164.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 45.4 -103.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 127.394 2.425 . . . . 0.0 113.321 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.96 -7.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.394 2.278 . . . . 0.0 111.275 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.2 25.92 3.8 Favored Glycine 0 C--N 1.336 0.572 0 O-C-N 121.127 -0.983 . . . . 0.0 112.889 -163.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.1 tp -47.18 -54.47 10.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.481 1.112 . . . . 0.0 110.704 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 74.79 0.95 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.13 125.4 44.41 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.94 -12.89 68.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.404 -170.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.21 172.02 17.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.139 2.176 . . . . 0.0 108.95 170.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -141.98 111.24 6.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.429 ' CB ' HD22 ' A' ' 45' ' ' LEU . 22.0 p90 -124.36 -178.79 4.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 128.308 2.643 . . . . 0.0 108.369 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.24 154.03 27.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.569 -1.332 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -116.89 131.4 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m -128.05 127.09 42.52 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 156.88 72.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 123.87 0.868 . . . . 0.0 108.851 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.1 153.28 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.856 1.037 . . . . 0.0 109.502 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.87 -33.15 70.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.03 -37.37 84.67 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.989 0.813 . . . . 0.0 110.316 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.94 -6.78 55.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.251 1.02 . . . . 0.0 111.527 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.5 -60.96 2.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.945 1.248 . . . . 0.0 112.386 -164.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.71 -36.0 79.68 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.447 0.699 . . . . 0.0 110.254 174.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.22 -57.52 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.984 1.714 . . . . 0.0 111.58 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -64.06 -42.76 96.9 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 124.912 1.285 . . . . 0.0 109.866 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -54.54 -39.39 67.63 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.149 -0.345 . . . . 0.0 110.791 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -81.02 8.07 9.34 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.419 1.487 . . . . 0.0 114.231 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.38 174.91 1.49 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 120.434 1.47 . . . . 0.0 110.989 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.96 -60.5 2.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.322 1.449 . . . . 0.0 111.455 163.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.92 -57.08 3.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.717 1.207 . . . . 0.0 109.774 -171.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -56.59 -17.17 7.66 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -44.59 -46.65 10.13 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 113.8 165.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 t -66.26 -31.83 72.89 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.676 -0.64 . . . . 0.0 110.518 -176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -83.35 4.72 26.13 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.389 -1.444 . . . . 0.0 112.283 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.58 5.03 2.63 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 120.219 -1.551 . . . . 0.0 112.466 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.81 -8.58 58.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.311 0.959 . . . . 0.0 112.524 167.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -138.65 14.1 2.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.665 1.12 . . . . 0.0 113.516 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.0 mt -91.7 138.97 18.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.51 164.52 39.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.183 -0.948 . . . . 0.0 109.681 165.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.91 164.4 27.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.131 1.887 . . . . 0.0 110.25 165.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.2 ptp . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 124.052 0.941 . . . . 0.0 109.873 -176.933 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 CA--C 1.543 0.954 0 N-CA-C 107.369 -1.82 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -152.68 164.57 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 122.183 0.992 . . . . 0.0 109.305 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.904 HG13 ' HE3' ' A' ' 13' ' ' LYS . 37.8 t -74.15 78.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 161.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.0 -167.27 32.81 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 152.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.22 39.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.639 2.22 . . . . 0.0 113.308 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' C ' ' HZ3' ' A' ' 13' ' ' LYS . 20.6 t70 -89.71 114.33 25.97 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.787 -1.821 . . . . 0.0 109.297 -159.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.904 ' HE3' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -80.75 89.1 5.77 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.365 -1.459 . . . . 0.0 108.551 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 t -156.15 -2.45 0.13 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -125.96 25.62 6.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.693 1.133 . . . . 0.0 112.363 -151.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -103.37 -36.98 7.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.591 1.156 . . . . 0.0 111.872 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 28.89 0.05 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.744 1.618 . . . . 0.0 113.038 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.35 -21.7 4.7 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.027 -1.985 . . . . 0.0 113.41 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -126.73 118.17 24.17 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 121.409 2.605 . . . . 0.0 111.615 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.0 p -74.71 18.29 0.18 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.234 2.213 . . . . 0.0 113.72 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.45 6.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.322 1.419 . . . . 0.0 111.476 -158.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -92.62 94.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.555 -1.34 . . . . 0.0 107.541 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -75.81 -13.97 60.29 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.533 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -140.41 135.89 32.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.649 1.113 . . . . 0.0 109.995 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.38 90.49 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.498 1.119 . . . . 0.0 108.767 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.9 m -65.75 141.92 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 165.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 9' ' ' VAL . 3.3 t -136.34 167.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.016 1.327 . . . . 0.0 110.505 174.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -114.34 163.99 17.58 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.279 1.432 . . . . 0.0 110.486 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.7 153.78 72.58 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.691 2.261 . . . . 0.0 109.878 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.39 64.12 1.43 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.79 2.036 . . . . 0.0 111.679 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.273 0.2 OUTLIER -140.71 55.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 123.708 1.718 . . . . 0.0 109.558 -176.52 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.72 49.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 125.706 1.622 . . . . 0.0 112.543 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.6 tp -105.69 131.74 52.69 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 123.212 1.482 . . . . 0.0 112.745 -157.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 5.4 mp -84.37 67.11 9.73 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.674 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -65.47 162.52 17.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.214 1.007 . . . . 0.0 110.058 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.75 109.8 12.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.681 1.192 . . . . 0.0 109.249 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.73 6.78 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.024 1.773 . . . . 0.0 112.803 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.1 -33.51 26.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.372 1.869 . . . . 0.0 113.105 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -114.89 7.94 15.81 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.875 1.67 . . . . 0.0 113.558 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -62.75 101.84 0.29 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.657 1.117 . . . . 0.0 108.616 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.86 -2.85 10.89 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.162 0.887 . . . . 0.0 113.835 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.4 m -77.54 78.7 4.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.489 2.144 . . . . 0.0 109.474 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.5 p -69.97 -23.67 63.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 112.923 -172.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.39 45.15 2.36 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.728 1.211 . . . . 0.0 108.829 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 70' ' ' PHE . 3.0 tt -98.6 109.41 22.18 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -110.66 -22.37 11.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.26 150.45 39.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.472 1.033 . . . . 0.0 111.942 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.52 142.45 24.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.958 2.503 . . . . 0.0 105.602 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.24 155.09 29.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.485 HD22 ' CE1' ' A' ' 58' ' ' TYR . 92.8 mt -128.08 127.84 43.82 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.5 172.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 p -88.52 38.27 0.86 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 110.076 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.83 159.52 24.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 125.102 1.335 . . . . 0.0 109.898 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -124.5 6.73 8.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.499 0.72 . . . . 0.0 112.482 -157.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -153.24 144.45 16.23 Favored Pre-proline 0 CA--C 1.535 0.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.64 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -66.49 -31.1 42.7 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.189 2.593 . . . . 0.0 113.059 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 m -76.22 -5.93 49.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.183 0.593 . . . . 0.0 112.044 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.99 3.16 27.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.171 0.896 . . . . 0.0 111.93 166.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.485 ' CE1' HD22 ' A' ' 50' ' ' LEU . 45.7 m-85 -133.7 165.62 24.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.87 1.319 . . . . 0.0 110.816 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -134.04 170.79 15.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.225 1.81 . . . . 0.0 108.818 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . . . -175.03 -177.56 1.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.997 3.719 . . . . 0.0 104.178 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.28 -145.91 5.34 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 0.2 21.89 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.803 -0.822 . . . . 0.0 113.015 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.99 74.47 0.11 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.832 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 64' ' ' LEU . 6.3 tt -44.44 -41.19 6.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.355 1.462 . . . . 0.0 109.098 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.443 ' NH1' ' H ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -125.33 34.75 4.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 126.009 1.724 . . . . 0.0 111.871 -173.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -52.26 121.14 6.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.966 0.803 . . . . 0.0 109.027 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.82 12.41 84.57 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.685 -1.064 . . . . 0.0 115.245 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 173.35 11.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.405 1.603 . . . . 0.0 109.85 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -157.43 95.16 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.782 ' HB2' HD22 ' A' ' 45' ' ' LEU . 37.8 p90 -131.62 168.9 16.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.157 1.383 . . . . 0.0 111.51 -173.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.27 146.08 29.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.21 1.004 . . . . 0.0 111.398 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.68 128.44 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 127.717 2.407 . . . . 0.0 108.688 -172.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.72 109.55 14.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.159 1.784 . . . . 0.0 112.208 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.72 160.87 26.37 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.448 1.099 . . . . 0.0 108.896 -175.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.2 138.19 65.39 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 108.01 -1.573 . . . . 0.0 108.01 171.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.6 -31.18 56.57 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.26 -33.2 75.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 -175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.81 -2.73 58.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.238 1.415 . . . . 0.0 112.273 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.97 -50.84 70.48 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 119.882 -1.761 . . . . 0.0 112.204 -166.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -65.28 -32.27 73.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.696 0.76 . . . . 0.0 111.039 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -57.27 -56.09 26.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.093 2.157 . . . . 0.0 110.419 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -60.87 -46.12 91.85 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.587 0.755 . . . . 0.0 110.587 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -58.54 -38.76 78.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.59 -0.96 22.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.911 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.56 164.88 6.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.212 1.369 . . . . 0.0 111.683 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.24 13.92 25.87 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.993 1.317 . . . . 0.0 113.162 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 60' ' ' ALA . 4.1 t80 -146.22 -59.25 0.31 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.843 2.057 . . . . 0.0 110.923 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -61.42 -9.05 4.74 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.931 1.241 . . . . 0.0 112.964 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.261 0.5 OUTLIER -43.38 -60.52 1.68 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.6 2.36 . . . . 0.0 114.177 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -50.85 37.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 109.849 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -71.02 -2.91 16.97 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.476 1.511 . . . . 0.0 113.285 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.93 -23.61 66.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.658 -1.276 . . . . 0.0 111.969 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.476 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . . . -61.0 -22.67 64.74 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.476 ' CE3' ' HB3' ' A' ' 93' ' ' ALA . 12.6 m-90 -116.41 10.45 14.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.296 1.438 . . . . 0.0 111.685 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.06 115.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.15 163.41 23.31 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.773 1.229 . . . . 0.0 109.872 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 164.34 34.37 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.171 1.914 . . . . 0.0 110.415 168.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.2 mtm . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 127.251 2.22 . . . . 0.0 111.647 174.226 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo . . . . . 0 CA--C 1.543 0.948 0 N-CA-C 113.637 0.591 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.86 139.74 47.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.52 123.6 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.165 0.586 . . . . 0.0 110.135 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.34 66.49 0.34 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 mmt 61.05 -55.43 0.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.425 2.69 . . . . 0.0 114.03 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -57.66 114.94 2.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 164.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 30.0 mmtp -104.02 88.55 3.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.38 1.072 . . . . 0.0 108.745 170.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -153.24 -14.94 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.176 0.99 . . . . 0.0 113.604 153.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.601 ' H ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -65.55 -4.1 5.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -165.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -71.07 -51.29 26.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.571 1.148 . . . . 0.0 109.864 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.36 13.77 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.78 4.83 30.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 127.256 2.36 . . . . 0.0 112.708 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -132.4 161.29 34.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.125 1.463 . . . . 0.0 109.683 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 -3.73 10.4 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.155 1.782 . . . . 0.0 112.175 -163.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.0 0.66 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.39 . . . . 0.0 110.474 -160.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.9 tt -71.81 98.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.349 1.86 . . . . 0.0 109.138 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -78.79 -3.47 44.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 117.026 -1.464 . . . . 0.0 112.077 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -152.26 137.69 17.64 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 120.513 1.506 . . . . 0.0 111.344 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -143.72 102.32 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 108.28 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.1 m -85.59 95.75 9.43 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.11 147.79 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -108.99 163.85 16.04 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 124.838 1.255 . . . . 0.0 107.796 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.61 168.08 17.5 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.372 2.048 . . . . 0.0 109.004 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 62.93 -7.13 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 167.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.466 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 5.9 tt -99.83 54.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 121.082 1.765 . . . . 0.0 112.803 -171.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.01 166.55 39.67 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.479 -1.388 . . . . 0.0 111.722 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.6 tp -76.12 165.88 24.28 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.527 1.931 . . . . 0.0 112.033 -171.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.9 73.94 0.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.029 0.831 . . . . 0.0 108.804 169.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.45 170.41 13.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.883 -169.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 150.77 41.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.343 1.068 . . . . 0.0 110.924 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.4 -2.55 37.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.268 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ptm -62.64 -11.25 15.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.833 . . . . 0.0 114.09 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.74 13.41 11.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 111.829 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -66.96 96.88 0.45 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.456 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.93 19.02 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.391 0.996 . . . . 0.0 112.901 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.9 m -73.66 68.8 1.24 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.026 1.413 . . . . 0.0 107.245 164.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -62.63 -55.08 30.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.51 58.01 3.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.377 -0.827 . . . . 0.0 109.002 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -114.84 121.14 42.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.233 1.813 . . . . 0.0 108.025 160.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -135.79 -5.24 2.2 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 177.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -124.87 153.12 43.1 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.636 -1.29 . . . . 0.0 110.821 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.46 131.02 11.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.66 144.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.6 mt -121.45 91.39 3.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 108.198 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 t -83.04 64.42 7.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.254 1.422 . . . . 0.0 110.213 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.3 150.49 18.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.059 1.314 . . . . 0.0 110.966 166.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -89.36 -20.41 24.05 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.988 1.315 . . . . 0.0 113.324 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 159.43 54.45 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 126.896 2.078 . . . . 0.0 107.155 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 81' ' ' ARG . 10.9 Cg_endo -74.1 -45.65 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.154 3.236 . . . . 0.0 111.851 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -61.7 -25.33 67.34 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -159.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.58 2.47 6.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 113.084 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -105.78 156.02 18.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.339 1.456 . . . . 0.0 108.373 169.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -134.06 142.83 47.72 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 107.386 169.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.56 154.3 34.02 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.778 3.231 . . . . 0.0 106.849 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.98 -160.84 23.68 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 122.073 0.818 . . . . 0.0 111.797 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.04 2.15 4.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.006 1.322 . . . . 0.0 112.87 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.02 74.59 0.17 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.716 1.627 . . . . 0.0 109.726 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.98 -46.22 64.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.583 1.192 . . . . 0.0 109.484 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -106.07 37.8 2.18 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.776 1.63 . . . . 0.0 110.663 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 117.65 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.75 -11.68 38.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.262 0.934 . . . . 0.0 114.398 168.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 -178.3 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.785 1.634 . . . . 0.0 108.587 166.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -142.62 90.42 2.22 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -173.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -135.27 163.88 28.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.3 160.02 14.74 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.321 1.448 . . . . 0.0 109.664 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.45 89.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -171.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -78.79 155.9 29.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.407 -0.808 . . . . 0.0 111.031 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.78 160.83 37.19 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 125.479 1.512 . . . . 0.0 109.457 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.32 141.24 51.04 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -53.81 -31.76 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.416 1.086 . . . . 0.0 112.54 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -46.42 76.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.942 1.697 . . . . 0.0 110.475 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 81' ' ' ARG . . . -82.3 0.14 42.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 112.248 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.5 -45.22 85.18 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.58 1.082 . . . . 0.0 112.419 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.7 -44.44 90.25 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.686 0.795 . . . . 0.0 110.852 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.475 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -49.84 -53.18 27.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.97 1.308 . . . . 0.0 110.815 -171.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -66.53 -38.08 86.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.09 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -61.9 -18.0 58.65 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.437 1.017 . . . . 0.0 111.694 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -87.85 -15.26 37.26 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.65 130.21 40.61 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.319 1.872 . . . . 0.0 109.27 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -47.25 -39.25 13.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.656 1.182 . . . . 0.0 110.885 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -69.04 -74.21 0.13 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.4 1.08 . . . . 0.0 109.95 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -55.77 -22.96 26.95 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -44.67 -48.14 10.57 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -60.14 -43.59 95.6 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.691 0.678 . . . . 0.0 109.682 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.14 7.08 5.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.888 -1.133 . . . . 0.0 112.73 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -62.68 -19.73 64.15 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 120.043 -1.661 . . . . 0.0 111.996 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.75 37.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -121.01 7.94 10.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.234 1.013 . . . . 0.0 111.813 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 92' ' ' ALA . 92.3 mt -83.99 148.03 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.122 0.969 . . . . 0.0 108.995 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.33 165.3 17.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.982 1.713 . . . . 0.0 109.654 164.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 163.88 31.61 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.979 1.786 . . . . 0.0 112.299 174.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.2 ptp . . . . . 0 CA--C 1.54 0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 110.812 178.427 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 CA--C 1.536 0.598 0 N-CA-C 111.168 -0.359 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.04 146.56 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 120.764 -1.21 . . . . 0.0 109.701 -169.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.12 132.56 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.241 0.616 . . . . 0.0 110.261 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.79 82.54 0.15 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.471 ' H ' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER 48.2 28.88 1.68 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.805 1.642 . . . . 0.0 111.914 -175.184 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -147.9 122.42 9.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 32.9 mmtp -106.32 94.98 5.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 162.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.68 19.73 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.943 1.697 . . . . 0.0 110.598 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.52 64.91 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.225 -1.547 . . . . 0.0 111.362 -167.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.0 -10.44 1.15 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.69 17.36 21.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.139 1.336 . . . . 0.0 112.483 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.6 -6.94 20.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.626 -168.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -138.43 105.17 5.36 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 120.354 2.077 . . . . 0.0 109.677 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -72.16 9.43 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -168.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.56 39.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 128.049 2.54 . . . . 0.0 109.442 -159.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.58 96.71 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 128.274 2.63 . . . . 0.0 106.557 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -78.83 -13.3 59.88 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.213 1.005 . . . . 0.0 111.557 -170.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.07 121.27 11.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.184 1.794 . . . . 0.0 107.143 -173.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.7 mt -111.39 103.41 15.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.0 m -72.71 143.41 48.05 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.77 159.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 127.308 2.243 . . . . 0.0 106.313 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.44 ' O ' HG22 ' A' ' 31' ' ' ILE . 4.5 pt20 -131.96 163.96 46.42 Favored Pre-proline 0 N--CA 1.451 -0.375 0 C-N-CA 124.033 0.933 . . . . 0.0 110.796 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.61 146.81 55.97 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 -171.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 51.31 66.08 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.09 2.156 . . . . 0.0 110.589 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.471 HD11 ' H ' ' A' ' 11' ' ' MET . 8.6 tp -133.88 40.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.877 1.271 . . . . 0.0 111.086 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.08 156.95 24.83 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.194 -1.566 . . . . 0.0 113.386 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.5 127.19 30.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 127.828 2.451 . . . . 0.0 111.015 -171.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.17 77.17 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -67.57 165.0 17.8 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.81 0.814 . . . . 0.0 110.302 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.96 144.26 33.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.963 -1.086 . . . . 0.0 110.333 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 85.84 5.62 83.59 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.718 0.675 . . . . 0.0 112.883 -178.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 mtp -54.81 -27.2 40.1 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.808 1.243 . . . . 0.0 112.849 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.67 20.53 4.24 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.627 1.171 . . . . 0.0 111.338 -162.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 t -65.44 115.86 6.13 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.88 56.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 76.0 m -68.02 74.81 0.21 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.971 1.385 . . . . 0.0 112.813 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.6 p -63.74 -31.23 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.289 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.57 63.87 0.71 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.178 1.354 . . . . 0.0 107.918 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -123.14 120.97 34.81 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.194 2.198 . . . . 0.0 106.804 162.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.5 ' N ' HD22 ' A' ' 45' ' ' LEU 0.307 1.2 pt-20 -131.44 -4.07 3.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.018 1.327 . . . . 0.0 114.382 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -144.63 157.99 43.97 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 122.491 1.139 . . . . 0.0 113.3 170.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 49' ' ' ILE . 1.7 tm? -140.65 141.04 35.09 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.378 3.071 . . . . 0.0 104.289 177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.527 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.4 mp -135.28 142.33 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -173.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -128.07 104.69 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.687 1.195 . . . . 0.0 108.694 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -79.28 37.22 0.32 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.577 0.751 . . . . 0.0 111.003 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.83 146.69 18.69 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -97.37 16.25 20.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.991 0.516 . . . . 0.0 111.434 -165.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.75 147.5 17.88 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 110.157 -164.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.22 -41.62 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.647 2.898 . . . . 0.0 110.663 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -67.06 -22.21 65.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.575 1.55 . . . . 0.0 114.229 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.37 4.79 10.0 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 112.158 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -122.62 172.7 8.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.708 1.242 . . . . 0.0 108.995 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.78 126.51 18.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.49 35.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.226 1.41 . . . . 0.0 107.478 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.3 -127.17 5.1 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.4 14.38 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.379 1.072 . . . . 0.0 111.859 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.45 82.86 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.7 tt -52.43 -50.96 61.54 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.52 40.95 1.28 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.473 1.109 . . . . 0.0 110.694 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 21.2 t70 -65.89 136.3 55.95 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 120.82 -1.175 . . . . 0.0 107.91 169.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.85 60.55 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.776 -1.569 . . . . 0.0 114.865 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 -172.62 4.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.923 1.861 . . . . 0.0 109.444 175.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -134.76 80.18 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -94.38 167.88 11.24 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.48 149.95 28.84 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.281 1.033 . . . . 0.0 109.457 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -109.53 149.63 12.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.15 1.38 . . . . 0.0 107.926 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.1 m -129.87 130.61 45.44 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.343 1.457 . . . . 0.0 107.514 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.21 160.55 67.49 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.944 1.698 . . . . 0.0 108.395 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.55 147.75 90.35 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 120.377 1.17 . . . . 0.0 109.962 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.26 -28.12 67.8 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 -5.99 49.11 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.635 0.774 . . . . 0.0 112.053 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.15 -3.46 31.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.011 -1.055 . . . . 0.0 112.829 167.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.57 -36.59 81.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.359 0.982 . . . . 0.0 113.427 -161.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.57 -30.81 32.9 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.001 -1.062 . . . . 0.0 109.173 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.8 ttm105 -56.38 -60.27 3.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.729 1.211 . . . . 0.0 110.618 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.2 p90 -54.87 -40.64 69.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.505 0.593 . . . . 0.0 110.939 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 1.3 mtp-105 -65.49 -19.85 66.1 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.883 -0.511 . . . . 0.0 111.433 -174.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -100.45 5.28 44.2 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.831 1.252 . . . . 0.0 111.655 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.02 162.7 21.53 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.707 1.139 . . . . 0.0 110.858 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.82 -43.83 64.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.306 -0.871 . . . . 0.0 111.346 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -95.42 -60.38 1.68 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.706 1.203 . . . . 0.0 109.926 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.78 -18.61 13.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.163 1.785 . . . . 0.0 113.936 -170.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -44.98 -42.97 8.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.316 1.446 . . . . 0.0 114.265 167.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -58.71 -37.96 77.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -85.59 10.92 11.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.395 1.478 . . . . 0.0 112.847 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.78 -0.69 7.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.497 -2.002 . . . . 0.0 112.729 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.82 -15.66 53.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.314 0.961 . . . . 0.0 113.451 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -118.11 0.35 11.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.4 92.87 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -168.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -99.35 163.14 19.19 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.371 1.068 . . . . 0.0 112.659 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.75 151.89 58.06 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.212 2.608 . . . . 0.0 112.067 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 mtm . . . . . 0 C--O 1.235 0.297 0 C-N-CA 125.855 1.662 . . . . 0.0 110.784 165.028 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.447 -1.23 0 N-CA-C 108.554 -1.364 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -133.24 165.78 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.423 1.889 . . . . 0.0 108.359 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.762 HG13 ' CE ' ' A' ' 13' ' ' LYS . 11.5 t -100.1 66.87 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.049 1.74 . . . . 0.0 108.309 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.86 82.87 0.32 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.7 mmt 57.98 -58.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 130.229 3.411 . . . . 0.0 115.747 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -62.59 101.53 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.243 1.817 . . . . 0.0 111.413 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.762 ' CE ' HG13 ' A' ' 9' ' ' VAL . 2.0 mmtm -94.21 76.41 4.0 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 119.518 -1.989 . . . . 0.0 108.545 171.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.79 -9.02 0.72 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.434 1.094 . . . . 0.0 113.243 168.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 6.66 15.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -165.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CE2' HG22 ' A' ' 9' ' ' VAL . 13.9 m-85 -68.48 -43.89 75.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.139 1.336 . . . . 0.0 111.761 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.68 47.62 0.18 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.256 2.223 . . . . 0.0 112.973 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -133.16 -39.03 0.21 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-O 119.219 -0.767 . . . . 0.0 111.238 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -85.09 100.95 12.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.481 1.141 . . . . 0.0 110.878 -172.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -70.99 9.92 0.62 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.282 2.633 . . . . 0.0 113.88 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.19 55.02 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.892 1.277 . . . . 0.0 109.223 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -129.94 92.36 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.214 -0.928 . . . . 0.0 110.325 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 1.9 mmt85 -76.17 -15.26 60.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.019 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -137.36 135.62 37.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.569 1.077 . . . . 0.0 108.843 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -133.55 113.14 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.5 m -93.16 107.67 19.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.682 HG13 HG11 ' A' ' 9' ' ' VAL . 4.2 t -103.14 105.46 18.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.455 1.502 . . . . 0.0 108.386 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.509 ' HG3' HG21 ' A' ' 31' ' ' ILE . 6.3 pt20 -65.02 165.07 17.45 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.798 167.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 28' ' ' GLN . 57.5 Cg_endo -73.5 168.68 24.16 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.503 2.136 . . . . 0.0 110.15 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 46.67 39.21 6.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.91 1.684 . . . . 0.0 112.981 171.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.509 HG21 ' HG3' ' A' ' 28' ' ' GLN 0.304 5.2 tt -130.25 22.6 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 120.233 1.379 . . . . 0.0 112.386 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.53 164.33 11.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.007 0.813 . . . . 0.0 113.206 155.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.94 117.49 9.88 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 126.314 1.845 . . . . 0.0 111.54 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -74.55 95.56 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 164.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -76.29 173.79 10.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.147 0.979 . . . . 0.0 111.447 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.0 129.15 39.55 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.423 1.089 . . . . 0.0 113.004 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.62 25.18 74.01 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -45.17 -36.62 3.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.708 2.003 . . . . 0.0 113.321 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.22 13.62 20.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.07 1.748 . . . . 0.0 111.72 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -49.79 119.35 3.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.849 0.859 . . . . 0.0 111.935 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.5 20.99 79.41 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.598 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -71.91 78.67 0.89 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -76.02 -6.37 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.381 1.872 . . . . 0.0 112.305 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.48 72.9 1.45 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 162.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 39.4 tp -134.85 123.6 23.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 130.785 3.634 . . . . 0.0 109.036 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -143.03 -20.48 0.64 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -100.86 145.79 28.13 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.795 2.088 . . . . 0.0 111.163 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.35 150.38 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.65 138.18 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -111.8 155.0 24.26 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -126.2 7.49 7.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.819 0.848 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.06 179.45 41.01 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -125.97 3.76 7.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.259 0.624 . . . . 0.0 111.768 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -147.65 144.17 18.91 Favored Pre-proline 0 N--CA 1.466 0.371 0 C-N-CA 124.6 1.16 . . . . 0.0 108.963 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.2 -27.3 16.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.768 2.312 . . . . 0.0 113.43 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.4 -14.67 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.827 1.251 . . . . 0.0 111.163 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.24 -2.96 23.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.699 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.93 165.33 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.76 1.624 . . . . 0.0 109.833 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 m -139.83 123.65 17.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -126.93 -0.63 6.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.195 1.398 . . . . 0.0 113.0 -168.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.73 -97.81 0.23 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 126.831 2.158 . . . . 0.0 109.029 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -147.56 -9.6 0.42 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.007 1.723 . . . . 0.0 111.375 160.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.73 24.22 9.71 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.771 1.177 . . . . 0.0 114.04 -163.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 19.0 tp -44.46 -44.59 8.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.367 1.867 . . . . 0.0 114.092 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.83 58.57 1.64 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -164.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.05 153.15 26.03 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.29 -11.13 51.69 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 117.88 -1.511 . . . . 0.0 114.566 170.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.5 165.32 31.54 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.733 2.013 . . . . 0.0 107.946 162.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.93 86.47 2.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.32 1.048 . . . . 0.0 109.595 -168.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -112.18 174.82 5.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.892 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.67 154.09 39.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.092 2.957 . . . . 0.0 107.929 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -117.03 107.92 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 126.207 1.803 . . . . 0.0 108.354 -163.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.12 151.63 36.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.728 161.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.07 161.72 51.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.236 1.814 . . . . 0.0 107.64 164.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.07 149.61 76.97 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 108.098 -1.539 . . . . 0.0 108.098 167.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.37 -33.09 41.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.832 0.853 . . . . 0.0 111.913 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -59.28 -42.82 92.13 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.714 1.605 . . . . 0.0 111.012 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 -7.22 56.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.688 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.97 -55.18 37.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.822 1.192 . . . . 0.0 112.985 -164.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.53 -33.24 60.7 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.465 -0.772 . . . . 0.0 111.466 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -45.43 -51.62 11.21 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.791 2.036 . . . . 0.0 109.422 167.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.06 -43.43 92.3 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.233 1.013 . . . . 0.0 111.433 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.01 -19.71 65.75 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.255 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -103.09 18.8 20.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.174 1.352 . . . . 0.0 112.993 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.53 166.32 19.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.603 1.561 . . . . 0.0 111.775 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.37 -34.65 16.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.827 0.851 . . . . 0.0 111.514 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -92.04 -59.38 2.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.17 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -65.04 -12.42 50.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -170.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -44.15 -45.5 8.31 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.426 HG23 ' CD2' ' A' ' 91' ' ' TYR . 15.3 t -60.67 -43.95 97.06 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 125.623 1.569 . . . . 0.0 110.37 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.426 ' CD2' HG23 ' A' ' 90' ' ' THR . 97.3 m-85 -71.96 0.59 8.92 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.327 1.451 . . . . 0.0 112.811 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.32 71.06 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 119.864 -1.773 . . . . 0.0 111.479 -172.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.65 5.07 1.56 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -125.1 7.77 7.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.907 1.683 . . . . 0.0 111.937 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.5 mt -102.89 116.2 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.933 1.242 . . . . 0.0 109.391 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.91 155.93 63.03 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 126.057 1.743 . . . . 0.0 111.037 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.37 146.71 40.4 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.978 3.119 . . . . 0.0 111.861 172.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 39.7 mtm . . . . . 0 C--O 1.24 0.566 0 C-N-CA 125.307 1.443 . . . . 0.0 112.151 177.339 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -123.35 157.17 33.89 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 167.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -145.63 74.5 1.39 Allowed 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 165.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -167.1 161.52 14.75 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.352 -164.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.3 -2.66 1.76 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.15 -1.361 . . . . 0.0 114.279 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -111.88 86.86 7.79 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 120.089 1.945 . . . . 0.0 110.064 -172.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 84.8 Cg_endo -72.5 79.79 1.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.469 2.113 . . . . 0.0 109.47 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.28 155.51 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 120.732 -1.23 . . . . 0.0 112.179 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.59 88.47 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.731 1.612 . . . . 0.0 109.846 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 96.41 0.2 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt 58.51 17.72 5.14 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.393 1.477 . . . . 0.0 114.455 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.17 175.37 11.82 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 31' ' ' ILE . 15.4 mttm -138.27 -0.59 2.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.154 2.181 . . . . 0.0 114.507 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -81.63 -29.36 33.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.606 1.094 . . . . 0.0 112.048 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 1.2 mm? -83.59 73.64 10.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.276 1.031 . . . . 0.0 110.893 -160.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -147.16 -49.45 0.18 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.289 0.636 . . . . 0.0 110.458 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.81 71.84 1.05 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.564 1.146 . . . . 0.0 110.702 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.4 -45.55 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -82.4 104.23 12.55 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -60.94 -5.2 1.25 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.546 1.539 . . . . 0.0 114.46 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.29 30.51 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.85 1.204 . . . . 0.0 110.601 -152.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -104.79 88.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 124.497 1.119 . . . . 0.0 109.018 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -70.83 -11.97 61.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.758 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -140.64 135.99 32.25 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 119.855 1.207 . . . . 0.0 108.078 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.18 102.62 7.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -73.66 145.38 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.92 149.75 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.687 1.995 . . . . 0.0 107.98 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -103.14 165.11 14.18 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 125.586 1.554 . . . . 0.0 111.253 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.59 161.49 45.68 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.998 2.465 . . . . 0.0 111.309 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 53.63 23.66 3.73 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.125 2.57 . . . . 0.0 115.432 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.433 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 tt -117.17 63.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.655 1.182 . . . . 0.0 111.4 -171.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' CA ' ' HE2' ' A' ' 13' ' ' LYS . . . 95.82 164.2 34.03 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 128.407 2.908 . . . . 0.0 112.718 174.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -85.17 124.1 31.44 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 173.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 33' ' ' LEU . 1.4 mt -72.34 76.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.692 1.997 . . . . 0.0 108.099 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.22 -165.24 0.17 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.272 -167.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.44 165.21 19.37 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.47 -1.394 . . . . 0.0 111.356 165.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.79 11.26 35.77 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 117.689 1.835 . . . . 0.0 117.689 168.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -43.27 78.39 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 121.53 2.665 . . . . 0.0 111.326 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -116.84 5.96 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.314 1.046 . . . . 0.0 112.382 -155.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -46.69 124.74 6.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.649 1.58 . . . . 0.0 112.852 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.32 20.71 61.87 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.374 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 45' ' ' LEU . 8.4 p -71.33 75.1 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.524 -0.986 . . . . 0.0 111.556 175.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.0 p -59.76 -16.51 28.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.52 1.128 . . . . 0.0 112.929 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.69 71.54 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.323 0.965 . . . . 0.0 110.888 162.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 42' ' ' CYS . 52.5 tp -115.79 115.07 25.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.421 1.089 . . . . 0.0 110.095 159.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -139.12 24.26 2.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.086 0.554 . . . . 0.0 111.662 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -159.44 152.02 21.44 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 120.751 -1.218 . . . . 0.0 109.922 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 tp -141.69 138.32 32.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.97 137.88 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 119.704 1.138 . . . . 0.0 108.024 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -114.7 117.27 30.34 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.107 0.963 . . . . 0.0 109.849 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -88.9 30.09 0.97 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.428 1.091 . . . . 0.0 111.735 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 164.43 18.24 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -113.18 2.81 15.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.35 144.56 31.52 Favored Pre-proline 0 N--CA 1.447 -0.621 0 O-C-N 120.636 -1.29 . . . . 0.0 110.892 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -73.85 -32.37 7.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.294 2.663 . . . . 0.0 114.238 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -66.46 -25.9 66.94 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.146 0.43 . . . . 0.0 111.455 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.17 4.88 1.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 113.071 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.17 149.05 52.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.559 1.072 . . . . 0.0 108.505 167.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.9 m -142.64 135.32 27.99 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.658 0.783 . . . . 0.0 109.046 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -146.26 2.6 0.88 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.56 -67.24 1.28 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.729 2.585 . . . . 0.0 113.916 163.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 174.85 -32.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 131.596 3.958 . . . . 0.0 107.734 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.47 4.17 74.44 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.407 -1.218 . . . . 0.0 115.507 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.516 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 14.2 tp -43.73 -54.03 5.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.69 1.596 . . . . 0.0 112.57 -158.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.6 33.51 5.61 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.54 132.66 53.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.437 1.017 . . . . 0.0 109.911 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 20.97 79.5 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.742 0.686 . . . . 0.0 113.943 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.01 178.61 7.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.43 1.492 . . . . 0.0 110.816 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.97 101.22 0.99 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.829 1.651 . . . . 0.0 108.432 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -146.05 169.08 19.4 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.631 -0.668 . . . . 0.0 112.266 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt -90.04 155.45 19.07 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 128.112 2.565 . . . . 0.0 110.82 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 mt -117.37 94.87 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.183 2.193 . . . . 0.0 108.222 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.82 129.7 38.45 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 121.037 -1.039 . . . . 0.0 110.125 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -130.89 160.1 68.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.52 1.528 . . . . 0.0 108.544 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -67.7 151.74 78.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.729 1.62 . . . . 0.0 110.939 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.72 -36.9 72.65 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.471 0.578 . . . . 0.0 111.594 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -72.61 -6.57 45.11 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.858 -0.527 . . . . 0.0 111.967 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.05 -8.17 20.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.087 1.355 . . . . 0.0 113.776 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tp -63.01 -50.79 69.34 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.639 1.108 . . . . 0.0 111.359 -165.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -63.03 -44.73 95.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -51.74 -53.93 34.1 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.786 1.234 . . . . 0.0 111.029 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -60.25 -38.44 83.5 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.53 0.519 . . . . 0.0 110.61 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -68.96 -25.17 64.41 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.332 -0.855 . . . . 0.0 113.091 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -87.63 -2.38 58.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.346 1.43 . . . . 0.0 112.508 173.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -71.04 157.74 37.69 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.064 0.847 . . . . 0.0 112.376 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 19.92 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.336 1.054 . . . . 0.0 113.812 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.92 -68.42 0.4 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 126.989 2.115 . . . . 0.0 108.012 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -57.53 -14.78 5.62 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.254 1.822 . . . . 0.0 114.676 -165.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -44.65 -47.0 10.49 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.506 1.048 . . . . 0.0 113.097 161.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.404 HG23 ' CD2' ' A' ' 91' ' ' TYR . 2.9 t -62.72 -16.4 57.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.79 0.836 . . . . 0.0 111.943 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CD2' HG23 ' A' ' 90' ' ' THR . 96.3 m-85 -108.35 10.97 27.47 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.039 -1.663 . . . . 0.0 111.335 175.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.15 -8.13 35.92 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 119.949 -1.719 . . . . 0.0 112.421 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.98 -6.17 57.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.901 0.881 . . . . 0.0 112.84 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -130.65 -14.85 3.59 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 124.06 0.944 . . . . 0.0 112.536 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.13 144.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 120.833 -1.167 . . . . 0.0 108.616 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -149.01 164.35 21.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.885 0.874 . . . . 0.0 110.882 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.73 149.92 73.71 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.98 2.453 . . . . 0.0 113.835 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 mtm -69.43 175.12 4.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.752 165.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -144.24 -176.62 5.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.703 2.801 . . . . 0.0 107.044 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--O 1.252 1.226 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 154.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m -89.94 121.38 31.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 156.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -130.16 56.26 1.76 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 170.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.68 165.01 33.63 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 128.412 2.685 . . . . 0.0 105.912 166.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.18 57.53 0.12 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 124.377 0.989 . . . . 0.0 111.097 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -68.01 162.35 60.12 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 117.848 0.824 . . . . 0.0 109.324 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -81.79 76.85 4.12 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.94 1.76 . . . . 0.0 109.539 -169.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.34 160.26 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.108 -1.62 . . . . 0.0 110.782 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.26 99.05 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.53 1.532 . . . . 0.0 108.411 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.16 121.68 1.08 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.73 -11.33 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.92 2.888 . . . . 0.0 117.429 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -135.16 153.5 51.95 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 121.122 1.783 . . . . 0.0 108.523 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HE3' HG23 ' A' ' 31' ' ' ILE . 40.9 mttt -135.35 51.61 2.07 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.229 1.811 . . . . 0.0 109.939 170.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -127.26 -17.95 4.63 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.7 75.92 0.95 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.066 1.303 . . . . 0.0 109.57 -167.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -130.51 -55.47 1.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.284 1.034 . . . . 0.0 110.71 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.68 30.52 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.806 2.043 . . . . 0.0 113.372 -165.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.05 -36.09 1.55 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.018 1.771 . . . . 0.0 113.07 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -89.26 102.53 15.2 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.283 2.042 . . . . 0.0 112.065 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.3 p -65.66 6.48 0.33 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.265 1.826 . . . . 0.0 114.21 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.82 -1.46 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.834 1.254 . . . . 0.0 109.96 -167.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.1 tt -69.54 111.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -91.05 -14.23 31.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.766 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -146.44 139.98 25.94 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.605 0.762 . . . . 0.0 110.402 -168.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.2 mt -137.4 101.41 2.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.1 132.96 45.86 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 162.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.02 133.79 67.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 126.058 1.743 . . . . 0.0 108.193 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -94.48 162.98 24.21 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 122.889 0.476 . . . . 0.0 110.969 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.79 151.9 78.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.291 1.994 . . . . 0.0 109.635 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 52.73 38.22 25.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.207 1.803 . . . . 0.0 113.471 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.42 HG23 ' HE3' ' A' ' 13' ' ' LYS . 5.0 tp -119.88 0.78 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.499 1.12 . . . . 0.0 113.192 -164.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.38 169.3 11.7 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.247 1.404 . . . . 0.0 112.445 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 132.49 37.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 112.028 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.96 77.98 9.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.147 1.779 . . . . 0.0 107.189 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -69.63 164.17 23.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.994 0.902 . . . . 0.0 110.342 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -66.99 110.83 3.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.311 1.445 . . . . 0.0 110.102 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.43 11.05 32.21 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.283 0.944 . . . . 0.0 114.546 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.5 mtp -52.93 -23.83 8.0 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -127.28 20.03 6.85 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 110.736 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 t -63.59 94.16 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.857 1.263 . . . . 0.0 110.671 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.21 -7.74 6.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.939 1.733 . . . . 0.0 112.859 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.97 70.37 9.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.127 1.963 . . . . 0.0 109.501 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.9 p -67.05 -25.32 66.2 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.161 -0.962 . . . . 0.0 113.338 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.0 -2.11 57.58 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.605 -1.309 . . . . 0.0 113.119 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.84 119.9 24.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.051 0.94 . . . . 0.0 110.207 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -141.11 2.75 1.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.518 0.727 . . . . 0.0 112.239 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -126.97 153.95 45.2 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.183 -1.573 . . . . 0.0 111.186 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 tp -146.14 100.96 3.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.434 3.494 . . . . 0.0 104.143 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.15 124.35 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 120.89 -1.132 . . . . 0.0 108.084 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 72' ' ' ILE . 3.5 mp -101.72 107.86 19.21 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 107.878 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.8 p -77.15 19.72 0.3 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.53 161.09 20.05 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 120.076 1.307 . . . . 0.0 112.445 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -97.31 -4.22 39.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.501 1.52 . . . . 0.0 112.976 -167.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.85 148.4 42.36 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 119.935 1.243 . . . . 0.0 110.4 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.28 -36.45 7.07 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.113 2.542 . . . . 0.0 112.45 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -25.39 63.82 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.484 0.584 . . . . 0.0 112.441 -172.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -1.4 31.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.688 1.595 . . . . 0.0 113.434 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -127.9 126.8 42.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.16 171.86 11.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.701 1.6 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.3 146.85 3.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.496 1.118 . . . . 0.0 109.624 159.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.27 -173.06 34.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 164.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.3 -48.55 81.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.131 0.972 . . . . 0.0 109.061 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.94 36.58 3.02 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 117.536 -1.702 . . . . 0.0 112.315 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tt -44.56 -56.4 4.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.114 1.457 . . . . 0.0 107.526 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 25.31 10.33 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 125.462 1.505 . . . . 0.0 113.241 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.27 130.1 41.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.49 1.041 . . . . 0.0 111.619 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.36 79.35 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.438 1.018 . . . . 0.0 114.641 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.73 -170.47 2.63 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.04 93.65 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.424 -0.798 . . . . 0.0 109.406 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -125.04 165.12 18.74 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -98.36 158.25 15.7 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 128.168 2.587 . . . . 0.0 110.145 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 50' ' ' LEU . 24.4 mt -116.05 90.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.278 1.831 . . . . 0.0 108.744 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.6 136.65 36.28 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.843 -1.161 . . . . 0.0 108.872 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.09 160.83 67.12 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 126.708 2.003 . . . . 0.0 108.379 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.49 153.58 60.55 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.555 1.504 . . . . 0.0 109.267 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.78 -35.63 64.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.071 0.548 . . . . 0.0 112.232 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.26 -42.48 73.59 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.936 1.294 . . . . 0.0 110.885 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.83 57.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.948 0.899 . . . . 0.0 112.318 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.2 tp -51.68 -61.57 2.17 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.099 1.318 . . . . 0.0 112.078 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.81 -28.38 61.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.533 1.133 . . . . 0.0 110.175 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -59.96 -46.16 90.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.469 1.508 . . . . 0.0 110.195 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -64.65 -41.48 96.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.03 0.832 . . . . 0.0 110.215 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -65.41 -12.64 54.25 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 116.921 -1.514 . . . . 0.0 114.361 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -96.38 2.73 52.94 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 121.685 2.039 . . . . 0.0 112.919 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.32 143.9 36.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.709 1.141 . . . . 0.0 111.994 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.72 10.45 1.39 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.044 1.338 . . . . 0.0 113.746 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -137.24 -64.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.123 1.769 . . . . 0.0 111.029 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -54.21 -20.82 7.54 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.776 1.171 . . . . 0.0 113.649 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -43.81 -47.66 8.13 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.852 1.261 . . . . 0.0 113.91 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.432 HG23 ' CD1' ' A' ' 91' ' ' TYR . 4.9 t -64.09 -24.16 67.6 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.665 0.666 . . . . 0.0 111.86 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CD1' HG23 ' A' ' 90' ' ' THR . 76.8 m-85 -96.77 14.55 24.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.361 1.064 . . . . 0.0 111.137 175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.14 -18.21 33.77 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 120.288 -1.508 . . . . 0.0 111.04 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.13 -22.36 28.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 113.084 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -119.45 -8.48 10.02 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.527 1.131 . . . . 0.0 112.983 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.11 115.65 29.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -149.27 165.46 17.62 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.269 1.028 . . . . 0.0 111.277 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.71 158.75 40.48 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.412 2.075 . . . . 0.0 114.441 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 13.4 mtm -78.15 176.34 9.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.169 1.787 . . . . 0.0 109.979 161.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -98.73 -177.45 3.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.124 0.97 . . . . 0.0 109.005 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.252 1.234 0 C-N-CA 124.925 1.29 . . . . 0.0 109.792 -179.297 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.394 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -78.74 91.76 4.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -174.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -124.76 150.42 46.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.586 1.554 . . . . 0.0 108.4 -169.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -61.77 125.09 22.59 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.162 0.985 . . . . 0.0 108.466 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.44 66.14 0.04 OUTLIER Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -115.21 160.36 34.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 125.208 1.403 . . . . 0.0 109.902 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.94 72.25 6.59 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.873 3.049 . . . . 0.0 110.48 -167.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.9 165.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.714 2.006 . . . . 0.0 107.518 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 p -113.33 157.19 14.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 109.199 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 -75.49 0.2 Allowed Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.5 mmt -123.69 3.17 8.9 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -167.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -136.94 156.09 48.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.5 1.046 . . . . 0.0 108.901 169.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -139.17 82.52 1.9 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.131 1.373 . . . . 0.0 110.167 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -150.01 -44.49 0.13 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.815 1.646 . . . . 0.0 111.689 162.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.61 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.85 10.48 0.05 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 -168.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -82.05 -12.64 58.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 119.801 -1.812 . . . . 0.0 113.618 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.02 79.74 1.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.61 -13.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.761 -1.577 . . . . 0.0 116.169 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -112.91 91.73 3.76 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 120.295 2.047 . . . . 0.0 109.345 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -66.35 31.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.755 3.622 . . . . 0.0 113.98 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.88 -7.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.371 1.869 . . . . 0.0 111.736 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.94 89.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.025 0.83 . . . . 0.0 110.511 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -72.1 -13.86 61.69 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.501 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -144.68 137.38 26.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -168.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -136.6 120.01 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.548 1.539 . . . . 0.0 106.963 170.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 m -84.42 143.75 29.22 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.949 -1.095 . . . . 0.0 108.162 158.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.42 139.79 44.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' HB2' ' HD2' ' A' ' 29' ' ' PRO . 6.0 pt20 -101.71 165.07 14.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.705 1.202 . . . . 0.0 111.573 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 28' ' ' GLN . 22.3 Cg_endo -66.71 144.95 73.85 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.631 1.554 . . . . 0.0 109.625 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 47.8 74.29 0.17 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.819 1.647 . . . . 0.0 112.282 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.268 4.8 tp -143.0 33.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 121.619 0.724 . . . . 0.0 112.153 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.48 170.88 16.89 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.84 1.686 . . . . 0.0 111.49 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.3 tp -83.92 127.38 33.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.115 0.958 . . . . 0.0 109.713 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 64' ' ' LEU . 46.6 mt -73.02 90.11 1.48 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 162.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 38' ' ' MET . 54.5 p90 -70.44 -164.61 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.91 0.884 . . . . 0.0 112.175 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -158.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.846 -0.597 . . . . 0.0 112.032 160.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.15 76.89 0.0 OUTLIER Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.57 2.033 . . . . 0.0 117.407 -165.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.464 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 30.9 mtp -67.62 -22.06 65.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.317 1.847 . . . . 0.0 111.125 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.72 10.06 4.67 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.129 0.972 . . . . 0.0 110.675 -161.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -62.38 118.16 7.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.33 52.32 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.709 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.1 p -68.39 73.79 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.131 1.965 . . . . 0.0 111.577 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 p -63.7 2.07 0.52 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.955 1.302 . . . . 0.0 113.627 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.91 39.88 0.87 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.229 -1.367 . . . . 0.0 112.272 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.77 120.64 42.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.477 1.944 . . . . 0.0 110.582 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.07 -13.3 5.12 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -117.86 162.98 17.23 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.662 1.119 . . . . 0.0 111.851 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.671 HD21 HD21 ' A' ' 50' ' ' LEU . 13.6 tp -148.67 145.76 27.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.014 2.126 . . . . 0.0 106.96 165.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -128.61 134.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.671 HD21 HD21 ' A' ' 48' ' ' LEU . 21.6 mt -111.57 112.4 24.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -74.58 -14.6 60.8 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.94 -176.44 50.75 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.36 0.981 . . . . 0.0 110.81 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.57 3.64 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.92 143.56 25.76 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 118.243 0.474 . . . . 0.0 110.169 -174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.63 -27.63 32.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.677 2.918 . . . . 0.0 112.373 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.9 m -75.62 9.88 2.02 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.276 -0.89 . . . . 0.0 112.553 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.04 7.43 36.47 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.255 -0.903 . . . . 0.0 112.433 162.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -138.38 111.64 7.99 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.234 1.413 . . . . 0.0 110.052 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -76.18 177.55 7.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.183 1.793 . . . . 0.0 110.848 175.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.65 160.96 15.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.395 3.078 . . . . 0.0 105.389 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.52 -101.63 2.73 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.04 -57.49 1.78 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.187 1.795 . . . . 0.0 108.017 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.1 74.58 0.22 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 124.486 1.041 . . . . 0.0 111.928 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 34' ' ' LEU . 2.0 tp -43.74 -41.78 5.08 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.972 2.109 . . . . 0.0 110.259 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.85 56.08 1.87 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.786 2.034 . . . . 0.0 107.985 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.46 129.86 41.5 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 164.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.29 87.13 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.069 0.842 . . . . 0.0 115.17 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.71 170.8 14.72 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.297 1.439 . . . . 0.0 110.61 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.65 101.82 2.01 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.856 1.662 . . . . 0.0 107.765 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.11 169.06 18.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.104 0.562 . . . . 0.0 111.409 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.61 HD13 ' N ' ' A' ' 72' ' ' ILE . 2.4 tm? -87.31 146.19 26.03 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.007 1.323 . . . . 0.0 110.609 -175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 71' ' ' LEU . 33.5 mt -112.01 96.49 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 128.363 2.665 . . . . 0.0 109.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.7 m -83.68 134.54 34.77 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.002 -1.061 . . . . 0.0 112.06 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.8 157.87 74.08 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 126.09 1.756 . . . . 0.0 109.443 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.96 148.86 64.73 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 CA-C-N 121.878 1.706 . . . . 0.0 111.15 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.99 -35.95 64.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.971 0.909 . . . . 0.0 112.014 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -67.8 -20.81 65.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.253 1.821 . . . . 0.0 111.852 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -112.41 -0.28 15.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.118 1.367 . . . . 0.0 112.4 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.23 -34.63 76.86 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.111 -0.993 . . . . 0.0 111.852 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -83.25 -33.05 26.13 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.187 0.995 . . . . 0.0 109.847 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.52 -63.31 1.16 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.235 2.214 . . . . 0.0 111.282 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -64.92 -37.13 86.62 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.848 0.459 . . . . 0.0 110.355 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.08 -24.79 67.83 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.445 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -85.72 -4.55 59.19 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.895 1.225 . . . . 0.0 113.067 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.01 150.05 47.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.108 1.322 . . . . 0.0 110.878 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.37 -44.57 90.95 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.455 -0.778 . . . . 0.0 110.281 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -83.28 -65.33 1.02 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.075 0.95 . . . . 0.0 109.271 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -58.0 -15.7 9.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -164.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -45.02 -43.79 9.52 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.567 1.076 . . . . 0.0 112.858 165.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 91' ' ' TYR . 6.8 t -63.39 -14.57 51.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CD1' HG23 ' A' ' 90' ' ' THR . 71.6 m-85 -113.56 14.97 19.05 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.377 -1.452 . . . . 0.0 111.663 173.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.1 3.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.423 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.58 -12.07 59.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.115 166.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -130.26 0.64 4.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.835 1.198 . . . . 0.0 112.805 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.9 mt -89.85 113.24 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.553 ' CG ' HD11 ' A' ' 71' ' ' LEU . 2.6 pt20 -135.42 164.64 42.22 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 126.249 1.819 . . . . 0.0 110.444 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.56 164.24 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.026 1.817 . . . . 0.0 113.407 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 mtm -82.58 172.44 12.97 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.188 1.795 . . . . 0.0 109.261 161.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -126.13 -173.15 2.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.655 1.182 . . . . 0.0 109.758 171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.608 1.963 . . . . 0.0 106.343 168.356 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.42 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.2 85.29 1.27 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.778 1.231 . . . . 0.0 107.725 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.7 m170 66.31 169.92 0.23 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.406 2.682 . . . . 0.0 111.981 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -66.41 152.44 45.09 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.263 0.625 . . . . 0.0 110.2 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.61 73.56 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -53.21 157.93 2.87 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 148.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.18 91.02 0.46 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.863 2.375 . . . . 0.0 107.954 167.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.16 130.46 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 120.554 -1.341 . . . . 0.0 107.479 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.55 122.48 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 122.913 0.485 . . . . 0.0 110.301 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.12 81.33 0.21 Allowed Glycine 0 C--O 1.223 -0.559 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 68.0 mtp 58.82 -60.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.896 2.478 . . . . 0.0 114.351 -168.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.91 91.43 2.47 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.417 1.008 . . . . 0.0 108.351 -171.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -72.71 88.55 1.3 Allowed 'General case' 0 CA--C 1.519 -0.221 0 O-C-N 120.915 -1.116 . . . . 0.0 108.02 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -173.21 54.13 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.922 2.089 . . . . 0.0 109.686 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.15 61.51 0.45 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.814 1.246 . . . . 0.0 110.58 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -131.44 -44.47 1.01 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.223 0.609 . . . . 0.0 111.413 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.34 77.25 1.01 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.154 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.06 -28.0 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.612 -1.66 . . . . 0.0 113.859 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.509 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.7 t30 -117.98 87.88 2.8 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.224 2.012 . . . . 0.0 112.769 -171.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.0 9.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 132.223 4.209 . . . . 0.0 118.108 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.87 19.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.72 1.608 . . . . 0.0 109.546 -166.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 19' ' ' ASN . 13.3 tt -89.04 113.44 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 166.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -95.86 -17.62 20.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.453 1.101 . . . . 0.0 111.444 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -148.31 134.0 18.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.93 0.769 . . . . 0.0 111.02 -160.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.431 HG12 HD11 ' A' ' 22' ' ' ILE . 7.5 mt -141.29 90.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.36 -166.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.3 m -86.16 87.71 7.47 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.558 0.743 . . . . 0.0 109.087 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.09 164.26 3.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 O-C-N 121.003 -1.061 . . . . 0.0 108.852 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' HG22 ' A' ' 31' ' ' ILE . 16.4 mt-30 -126.23 165.54 27.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.959 1.303 . . . . 0.0 109.919 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.8 149.76 60.79 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.074 1.849 . . . . 0.0 111.026 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 48.48 66.03 1.18 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.191 2.996 . . . . 0.0 111.374 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 28' ' ' GLN . 0.7 OUTLIER -144.93 55.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 110.685 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.21 144.45 15.31 Favored Glycine 0 C--O 1.241 0.561 0 O-C-N 121.018 -1.051 . . . . 0.0 112.603 170.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.83 141.38 58.67 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.319 1.048 . . . . 0.0 108.445 171.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.43 77.83 2.99 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.495 1.118 . . . . 0.0 108.316 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -70.46 162.7 28.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.081 0.943 . . . . 0.0 111.12 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -70.23 113.57 7.53 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.582 1.953 . . . . 0.0 110.312 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.89 4.85 36.12 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.456 1.027 . . . . 0.0 114.156 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.7 mmm -48.2 -41.36 26.99 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.835 1.317 . . . . 0.0 112.824 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -112.27 18.75 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.789 1.236 . . . . 0.0 111.787 -165.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -60.22 121.2 11.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.89 12.9 65.47 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.204 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.4 m -80.03 63.52 4.58 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.855 1.327 . . . . 0.0 110.296 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.5 p -63.47 -13.74 43.64 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -164.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.14 -1.35 29.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.47 -1.393 . . . . 0.0 113.029 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.78 108.74 14.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 110.313 -171.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -126.46 -10.12 6.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -135.9 143.15 44.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.949 1.299 . . . . 0.0 111.837 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.463 HD21 HD21 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -140.46 140.31 35.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.237 2.215 . . . . 0.0 107.112 173.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -131.57 150.48 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.463 HD21 HD21 ' A' ' 48' ' ' LEU . 74.8 mt -133.39 106.55 7.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.832 1.253 . . . . 0.0 109.627 -169.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.2 p -82.27 45.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.886 0.766 . . . . 0.0 111.373 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -143.35 129.86 3.89 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.749 -1.219 . . . . 0.0 111.08 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.45 3.3 47.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.469 2.307 . . . . 0.0 112.753 -163.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.04 144.22 34.25 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 120.531 -1.356 . . . . 0.0 108.477 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -67.03 -33.48 31.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.735 1.623 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -62.24 -20.67 64.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.033 0.933 . . . . 0.0 112.541 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 9.82 0.43 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.956 1.702 . . . . 0.0 113.568 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.54 -177.07 5.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 109.46 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 t -145.65 -177.04 5.37 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.334 1.454 . . . . 0.0 108.847 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.82 6.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 128.492 2.717 . . . . 0.0 107.947 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.23 -171.21 24.92 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 151.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.4 -51.52 43.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.21 58.37 5.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.507 1.051 . . . . 0.0 112.095 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD23 HH22 ' A' ' 65' ' ' ARG . 17.8 tp -44.94 -35.01 2.64 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.398 1.879 . . . . 0.0 112.048 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.476 HH22 HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -132.42 29.86 4.22 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 119.821 -1.799 . . . . 0.0 112.087 178.169 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.87 135.36 15.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.666 0.666 . . . . 0.0 111.101 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.06 -18.7 52.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.267 0.937 . . . . 0.0 112.889 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.0 -178.51 4.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.81 1.644 . . . . 0.0 109.461 173.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -160.91 104.58 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -133.52 168.12 19.22 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.801 0.84 . . . . 0.0 111.603 -169.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -85.61 145.42 27.35 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.994 0.918 . . . . 0.0 112.092 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -105.8 143.51 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.872 2.469 . . . . 0.0 108.986 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -127.87 138.59 52.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.044 1.338 . . . . 0.0 108.986 171.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.22 164.51 42.4 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.951 2.101 . . . . 0.0 108.376 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.62 147.74 82.23 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.816 1.684 . . . . 0.0 109.446 171.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -51.28 -33.48 28.78 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.63 -26.41 67.81 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.336 1.454 . . . . 0.0 110.689 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.78 -4.88 25.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.581 1.552 . . . . 0.0 112.21 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.75 -54.32 45.77 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.878 1.217 . . . . 0.0 112.081 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.72 -33.78 76.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.447 0.699 . . . . 0.0 110.068 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -59.83 -52.75 64.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.534 1.534 . . . . 0.0 111.816 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -58.85 -40.73 85.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.502 0.721 . . . . 0.0 110.027 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 -70.9 -16.91 62.71 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.89 5.38 45.35 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.95 1.25 . . . . 0.0 112.713 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.47 178.15 0.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.701 1.6 . . . . 0.0 113.039 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.4 -20.25 17.93 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.6 -1.313 . . . . 0.0 112.33 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -113.03 -53.94 2.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.684 1.129 . . . . 0.0 110.656 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -58.53 -15.64 12.07 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -46.07 -43.82 14.94 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 115.443 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -44.91 75.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.033 1.288 . . . . 0.0 108.564 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.1 5.74 6.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 112.823 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.461 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -63.51 -21.22 66.2 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.949 1.249 . . . . 0.0 111.769 -174.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -10.58 19.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -119.48 4.55 11.16 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 124.623 1.169 . . . . 0.0 111.563 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 92' ' ' ALA . 80.7 mt -97.13 100.97 11.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -172.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -119.23 165.14 18.01 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.18 0.992 . . . . 0.0 112.571 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.29 169.1 22.41 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.508 2.805 . . . . 0.0 112.534 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.2 mtm -84.76 169.21 14.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.162 2.185 . . . . 0.0 111.758 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.73 172.7 10.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.578 1.951 . . . . 0.0 108.336 164.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.202 0 CA-C-O 116.285 -1.817 . . . . 0.0 111.986 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.9 t -158.04 145.29 18.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.966 1.307 . . . . 0.0 108.152 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 44.23 81.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.02 2.128 . . . . 0.0 111.955 -171.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -148.78 -165.51 2.3 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.77 22.53 15.71 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-O 118.435 -1.203 . . . . 0.0 113.667 168.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.67 82.3 1.32 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 163.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.43 64.64 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.026 3.151 . . . . 0.0 109.685 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.65 153.15 27.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.639 -1.288 . . . . 0.0 109.548 -168.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG11 HG13 ' A' ' 27' ' ' VAL . 3.2 t -92.81 61.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.77 -83.93 0.09 OUTLIER Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.4 mtp -140.18 -35.58 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.89 130.82 44.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.024 1.284 . . . . 0.0 111.939 -172.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -91.98 95.38 9.77 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.92 -52.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 108.334 173.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 8.41 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.589 2.356 . . . . 0.0 117.339 -171.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -89.26 -0.59 57.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.916 1.235 . . . . 0.0 113.736 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.55 86.5 2.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.474 1.034 . . . . 0.0 109.741 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.41 -26.98 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 117.608 -1.662 . . . . 0.0 114.741 167.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -95.65 99.21 11.1 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.806 2.303 . . . . 0.0 110.116 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 p -65.57 19.61 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.051 2.941 . . . . 0.0 115.155 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.81 4.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 120.594 -1.316 . . . . 0.0 111.786 -159.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 tt -90.94 104.38 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 O-C-N 120.103 -1.623 . . . . 0.0 107.155 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -84.08 -15.9 45.72 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 117.667 -1.159 . . . . 0.0 111.835 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -138.83 129.75 26.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.249 0.931 . . . . 0.0 110.194 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.449 HD12 HD11 ' A' ' 45' ' ' LEU . 73.9 mt -129.89 97.87 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -79.4 115.18 18.88 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.411 -0.806 . . . . 0.0 109.118 171.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG13 HG11 ' A' ' 9' ' ' VAL . 2.7 t -114.49 125.33 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.145 1.778 . . . . 0.0 110.598 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.76 164.77 51.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 170.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.43 162.03 36.61 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.321 2.014 . . . . 0.0 108.738 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 46.79 53.08 10.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.191 1.396 . . . . 0.0 111.932 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.25 22.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.095 -1.003 . . . . 0.0 113.023 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.63 160.36 9.11 Favored Glycine 0 CA--C 1.521 0.437 0 O-C-N 120.843 -1.161 . . . . 0.0 111.028 165.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 35' ' ' TYR . 9.9 tp -72.25 129.09 37.6 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.963 -1.316 . . . . 0.0 108.418 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -85.52 87.83 7.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.413 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -75.69 -166.62 0.58 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.302 0.641 . . . . 0.0 109.375 176.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.93 148.26 36.47 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 2.59 90.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.1 -1.389 . . . . 0.0 116.312 164.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -34.93 70.34 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.483 2.142 . . . . 0.0 110.107 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.06 17.51 22.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.685 1.594 . . . . 0.0 111.196 -172.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 t -57.16 109.78 0.72 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.55 0.99 46.73 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.631 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -79.02 66.63 4.51 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.538 2.169 . . . . 0.0 110.203 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.0 p -66.04 -6.61 13.48 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.652 1.981 . . . . 0.0 113.695 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.82 25.81 3.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.829 1.252 . . . . 0.0 110.887 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.734 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -70.8 135.19 47.98 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 171.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.6 -25.09 1.03 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.256 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.05 154.92 43.73 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.554 1.941 . . . . 0.0 110.88 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.45 147.7 27.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.32 2.248 . . . . 0.0 105.311 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.29 142.81 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' A' ' 58' ' ' TYR . 37.5 mt -121.12 116.19 24.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.858 0.863 . . . . 0.0 110.212 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.7 p -86.25 3.22 44.12 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.628 0.974 . . . . 0.0 113.628 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.93 162.17 23.92 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 120.802 -1.186 . . . . 0.0 110.931 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -110.61 3.25 19.21 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -164.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -152.6 144.66 16.7 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.119 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.53 -23.25 64.52 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.397 2.731 . . . . 0.0 112.87 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -60.95 -23.75 65.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.395 0.998 . . . . 0.0 112.143 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.84 4.87 17.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.134 0.973 . . . . 0.0 113.151 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.444 ' CE1' HD22 ' A' ' 50' ' ' LEU . 59.7 m-85 -134.9 170.58 15.65 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 126.8 2.04 . . . . 0.0 110.027 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 m -122.16 -176.56 3.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.147 1.379 . . . . 0.0 109.027 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . 174.72 -17.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.884 1.674 . . . . 0.0 113.02 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 47.35 -97.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 128.24 2.829 . . . . 0.0 111.349 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.27 14.78 1.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.233 1.413 . . . . 0.0 109.896 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.05 14.09 3.31 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 117.474 -1.736 . . . . 0.0 115.251 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.588 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 5.4 tt -44.22 -51.62 8.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.822 2.311 . . . . 0.0 111.874 -165.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -86.09 -7.36 58.65 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 116.975 -1.488 . . . . 0.0 114.823 -171.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.2 118.3 4.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.967 0.803 . . . . 0.0 111.11 -152.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.51 -9.28 38.14 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.823 1.677 . . . . 0.0 114.266 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.57 -174.38 3.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.147 1.474 . . . . 0.0 114.064 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -151.0 115.66 5.18 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 131.453 3.901 . . . . 0.0 103.749 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.734 ' HB2' HD22 ' A' ' 45' ' ' LEU . 46.8 p90 -147.91 -175.11 4.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.392 1.077 . . . . 0.0 109.972 174.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.7 tp -127.64 148.4 50.38 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.346 -1.471 . . . . 0.0 110.035 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -110.72 136.87 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.036 2.134 . . . . 0.0 107.77 -173.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 33.7 m -123.43 122.62 38.73 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.994 2.117 . . . . 0.0 110.813 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.88 158.79 58.86 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 107.29 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -69.77 153.57 68.72 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.32 -32.54 73.31 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -27.03 66.65 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.39 0.541 . . . . 0.0 110.445 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -92.74 -7.82 45.55 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.167 -0.958 . . . . 0.0 111.857 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 tp -62.04 -55.94 24.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.104 1.775 . . . . 0.0 111.517 -162.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.72 -30.03 70.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.737 -0.602 . . . . 0.0 110.691 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -59.21 -31.58 69.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.178 1.391 . . . . 0.0 112.475 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -77.69 -41.5 37.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.342 0.974 . . . . 0.0 110.497 166.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -65.98 -27.06 67.86 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 0.0 113.506 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -77.12 -3.07 37.49 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.157 -0.965 . . . . 0.0 111.819 173.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 130.45 35.04 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 121.026 1.739 . . . . 0.0 107.902 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.67 -38.15 90.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.09 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 60' ' ' ALA . 1.5 t80 -71.42 -61.77 1.65 Allowed 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.601 0.637 . . . . 0.0 110.378 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -58.52 -9.1 1.45 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.32 -47.78 6.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.083 0.953 . . . . 0.0 111.908 163.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 t -61.11 -17.92 55.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.576 0.751 . . . . 0.0 111.272 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -113.14 5.61 17.14 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.614 1.966 . . . . 0.0 113.755 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.46 -24.95 65.64 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.946 1.248 . . . . 0.0 111.548 -171.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.09 -13.98 62.63 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -123.33 17.03 9.81 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.632 1.106 . . . . 0.0 111.546 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -103.73 123.07 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 5.0 pt20 -130.01 166.04 29.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.553 1.941 . . . . 0.0 110.917 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 96' ' ' GLN . 55.4 Cg_endo -64.22 174.19 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.317 2.678 . . . . 0.0 112.006 169.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 mtm -96.3 170.7 9.06 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.74 1.616 . . . . 0.0 111.562 170.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -91.17 175.29 6.99 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.4 1.08 . . . . 0.0 110.279 162.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 130.047 3.339 . . . . 0.0 108.107 -160.256 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.912 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -57.93 148.76 24.7 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 118.843 1.321 . . . . 0.0 111.776 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 176.5 159.82 0.33 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 128.325 2.65 . . . . 0.0 108.312 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -92.34 163.92 13.7 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.604 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -113.55 16.92 21.36 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 117.575 -1.681 . . . . 0.0 113.989 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.8 86.01 0.55 Allowed Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 119.762 1.781 . . . . 0.0 108.872 173.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.11 78.95 2.13 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.78 2.986 . . . . 0.0 108.793 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.97 154.84 19.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 120.687 -1.258 . . . . 0.0 108.013 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.45 155.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 123.932 0.77 . . . . 0.0 109.189 165.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.4 -70.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 36.2 mtp -146.54 -51.98 0.22 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.245 1.418 . . . . 0.0 109.499 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -84.67 113.96 21.67 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.505 0.722 . . . . 0.0 109.695 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 27.2 mmtp -75.28 6.93 3.87 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -85.94 5.11 34.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -104.18 4.9 34.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -159.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -85.85 -57.28 3.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.364 0.984 . . . . 0.0 110.506 -165.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.47 85.21 0.28 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.019 2.528 . . . . 0.0 110.643 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.2 -17.72 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.934 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.04 114.9 28.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.378 1.589 . . . . 0.0 110.797 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 p -73.2 -0.66 14.95 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.597 -1.314 . . . . 0.0 114.173 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.84 -8.89 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 120.305 1.411 . . . . 0.0 110.8 -152.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 tt -65.16 99.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 127.637 2.375 . . . . 0.0 108.103 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -85.95 -10.0 55.91 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.739 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -141.43 134.98 29.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.286 0.948 . . . . 0.0 108.839 -172.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.03 122.55 49.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -83.09 141.17 32.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 160.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.7 143.31 32.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 124.147 0.979 . . . . 0.0 108.367 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -92.78 164.28 22.69 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 110.226 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.81 171.25 14.85 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.634 2.223 . . . . 0.0 110.007 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 48.68 35.39 6.19 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.601 1.96 . . . . 0.0 113.91 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.533 ' O ' ' HE3' ' A' ' 13' ' ' LYS 0.255 5.4 tt -131.53 63.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 122.634 1.207 . . . . 0.0 112.432 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.64 159.56 32.05 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.153 1.358 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.1 168.54 8.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.8 1.24 . . . . 0.0 111.671 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD13 HD13 ' A' ' 64' ' ' LEU . 37.1 mt -133.2 84.78 2.16 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 170.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -84.43 162.05 20.09 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.061 0.391 . . . . 0.0 110.726 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.18 126.03 26.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.371 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.49 11.44 64.21 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.692 -1.06 . . . . 0.0 114.693 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -62.38 -32.94 73.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.22 2.01 . . . . 0.0 112.415 172.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -107.02 29.3 7.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.027 1.731 . . . . 0.0 110.996 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 t -66.12 102.83 0.87 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.78 48.32 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.828 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.09 63.37 1.8 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.78 1.79 . . . . 0.0 109.618 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 p -73.62 -12.51 60.77 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -158.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.42 13.8 19.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.857 1.208 . . . . 0.0 112.131 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.721 HD22 ' CB ' ' A' ' 70' ' ' PHE . 2.7 tt -65.32 117.59 8.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -126.94 -8.65 6.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -148.33 148.55 30.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.18 0.992 . . . . 0.0 112.282 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tp -151.39 100.49 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.88 138.15 21.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 mt -123.48 129.85 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.051 0.94 . . . . 0.0 108.976 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 p -113.67 35.58 3.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.173 0.989 . . . . 0.0 111.409 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.62 139.9 11.35 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.1 4.13 21.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -163.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -151.75 144.49 16.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 120.64 -1.288 . . . . 0.0 109.423 -164.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -37.97 3.05 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.152 2.568 . . . . 0.0 113.241 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -74.95 -7.04 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.012 0.824 . . . . 0.0 112.095 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.08 -10.93 59.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.031 0.932 . . . . 0.0 112.237 165.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -97.71 173.11 7.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 123.263 1.506 . . . . 0.0 110.709 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -164.39 1.08 Allowed 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 129.111 2.964 . . . . 0.0 106.869 169.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 77.05 142.64 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 130.223 3.409 . . . . 0.0 110.567 -169.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.91 -31.63 0.02 OUTLIER Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.214 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.5 -45.33 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.276 2.231 . . . . 0.0 110.235 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.44 71.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.554 -1.137 . . . . 0.0 112.248 -162.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.45 HD13 HD13 ' A' ' 34' ' ' LEU . 42.1 tp -44.63 -63.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.276 1.038 . . . . 0.0 110.766 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.6 -9.74 59.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 116.916 -1.516 . . . . 0.0 112.311 -164.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -45.29 112.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.954 1.302 . . . . 0.0 110.497 -157.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.08 -6.06 28.89 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.606 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.31 173.26 13.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.223 1.809 . . . . 0.0 110.73 168.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -140.48 81.91 1.83 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.167 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.721 ' CB ' HD22 ' A' ' 45' ' ' LEU . 24.8 p90 -95.26 -176.79 3.91 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.197 1.399 . . . . 0.0 109.023 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.85 157.86 28.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 107.515 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.5 139.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.637 1.175 . . . . 0.0 108.814 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.26 135.36 54.21 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.533 1.133 . . . . 0.0 110.126 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -136.74 155.29 76.7 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 126.166 1.786 . . . . 0.0 107.036 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 153.71 71.22 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 121.536 1.584 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.09 -30.2 66.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.1 -29.69 69.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.322 1.049 . . . . 0.0 111.326 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.09 -11.63 22.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.33 1.052 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 tp -57.68 -52.06 66.97 Favored 'General case' 0 C--O 1.228 -0.055 0 O-C-N 121.108 -0.995 . . . . 0.0 110.45 -170.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -27.38 68.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -59.11 5.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.442 1.497 . . . . 0.0 109.551 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -63.01 -26.62 68.94 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.556 1.071 . . . . 0.0 111.414 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -17.17 61.45 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -103.26 -9.43 19.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.637 1.108 . . . . 0.0 113.612 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.97 151.27 26.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.489 1.116 . . . . 0.0 111.831 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.64 -50.74 72.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.014 -0.429 . . . . 0.0 111.679 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -82.94 -60.68 2.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 108.936 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -60.06 -15.63 24.63 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -43.96 -49.5 8.51 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 120.105 1.32 . . . . 0.0 112.98 164.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 t -57.19 -31.3 65.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -93.8 15.86 15.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.806 1.242 . . . . 0.0 112.658 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.71 65.69 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.016 -1.677 . . . . 0.0 112.18 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.44 38.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.112 0.965 . . . . 0.0 112.979 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -127.43 21.07 6.66 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.87 106.95 21.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 119.898 1.226 . . . . 0.0 108.739 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.62 164.86 26.03 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.088 1.755 . . . . 0.0 111.161 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.55 163.0 36.62 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.66 2.24 . . . . 0.0 112.211 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.7 mtt -75.78 176.82 7.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.859 1.264 . . . . 0.0 109.581 163.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -103.2 -166.66 1.29 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.133 1.373 . . . . 0.0 110.059 167.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.858 1.663 . . . . 0.0 107.999 -170.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.7 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 m -62.57 144.42 56.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.051 0.426 . . . . 0.0 110.796 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -147.14 36.93 0.93 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.612 1.165 . . . . 0.0 109.881 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -139.71 145.24 38.1 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.732 1.213 . . . . 0.0 108.541 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.452 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 129.29 74.66 0.16 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -66.64 165.28 25.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.239 0.615 . . . . 0.0 110.494 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.34 68.39 5.17 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.112 3.208 . . . . 0.0 109.816 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.54 146.79 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 108.062 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.415 HG11 HG13 ' A' ' 27' ' ' VAL . 21.8 t -86.03 99.54 7.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.06 86.82 0.18 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 167.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.3 mtp 57.89 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 129.309 3.044 . . . . 0.0 118.241 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -110.44 97.07 6.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 121.69 2.041 . . . . 0.0 111.034 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -73.16 28.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.921 1.288 . . . . 0.0 113.221 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.71 28.47 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.626 1.103 . . . . 0.0 111.671 -168.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.452 HD22 ' HA3' ' A' ' 5' ' ' GLY . 88.9 mt -125.1 1.94 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.11 1.364 . . . . 0.0 113.562 -171.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 18' ' ' GLY . 26.4 m-85 -91.67 -36.3 13.7 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.321 -0.862 . . . . 0.0 111.418 -162.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.53 14.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.458 2.303 . . . . 0.0 114.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -114.58 -13.54 9.51 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.328 1.918 . . . . 0.0 113.848 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -120.86 107.13 12.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.215 2.007 . . . . 0.0 111.894 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.4 p -79.09 9.62 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.013 1.725 . . . . 0.0 114.355 -168.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.7 -4.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.146 -170.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.35 104.32 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -81.74 -15.62 53.75 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 117.954 -1.022 . . . . 0.0 111.13 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -143.44 126.03 15.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.002 0.921 . . . . 0.0 109.452 -162.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 45' ' ' LEU . 88.0 mt -133.15 103.98 6.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -175.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.4 m -75.03 139.77 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 166.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 9' ' ' VAL . 1.9 t -135.02 165.45 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.57 1.948 . . . . 0.0 108.024 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' HG22 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -125.08 165.87 23.57 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 108.992 176.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.65 162.52 41.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.928 1.752 . . . . 0.0 110.167 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 48.51 19.43 0.23 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.141 2.177 . . . . 0.0 114.549 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 28' ' ' GLN . 4.9 tp -95.06 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 119.895 -1.753 . . . . 0.0 110.758 -170.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.76 151.23 21.33 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 121.14 -0.975 . . . . 0.0 111.728 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.3 tp -70.44 138.47 51.24 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 121.769 0.795 . . . . 0.0 110.293 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.27 99.9 11.9 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 164.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -75.02 165.14 25.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.0 134.62 35.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.833 -1.167 . . . . 0.0 108.352 173.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.17 -0.07 71.58 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.928 1.252 . . . . 0.0 113.204 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -48.75 -44.03 38.23 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.457 2.303 . . . . 0.0 112.676 173.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -95.64 9.83 38.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.598 0.759 . . . . 0.0 112.668 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -58.24 113.65 2.04 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.651 1.114 . . . . 0.0 109.861 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.54 -0.29 53.1 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.004 -1.442 . . . . 0.0 113.721 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.5 m -74.74 67.64 1.61 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.916 1.858 . . . . 0.0 109.284 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -75.17 10.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.389 1.876 . . . . 0.0 113.66 -168.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.32 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.113 0.965 . . . . 0.0 112.943 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.737 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -66.48 118.9 10.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.673 1.579 . . . . 0.0 109.68 -175.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -126.08 -11.59 6.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.313 0.645 . . . . 0.0 111.785 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.81 146.6 25.19 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.168 1.349 . . . . 0.0 111.322 -173.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -147.33 141.28 25.9 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.542 1.937 . . . . 0.0 106.417 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.25 141.27 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 48' ' ' LEU . 43.1 mt -122.74 103.87 8.94 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 109.369 -170.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.8 p -77.53 39.24 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.456 1.502 . . . . 0.0 113.216 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.83 153.52 25.36 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 119.824 -1.798 . . . . 0.0 110.495 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -108.32 4.38 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -158.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.44 144.6 40.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.219 1.008 . . . . 0.0 111.37 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.28 -22.27 5.93 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.3 2.667 . . . . 0.0 115.383 -172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 m -64.95 -36.83 85.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.057 1.299 . . . . 0.0 109.822 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.81 7.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -126.54 128.42 46.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.373 1.069 . . . . 0.0 109.575 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 167.04 13.41 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.221 1.009 . . . . 0.0 110.817 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.88 167.67 16.56 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.117 2.167 . . . . 0.0 108.537 153.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.84 -177.45 40.97 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 158.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -51.76 -44.86 63.51 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.3 1.44 . . . . 0.0 109.847 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.26 82.09 0.3 Allowed Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 127.233 2.349 . . . . 0.0 109.738 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.8 tp -51.53 -63.47 1.12 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.16 0.984 . . . . 0.0 109.623 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.47 17.12 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.121 1.368 . . . . 0.0 112.165 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.26 127.18 28.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.797 0.726 . . . . 0.0 109.244 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.33 81.48 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.249 0.928 . . . . 0.0 113.762 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.54 -164.41 1.82 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.72 2.008 . . . . 0.0 107.402 170.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -167.73 99.37 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 167.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.737 ' CB ' HD22 ' A' ' 45' ' ' LEU . 19.6 p90 -131.52 168.81 17.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.022 1.329 . . . . 0.0 109.486 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -98.18 152.82 18.96 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.147 1.379 . . . . 0.0 109.653 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.88 138.63 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 0.0 109.458 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -127.52 145.13 50.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.221 1.008 . . . . 0.0 110.014 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.12 158.77 74.95 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 108.58 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -67.17 148.85 81.53 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 CA-C-N 120.938 1.371 . . . . 0.0 110.229 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.4 -22.54 63.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -81.07 -22.85 38.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.022 1.329 . . . . 0.0 112.128 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.71 -1.58 32.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.151 1.38 . . . . 0.0 111.889 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.02 -47.39 83.19 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.769 -0.582 . . . . 0.0 112.019 -165.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.91 -43.67 78.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.443 0.297 . . . . 0.0 110.783 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -46.86 -55.0 8.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.19 1.396 . . . . 0.0 111.61 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -63.44 -41.47 98.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.012 0.824 . . . . 0.0 110.584 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -64.78 -16.09 62.55 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.312 -0.868 . . . . 0.0 112.475 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -101.11 15.55 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.262 1.825 . . . . 0.0 112.817 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.3 179.29 5.88 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.62 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -106.71 -29.33 9.64 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.609 1.964 . . . . 0.0 112.859 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.01 -56.2 2.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.772 0.829 . . . . 0.0 108.764 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -61.57 -10.71 8.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.743 -172.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.308 0.3 OUTLIER -43.89 -57.63 3.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.765 1.226 . . . . 0.0 113.373 168.154 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.6 t -69.86 -9.87 56.42 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.688 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -104.73 1.32 29.19 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.645 -1.285 . . . . 0.0 111.927 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -68.45 -3.86 12.85 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 119.671 -1.893 . . . . 0.0 112.585 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.82 -14.05 60.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.169 1.387 . . . . 0.0 112.375 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -127.78 34.96 4.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.203 1.401 . . . . 0.0 109.845 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 92' ' ' ALA . 63.2 mt -109.45 139.0 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.65 163.86 43.84 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.851 1.66 . . . . 0.0 110.127 166.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.92 149.04 91.49 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.86 1.707 . . . . 0.0 110.148 167.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ptp -77.96 160.05 28.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.641 1.177 . . . . 0.0 108.729 173.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.67 -168.55 2.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.876 1.67 . . . . 0.0 107.752 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 C--O 1.246 0.897 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.595 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -71.69 166.16 22.51 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.027 1.331 . . . . 0.0 108.472 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -154.47 39.38 0.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.111 0.964 . . . . 0.0 110.077 163.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.07 -179.24 7.94 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.727 1.611 . . . . 0.0 111.065 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.53 -88.32 0.07 OUTLIER Glycine 0 CA--C 1.521 0.464 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 168.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -133.25 156.2 80.1 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.976 1.311 . . . . 0.0 108.947 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.96 85.52 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.732 3.622 . . . . 0.0 107.298 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -150.1 147.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 120.448 -1.407 . . . . 0.0 107.92 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 t -78.8 101.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.43 -75.52 0.58 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -51.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.379 1.872 . . . . 0.0 111.365 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -87.36 172.44 9.84 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -126.31 3.98 7.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.533 1.133 . . . . 0.0 113.939 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -83.38 -28.77 28.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.02 23.65 0.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.887 1.275 . . . . 0.0 113.733 -157.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.98 -47.34 5.57 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.088 -1.008 . . . . 0.0 110.57 -171.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.31 1.444 . . . . 0.0 108.054 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.61 -23.44 0.09 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.821 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -108.64 105.22 14.74 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.748 2.274 . . . . 0.0 111.56 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -68.81 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.908 2.483 . . . . 0.0 113.055 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.96 -9.28 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.884 1.274 . . . . 0.0 111.538 -163.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.2 tt -77.48 96.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 120.897 -1.127 . . . . 0.0 108.8 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -75.07 -16.12 60.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.18 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -149.19 134.81 18.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.601 0.761 . . . . 0.0 109.53 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.4 114.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.0 m -89.82 137.72 32.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 t -130.77 121.37 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.935 1.694 . . . . 0.0 108.268 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -77.09 160.85 75.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.401 0.546 . . . . 0.0 110.798 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -75.49 159.9 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.723 2.282 . . . . 0.0 110.83 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 54.9 37.13 28.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.883 1.673 . . . . 0.0 113.007 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.292 3.7 tt -133.4 25.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.675 1.19 . . . . 0.0 112.205 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.61 159.3 8.15 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 127.132 2.301 . . . . 0.0 111.529 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.8 tp -71.96 126.15 29.03 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 124.306 1.042 . . . . 0.0 110.065 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.95 78.42 7.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -68.89 168.18 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.083 0.944 . . . . 0.0 111.548 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -75.54 137.42 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.59 -1.944 . . . . 0.0 108.667 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.34 3.4 90.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.101 0.858 . . . . 0.0 113.937 -174.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.1 ttp -59.77 -25.15 64.66 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 120.158 1.979 . . . . 0.0 113.364 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -114.4 15.69 17.9 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.848 1.259 . . . . 0.0 111.594 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.429 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 58.6 m -48.33 119.28 2.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 111.371 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.56 6.95 85.27 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.297 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.96 73.77 0.61 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.609 2.204 . . . . 0.0 107.092 163.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.6 p -65.31 -51.99 56.97 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.43 1.092 . . . . 0.0 111.532 -167.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.62 3.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.921 1.289 . . . . 0.0 113.957 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.2 tp -76.85 108.28 9.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.279 1.032 . . . . 0.0 110.129 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.62 -12.45 9.74 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.551 169.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -119.14 142.54 47.85 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.522 1.055 . . . . 0.0 113.236 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 49' ' ' ILE . 2.0 tm? -146.53 136.57 23.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.541 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.4 mp -133.94 137.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.2 113.75 22.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 p -83.97 0.38 48.2 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.33 179.05 41.96 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.216 0.912 . . . . 0.0 110.992 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.96 6.26 4.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.017 0.927 . . . . 0.0 112.63 -169.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -141.99 143.82 29.75 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.658 1.583 . . . . 0.0 107.721 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.53 -30.73 4.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.317 2.011 . . . . 0.0 112.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -77.07 -15.84 59.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 111.824 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.64 12.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.441 1.496 . . . . 0.0 112.804 165.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -124.33 168.55 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.252 1.021 . . . . 0.0 110.07 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -141.78 133.68 27.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.61 172.69 9.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.322 2.249 . . . . 0.0 106.388 172.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.73 -145.04 8.1 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.342 1.925 . . . . 0.0 109.361 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.01 -8.86 58.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.782 -0.834 . . . . 0.0 113.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.98 68.23 0.27 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -170.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 tp -46.14 -44.02 15.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.204 1.402 . . . . 0.0 111.022 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -113.7 16.75 18.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.016 0.926 . . . . 0.0 111.419 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.67 146.24 52.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.861 0.755 . . . . 0.0 110.808 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 76.47 -1.02 62.56 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.753 1.168 . . . . 0.0 113.825 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.27 -175.46 4.18 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 128.921 2.888 . . . . 0.0 107.456 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -156.56 94.49 1.48 Allowed 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.812 -1.18 . . . . 0.0 110.737 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -125.21 163.4 22.57 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.112 0.965 . . . . 0.0 111.134 -171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.68 152.39 18.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 108.113 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.4 mt -122.08 101.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -167.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.2 m -87.78 138.05 31.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.365 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.16 155.28 72.62 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.42 1.888 . . . . 0.0 109.7 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.84 144.54 53.91 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 CA-C-N 121.432 1.547 . . . . 0.0 109.46 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -55.24 -32.78 62.57 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -67.33 -18.24 65.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.224 3.01 . . . . 0.0 112.159 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.46 -0.19 19.01 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.83 -1.168 . . . . 0.0 113.135 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 tp -62.7 -50.27 71.8 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.172 0.896 . . . . 0.0 111.351 -168.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.61 -43.21 99.28 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.8 -56.28 9.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.525 1.93 . . . . 0.0 111.795 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -70.61 -40.22 73.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.292 0.496 . . . . 0.0 109.744 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -62.7 -25.41 68.15 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 121.208 -0.933 . . . . 0.0 112.565 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -85.14 -13.69 49.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.275 1.43 . . . . 0.0 112.679 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.73 143.1 57.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.443 0.565 . . . . 0.0 111.553 -160.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.89 24.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.133 2.573 . . . . 0.0 113.439 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -67.32 0.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.983 2.513 . . . . 0.0 107.207 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -58.6 -16.96 18.19 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -167.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -44.08 -45.01 7.88 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.499 1.52 . . . . 0.0 113.775 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -69.36 -6.15 28.03 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.77 15.81 14.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.04 1.291 . . . . 0.0 111.567 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.66 66.55 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.48 -1.388 . . . . 0.0 110.707 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.28 3.28 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -127.29 4.74 6.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.878 1.217 . . . . 0.0 111.889 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.85 123.65 46.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -136.06 162.42 56.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.771 0.828 . . . . 0.0 111.508 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.75 149.16 91.43 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.315 2.677 . . . . 0.0 114.208 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.5 mtm -73.51 156.37 38.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.557 166.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -98.64 -178.02 3.85 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.061 2.144 . . . . 0.0 109.865 171.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 154.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -84.23 120.18 25.91 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.249 1.42 . . . . 0.0 110.238 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 47.45 51.91 13.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.29 1.036 . . . . 0.0 112.052 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -145.9 -174.22 4.36 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.157 1.783 . . . . 0.0 107.523 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.22 80.03 0.25 Allowed Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -116.94 85.75 18.33 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.558 1.543 . . . . 0.0 109.635 -175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -76.22 64.64 7.11 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.373 3.382 . . . . 0.0 110.639 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.34 165.42 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 108.791 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.503 HG22 HD12 ' A' ' 31' ' ' ILE 0.268 7.0 p -110.57 68.23 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.28 1.038 . . . . 0.0 109.826 -161.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.75 79.62 0.26 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 125.766 1.651 . . . . 0.0 109.791 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.2 10.07 1.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.786 2.034 . . . . 0.0 114.388 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.59 122.68 15.67 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.878 1.217 . . . . 0.0 110.225 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -105.29 90.94 3.58 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.391 1.476 . . . . 0.0 107.066 168.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -162.46 10.43 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 14' ' ' SER . 1.3 mp -131.67 1.28 4.02 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.782 -1.199 . . . . 0.0 113.053 -160.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.24 -36.66 16.61 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.664 -0.647 . . . . 0.0 111.573 -163.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 43.87 0.09 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.905 2.082 . . . . 0.0 112.255 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.82 -27.46 0.37 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.381 -1.233 . . . . 0.0 113.352 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -106.78 94.15 4.96 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.438 1.619 . . . . 0.0 110.63 -173.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.5 p -64.24 22.04 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 129.537 3.135 . . . . 0.0 115.107 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.29 7.56 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 O-C-N 119.861 -1.774 . . . . 0.0 110.074 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.94 98.55 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.241 -1.537 . . . . 0.0 107.147 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -71.29 -26.36 62.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.744 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -136.79 120.72 17.57 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.432 0.56 . . . . 0.0 111.218 -160.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mt -122.29 89.96 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 m -66.82 130.93 44.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 161.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.1 155.4 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.328 1.851 . . . . 0.0 107.047 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -119.59 159.66 45.21 Favored Pre-proline 0 N--CA 1.452 -0.368 0 C-N-CA 124.809 1.243 . . . . 0.0 107.864 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.1 152.98 51.68 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.733 1.622 . . . . 0.0 111.196 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 59.85 21.38 10.29 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.524 1.93 . . . . 0.0 113.849 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.503 HD12 HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -118.25 93.86 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 124.505 2.097 . . . . 0.0 107.198 176.036 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.49 138.62 5.21 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 127.27 2.367 . . . . 0.0 113.28 161.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -58.47 130.23 45.77 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mt -88.07 123.37 32.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -133.99 176.56 8.46 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.57 1.148 . . . . 0.0 109.407 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -72.42 152.07 42.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.545 1.164 . . . . 0.0 111.512 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.477 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 66.13 -3.67 3.07 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.085 1.326 . . . . 0.0 114.425 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.469 ' HE3' ' CZ ' ' A' ' 39' ' ' PHE . 3.6 tmm? -57.74 -32.56 67.56 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.805 . . . . 0.0 112.094 -170.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.469 ' CZ ' ' HE3' ' A' ' 38' ' ' MET . 59.7 m-85 -102.49 -5.92 23.48 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.406 1.482 . . . . 0.0 113.468 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 t -54.23 124.78 16.83 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.342 0.974 . . . . 0.0 110.974 -164.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.31 9.24 48.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.764 1.173 . . . . 0.0 112.784 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.7 p -69.85 74.19 0.43 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.951 1.7 . . . . 0.0 111.93 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -58.16 -7.83 0.93 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.49 0.23 5.6 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.609 -1.186 . . . . 0.0 113.5 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.35 123.34 24.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.5 1.955 . . . . 0.0 112.383 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.08 8.66 0.95 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -146.09 126.24 13.81 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.347 -1.471 . . . . 0.0 109.374 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 72' ' ' ILE . 2.3 tp -120.68 139.78 52.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.23 146.75 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -121.86 136.33 54.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.384 1.474 . . . . 0.0 107.154 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 p -111.37 33.69 4.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.122 0.963 . . . . 0.0 111.246 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.85 161.66 20.22 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -113.75 4.17 15.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -157.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.99 147.81 19.46 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.466 1.03 . . . . 0.0 109.64 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.52 -27.51 70.04 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.042 3.161 . . . . 0.0 113.695 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m -72.58 -13.24 61.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.36 7.17 4.6 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.061 -1.024 . . . . 0.0 112.125 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -139.89 179.45 6.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.162 2.185 . . . . 0.0 109.336 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -139.25 179.4 6.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.977 2.111 . . . . 0.0 108.625 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -161.06 1.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.21 -108.14 0.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -150.69 38.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.747 1.619 . . . . 0.0 109.568 163.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.09 28.38 0.2 Allowed Glycine 0 C--O 1.225 -0.415 0 CA-C-O 118.043 -1.421 . . . . 0.0 114.285 -165.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 64' ' ' LEU . 7.2 tt -45.29 -41.97 9.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.55 1.675 . . . . 0.0 112.175 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -117.89 26.15 9.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.856 1.262 . . . . 0.0 112.071 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -58.55 141.64 51.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 110.151 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 -29.95 3.03 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.341 0.972 . . . . 0.0 112.389 -173.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.17 -179.82 4.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.269 1.828 . . . . 0.0 110.25 -175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -161.02 106.87 1.4 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.58 1.152 . . . . 0.0 107.973 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -139.13 167.27 22.43 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.245 1.418 . . . . 0.0 109.76 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.9 mt -89.92 141.93 28.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.949 1.299 . . . . 0.0 108.986 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.412 HG23 HD23 ' A' ' 48' ' ' LEU . 9.9 mt -90.19 138.12 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.627 1.971 . . . . 0.0 105.823 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.2 m -120.81 136.0 55.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.31 161.11 62.36 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 124.615 1.166 . . . . 0.0 107.997 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.04 147.7 84.68 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.997 1.035 . . . . 0.0 110.425 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -50.34 -37.2 35.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.236 1.014 . . . . 0.0 112.6 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -31.93 59.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.797 -0.565 . . . . 0.0 110.482 -170.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.23 -5.84 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.926 1.29 . . . . 0.0 112.302 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.4 tp -56.14 -38.04 70.28 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 112.12 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -69.8 -47.4 62.98 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.57 -0.706 . . . . 0.0 111.409 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -49.03 -53.28 20.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.136 1.774 . . . . 0.0 111.955 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -66.12 -42.6 88.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.288 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -57.1 -48.67 78.04 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.936 0.789 . . . . 0.0 111.657 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -68.87 -11.54 60.64 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.34 137.85 48.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.308 0.958 . . . . 0.0 111.218 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -61.4 -38.08 85.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.384 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.59 -66.73 0.66 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.369 1.068 . . . . 0.0 108.46 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -58.68 -23.17 58.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.563 -1.208 . . . . 0.0 112.232 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -44.7 -35.18 2.54 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -56.27 -41.1 75.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.085 0.402 . . . . 0.0 110.153 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -89.43 9.91 24.58 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 112.432 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -65.27 -22.06 66.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.083 -1.635 . . . . 0.0 112.393 -167.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.1 -19.16 64.17 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -113.43 5.27 16.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.891 0.769 . . . . 0.0 112.007 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 92' ' ' ALA . 29.9 mt -86.98 134.05 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.471 1.508 . . . . 0.0 109.271 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.42 166.44 19.94 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.694 1.998 . . . . 0.0 111.51 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.7 175.83 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.002 2.468 . . . . 0.0 112.599 169.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp -102.22 170.88 7.81 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.134 1.774 . . . . 0.0 109.39 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.47 -177.55 3.43 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.488 0.715 . . . . 0.0 110.678 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 . . . . . 0 C--O 1.246 0.885 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 161.553 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.632 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.8 m -153.1 88.64 1.32 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -120.34 51.47 1.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 127.446 2.299 . . . . 0.0 107.144 -170.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -167.69 100.37 0.48 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.52 90.64 0.08 OUTLIER Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -107.86 164.12 15.48 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.865 1.266 . . . . 0.0 110.71 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.44 67.65 7.72 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.979 3.119 . . . . 0.0 109.704 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.56 165.57 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 126.379 1.871 . . . . 0.0 107.948 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.676 HG23 ' CE ' ' A' ' 13' ' ' LYS . 2.1 p -93.48 95.79 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.12 -84.99 1.5 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.8 mtp -128.38 -56.79 1.23 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.197 1.799 . . . . 0.0 109.954 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 115.93 23.42 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.34 -0.85 . . . . 0.0 110.49 -163.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.676 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -72.6 4.02 4.37 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -164.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.5 m -114.27 62.61 0.66 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.846 2.112 . . . . 0.0 112.33 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -133.9 4.47 3.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.402 1.081 . . . . 0.0 112.529 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.03 -55.96 3.25 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.443 1.497 . . . . 0.0 111.145 -167.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.28 92.57 0.04 OUTLIER 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.47 -6.04 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.199 -1.334 . . . . 0.0 112.988 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -139.34 144.85 38.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.056 1.928 . . . . 0.0 112.525 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.1 p -115.65 16.34 16.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.44 2.296 . . . . 0.0 113.264 -159.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.72 14.02 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 127.81 2.444 . . . . 0.0 111.254 -168.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tt -95.43 85.22 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 O-C-N 119.887 -1.758 . . . . 0.0 108.464 -165.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -87.51 18.14 4.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.032 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.95 145.92 26.75 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -137.19 104.25 3.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -70.13 144.26 52.1 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 162.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.6 123.01 35.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.19 161.82 66.52 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.809 -0.557 . . . . 0.0 109.909 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.79 167.2 26.76 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.583 2.189 . . . . 0.0 111.285 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 45.09 42.68 6.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.365 2.266 . . . . 0.0 114.411 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 tt -141.42 2.17 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.417 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . 178.16 130.47 1.41 Allowed Glycine 0 C--N 1.336 0.561 0 O-C-N 120.056 -1.653 . . . . 0.0 112.546 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 tp -59.09 136.67 58.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 164.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.5 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 5.5 mt -100.64 75.08 1.71 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.205 1.002 . . . . 0.0 109.408 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -75.03 163.22 27.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.96 0.504 . . . . 0.0 111.63 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 10.6 p-10 -69.32 114.62 7.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.563 1.545 . . . . 0.0 110.517 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.54 -5.75 24.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.297 1.427 . . . . 0.0 112.761 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' A' ' 34' ' ' LEU . 16.6 mtp -50.17 -54.0 23.84 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.952 1.301 . . . . 0.0 111.796 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -98.29 9.9 41.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.624 1.17 . . . . 0.0 111.497 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.403 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 11.6 t -66.76 112.28 4.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.34 -4.38 37.79 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.838 0.732 . . . . 0.0 112.598 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -76.58 72.63 3.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.331 1.565 . . . . 0.0 108.508 168.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 p -72.87 4.05 4.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.266 2.226 . . . . 0.0 113.189 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 49.89 1.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.215 1.806 . . . . 0.0 107.667 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.3 tp -122.67 105.34 10.0 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.32 -11.43 7.93 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.583 1.177 . . . . 0.0 114.159 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -129.98 124.2 32.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.537 HD21 HD21 ' A' ' 50' ' ' LEU . 2.4 tp -117.89 140.53 49.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.26 132.18 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.537 HD21 HD21 ' A' ' 48' ' ' LEU . 25.3 mt -110.92 113.85 26.73 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.481 0.713 . . . . 0.0 109.263 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.69 12.8 6.54 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.45 177.22 27.04 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -136.48 29.9 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 109.261 -170.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.69 147.3 9.4 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.314 -0.866 . . . . 0.0 111.35 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.33 -42.84 9.35 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.706 2.938 . . . . 0.0 112.592 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -74.67 -15.31 60.81 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.377 -0.827 . . . . 0.0 112.759 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.79 -7.92 43.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.889 0.768 . . . . 0.0 113.06 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.41 -168.63 1.34 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.27 1.428 . . . . 0.0 109.579 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.9 m -145.62 172.69 12.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.552 1.541 . . . . 0.0 107.052 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.87 137.85 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.09 -165.39 11.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 156.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.57 -59.89 4.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.283 0.563 . . . . 0.0 109.536 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 36' ' ' ASP . . . -87.72 65.75 3.49 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 125.021 1.296 . . . . 0.0 111.45 -170.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.8 tp -45.07 -48.42 11.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.299 1.04 . . . . 0.0 110.719 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.94 36.69 2.78 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.567 -0.708 . . . . 0.0 111.108 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.66 121.2 12.2 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.445 -1.41 . . . . 0.0 110.029 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 83.73 10.18 81.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.08 171.89 13.45 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.674 1.237 . . . . 0.0 108.485 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -140.08 94.23 2.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 122.218 1.008 . . . . 0.0 108.299 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.59 165.04 16.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.272 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.8 mt -105.12 158.14 16.78 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.088 1.355 . . . . 0.0 109.051 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.78 101.39 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 127.089 2.155 . . . . 0.0 106.548 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.9 m -75.27 127.11 32.43 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.88 156.18 80.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 125.309 1.444 . . . . 0.0 107.116 172.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.59 143.16 67.48 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -51.61 -43.03 62.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.05 1.74 . . . . 0.0 110.568 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.91 -10.11 12.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.71 -4.66 12.16 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 125.139 1.376 . . . . 0.0 112.434 168.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.64 -59.1 5.93 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 121.286 1.857 . . . . 0.0 110.841 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.48 -18.05 61.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.457 0.646 . . . . 0.0 112.222 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -66.24 -45.06 81.96 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.462 2.305 . . . . 0.0 110.0 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -64.05 -49.91 70.47 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -56.27 -32.25 64.36 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.732 1.151 . . . . 0.0 113.947 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -80.69 2.27 26.65 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -64.13 167.04 6.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.393 1.092 . . . . 0.0 111.554 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.03 -45.61 60.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.746 0.818 . . . . 0.0 110.702 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -104.0 -47.93 4.04 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.048 0.939 . . . . 0.0 111.091 -162.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -55.03 -21.15 11.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.893 0.769 . . . . 0.0 112.188 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -46.15 -45.19 16.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.265 1.826 . . . . 0.0 113.099 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 t -64.56 -25.5 68.0 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.338 0.517 . . . . 0.0 110.297 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.28 9.34 38.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.24 1.816 . . . . 0.0 112.62 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -8.94 32.58 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.36 -1.463 . . . . 0.0 112.168 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.12 -18.62 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.471 1.032 . . . . 0.0 113.488 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -112.48 -4.3 14.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 112.629 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.44 134.23 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.62 160.08 55.1 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.153 0.981 . . . . 0.0 111.031 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.17 164.12 26.48 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 111.963 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.1 mtt -83.71 -173.47 4.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.389 1.876 . . . . 0.0 111.645 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -137.8 179.92 6.14 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.203 2.601 . . . . 0.0 109.026 165.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 . . . . . 0 C--O 1.248 0.986 0 C-N-CA 125.928 1.691 . . . . 0.0 107.046 169.668 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.867 0 CA-C-O 120.122 -0.266 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -141.85 142.72 33.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.715 1.206 . . . . 0.0 110.456 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 45.59 45.5 10.79 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.79 1.636 . . . . 0.0 112.051 -166.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -147.29 147.77 30.73 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.516 -0.74 . . . . 0.0 109.517 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.16 71.67 0.32 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -170.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -130.49 78.0 74.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.003 2.121 . . . . 0.0 106.584 171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.25 64.03 8.27 Favored 'Trans proline' 0 N--CA 1.458 -0.611 1 C-N-CA 126.484 4.789 . . . . 0.0 107.483 -171.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.96 140.75 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.534 1.134 . . . . 0.0 108.163 -164.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 27' ' ' VAL . 41.8 t -76.43 77.79 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.04 72.32 0.46 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.365 1.46 . . . . 0.0 110.086 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.39 9.49 2.02 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.467 1.907 . . . . 0.0 115.895 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -132.23 159.14 39.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.284 1.402 . . . . 0.0 109.374 158.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -138.46 31.92 2.32 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.392 1.477 . . . . 0.0 112.22 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.0 t -133.67 29.0 3.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.799 1.24 . . . . 0.0 110.882 175.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -115.4 2.72 13.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.161 1.785 . . . . 0.0 112.42 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.27 -41.07 11.77 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.967 -1.083 . . . . 0.0 110.926 -163.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.59 84.79 1.15 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.311 1.044 . . . . 0.0 109.759 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.06 -41.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -87.34 91.16 8.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.015 0.912 . . . . 0.0 112.37 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.2 p -70.94 33.48 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 128.425 2.69 . . . . 0.0 114.589 -171.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.0 1.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 120.352 -1.468 . . . . 0.0 112.319 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -71.9 83.89 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-O 121.975 0.893 . . . . 0.0 111.473 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -79.37 4.31 15.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.797 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -153.29 138.28 17.23 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.1 1.36 . . . . 0.0 108.427 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -134.66 126.0 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 167.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.5 m -102.49 122.15 43.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 9' ' ' VAL . 2.3 t -112.12 112.49 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.96 1.304 . . . . 0.0 107.962 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -65.15 164.02 26.3 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.329 0.652 . . . . 0.0 110.491 167.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.24 154.97 68.98 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.216 1.944 . . . . 0.0 110.627 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.69 51.85 8.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.784 2.034 . . . . 0.0 113.109 171.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 tt -136.95 84.0 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 124.227 1.965 . . . . 0.0 107.808 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.82 149.48 0.11 Allowed Glycine 0 CA--C 1.525 0.682 1 C-N-CA 131.168 4.223 . . . . 0.0 113.014 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.86 HD21 ' HB3' ' A' ' 35' ' ' TYR 0.334 0.0 OUTLIER -64.81 155.33 34.29 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.792 -0.828 . . . . 0.0 110.195 170.789 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.534 ' H ' ' HB2' ' A' ' 59' ' ' SER . 5.0 mt -102.15 123.09 45.4 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 168.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.86 ' HB3' HD21 ' A' ' 33' ' ' LEU . 23.7 p90 -122.53 175.51 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 111.306 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.9 126.4 27.88 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.419 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.45 46.81 93.6 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 mtp -70.64 -34.24 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.815 1.246 . . . . 0.0 110.805 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -114.84 29.85 7.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.088 1.355 . . . . 0.0 110.655 -167.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.3 t -61.73 109.69 1.3 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.891 0.876 . . . . 0.0 110.53 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.79 12.88 55.03 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.978 -0.901 . . . . 0.0 113.462 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -78.2 73.82 4.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.392 1.596 . . . . 0.0 109.441 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 p -68.06 -3.17 9.36 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.971 2.508 . . . . 0.0 113.5 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.68 53.43 1.85 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.486 1.514 . . . . 0.0 107.889 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 tp -129.63 111.78 13.03 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.607 1.563 . . . . 0.0 107.882 174.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.77 8.95 3.06 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -137.3 152.7 50.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 O-C-N 120.878 -1.139 . . . . 0.0 110.503 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.8 tp -146.1 94.03 2.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.86 1.664 . . . . 0.0 107.169 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -82.71 141.52 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -128.18 118.05 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 p -88.48 -4.53 58.6 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -167.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.8 154.31 20.56 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 119.064 0.847 . . . . 0.0 112.111 -167.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.31 -2.82 58.49 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.37 148.1 39.42 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 120.288 1.403 . . . . 0.0 111.868 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.91 -23.61 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.23 2.62 . . . . 0.0 113.803 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 t -73.69 -21.18 60.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.698 1.599 . . . . 0.0 110.869 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.26 6.27 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.263 1.825 . . . . 0.0 113.031 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -141.72 175.36 9.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.261 1.824 . . . . 0.0 111.001 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.534 ' HB2' ' H ' ' A' ' 34' ' ' LEU . 3.8 m -135.12 -171.95 2.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.42 2.688 . . . . 0.0 108.584 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 177.1 -13.56 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.393 1.477 . . . . 0.0 113.425 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.22 -100.24 0.51 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.588 1.566 . . . . 0.0 110.134 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -140.39 -13.16 1.02 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.372 1.069 . . . . 0.0 111.299 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.08 42.8 0.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 124.007 0.813 . . . . 0.0 111.343 -159.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -44.47 -55.56 4.97 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.216 1.406 . . . . 0.0 111.569 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -98.33 12.38 35.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.931 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -64.32 158.28 23.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.266 0.939 . . . . 0.0 110.17 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.8 6.52 51.71 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.894 1.235 . . . . 0.0 114.695 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.26 -163.84 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.318 2.247 . . . . 0.0 107.499 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -155.74 112.29 3.16 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 120.456 -1.403 . . . . 0.0 110.051 164.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 175.42 8.02 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.56 1.144 . . . . 0.0 112.774 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.2 tp -111.04 155.75 22.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.954 2.502 . . . . 0.0 108.553 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.9 mt -117.76 138.9 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.462 1.105 . . . . 0.0 108.206 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.93 130.7 50.62 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.556 1.542 . . . . 0.0 107.686 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 82' ' ' TYR . 34.6 m -131.74 160.18 68.66 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.18 144.54 69.33 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.44 -29.99 27.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.53 0.732 . . . . 0.0 111.477 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.05 -33.08 73.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.022 1.329 . . . . 0.0 112.29 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.53 -3.82 19.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.584 1.154 . . . . 0.0 112.391 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.88 -46.4 74.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.47 -36.93 60.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.04 -52.5 42.53 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 109.799 172.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.476 ' CD2' HG11 ' A' ' 74' ' ' VAL . 3.2 m-85 -63.91 -42.03 97.51 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.868 0.867 . . . . 0.0 109.817 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -67.01 -11.61 57.51 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -110.12 18.13 20.3 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.027 1.731 . . . . 0.0 110.707 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -79.53 159.43 26.9 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.757 -1.214 . . . . 0.0 112.036 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -81.71 -35.47 29.74 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.124 -0.985 . . . . 0.0 112.103 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -90.96 -54.21 4.06 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.606 -0.684 . . . . 0.0 109.225 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -69.54 -12.51 61.71 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -47.43 -35.5 8.55 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 121.27 1.85 . . . . 0.0 115.158 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -63.15 -41.41 99.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.116 0.871 . . . . 0.0 111.181 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -75.94 3.77 9.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.221 1.008 . . . . 0.0 112.35 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -63.85 -19.87 65.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.678 -1.263 . . . . 0.0 112.024 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.5 -5.94 6.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.742 -1.123 . . . . 0.0 113.626 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -133.41 12.61 4.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.369 1.44 . . . . 0.0 112.474 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 92' ' ' ALA . 54.3 mt -89.54 130.78 38.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -138.08 165.39 33.79 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 111.284 165.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 176.37 2.48 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.446 2.097 . . . . 0.0 111.36 168.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.3 ptp -109.36 154.15 22.95 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.731 1.613 . . . . 0.0 107.311 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.28 177.11 8.22 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.7 1.2 . . . . 0.0 109.698 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 115.977 -1.963 . . . . 0.0 111.344 -177.64 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.428 0 CA-C-O 121.403 0.446 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 p -152.38 177.12 10.92 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 129.416 3.086 . . . . 0.0 104.804 162.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -124.25 156.33 37.04 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.541 1.064 . . . . 0.0 111.341 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.39 168.36 12.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.977 1.711 . . . . 0.0 110.081 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.89 10.46 72.15 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.833 -0.982 . . . . 0.0 112.796 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -113.61 85.18 8.86 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.343 1.457 . . . . 0.0 110.65 -170.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.96 64.44 8.27 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.742 2.294 . . . . 0.0 110.397 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -134.67 165.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -169.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.06 70.07 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.381 -0.824 . . . . 0.0 108.796 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.99 69.51 0.51 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.1 mtp 58.42 13.8 2.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.679 1.992 . . . . 0.0 115.61 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.27 172.07 13.38 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.301 1.41 . . . . 0.0 109.899 157.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 mmpt? -118.2 4.6 11.95 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.254 1.422 . . . . 0.0 113.422 -175.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -82.43 -23.93 34.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.395 1.452 . . . . 0.0 113.301 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.88 62.27 4.06 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.531 . . . . 0.0 111.999 -165.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -142.24 -49.06 0.36 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.686 -1.259 . . . . 0.0 112.13 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.77 66.06 2.0 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.476 1.11 . . . . 0.0 110.57 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 -34.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.587 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' O ' HG22 ' A' ' 22' ' ' ILE . 55.4 t30 -94.9 80.58 3.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.413 1.606 . . . . 0.0 112.297 -168.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.5 p -62.34 24.21 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 130.869 3.668 . . . . 0.0 116.511 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.36 -14.48 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 128.552 2.741 . . . . 0.0 110.947 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 19' ' ' ASN . 16.4 tt -62.51 99.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 119.348 0.976 . . . . 0.0 110.099 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -4.11 52.96 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.736 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -152.56 134.1 14.53 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 119.033 0.833 . . . . 0.0 112.163 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.5 108.88 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -81.0 146.53 30.63 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -139.65 115.0 8.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -66.5 164.2 34.06 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 118.202 0.455 . . . . 0.0 110.172 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.32 162.38 36.49 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.849 1.699 . . . . 0.0 110.848 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 44.7 56.47 5.17 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.187 2.595 . . . . 0.0 112.693 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.5 tt -144.69 71.12 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 124.282 1.992 . . . . 0.0 109.37 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.46 170.81 42.4 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 126.988 2.232 . . . . 0.0 112.416 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.4 tp -83.84 133.71 34.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.901 1.28 . . . . 0.0 110.638 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.42 122.1 28.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 159.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -126.75 175.51 7.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.817 1.247 . . . . 0.0 109.35 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.42 156.14 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.829 0.851 . . . . 0.0 110.237 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 63.75 -1.01 2.69 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.737 2.113 . . . . 0.0 115.307 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -29.65 60.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.013 1.725 . . . . 0.0 112.643 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -110.56 18.45 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.795 1.238 . . . . 0.0 113.373 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 t -56.91 105.54 0.23 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.776 0.831 . . . . 0.0 111.577 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.43 23.47 39.95 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.128 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -72.37 76.96 1.02 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.743 1.772 . . . . 0.0 109.182 164.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -71.79 15.68 0.14 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.816 2.446 . . . . 0.0 114.243 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.41 4.39 1.98 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.759 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -68.37 119.85 13.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.394 0.997 . . . . 0.0 110.631 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -122.25 -35.21 3.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.31 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -121.06 141.91 50.32 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 122.021 2.192 . . . . 0.0 113.178 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.7 tp -119.74 138.99 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.916 2.487 . . . . 0.0 104.561 161.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.05 140.59 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -115.44 151.38 34.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -119.47 5.14 11.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 112.395 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.12 169.03 30.37 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 118.971 0.805 . . . . 0.0 111.828 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.39 15.69 8.96 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.59 152.7 42.2 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 120.641 -1.287 . . . . 0.0 108.632 163.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -3.32 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 124.526 3.484 . . . . 0.0 113.896 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 m -91.48 14.64 14.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.865 1.212 . . . . 0.0 112.495 161.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.59 -4.49 55.26 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.181 1.355 . . . . 0.0 113.497 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -129.07 174.74 9.27 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.987 1.715 . . . . 0.0 109.72 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -119.35 172.4 7.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.807 1.643 . . . . 0.0 108.316 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -174.06 118.81 0.25 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 127.977 2.511 . . . . 0.0 105.948 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.66 -178.91 5.27 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 125.817 1.675 . . . . 0.0 109.425 161.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.51 -38.82 88.74 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.452 1.101 . . . . 0.0 111.779 -162.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.21 81.79 0.29 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 126.892 2.187 . . . . 0.0 107.832 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 tt -51.81 -47.06 64.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.544 1.172 . . . . 0.0 109.106 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -85.99 -7.0 58.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 117.573 -1.203 . . . . 0.0 114.157 -165.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -54.64 112.66 1.06 Allowed 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.684 0.615 . . . . 0.0 110.007 -159.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.38 -13.31 12.27 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.313 -1.271 . . . . 0.0 115.755 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.5 -172.43 4.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.014 1.407 . . . . 0.0 109.503 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -151.0 97.79 2.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.135 -0.978 . . . . 0.0 111.646 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.759 ' CB ' HD22 ' A' ' 45' ' ' LEU . 13.8 p90 -122.73 164.9 17.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 109.685 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.5 149.0 21.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.375 1.87 . . . . 0.0 110.689 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.26 126.34 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 m -112.78 140.15 47.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -133.39 160.21 69.53 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.075 1.35 . . . . 0.0 107.431 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.82 147.73 81.35 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.292 -1.465 . . . . 0.0 108.292 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.91 -30.21 32.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.964 0.506 . . . . 0.0 112.182 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -71.38 -25.58 62.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.871 1.268 . . . . 0.0 112.343 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.71 -3.28 46.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 113.049 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 tp -62.2 -50.09 73.19 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.358 -0.839 . . . . 0.0 113.216 -163.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -74.54 -37.85 62.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.805 0.842 . . . . 0.0 109.917 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -49.34 -52.81 25.69 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.529 1.132 . . . . 0.0 109.086 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -70.29 -30.22 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.09 0.556 . . . . 0.0 110.762 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -22.91 62.21 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.379 -0.826 . . . . 0.0 112.763 169.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -91.22 6.66 44.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.001 1.32 . . . . 0.0 112.175 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.98 159.73 24.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 120.807 1.64 . . . . 0.0 112.14 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -72.04 -43.73 64.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 120.768 -1.208 . . . . 0.0 110.978 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -95.36 -53.12 3.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.933 0.893 . . . . 0.0 110.22 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.86 -13.18 22.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.404 1.002 . . . . 0.0 113.415 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -48.64 -48.26 39.72 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.503 1.521 . . . . 0.0 114.743 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 t -52.04 -43.81 63.94 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.022 1.283 . . . . 0.0 110.171 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -80.38 6.7 11.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.435 1.094 . . . . 0.0 113.665 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.7 70.24 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.066 1.303 . . . . 0.0 111.533 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.1 -3.07 0.73 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 114.239 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -135.89 12.49 3.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.194 1.398 . . . . 0.0 112.271 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.9 mt -98.02 131.09 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.676 1.125 . . . . 0.0 108.949 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.58 166.14 26.35 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.771 2.028 . . . . 0.0 111.737 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.2 154.16 69.47 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.134 1.89 . . . . 0.0 113.214 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.3 ptp -78.68 162.85 25.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.604 1.961 . . . . 0.0 109.515 173.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . 0.255 1.3 pt-20 -100.98 -167.96 1.5 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.832 0.853 . . . . 0.0 110.823 169.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 117.289 -1.338 . . . . 0.0 111.064 -166.886 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 CA-C-O 118.438 -1.201 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.85 123.49 7.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.164 1.386 . . . . 0.0 108.669 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -171.92 152.86 3.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.169 1.787 . . . . 0.0 108.336 176.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -88.08 40.77 0.96 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 122.415 1.102 . . . . 0.0 111.395 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.03 -41.44 2.76 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.687 1.613 . . . . 0.0 112.632 171.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.58 159.4 38.62 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 125.942 1.697 . . . . 0.0 108.59 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.19 100.83 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.385 2.057 . . . . 0.0 110.416 -171.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.29 165.78 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.242 1.417 . . . . 0.0 109.042 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 ' CE ' ' A' ' 13' ' ' LYS . 4.0 p -109.3 127.02 66.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.328 1.051 . . . . 0.0 111.806 -172.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.18 76.01 0.2 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.011 1.291 . . . . 0.0 110.018 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.4 mtm 63.19 -31.68 0.1 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.822 2.849 . . . . 0.0 115.99 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -44.39 43.39 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.746 1 C-N-CA 136.928 6.091 . . . . 0.0 118.52 169.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.629 ' CE ' HG23 ' A' ' 9' ' ' VAL . 3.1 mmtm -73.22 72.11 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 119.372 -2.08 . . . . 0.0 111.029 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.61 4.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.055 2.142 . . . . 0.0 112.266 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.06 -13.92 14.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.721 1.6 . . . . 0.0 113.096 -174.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CD1' ' SD ' ' A' ' 38' ' ' MET . 21.4 m-85 -69.4 -35.0 75.35 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.708 0.803 . . . . 0.0 111.777 -160.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 33.27 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.896 2.078 . . . . 0.0 112.827 168.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.62 -40.8 1.55 Allowed Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.5 -1.375 . . . . 0.0 112.37 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -102.37 157.28 17.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.924 1.362 . . . . 0.0 109.997 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 p -123.21 22.65 9.36 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.534 1.534 . . . . 0.0 110.671 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.05 16.79 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.13 1.772 . . . . 0.0 108.78 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -87.62 104.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -107.65 9.59 29.23 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.168 1.787 . . . . 0.0 111.646 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -154.13 148.35 25.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 156.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.45 118.25 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -82.38 125.02 30.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 166.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 28' ' ' GLN . 1.8 t -119.24 164.45 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.442 ' H ' HG12 ' A' ' 27' ' ' VAL . 36.4 mt-30 -131.24 157.86 76.9 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -167.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 59.2 Cg_endo -70.7 157.07 59.59 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -177.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m120 46.73 37.72 5.01 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.179 1.791 . . . . 0.0 114.855 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.265 4.7 tt -117.12 18.65 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.242 . . . . 0.0 113.168 -174.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.62 149.56 5.68 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.59 1.566 . . . . 0.0 110.465 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 34' ' ' LEU . 1.4 tm? -65.82 130.23 42.54 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.574 ' N ' HD13 ' A' ' 33' ' ' LEU . 2.6 mt -79.44 78.01 5.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.66 1.184 . . . . 0.0 107.904 173.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HA ' HD12 ' A' ' 33' ' ' LEU . 3.3 p90 -75.36 168.63 19.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.833 0.825 . . . . 0.0 111.432 -162.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -74.56 98.08 3.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.512 0.725 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.77 -1.72 11.02 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.833 1.682 . . . . 0.0 113.815 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.465 ' SD ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 tmm? -59.24 -37.61 77.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.723 2.009 . . . . 0.0 113.431 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -103.68 11.88 35.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.042 1.337 . . . . 0.0 112.492 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 t -69.89 94.41 0.84 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -171.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.69 -6.65 6.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.157 -1.357 . . . . 0.0 113.478 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.2 m -74.63 70.54 1.84 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.652 2.226 . . . . 0.0 109.957 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p -67.83 -11.05 57.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.807 1.243 . . . . 0.0 114.326 -168.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.6 18.44 17.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.853 1.261 . . . . 0.0 111.714 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.756 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.2 tt -79.86 119.48 22.8 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 120.458 -1.401 . . . . 0.0 108.477 -173.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.82 -17.53 5.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.505 1.522 . . . . 0.0 112.447 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -152.02 150.15 29.65 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.175 2.19 . . . . 0.0 110.859 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.443 HD21 HD21 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -150.79 145.43 25.73 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 128.45 2.7 . . . . 0.0 104.451 178.209 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.29 141.38 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' A' ' 58' ' ' TYR . 94.9 mt -126.97 115.03 18.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.242 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.7 p -82.17 12.32 4.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.87 175.36 32.46 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.456 -1.402 . . . . 0.0 109.893 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -132.85 19.57 4.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.76 0.824 . . . . 0.0 110.982 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -160.88 144.81 10.12 Favored Pre-proline 0 N--CA 1.467 0.411 0 C-N-CA 125.029 1.332 . . . . 0.0 109.224 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.98 -25.03 44.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.01 2.473 . . . . 0.0 113.423 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 m -65.34 -11.67 44.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.346 0.658 . . . . 0.0 112.139 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 29' ' ' PRO . . . -79.52 -1.01 35.74 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.728 1.149 . . . . 0.0 112.869 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.47 ' CE2' HD22 ' A' ' 50' ' ' LEU . 83.9 m-85 -137.78 170.51 15.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 110.468 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.7 m -156.8 149.06 23.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.928 1.291 . . . . 0.0 109.59 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.21 158.3 44.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.231 2.213 . . . . 0.0 110.106 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.3 -166.23 42.0 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.67 -24.4 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.298 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.34 73.81 0.44 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.888 1.709 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.2 -40.75 5.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.642 1.577 . . . . 0.0 110.808 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.66 24.06 7.25 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 0.0 111.415 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -51.53 121.93 7.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.144 0.884 . . . . 0.0 110.941 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.54 13.39 82.98 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.855 -0.969 . . . . 0.0 114.231 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.52 176.03 8.9 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.604 1.962 . . . . 0.0 108.178 162.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.61 76.27 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.08 -1.012 . . . . 0.0 110.159 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.756 ' HB2' HD22 ' A' ' 45' ' ' LEU . 18.8 p90 -119.83 171.06 8.68 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.391 1.076 . . . . 0.0 111.979 -165.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.03 160.79 17.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.254 1.822 . . . . 0.0 110.303 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -131.08 104.78 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.028 2.131 . . . . 0.0 110.016 -163.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.2 m -95.25 105.25 17.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.574 1.95 . . . . 0.0 113.334 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -113.22 156.14 43.45 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.702 1.201 . . . . 0.0 109.254 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.51 151.81 82.17 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.585 1.602 . . . . 0.0 109.158 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.62 -31.24 66.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.781 0.832 . . . . 0.0 112.226 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -59.51 -33.17 71.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.333 1.453 . . . . 0.0 112.093 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.08 -6.52 38.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.499 -0.751 . . . . 0.0 111.978 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -61.9 -50.66 71.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.298 0.954 . . . . 0.0 111.663 -164.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.57 -30.65 46.88 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.688 -0.633 . . . . 0.0 111.078 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -50.32 -55.17 16.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.21 1.404 . . . . 0.0 109.242 168.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.25 -37.98 85.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.235 0.614 . . . . 0.0 111.054 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -68.12 -28.16 67.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 118.463 -0.78 . . . . 0.0 112.863 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.11 3.95 47.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.02 1.282 . . . . 0.0 113.291 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.36 148.36 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.738 0.815 . . . . 0.0 112.029 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -58.64 -42.77 89.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 112.815 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -102.88 -52.94 2.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.154 0.981 . . . . 0.0 109.731 -171.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -60.39 -12.25 8.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -44.28 -44.62 8.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 164.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.4 t -64.03 -46.35 84.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.358 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.98 6.37 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.111 -0.993 . . . . 0.0 112.812 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.11 68.3 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.663 -1.273 . . . . 0.0 111.181 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -19.04 15.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.008 0.923 . . . . 0.0 113.315 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -117.62 4.87 12.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.614 1.166 . . . . 0.0 112.673 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.5 mt -99.26 95.41 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -95.45 163.13 22.31 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.8 0.84 . . . . 0.0 109.245 173.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 96' ' ' GLN . 86.2 Cg_endo -69.48 166.57 26.79 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 168.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.6 mtm -86.82 172.96 9.72 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.127 1.371 . . . . 0.0 109.511 166.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -111.81 -164.96 0.95 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.283 2.233 . . . . 0.0 106.984 167.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.246 0.894 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 171.335 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.28 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 m -150.55 -166.85 2.65 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.39 2.676 . . . . 0.0 105.134 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.1 m170 57.81 37.93 27.15 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.962 0.905 . . . . 0.0 110.76 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.47 156.5 36.83 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.34 1.456 . . . . 0.0 108.297 170.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.96 81.94 0.44 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.011 1.291 . . . . 0.0 110.654 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HG3' HG23 ' A' ' 8' ' ' VAL . 43.8 tp10 -81.14 144.05 53.76 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.896 1.679 . . . . 0.0 108.491 172.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.27 64.57 8.45 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 124.211 3.274 . . . . 0.0 113.498 -171.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 6' ' ' GLU . 92.7 t -134.48 144.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 O-C-N 120.433 -1.417 . . . . 0.0 109.341 -170.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.927 HG13 ' HE3' ' A' ' 13' ' ' LYS . 16.6 t -77.71 94.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.66 84.25 0.22 Allowed Glycine 0 C--O 1.223 -0.554 0 N-CA-C 106.561 -2.616 . . . . 0.0 106.561 165.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 ttt 56.4 4.13 0.13 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 166.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -132.14 85.22 2.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.905 1.23 . . . . 0.0 111.51 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.927 ' HE3' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -74.81 73.49 2.09 Favored 'General case' 0 C--N 1.339 0.114 0 O-C-N 120.118 -1.614 . . . . 0.0 109.316 174.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -145.14 -16.98 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.558 1.143 . . . . 0.0 113.229 172.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.76 86.09 2.46 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 126.98 2.112 . . . . 0.0 107.817 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -142.01 -52.0 0.41 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.18 0.992 . . . . 0.0 112.047 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.92 87.17 1.01 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.22 1.808 . . . . 0.0 108.275 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 -41.59 0.05 OUTLIER Glycine 0 C--N 1.33 0.238 0 CA-C-O 118.488 -1.174 . . . . 0.0 112.535 -171.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -110.0 133.28 53.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.971 0.885 . . . . 0.0 109.909 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 p -101.28 6.3 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 114.054 -155.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.76 17.81 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 110.666 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tt -97.92 90.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.86 -17.98 62.09 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.15 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -138.99 120.06 14.55 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.675 1.125 . . . . 0.0 108.786 -165.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.92 135.57 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.6 m -117.72 133.06 56.33 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG13 HG11 ' A' ' 9' ' ' VAL . 2.2 t -132.37 122.41 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.897 1.679 . . . . 0.0 109.195 -173.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 28' ' ' GLN . 6.4 mp0 -79.14 165.06 51.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -75.36 168.71 23.99 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.967 2.445 . . . . 0.0 111.922 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 50.0 34.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.964 2.106 . . . . 0.0 114.002 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.275 4.9 tt -138.47 27.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.58 162.59 9.17 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.43 0.538 . . . . 0.0 113.791 152.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.6 tp -80.77 121.13 25.54 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 109.564 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -78.95 83.34 5.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -69.37 167.03 17.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.678 0.751 . . . . 0.0 111.447 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.2 124.91 25.55 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.817 1.247 . . . . 0.0 110.094 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.16 28.54 66.12 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.659 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.7 mtp -54.29 -35.04 62.17 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.2 1.5 . . . . 0.0 110.128 161.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.3 22.09 16.27 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.191 1.796 . . . . 0.0 111.807 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.419 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -67.34 121.22 15.26 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.22 11.06 70.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.949 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.95 91.13 1.52 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.47 1.635 . . . . 0.0 108.485 171.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -3.68 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.933 2.093 . . . . 0.0 113.677 -166.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.16 68.0 1.3 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 161.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.6 tp -121.17 109.93 15.57 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.634 1.173 . . . . 0.0 109.978 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -139.98 30.66 2.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.816 0.446 . . . . 0.0 112.103 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -157.02 147.54 21.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 119.874 -1.766 . . . . 0.0 110.196 169.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.657 HD12 HG23 ' A' ' 72' ' ' ILE . 2.1 tm? -134.41 150.22 50.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.195 1.798 . . . . 0.0 107.157 172.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.1 mp -137.62 145.4 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.7 mt -128.6 108.56 10.61 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.323 0.965 . . . . 0.0 111.775 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.284 9.5 t -93.44 57.43 2.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.082 1.353 . . . . 0.0 109.51 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.34 175.54 20.11 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.687 2.565 . . . . 0.0 107.95 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -132.17 6.39 4.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.616 0.766 . . . . 0.0 111.956 -165.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.1 144.11 19.27 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 119.658 1.117 . . . . 0.0 109.974 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -70.43 -30.06 19.76 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.899 2.399 . . . . 0.0 113.25 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 m -74.29 -18.29 60.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.711 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.5 15.12 0.19 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.373 1.469 . . . . 0.0 114.018 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -139.7 170.14 16.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.558 1.943 . . . . 0.0 108.077 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.0 m -138.0 165.49 26.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.391 1.077 . . . . 0.0 108.427 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.7 163.47 37.23 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.986 1.714 . . . . 0.0 106.931 162.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -154.06 27.17 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 164.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -23.04 65.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.582 0.753 . . . . 0.0 112.013 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 76.97 0.25 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -169.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.9 tp -45.58 -61.07 1.85 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.405 1.482 . . . . 0.0 110.824 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -90.46 16.81 8.21 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.979 1.312 . . . . 0.0 111.265 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -56.91 140.53 48.2 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.635 1.107 . . . . 0.0 109.348 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 87.15 -10.15 69.84 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.315 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.95 -174.31 3.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.212 1.805 . . . . 0.0 109.704 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -155.58 100.78 2.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.411 1.484 . . . . 0.0 108.283 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -138.1 171.32 14.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.43 1.492 . . . . 0.0 110.47 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -101.81 151.71 21.74 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.203 1.401 . . . . 0.0 110.697 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.657 HG23 HD12 ' A' ' 48' ' ' LEU . 44.4 mt -106.79 104.4 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 126.53 1.932 . . . . 0.0 109.363 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.8 m -80.55 131.64 35.56 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.87 159.16 71.27 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 126.059 1.743 . . . . 0.0 108.311 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.35 157.7 49.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 121.459 1.557 . . . . 0.0 110.781 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -66.31 -24.72 66.59 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.15 -43.29 82.68 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.37 1.468 . . . . 0.0 110.396 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.09 -8.62 59.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.698 0.399 . . . . 0.0 111.269 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.41 -46.78 84.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.077 0.951 . . . . 0.0 111.24 -167.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.47 -29.81 59.71 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.548 -1.345 . . . . 0.0 110.495 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -59.07 5.83 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.615 1.566 . . . . 0.0 110.502 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -60.97 -39.65 90.41 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.92 0.782 . . . . 0.0 110.335 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 3.0 mtm180 -60.05 -39.27 85.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.896 -0.503 . . . . 0.0 110.121 -174.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -76.66 0.19 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.382 1.473 . . . . 0.0 113.685 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.57 173.02 8.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.993 1.27 . . . . 0.0 112.13 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -91.81 -21.25 20.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.837 1.655 . . . . 0.0 112.963 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 -56.53 2.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.915 1.286 . . . . 0.0 110.735 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -59.22 -11.42 3.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.324 1.9 pt20 -44.43 -62.31 1.22 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.683 2.393 . . . . 0.0 114.629 168.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -46.4 80.87 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -67.8 -6.6 22.1 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.093 -1.004 . . . . 0.0 113.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.54 61.46 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 119.973 -1.704 . . . . 0.0 112.171 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.5 57.57 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -124.33 -1.43 8.14 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.2 1.0 . . . . 0.0 112.465 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 82' ' ' TYR . 64.8 mt -85.14 134.31 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.52 164.91 33.68 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 126.282 1.833 . . . . 0.0 109.674 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.98 171.07 7.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.334 2.023 . . . . 0.0 112.814 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtt -88.7 175.79 7.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 123.172 1.463 . . . . 0.0 109.897 168.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -123.19 170.19 10.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 156.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 127.602 2.361 . . . . 0.0 113.114 163.679 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 p -153.89 72.21 0.89 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -152.58 170.56 19.89 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.697 1.599 . . . . 0.0 109.116 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -85.16 109.97 18.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.61 51.49 0.03 OUTLIER Glycine 0 C--N 1.334 0.45 0 O-C-N 121.304 -0.872 . . . . 0.0 111.958 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -65.75 162.9 39.95 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.581 1.152 . . . . 0.0 111.577 170.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.33 72.0 4.33 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.369 3.379 . . . . 0.0 111.024 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -144.6 143.07 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.26 165.98 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.561 1.544 . . . . 0.0 111.331 165.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.16 -95.98 0.1 Allowed Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 104.002 -3.639 . . . . 0.0 104.002 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtt -141.41 27.08 1.92 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.246 1.023 . . . . 0.0 112.434 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -146.57 164.56 32.21 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.354 -0.841 . . . . 0.0 109.342 161.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -129.36 11.93 5.92 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -163.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.39 -16.82 30.08 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 122.403 2.365 . . . . 0.0 113.287 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.61 23.03 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.454 2.702 . . . . 0.0 114.877 -161.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.53 -33.71 4.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.4 -1.437 . . . . 0.0 111.298 -165.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.77 56.94 2.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.603 0.761 . . . . 0.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.97 -18.12 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 CA-C-O 117.77 -1.572 . . . . 0.0 115.974 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -119.95 147.73 44.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.808 . . . . 0.0 111.486 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -126.9 16.57 7.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 111.559 -155.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.81 29.41 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 126.104 1.762 . . . . 0.0 109.583 -166.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tt -113.87 98.5 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 126.706 2.002 . . . . 0.0 106.987 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 mtt85 -89.27 -9.62 49.94 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.071 -1.442 . . . . 0.0 111.144 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.97 135.75 36.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.626 1.557 . . . . 0.0 109.097 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 mt -138.94 102.76 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.2 m -90.78 94.55 9.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.44 127.37 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 120.209 -1.557 . . . . 0.0 110.223 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -79.6 162.67 62.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.656 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.83 164.83 31.19 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.922 2.415 . . . . 0.0 111.085 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 45.15 49.89 9.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.994 2.118 . . . . 0.0 112.015 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.91 -5.02 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.31 158.42 11.04 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 120.636 -1.29 . . . . 0.0 111.384 157.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' H ' ' A' ' 34' ' ' LEU . 36.5 tp -57.17 158.39 5.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.9 mt -124.87 81.62 1.97 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.125 1.37 . . . . 0.0 109.494 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -70.19 174.68 5.25 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.616 -0.678 . . . . 0.0 112.189 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -73.24 131.1 41.57 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 120.631 -1.293 . . . . 0.0 109.736 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 66' ' ' ASP . . . 81.19 8.3 87.44 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.612 -1.105 . . . . 0.0 113.222 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -12.55 2.01 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.81 2.305 . . . . 0.0 113.038 175.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -122.05 11.5 10.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.36 1.464 . . . . 0.0 111.518 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.5 p -66.31 98.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.068 -1.02 . . . . 0.0 110.555 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.15 -6.35 6.8 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.107 1.337 . . . . 0.0 112.6 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.8 m -73.57 61.53 0.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.376 1.588 . . . . 0.0 111.381 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 p -72.19 25.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.998 1.719 . . . . 0.0 114.592 -171.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.92 17.02 2.3 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.528 -1.358 . . . . 0.0 111.796 161.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.773 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.3 tt -70.23 120.92 16.63 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.899 1.227 . . . . 0.0 109.193 -177.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.16 -17.46 4.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.133 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.881 1.673 . . . . 0.0 112.908 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.39 103.83 4.16 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 128.256 2.622 . . . . 0.0 104.39 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.29 142.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 58' ' ' TYR . 59.9 mt -117.11 146.38 43.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -119.6 28.12 8.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.602 0.761 . . . . 0.0 110.684 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.18 17.21 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.85 5.8 22.85 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.65 144.03 21.46 Favored Pre-proline 0 C--O 1.232 0.182 0 C-N-CA 124.83 1.252 . . . . 0.0 107.93 171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.06 -11.57 30.7 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.121 2.547 . . . . 0.0 113.691 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -59.55 -30.08 68.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.323 1.449 . . . . 0.0 111.057 167.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.76 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.881 1.272 . . . . 0.0 113.538 -166.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.477 ' CE2' HD22 ' A' ' 50' ' ' LEU . 86.0 m-85 -139.68 -175.93 4.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.271 1.829 . . . . 0.0 110.134 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 34' ' ' LEU . 8.3 t -144.42 172.74 12.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.881 2.072 . . . . 0.0 107.916 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.07 168.63 24.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.708 1.203 . . . . 0.0 108.295 161.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.0 -107.03 2.71 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -105.14 -21.41 13.27 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.186 0.594 . . . . 0.0 111.367 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.63 -136.36 3.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 105.408 -3.077 . . . . 0.0 105.408 152.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -160.37 -47.69 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.281 1.032 . . . . 0.0 110.971 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 12.42 28.79 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.249 -0.907 . . . . 0.0 112.526 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -58.97 145.93 39.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.473 1.109 . . . . 0.0 111.8 -165.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.03 -30.39 1.82 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.488 1.518 . . . . 0.0 112.778 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.67 -175.17 2.72 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 110.318 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -164.6 91.61 0.59 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.921 2.488 . . . . 0.0 106.371 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.773 ' HB2' HD22 ' A' ' 45' ' ' LEU . 24.4 p90 -134.09 172.65 12.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.595 1.958 . . . . 0.0 109.317 -172.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.15 157.46 16.98 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.809 -1.182 . . . . 0.0 110.887 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.15 102.5 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.629 1.972 . . . . 0.0 106.358 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 m -99.35 110.41 22.92 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.86 1.664 . . . . 0.0 111.195 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.8 157.8 40.76 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.18 1.354 . . . . 0.0 110.34 -166.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -65.35 147.27 87.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 CA-C-N 120.385 1.173 . . . . 0.0 110.016 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.73 -37.49 71.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.899 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -38.86 89.47 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.606 -0.684 . . . . 0.0 110.138 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.2 -18.54 49.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.7 0.8 . . . . 0.0 112.475 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.0 tp -47.26 -53.49 13.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.451 . . . . 0.0 112.576 -166.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.1 -28.37 60.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.908 1.283 . . . . 0.0 109.629 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.98 -38.58 91.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.273 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -67.89 -31.93 72.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -84.25 9.83 11.94 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.65 163.47 21.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.518 1.054 . . . . 0.0 112.773 -169.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -88.12 -36.7 16.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.477 -0.764 . . . . 0.0 111.176 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -82.77 -66.55 0.88 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -68.6 -2.79 9.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.698 1.199 . . . . 0.0 114.172 -163.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.276 1.0 OUTLIER -43.76 -56.04 4.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.651 2.38 . . . . 0.0 112.666 174.324 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.447 HG23 ' CD2' ' A' ' 91' ' ' TYR . 5.9 t -52.75 -40.98 63.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.412 1.085 . . . . 0.0 111.183 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CD2' HG23 ' A' ' 90' ' ' THR . 97.2 m-85 -73.69 4.3 5.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.339 -0.851 . . . . 0.0 113.073 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -59.17 -26.48 64.82 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 119.71 -1.869 . . . . 0.0 112.097 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.55 -12.3 14.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -125.92 16.22 7.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.273 0.942 . . . . 0.0 110.188 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 92' ' ' ALA . 84.8 mt -99.27 122.03 50.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -132.73 165.61 35.2 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.59 1.556 . . . . 0.0 109.239 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.99 175.02 5.05 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.167 1.912 . . . . 0.0 112.072 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptp -101.22 165.23 11.39 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.842 1.657 . . . . 0.0 110.541 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.47 -174.44 4.04 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.206 1.403 . . . . 0.0 110.8 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 . . . . . 0 C--O 1.255 1.394 0 C-N-CA 129.019 2.928 . . . . 0.0 105.007 163.691 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.51 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.58 156.14 45.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.578 1.551 . . . . 0.0 108.25 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -163.3 175.31 11.02 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.299 1.84 . . . . 0.0 107.695 163.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -96.71 68.0 2.39 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -173.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -117.66 100.9 0.89 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 126.088 1.804 . . . . 0.0 109.441 -171.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.31 158.97 39.95 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.941 1.696 . . . . 0.0 108.919 170.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -80.86 64.78 8.93 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.955 3.77 . . . . 0.0 112.181 -163.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.64 158.28 31.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.58 1.952 . . . . 0.0 110.634 -165.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.672 HG13 ' CE ' ' A' ' 13' ' ' LYS . 36.7 t -80.9 67.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.977 1.311 . . . . 0.0 109.911 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.6 59.53 0.91 Allowed Glycine 0 C--N 1.332 0.353 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 69.82 -55.74 0.59 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.934 2.094 . . . . 0.0 114.016 -176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 106.9 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.548 1.539 . . . . 0.0 111.024 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.672 ' CE ' HG13 ' A' ' 9' ' ' VAL . 2.6 mmtm -94.36 81.27 3.97 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 119.612 -1.93 . . . . 0.0 108.169 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 p -168.19 -16.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.545 -162.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.14 8.23 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.073 0.851 . . . . 0.0 112.79 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.32 -64.21 0.92 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.945 1.298 . . . . 0.0 109.453 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.67 95.32 0.01 OUTLIER 'General case' 0 C--N 1.34 0.171 0 C-N-CA 127.203 2.201 . . . . 0.0 110.62 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.77 -42.82 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -81.51 112.7 18.98 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.279 0.54 . . . . 0.0 111.348 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.1 p -84.89 14.69 4.58 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.391 1.876 . . . . 0.0 112.559 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.62 46.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.687 1.595 . . . . 0.0 109.733 -170.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.28 86.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 O-C-N 120.922 -1.111 . . . . 0.0 108.88 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -68.82 -19.8 64.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.892 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -138.95 126.84 22.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.69 90.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 m -64.69 141.37 58.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.74 159.55 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 128.079 2.552 . . . . 0.0 105.964 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' O ' HG22 ' A' ' 31' ' ' ILE . 3.1 mp0 -118.36 163.8 23.46 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.15 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.442 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 61.5 Cg_endo -73.65 172.06 16.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.791 1.66 . . . . 0.0 110.883 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 51.42 27.39 3.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.33 1.852 . . . . 0.0 114.519 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 28' ' ' GLN . 5.2 tt -124.35 5.09 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 112.164 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.84 171.4 18.27 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.083 0.849 . . . . 0.0 112.692 164.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.4 tp -91.21 124.77 35.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.575 1.55 . . . . 0.0 107.402 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.21 104.64 11.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 168.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -107.97 175.49 5.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.756 1.222 . . . . 0.0 110.463 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.59 117.45 8.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.162 1.385 . . . . 0.0 111.168 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.74 40.76 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.217 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.4 mtp -61.23 -52.69 63.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.405 1.603 . . . . 0.0 108.557 156.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -90.11 22.46 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -47.77 123.91 6.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.46 10.58 86.15 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.339 -1.256 . . . . 0.0 114.358 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.9 m -75.91 67.74 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.904 2.352 . . . . 0.0 109.153 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -66.58 -26.23 67.01 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.115 2.166 . . . . 0.0 112.865 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.96 61.95 1.01 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.332 1.453 . . . . 0.0 108.455 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -109.29 129.69 55.51 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 165.447 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.97 -15.57 5.83 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.047 166.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -135.52 148.48 49.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 122.543 2.429 . . . . 0.0 114.122 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 70' ' ' PHE . 5.7 tp -137.77 92.17 2.65 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.788 2.835 . . . . 0.0 106.717 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.44 145.95 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -129.58 112.19 13.47 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.151 0.98 . . . . 0.0 108.634 -167.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.8 p -72.16 -6.18 40.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.606 1.093 . . . . 0.0 113.891 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 134.79 12.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.869 1.213 . . . . 0.0 110.583 -163.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.58 -14.64 60.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.926 1.29 . . . . 0.0 113.486 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.87 143.6 40.69 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 108.225 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.68 -36.45 41.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.531 2.154 . . . . 0.0 111.689 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.8 p -66.26 -12.8 58.54 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 29' ' ' PRO . . . -75.57 -6.75 51.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.37 1.068 . . . . 0.0 112.218 176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.95 177.59 4.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.748 2.019 . . . . 0.0 111.646 -174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -161.17 124.25 3.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.067 1.347 . . . . 0.0 109.383 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.37 1.62 2.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -164.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 45.4 -103.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 127.394 2.425 . . . . 0.0 113.321 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.96 -7.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.394 2.278 . . . . 0.0 111.275 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.2 25.92 3.8 Favored Glycine 0 C--N 1.336 0.572 0 O-C-N 121.127 -0.983 . . . . 0.0 112.889 -163.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.1 tp -47.18 -54.47 10.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.481 1.112 . . . . 0.0 110.704 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 74.79 0.95 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.13 125.4 44.41 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.94 -12.89 68.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.404 -170.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.21 172.02 17.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.139 2.176 . . . . 0.0 108.95 170.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -141.98 111.24 6.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.429 ' CB ' HD22 ' A' ' 45' ' ' LEU . 22.0 p90 -124.36 -178.79 4.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 128.308 2.643 . . . . 0.0 108.369 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.24 154.03 27.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.569 -1.332 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -116.89 131.4 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m -128.05 127.09 42.52 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 156.88 72.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 123.87 0.868 . . . . 0.0 108.851 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.1 153.28 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.856 1.037 . . . . 0.0 109.502 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.87 -33.15 70.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.03 -37.37 84.67 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.989 0.813 . . . . 0.0 110.316 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.94 -6.78 55.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.251 1.02 . . . . 0.0 111.527 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.5 -60.96 2.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.945 1.248 . . . . 0.0 112.386 -164.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.71 -36.0 79.68 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.447 0.699 . . . . 0.0 110.254 174.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.22 -57.52 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.984 1.714 . . . . 0.0 111.58 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -64.06 -42.76 96.9 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 124.912 1.285 . . . . 0.0 109.866 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -54.54 -39.39 67.63 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.149 -0.345 . . . . 0.0 110.791 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -81.02 8.07 9.34 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.419 1.487 . . . . 0.0 114.231 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.38 174.91 1.49 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 120.434 1.47 . . . . 0.0 110.989 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.96 -60.5 2.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.322 1.449 . . . . 0.0 111.455 163.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.92 -57.08 3.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.717 1.207 . . . . 0.0 109.774 -171.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -56.59 -17.17 7.66 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -44.59 -46.65 10.13 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 113.8 165.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 t -66.26 -31.83 72.89 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.676 -0.64 . . . . 0.0 110.518 -176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -83.35 4.72 26.13 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.389 -1.444 . . . . 0.0 112.283 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.58 5.03 2.63 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 120.219 -1.551 . . . . 0.0 112.466 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.81 -8.58 58.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.311 0.959 . . . . 0.0 112.524 167.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -138.65 14.1 2.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.665 1.12 . . . . 0.0 113.516 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.0 mt -91.7 138.97 18.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.51 164.52 39.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.183 -0.948 . . . . 0.0 109.681 165.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.91 164.4 27.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.131 1.887 . . . . 0.0 110.25 165.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.2 ptp -89.66 164.41 14.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.052 0.941 . . . . 0.0 109.873 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -153.29 172.89 16.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.707 1.203 . . . . 0.0 110.71 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.501 159.033 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.629 0 CA-C-O 119.167 -0.796 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.85 168.52 19.74 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 162.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -106.35 38.5 2.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.28 1.032 . . . . 0.0 110.945 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.4 164.13 39.14 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.509 -0.744 . . . . 0.0 109.854 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.06 78.37 1.41 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.13 0.871 . . . . 0.0 111.712 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -79.35 164.9 51.85 Favored Pre-proline 0 C--O 1.238 0.476 0 O-C-N 121.406 -1.055 . . . . 0.0 110.672 171.226 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 6' ' ' GLU . 62.6 Cg_endo -63.7 107.97 0.81 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.46 2.773 . . . . 0.0 107.369 161.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -152.68 164.57 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 122.183 0.992 . . . . 0.0 109.305 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.904 HG13 ' HE3' ' A' ' 13' ' ' LYS . 37.8 t -74.15 78.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 161.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.0 -167.27 32.81 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 152.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.22 39.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.639 2.22 . . . . 0.0 113.308 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' C ' ' HZ3' ' A' ' 13' ' ' LYS . 20.6 t70 -89.71 114.33 25.97 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.787 -1.821 . . . . 0.0 109.297 -159.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.904 ' HE3' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -80.75 89.1 5.77 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.365 -1.459 . . . . 0.0 108.551 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 t -156.15 -2.45 0.13 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -125.96 25.62 6.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.693 1.133 . . . . 0.0 112.363 -151.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -103.37 -36.98 7.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.591 1.156 . . . . 0.0 111.872 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 28.89 0.05 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.744 1.618 . . . . 0.0 113.038 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.35 -21.7 4.7 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.027 -1.985 . . . . 0.0 113.41 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -126.73 118.17 24.17 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 121.409 2.605 . . . . 0.0 111.615 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.0 p -74.71 18.29 0.18 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.234 2.213 . . . . 0.0 113.72 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.45 6.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.322 1.419 . . . . 0.0 111.476 -158.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -92.62 94.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.555 -1.34 . . . . 0.0 107.541 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -75.81 -13.97 60.29 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.533 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -140.41 135.89 32.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.649 1.113 . . . . 0.0 109.995 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.38 90.49 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.498 1.119 . . . . 0.0 108.767 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.9 m -65.75 141.92 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 165.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 9' ' ' VAL . 3.3 t -136.34 167.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.016 1.327 . . . . 0.0 110.505 174.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -114.34 163.99 17.58 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.279 1.432 . . . . 0.0 110.486 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.7 153.78 72.58 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.691 2.261 . . . . 0.0 109.878 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.39 64.12 1.43 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.79 2.036 . . . . 0.0 111.679 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.273 0.2 OUTLIER -140.71 55.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 123.708 1.718 . . . . 0.0 109.558 -176.52 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.72 49.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 125.706 1.622 . . . . 0.0 112.543 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.6 tp -105.69 131.74 52.69 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 123.212 1.482 . . . . 0.0 112.745 -157.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 5.4 mp -84.37 67.11 9.73 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.674 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -65.47 162.52 17.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.214 1.007 . . . . 0.0 110.058 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.75 109.8 12.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.681 1.192 . . . . 0.0 109.249 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.73 6.78 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.024 1.773 . . . . 0.0 112.803 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.1 -33.51 26.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.372 1.869 . . . . 0.0 113.105 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -114.89 7.94 15.81 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.875 1.67 . . . . 0.0 113.558 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -62.75 101.84 0.29 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.657 1.117 . . . . 0.0 108.616 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.86 -2.85 10.89 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.162 0.887 . . . . 0.0 113.835 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.4 m -77.54 78.7 4.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.489 2.144 . . . . 0.0 109.474 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.5 p -69.97 -23.67 63.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 112.923 -172.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.39 45.15 2.36 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.728 1.211 . . . . 0.0 108.829 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 70' ' ' PHE . 3.0 tt -98.6 109.41 22.18 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -110.66 -22.37 11.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.26 150.45 39.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.472 1.033 . . . . 0.0 111.942 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.52 142.45 24.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.958 2.503 . . . . 0.0 105.602 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.24 155.09 29.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.485 HD22 ' CE1' ' A' ' 58' ' ' TYR . 92.8 mt -128.08 127.84 43.82 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.5 172.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 p -88.52 38.27 0.86 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 110.076 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.83 159.52 24.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 125.102 1.335 . . . . 0.0 109.898 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -124.5 6.73 8.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.499 0.72 . . . . 0.0 112.482 -157.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -153.24 144.45 16.23 Favored Pre-proline 0 CA--C 1.535 0.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.64 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -66.49 -31.1 42.7 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.189 2.593 . . . . 0.0 113.059 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 m -76.22 -5.93 49.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.183 0.593 . . . . 0.0 112.044 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.99 3.16 27.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.171 0.896 . . . . 0.0 111.93 166.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.485 ' CE1' HD22 ' A' ' 50' ' ' LEU . 45.7 m-85 -133.7 165.62 24.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.87 1.319 . . . . 0.0 110.816 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -134.04 170.79 15.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.225 1.81 . . . . 0.0 108.818 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . . . -175.03 -177.56 1.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.997 3.719 . . . . 0.0 104.178 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.28 -145.91 5.34 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 0.2 21.89 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.803 -0.822 . . . . 0.0 113.015 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.99 74.47 0.11 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.832 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 64' ' ' LEU . 6.3 tt -44.44 -41.19 6.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.355 1.462 . . . . 0.0 109.098 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.443 ' NH1' ' H ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -125.33 34.75 4.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 126.009 1.724 . . . . 0.0 111.871 -173.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -52.26 121.14 6.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.966 0.803 . . . . 0.0 109.027 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.82 12.41 84.57 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.685 -1.064 . . . . 0.0 115.245 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 173.35 11.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.405 1.603 . . . . 0.0 109.85 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -157.43 95.16 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.782 ' HB2' HD22 ' A' ' 45' ' ' LEU . 37.8 p90 -131.62 168.9 16.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.157 1.383 . . . . 0.0 111.51 -173.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.27 146.08 29.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.21 1.004 . . . . 0.0 111.398 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.68 128.44 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 127.717 2.407 . . . . 0.0 108.688 -172.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.72 109.55 14.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.159 1.784 . . . . 0.0 112.208 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.72 160.87 26.37 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.448 1.099 . . . . 0.0 108.896 -175.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.2 138.19 65.39 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 108.01 -1.573 . . . . 0.0 108.01 171.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.6 -31.18 56.57 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.26 -33.2 75.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 -175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.81 -2.73 58.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.238 1.415 . . . . 0.0 112.273 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.97 -50.84 70.48 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 119.882 -1.761 . . . . 0.0 112.204 -166.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -65.28 -32.27 73.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.696 0.76 . . . . 0.0 111.039 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -57.27 -56.09 26.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.093 2.157 . . . . 0.0 110.419 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -60.87 -46.12 91.85 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.587 0.755 . . . . 0.0 110.587 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -58.54 -38.76 78.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.59 -0.96 22.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.911 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.56 164.88 6.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.212 1.369 . . . . 0.0 111.683 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.24 13.92 25.87 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.993 1.317 . . . . 0.0 113.162 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 60' ' ' ALA . 4.1 t80 -146.22 -59.25 0.31 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.843 2.057 . . . . 0.0 110.923 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -61.42 -9.05 4.74 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.931 1.241 . . . . 0.0 112.964 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.261 0.5 OUTLIER -43.38 -60.52 1.68 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.6 2.36 . . . . 0.0 114.177 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -50.85 37.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 109.849 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -71.02 -2.91 16.97 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.476 1.511 . . . . 0.0 113.285 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.93 -23.61 66.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.658 -1.276 . . . . 0.0 111.969 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.476 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . . . -61.0 -22.67 64.74 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.476 ' CE3' ' HB3' ' A' ' 93' ' ' ALA . 12.6 m-90 -116.41 10.45 14.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.296 1.438 . . . . 0.0 111.685 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.06 115.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.15 163.41 23.31 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.773 1.229 . . . . 0.0 109.872 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 164.34 34.37 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.171 1.914 . . . . 0.0 110.415 168.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.2 mtm -76.38 -171.44 1.79 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.251 2.22 . . . . 0.0 111.647 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -99.95 -177.01 3.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.708 2.003 . . . . 0.0 109.512 166.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 . . . . . 0 C--O 1.246 0.882 0 C-N-CA 128.093 2.557 . . . . 0.0 106.121 171.924 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.558 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -146.97 -167.96 2.91 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.769 0.827 . . . . 0.0 109.418 -170.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -135.86 48.62 2.18 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.025 1.73 . . . . 0.0 108.276 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -151.33 153.2 34.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.633 0.773 . . . . 0.0 109.439 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.59 4.24 0.18 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.926 1.25 . . . . 0.0 113.449 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -61.27 143.47 92.67 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 119.799 1.799 . . . . 0.0 107.815 168.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.41 66.49 8.44 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.781 3.654 . . . . 0.0 113.637 -171.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.86 139.74 47.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.52 123.6 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.165 0.586 . . . . 0.0 110.135 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.34 66.49 0.34 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 mmt 61.05 -55.43 0.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.425 2.69 . . . . 0.0 114.03 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -57.66 114.94 2.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 164.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 30.0 mmtp -104.02 88.55 3.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.38 1.072 . . . . 0.0 108.745 170.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -153.24 -14.94 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.176 0.99 . . . . 0.0 113.604 153.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.601 ' H ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -65.55 -4.1 5.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -165.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -71.07 -51.29 26.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.571 1.148 . . . . 0.0 109.864 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.36 13.77 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.78 4.83 30.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 127.256 2.36 . . . . 0.0 112.708 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -132.4 161.29 34.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.125 1.463 . . . . 0.0 109.683 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 -3.73 10.4 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.155 1.782 . . . . 0.0 112.175 -163.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.0 0.66 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.39 . . . . 0.0 110.474 -160.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.9 tt -71.81 98.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.349 1.86 . . . . 0.0 109.138 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -78.79 -3.47 44.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 117.026 -1.464 . . . . 0.0 112.077 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -152.26 137.69 17.64 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 120.513 1.506 . . . . 0.0 111.344 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -143.72 102.32 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 108.28 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.1 m -85.59 95.75 9.43 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.11 147.79 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -108.99 163.85 16.04 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 124.838 1.255 . . . . 0.0 107.796 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.61 168.08 17.5 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.372 2.048 . . . . 0.0 109.004 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 62.93 -7.13 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 167.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.466 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 5.9 tt -99.83 54.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 121.082 1.765 . . . . 0.0 112.803 -171.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.01 166.55 39.67 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.479 -1.388 . . . . 0.0 111.722 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.6 tp -76.12 165.88 24.28 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.527 1.931 . . . . 0.0 112.033 -171.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.9 73.94 0.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.029 0.831 . . . . 0.0 108.804 169.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.45 170.41 13.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.883 -169.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 150.77 41.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.343 1.068 . . . . 0.0 110.924 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.4 -2.55 37.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.268 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ptm -62.64 -11.25 15.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.833 . . . . 0.0 114.09 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.74 13.41 11.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 111.829 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -66.96 96.88 0.45 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.456 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.93 19.02 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.391 0.996 . . . . 0.0 112.901 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.9 m -73.66 68.8 1.24 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.026 1.413 . . . . 0.0 107.245 164.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -62.63 -55.08 30.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.51 58.01 3.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.377 -0.827 . . . . 0.0 109.002 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -114.84 121.14 42.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.233 1.813 . . . . 0.0 108.025 160.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -135.79 -5.24 2.2 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 177.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -124.87 153.12 43.1 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.636 -1.29 . . . . 0.0 110.821 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.46 131.02 11.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.66 144.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.6 mt -121.45 91.39 3.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 108.198 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 t -83.04 64.42 7.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.254 1.422 . . . . 0.0 110.213 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.3 150.49 18.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.059 1.314 . . . . 0.0 110.966 166.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -89.36 -20.41 24.05 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.988 1.315 . . . . 0.0 113.324 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 159.43 54.45 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 126.896 2.078 . . . . 0.0 107.155 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 81' ' ' ARG . 10.9 Cg_endo -74.1 -45.65 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.154 3.236 . . . . 0.0 111.851 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -61.7 -25.33 67.34 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -159.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.58 2.47 6.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 113.084 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -105.78 156.02 18.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.339 1.456 . . . . 0.0 108.373 169.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -134.06 142.83 47.72 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 107.386 169.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.56 154.3 34.02 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.778 3.231 . . . . 0.0 106.849 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.98 -160.84 23.68 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 122.073 0.818 . . . . 0.0 111.797 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.04 2.15 4.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.006 1.322 . . . . 0.0 112.87 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.02 74.59 0.17 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.716 1.627 . . . . 0.0 109.726 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.98 -46.22 64.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.583 1.192 . . . . 0.0 109.484 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -106.07 37.8 2.18 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.776 1.63 . . . . 0.0 110.663 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 117.65 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.75 -11.68 38.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.262 0.934 . . . . 0.0 114.398 168.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 -178.3 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.785 1.634 . . . . 0.0 108.587 166.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -142.62 90.42 2.22 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -173.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -135.27 163.88 28.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.3 160.02 14.74 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.321 1.448 . . . . 0.0 109.664 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.45 89.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -171.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -78.79 155.9 29.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.407 -0.808 . . . . 0.0 111.031 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.78 160.83 37.19 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 125.479 1.512 . . . . 0.0 109.457 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.32 141.24 51.04 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -53.81 -31.76 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.416 1.086 . . . . 0.0 112.54 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -46.42 76.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.942 1.697 . . . . 0.0 110.475 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 81' ' ' ARG . . . -82.3 0.14 42.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 112.248 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.5 -45.22 85.18 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.58 1.082 . . . . 0.0 112.419 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.7 -44.44 90.25 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.686 0.795 . . . . 0.0 110.852 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.475 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -49.84 -53.18 27.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.97 1.308 . . . . 0.0 110.815 -171.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -66.53 -38.08 86.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.09 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -61.9 -18.0 58.65 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.437 1.017 . . . . 0.0 111.694 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -87.85 -15.26 37.26 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.65 130.21 40.61 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.319 1.872 . . . . 0.0 109.27 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -47.25 -39.25 13.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.656 1.182 . . . . 0.0 110.885 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -69.04 -74.21 0.13 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.4 1.08 . . . . 0.0 109.95 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -55.77 -22.96 26.95 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -44.67 -48.14 10.57 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -60.14 -43.59 95.6 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.691 0.678 . . . . 0.0 109.682 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.14 7.08 5.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.888 -1.133 . . . . 0.0 112.73 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -62.68 -19.73 64.15 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 120.043 -1.661 . . . . 0.0 111.996 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.75 37.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -121.01 7.94 10.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.234 1.013 . . . . 0.0 111.813 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 92' ' ' ALA . 92.3 mt -83.99 148.03 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.122 0.969 . . . . 0.0 108.995 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.33 165.3 17.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.982 1.713 . . . . 0.0 109.654 164.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 163.88 31.61 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.979 1.786 . . . . 0.0 112.299 174.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.2 ptp -82.17 -174.55 5.17 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 110.812 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.61 -170.0 2.15 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.258 2.223 . . . . 0.0 108.42 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 124.69 1.196 . . . . 0.0 107.773 176.474 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.29 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -168.57 1.15 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.394 1.092 . . . . 0.0 110.713 173.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -141.03 80.2 1.73 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.445 2.698 . . . . 0.0 105.205 173.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -166.9 166.67 15.37 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.312 0.645 . . . . 0.0 110.373 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.46 84.45 1.62 Allowed Glycine 0 C--N 1.331 0.291 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 163.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.82 161.15 80.75 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 160.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.38 70.99 5.39 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.648 3.565 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.04 146.56 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 120.764 -1.21 . . . . 0.0 109.701 -169.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.12 132.56 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.241 0.616 . . . . 0.0 110.261 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.79 82.54 0.15 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.471 ' H ' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER 48.2 28.88 1.68 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.805 1.642 . . . . 0.0 111.914 -175.184 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -147.9 122.42 9.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 32.9 mmtp -106.32 94.98 5.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 162.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.68 19.73 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.943 1.697 . . . . 0.0 110.598 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.52 64.91 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.225 -1.547 . . . . 0.0 111.362 -167.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.0 -10.44 1.15 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.69 17.36 21.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.139 1.336 . . . . 0.0 112.483 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.6 -6.94 20.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.626 -168.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -138.43 105.17 5.36 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 120.354 2.077 . . . . 0.0 109.677 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -72.16 9.43 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -168.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.56 39.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 128.049 2.54 . . . . 0.0 109.442 -159.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.58 96.71 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 128.274 2.63 . . . . 0.0 106.557 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -78.83 -13.3 59.88 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.213 1.005 . . . . 0.0 111.557 -170.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.07 121.27 11.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.184 1.794 . . . . 0.0 107.143 -173.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.7 mt -111.39 103.41 15.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.0 m -72.71 143.41 48.05 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.77 159.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 127.308 2.243 . . . . 0.0 106.313 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.44 ' O ' HG22 ' A' ' 31' ' ' ILE . 4.5 pt20 -131.96 163.96 46.42 Favored Pre-proline 0 N--CA 1.451 -0.375 0 C-N-CA 124.033 0.933 . . . . 0.0 110.796 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.61 146.81 55.97 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 -171.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 51.31 66.08 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.09 2.156 . . . . 0.0 110.589 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.471 HD11 ' H ' ' A' ' 11' ' ' MET . 8.6 tp -133.88 40.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.877 1.271 . . . . 0.0 111.086 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.08 156.95 24.83 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.194 -1.566 . . . . 0.0 113.386 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.5 127.19 30.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 127.828 2.451 . . . . 0.0 111.015 -171.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.17 77.17 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -67.57 165.0 17.8 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.81 0.814 . . . . 0.0 110.302 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.96 144.26 33.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.963 -1.086 . . . . 0.0 110.333 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 85.84 5.62 83.59 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.718 0.675 . . . . 0.0 112.883 -178.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 mtp -54.81 -27.2 40.1 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.808 1.243 . . . . 0.0 112.849 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.67 20.53 4.24 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.627 1.171 . . . . 0.0 111.338 -162.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 t -65.44 115.86 6.13 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.88 56.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 76.0 m -68.02 74.81 0.21 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.971 1.385 . . . . 0.0 112.813 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.6 p -63.74 -31.23 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.289 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.57 63.87 0.71 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.178 1.354 . . . . 0.0 107.918 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -123.14 120.97 34.81 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.194 2.198 . . . . 0.0 106.804 162.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.5 ' N ' HD22 ' A' ' 45' ' ' LEU 0.307 1.2 pt-20 -131.44 -4.07 3.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.018 1.327 . . . . 0.0 114.382 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -144.63 157.99 43.97 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 122.491 1.139 . . . . 0.0 113.3 170.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 49' ' ' ILE . 1.7 tm? -140.65 141.04 35.09 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.378 3.071 . . . . 0.0 104.289 177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.527 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.4 mp -135.28 142.33 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -173.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -128.07 104.69 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.687 1.195 . . . . 0.0 108.694 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -79.28 37.22 0.32 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.577 0.751 . . . . 0.0 111.003 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.83 146.69 18.69 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -97.37 16.25 20.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.991 0.516 . . . . 0.0 111.434 -165.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.75 147.5 17.88 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 110.157 -164.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.22 -41.62 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.647 2.898 . . . . 0.0 110.663 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -67.06 -22.21 65.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.575 1.55 . . . . 0.0 114.229 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.37 4.79 10.0 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 112.158 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -122.62 172.7 8.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.708 1.242 . . . . 0.0 108.995 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.78 126.51 18.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.49 35.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.226 1.41 . . . . 0.0 107.478 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.3 -127.17 5.1 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.4 14.38 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.379 1.072 . . . . 0.0 111.859 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.45 82.86 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.7 tt -52.43 -50.96 61.54 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.52 40.95 1.28 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.473 1.109 . . . . 0.0 110.694 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 21.2 t70 -65.89 136.3 55.95 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 120.82 -1.175 . . . . 0.0 107.91 169.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.85 60.55 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.776 -1.569 . . . . 0.0 114.865 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 -172.62 4.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.923 1.861 . . . . 0.0 109.444 175.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -134.76 80.18 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -94.38 167.88 11.24 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.48 149.95 28.84 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.281 1.033 . . . . 0.0 109.457 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -109.53 149.63 12.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.15 1.38 . . . . 0.0 107.926 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.1 m -129.87 130.61 45.44 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.343 1.457 . . . . 0.0 107.514 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.21 160.55 67.49 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.944 1.698 . . . . 0.0 108.395 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.55 147.75 90.35 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 120.377 1.17 . . . . 0.0 109.962 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.26 -28.12 67.8 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 -5.99 49.11 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.635 0.774 . . . . 0.0 112.053 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.15 -3.46 31.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.011 -1.055 . . . . 0.0 112.829 167.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.57 -36.59 81.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.359 0.982 . . . . 0.0 113.427 -161.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.57 -30.81 32.9 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.001 -1.062 . . . . 0.0 109.173 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.8 ttm105 -56.38 -60.27 3.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.729 1.211 . . . . 0.0 110.618 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.2 p90 -54.87 -40.64 69.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.505 0.593 . . . . 0.0 110.939 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 1.3 mtp-105 -65.49 -19.85 66.1 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.883 -0.511 . . . . 0.0 111.433 -174.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -100.45 5.28 44.2 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.831 1.252 . . . . 0.0 111.655 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.02 162.7 21.53 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.707 1.139 . . . . 0.0 110.858 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.82 -43.83 64.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.306 -0.871 . . . . 0.0 111.346 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -95.42 -60.38 1.68 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.706 1.203 . . . . 0.0 109.926 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.78 -18.61 13.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.163 1.785 . . . . 0.0 113.936 -170.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -44.98 -42.97 8.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.316 1.446 . . . . 0.0 114.265 167.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -58.71 -37.96 77.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -85.59 10.92 11.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.395 1.478 . . . . 0.0 112.847 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.78 -0.69 7.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.497 -2.002 . . . . 0.0 112.729 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.82 -15.66 53.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.314 0.961 . . . . 0.0 113.451 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -118.11 0.35 11.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.4 92.87 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -168.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -99.35 163.14 19.19 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.371 1.068 . . . . 0.0 112.659 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.75 151.89 58.06 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.212 2.608 . . . . 0.0 112.067 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 mtm -71.15 179.84 2.66 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.855 1.662 . . . . 0.0 110.784 165.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.4 -177.2 3.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.167 1.387 . . . . 0.0 111.758 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 . . . . . 0 C--O 1.253 1.277 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 156.125 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.754 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.55 178.17 8.15 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.609 1.164 . . . . 0.0 110.351 -170.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -144.02 47.32 1.43 Allowed 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.527 0.731 . . . . 0.0 111.743 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -151.06 139.86 20.83 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -127.32 17.81 6.17 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.495 -1.169 . . . . 0.0 114.471 -169.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.3 85.46 0.74 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 119.692 1.746 . . . . 0.0 110.853 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.36 73.5 2.72 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 123.097 2.532 . . . . 0.0 108.554 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -133.24 165.78 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.423 1.889 . . . . 0.0 108.359 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.762 HG13 ' CE ' ' A' ' 13' ' ' LYS . 11.5 t -100.1 66.87 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.049 1.74 . . . . 0.0 108.309 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.86 82.87 0.32 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.7 mmt 57.98 -58.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 130.229 3.411 . . . . 0.0 115.747 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -62.59 101.53 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.243 1.817 . . . . 0.0 111.413 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.762 ' CE ' HG13 ' A' ' 9' ' ' VAL . 2.0 mmtm -94.21 76.41 4.0 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 119.518 -1.989 . . . . 0.0 108.545 171.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.79 -9.02 0.72 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.434 1.094 . . . . 0.0 113.243 168.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 6.66 15.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -165.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CE2' HG22 ' A' ' 9' ' ' VAL . 13.9 m-85 -68.48 -43.89 75.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.139 1.336 . . . . 0.0 111.761 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.68 47.62 0.18 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.256 2.223 . . . . 0.0 112.973 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -133.16 -39.03 0.21 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-O 119.219 -0.767 . . . . 0.0 111.238 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -85.09 100.95 12.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.481 1.141 . . . . 0.0 110.878 -172.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -70.99 9.92 0.62 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.282 2.633 . . . . 0.0 113.88 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.19 55.02 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.892 1.277 . . . . 0.0 109.223 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -129.94 92.36 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.214 -0.928 . . . . 0.0 110.325 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 1.9 mmt85 -76.17 -15.26 60.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.019 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -137.36 135.62 37.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.569 1.077 . . . . 0.0 108.843 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -133.55 113.14 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.5 m -93.16 107.67 19.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.682 HG13 HG11 ' A' ' 9' ' ' VAL . 4.2 t -103.14 105.46 18.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.455 1.502 . . . . 0.0 108.386 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.509 ' HG3' HG21 ' A' ' 31' ' ' ILE . 6.3 pt20 -65.02 165.07 17.45 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.798 167.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 28' ' ' GLN . 57.5 Cg_endo -73.5 168.68 24.16 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.503 2.136 . . . . 0.0 110.15 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 46.67 39.21 6.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.91 1.684 . . . . 0.0 112.981 171.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.509 HG21 ' HG3' ' A' ' 28' ' ' GLN 0.304 5.2 tt -130.25 22.6 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 120.233 1.379 . . . . 0.0 112.386 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.53 164.33 11.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.007 0.813 . . . . 0.0 113.206 155.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.94 117.49 9.88 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 126.314 1.845 . . . . 0.0 111.54 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -74.55 95.56 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 164.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -76.29 173.79 10.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.147 0.979 . . . . 0.0 111.447 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.0 129.15 39.55 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.423 1.089 . . . . 0.0 113.004 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.62 25.18 74.01 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -45.17 -36.62 3.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.708 2.003 . . . . 0.0 113.321 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.22 13.62 20.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.07 1.748 . . . . 0.0 111.72 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -49.79 119.35 3.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.849 0.859 . . . . 0.0 111.935 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.5 20.99 79.41 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.598 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -71.91 78.67 0.89 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -76.02 -6.37 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.381 1.872 . . . . 0.0 112.305 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.48 72.9 1.45 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 162.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 39.4 tp -134.85 123.6 23.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 130.785 3.634 . . . . 0.0 109.036 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -143.03 -20.48 0.64 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -100.86 145.79 28.13 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.795 2.088 . . . . 0.0 111.163 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.35 150.38 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.65 138.18 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -111.8 155.0 24.26 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -126.2 7.49 7.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.819 0.848 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.06 179.45 41.01 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -125.97 3.76 7.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.259 0.624 . . . . 0.0 111.768 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -147.65 144.17 18.91 Favored Pre-proline 0 N--CA 1.466 0.371 0 C-N-CA 124.6 1.16 . . . . 0.0 108.963 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.2 -27.3 16.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.768 2.312 . . . . 0.0 113.43 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.4 -14.67 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.827 1.251 . . . . 0.0 111.163 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.24 -2.96 23.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.699 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.93 165.33 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.76 1.624 . . . . 0.0 109.833 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 m -139.83 123.65 17.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -126.93 -0.63 6.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.195 1.398 . . . . 0.0 113.0 -168.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.73 -97.81 0.23 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 126.831 2.158 . . . . 0.0 109.029 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -147.56 -9.6 0.42 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.007 1.723 . . . . 0.0 111.375 160.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.73 24.22 9.71 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.771 1.177 . . . . 0.0 114.04 -163.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 19.0 tp -44.46 -44.59 8.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.367 1.867 . . . . 0.0 114.092 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.83 58.57 1.64 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -164.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.05 153.15 26.03 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.29 -11.13 51.69 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 117.88 -1.511 . . . . 0.0 114.566 170.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.5 165.32 31.54 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.733 2.013 . . . . 0.0 107.946 162.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.93 86.47 2.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.32 1.048 . . . . 0.0 109.595 -168.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -112.18 174.82 5.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.892 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.67 154.09 39.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.092 2.957 . . . . 0.0 107.929 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -117.03 107.92 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 126.207 1.803 . . . . 0.0 108.354 -163.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.12 151.63 36.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.728 161.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.07 161.72 51.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.236 1.814 . . . . 0.0 107.64 164.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.07 149.61 76.97 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 108.098 -1.539 . . . . 0.0 108.098 167.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.37 -33.09 41.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.832 0.853 . . . . 0.0 111.913 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -59.28 -42.82 92.13 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.714 1.605 . . . . 0.0 111.012 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 -7.22 56.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.688 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.97 -55.18 37.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.822 1.192 . . . . 0.0 112.985 -164.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.53 -33.24 60.7 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.465 -0.772 . . . . 0.0 111.466 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -45.43 -51.62 11.21 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.791 2.036 . . . . 0.0 109.422 167.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.06 -43.43 92.3 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.233 1.013 . . . . 0.0 111.433 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.01 -19.71 65.75 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.255 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -103.09 18.8 20.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.174 1.352 . . . . 0.0 112.993 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.53 166.32 19.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.603 1.561 . . . . 0.0 111.775 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.37 -34.65 16.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.827 0.851 . . . . 0.0 111.514 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -92.04 -59.38 2.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.17 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -65.04 -12.42 50.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -170.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -44.15 -45.5 8.31 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.426 HG23 ' CD2' ' A' ' 91' ' ' TYR . 15.3 t -60.67 -43.95 97.06 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 125.623 1.569 . . . . 0.0 110.37 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.426 ' CD2' HG23 ' A' ' 90' ' ' THR . 97.3 m-85 -71.96 0.59 8.92 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.327 1.451 . . . . 0.0 112.811 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.32 71.06 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 119.864 -1.773 . . . . 0.0 111.479 -172.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.65 5.07 1.56 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -125.1 7.77 7.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.907 1.683 . . . . 0.0 111.937 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.5 mt -102.89 116.2 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.933 1.242 . . . . 0.0 109.391 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.91 155.93 63.03 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 126.057 1.743 . . . . 0.0 111.037 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.37 146.71 40.4 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.978 3.119 . . . . 0.0 111.861 172.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 39.7 mtm -65.65 165.19 12.91 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.307 1.443 . . . . 0.0 112.151 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.08 -177.6 1.09 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.132 1.773 . . . . 0.0 110.375 160.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 . . . . . 0 C--O 1.245 0.842 0 C-N-CA 126.636 1.974 . . . . 0.0 105.871 178.106 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 84.8 Cg_endo . . . . . 0 N--CA 1.45 -1.05 0 N-CA-C 109.47 -1.011 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.28 155.51 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 120.732 -1.23 . . . . 0.0 112.179 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.59 88.47 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.731 1.612 . . . . 0.0 109.846 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 96.41 0.2 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt 58.51 17.72 5.14 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.393 1.477 . . . . 0.0 114.455 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.17 175.37 11.82 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 31' ' ' ILE . 15.4 mttm -138.27 -0.59 2.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.154 2.181 . . . . 0.0 114.507 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -81.63 -29.36 33.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.606 1.094 . . . . 0.0 112.048 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 1.2 mm? -83.59 73.64 10.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.276 1.031 . . . . 0.0 110.893 -160.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -147.16 -49.45 0.18 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.289 0.636 . . . . 0.0 110.458 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.81 71.84 1.05 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.564 1.146 . . . . 0.0 110.702 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.4 -45.55 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -82.4 104.23 12.55 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -60.94 -5.2 1.25 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.546 1.539 . . . . 0.0 114.46 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.29 30.51 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.85 1.204 . . . . 0.0 110.601 -152.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -104.79 88.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 124.497 1.119 . . . . 0.0 109.018 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -70.83 -11.97 61.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.758 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -140.64 135.99 32.25 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 119.855 1.207 . . . . 0.0 108.078 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.18 102.62 7.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -73.66 145.38 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.92 149.75 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.687 1.995 . . . . 0.0 107.98 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -103.14 165.11 14.18 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 125.586 1.554 . . . . 0.0 111.253 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.59 161.49 45.68 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.998 2.465 . . . . 0.0 111.309 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 53.63 23.66 3.73 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.125 2.57 . . . . 0.0 115.432 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.433 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 tt -117.17 63.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.655 1.182 . . . . 0.0 111.4 -171.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' CA ' ' HE2' ' A' ' 13' ' ' LYS . . . 95.82 164.2 34.03 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 128.407 2.908 . . . . 0.0 112.718 174.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -85.17 124.1 31.44 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 173.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 33' ' ' LEU . 1.4 mt -72.34 76.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.692 1.997 . . . . 0.0 108.099 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.22 -165.24 0.17 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.272 -167.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.44 165.21 19.37 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.47 -1.394 . . . . 0.0 111.356 165.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.79 11.26 35.77 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 117.689 1.835 . . . . 0.0 117.689 168.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -43.27 78.39 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 121.53 2.665 . . . . 0.0 111.326 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -116.84 5.96 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.314 1.046 . . . . 0.0 112.382 -155.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -46.69 124.74 6.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.649 1.58 . . . . 0.0 112.852 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.32 20.71 61.87 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.374 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 45' ' ' LEU . 8.4 p -71.33 75.1 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.524 -0.986 . . . . 0.0 111.556 175.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.0 p -59.76 -16.51 28.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.52 1.128 . . . . 0.0 112.929 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.69 71.54 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.323 0.965 . . . . 0.0 110.888 162.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 42' ' ' CYS . 52.5 tp -115.79 115.07 25.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.421 1.089 . . . . 0.0 110.095 159.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -139.12 24.26 2.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.086 0.554 . . . . 0.0 111.662 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -159.44 152.02 21.44 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 120.751 -1.218 . . . . 0.0 109.922 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 tp -141.69 138.32 32.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.97 137.88 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 119.704 1.138 . . . . 0.0 108.024 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -114.7 117.27 30.34 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.107 0.963 . . . . 0.0 109.849 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -88.9 30.09 0.97 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.428 1.091 . . . . 0.0 111.735 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 164.43 18.24 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -113.18 2.81 15.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.35 144.56 31.52 Favored Pre-proline 0 N--CA 1.447 -0.621 0 O-C-N 120.636 -1.29 . . . . 0.0 110.892 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -73.85 -32.37 7.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.294 2.663 . . . . 0.0 114.238 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -66.46 -25.9 66.94 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.146 0.43 . . . . 0.0 111.455 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.17 4.88 1.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 113.071 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.17 149.05 52.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.559 1.072 . . . . 0.0 108.505 167.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.9 m -142.64 135.32 27.99 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.658 0.783 . . . . 0.0 109.046 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -146.26 2.6 0.88 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.56 -67.24 1.28 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.729 2.585 . . . . 0.0 113.916 163.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 174.85 -32.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 131.596 3.958 . . . . 0.0 107.734 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.47 4.17 74.44 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.407 -1.218 . . . . 0.0 115.507 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.516 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 14.2 tp -43.73 -54.03 5.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.69 1.596 . . . . 0.0 112.57 -158.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.6 33.51 5.61 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.54 132.66 53.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.437 1.017 . . . . 0.0 109.911 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 20.97 79.5 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.742 0.686 . . . . 0.0 113.943 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.01 178.61 7.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.43 1.492 . . . . 0.0 110.816 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.97 101.22 0.99 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.829 1.651 . . . . 0.0 108.432 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -146.05 169.08 19.4 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.631 -0.668 . . . . 0.0 112.266 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt -90.04 155.45 19.07 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 128.112 2.565 . . . . 0.0 110.82 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 mt -117.37 94.87 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.183 2.193 . . . . 0.0 108.222 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.82 129.7 38.45 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 121.037 -1.039 . . . . 0.0 110.125 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -130.89 160.1 68.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.52 1.528 . . . . 0.0 108.544 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -67.7 151.74 78.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.729 1.62 . . . . 0.0 110.939 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.72 -36.9 72.65 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.471 0.578 . . . . 0.0 111.594 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -72.61 -6.57 45.11 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.858 -0.527 . . . . 0.0 111.967 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.05 -8.17 20.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.087 1.355 . . . . 0.0 113.776 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tp -63.01 -50.79 69.34 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.639 1.108 . . . . 0.0 111.359 -165.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -63.03 -44.73 95.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -51.74 -53.93 34.1 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.786 1.234 . . . . 0.0 111.029 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -60.25 -38.44 83.5 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.53 0.519 . . . . 0.0 110.61 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -68.96 -25.17 64.41 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.332 -0.855 . . . . 0.0 113.091 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -87.63 -2.38 58.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.346 1.43 . . . . 0.0 112.508 173.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -71.04 157.74 37.69 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.064 0.847 . . . . 0.0 112.376 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 19.92 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.336 1.054 . . . . 0.0 113.812 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.92 -68.42 0.4 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 126.989 2.115 . . . . 0.0 108.012 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -57.53 -14.78 5.62 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.254 1.822 . . . . 0.0 114.676 -165.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -44.65 -47.0 10.49 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.506 1.048 . . . . 0.0 113.097 161.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.404 HG23 ' CD2' ' A' ' 91' ' ' TYR . 2.9 t -62.72 -16.4 57.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.79 0.836 . . . . 0.0 111.943 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CD2' HG23 ' A' ' 90' ' ' THR . 96.3 m-85 -108.35 10.97 27.47 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.039 -1.663 . . . . 0.0 111.335 175.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.15 -8.13 35.92 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 119.949 -1.719 . . . . 0.0 112.421 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.98 -6.17 57.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.901 0.881 . . . . 0.0 112.84 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -130.65 -14.85 3.59 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 124.06 0.944 . . . . 0.0 112.536 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.13 144.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 120.833 -1.167 . . . . 0.0 108.616 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -149.01 164.35 21.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.885 0.874 . . . . 0.0 110.882 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.73 149.92 73.71 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.98 2.453 . . . . 0.0 113.835 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 mtm . . . . . 0 C--O 1.239 0.503 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.752 165.488 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.446 -1.281 0 N-CA-C 109.539 -0.985 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.34 160.26 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.108 -1.62 . . . . 0.0 110.782 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.26 99.05 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.53 1.532 . . . . 0.0 108.411 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.16 121.68 1.08 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.73 -11.33 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.92 2.888 . . . . 0.0 117.429 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -135.16 153.5 51.95 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 121.122 1.783 . . . . 0.0 108.523 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HE3' HG23 ' A' ' 31' ' ' ILE . 40.9 mttt -135.35 51.61 2.07 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.229 1.811 . . . . 0.0 109.939 170.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -127.26 -17.95 4.63 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.7 75.92 0.95 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.066 1.303 . . . . 0.0 109.57 -167.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -130.51 -55.47 1.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.284 1.034 . . . . 0.0 110.71 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.68 30.52 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.806 2.043 . . . . 0.0 113.372 -165.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.05 -36.09 1.55 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.018 1.771 . . . . 0.0 113.07 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -89.26 102.53 15.2 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.283 2.042 . . . . 0.0 112.065 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.3 p -65.66 6.48 0.33 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.265 1.826 . . . . 0.0 114.21 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.82 -1.46 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.834 1.254 . . . . 0.0 109.96 -167.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.1 tt -69.54 111.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -91.05 -14.23 31.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.766 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -146.44 139.98 25.94 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.605 0.762 . . . . 0.0 110.402 -168.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.2 mt -137.4 101.41 2.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.1 132.96 45.86 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 162.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.02 133.79 67.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 126.058 1.743 . . . . 0.0 108.193 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -94.48 162.98 24.21 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 122.889 0.476 . . . . 0.0 110.969 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.79 151.9 78.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.291 1.994 . . . . 0.0 109.635 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 52.73 38.22 25.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.207 1.803 . . . . 0.0 113.471 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.42 HG23 ' HE3' ' A' ' 13' ' ' LYS . 5.0 tp -119.88 0.78 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.499 1.12 . . . . 0.0 113.192 -164.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.38 169.3 11.7 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.247 1.404 . . . . 0.0 112.445 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 132.49 37.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 112.028 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.96 77.98 9.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.147 1.779 . . . . 0.0 107.189 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -69.63 164.17 23.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.994 0.902 . . . . 0.0 110.342 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -66.99 110.83 3.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.311 1.445 . . . . 0.0 110.102 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.43 11.05 32.21 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.283 0.944 . . . . 0.0 114.546 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.5 mtp -52.93 -23.83 8.0 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -127.28 20.03 6.85 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 110.736 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 t -63.59 94.16 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.857 1.263 . . . . 0.0 110.671 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.21 -7.74 6.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.939 1.733 . . . . 0.0 112.859 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.97 70.37 9.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.127 1.963 . . . . 0.0 109.501 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.9 p -67.05 -25.32 66.2 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.161 -0.962 . . . . 0.0 113.338 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.0 -2.11 57.58 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.605 -1.309 . . . . 0.0 113.119 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.84 119.9 24.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.051 0.94 . . . . 0.0 110.207 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -141.11 2.75 1.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.518 0.727 . . . . 0.0 112.239 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -126.97 153.95 45.2 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.183 -1.573 . . . . 0.0 111.186 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 tp -146.14 100.96 3.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.434 3.494 . . . . 0.0 104.143 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.15 124.35 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 120.89 -1.132 . . . . 0.0 108.084 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 72' ' ' ILE . 3.5 mp -101.72 107.86 19.21 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 107.878 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.8 p -77.15 19.72 0.3 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.53 161.09 20.05 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 120.076 1.307 . . . . 0.0 112.445 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -97.31 -4.22 39.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.501 1.52 . . . . 0.0 112.976 -167.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.85 148.4 42.36 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 119.935 1.243 . . . . 0.0 110.4 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.28 -36.45 7.07 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.113 2.542 . . . . 0.0 112.45 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -25.39 63.82 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.484 0.584 . . . . 0.0 112.441 -172.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -1.4 31.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.688 1.595 . . . . 0.0 113.434 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -127.9 126.8 42.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.16 171.86 11.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.701 1.6 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.3 146.85 3.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.496 1.118 . . . . 0.0 109.624 159.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.27 -173.06 34.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 164.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.3 -48.55 81.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.131 0.972 . . . . 0.0 109.061 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.94 36.58 3.02 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 117.536 -1.702 . . . . 0.0 112.315 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tt -44.56 -56.4 4.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.114 1.457 . . . . 0.0 107.526 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 25.31 10.33 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 125.462 1.505 . . . . 0.0 113.241 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.27 130.1 41.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.49 1.041 . . . . 0.0 111.619 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.36 79.35 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.438 1.018 . . . . 0.0 114.641 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.73 -170.47 2.63 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.04 93.65 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.424 -0.798 . . . . 0.0 109.406 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -125.04 165.12 18.74 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -98.36 158.25 15.7 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 128.168 2.587 . . . . 0.0 110.145 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 50' ' ' LEU . 24.4 mt -116.05 90.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.278 1.831 . . . . 0.0 108.744 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.6 136.65 36.28 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.843 -1.161 . . . . 0.0 108.872 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.09 160.83 67.12 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 126.708 2.003 . . . . 0.0 108.379 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.49 153.58 60.55 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.555 1.504 . . . . 0.0 109.267 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.78 -35.63 64.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.071 0.548 . . . . 0.0 112.232 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.26 -42.48 73.59 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.936 1.294 . . . . 0.0 110.885 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.83 57.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.948 0.899 . . . . 0.0 112.318 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.2 tp -51.68 -61.57 2.17 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.099 1.318 . . . . 0.0 112.078 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.81 -28.38 61.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.533 1.133 . . . . 0.0 110.175 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -59.96 -46.16 90.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.469 1.508 . . . . 0.0 110.195 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -64.65 -41.48 96.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.03 0.832 . . . . 0.0 110.215 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -65.41 -12.64 54.25 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 116.921 -1.514 . . . . 0.0 114.361 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -96.38 2.73 52.94 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 121.685 2.039 . . . . 0.0 112.919 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.32 143.9 36.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.709 1.141 . . . . 0.0 111.994 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.72 10.45 1.39 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.044 1.338 . . . . 0.0 113.746 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -137.24 -64.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.123 1.769 . . . . 0.0 111.029 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -54.21 -20.82 7.54 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.776 1.171 . . . . 0.0 113.649 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -43.81 -47.66 8.13 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.852 1.261 . . . . 0.0 113.91 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.432 HG23 ' CD1' ' A' ' 91' ' ' TYR . 4.9 t -64.09 -24.16 67.6 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.665 0.666 . . . . 0.0 111.86 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CD1' HG23 ' A' ' 90' ' ' THR . 76.8 m-85 -96.77 14.55 24.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.361 1.064 . . . . 0.0 111.137 175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.14 -18.21 33.77 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 120.288 -1.508 . . . . 0.0 111.04 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.13 -22.36 28.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 113.084 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -119.45 -8.48 10.02 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.527 1.131 . . . . 0.0 112.983 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.11 115.65 29.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -149.27 165.46 17.62 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.269 1.028 . . . . 0.0 111.277 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.71 158.75 40.48 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.412 2.075 . . . . 0.0 114.441 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 13.4 mtm . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 126.169 1.787 . . . . 0.0 109.979 161.448 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 CA-C-O 121.783 0.659 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.9 165.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.714 2.006 . . . . 0.0 107.518 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 p -113.33 157.19 14.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 109.199 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 -75.49 0.2 Allowed Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.5 mmt -123.69 3.17 8.9 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -167.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -136.94 156.09 48.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.5 1.046 . . . . 0.0 108.901 169.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -139.17 82.52 1.9 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.131 1.373 . . . . 0.0 110.167 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -150.01 -44.49 0.13 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.815 1.646 . . . . 0.0 111.689 162.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.61 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.85 10.48 0.05 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 -168.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -82.05 -12.64 58.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 119.801 -1.812 . . . . 0.0 113.618 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.02 79.74 1.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.61 -13.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.761 -1.577 . . . . 0.0 116.169 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -112.91 91.73 3.76 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 120.295 2.047 . . . . 0.0 109.345 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -66.35 31.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.755 3.622 . . . . 0.0 113.98 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.88 -7.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.371 1.869 . . . . 0.0 111.736 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.94 89.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.025 0.83 . . . . 0.0 110.511 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -72.1 -13.86 61.69 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.501 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -144.68 137.38 26.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -168.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -136.6 120.01 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.548 1.539 . . . . 0.0 106.963 170.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 m -84.42 143.75 29.22 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.949 -1.095 . . . . 0.0 108.162 158.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.42 139.79 44.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' HB2' ' HD2' ' A' ' 29' ' ' PRO . 6.0 pt20 -101.71 165.07 14.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.705 1.202 . . . . 0.0 111.573 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 28' ' ' GLN . 22.3 Cg_endo -66.71 144.95 73.85 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.631 1.554 . . . . 0.0 109.625 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 47.8 74.29 0.17 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.819 1.647 . . . . 0.0 112.282 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.268 4.8 tp -143.0 33.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 121.619 0.724 . . . . 0.0 112.153 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.48 170.88 16.89 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.84 1.686 . . . . 0.0 111.49 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.3 tp -83.92 127.38 33.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.115 0.958 . . . . 0.0 109.713 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 64' ' ' LEU . 46.6 mt -73.02 90.11 1.48 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 162.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 38' ' ' MET . 54.5 p90 -70.44 -164.61 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.91 0.884 . . . . 0.0 112.175 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -158.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.846 -0.597 . . . . 0.0 112.032 160.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.15 76.89 0.0 OUTLIER Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.57 2.033 . . . . 0.0 117.407 -165.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.464 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 30.9 mtp -67.62 -22.06 65.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.317 1.847 . . . . 0.0 111.125 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.72 10.06 4.67 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.129 0.972 . . . . 0.0 110.675 -161.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -62.38 118.16 7.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.33 52.32 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.709 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.1 p -68.39 73.79 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.131 1.965 . . . . 0.0 111.577 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 p -63.7 2.07 0.52 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.955 1.302 . . . . 0.0 113.627 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.91 39.88 0.87 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.229 -1.367 . . . . 0.0 112.272 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.77 120.64 42.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.477 1.944 . . . . 0.0 110.582 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.07 -13.3 5.12 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -117.86 162.98 17.23 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.662 1.119 . . . . 0.0 111.851 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.671 HD21 HD21 ' A' ' 50' ' ' LEU . 13.6 tp -148.67 145.76 27.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.014 2.126 . . . . 0.0 106.96 165.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -128.61 134.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.671 HD21 HD21 ' A' ' 48' ' ' LEU . 21.6 mt -111.57 112.4 24.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -74.58 -14.6 60.8 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.94 -176.44 50.75 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.36 0.981 . . . . 0.0 110.81 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.57 3.64 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.92 143.56 25.76 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 118.243 0.474 . . . . 0.0 110.169 -174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.63 -27.63 32.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.677 2.918 . . . . 0.0 112.373 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.9 m -75.62 9.88 2.02 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.276 -0.89 . . . . 0.0 112.553 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.04 7.43 36.47 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.255 -0.903 . . . . 0.0 112.433 162.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -138.38 111.64 7.99 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.234 1.413 . . . . 0.0 110.052 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -76.18 177.55 7.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.183 1.793 . . . . 0.0 110.848 175.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.65 160.96 15.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.395 3.078 . . . . 0.0 105.389 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.52 -101.63 2.73 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.04 -57.49 1.78 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.187 1.795 . . . . 0.0 108.017 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.1 74.58 0.22 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 124.486 1.041 . . . . 0.0 111.928 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 34' ' ' LEU . 2.0 tp -43.74 -41.78 5.08 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.972 2.109 . . . . 0.0 110.259 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.85 56.08 1.87 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.786 2.034 . . . . 0.0 107.985 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.46 129.86 41.5 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 164.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.29 87.13 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.069 0.842 . . . . 0.0 115.17 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.71 170.8 14.72 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.297 1.439 . . . . 0.0 110.61 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.65 101.82 2.01 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.856 1.662 . . . . 0.0 107.765 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.11 169.06 18.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.104 0.562 . . . . 0.0 111.409 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.61 HD13 ' N ' ' A' ' 72' ' ' ILE . 2.4 tm? -87.31 146.19 26.03 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.007 1.323 . . . . 0.0 110.609 -175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 71' ' ' LEU . 33.5 mt -112.01 96.49 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 128.363 2.665 . . . . 0.0 109.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.7 m -83.68 134.54 34.77 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.002 -1.061 . . . . 0.0 112.06 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.8 157.87 74.08 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 126.09 1.756 . . . . 0.0 109.443 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.96 148.86 64.73 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 CA-C-N 121.878 1.706 . . . . 0.0 111.15 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.99 -35.95 64.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.971 0.909 . . . . 0.0 112.014 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -67.8 -20.81 65.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.253 1.821 . . . . 0.0 111.852 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -112.41 -0.28 15.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.118 1.367 . . . . 0.0 112.4 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.23 -34.63 76.86 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.111 -0.993 . . . . 0.0 111.852 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -83.25 -33.05 26.13 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.187 0.995 . . . . 0.0 109.847 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.52 -63.31 1.16 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.235 2.214 . . . . 0.0 111.282 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -64.92 -37.13 86.62 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.848 0.459 . . . . 0.0 110.355 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.08 -24.79 67.83 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.445 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -85.72 -4.55 59.19 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.895 1.225 . . . . 0.0 113.067 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.01 150.05 47.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.108 1.322 . . . . 0.0 110.878 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.37 -44.57 90.95 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.455 -0.778 . . . . 0.0 110.281 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -83.28 -65.33 1.02 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.075 0.95 . . . . 0.0 109.271 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -58.0 -15.7 9.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -164.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -45.02 -43.79 9.52 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.567 1.076 . . . . 0.0 112.858 165.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 91' ' ' TYR . 6.8 t -63.39 -14.57 51.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CD1' HG23 ' A' ' 90' ' ' THR . 71.6 m-85 -113.56 14.97 19.05 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.377 -1.452 . . . . 0.0 111.663 173.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.1 3.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.423 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.58 -12.07 59.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.115 166.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -130.26 0.64 4.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.835 1.198 . . . . 0.0 112.805 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.9 mt -89.85 113.24 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.553 ' CG ' HD11 ' A' ' 71' ' ' LEU . 2.6 pt20 -135.42 164.64 42.22 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 126.249 1.819 . . . . 0.0 110.444 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.56 164.24 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.026 1.817 . . . . 0.0 113.407 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 mtm . . . . . 0 N--CA 1.453 -0.286 0 C-N-CA 126.188 1.795 . . . . 0.0 109.261 161.809 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 CA--C 1.547 1.126 0 N-CA-C 107.954 -1.595 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.16 130.46 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 120.554 -1.341 . . . . 0.0 107.479 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.55 122.48 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 122.913 0.485 . . . . 0.0 110.301 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.12 81.33 0.21 Allowed Glycine 0 C--O 1.223 -0.559 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 68.0 mtp 58.82 -60.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.896 2.478 . . . . 0.0 114.351 -168.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.91 91.43 2.47 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.417 1.008 . . . . 0.0 108.351 -171.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -72.71 88.55 1.3 Allowed 'General case' 0 CA--C 1.519 -0.221 0 O-C-N 120.915 -1.116 . . . . 0.0 108.02 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -173.21 54.13 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.922 2.089 . . . . 0.0 109.686 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.15 61.51 0.45 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.814 1.246 . . . . 0.0 110.58 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -131.44 -44.47 1.01 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.223 0.609 . . . . 0.0 111.413 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.34 77.25 1.01 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.154 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.06 -28.0 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.612 -1.66 . . . . 0.0 113.859 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.509 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.7 t30 -117.98 87.88 2.8 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.224 2.012 . . . . 0.0 112.769 -171.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.0 9.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 132.223 4.209 . . . . 0.0 118.108 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.87 19.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.72 1.608 . . . . 0.0 109.546 -166.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 19' ' ' ASN . 13.3 tt -89.04 113.44 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 166.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -95.86 -17.62 20.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.453 1.101 . . . . 0.0 111.444 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -148.31 134.0 18.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.93 0.769 . . . . 0.0 111.02 -160.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.431 HG12 HD11 ' A' ' 22' ' ' ILE . 7.5 mt -141.29 90.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.36 -166.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.3 m -86.16 87.71 7.47 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.558 0.743 . . . . 0.0 109.087 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.09 164.26 3.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 O-C-N 121.003 -1.061 . . . . 0.0 108.852 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' HG22 ' A' ' 31' ' ' ILE . 16.4 mt-30 -126.23 165.54 27.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.959 1.303 . . . . 0.0 109.919 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.8 149.76 60.79 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.074 1.849 . . . . 0.0 111.026 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 48.48 66.03 1.18 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.191 2.996 . . . . 0.0 111.374 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 28' ' ' GLN . 0.7 OUTLIER -144.93 55.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 110.685 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.21 144.45 15.31 Favored Glycine 0 C--O 1.241 0.561 0 O-C-N 121.018 -1.051 . . . . 0.0 112.603 170.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.83 141.38 58.67 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.319 1.048 . . . . 0.0 108.445 171.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.43 77.83 2.99 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.495 1.118 . . . . 0.0 108.316 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -70.46 162.7 28.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.081 0.943 . . . . 0.0 111.12 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -70.23 113.57 7.53 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.582 1.953 . . . . 0.0 110.312 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.89 4.85 36.12 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.456 1.027 . . . . 0.0 114.156 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.7 mmm -48.2 -41.36 26.99 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.835 1.317 . . . . 0.0 112.824 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -112.27 18.75 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.789 1.236 . . . . 0.0 111.787 -165.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -60.22 121.2 11.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.89 12.9 65.47 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.204 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.4 m -80.03 63.52 4.58 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.855 1.327 . . . . 0.0 110.296 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.5 p -63.47 -13.74 43.64 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -164.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.14 -1.35 29.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.47 -1.393 . . . . 0.0 113.029 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.78 108.74 14.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 110.313 -171.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -126.46 -10.12 6.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -135.9 143.15 44.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.949 1.299 . . . . 0.0 111.837 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.463 HD21 HD21 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -140.46 140.31 35.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.237 2.215 . . . . 0.0 107.112 173.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -131.57 150.48 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.463 HD21 HD21 ' A' ' 48' ' ' LEU . 74.8 mt -133.39 106.55 7.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.832 1.253 . . . . 0.0 109.627 -169.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.2 p -82.27 45.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.886 0.766 . . . . 0.0 111.373 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -143.35 129.86 3.89 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.749 -1.219 . . . . 0.0 111.08 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.45 3.3 47.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.469 2.307 . . . . 0.0 112.753 -163.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.04 144.22 34.25 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 120.531 -1.356 . . . . 0.0 108.477 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -67.03 -33.48 31.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.735 1.623 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -62.24 -20.67 64.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.033 0.933 . . . . 0.0 112.541 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 9.82 0.43 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.956 1.702 . . . . 0.0 113.568 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.54 -177.07 5.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 109.46 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 t -145.65 -177.04 5.37 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.334 1.454 . . . . 0.0 108.847 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.82 6.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 128.492 2.717 . . . . 0.0 107.947 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.23 -171.21 24.92 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 151.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.4 -51.52 43.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.21 58.37 5.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.507 1.051 . . . . 0.0 112.095 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD23 HH22 ' A' ' 65' ' ' ARG . 17.8 tp -44.94 -35.01 2.64 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.398 1.879 . . . . 0.0 112.048 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.476 HH22 HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -132.42 29.86 4.22 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 119.821 -1.799 . . . . 0.0 112.087 178.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.87 135.36 15.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.666 0.666 . . . . 0.0 111.101 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.06 -18.7 52.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.267 0.937 . . . . 0.0 112.889 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.0 -178.51 4.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.81 1.644 . . . . 0.0 109.461 173.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -160.91 104.58 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -133.52 168.12 19.22 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.801 0.84 . . . . 0.0 111.603 -169.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -85.61 145.42 27.35 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.994 0.918 . . . . 0.0 112.092 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -105.8 143.51 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.872 2.469 . . . . 0.0 108.986 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -127.87 138.59 52.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.044 1.338 . . . . 0.0 108.986 171.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.22 164.51 42.4 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.951 2.101 . . . . 0.0 108.376 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.62 147.74 82.23 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.816 1.684 . . . . 0.0 109.446 171.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -51.28 -33.48 28.78 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.63 -26.41 67.81 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.336 1.454 . . . . 0.0 110.689 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.78 -4.88 25.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.581 1.552 . . . . 0.0 112.21 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.75 -54.32 45.77 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.878 1.217 . . . . 0.0 112.081 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.72 -33.78 76.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.447 0.699 . . . . 0.0 110.068 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -59.83 -52.75 64.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.534 1.534 . . . . 0.0 111.816 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -58.85 -40.73 85.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.502 0.721 . . . . 0.0 110.027 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 -70.9 -16.91 62.71 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.89 5.38 45.35 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.95 1.25 . . . . 0.0 112.713 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.47 178.15 0.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.701 1.6 . . . . 0.0 113.039 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.4 -20.25 17.93 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.6 -1.313 . . . . 0.0 112.33 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -113.03 -53.94 2.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.684 1.129 . . . . 0.0 110.656 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -58.53 -15.64 12.07 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -46.07 -43.82 14.94 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 115.443 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -44.91 75.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.033 1.288 . . . . 0.0 108.564 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.1 5.74 6.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 112.823 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.461 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -63.51 -21.22 66.2 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.949 1.249 . . . . 0.0 111.769 -174.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -10.58 19.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -119.48 4.55 11.16 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 124.623 1.169 . . . . 0.0 111.563 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 92' ' ' ALA . 80.7 mt -97.13 100.97 11.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -172.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -119.23 165.14 18.01 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.18 0.992 . . . . 0.0 112.571 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.29 169.1 22.41 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.508 2.805 . . . . 0.0 112.534 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.2 mtm . . . . . 0 CA--C 1.54 0.581 0 C-N-CA 127.162 2.185 . . . . 0.0 111.758 171.432 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 CA--C 1.541 0.831 0 N-CA-C 109.685 -0.929 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.65 153.15 27.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.639 -1.288 . . . . 0.0 109.548 -168.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG11 HG13 ' A' ' 27' ' ' VAL . 3.2 t -92.81 61.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.77 -83.93 0.09 OUTLIER Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.4 mtp -140.18 -35.58 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.89 130.82 44.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.024 1.284 . . . . 0.0 111.939 -172.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -91.98 95.38 9.77 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.92 -52.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 108.334 173.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 8.41 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.589 2.356 . . . . 0.0 117.339 -171.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -89.26 -0.59 57.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.916 1.235 . . . . 0.0 113.736 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.55 86.5 2.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.474 1.034 . . . . 0.0 109.741 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.41 -26.98 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 117.608 -1.662 . . . . 0.0 114.741 167.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -95.65 99.21 11.1 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.806 2.303 . . . . 0.0 110.116 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 p -65.57 19.61 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.051 2.941 . . . . 0.0 115.155 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.81 4.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 120.594 -1.316 . . . . 0.0 111.786 -159.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 tt -90.94 104.38 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 O-C-N 120.103 -1.623 . . . . 0.0 107.155 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -84.08 -15.9 45.72 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 117.667 -1.159 . . . . 0.0 111.835 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -138.83 129.75 26.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.249 0.931 . . . . 0.0 110.194 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.449 HD12 HD11 ' A' ' 45' ' ' LEU . 73.9 mt -129.89 97.87 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -79.4 115.18 18.88 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.411 -0.806 . . . . 0.0 109.118 171.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG13 HG11 ' A' ' 9' ' ' VAL . 2.7 t -114.49 125.33 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.145 1.778 . . . . 0.0 110.598 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.76 164.77 51.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 170.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.43 162.03 36.61 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.321 2.014 . . . . 0.0 108.738 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 46.79 53.08 10.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.191 1.396 . . . . 0.0 111.932 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.25 22.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.095 -1.003 . . . . 0.0 113.023 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.63 160.36 9.11 Favored Glycine 0 CA--C 1.521 0.437 0 O-C-N 120.843 -1.161 . . . . 0.0 111.028 165.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 35' ' ' TYR . 9.9 tp -72.25 129.09 37.6 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.963 -1.316 . . . . 0.0 108.418 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -85.52 87.83 7.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.413 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -75.69 -166.62 0.58 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.302 0.641 . . . . 0.0 109.375 176.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.93 148.26 36.47 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 2.59 90.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.1 -1.389 . . . . 0.0 116.312 164.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -34.93 70.34 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.483 2.142 . . . . 0.0 110.107 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.06 17.51 22.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.685 1.594 . . . . 0.0 111.196 -172.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 t -57.16 109.78 0.72 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.55 0.99 46.73 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.631 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -79.02 66.63 4.51 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.538 2.169 . . . . 0.0 110.203 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.0 p -66.04 -6.61 13.48 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.652 1.981 . . . . 0.0 113.695 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.82 25.81 3.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.829 1.252 . . . . 0.0 110.887 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.734 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -70.8 135.19 47.98 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 171.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.6 -25.09 1.03 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.256 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.05 154.92 43.73 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.554 1.941 . . . . 0.0 110.88 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.45 147.7 27.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.32 2.248 . . . . 0.0 105.311 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.29 142.81 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' A' ' 58' ' ' TYR . 37.5 mt -121.12 116.19 24.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.858 0.863 . . . . 0.0 110.212 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.7 p -86.25 3.22 44.12 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.628 0.974 . . . . 0.0 113.628 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.93 162.17 23.92 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 120.802 -1.186 . . . . 0.0 110.931 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -110.61 3.25 19.21 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -164.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -152.6 144.66 16.7 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.119 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.53 -23.25 64.52 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.397 2.731 . . . . 0.0 112.87 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -60.95 -23.75 65.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.395 0.998 . . . . 0.0 112.143 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.84 4.87 17.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.134 0.973 . . . . 0.0 113.151 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.444 ' CE1' HD22 ' A' ' 50' ' ' LEU . 59.7 m-85 -134.9 170.58 15.65 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 126.8 2.04 . . . . 0.0 110.027 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 m -122.16 -176.56 3.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.147 1.379 . . . . 0.0 109.027 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . 174.72 -17.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.884 1.674 . . . . 0.0 113.02 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 47.35 -97.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 128.24 2.829 . . . . 0.0 111.349 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.27 14.78 1.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.233 1.413 . . . . 0.0 109.896 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.05 14.09 3.31 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 117.474 -1.736 . . . . 0.0 115.251 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.588 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 5.4 tt -44.22 -51.62 8.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.822 2.311 . . . . 0.0 111.874 -165.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -86.09 -7.36 58.65 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 116.975 -1.488 . . . . 0.0 114.823 -171.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.2 118.3 4.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.967 0.803 . . . . 0.0 111.11 -152.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.51 -9.28 38.14 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.823 1.677 . . . . 0.0 114.266 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.57 -174.38 3.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.147 1.474 . . . . 0.0 114.064 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -151.0 115.66 5.18 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 131.453 3.901 . . . . 0.0 103.749 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.734 ' HB2' HD22 ' A' ' 45' ' ' LEU . 46.8 p90 -147.91 -175.11 4.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.392 1.077 . . . . 0.0 109.972 174.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.7 tp -127.64 148.4 50.38 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.346 -1.471 . . . . 0.0 110.035 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -110.72 136.87 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.036 2.134 . . . . 0.0 107.77 -173.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 33.7 m -123.43 122.62 38.73 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.994 2.117 . . . . 0.0 110.813 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.88 158.79 58.86 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 107.29 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -69.77 153.57 68.72 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.32 -32.54 73.31 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -27.03 66.65 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.39 0.541 . . . . 0.0 110.445 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -92.74 -7.82 45.55 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.167 -0.958 . . . . 0.0 111.857 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 tp -62.04 -55.94 24.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.104 1.775 . . . . 0.0 111.517 -162.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.72 -30.03 70.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.737 -0.602 . . . . 0.0 110.691 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -59.21 -31.58 69.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.178 1.391 . . . . 0.0 112.475 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -77.69 -41.5 37.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.342 0.974 . . . . 0.0 110.497 166.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -65.98 -27.06 67.86 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 0.0 113.506 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -77.12 -3.07 37.49 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.157 -0.965 . . . . 0.0 111.819 173.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 130.45 35.04 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 121.026 1.739 . . . . 0.0 107.902 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.67 -38.15 90.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.09 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 60' ' ' ALA . 1.5 t80 -71.42 -61.77 1.65 Allowed 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.601 0.637 . . . . 0.0 110.378 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -58.52 -9.1 1.45 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.32 -47.78 6.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.083 0.953 . . . . 0.0 111.908 163.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 t -61.11 -17.92 55.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.576 0.751 . . . . 0.0 111.272 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -113.14 5.61 17.14 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.614 1.966 . . . . 0.0 113.755 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.46 -24.95 65.64 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.946 1.248 . . . . 0.0 111.548 -171.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.09 -13.98 62.63 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -123.33 17.03 9.81 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.632 1.106 . . . . 0.0 111.546 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -103.73 123.07 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 1.9 pt20 -130.01 166.04 29.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.553 1.941 . . . . 0.0 110.917 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 96' ' ' GLN . 55.4 Cg_endo -64.22 174.19 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.317 2.678 . . . . 0.0 112.006 169.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 mtm . . . . . 0 N--CA 1.463 0.185 0 C-N-CA 125.74 1.616 . . . . 0.0 111.562 170.006 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 N-CA-C 108.793 -1.272 . . . . 0.0 108.793 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.97 154.84 19.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 120.687 -1.258 . . . . 0.0 108.013 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.45 155.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 123.932 0.77 . . . . 0.0 109.189 165.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.4 -70.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 36.2 mtp -146.54 -51.98 0.22 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.245 1.418 . . . . 0.0 109.499 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -84.67 113.96 21.67 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.505 0.722 . . . . 0.0 109.695 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 27.2 mmtp -75.28 6.93 3.87 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -85.94 5.11 34.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -104.18 4.9 34.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -159.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -85.85 -57.28 3.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.364 0.984 . . . . 0.0 110.506 -165.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.47 85.21 0.28 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.019 2.528 . . . . 0.0 110.643 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.2 -17.72 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.934 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.04 114.9 28.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.378 1.589 . . . . 0.0 110.797 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 p -73.2 -0.66 14.95 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.597 -1.314 . . . . 0.0 114.173 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.84 -8.89 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 120.305 1.411 . . . . 0.0 110.8 -152.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 tt -65.16 99.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 127.637 2.375 . . . . 0.0 108.103 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -85.95 -10.0 55.91 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.739 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -141.43 134.98 29.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.286 0.948 . . . . 0.0 108.839 -172.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.03 122.55 49.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -83.09 141.17 32.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 160.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.7 143.31 32.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 124.147 0.979 . . . . 0.0 108.367 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -92.78 164.28 22.69 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 110.226 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.81 171.25 14.85 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.634 2.223 . . . . 0.0 110.007 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 48.68 35.39 6.19 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.601 1.96 . . . . 0.0 113.91 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.533 ' O ' ' HE3' ' A' ' 13' ' ' LYS 0.255 5.4 tt -131.53 63.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 122.634 1.207 . . . . 0.0 112.432 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.64 159.56 32.05 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.153 1.358 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.1 168.54 8.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.8 1.24 . . . . 0.0 111.671 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.45 HD13 HD13 ' A' ' 64' ' ' LEU . 37.1 mt -133.2 84.78 2.16 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 170.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -84.43 162.05 20.09 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.061 0.391 . . . . 0.0 110.726 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.18 126.03 26.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.371 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.49 11.44 64.21 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.692 -1.06 . . . . 0.0 114.693 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -62.38 -32.94 73.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.22 2.01 . . . . 0.0 112.415 172.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -107.02 29.3 7.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.027 1.731 . . . . 0.0 110.996 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 t -66.12 102.83 0.87 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.78 48.32 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.828 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.09 63.37 1.8 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.78 1.79 . . . . 0.0 109.618 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 p -73.62 -12.51 60.77 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -158.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.42 13.8 19.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.857 1.208 . . . . 0.0 112.131 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.721 HD22 ' CB ' ' A' ' 70' ' ' PHE . 2.7 tt -65.32 117.59 8.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -126.94 -8.65 6.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -148.33 148.55 30.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.18 0.992 . . . . 0.0 112.282 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tp -151.39 100.49 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.88 138.15 21.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 mt -123.48 129.85 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.051 0.94 . . . . 0.0 108.976 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 p -113.67 35.58 3.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.173 0.989 . . . . 0.0 111.409 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.62 139.9 11.35 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.1 4.13 21.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -163.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -151.75 144.49 16.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 120.64 -1.288 . . . . 0.0 109.423 -164.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -37.97 3.05 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.152 2.568 . . . . 0.0 113.241 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -74.95 -7.04 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.012 0.824 . . . . 0.0 112.095 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.08 -10.93 59.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.031 0.932 . . . . 0.0 112.237 165.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -97.71 173.11 7.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 123.263 1.506 . . . . 0.0 110.709 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -164.39 1.08 Allowed 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 129.111 2.964 . . . . 0.0 106.869 169.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 77.05 142.64 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 130.223 3.409 . . . . 0.0 110.567 -169.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.91 -31.63 0.02 OUTLIER Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.214 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.5 -45.33 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.276 2.231 . . . . 0.0 110.235 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.44 71.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.554 -1.137 . . . . 0.0 112.248 -162.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.45 HD13 HD13 ' A' ' 34' ' ' LEU . 42.1 tp -44.63 -63.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.276 1.038 . . . . 0.0 110.766 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.6 -9.74 59.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 116.916 -1.516 . . . . 0.0 112.311 -164.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -45.29 112.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.954 1.302 . . . . 0.0 110.497 -157.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.08 -6.06 28.89 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.606 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.31 173.26 13.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.223 1.809 . . . . 0.0 110.73 168.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -140.48 81.91 1.83 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.167 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.721 ' CB ' HD22 ' A' ' 45' ' ' LEU . 24.8 p90 -95.26 -176.79 3.91 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.197 1.399 . . . . 0.0 109.023 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.85 157.86 28.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 107.515 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.5 139.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.637 1.175 . . . . 0.0 108.814 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.26 135.36 54.21 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.533 1.133 . . . . 0.0 110.126 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -136.74 155.29 76.7 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 126.166 1.786 . . . . 0.0 107.036 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 153.71 71.22 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 121.536 1.584 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.09 -30.2 66.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.1 -29.69 69.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.322 1.049 . . . . 0.0 111.326 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.09 -11.63 22.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.33 1.052 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 tp -57.68 -52.06 66.97 Favored 'General case' 0 C--O 1.228 -0.055 0 O-C-N 121.108 -0.995 . . . . 0.0 110.45 -170.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -27.38 68.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -59.11 5.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.442 1.497 . . . . 0.0 109.551 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -63.01 -26.62 68.94 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.556 1.071 . . . . 0.0 111.414 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -17.17 61.45 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -103.26 -9.43 19.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.637 1.108 . . . . 0.0 113.612 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.97 151.27 26.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.489 1.116 . . . . 0.0 111.831 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.64 -50.74 72.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.014 -0.429 . . . . 0.0 111.679 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -82.94 -60.68 2.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 108.936 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -60.06 -15.63 24.63 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -43.96 -49.5 8.51 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 120.105 1.32 . . . . 0.0 112.98 164.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 t -57.19 -31.3 65.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -93.8 15.86 15.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.806 1.242 . . . . 0.0 112.658 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.71 65.69 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.016 -1.677 . . . . 0.0 112.18 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.44 38.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.112 0.965 . . . . 0.0 112.979 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -127.43 21.07 6.66 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.87 106.95 21.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 119.898 1.226 . . . . 0.0 108.739 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.62 164.86 26.03 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.088 1.755 . . . . 0.0 111.161 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.55 163.0 36.62 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.66 2.24 . . . . 0.0 112.211 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.7 mtt . . . . . 0 N--CA 1.454 -0.254 0 C-N-CA 124.859 1.264 . . . . 0.0 109.581 163.325 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 CA--C 1.542 0.898 0 N-CA-C 109.816 -0.879 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.54 146.79 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 108.062 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.415 HG11 HG13 ' A' ' 27' ' ' VAL . 21.8 t -86.03 99.54 7.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.06 86.82 0.18 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 167.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.3 mtp 57.89 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 129.309 3.044 . . . . 0.0 118.241 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -110.44 97.07 6.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 121.69 2.041 . . . . 0.0 111.034 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -73.16 28.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.921 1.288 . . . . 0.0 113.221 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.71 28.47 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.626 1.103 . . . . 0.0 111.671 -168.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -125.1 1.94 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.11 1.364 . . . . 0.0 113.562 -171.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 18' ' ' GLY . 26.4 m-85 -91.67 -36.3 13.7 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.321 -0.862 . . . . 0.0 111.418 -162.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.53 14.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.458 2.303 . . . . 0.0 114.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -114.58 -13.54 9.51 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.328 1.918 . . . . 0.0 113.848 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -120.86 107.13 12.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.215 2.007 . . . . 0.0 111.894 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.4 p -79.09 9.62 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.013 1.725 . . . . 0.0 114.355 -168.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.7 -4.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.146 -170.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.35 104.32 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -81.74 -15.62 53.75 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 117.954 -1.022 . . . . 0.0 111.13 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -143.44 126.03 15.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.002 0.921 . . . . 0.0 109.452 -162.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 45' ' ' LEU . 88.0 mt -133.15 103.98 6.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -175.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.4 m -75.03 139.77 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 166.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 9' ' ' VAL . 1.9 t -135.02 165.45 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.57 1.948 . . . . 0.0 108.024 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' HG22 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -125.08 165.87 23.57 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 108.992 176.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.65 162.52 41.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.928 1.752 . . . . 0.0 110.167 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 48.51 19.43 0.23 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.141 2.177 . . . . 0.0 114.549 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 28' ' ' GLN . 4.9 tp -95.06 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 119.895 -1.753 . . . . 0.0 110.758 -170.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.76 151.23 21.33 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 121.14 -0.975 . . . . 0.0 111.728 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.3 tp -70.44 138.47 51.24 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 121.769 0.795 . . . . 0.0 110.293 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.27 99.9 11.9 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 164.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -75.02 165.14 25.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.0 134.62 35.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.833 -1.167 . . . . 0.0 108.352 173.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.17 -0.07 71.58 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.928 1.252 . . . . 0.0 113.204 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -48.75 -44.03 38.23 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.457 2.303 . . . . 0.0 112.676 173.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -95.64 9.83 38.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.598 0.759 . . . . 0.0 112.668 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -58.24 113.65 2.04 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.651 1.114 . . . . 0.0 109.861 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.54 -0.29 53.1 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.004 -1.442 . . . . 0.0 113.721 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.5 m -74.74 67.64 1.61 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.916 1.858 . . . . 0.0 109.284 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -75.17 10.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.389 1.876 . . . . 0.0 113.66 -168.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.32 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.113 0.965 . . . . 0.0 112.943 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.737 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -66.48 118.9 10.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.673 1.579 . . . . 0.0 109.68 -175.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -126.08 -11.59 6.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.313 0.645 . . . . 0.0 111.785 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.81 146.6 25.19 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.168 1.349 . . . . 0.0 111.322 -173.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -147.33 141.28 25.9 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.542 1.937 . . . . 0.0 106.417 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.25 141.27 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 48' ' ' LEU . 43.1 mt -122.74 103.87 8.94 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 109.369 -170.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.8 p -77.53 39.24 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.456 1.502 . . . . 0.0 113.216 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.83 153.52 25.36 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 119.824 -1.798 . . . . 0.0 110.495 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -108.32 4.38 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -158.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.44 144.6 40.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.219 1.008 . . . . 0.0 111.37 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.28 -22.27 5.93 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.3 2.667 . . . . 0.0 115.383 -172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 m -64.95 -36.83 85.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.057 1.299 . . . . 0.0 109.822 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.81 7.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -126.54 128.42 46.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.373 1.069 . . . . 0.0 109.575 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 167.04 13.41 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.221 1.009 . . . . 0.0 110.817 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.88 167.67 16.56 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.117 2.167 . . . . 0.0 108.537 153.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.84 -177.45 40.97 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 158.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -51.76 -44.86 63.51 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.3 1.44 . . . . 0.0 109.847 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.26 82.09 0.3 Allowed Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 127.233 2.349 . . . . 0.0 109.738 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.8 tp -51.53 -63.47 1.12 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.16 0.984 . . . . 0.0 109.623 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.47 17.12 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.121 1.368 . . . . 0.0 112.165 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.26 127.18 28.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.797 0.726 . . . . 0.0 109.244 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.33 81.48 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.249 0.928 . . . . 0.0 113.762 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.54 -164.41 1.82 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.72 2.008 . . . . 0.0 107.402 170.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -167.73 99.37 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 167.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.737 ' CB ' HD22 ' A' ' 45' ' ' LEU . 19.6 p90 -131.52 168.81 17.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.022 1.329 . . . . 0.0 109.486 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -98.18 152.82 18.96 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.147 1.379 . . . . 0.0 109.653 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.88 138.63 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 0.0 109.458 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -127.52 145.13 50.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.221 1.008 . . . . 0.0 110.014 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.12 158.77 74.95 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 108.58 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -67.17 148.85 81.53 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 CA-C-N 120.938 1.371 . . . . 0.0 110.229 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.4 -22.54 63.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -81.07 -22.85 38.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.022 1.329 . . . . 0.0 112.128 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.71 -1.58 32.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.151 1.38 . . . . 0.0 111.889 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.02 -47.39 83.19 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.769 -0.582 . . . . 0.0 112.019 -165.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.91 -43.67 78.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.443 0.297 . . . . 0.0 110.783 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -46.86 -55.0 8.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.19 1.396 . . . . 0.0 111.61 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -63.44 -41.47 98.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.012 0.824 . . . . 0.0 110.584 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -64.78 -16.09 62.55 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.312 -0.868 . . . . 0.0 112.475 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -101.11 15.55 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.262 1.825 . . . . 0.0 112.817 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.3 179.29 5.88 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.62 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -106.71 -29.33 9.64 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.609 1.964 . . . . 0.0 112.859 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.01 -56.2 2.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.772 0.829 . . . . 0.0 108.764 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -61.57 -10.71 8.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.743 -172.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.308 0.3 OUTLIER -43.89 -57.63 3.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.765 1.226 . . . . 0.0 113.373 168.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.6 t -69.86 -9.87 56.42 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.688 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -104.73 1.32 29.19 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.645 -1.285 . . . . 0.0 111.927 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -68.45 -3.86 12.85 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 119.671 -1.893 . . . . 0.0 112.585 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.82 -14.05 60.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.169 1.387 . . . . 0.0 112.375 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -127.78 34.96 4.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.203 1.401 . . . . 0.0 109.845 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 92' ' ' ALA . 63.2 mt -109.45 139.0 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.65 163.86 43.84 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.851 1.66 . . . . 0.0 110.127 166.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.92 149.04 91.49 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.86 1.707 . . . . 0.0 110.148 167.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ptp . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 124.641 1.177 . . . . 0.0 108.729 173.208 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 N-CA-C 107.298 -1.847 . . . . 0.0 107.298 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -150.1 147.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 120.448 -1.407 . . . . 0.0 107.92 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 t -78.8 101.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.43 -75.52 0.58 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -51.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.379 1.872 . . . . 0.0 111.365 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -87.36 172.44 9.84 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -126.31 3.98 7.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.533 1.133 . . . . 0.0 113.939 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -83.38 -28.77 28.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.02 23.65 0.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.887 1.275 . . . . 0.0 113.733 -157.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.98 -47.34 5.57 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.088 -1.008 . . . . 0.0 110.57 -171.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.31 1.444 . . . . 0.0 108.054 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.61 -23.44 0.09 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.821 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -108.64 105.22 14.74 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.748 2.274 . . . . 0.0 111.56 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -68.81 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.908 2.483 . . . . 0.0 113.055 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.96 -9.28 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.884 1.274 . . . . 0.0 111.538 -163.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.2 tt -77.48 96.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 120.897 -1.127 . . . . 0.0 108.8 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -75.07 -16.12 60.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.18 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -149.19 134.81 18.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.601 0.761 . . . . 0.0 109.53 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.4 114.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.0 m -89.82 137.72 32.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 t -130.77 121.37 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.935 1.694 . . . . 0.0 108.268 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -77.09 160.85 75.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.401 0.546 . . . . 0.0 110.798 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -75.49 159.9 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.723 2.282 . . . . 0.0 110.83 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 54.9 37.13 28.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.883 1.673 . . . . 0.0 113.007 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.292 3.7 tt -133.4 25.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.675 1.19 . . . . 0.0 112.205 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.61 159.3 8.15 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 127.132 2.301 . . . . 0.0 111.529 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.8 tp -71.96 126.15 29.03 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 124.306 1.042 . . . . 0.0 110.065 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.95 78.42 7.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -68.89 168.18 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.083 0.944 . . . . 0.0 111.548 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -75.54 137.42 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.59 -1.944 . . . . 0.0 108.667 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.34 3.4 90.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.101 0.858 . . . . 0.0 113.937 -174.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.1 ttp -59.77 -25.15 64.66 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 120.158 1.979 . . . . 0.0 113.364 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -114.4 15.69 17.9 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.848 1.259 . . . . 0.0 111.594 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.429 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 58.6 m -48.33 119.28 2.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 111.371 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.56 6.95 85.27 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.297 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.96 73.77 0.61 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.609 2.204 . . . . 0.0 107.092 163.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.6 p -65.31 -51.99 56.97 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.43 1.092 . . . . 0.0 111.532 -167.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.62 3.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.921 1.289 . . . . 0.0 113.957 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.2 tp -76.85 108.28 9.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.279 1.032 . . . . 0.0 110.129 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.62 -12.45 9.74 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.551 169.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -119.14 142.54 47.85 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.522 1.055 . . . . 0.0 113.236 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 49' ' ' ILE . 2.0 tm? -146.53 136.57 23.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.541 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.4 mp -133.94 137.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.2 113.75 22.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 p -83.97 0.38 48.2 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.33 179.05 41.96 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.216 0.912 . . . . 0.0 110.992 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.96 6.26 4.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.017 0.927 . . . . 0.0 112.63 -169.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -141.99 143.82 29.75 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.658 1.583 . . . . 0.0 107.721 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.53 -30.73 4.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.317 2.011 . . . . 0.0 112.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -77.07 -15.84 59.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 111.824 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.64 12.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.441 1.496 . . . . 0.0 112.804 165.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -124.33 168.55 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.252 1.021 . . . . 0.0 110.07 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -141.78 133.68 27.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.61 172.69 9.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.322 2.249 . . . . 0.0 106.388 172.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.73 -145.04 8.1 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.342 1.925 . . . . 0.0 109.361 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.01 -8.86 58.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.782 -0.834 . . . . 0.0 113.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.98 68.23 0.27 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -170.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 tp -46.14 -44.02 15.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.204 1.402 . . . . 0.0 111.022 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -113.7 16.75 18.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.016 0.926 . . . . 0.0 111.419 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.67 146.24 52.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.861 0.755 . . . . 0.0 110.808 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 76.47 -1.02 62.56 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.753 1.168 . . . . 0.0 113.825 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.27 -175.46 4.18 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 128.921 2.888 . . . . 0.0 107.456 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -156.56 94.49 1.48 Allowed 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.812 -1.18 . . . . 0.0 110.737 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -125.21 163.4 22.57 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.112 0.965 . . . . 0.0 111.134 -171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.68 152.39 18.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 108.113 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.4 mt -122.08 101.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -167.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.2 m -87.78 138.05 31.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.365 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.16 155.28 72.62 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.42 1.888 . . . . 0.0 109.7 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.84 144.54 53.91 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 CA-C-N 121.432 1.547 . . . . 0.0 109.46 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -55.24 -32.78 62.57 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -67.33 -18.24 65.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.224 3.01 . . . . 0.0 112.159 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.46 -0.19 19.01 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.83 -1.168 . . . . 0.0 113.135 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 tp -62.7 -50.27 71.8 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.172 0.896 . . . . 0.0 111.351 -168.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.61 -43.21 99.28 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.8 -56.28 9.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.525 1.93 . . . . 0.0 111.795 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -70.61 -40.22 73.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.292 0.496 . . . . 0.0 109.744 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -62.7 -25.41 68.15 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 121.208 -0.933 . . . . 0.0 112.565 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -85.14 -13.69 49.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.275 1.43 . . . . 0.0 112.679 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.73 143.1 57.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.443 0.565 . . . . 0.0 111.553 -160.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.89 24.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.133 2.573 . . . . 0.0 113.439 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -67.32 0.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.983 2.513 . . . . 0.0 107.207 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -58.6 -16.96 18.19 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -167.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -44.08 -45.01 7.88 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.499 1.52 . . . . 0.0 113.775 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -69.36 -6.15 28.03 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.77 15.81 14.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.04 1.291 . . . . 0.0 111.567 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.66 66.55 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.48 -1.388 . . . . 0.0 110.707 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.28 3.28 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -127.29 4.74 6.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.878 1.217 . . . . 0.0 111.889 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.85 123.65 46.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -136.06 162.42 56.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.771 0.828 . . . . 0.0 111.508 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.75 149.16 91.43 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.315 2.677 . . . . 0.0 114.208 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.5 mtm . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.557 166.127 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo . . . . . 0 CA--C 1.541 0.858 0 CA-C-O 121.63 0.596 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.34 165.42 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 108.791 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.503 HG22 HD12 ' A' ' 31' ' ' ILE 0.268 7.0 p -110.57 68.23 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.28 1.038 . . . . 0.0 109.826 -161.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.75 79.62 0.26 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 125.766 1.651 . . . . 0.0 109.791 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.2 10.07 1.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.786 2.034 . . . . 0.0 114.388 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.59 122.68 15.67 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.878 1.217 . . . . 0.0 110.225 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -105.29 90.94 3.58 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.391 1.476 . . . . 0.0 107.066 168.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -162.46 10.43 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 14' ' ' SER . 1.3 mp -131.67 1.28 4.02 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.782 -1.199 . . . . 0.0 113.053 -160.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.24 -36.66 16.61 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.664 -0.647 . . . . 0.0 111.573 -163.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 43.87 0.09 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.905 2.082 . . . . 0.0 112.255 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.82 -27.46 0.37 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.381 -1.233 . . . . 0.0 113.352 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -106.78 94.15 4.96 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.438 1.619 . . . . 0.0 110.63 -173.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.5 p -64.24 22.04 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 129.537 3.135 . . . . 0.0 115.107 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.29 7.56 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 O-C-N 119.861 -1.774 . . . . 0.0 110.074 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.94 98.55 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.241 -1.537 . . . . 0.0 107.147 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -71.29 -26.36 62.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.744 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -136.79 120.72 17.57 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.432 0.56 . . . . 0.0 111.218 -160.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mt -122.29 89.96 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 m -66.82 130.93 44.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 161.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.1 155.4 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.328 1.851 . . . . 0.0 107.047 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -119.59 159.66 45.21 Favored Pre-proline 0 N--CA 1.452 -0.368 0 C-N-CA 124.809 1.243 . . . . 0.0 107.864 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.1 152.98 51.68 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.733 1.622 . . . . 0.0 111.196 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 59.85 21.38 10.29 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.524 1.93 . . . . 0.0 113.849 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.503 HD12 HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -118.25 93.86 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 124.505 2.097 . . . . 0.0 107.198 176.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.49 138.62 5.21 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 127.27 2.367 . . . . 0.0 113.28 161.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -58.47 130.23 45.77 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mt -88.07 123.37 32.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -133.99 176.56 8.46 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.57 1.148 . . . . 0.0 109.407 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -72.42 152.07 42.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.545 1.164 . . . . 0.0 111.512 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.477 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 66.13 -3.67 3.07 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.085 1.326 . . . . 0.0 114.425 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.469 ' HE3' ' CZ ' ' A' ' 39' ' ' PHE . 3.6 tmm? -57.74 -32.56 67.56 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.805 . . . . 0.0 112.094 -170.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.469 ' CZ ' ' HE3' ' A' ' 38' ' ' MET . 59.7 m-85 -102.49 -5.92 23.48 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.406 1.482 . . . . 0.0 113.468 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 t -54.23 124.78 16.83 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.342 0.974 . . . . 0.0 110.974 -164.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.31 9.24 48.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.764 1.173 . . . . 0.0 112.784 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.7 p -69.85 74.19 0.43 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.951 1.7 . . . . 0.0 111.93 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -58.16 -7.83 0.93 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.49 0.23 5.6 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.609 -1.186 . . . . 0.0 113.5 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.35 123.34 24.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.5 1.955 . . . . 0.0 112.383 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.08 8.66 0.95 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -146.09 126.24 13.81 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.347 -1.471 . . . . 0.0 109.374 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 72' ' ' ILE . 2.3 tp -120.68 139.78 52.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.23 146.75 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -121.86 136.33 54.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.384 1.474 . . . . 0.0 107.154 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 p -111.37 33.69 4.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.122 0.963 . . . . 0.0 111.246 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.85 161.66 20.22 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -113.75 4.17 15.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -157.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.99 147.81 19.46 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.466 1.03 . . . . 0.0 109.64 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.52 -27.51 70.04 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.042 3.161 . . . . 0.0 113.695 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m -72.58 -13.24 61.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.36 7.17 4.6 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.061 -1.024 . . . . 0.0 112.125 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -139.89 179.45 6.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.162 2.185 . . . . 0.0 109.336 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -139.25 179.4 6.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.977 2.111 . . . . 0.0 108.625 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -161.06 1.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.21 -108.14 0.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -150.69 38.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.747 1.619 . . . . 0.0 109.568 163.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.09 28.38 0.2 Allowed Glycine 0 C--O 1.225 -0.415 0 CA-C-O 118.043 -1.421 . . . . 0.0 114.285 -165.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 64' ' ' LEU . 7.2 tt -45.29 -41.97 9.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.55 1.675 . . . . 0.0 112.175 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -117.89 26.15 9.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.856 1.262 . . . . 0.0 112.071 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -58.55 141.64 51.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 110.151 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 -29.95 3.03 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.341 0.972 . . . . 0.0 112.389 -173.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.17 -179.82 4.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.269 1.828 . . . . 0.0 110.25 -175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -161.02 106.87 1.4 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.58 1.152 . . . . 0.0 107.973 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -139.13 167.27 22.43 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.245 1.418 . . . . 0.0 109.76 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.9 mt -89.92 141.93 28.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.949 1.299 . . . . 0.0 108.986 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.412 HG23 HD23 ' A' ' 48' ' ' LEU . 9.9 mt -90.19 138.12 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.627 1.971 . . . . 0.0 105.823 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.2 m -120.81 136.0 55.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.31 161.11 62.36 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 124.615 1.166 . . . . 0.0 107.997 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.04 147.7 84.68 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.997 1.035 . . . . 0.0 110.425 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -50.34 -37.2 35.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.236 1.014 . . . . 0.0 112.6 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -31.93 59.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.797 -0.565 . . . . 0.0 110.482 -170.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.23 -5.84 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.926 1.29 . . . . 0.0 112.302 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.4 tp -56.14 -38.04 70.28 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 112.12 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -69.8 -47.4 62.98 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.57 -0.706 . . . . 0.0 111.409 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -49.03 -53.28 20.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.136 1.774 . . . . 0.0 111.955 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -66.12 -42.6 88.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.288 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -57.1 -48.67 78.04 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.936 0.789 . . . . 0.0 111.657 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -68.87 -11.54 60.64 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.34 137.85 48.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.308 0.958 . . . . 0.0 111.218 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -61.4 -38.08 85.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.384 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.59 -66.73 0.66 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.369 1.068 . . . . 0.0 108.46 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -58.68 -23.17 58.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.563 -1.208 . . . . 0.0 112.232 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -44.7 -35.18 2.54 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -56.27 -41.1 75.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.085 0.402 . . . . 0.0 110.153 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -89.43 9.91 24.58 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 112.432 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -65.27 -22.06 66.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.083 -1.635 . . . . 0.0 112.393 -167.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.1 -19.16 64.17 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -113.43 5.27 16.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.891 0.769 . . . . 0.0 112.007 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 92' ' ' ALA . 29.9 mt -86.98 134.05 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.471 1.508 . . . . 0.0 109.271 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.42 166.44 19.94 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.694 1.998 . . . . 0.0 111.51 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.7 175.83 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.002 2.468 . . . . 0.0 112.599 169.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 126.134 1.774 . . . . 0.0 109.39 174.491 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.543 0.928 0 N-CA-C 109.704 -0.922 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.56 165.57 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 126.379 1.871 . . . . 0.0 107.948 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.676 HG23 ' CE ' ' A' ' 13' ' ' LYS . 2.1 p -93.48 95.79 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.12 -84.99 1.5 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.8 mtp -128.38 -56.79 1.23 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.197 1.799 . . . . 0.0 109.954 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 115.93 23.42 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.34 -0.85 . . . . 0.0 110.49 -163.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.676 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -72.6 4.02 4.37 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -164.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.5 m -114.27 62.61 0.66 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.846 2.112 . . . . 0.0 112.33 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -133.9 4.47 3.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.402 1.081 . . . . 0.0 112.529 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.03 -55.96 3.25 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.443 1.497 . . . . 0.0 111.145 -167.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.28 92.57 0.04 OUTLIER 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.47 -6.04 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.199 -1.334 . . . . 0.0 112.988 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -139.34 144.85 38.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.056 1.928 . . . . 0.0 112.525 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.1 p -115.65 16.34 16.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.44 2.296 . . . . 0.0 113.264 -159.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.72 14.02 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 127.81 2.444 . . . . 0.0 111.254 -168.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tt -95.43 85.22 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 O-C-N 119.887 -1.758 . . . . 0.0 108.464 -165.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -87.51 18.14 4.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.032 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.95 145.92 26.75 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -137.19 104.25 3.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -70.13 144.26 52.1 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 162.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.6 123.01 35.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.19 161.82 66.52 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.809 -0.557 . . . . 0.0 109.909 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.79 167.2 26.76 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.583 2.189 . . . . 0.0 111.285 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 45.09 42.68 6.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.365 2.266 . . . . 0.0 114.411 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 tt -141.42 2.17 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.417 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . 178.16 130.47 1.41 Allowed Glycine 0 C--N 1.336 0.561 0 O-C-N 120.056 -1.653 . . . . 0.0 112.546 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 tp -59.09 136.67 58.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 164.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.5 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 5.5 mt -100.64 75.08 1.71 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.205 1.002 . . . . 0.0 109.408 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -75.03 163.22 27.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.96 0.504 . . . . 0.0 111.63 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 10.6 p-10 -69.32 114.62 7.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.563 1.545 . . . . 0.0 110.517 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.54 -5.75 24.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.297 1.427 . . . . 0.0 112.761 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' A' ' 34' ' ' LEU . 16.6 mtp -50.17 -54.0 23.84 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.952 1.301 . . . . 0.0 111.796 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -98.29 9.9 41.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.624 1.17 . . . . 0.0 111.497 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.403 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 11.6 t -66.76 112.28 4.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.34 -4.38 37.79 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.838 0.732 . . . . 0.0 112.598 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -76.58 72.63 3.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.331 1.565 . . . . 0.0 108.508 168.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 p -72.87 4.05 4.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.266 2.226 . . . . 0.0 113.189 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 49.89 1.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.215 1.806 . . . . 0.0 107.667 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.3 tp -122.67 105.34 10.0 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.32 -11.43 7.93 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.583 1.177 . . . . 0.0 114.159 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -129.98 124.2 32.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.537 HD21 HD21 ' A' ' 50' ' ' LEU . 2.4 tp -117.89 140.53 49.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.26 132.18 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.537 HD21 HD21 ' A' ' 48' ' ' LEU . 25.3 mt -110.92 113.85 26.73 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.481 0.713 . . . . 0.0 109.263 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.69 12.8 6.54 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.45 177.22 27.04 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -136.48 29.9 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 109.261 -170.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.69 147.3 9.4 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.314 -0.866 . . . . 0.0 111.35 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.33 -42.84 9.35 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.706 2.938 . . . . 0.0 112.592 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -74.67 -15.31 60.81 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.377 -0.827 . . . . 0.0 112.759 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.79 -7.92 43.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.889 0.768 . . . . 0.0 113.06 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.41 -168.63 1.34 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.27 1.428 . . . . 0.0 109.579 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.9 m -145.62 172.69 12.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.552 1.541 . . . . 0.0 107.052 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.87 137.85 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.09 -165.39 11.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 156.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.57 -59.89 4.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.283 0.563 . . . . 0.0 109.536 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 36' ' ' ASP . . . -87.72 65.75 3.49 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 125.021 1.296 . . . . 0.0 111.45 -170.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.8 tp -45.07 -48.42 11.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.299 1.04 . . . . 0.0 110.719 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.94 36.69 2.78 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.567 -0.708 . . . . 0.0 111.108 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.66 121.2 12.2 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.445 -1.41 . . . . 0.0 110.029 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 83.73 10.18 81.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.08 171.89 13.45 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.674 1.237 . . . . 0.0 108.485 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -140.08 94.23 2.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 122.218 1.008 . . . . 0.0 108.299 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.59 165.04 16.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.272 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.8 mt -105.12 158.14 16.78 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.088 1.355 . . . . 0.0 109.051 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.78 101.39 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 127.089 2.155 . . . . 0.0 106.548 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.9 m -75.27 127.11 32.43 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.88 156.18 80.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 125.309 1.444 . . . . 0.0 107.116 172.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.59 143.16 67.48 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -51.61 -43.03 62.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.05 1.74 . . . . 0.0 110.568 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.91 -10.11 12.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.71 -4.66 12.16 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 125.139 1.376 . . . . 0.0 112.434 168.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.64 -59.1 5.93 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 121.286 1.857 . . . . 0.0 110.841 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.48 -18.05 61.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.457 0.646 . . . . 0.0 112.222 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -66.24 -45.06 81.96 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.462 2.305 . . . . 0.0 110.0 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -64.05 -49.91 70.47 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -56.27 -32.25 64.36 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.732 1.151 . . . . 0.0 113.947 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -80.69 2.27 26.65 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -64.13 167.04 6.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.393 1.092 . . . . 0.0 111.554 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.03 -45.61 60.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.746 0.818 . . . . 0.0 110.702 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -104.0 -47.93 4.04 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.048 0.939 . . . . 0.0 111.091 -162.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -55.03 -21.15 11.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.893 0.769 . . . . 0.0 112.188 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -46.15 -45.19 16.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.265 1.826 . . . . 0.0 113.099 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 t -64.56 -25.5 68.0 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.338 0.517 . . . . 0.0 110.297 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.28 9.34 38.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.24 1.816 . . . . 0.0 112.62 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -8.94 32.58 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.36 -1.463 . . . . 0.0 112.168 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.12 -18.62 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.471 1.032 . . . . 0.0 113.488 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -112.48 -4.3 14.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 112.629 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.44 134.23 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.62 160.08 55.1 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.153 0.981 . . . . 0.0 111.031 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.17 164.12 26.48 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 111.963 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 CA--C 1.533 0.3 0 C-N-CA 126.389 1.876 . . . . 0.0 111.645 176.305 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 N--CA 1.458 -0.611 0 N-CA-C 107.483 -1.776 . . . . 0.0 107.483 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.96 140.75 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.534 1.134 . . . . 0.0 108.163 -164.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 27' ' ' VAL . 41.8 t -76.43 77.79 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.04 72.32 0.46 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.365 1.46 . . . . 0.0 110.086 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.39 9.49 2.02 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.467 1.907 . . . . 0.0 115.895 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -132.23 159.14 39.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.284 1.402 . . . . 0.0 109.374 158.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -138.46 31.92 2.32 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.392 1.477 . . . . 0.0 112.22 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.0 t -133.67 29.0 3.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.799 1.24 . . . . 0.0 110.882 175.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -115.4 2.72 13.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.161 1.785 . . . . 0.0 112.42 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.27 -41.07 11.77 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.967 -1.083 . . . . 0.0 110.926 -163.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.59 84.79 1.15 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.311 1.044 . . . . 0.0 109.759 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.06 -41.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -87.34 91.16 8.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.015 0.912 . . . . 0.0 112.37 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.2 p -70.94 33.48 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 128.425 2.69 . . . . 0.0 114.589 -171.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.0 1.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 120.352 -1.468 . . . . 0.0 112.319 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -71.9 83.89 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-O 121.975 0.893 . . . . 0.0 111.473 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -79.37 4.31 15.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.797 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -153.29 138.28 17.23 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.1 1.36 . . . . 0.0 108.427 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -134.66 126.0 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 167.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.5 m -102.49 122.15 43.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 9' ' ' VAL . 2.3 t -112.12 112.49 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.96 1.304 . . . . 0.0 107.962 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -65.15 164.02 26.3 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.329 0.652 . . . . 0.0 110.491 167.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.24 154.97 68.98 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.216 1.944 . . . . 0.0 110.627 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.69 51.85 8.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.784 2.034 . . . . 0.0 113.109 171.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 tt -136.95 84.0 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 124.227 1.965 . . . . 0.0 107.808 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.82 149.48 0.11 Allowed Glycine 0 CA--C 1.525 0.682 1 C-N-CA 131.168 4.223 . . . . 0.0 113.014 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.86 HD21 ' HB3' ' A' ' 35' ' ' TYR 0.334 0.0 OUTLIER -64.81 155.33 34.29 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.792 -0.828 . . . . 0.0 110.195 170.789 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.534 ' H ' ' HB2' ' A' ' 59' ' ' SER . 5.0 mt -102.15 123.09 45.4 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 168.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.86 ' HB3' HD21 ' A' ' 33' ' ' LEU . 23.7 p90 -122.53 175.51 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 111.306 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.9 126.4 27.88 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.419 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.45 46.81 93.6 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 mtp -70.64 -34.24 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.815 1.246 . . . . 0.0 110.805 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -114.84 29.85 7.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.088 1.355 . . . . 0.0 110.655 -167.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.3 t -61.73 109.69 1.3 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.891 0.876 . . . . 0.0 110.53 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.79 12.88 55.03 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.978 -0.901 . . . . 0.0 113.462 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -78.2 73.82 4.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.392 1.596 . . . . 0.0 109.441 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 p -68.06 -3.17 9.36 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.971 2.508 . . . . 0.0 113.5 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.68 53.43 1.85 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.486 1.514 . . . . 0.0 107.889 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 tp -129.63 111.78 13.03 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.607 1.563 . . . . 0.0 107.882 174.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.77 8.95 3.06 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -137.3 152.7 50.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 O-C-N 120.878 -1.139 . . . . 0.0 110.503 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.8 tp -146.1 94.03 2.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.86 1.664 . . . . 0.0 107.169 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -82.71 141.52 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -128.18 118.05 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 p -88.48 -4.53 58.6 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -167.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.8 154.31 20.56 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 119.064 0.847 . . . . 0.0 112.111 -167.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.31 -2.82 58.49 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.37 148.1 39.42 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 120.288 1.403 . . . . 0.0 111.868 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.91 -23.61 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.23 2.62 . . . . 0.0 113.803 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 t -73.69 -21.18 60.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.698 1.599 . . . . 0.0 110.869 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.26 6.27 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.263 1.825 . . . . 0.0 113.031 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -141.72 175.36 9.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.261 1.824 . . . . 0.0 111.001 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.534 ' HB2' ' H ' ' A' ' 34' ' ' LEU . 3.8 m -135.12 -171.95 2.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.42 2.688 . . . . 0.0 108.584 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 177.1 -13.56 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.393 1.477 . . . . 0.0 113.425 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.22 -100.24 0.51 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.588 1.566 . . . . 0.0 110.134 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -140.39 -13.16 1.02 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.372 1.069 . . . . 0.0 111.299 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.08 42.8 0.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 124.007 0.813 . . . . 0.0 111.343 -159.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -44.47 -55.56 4.97 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.216 1.406 . . . . 0.0 111.569 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -98.33 12.38 35.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.931 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -64.32 158.28 23.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.266 0.939 . . . . 0.0 110.17 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.8 6.52 51.71 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.894 1.235 . . . . 0.0 114.695 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.26 -163.84 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.318 2.247 . . . . 0.0 107.499 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -155.74 112.29 3.16 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 120.456 -1.403 . . . . 0.0 110.051 164.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 175.42 8.02 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.56 1.144 . . . . 0.0 112.774 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.2 tp -111.04 155.75 22.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.954 2.502 . . . . 0.0 108.553 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.9 mt -117.76 138.9 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.462 1.105 . . . . 0.0 108.206 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.93 130.7 50.62 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.556 1.542 . . . . 0.0 107.686 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 82' ' ' TYR . 34.6 m -131.74 160.18 68.66 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.18 144.54 69.33 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.44 -29.99 27.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.53 0.732 . . . . 0.0 111.477 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.05 -33.08 73.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.022 1.329 . . . . 0.0 112.29 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.53 -3.82 19.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.584 1.154 . . . . 0.0 112.391 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.88 -46.4 74.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.47 -36.93 60.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.04 -52.5 42.53 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 109.799 172.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.476 ' CD2' HG11 ' A' ' 74' ' ' VAL . 3.2 m-85 -63.91 -42.03 97.51 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.868 0.867 . . . . 0.0 109.817 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -67.01 -11.61 57.51 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -110.12 18.13 20.3 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.027 1.731 . . . . 0.0 110.707 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -79.53 159.43 26.9 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.757 -1.214 . . . . 0.0 112.036 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -81.71 -35.47 29.74 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.124 -0.985 . . . . 0.0 112.103 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -90.96 -54.21 4.06 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.606 -0.684 . . . . 0.0 109.225 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -69.54 -12.51 61.71 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -47.43 -35.5 8.55 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 121.27 1.85 . . . . 0.0 115.158 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -63.15 -41.41 99.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.116 0.871 . . . . 0.0 111.181 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -75.94 3.77 9.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.221 1.008 . . . . 0.0 112.35 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -63.85 -19.87 65.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.678 -1.263 . . . . 0.0 112.024 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.5 -5.94 6.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.742 -1.123 . . . . 0.0 113.626 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -133.41 12.61 4.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.369 1.44 . . . . 0.0 112.474 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 92' ' ' ALA . 54.3 mt -89.54 130.78 38.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -138.08 165.39 33.79 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 111.284 165.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 176.37 2.48 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.446 2.097 . . . . 0.0 111.36 168.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 125.731 1.613 . . . . 0.0 107.311 175.044 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 N-CA-C 110.397 -0.655 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -134.67 165.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -169.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.06 70.07 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.381 -0.824 . . . . 0.0 108.796 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.99 69.51 0.51 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.1 mtp 58.42 13.8 2.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.679 1.992 . . . . 0.0 115.61 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.27 172.07 13.38 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.301 1.41 . . . . 0.0 109.899 157.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 13' ' ' LYS . 7.7 mmpt? -118.2 4.6 11.95 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.254 1.422 . . . . 0.0 113.422 -175.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -82.43 -23.93 34.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.395 1.452 . . . . 0.0 113.301 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.88 62.27 4.06 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.531 . . . . 0.0 111.999 -165.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -142.24 -49.06 0.36 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.686 -1.259 . . . . 0.0 112.13 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.77 66.06 2.0 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.476 1.11 . . . . 0.0 110.57 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 -34.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.587 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' O ' HG22 ' A' ' 22' ' ' ILE . 55.4 t30 -94.9 80.58 3.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.413 1.606 . . . . 0.0 112.297 -168.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.5 p -62.34 24.21 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 130.869 3.668 . . . . 0.0 116.511 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.36 -14.48 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 128.552 2.741 . . . . 0.0 110.947 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 19' ' ' ASN . 16.4 tt -62.51 99.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 119.348 0.976 . . . . 0.0 110.099 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -4.11 52.96 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.736 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -152.56 134.1 14.53 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 119.033 0.833 . . . . 0.0 112.163 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.5 108.88 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -81.0 146.53 30.63 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -139.65 115.0 8.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -66.5 164.2 34.06 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 118.202 0.455 . . . . 0.0 110.172 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.32 162.38 36.49 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.849 1.699 . . . . 0.0 110.848 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 44.7 56.47 5.17 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.187 2.595 . . . . 0.0 112.693 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.5 tt -144.69 71.12 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 124.282 1.992 . . . . 0.0 109.37 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.46 170.81 42.4 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 126.988 2.232 . . . . 0.0 112.416 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.4 tp -83.84 133.71 34.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.901 1.28 . . . . 0.0 110.638 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.42 122.1 28.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 159.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -126.75 175.51 7.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.817 1.247 . . . . 0.0 109.35 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.42 156.14 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.829 0.851 . . . . 0.0 110.237 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 63.75 -1.01 2.69 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.737 2.113 . . . . 0.0 115.307 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -29.65 60.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.013 1.725 . . . . 0.0 112.643 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -110.56 18.45 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.795 1.238 . . . . 0.0 113.373 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 t -56.91 105.54 0.23 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.776 0.831 . . . . 0.0 111.577 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.43 23.47 39.95 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.128 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -72.37 76.96 1.02 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.743 1.772 . . . . 0.0 109.182 164.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -71.79 15.68 0.14 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.816 2.446 . . . . 0.0 114.243 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.41 4.39 1.98 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.759 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -68.37 119.85 13.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.394 0.997 . . . . 0.0 110.631 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -122.25 -35.21 3.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.31 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -121.06 141.91 50.32 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 122.021 2.192 . . . . 0.0 113.178 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.7 tp -119.74 138.99 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.916 2.487 . . . . 0.0 104.561 161.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.05 140.59 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -115.44 151.38 34.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -119.47 5.14 11.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 112.395 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.12 169.03 30.37 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 118.971 0.805 . . . . 0.0 111.828 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.39 15.69 8.96 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.59 152.7 42.2 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 120.641 -1.287 . . . . 0.0 108.632 163.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -3.32 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 124.526 3.484 . . . . 0.0 113.896 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 m -91.48 14.64 14.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.865 1.212 . . . . 0.0 112.495 161.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.59 -4.49 55.26 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.181 1.355 . . . . 0.0 113.497 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -129.07 174.74 9.27 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.987 1.715 . . . . 0.0 109.72 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -119.35 172.4 7.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.807 1.643 . . . . 0.0 108.316 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -174.06 118.81 0.25 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 127.977 2.511 . . . . 0.0 105.948 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.66 -178.91 5.27 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 125.817 1.675 . . . . 0.0 109.425 161.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.51 -38.82 88.74 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.452 1.101 . . . . 0.0 111.779 -162.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.21 81.79 0.29 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 126.892 2.187 . . . . 0.0 107.832 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 tt -51.81 -47.06 64.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.544 1.172 . . . . 0.0 109.106 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -85.99 -7.0 58.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 117.573 -1.203 . . . . 0.0 114.157 -165.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -54.64 112.66 1.06 Allowed 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.684 0.615 . . . . 0.0 110.007 -159.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.38 -13.31 12.27 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.313 -1.271 . . . . 0.0 115.755 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.5 -172.43 4.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.014 1.407 . . . . 0.0 109.503 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -151.0 97.79 2.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.135 -0.978 . . . . 0.0 111.646 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.759 ' CB ' HD22 ' A' ' 45' ' ' LEU . 13.8 p90 -122.73 164.9 17.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 109.685 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.5 149.0 21.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.375 1.87 . . . . 0.0 110.689 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.26 126.34 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 m -112.78 140.15 47.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -133.39 160.21 69.53 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.075 1.35 . . . . 0.0 107.431 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.82 147.73 81.35 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.292 -1.465 . . . . 0.0 108.292 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.91 -30.21 32.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.964 0.506 . . . . 0.0 112.182 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -71.38 -25.58 62.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.871 1.268 . . . . 0.0 112.343 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.71 -3.28 46.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 113.049 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 tp -62.2 -50.09 73.19 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.358 -0.839 . . . . 0.0 113.216 -163.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -74.54 -37.85 62.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.805 0.842 . . . . 0.0 109.917 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -49.34 -52.81 25.69 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.529 1.132 . . . . 0.0 109.086 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -70.29 -30.22 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.09 0.556 . . . . 0.0 110.762 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -22.91 62.21 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.379 -0.826 . . . . 0.0 112.763 169.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -91.22 6.66 44.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.001 1.32 . . . . 0.0 112.175 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.98 159.73 24.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 120.807 1.64 . . . . 0.0 112.14 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -72.04 -43.73 64.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 120.768 -1.208 . . . . 0.0 110.978 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -95.36 -53.12 3.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.933 0.893 . . . . 0.0 110.22 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.86 -13.18 22.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.404 1.002 . . . . 0.0 113.415 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -48.64 -48.26 39.72 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.503 1.521 . . . . 0.0 114.743 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 t -52.04 -43.81 63.94 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.022 1.283 . . . . 0.0 110.171 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -80.38 6.7 11.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.435 1.094 . . . . 0.0 113.665 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.7 70.24 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.066 1.303 . . . . 0.0 111.533 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.1 -3.07 0.73 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 114.239 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -135.89 12.49 3.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.194 1.398 . . . . 0.0 112.271 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.9 mt -98.02 131.09 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.676 1.125 . . . . 0.0 108.949 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.58 166.14 26.35 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.771 2.028 . . . . 0.0 111.737 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.2 154.16 69.47 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.134 1.89 . . . . 0.0 113.214 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.3 ptp . . . . . 0 CA--C 1.536 0.433 0 C-N-CA 126.604 1.961 . . . . 0.0 109.515 173.05 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 N-CA-C 110.416 -0.648 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.29 165.78 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.242 1.417 . . . . 0.0 109.042 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 ' CE ' ' A' ' 13' ' ' LYS . 4.0 p -109.3 127.02 66.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.328 1.051 . . . . 0.0 111.806 -172.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.18 76.01 0.2 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.011 1.291 . . . . 0.0 110.018 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.4 mtm 63.19 -31.68 0.1 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.822 2.849 . . . . 0.0 115.99 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -44.39 43.39 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.746 1 C-N-CA 136.928 6.091 . . . . 0.0 118.52 169.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.629 ' CE ' HG23 ' A' ' 9' ' ' VAL . 3.1 mmtm -73.22 72.11 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 119.372 -2.08 . . . . 0.0 111.029 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.61 4.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.055 2.142 . . . . 0.0 112.266 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.06 -13.92 14.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.721 1.6 . . . . 0.0 113.096 -174.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CD1' ' SD ' ' A' ' 38' ' ' MET . 21.4 m-85 -69.4 -35.0 75.35 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.708 0.803 . . . . 0.0 111.777 -160.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 33.27 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.896 2.078 . . . . 0.0 112.827 168.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.62 -40.8 1.55 Allowed Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.5 -1.375 . . . . 0.0 112.37 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -102.37 157.28 17.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.924 1.362 . . . . 0.0 109.997 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 p -123.21 22.65 9.36 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.534 1.534 . . . . 0.0 110.671 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.05 16.79 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.13 1.772 . . . . 0.0 108.78 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -87.62 104.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -107.65 9.59 29.23 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.168 1.787 . . . . 0.0 111.646 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -154.13 148.35 25.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 156.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.45 118.25 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -82.38 125.02 30.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 166.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 28' ' ' GLN . 1.8 t -119.24 164.45 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.442 ' H ' HG12 ' A' ' 27' ' ' VAL . 36.4 mt-30 -131.24 157.86 76.9 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -167.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 59.2 Cg_endo -70.7 157.07 59.59 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -177.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m120 46.73 37.72 5.01 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.179 1.791 . . . . 0.0 114.855 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.265 4.7 tt -117.12 18.65 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.242 . . . . 0.0 113.168 -174.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.62 149.56 5.68 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.59 1.566 . . . . 0.0 110.465 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 34' ' ' LEU . 1.4 tm? -65.82 130.23 42.54 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.574 ' N ' HD13 ' A' ' 33' ' ' LEU . 2.6 mt -79.44 78.01 5.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.66 1.184 . . . . 0.0 107.904 173.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HA ' HD12 ' A' ' 33' ' ' LEU . 3.3 p90 -75.36 168.63 19.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.833 0.825 . . . . 0.0 111.432 -162.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -74.56 98.08 3.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.512 0.725 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.77 -1.72 11.02 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.833 1.682 . . . . 0.0 113.815 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.465 ' SD ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 tmm? -59.24 -37.61 77.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.723 2.009 . . . . 0.0 113.431 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -103.68 11.88 35.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.042 1.337 . . . . 0.0 112.492 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 t -69.89 94.41 0.84 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -171.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.69 -6.65 6.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.157 -1.357 . . . . 0.0 113.478 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.2 m -74.63 70.54 1.84 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.652 2.226 . . . . 0.0 109.957 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p -67.83 -11.05 57.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.807 1.243 . . . . 0.0 114.326 -168.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.6 18.44 17.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.853 1.261 . . . . 0.0 111.714 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.756 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.2 tt -79.86 119.48 22.8 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 120.458 -1.401 . . . . 0.0 108.477 -173.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.82 -17.53 5.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.505 1.522 . . . . 0.0 112.447 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -152.02 150.15 29.65 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.175 2.19 . . . . 0.0 110.859 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.443 HD21 HD21 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -150.79 145.43 25.73 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 128.45 2.7 . . . . 0.0 104.451 178.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.29 141.38 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' A' ' 58' ' ' TYR . 94.9 mt -126.97 115.03 18.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.242 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.7 p -82.17 12.32 4.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.87 175.36 32.46 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.456 -1.402 . . . . 0.0 109.893 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -132.85 19.57 4.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.76 0.824 . . . . 0.0 110.982 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -160.88 144.81 10.12 Favored Pre-proline 0 N--CA 1.467 0.411 0 C-N-CA 125.029 1.332 . . . . 0.0 109.224 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.98 -25.03 44.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.01 2.473 . . . . 0.0 113.423 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 m -65.34 -11.67 44.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.346 0.658 . . . . 0.0 112.139 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 29' ' ' PRO . . . -79.52 -1.01 35.74 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.728 1.149 . . . . 0.0 112.869 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.47 ' CE2' HD22 ' A' ' 50' ' ' LEU . 83.9 m-85 -137.78 170.51 15.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 110.468 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.7 m -156.8 149.06 23.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.928 1.291 . . . . 0.0 109.59 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.21 158.3 44.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.231 2.213 . . . . 0.0 110.106 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.3 -166.23 42.0 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.67 -24.4 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.298 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.34 73.81 0.44 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.888 1.709 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.2 -40.75 5.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.642 1.577 . . . . 0.0 110.808 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.66 24.06 7.25 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 0.0 111.415 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -51.53 121.93 7.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.144 0.884 . . . . 0.0 110.941 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.54 13.39 82.98 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.855 -0.969 . . . . 0.0 114.231 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.52 176.03 8.9 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.604 1.962 . . . . 0.0 108.178 162.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.61 76.27 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.08 -1.012 . . . . 0.0 110.159 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.756 ' HB2' HD22 ' A' ' 45' ' ' LEU . 18.8 p90 -119.83 171.06 8.68 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.391 1.076 . . . . 0.0 111.979 -165.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.03 160.79 17.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.254 1.822 . . . . 0.0 110.303 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -131.08 104.78 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.028 2.131 . . . . 0.0 110.016 -163.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.2 m -95.25 105.25 17.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.574 1.95 . . . . 0.0 113.334 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -113.22 156.14 43.45 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.702 1.201 . . . . 0.0 109.254 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.51 151.81 82.17 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.585 1.602 . . . . 0.0 109.158 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.62 -31.24 66.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.781 0.832 . . . . 0.0 112.226 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -59.51 -33.17 71.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.333 1.453 . . . . 0.0 112.093 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.08 -6.52 38.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.499 -0.751 . . . . 0.0 111.978 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -61.9 -50.66 71.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.298 0.954 . . . . 0.0 111.663 -164.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.57 -30.65 46.88 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.688 -0.633 . . . . 0.0 111.078 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -50.32 -55.17 16.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.21 1.404 . . . . 0.0 109.242 168.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.25 -37.98 85.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.235 0.614 . . . . 0.0 111.054 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -68.12 -28.16 67.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 118.463 -0.78 . . . . 0.0 112.863 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.11 3.95 47.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.02 1.282 . . . . 0.0 113.291 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.36 148.36 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.738 0.815 . . . . 0.0 112.029 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -58.64 -42.77 89.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 112.815 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -102.88 -52.94 2.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.154 0.981 . . . . 0.0 109.731 -171.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -60.39 -12.25 8.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -44.28 -44.62 8.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 164.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.4 t -64.03 -46.35 84.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.358 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.98 6.37 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.111 -0.993 . . . . 0.0 112.812 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.11 68.3 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.663 -1.273 . . . . 0.0 111.181 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -19.04 15.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.008 0.923 . . . . 0.0 113.315 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -117.62 4.87 12.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.614 1.166 . . . . 0.0 112.673 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.5 mt -99.26 95.41 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -95.45 163.13 22.31 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.8 0.84 . . . . 0.0 109.245 173.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 96' ' ' GLN . 86.2 Cg_endo -69.48 166.57 26.79 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 168.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.6 mtm . . . . . 0 C--O 1.236 0.347 0 C-N-CA 125.127 1.371 . . . . 0.0 109.511 166.451 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 CA--C 1.543 0.972 0 CA-C-O 121.91 0.712 . . . . 0.0 113.498 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -134.48 144.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 O-C-N 120.433 -1.417 . . . . 0.0 109.341 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.927 HG13 ' HE3' ' A' ' 13' ' ' LYS . 16.6 t -77.71 94.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.66 84.25 0.22 Allowed Glycine 0 C--O 1.223 -0.554 0 N-CA-C 106.561 -2.616 . . . . 0.0 106.561 165.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 ttt 56.4 4.13 0.13 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 166.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -132.14 85.22 2.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.905 1.23 . . . . 0.0 111.51 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.927 ' HE3' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -74.81 73.49 2.09 Favored 'General case' 0 C--N 1.339 0.114 0 O-C-N 120.118 -1.614 . . . . 0.0 109.316 174.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -145.14 -16.98 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.558 1.143 . . . . 0.0 113.229 172.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.76 86.09 2.46 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 126.98 2.112 . . . . 0.0 107.817 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -142.01 -52.0 0.41 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.18 0.992 . . . . 0.0 112.047 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.92 87.17 1.01 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.22 1.808 . . . . 0.0 108.275 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 -41.59 0.05 OUTLIER Glycine 0 C--N 1.33 0.238 0 CA-C-O 118.488 -1.174 . . . . 0.0 112.535 -171.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -110.0 133.28 53.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.971 0.885 . . . . 0.0 109.909 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 p -101.28 6.3 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 114.054 -155.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.76 17.81 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 110.666 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tt -97.92 90.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.86 -17.98 62.09 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.15 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -138.99 120.06 14.55 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.675 1.125 . . . . 0.0 108.786 -165.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.92 135.57 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.6 m -117.72 133.06 56.33 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG13 HG11 ' A' ' 9' ' ' VAL . 2.2 t -132.37 122.41 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.897 1.679 . . . . 0.0 109.195 -173.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 28' ' ' GLN . 6.4 mp0 -79.14 165.06 51.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -75.36 168.71 23.99 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.967 2.445 . . . . 0.0 111.922 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 50.0 34.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.964 2.106 . . . . 0.0 114.002 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.275 4.9 tt -138.47 27.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.58 162.59 9.17 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.43 0.538 . . . . 0.0 113.791 152.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.6 tp -80.77 121.13 25.54 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 109.564 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -78.95 83.34 5.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -69.37 167.03 17.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.678 0.751 . . . . 0.0 111.447 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.2 124.91 25.55 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.817 1.247 . . . . 0.0 110.094 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.16 28.54 66.12 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.659 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.7 mtp -54.29 -35.04 62.17 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.2 1.5 . . . . 0.0 110.128 161.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.3 22.09 16.27 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.191 1.796 . . . . 0.0 111.807 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.419 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -67.34 121.22 15.26 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.22 11.06 70.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.949 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.95 91.13 1.52 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.47 1.635 . . . . 0.0 108.485 171.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -3.68 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.933 2.093 . . . . 0.0 113.677 -166.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.16 68.0 1.3 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 161.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.6 tp -121.17 109.93 15.57 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.634 1.173 . . . . 0.0 109.978 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -139.98 30.66 2.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.816 0.446 . . . . 0.0 112.103 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -157.02 147.54 21.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 119.874 -1.766 . . . . 0.0 110.196 169.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.657 HD12 HG23 ' A' ' 72' ' ' ILE . 2.1 tm? -134.41 150.22 50.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.195 1.798 . . . . 0.0 107.157 172.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.1 mp -137.62 145.4 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.7 mt -128.6 108.56 10.61 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.323 0.965 . . . . 0.0 111.775 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.284 9.5 t -93.44 57.43 2.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.082 1.353 . . . . 0.0 109.51 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.34 175.54 20.11 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.687 2.565 . . . . 0.0 107.95 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -132.17 6.39 4.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.616 0.766 . . . . 0.0 111.956 -165.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.1 144.11 19.27 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 119.658 1.117 . . . . 0.0 109.974 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -70.43 -30.06 19.76 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.899 2.399 . . . . 0.0 113.25 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 m -74.29 -18.29 60.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.711 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.5 15.12 0.19 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.373 1.469 . . . . 0.0 114.018 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -139.7 170.14 16.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.558 1.943 . . . . 0.0 108.077 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.0 m -138.0 165.49 26.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.391 1.077 . . . . 0.0 108.427 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.7 163.47 37.23 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.986 1.714 . . . . 0.0 106.931 162.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -154.06 27.17 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 164.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -23.04 65.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.582 0.753 . . . . 0.0 112.013 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 76.97 0.25 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -169.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.9 tp -45.58 -61.07 1.85 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.405 1.482 . . . . 0.0 110.824 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -90.46 16.81 8.21 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.979 1.312 . . . . 0.0 111.265 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -56.91 140.53 48.2 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.635 1.107 . . . . 0.0 109.348 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 87.15 -10.15 69.84 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.315 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.95 -174.31 3.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.212 1.805 . . . . 0.0 109.704 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -155.58 100.78 2.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.411 1.484 . . . . 0.0 108.283 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -138.1 171.32 14.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.43 1.492 . . . . 0.0 110.47 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -101.81 151.71 21.74 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.203 1.401 . . . . 0.0 110.697 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.657 HG23 HD12 ' A' ' 48' ' ' LEU . 44.4 mt -106.79 104.4 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 126.53 1.932 . . . . 0.0 109.363 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.8 m -80.55 131.64 35.56 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.87 159.16 71.27 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 126.059 1.743 . . . . 0.0 108.311 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.35 157.7 49.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 121.459 1.557 . . . . 0.0 110.781 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -66.31 -24.72 66.59 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.15 -43.29 82.68 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.37 1.468 . . . . 0.0 110.396 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.09 -8.62 59.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.698 0.399 . . . . 0.0 111.269 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.41 -46.78 84.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.077 0.951 . . . . 0.0 111.24 -167.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.47 -29.81 59.71 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.548 -1.345 . . . . 0.0 110.495 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -59.07 5.83 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.615 1.566 . . . . 0.0 110.502 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -60.97 -39.65 90.41 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.92 0.782 . . . . 0.0 110.335 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 3.0 mtm180 -60.05 -39.27 85.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.896 -0.503 . . . . 0.0 110.121 -174.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -76.66 0.19 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.382 1.473 . . . . 0.0 113.685 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.57 173.02 8.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.993 1.27 . . . . 0.0 112.13 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -91.81 -21.25 20.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.837 1.655 . . . . 0.0 112.963 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 -56.53 2.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.915 1.286 . . . . 0.0 110.735 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -59.22 -11.42 3.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.324 1.9 pt20 -44.43 -62.31 1.22 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.683 2.393 . . . . 0.0 114.629 168.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -46.4 80.87 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -67.8 -6.6 22.1 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.093 -1.004 . . . . 0.0 113.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.54 61.46 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 119.973 -1.704 . . . . 0.0 112.171 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.5 57.57 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -124.33 -1.43 8.14 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.2 1.0 . . . . 0.0 112.465 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 82' ' ' TYR . 64.8 mt -85.14 134.31 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.52 164.91 33.68 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 126.282 1.833 . . . . 0.0 109.674 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.98 171.07 7.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.334 2.023 . . . . 0.0 112.814 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtt . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 123.172 1.463 . . . . 0.0 109.897 168.485 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.54 0.802 0 N-CA-C 111.024 -0.414 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -144.6 143.07 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.26 165.98 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.561 1.544 . . . . 0.0 111.331 165.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.16 -95.98 0.1 Allowed Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 104.002 -3.639 . . . . 0.0 104.002 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtt -141.41 27.08 1.92 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.246 1.023 . . . . 0.0 112.434 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -146.57 164.56 32.21 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.354 -0.841 . . . . 0.0 109.342 161.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -129.36 11.93 5.92 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -163.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.39 -16.82 30.08 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 122.403 2.365 . . . . 0.0 113.287 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.61 23.03 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.454 2.702 . . . . 0.0 114.877 -161.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.53 -33.71 4.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.4 -1.437 . . . . 0.0 111.298 -165.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.77 56.94 2.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.603 0.761 . . . . 0.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.97 -18.12 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 CA-C-O 117.77 -1.572 . . . . 0.0 115.974 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -119.95 147.73 44.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.808 . . . . 0.0 111.486 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -126.9 16.57 7.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 111.559 -155.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.81 29.41 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 126.104 1.762 . . . . 0.0 109.583 -166.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tt -113.87 98.5 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 126.706 2.002 . . . . 0.0 106.987 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 mtt85 -89.27 -9.62 49.94 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.071 -1.442 . . . . 0.0 111.144 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.97 135.75 36.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.626 1.557 . . . . 0.0 109.097 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 mt -138.94 102.76 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.2 m -90.78 94.55 9.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.44 127.37 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 120.209 -1.557 . . . . 0.0 110.223 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -79.6 162.67 62.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.656 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.83 164.83 31.19 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.922 2.415 . . . . 0.0 111.085 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 45.15 49.89 9.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.994 2.118 . . . . 0.0 112.015 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.91 -5.02 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.31 158.42 11.04 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 120.636 -1.29 . . . . 0.0 111.384 157.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' H ' ' A' ' 34' ' ' LEU . 36.5 tp -57.17 158.39 5.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.9 mt -124.87 81.62 1.97 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.125 1.37 . . . . 0.0 109.494 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -70.19 174.68 5.25 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.616 -0.678 . . . . 0.0 112.189 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -73.24 131.1 41.57 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 120.631 -1.293 . . . . 0.0 109.736 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 66' ' ' ASP . . . 81.19 8.3 87.44 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.612 -1.105 . . . . 0.0 113.222 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -12.55 2.01 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.81 2.305 . . . . 0.0 113.038 175.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -122.05 11.5 10.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.36 1.464 . . . . 0.0 111.518 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.5 p -66.31 98.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.068 -1.02 . . . . 0.0 110.555 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.15 -6.35 6.8 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.107 1.337 . . . . 0.0 112.6 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.8 m -73.57 61.53 0.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.376 1.588 . . . . 0.0 111.381 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 p -72.19 25.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.998 1.719 . . . . 0.0 114.592 -171.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.92 17.02 2.3 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.528 -1.358 . . . . 0.0 111.796 161.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.773 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.3 tt -70.23 120.92 16.63 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.899 1.227 . . . . 0.0 109.193 -177.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.16 -17.46 4.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.133 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.881 1.673 . . . . 0.0 112.908 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.39 103.83 4.16 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 128.256 2.622 . . . . 0.0 104.39 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.29 142.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 58' ' ' TYR . 59.9 mt -117.11 146.38 43.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -119.6 28.12 8.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.602 0.761 . . . . 0.0 110.684 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.18 17.21 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.85 5.8 22.85 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.65 144.03 21.46 Favored Pre-proline 0 C--O 1.232 0.182 0 C-N-CA 124.83 1.252 . . . . 0.0 107.93 171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.06 -11.57 30.7 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.121 2.547 . . . . 0.0 113.691 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -59.55 -30.08 68.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.323 1.449 . . . . 0.0 111.057 167.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.76 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.881 1.272 . . . . 0.0 113.538 -166.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.477 ' CE2' HD22 ' A' ' 50' ' ' LEU . 86.0 m-85 -139.68 -175.93 4.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.271 1.829 . . . . 0.0 110.134 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 34' ' ' LEU . 8.3 t -144.42 172.74 12.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.881 2.072 . . . . 0.0 107.916 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.07 168.63 24.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.708 1.203 . . . . 0.0 108.295 161.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.0 -107.03 2.71 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -105.14 -21.41 13.27 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.186 0.594 . . . . 0.0 111.367 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.63 -136.36 3.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 105.408 -3.077 . . . . 0.0 105.408 152.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -160.37 -47.69 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.281 1.032 . . . . 0.0 110.971 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 12.42 28.79 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.249 -0.907 . . . . 0.0 112.526 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -58.97 145.93 39.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.473 1.109 . . . . 0.0 111.8 -165.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.03 -30.39 1.82 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.488 1.518 . . . . 0.0 112.778 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.67 -175.17 2.72 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 110.318 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -164.6 91.61 0.59 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.921 2.488 . . . . 0.0 106.371 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.773 ' HB2' HD22 ' A' ' 45' ' ' LEU . 24.4 p90 -134.09 172.65 12.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.595 1.958 . . . . 0.0 109.317 -172.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.15 157.46 16.98 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.809 -1.182 . . . . 0.0 110.887 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.15 102.5 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.629 1.972 . . . . 0.0 106.358 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 m -99.35 110.41 22.92 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.86 1.664 . . . . 0.0 111.195 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.8 157.8 40.76 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.18 1.354 . . . . 0.0 110.34 -166.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -65.35 147.27 87.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 CA-C-N 120.385 1.173 . . . . 0.0 110.016 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.73 -37.49 71.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.899 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -38.86 89.47 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.606 -0.684 . . . . 0.0 110.138 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.2 -18.54 49.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.7 0.8 . . . . 0.0 112.475 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.0 tp -47.26 -53.49 13.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.451 . . . . 0.0 112.576 -166.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.1 -28.37 60.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.908 1.283 . . . . 0.0 109.629 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.98 -38.58 91.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.273 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -67.89 -31.93 72.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -84.25 9.83 11.94 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.65 163.47 21.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.518 1.054 . . . . 0.0 112.773 -169.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -88.12 -36.7 16.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.477 -0.764 . . . . 0.0 111.176 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -82.77 -66.55 0.88 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -68.6 -2.79 9.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.698 1.199 . . . . 0.0 114.172 -163.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.276 1.0 OUTLIER -43.76 -56.04 4.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.651 2.38 . . . . 0.0 112.666 174.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.447 HG23 ' CD2' ' A' ' 91' ' ' TYR . 5.9 t -52.75 -40.98 63.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.412 1.085 . . . . 0.0 111.183 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CD2' HG23 ' A' ' 90' ' ' THR . 97.2 m-85 -73.69 4.3 5.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.339 -0.851 . . . . 0.0 113.073 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -59.17 -26.48 64.82 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 119.71 -1.869 . . . . 0.0 112.097 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.55 -12.3 14.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -125.92 16.22 7.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.273 0.942 . . . . 0.0 110.188 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 92' ' ' ALA . 84.8 mt -99.27 122.03 50.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -132.73 165.61 35.2 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.59 1.556 . . . . 0.0 109.239 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.99 175.02 5.05 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.167 1.912 . . . . 0.0 112.072 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 CA--C 1.537 0.445 0 C-N-CA 125.842 1.657 . . . . 0.0 110.541 175.844 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 CA--C 1.546 1.107 0 CA-C-O 121.27 0.446 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.64 158.28 31.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.58 1.952 . . . . 0.0 110.634 -165.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.672 HG13 ' CE ' ' A' ' 13' ' ' LYS . 36.7 t -80.9 67.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.977 1.311 . . . . 0.0 109.911 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.6 59.53 0.91 Allowed Glycine 0 C--N 1.332 0.353 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 69.82 -55.74 0.59 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.934 2.094 . . . . 0.0 114.016 -176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 106.9 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.548 1.539 . . . . 0.0 111.024 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.672 ' CE ' HG13 ' A' ' 9' ' ' VAL . 2.6 mmtm -94.36 81.27 3.97 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 119.612 -1.93 . . . . 0.0 108.169 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 p -168.19 -16.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.545 -162.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.14 8.23 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.073 0.851 . . . . 0.0 112.79 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.32 -64.21 0.92 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.945 1.298 . . . . 0.0 109.453 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.67 95.32 0.01 OUTLIER 'General case' 0 C--N 1.34 0.171 0 C-N-CA 127.203 2.201 . . . . 0.0 110.62 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.77 -42.82 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -81.51 112.7 18.98 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.279 0.54 . . . . 0.0 111.348 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.1 p -84.89 14.69 4.58 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.391 1.876 . . . . 0.0 112.559 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.62 46.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.687 1.595 . . . . 0.0 109.733 -170.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.28 86.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 O-C-N 120.922 -1.111 . . . . 0.0 108.88 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -68.82 -19.8 64.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.892 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -138.95 126.84 22.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.69 90.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 m -64.69 141.37 58.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.74 159.55 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 128.079 2.552 . . . . 0.0 105.964 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.401 ' O ' HG22 ' A' ' 31' ' ' ILE . 3.1 mp0 -118.36 163.8 23.46 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.15 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.442 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 61.5 Cg_endo -73.65 172.06 16.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.791 1.66 . . . . 0.0 110.883 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 51.42 27.39 3.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.33 1.852 . . . . 0.0 114.519 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 28' ' ' GLN . 5.2 tt -124.35 5.09 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 112.164 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.84 171.4 18.27 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.083 0.849 . . . . 0.0 112.692 164.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.4 tp -91.21 124.77 35.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.575 1.55 . . . . 0.0 107.402 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.21 104.64 11.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 168.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -107.97 175.49 5.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.756 1.222 . . . . 0.0 110.463 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.59 117.45 8.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.162 1.385 . . . . 0.0 111.168 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.74 40.76 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.217 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.4 mtp -61.23 -52.69 63.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.405 1.603 . . . . 0.0 108.557 156.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -90.11 22.46 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -47.77 123.91 6.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.46 10.58 86.15 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.339 -1.256 . . . . 0.0 114.358 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.9 m -75.91 67.74 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.904 2.352 . . . . 0.0 109.153 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -66.58 -26.23 67.01 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.115 2.166 . . . . 0.0 112.865 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.96 61.95 1.01 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.332 1.453 . . . . 0.0 108.455 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -109.29 129.69 55.51 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 165.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.97 -15.57 5.83 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.047 166.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -135.52 148.48 49.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 122.543 2.429 . . . . 0.0 114.122 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 70' ' ' PHE . 5.7 tp -137.77 92.17 2.65 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.788 2.835 . . . . 0.0 106.717 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.44 145.95 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -129.58 112.19 13.47 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.151 0.98 . . . . 0.0 108.634 -167.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.8 p -72.16 -6.18 40.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.606 1.093 . . . . 0.0 113.891 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 134.79 12.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.869 1.213 . . . . 0.0 110.583 -163.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.58 -14.64 60.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.926 1.29 . . . . 0.0 113.486 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.87 143.6 40.69 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 108.225 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.68 -36.45 41.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.531 2.154 . . . . 0.0 111.689 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.8 p -66.26 -12.8 58.54 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 29' ' ' PRO . . . -75.57 -6.75 51.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.37 1.068 . . . . 0.0 112.218 176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.95 177.59 4.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.748 2.019 . . . . 0.0 111.646 -174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -161.17 124.25 3.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.067 1.347 . . . . 0.0 109.383 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.37 1.62 2.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -164.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 45.4 -103.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 127.394 2.425 . . . . 0.0 113.321 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.96 -7.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.394 2.278 . . . . 0.0 111.275 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.2 25.92 3.8 Favored Glycine 0 C--N 1.336 0.572 0 O-C-N 121.127 -0.983 . . . . 0.0 112.889 -163.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.1 tp -47.18 -54.47 10.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.481 1.112 . . . . 0.0 110.704 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 74.79 0.95 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.13 125.4 44.41 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.94 -12.89 68.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.404 -170.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.21 172.02 17.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.139 2.176 . . . . 0.0 108.95 170.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -141.98 111.24 6.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.429 ' CB ' HD22 ' A' ' 45' ' ' LEU . 22.0 p90 -124.36 -178.79 4.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 128.308 2.643 . . . . 0.0 108.369 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.24 154.03 27.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.569 -1.332 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -116.89 131.4 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m -128.05 127.09 42.52 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 156.88 72.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 123.87 0.868 . . . . 0.0 108.851 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.1 153.28 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.856 1.037 . . . . 0.0 109.502 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.87 -33.15 70.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.03 -37.37 84.67 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.989 0.813 . . . . 0.0 110.316 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.94 -6.78 55.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.251 1.02 . . . . 0.0 111.527 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.5 -60.96 2.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.945 1.248 . . . . 0.0 112.386 -164.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.71 -36.0 79.68 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.447 0.699 . . . . 0.0 110.254 174.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.22 -57.52 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.984 1.714 . . . . 0.0 111.58 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -64.06 -42.76 96.9 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 124.912 1.285 . . . . 0.0 109.866 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -54.54 -39.39 67.63 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.149 -0.345 . . . . 0.0 110.791 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -81.02 8.07 9.34 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.419 1.487 . . . . 0.0 114.231 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.38 174.91 1.49 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 120.434 1.47 . . . . 0.0 110.989 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.96 -60.5 2.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.322 1.449 . . . . 0.0 111.455 163.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.92 -57.08 3.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.717 1.207 . . . . 0.0 109.774 -171.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -56.59 -17.17 7.66 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -44.59 -46.65 10.13 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 113.8 165.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 t -66.26 -31.83 72.89 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.676 -0.64 . . . . 0.0 110.518 -176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -83.35 4.72 26.13 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.389 -1.444 . . . . 0.0 112.283 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.58 5.03 2.63 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 120.219 -1.551 . . . . 0.0 112.466 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.81 -8.58 58.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.311 0.959 . . . . 0.0 112.524 167.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -138.65 14.1 2.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.665 1.12 . . . . 0.0 113.516 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.0 mt -91.7 138.97 18.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.51 164.52 39.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.183 -0.948 . . . . 0.0 109.681 165.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.91 164.4 27.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.131 1.887 . . . . 0.0 110.25 165.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.2 ptp . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 124.052 0.941 . . . . 0.0 109.873 -176.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 CA--C 1.543 0.954 0 N-CA-C 107.369 -1.82 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -152.68 164.57 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 122.183 0.992 . . . . 0.0 109.305 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.904 HG13 ' HE3' ' A' ' 13' ' ' LYS . 37.8 t -74.15 78.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 161.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.0 -167.27 32.81 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 152.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.22 39.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.639 2.22 . . . . 0.0 113.308 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' C ' ' HZ3' ' A' ' 13' ' ' LYS . 20.6 t70 -89.71 114.33 25.97 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.787 -1.821 . . . . 0.0 109.297 -159.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.904 ' HE3' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -80.75 89.1 5.77 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.365 -1.459 . . . . 0.0 108.551 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 t -156.15 -2.45 0.13 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -125.96 25.62 6.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.693 1.133 . . . . 0.0 112.363 -151.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -103.37 -36.98 7.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.591 1.156 . . . . 0.0 111.872 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 28.89 0.05 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.744 1.618 . . . . 0.0 113.038 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.35 -21.7 4.7 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.027 -1.985 . . . . 0.0 113.41 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -126.73 118.17 24.17 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 121.409 2.605 . . . . 0.0 111.615 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.0 p -74.71 18.29 0.18 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.234 2.213 . . . . 0.0 113.72 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.45 6.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.322 1.419 . . . . 0.0 111.476 -158.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -92.62 94.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.555 -1.34 . . . . 0.0 107.541 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -75.81 -13.97 60.29 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.533 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -140.41 135.89 32.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.649 1.113 . . . . 0.0 109.995 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.38 90.49 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.498 1.119 . . . . 0.0 108.767 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.9 m -65.75 141.92 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 165.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 9' ' ' VAL . 3.3 t -136.34 167.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.016 1.327 . . . . 0.0 110.505 174.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -114.34 163.99 17.58 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.279 1.432 . . . . 0.0 110.486 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.7 153.78 72.58 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.691 2.261 . . . . 0.0 109.878 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.39 64.12 1.43 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.79 2.036 . . . . 0.0 111.679 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.273 0.2 OUTLIER -140.71 55.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 123.708 1.718 . . . . 0.0 109.558 -176.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.72 49.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 125.706 1.622 . . . . 0.0 112.543 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.6 tp -105.69 131.74 52.69 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 123.212 1.482 . . . . 0.0 112.745 -157.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 5.4 mp -84.37 67.11 9.73 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.674 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -65.47 162.52 17.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.214 1.007 . . . . 0.0 110.058 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.75 109.8 12.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.681 1.192 . . . . 0.0 109.249 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.73 6.78 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.024 1.773 . . . . 0.0 112.803 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.1 -33.51 26.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.372 1.869 . . . . 0.0 113.105 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -114.89 7.94 15.81 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.875 1.67 . . . . 0.0 113.558 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -62.75 101.84 0.29 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.657 1.117 . . . . 0.0 108.616 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.86 -2.85 10.89 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.162 0.887 . . . . 0.0 113.835 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.4 m -77.54 78.7 4.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.489 2.144 . . . . 0.0 109.474 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.5 p -69.97 -23.67 63.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 112.923 -172.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.39 45.15 2.36 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.728 1.211 . . . . 0.0 108.829 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 70' ' ' PHE . 3.0 tt -98.6 109.41 22.18 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -110.66 -22.37 11.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.26 150.45 39.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.472 1.033 . . . . 0.0 111.942 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.52 142.45 24.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.958 2.503 . . . . 0.0 105.602 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.24 155.09 29.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.485 HD22 ' CE1' ' A' ' 58' ' ' TYR . 92.8 mt -128.08 127.84 43.82 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.5 172.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 p -88.52 38.27 0.86 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 110.076 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.83 159.52 24.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 125.102 1.335 . . . . 0.0 109.898 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -124.5 6.73 8.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.499 0.72 . . . . 0.0 112.482 -157.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -153.24 144.45 16.23 Favored Pre-proline 0 CA--C 1.535 0.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.64 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -66.49 -31.1 42.7 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.189 2.593 . . . . 0.0 113.059 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 m -76.22 -5.93 49.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.183 0.593 . . . . 0.0 112.044 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.99 3.16 27.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.171 0.896 . . . . 0.0 111.93 166.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.485 ' CE1' HD22 ' A' ' 50' ' ' LEU . 45.7 m-85 -133.7 165.62 24.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.87 1.319 . . . . 0.0 110.816 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -134.04 170.79 15.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.225 1.81 . . . . 0.0 108.818 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . . . -175.03 -177.56 1.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.997 3.719 . . . . 0.0 104.178 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.28 -145.91 5.34 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 0.2 21.89 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.803 -0.822 . . . . 0.0 113.015 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.99 74.47 0.11 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.832 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.483 HD23 ' C ' ' A' ' 64' ' ' LEU . 6.3 tt -44.44 -41.19 6.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.355 1.462 . . . . 0.0 109.098 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.443 ' NH1' ' H ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -125.33 34.75 4.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 126.009 1.724 . . . . 0.0 111.871 -173.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -52.26 121.14 6.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.966 0.803 . . . . 0.0 109.027 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.82 12.41 84.57 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.685 -1.064 . . . . 0.0 115.245 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 173.35 11.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.405 1.603 . . . . 0.0 109.85 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -157.43 95.16 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.782 ' HB2' HD22 ' A' ' 45' ' ' LEU . 37.8 p90 -131.62 168.9 16.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.157 1.383 . . . . 0.0 111.51 -173.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.27 146.08 29.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.21 1.004 . . . . 0.0 111.398 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.68 128.44 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 127.717 2.407 . . . . 0.0 108.688 -172.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.72 109.55 14.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.159 1.784 . . . . 0.0 112.208 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.72 160.87 26.37 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.448 1.099 . . . . 0.0 108.896 -175.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.2 138.19 65.39 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 108.01 -1.573 . . . . 0.0 108.01 171.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.6 -31.18 56.57 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.26 -33.2 75.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 -175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.81 -2.73 58.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.238 1.415 . . . . 0.0 112.273 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.97 -50.84 70.48 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 119.882 -1.761 . . . . 0.0 112.204 -166.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -65.28 -32.27 73.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.696 0.76 . . . . 0.0 111.039 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -57.27 -56.09 26.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.093 2.157 . . . . 0.0 110.419 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -60.87 -46.12 91.85 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.587 0.755 . . . . 0.0 110.587 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -58.54 -38.76 78.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.59 -0.96 22.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.911 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.56 164.88 6.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.212 1.369 . . . . 0.0 111.683 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.24 13.92 25.87 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.993 1.317 . . . . 0.0 113.162 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 60' ' ' ALA . 4.1 t80 -146.22 -59.25 0.31 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.843 2.057 . . . . 0.0 110.923 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -61.42 -9.05 4.74 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.931 1.241 . . . . 0.0 112.964 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.261 0.5 OUTLIER -43.38 -60.52 1.68 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.6 2.36 . . . . 0.0 114.177 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -50.85 37.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 109.849 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -71.02 -2.91 16.97 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.476 1.511 . . . . 0.0 113.285 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.93 -23.61 66.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.658 -1.276 . . . . 0.0 111.969 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.476 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . . . -61.0 -22.67 64.74 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.476 ' CE3' ' HB3' ' A' ' 93' ' ' ALA . 12.6 m-90 -116.41 10.45 14.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.296 1.438 . . . . 0.0 111.685 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.06 115.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.15 163.41 23.31 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.773 1.229 . . . . 0.0 109.872 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 164.34 34.37 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.171 1.914 . . . . 0.0 110.415 168.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.2 mtm . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 127.251 2.22 . . . . 0.0 111.647 174.226 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo . . . . . 0 CA--C 1.543 0.948 0 N-CA-C 113.637 0.591 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.86 139.74 47.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.52 123.6 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.165 0.586 . . . . 0.0 110.135 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.34 66.49 0.34 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 mmt 61.05 -55.43 0.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.425 2.69 . . . . 0.0 114.03 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -57.66 114.94 2.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 164.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 30.0 mmtp -104.02 88.55 3.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.38 1.072 . . . . 0.0 108.745 170.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -153.24 -14.94 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.176 0.99 . . . . 0.0 113.604 153.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.601 HD22 ' H ' ' A' ' 15' ' ' LEU . 1.7 mm? -65.55 -4.1 5.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -165.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -71.07 -51.29 26.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.571 1.148 . . . . 0.0 109.864 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.36 13.77 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.78 4.83 30.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 127.256 2.36 . . . . 0.0 112.708 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -132.4 161.29 34.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.125 1.463 . . . . 0.0 109.683 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 -3.73 10.4 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.155 1.782 . . . . 0.0 112.175 -163.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.0 0.66 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.39 . . . . 0.0 110.474 -160.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.9 tt -71.81 98.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.349 1.86 . . . . 0.0 109.138 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -78.79 -3.47 44.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 117.026 -1.464 . . . . 0.0 112.077 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -152.26 137.69 17.64 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 120.513 1.506 . . . . 0.0 111.344 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -143.72 102.32 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 108.28 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.1 m -85.59 95.75 9.43 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.11 147.79 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -108.99 163.85 16.04 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 124.838 1.255 . . . . 0.0 107.796 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.61 168.08 17.5 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.372 2.048 . . . . 0.0 109.004 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 62.93 -7.13 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 167.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.466 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 5.9 tt -99.83 54.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 121.082 1.765 . . . . 0.0 112.803 -171.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.01 166.55 39.67 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.479 -1.388 . . . . 0.0 111.722 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.6 tp -76.12 165.88 24.28 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.527 1.931 . . . . 0.0 112.033 -171.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.9 73.94 0.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.029 0.831 . . . . 0.0 108.804 169.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.45 170.41 13.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.883 -169.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 150.77 41.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.343 1.068 . . . . 0.0 110.924 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.4 -2.55 37.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.268 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ptm -62.64 -11.25 15.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.833 . . . . 0.0 114.09 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.74 13.41 11.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 111.829 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -66.96 96.88 0.45 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.456 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.93 19.02 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.391 0.996 . . . . 0.0 112.901 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.9 m -73.66 68.8 1.24 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.026 1.413 . . . . 0.0 107.245 164.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -62.63 -55.08 30.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.51 58.01 3.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.377 -0.827 . . . . 0.0 109.002 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -114.84 121.14 42.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.233 1.813 . . . . 0.0 108.025 160.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -135.79 -5.24 2.2 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 177.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -124.87 153.12 43.1 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.636 -1.29 . . . . 0.0 110.821 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.46 131.02 11.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.66 144.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.6 mt -121.45 91.39 3.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 108.198 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 t -83.04 64.42 7.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.254 1.422 . . . . 0.0 110.213 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.3 150.49 18.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.059 1.314 . . . . 0.0 110.966 166.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -89.36 -20.41 24.05 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.988 1.315 . . . . 0.0 113.324 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 159.43 54.45 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 126.896 2.078 . . . . 0.0 107.155 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 81' ' ' ARG . 10.9 Cg_endo -74.1 -45.65 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.154 3.236 . . . . 0.0 111.851 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -61.7 -25.33 67.34 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -159.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.58 2.47 6.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 113.084 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -105.78 156.02 18.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.339 1.456 . . . . 0.0 108.373 169.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -134.06 142.83 47.72 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 107.386 169.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.56 154.3 34.02 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.778 3.231 . . . . 0.0 106.849 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.98 -160.84 23.68 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 122.073 0.818 . . . . 0.0 111.797 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.04 2.15 4.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.006 1.322 . . . . 0.0 112.87 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.02 74.59 0.17 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.716 1.627 . . . . 0.0 109.726 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.98 -46.22 64.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.583 1.192 . . . . 0.0 109.484 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -106.07 37.8 2.18 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.776 1.63 . . . . 0.0 110.663 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 117.65 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.75 -11.68 38.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.262 0.934 . . . . 0.0 114.398 168.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 -178.3 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.785 1.634 . . . . 0.0 108.587 166.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -142.62 90.42 2.22 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -173.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -135.27 163.88 28.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.3 160.02 14.74 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.321 1.448 . . . . 0.0 109.664 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.45 89.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -171.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -78.79 155.9 29.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.407 -0.808 . . . . 0.0 111.031 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.78 160.83 37.19 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 125.479 1.512 . . . . 0.0 109.457 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.32 141.24 51.04 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -53.81 -31.76 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.416 1.086 . . . . 0.0 112.54 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -46.42 76.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.942 1.697 . . . . 0.0 110.475 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 81' ' ' ARG . . . -82.3 0.14 42.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 112.248 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.5 -45.22 85.18 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.58 1.082 . . . . 0.0 112.419 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.7 -44.44 90.25 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.686 0.795 . . . . 0.0 110.852 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.475 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -49.84 -53.18 27.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.97 1.308 . . . . 0.0 110.815 -171.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -66.53 -38.08 86.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.09 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -61.9 -18.0 58.65 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.437 1.017 . . . . 0.0 111.694 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -87.85 -15.26 37.26 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.65 130.21 40.61 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.319 1.872 . . . . 0.0 109.27 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -47.25 -39.25 13.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.656 1.182 . . . . 0.0 110.885 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -69.04 -74.21 0.13 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.4 1.08 . . . . 0.0 109.95 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -55.77 -22.96 26.95 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -44.67 -48.14 10.57 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -60.14 -43.59 95.6 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.691 0.678 . . . . 0.0 109.682 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.14 7.08 5.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.888 -1.133 . . . . 0.0 112.73 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -62.68 -19.73 64.15 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 120.043 -1.661 . . . . 0.0 111.996 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.75 37.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -121.01 7.94 10.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.234 1.013 . . . . 0.0 111.813 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 92' ' ' ALA . 92.3 mt -83.99 148.03 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.122 0.969 . . . . 0.0 108.995 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.33 165.3 17.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.982 1.713 . . . . 0.0 109.654 164.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 163.88 31.61 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.979 1.786 . . . . 0.0 112.299 174.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.2 ptp . . . . . 0 CA--C 1.54 0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 110.812 178.427 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 CA--C 1.536 0.598 0 N-CA-C 111.168 -0.359 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.04 146.56 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 120.764 -1.21 . . . . 0.0 109.701 -169.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.12 132.56 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.241 0.616 . . . . 0.0 110.261 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.79 82.54 0.15 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.471 ' H ' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER 48.2 28.88 1.68 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.805 1.642 . . . . 0.0 111.914 -175.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -147.9 122.42 9.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 32.9 mmtp -106.32 94.98 5.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 162.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.68 19.73 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.943 1.697 . . . . 0.0 110.598 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.52 64.91 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.225 -1.547 . . . . 0.0 111.362 -167.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.0 -10.44 1.15 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.69 17.36 21.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.139 1.336 . . . . 0.0 112.483 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.6 -6.94 20.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.626 -168.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -138.43 105.17 5.36 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 120.354 2.077 . . . . 0.0 109.677 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -72.16 9.43 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -168.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.56 39.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 128.049 2.54 . . . . 0.0 109.442 -159.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.58 96.71 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 128.274 2.63 . . . . 0.0 106.557 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -78.83 -13.3 59.88 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.213 1.005 . . . . 0.0 111.557 -170.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.07 121.27 11.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.184 1.794 . . . . 0.0 107.143 -173.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.7 mt -111.39 103.41 15.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.0 m -72.71 143.41 48.05 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.77 159.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 127.308 2.243 . . . . 0.0 106.313 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.44 ' O ' HG22 ' A' ' 31' ' ' ILE . 4.5 pt20 -131.96 163.96 46.42 Favored Pre-proline 0 N--CA 1.451 -0.375 0 C-N-CA 124.033 0.933 . . . . 0.0 110.796 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.61 146.81 55.97 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 -171.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 51.31 66.08 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.09 2.156 . . . . 0.0 110.589 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.471 HD11 ' H ' ' A' ' 11' ' ' MET . 8.6 tp -133.88 40.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.877 1.271 . . . . 0.0 111.086 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.08 156.95 24.83 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.194 -1.566 . . . . 0.0 113.386 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.5 127.19 30.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 127.828 2.451 . . . . 0.0 111.015 -171.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.17 77.17 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -67.57 165.0 17.8 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.81 0.814 . . . . 0.0 110.302 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.96 144.26 33.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.963 -1.086 . . . . 0.0 110.333 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 85.84 5.62 83.59 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.718 0.675 . . . . 0.0 112.883 -178.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 mtp -54.81 -27.2 40.1 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.808 1.243 . . . . 0.0 112.849 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.67 20.53 4.24 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.627 1.171 . . . . 0.0 111.338 -162.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 t -65.44 115.86 6.13 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.88 56.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 76.0 m -68.02 74.81 0.21 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.971 1.385 . . . . 0.0 112.813 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.6 p -63.74 -31.23 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.289 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.57 63.87 0.71 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.178 1.354 . . . . 0.0 107.918 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -123.14 120.97 34.81 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.194 2.198 . . . . 0.0 106.804 162.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.5 ' N ' HD22 ' A' ' 45' ' ' LEU 0.307 1.2 pt-20 -131.44 -4.07 3.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.018 1.327 . . . . 0.0 114.382 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -144.63 157.99 43.97 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 122.491 1.139 . . . . 0.0 113.3 170.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 49' ' ' ILE . 1.7 tm? -140.65 141.04 35.09 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.378 3.071 . . . . 0.0 104.289 177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.527 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.4 mp -135.28 142.33 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -173.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -128.07 104.69 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.687 1.195 . . . . 0.0 108.694 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -79.28 37.22 0.32 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.577 0.751 . . . . 0.0 111.003 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.83 146.69 18.69 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -97.37 16.25 20.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.991 0.516 . . . . 0.0 111.434 -165.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.75 147.5 17.88 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 110.157 -164.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.22 -41.62 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.647 2.898 . . . . 0.0 110.663 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -67.06 -22.21 65.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.575 1.55 . . . . 0.0 114.229 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.37 4.79 10.0 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 112.158 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -122.62 172.7 8.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.708 1.242 . . . . 0.0 108.995 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.78 126.51 18.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.49 35.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.226 1.41 . . . . 0.0 107.478 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.3 -127.17 5.1 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.4 14.38 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.379 1.072 . . . . 0.0 111.859 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.45 82.86 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.7 tt -52.43 -50.96 61.54 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.52 40.95 1.28 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.473 1.109 . . . . 0.0 110.694 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 21.2 t70 -65.89 136.3 55.95 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 120.82 -1.175 . . . . 0.0 107.91 169.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.85 60.55 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.776 -1.569 . . . . 0.0 114.865 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 -172.62 4.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.923 1.861 . . . . 0.0 109.444 175.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -134.76 80.18 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -94.38 167.88 11.24 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.48 149.95 28.84 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.281 1.033 . . . . 0.0 109.457 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -109.53 149.63 12.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.15 1.38 . . . . 0.0 107.926 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.1 m -129.87 130.61 45.44 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.343 1.457 . . . . 0.0 107.514 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.21 160.55 67.49 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.944 1.698 . . . . 0.0 108.395 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.55 147.75 90.35 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 120.377 1.17 . . . . 0.0 109.962 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.26 -28.12 67.8 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 -5.99 49.11 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.635 0.774 . . . . 0.0 112.053 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.15 -3.46 31.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.011 -1.055 . . . . 0.0 112.829 167.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.57 -36.59 81.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.359 0.982 . . . . 0.0 113.427 -161.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.57 -30.81 32.9 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.001 -1.062 . . . . 0.0 109.173 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.8 ttm105 -56.38 -60.27 3.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.729 1.211 . . . . 0.0 110.618 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.2 p90 -54.87 -40.64 69.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.505 0.593 . . . . 0.0 110.939 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 1.3 mtp-105 -65.49 -19.85 66.1 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.883 -0.511 . . . . 0.0 111.433 -174.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -100.45 5.28 44.2 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.831 1.252 . . . . 0.0 111.655 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.02 162.7 21.53 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.707 1.139 . . . . 0.0 110.858 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.82 -43.83 64.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.306 -0.871 . . . . 0.0 111.346 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -95.42 -60.38 1.68 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.706 1.203 . . . . 0.0 109.926 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.78 -18.61 13.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.163 1.785 . . . . 0.0 113.936 -170.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -44.98 -42.97 8.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.316 1.446 . . . . 0.0 114.265 167.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -58.71 -37.96 77.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -85.59 10.92 11.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.395 1.478 . . . . 0.0 112.847 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.78 -0.69 7.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.497 -2.002 . . . . 0.0 112.729 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.82 -15.66 53.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.314 0.961 . . . . 0.0 113.451 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -118.11 0.35 11.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.4 92.87 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -168.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -99.35 163.14 19.19 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.371 1.068 . . . . 0.0 112.659 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.75 151.89 58.06 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.212 2.608 . . . . 0.0 112.067 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 mtm . . . . . 0 C--O 1.235 0.297 0 C-N-CA 125.855 1.662 . . . . 0.0 110.784 165.028 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.447 -1.23 0 N-CA-C 108.554 -1.364 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -133.24 165.78 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.423 1.889 . . . . 0.0 108.359 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.762 HG13 ' CE ' ' A' ' 13' ' ' LYS . 11.5 t -100.1 66.87 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.049 1.74 . . . . 0.0 108.309 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.86 82.87 0.32 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.7 mmt 57.98 -58.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 130.229 3.411 . . . . 0.0 115.747 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -62.59 101.53 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.243 1.817 . . . . 0.0 111.413 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.762 ' CE ' HG13 ' A' ' 9' ' ' VAL . 2.0 mmtm -94.21 76.41 4.0 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 119.518 -1.989 . . . . 0.0 108.545 171.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.79 -9.02 0.72 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.434 1.094 . . . . 0.0 113.243 168.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 6.66 15.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -165.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CE2' HG22 ' A' ' 9' ' ' VAL . 13.9 m-85 -68.48 -43.89 75.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.139 1.336 . . . . 0.0 111.761 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.68 47.62 0.18 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.256 2.223 . . . . 0.0 112.973 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -133.16 -39.03 0.21 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-O 119.219 -0.767 . . . . 0.0 111.238 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -85.09 100.95 12.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.481 1.141 . . . . 0.0 110.878 -172.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -70.99 9.92 0.62 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.282 2.633 . . . . 0.0 113.88 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.19 55.02 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.892 1.277 . . . . 0.0 109.223 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -129.94 92.36 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.214 -0.928 . . . . 0.0 110.325 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 1.9 mmt85 -76.17 -15.26 60.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.019 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -137.36 135.62 37.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.569 1.077 . . . . 0.0 108.843 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -133.55 113.14 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.5 m -93.16 107.67 19.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.682 HG13 HG11 ' A' ' 9' ' ' VAL . 4.2 t -103.14 105.46 18.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.455 1.502 . . . . 0.0 108.386 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.509 ' HG3' HG21 ' A' ' 31' ' ' ILE . 6.3 pt20 -65.02 165.07 17.45 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.798 167.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 28' ' ' GLN . 57.5 Cg_endo -73.5 168.68 24.16 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.503 2.136 . . . . 0.0 110.15 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 46.67 39.21 6.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.91 1.684 . . . . 0.0 112.981 171.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.509 HG21 ' HG3' ' A' ' 28' ' ' GLN 0.304 5.2 tt -130.25 22.6 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 120.233 1.379 . . . . 0.0 112.386 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.53 164.33 11.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.007 0.813 . . . . 0.0 113.206 155.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.94 117.49 9.88 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 126.314 1.845 . . . . 0.0 111.54 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -74.55 95.56 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 164.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -76.29 173.79 10.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.147 0.979 . . . . 0.0 111.447 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.0 129.15 39.55 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.423 1.089 . . . . 0.0 113.004 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.62 25.18 74.01 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -45.17 -36.62 3.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.708 2.003 . . . . 0.0 113.321 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.22 13.62 20.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.07 1.748 . . . . 0.0 111.72 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -49.79 119.35 3.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.849 0.859 . . . . 0.0 111.935 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.5 20.99 79.41 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.598 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -71.91 78.67 0.89 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -76.02 -6.37 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.381 1.872 . . . . 0.0 112.305 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.48 72.9 1.45 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 162.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 39.4 tp -134.85 123.6 23.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 130.785 3.634 . . . . 0.0 109.036 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -143.03 -20.48 0.64 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -100.86 145.79 28.13 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.795 2.088 . . . . 0.0 111.163 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.35 150.38 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.65 138.18 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -111.8 155.0 24.26 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -126.2 7.49 7.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.819 0.848 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.06 179.45 41.01 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -125.97 3.76 7.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.259 0.624 . . . . 0.0 111.768 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -147.65 144.17 18.91 Favored Pre-proline 0 N--CA 1.466 0.371 0 C-N-CA 124.6 1.16 . . . . 0.0 108.963 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.2 -27.3 16.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.768 2.312 . . . . 0.0 113.43 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.4 -14.67 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.827 1.251 . . . . 0.0 111.163 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.24 -2.96 23.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.699 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.93 165.33 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.76 1.624 . . . . 0.0 109.833 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 m -139.83 123.65 17.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -126.93 -0.63 6.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.195 1.398 . . . . 0.0 113.0 -168.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.73 -97.81 0.23 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 126.831 2.158 . . . . 0.0 109.029 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -147.56 -9.6 0.42 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.007 1.723 . . . . 0.0 111.375 160.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.73 24.22 9.71 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.771 1.177 . . . . 0.0 114.04 -163.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 19.0 tp -44.46 -44.59 8.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.367 1.867 . . . . 0.0 114.092 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.83 58.57 1.64 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -164.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.05 153.15 26.03 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.29 -11.13 51.69 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 117.88 -1.511 . . . . 0.0 114.566 170.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.5 165.32 31.54 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.733 2.013 . . . . 0.0 107.946 162.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.93 86.47 2.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.32 1.048 . . . . 0.0 109.595 -168.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -112.18 174.82 5.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.892 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.67 154.09 39.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.092 2.957 . . . . 0.0 107.929 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -117.03 107.92 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 126.207 1.803 . . . . 0.0 108.354 -163.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.12 151.63 36.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.728 161.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.07 161.72 51.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.236 1.814 . . . . 0.0 107.64 164.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.07 149.61 76.97 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 108.098 -1.539 . . . . 0.0 108.098 167.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.37 -33.09 41.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.832 0.853 . . . . 0.0 111.913 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -59.28 -42.82 92.13 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.714 1.605 . . . . 0.0 111.012 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 -7.22 56.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.688 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.97 -55.18 37.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.822 1.192 . . . . 0.0 112.985 -164.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.53 -33.24 60.7 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.465 -0.772 . . . . 0.0 111.466 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -45.43 -51.62 11.21 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.791 2.036 . . . . 0.0 109.422 167.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.06 -43.43 92.3 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.233 1.013 . . . . 0.0 111.433 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.01 -19.71 65.75 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.255 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -103.09 18.8 20.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.174 1.352 . . . . 0.0 112.993 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.53 166.32 19.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.603 1.561 . . . . 0.0 111.775 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.37 -34.65 16.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.827 0.851 . . . . 0.0 111.514 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -92.04 -59.38 2.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -65.04 -12.42 50.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -170.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -44.15 -45.5 8.31 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.426 HG23 ' CD2' ' A' ' 91' ' ' TYR . 15.3 t -60.67 -43.95 97.06 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 125.623 1.569 . . . . 0.0 110.37 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.426 ' CD2' HG23 ' A' ' 90' ' ' THR . 97.3 m-85 -71.96 0.59 8.92 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.327 1.451 . . . . 0.0 112.811 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.32 71.06 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 119.864 -1.773 . . . . 0.0 111.479 -172.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.65 5.07 1.56 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -125.1 7.77 7.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.907 1.683 . . . . 0.0 111.937 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.5 mt -102.89 116.2 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.933 1.242 . . . . 0.0 109.391 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.91 155.93 63.03 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 126.057 1.743 . . . . 0.0 111.037 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.37 146.71 40.4 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.978 3.119 . . . . 0.0 111.861 172.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 39.7 mtm . . . . . 0 C--O 1.24 0.566 0 C-N-CA 125.307 1.443 . . . . 0.0 112.151 177.339 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -123.35 157.17 33.89 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 167.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -145.63 74.5 1.39 Allowed 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 165.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -167.1 161.52 14.75 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.352 -164.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.3 -2.66 1.76 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.15 -1.361 . . . . 0.0 114.279 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -111.88 86.86 7.79 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 120.089 1.945 . . . . 0.0 110.064 -172.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 84.8 Cg_endo -72.5 79.79 1.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.469 2.113 . . . . 0.0 109.47 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.28 155.51 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 120.732 -1.23 . . . . 0.0 112.179 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.59 88.47 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.731 1.612 . . . . 0.0 109.846 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 96.41 0.2 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt 58.51 17.72 5.14 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.393 1.477 . . . . 0.0 114.455 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.17 175.37 11.82 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 31' ' ' ILE . 15.4 mttm -138.27 -0.59 2.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.154 2.181 . . . . 0.0 114.507 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -81.63 -29.36 33.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.606 1.094 . . . . 0.0 112.048 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 1.2 mm? -83.59 73.64 10.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.276 1.031 . . . . 0.0 110.893 -160.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -147.16 -49.45 0.18 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.289 0.636 . . . . 0.0 110.458 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.81 71.84 1.05 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.564 1.146 . . . . 0.0 110.702 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.4 -45.55 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -82.4 104.23 12.55 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -60.94 -5.2 1.25 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.546 1.539 . . . . 0.0 114.46 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.29 30.51 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 119.85 1.204 . . . . 0.0 110.601 -152.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -104.79 88.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 124.497 1.119 . . . . 0.0 109.018 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -70.83 -11.97 61.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.758 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -140.64 135.99 32.25 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 119.855 1.207 . . . . 0.0 108.078 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.18 102.62 7.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -73.66 145.38 45.33 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.92 149.75 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.687 1.995 . . . . 0.0 107.98 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -103.14 165.11 14.18 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 125.586 1.554 . . . . 0.0 111.253 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.59 161.49 45.68 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.998 2.465 . . . . 0.0 111.309 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 53.63 23.66 3.73 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.125 2.57 . . . . 0.0 115.432 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.433 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 7.7 tt -117.17 63.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.655 1.182 . . . . 0.0 111.4 -171.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' CA ' ' HE2' ' A' ' 13' ' ' LYS . . . 95.82 164.2 34.03 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 128.407 2.908 . . . . 0.0 112.718 174.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -85.17 124.1 31.44 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 173.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 33' ' ' LEU . 1.4 mt -72.34 76.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.692 1.997 . . . . 0.0 108.099 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -72.22 -165.24 0.17 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.272 -167.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.44 165.21 19.37 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.47 -1.394 . . . . 0.0 111.356 165.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.79 11.26 35.77 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 117.689 1.835 . . . . 0.0 117.689 168.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -43.27 78.39 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 121.53 2.665 . . . . 0.0 111.326 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -116.84 5.96 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.314 1.046 . . . . 0.0 112.382 -155.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -46.69 124.74 6.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.649 1.58 . . . . 0.0 112.852 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.32 20.71 61.87 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.374 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 45' ' ' LEU . 8.4 p -71.33 75.1 0.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.524 -0.986 . . . . 0.0 111.556 175.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.0 p -59.76 -16.51 28.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.52 1.128 . . . . 0.0 112.929 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.69 71.54 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.323 0.965 . . . . 0.0 110.888 162.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 42' ' ' CYS . 52.5 tp -115.79 115.07 25.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.421 1.089 . . . . 0.0 110.095 159.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -139.12 24.26 2.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.086 0.554 . . . . 0.0 111.662 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -159.44 152.02 21.44 Favored 'General case' 0 CA--C 1.518 -0.282 0 O-C-N 120.751 -1.218 . . . . 0.0 109.922 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 tp -141.69 138.32 32.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.97 137.88 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 119.704 1.138 . . . . 0.0 108.024 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -114.7 117.27 30.34 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.107 0.963 . . . . 0.0 109.849 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -88.9 30.09 0.97 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.428 1.091 . . . . 0.0 111.735 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 164.43 18.24 Favored Glycine 0 N--CA 1.464 0.559 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -113.18 2.81 15.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -171.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.35 144.56 31.52 Favored Pre-proline 0 N--CA 1.447 -0.621 0 O-C-N 120.636 -1.29 . . . . 0.0 110.892 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -73.85 -32.37 7.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.294 2.663 . . . . 0.0 114.238 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -66.46 -25.9 66.94 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.146 0.43 . . . . 0.0 111.455 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.17 4.88 1.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.417 1.087 . . . . 0.0 113.071 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.17 149.05 52.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.559 1.072 . . . . 0.0 108.505 167.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.9 m -142.64 135.32 27.99 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.658 0.783 . . . . 0.0 109.046 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -146.26 2.6 0.88 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.56 -67.24 1.28 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.729 2.585 . . . . 0.0 113.916 163.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 174.85 -32.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 131.596 3.958 . . . . 0.0 107.734 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.47 4.17 74.44 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.407 -1.218 . . . . 0.0 115.507 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.516 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 14.2 tp -43.73 -54.03 5.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.69 1.596 . . . . 0.0 112.57 -158.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.6 33.51 5.61 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -57.54 132.66 53.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.437 1.017 . . . . 0.0 109.911 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 20.97 79.5 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.742 0.686 . . . . 0.0 113.943 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.01 178.61 7.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.43 1.492 . . . . 0.0 110.816 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.97 101.22 0.99 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.829 1.651 . . . . 0.0 108.432 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -146.05 169.08 19.4 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.631 -0.668 . . . . 0.0 112.266 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt -90.04 155.45 19.07 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 128.112 2.565 . . . . 0.0 110.82 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.4 mt -117.37 94.87 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.183 2.193 . . . . 0.0 108.222 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.82 129.7 38.45 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 121.037 -1.039 . . . . 0.0 110.125 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -130.89 160.1 68.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.52 1.528 . . . . 0.0 108.544 171.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -67.7 151.74 78.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 121.729 1.62 . . . . 0.0 110.939 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.72 -36.9 72.65 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.471 0.578 . . . . 0.0 111.594 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -72.61 -6.57 45.11 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.858 -0.527 . . . . 0.0 111.967 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.05 -8.17 20.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.087 1.355 . . . . 0.0 113.776 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.2 tp -63.01 -50.79 69.34 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.639 1.108 . . . . 0.0 111.359 -165.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -63.03 -44.73 95.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.424 1.09 . . . . 0.0 109.273 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -51.74 -53.93 34.1 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.786 1.234 . . . . 0.0 111.029 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -60.25 -38.44 83.5 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.53 0.519 . . . . 0.0 110.61 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -68.96 -25.17 64.41 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.332 -0.855 . . . . 0.0 113.091 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -87.63 -2.38 58.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.346 1.43 . . . . 0.0 112.508 173.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -71.04 157.74 37.69 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.064 0.847 . . . . 0.0 112.376 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 19.92 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.336 1.054 . . . . 0.0 113.812 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.92 -68.42 0.4 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 126.989 2.115 . . . . 0.0 108.012 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -57.53 -14.78 5.62 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.254 1.822 . . . . 0.0 114.676 -165.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -44.65 -47.0 10.49 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.506 1.048 . . . . 0.0 113.097 161.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.404 HG23 ' CD2' ' A' ' 91' ' ' TYR . 2.9 t -62.72 -16.4 57.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.79 0.836 . . . . 0.0 111.943 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CD2' HG23 ' A' ' 90' ' ' THR . 96.3 m-85 -108.35 10.97 27.47 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.039 -1.663 . . . . 0.0 111.335 175.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.15 -8.13 35.92 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 119.949 -1.719 . . . . 0.0 112.421 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.98 -6.17 57.04 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.901 0.881 . . . . 0.0 112.84 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -130.65 -14.85 3.59 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 124.06 0.944 . . . . 0.0 112.536 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.13 144.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 120.833 -1.167 . . . . 0.0 108.616 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -149.01 164.35 21.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.885 0.874 . . . . 0.0 110.882 167.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.73 149.92 73.71 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.98 2.453 . . . . 0.0 113.835 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.5 mtm -69.43 175.12 4.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.752 165.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -144.24 -176.62 5.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.703 2.801 . . . . 0.0 107.044 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--O 1.252 1.226 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 154.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m -89.94 121.38 31.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 156.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -130.16 56.26 1.76 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 170.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.68 165.01 33.63 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 128.412 2.685 . . . . 0.0 105.912 166.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.18 57.53 0.12 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 124.377 0.989 . . . . 0.0 111.097 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -68.01 162.35 60.12 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 117.848 0.824 . . . . 0.0 109.324 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -81.79 76.85 4.12 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.94 1.76 . . . . 0.0 109.539 -169.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.34 160.26 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.108 -1.62 . . . . 0.0 110.782 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.26 99.05 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.53 1.532 . . . . 0.0 108.411 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.16 121.68 1.08 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.73 -11.33 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.92 2.888 . . . . 0.0 117.429 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -135.16 153.5 51.95 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 121.122 1.783 . . . . 0.0 108.523 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HE3' HG23 ' A' ' 31' ' ' ILE . 40.9 mttt -135.35 51.61 2.07 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.229 1.811 . . . . 0.0 109.939 170.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -127.26 -17.95 4.63 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.7 75.92 0.95 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.066 1.303 . . . . 0.0 109.57 -167.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -130.51 -55.47 1.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.284 1.034 . . . . 0.0 110.71 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.68 30.52 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.806 2.043 . . . . 0.0 113.372 -165.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.05 -36.09 1.55 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 126.018 1.771 . . . . 0.0 113.07 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -89.26 102.53 15.2 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 120.283 2.042 . . . . 0.0 112.065 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.3 p -65.66 6.48 0.33 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.265 1.826 . . . . 0.0 114.21 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.82 -1.46 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.834 1.254 . . . . 0.0 109.96 -167.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.1 tt -69.54 111.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -91.05 -14.23 31.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.766 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -146.44 139.98 25.94 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.605 0.762 . . . . 0.0 110.402 -168.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.2 mt -137.4 101.41 2.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.1 132.96 45.86 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 162.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.02 133.79 67.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 126.058 1.743 . . . . 0.0 108.193 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -94.48 162.98 24.21 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 122.889 0.476 . . . . 0.0 110.969 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.79 151.9 78.13 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.291 1.994 . . . . 0.0 109.635 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 52.73 38.22 25.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.207 1.803 . . . . 0.0 113.471 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.42 HG23 ' HE3' ' A' ' 13' ' ' LYS . 5.0 tp -119.88 0.78 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.499 1.12 . . . . 0.0 113.192 -164.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.38 169.3 11.7 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.247 1.404 . . . . 0.0 112.445 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 132.49 37.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 112.028 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.96 77.98 9.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.147 1.779 . . . . 0.0 107.189 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -69.63 164.17 23.95 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.994 0.902 . . . . 0.0 110.342 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -66.99 110.83 3.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.311 1.445 . . . . 0.0 110.102 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.43 11.05 32.21 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.283 0.944 . . . . 0.0 114.546 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.5 mtp -52.93 -23.83 8.0 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -127.28 20.03 6.85 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.867 1.267 . . . . 0.0 110.736 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.3 t -63.59 94.16 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.857 1.263 . . . . 0.0 110.671 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.21 -7.74 6.0 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.939 1.733 . . . . 0.0 112.859 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.97 70.37 9.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.127 1.963 . . . . 0.0 109.501 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.9 p -67.05 -25.32 66.2 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.161 -0.962 . . . . 0.0 113.338 -167.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.0 -2.11 57.58 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.605 -1.309 . . . . 0.0 113.119 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.84 119.9 24.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.051 0.94 . . . . 0.0 110.207 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -141.11 2.75 1.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.518 0.727 . . . . 0.0 112.239 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -126.97 153.95 45.2 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.183 -1.573 . . . . 0.0 111.186 169.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 tp -146.14 100.96 3.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.434 3.494 . . . . 0.0 104.143 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.15 124.35 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 120.89 -1.132 . . . . 0.0 108.084 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 72' ' ' ILE . 3.5 mp -101.72 107.86 19.21 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 107.878 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.8 p -77.15 19.72 0.3 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.53 161.09 20.05 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 120.076 1.307 . . . . 0.0 112.445 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -97.31 -4.22 39.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.501 1.52 . . . . 0.0 112.976 -167.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.85 148.4 42.36 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 119.935 1.243 . . . . 0.0 110.4 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.28 -36.45 7.07 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.113 2.542 . . . . 0.0 112.45 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.13 -25.39 63.82 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.484 0.584 . . . . 0.0 112.441 -172.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -1.4 31.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.688 1.595 . . . . 0.0 113.434 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -127.9 126.8 42.22 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.858 1.263 . . . . 0.0 108.194 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.16 171.86 11.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.701 1.6 . . . . 0.0 109.992 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.3 146.85 3.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.496 1.118 . . . . 0.0 109.624 159.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.27 -173.06 34.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 164.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.3 -48.55 81.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.131 0.972 . . . . 0.0 109.061 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.94 36.58 3.02 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 117.536 -1.702 . . . . 0.0 112.315 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tt -44.56 -56.4 4.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.114 1.457 . . . . 0.0 107.526 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 25.31 10.33 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 125.462 1.505 . . . . 0.0 113.241 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -68.27 130.1 41.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.49 1.041 . . . . 0.0 111.619 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.83 -5.36 79.35 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.438 1.018 . . . . 0.0 114.641 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.73 -170.47 2.63 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.04 93.65 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.424 -0.798 . . . . 0.0 109.406 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -125.04 165.12 18.74 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -98.36 158.25 15.7 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 128.168 2.587 . . . . 0.0 110.145 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 50' ' ' LEU . 24.4 mt -116.05 90.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.278 1.831 . . . . 0.0 108.744 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.6 136.65 36.28 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.843 -1.161 . . . . 0.0 108.872 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.09 160.83 67.12 Favored Pre-proline 0 N--CA 1.47 0.527 0 C-N-CA 126.708 2.003 . . . . 0.0 108.379 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.49 153.58 60.55 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.555 1.504 . . . . 0.0 109.267 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.78 -35.63 64.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.071 0.548 . . . . 0.0 112.232 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.26 -42.48 73.59 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.936 1.294 . . . . 0.0 110.885 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.83 57.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.948 0.899 . . . . 0.0 112.318 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.2 tp -51.68 -61.57 2.17 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.099 1.318 . . . . 0.0 112.078 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.81 -28.38 61.6 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.533 1.133 . . . . 0.0 110.175 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -59.96 -46.16 90.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.469 1.508 . . . . 0.0 110.195 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -64.65 -41.48 96.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.03 0.832 . . . . 0.0 110.215 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -65.41 -12.64 54.25 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 116.921 -1.514 . . . . 0.0 114.361 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -96.38 2.73 52.94 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 121.685 2.039 . . . . 0.0 112.919 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.32 143.9 36.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.709 1.141 . . . . 0.0 111.994 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.72 10.45 1.39 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.044 1.338 . . . . 0.0 113.746 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -137.24 -64.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.123 1.769 . . . . 0.0 111.029 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -54.21 -20.82 7.54 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.776 1.171 . . . . 0.0 113.649 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -43.81 -47.66 8.13 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.852 1.261 . . . . 0.0 113.91 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.432 HG23 ' CD1' ' A' ' 91' ' ' TYR . 4.9 t -64.09 -24.16 67.6 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.665 0.666 . . . . 0.0 111.86 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CD1' HG23 ' A' ' 90' ' ' THR . 76.8 m-85 -96.77 14.55 24.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.361 1.064 . . . . 0.0 111.137 175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.14 -18.21 33.77 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 120.288 -1.508 . . . . 0.0 111.04 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.13 -22.36 28.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.002 0.921 . . . . 0.0 113.084 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -119.45 -8.48 10.02 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.527 1.131 . . . . 0.0 112.983 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 85.6 mt -90.11 115.65 29.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -171.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -149.27 165.46 17.62 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.269 1.028 . . . . 0.0 111.277 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.71 158.75 40.48 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.412 2.075 . . . . 0.0 114.441 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 13.4 mtm -78.15 176.34 9.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.169 1.787 . . . . 0.0 109.979 161.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -98.73 -177.45 3.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.124 0.97 . . . . 0.0 109.005 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.252 1.234 0 C-N-CA 124.925 1.29 . . . . 0.0 109.792 -179.297 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.394 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -78.74 91.76 4.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -174.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -124.76 150.42 46.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.586 1.554 . . . . 0.0 108.4 -169.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -61.77 125.09 22.59 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.162 0.985 . . . . 0.0 108.466 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.44 66.14 0.04 OUTLIER Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -115.21 160.36 34.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 125.208 1.403 . . . . 0.0 109.902 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.94 72.25 6.59 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.873 3.049 . . . . 0.0 110.48 -167.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.9 165.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.714 2.006 . . . . 0.0 107.518 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 p -113.33 157.19 14.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 109.199 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.9 -75.49 0.2 Allowed Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.5 mmt -123.69 3.17 8.9 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -167.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -136.94 156.09 48.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.5 1.046 . . . . 0.0 108.901 169.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -139.17 82.52 1.9 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.131 1.373 . . . . 0.0 110.167 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -150.01 -44.49 0.13 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.815 1.646 . . . . 0.0 111.689 162.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.61 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.85 10.48 0.05 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 -168.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -82.05 -12.64 58.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 119.801 -1.812 . . . . 0.0 113.618 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.02 79.74 1.79 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.61 -13.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.761 -1.577 . . . . 0.0 116.169 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -112.91 91.73 3.76 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 120.295 2.047 . . . . 0.0 109.345 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 p -66.35 31.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.755 3.622 . . . . 0.0 113.98 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.88 -7.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.371 1.869 . . . . 0.0 111.736 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -72.94 89.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.025 0.83 . . . . 0.0 110.511 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.5 mtm105 -72.1 -13.86 61.69 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.501 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -144.68 137.38 26.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -168.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -136.6 120.01 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.548 1.539 . . . . 0.0 106.963 170.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 m -84.42 143.75 29.22 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.949 -1.095 . . . . 0.0 108.162 158.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.42 139.79 44.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' HB2' ' HD2' ' A' ' 29' ' ' PRO . 6.0 pt20 -101.71 165.07 14.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.705 1.202 . . . . 0.0 111.573 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 28' ' ' GLN . 22.3 Cg_endo -66.71 144.95 73.85 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.631 1.554 . . . . 0.0 109.625 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 47.8 74.29 0.17 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.819 1.647 . . . . 0.0 112.282 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.268 4.8 tp -143.0 33.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 121.619 0.724 . . . . 0.0 112.153 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.48 170.88 16.89 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.84 1.686 . . . . 0.0 111.49 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.3 tp -83.92 127.38 33.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.115 0.958 . . . . 0.0 109.713 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 64' ' ' LEU . 46.6 mt -73.02 90.11 1.48 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 162.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 38' ' ' MET . 54.5 p90 -70.44 -164.61 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.91 0.884 . . . . 0.0 112.175 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -158.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.846 -0.597 . . . . 0.0 112.032 160.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.15 76.89 0.0 OUTLIER Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.57 2.033 . . . . 0.0 117.407 -165.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.464 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 30.9 mtp -67.62 -22.06 65.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.317 1.847 . . . . 0.0 111.125 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.72 10.06 4.67 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.129 0.972 . . . . 0.0 110.675 -161.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -62.38 118.16 7.12 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.33 52.32 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.709 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.1 p -68.39 73.79 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.131 1.965 . . . . 0.0 111.577 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 p -63.7 2.07 0.52 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.955 1.302 . . . . 0.0 113.627 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.91 39.88 0.87 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.229 -1.367 . . . . 0.0 112.272 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.77 120.64 42.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.477 1.944 . . . . 0.0 110.582 171.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.07 -13.3 5.12 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -117.86 162.98 17.23 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.662 1.119 . . . . 0.0 111.851 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.671 HD21 HD21 ' A' ' 50' ' ' LEU . 13.6 tp -148.67 145.76 27.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.014 2.126 . . . . 0.0 106.96 165.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -128.61 134.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.671 HD21 HD21 ' A' ' 48' ' ' LEU . 21.6 mt -111.57 112.4 24.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -74.58 -14.6 60.8 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.94 -176.44 50.75 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 124.36 0.981 . . . . 0.0 110.81 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.57 3.64 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.92 143.56 25.76 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 118.243 0.474 . . . . 0.0 110.169 -174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.63 -27.63 32.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.677 2.918 . . . . 0.0 112.373 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.9 m -75.62 9.88 2.02 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.276 -0.89 . . . . 0.0 112.553 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.04 7.43 36.47 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.255 -0.903 . . . . 0.0 112.433 162.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -138.38 111.64 7.99 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.234 1.413 . . . . 0.0 110.052 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -76.18 177.55 7.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.183 1.793 . . . . 0.0 110.848 175.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.65 160.96 15.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 129.395 3.078 . . . . 0.0 105.389 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.52 -101.63 2.73 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 105.48 -3.048 . . . . 0.0 105.48 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.04 -57.49 1.78 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.187 1.795 . . . . 0.0 108.017 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.1 74.58 0.22 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 124.486 1.041 . . . . 0.0 111.928 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 34' ' ' LEU . 2.0 tp -43.74 -41.78 5.08 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.972 2.109 . . . . 0.0 110.259 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.85 56.08 1.87 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.786 2.034 . . . . 0.0 107.985 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.46 129.86 41.5 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 164.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.29 87.13 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.069 0.842 . . . . 0.0 115.17 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.71 170.8 14.72 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.297 1.439 . . . . 0.0 110.61 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.65 101.82 2.01 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.856 1.662 . . . . 0.0 107.765 173.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.11 169.06 18.39 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.104 0.562 . . . . 0.0 111.409 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.61 HD13 ' N ' ' A' ' 72' ' ' ILE . 2.4 tm? -87.31 146.19 26.03 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.007 1.323 . . . . 0.0 110.609 -175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 71' ' ' LEU . 33.5 mt -112.01 96.49 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 128.363 2.665 . . . . 0.0 109.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.7 m -83.68 134.54 34.77 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.002 -1.061 . . . . 0.0 112.06 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.8 157.87 74.08 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 126.09 1.756 . . . . 0.0 109.443 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.96 148.86 64.73 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 CA-C-N 121.878 1.706 . . . . 0.0 111.15 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.99 -35.95 64.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.971 0.909 . . . . 0.0 112.014 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -67.8 -20.81 65.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.253 1.821 . . . . 0.0 111.852 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -112.41 -0.28 15.38 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.118 1.367 . . . . 0.0 112.4 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.23 -34.63 76.86 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.111 -0.993 . . . . 0.0 111.852 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -83.25 -33.05 26.13 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.187 0.995 . . . . 0.0 109.847 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.52 -63.31 1.16 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.235 2.214 . . . . 0.0 111.282 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -64.92 -37.13 86.62 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 122.848 0.459 . . . . 0.0 110.355 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.08 -24.79 67.83 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.445 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -85.72 -4.55 59.19 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.895 1.225 . . . . 0.0 113.067 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.01 150.05 47.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.108 1.322 . . . . 0.0 110.878 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.37 -44.57 90.95 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.455 -0.778 . . . . 0.0 110.281 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -83.28 -65.33 1.02 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.075 0.95 . . . . 0.0 109.271 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -58.0 -15.7 9.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -164.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -45.02 -43.79 9.52 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 119.567 1.076 . . . . 0.0 112.858 165.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 91' ' ' TYR . 6.8 t -63.39 -14.57 51.59 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CD1' HG23 ' A' ' 90' ' ' THR . 71.6 m-85 -113.56 14.97 19.05 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.377 -1.452 . . . . 0.0 111.663 173.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.1 3.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.341 -1.474 . . . . 0.0 112.423 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.58 -12.07 59.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.115 166.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -130.26 0.64 4.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.835 1.198 . . . . 0.0 112.805 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.9 mt -89.85 113.24 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.553 ' CG ' HD11 ' A' ' 71' ' ' LEU . 2.6 pt20 -135.42 164.64 42.22 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 126.249 1.819 . . . . 0.0 110.444 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.56 164.24 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.026 1.817 . . . . 0.0 113.407 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 mtm -82.58 172.44 12.97 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.188 1.795 . . . . 0.0 109.261 161.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -126.13 -173.15 2.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.655 1.182 . . . . 0.0 109.758 171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.608 1.963 . . . . 0.0 106.343 168.356 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.42 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.2 85.29 1.27 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.778 1.231 . . . . 0.0 107.725 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.7 m170 66.31 169.92 0.23 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.406 2.682 . . . . 0.0 111.981 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -66.41 152.44 45.09 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.263 0.625 . . . . 0.0 110.2 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.61 73.56 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -53.21 157.93 2.87 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 148.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.18 91.02 0.46 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.863 2.375 . . . . 0.0 107.954 167.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.16 130.46 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 120.554 -1.341 . . . . 0.0 107.479 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.55 122.48 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 122.913 0.485 . . . . 0.0 110.301 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.12 81.33 0.21 Allowed Glycine 0 C--O 1.223 -0.559 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 68.0 mtp 58.82 -60.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.896 2.478 . . . . 0.0 114.351 -168.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.91 91.43 2.47 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.417 1.008 . . . . 0.0 108.351 -171.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -72.71 88.55 1.3 Allowed 'General case' 0 CA--C 1.519 -0.221 0 O-C-N 120.915 -1.116 . . . . 0.0 108.02 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 p -173.21 54.13 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.922 2.089 . . . . 0.0 109.686 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.15 61.51 0.45 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.814 1.246 . . . . 0.0 110.58 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -131.44 -44.47 1.01 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.223 0.609 . . . . 0.0 111.413 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.34 77.25 1.01 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.154 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.06 -28.0 0.02 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.612 -1.66 . . . . 0.0 113.859 172.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.509 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.7 t30 -117.98 87.88 2.8 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.224 2.012 . . . . 0.0 112.769 -171.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.0 9.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 132.223 4.209 . . . . 0.0 118.108 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.87 19.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.72 1.608 . . . . 0.0 109.546 -166.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 19' ' ' ASN . 13.3 tt -89.04 113.44 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 166.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -95.86 -17.62 20.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.453 1.101 . . . . 0.0 111.444 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -148.31 134.0 18.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.93 0.769 . . . . 0.0 111.02 -160.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.431 HG12 HD11 ' A' ' 22' ' ' ILE . 7.5 mt -141.29 90.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.36 -166.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.3 m -86.16 87.71 7.47 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.558 0.743 . . . . 0.0 109.087 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.09 164.26 3.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 O-C-N 121.003 -1.061 . . . . 0.0 108.852 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' HG22 ' A' ' 31' ' ' ILE . 16.4 mt-30 -126.23 165.54 27.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.959 1.303 . . . . 0.0 109.919 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.8 149.76 60.79 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.074 1.849 . . . . 0.0 111.026 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 48.48 66.03 1.18 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.191 2.996 . . . . 0.0 111.374 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 28' ' ' GLN . 0.7 OUTLIER -144.93 55.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.545 1.138 . . . . 0.0 110.685 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.21 144.45 15.31 Favored Glycine 0 C--O 1.241 0.561 0 O-C-N 121.018 -1.051 . . . . 0.0 112.603 170.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.83 141.38 58.67 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.319 1.048 . . . . 0.0 108.445 171.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.43 77.83 2.99 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.495 1.118 . . . . 0.0 108.316 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -70.46 162.7 28.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.081 0.943 . . . . 0.0 111.12 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -70.23 113.57 7.53 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.582 1.953 . . . . 0.0 110.312 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.89 4.85 36.12 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.456 1.027 . . . . 0.0 114.156 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.7 mmm -48.2 -41.36 26.99 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.835 1.317 . . . . 0.0 112.824 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -112.27 18.75 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.789 1.236 . . . . 0.0 111.787 -165.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 t -60.22 121.2 11.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.89 12.9 65.47 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.204 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.4 m -80.03 63.52 4.58 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.855 1.327 . . . . 0.0 110.296 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.5 p -63.47 -13.74 43.64 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -164.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.14 -1.35 29.2 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.47 -1.393 . . . . 0.0 113.029 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.78 108.74 14.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 110.313 -171.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -126.46 -10.12 6.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -135.9 143.15 44.84 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.949 1.299 . . . . 0.0 111.837 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.463 HD21 HD21 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -140.46 140.31 35.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.237 2.215 . . . . 0.0 107.112 173.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -131.57 150.48 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.463 HD21 HD21 ' A' ' 48' ' ' LEU . 74.8 mt -133.39 106.55 7.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.832 1.253 . . . . 0.0 109.627 -169.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.2 p -82.27 45.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.886 0.766 . . . . 0.0 111.373 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -143.35 129.86 3.89 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 120.749 -1.219 . . . . 0.0 111.08 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.45 3.3 47.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.469 2.307 . . . . 0.0 112.753 -163.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.04 144.22 34.25 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 120.531 -1.356 . . . . 0.0 108.477 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -67.03 -33.48 31.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.735 1.623 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -62.24 -20.67 64.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.033 0.933 . . . . 0.0 112.541 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 9.82 0.43 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.956 1.702 . . . . 0.0 113.568 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.54 -177.07 5.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.758 2.023 . . . . 0.0 109.46 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 t -145.65 -177.04 5.37 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.334 1.454 . . . . 0.0 108.847 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.82 6.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 128.492 2.717 . . . . 0.0 107.947 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.23 -171.21 24.92 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 151.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.4 -51.52 43.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.21 58.37 5.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.507 1.051 . . . . 0.0 112.095 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD23 HH22 ' A' ' 65' ' ' ARG . 17.8 tp -44.94 -35.01 2.64 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.398 1.879 . . . . 0.0 112.048 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.476 HH22 HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -132.42 29.86 4.22 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 119.821 -1.799 . . . . 0.0 112.087 178.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.87 135.36 15.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.666 0.666 . . . . 0.0 111.101 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.06 -18.7 52.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.267 0.937 . . . . 0.0 112.889 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.0 -178.51 4.76 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.81 1.644 . . . . 0.0 109.461 173.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -160.91 104.58 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -133.52 168.12 19.22 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.801 0.84 . . . . 0.0 111.603 -169.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -85.61 145.42 27.35 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.994 0.918 . . . . 0.0 112.092 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -105.8 143.51 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.872 2.469 . . . . 0.0 108.986 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -127.87 138.59 52.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.044 1.338 . . . . 0.0 108.986 171.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.22 164.51 42.4 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.951 2.101 . . . . 0.0 108.376 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.62 147.74 82.23 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.816 1.684 . . . . 0.0 109.446 171.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -51.28 -33.48 28.78 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.63 -26.41 67.81 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.336 1.454 . . . . 0.0 110.689 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.78 -4.88 25.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.581 1.552 . . . . 0.0 112.21 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.75 -54.32 45.77 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.878 1.217 . . . . 0.0 112.081 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.72 -33.78 76.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.447 0.699 . . . . 0.0 110.068 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -59.83 -52.75 64.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.534 1.534 . . . . 0.0 111.816 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -58.85 -40.73 85.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.502 0.721 . . . . 0.0 110.027 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 -70.9 -16.91 62.71 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.89 5.38 45.35 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.95 1.25 . . . . 0.0 112.713 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.47 178.15 0.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.701 1.6 . . . . 0.0 113.039 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.4 -20.25 17.93 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.6 -1.313 . . . . 0.0 112.33 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -113.03 -53.94 2.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.684 1.129 . . . . 0.0 110.656 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -58.53 -15.64 12.07 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -46.07 -43.82 14.94 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.855 1.662 . . . . 0.0 115.443 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -44.91 75.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.033 1.288 . . . . 0.0 108.564 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.1 5.74 6.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 112.823 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.461 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -63.51 -21.22 66.2 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.949 1.249 . . . . 0.0 111.769 -174.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -10.58 19.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -119.48 4.55 11.16 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 124.623 1.169 . . . . 0.0 111.563 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 92' ' ' ALA . 80.7 mt -97.13 100.97 11.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -172.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -119.23 165.14 18.01 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.18 0.992 . . . . 0.0 112.571 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.29 169.1 22.41 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.508 2.805 . . . . 0.0 112.534 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.2 mtm -84.76 169.21 14.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.162 2.185 . . . . 0.0 111.758 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.73 172.7 10.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.578 1.951 . . . . 0.0 108.336 164.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.202 0 CA-C-O 116.285 -1.817 . . . . 0.0 111.986 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.9 t -158.04 145.29 18.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.966 1.307 . . . . 0.0 108.152 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 44.23 81.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.02 2.128 . . . . 0.0 111.955 -171.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -148.78 -165.51 2.3 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.77 22.53 15.71 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-O 118.435 -1.203 . . . . 0.0 113.667 168.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.67 82.3 1.32 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 163.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.43 64.64 5.51 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.026 3.151 . . . . 0.0 109.685 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.65 153.15 27.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 120.639 -1.288 . . . . 0.0 109.548 -168.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG11 HG13 ' A' ' 27' ' ' VAL . 3.2 t -92.81 61.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.77 -83.93 0.09 OUTLIER Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.4 mtp -140.18 -35.58 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.89 130.82 44.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.024 1.284 . . . . 0.0 111.939 -172.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -91.98 95.38 9.77 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.92 -52.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 108.334 173.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 8.41 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.589 2.356 . . . . 0.0 117.339 -171.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -89.26 -0.59 57.58 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.916 1.235 . . . . 0.0 113.736 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.55 86.5 2.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.474 1.034 . . . . 0.0 109.741 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.41 -26.98 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 117.608 -1.662 . . . . 0.0 114.741 167.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -95.65 99.21 11.1 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.806 2.303 . . . . 0.0 110.116 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 p -65.57 19.61 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.051 2.941 . . . . 0.0 115.155 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.81 4.03 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 120.594 -1.316 . . . . 0.0 111.786 -159.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 tt -90.94 104.38 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 O-C-N 120.103 -1.623 . . . . 0.0 107.155 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -84.08 -15.9 45.72 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 117.667 -1.159 . . . . 0.0 111.835 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -138.83 129.75 26.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.249 0.931 . . . . 0.0 110.194 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.449 HD12 HD11 ' A' ' 45' ' ' LEU . 73.9 mt -129.89 97.87 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.8 m -79.4 115.18 18.88 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.411 -0.806 . . . . 0.0 109.118 171.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG13 HG11 ' A' ' 9' ' ' VAL . 2.7 t -114.49 125.33 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.145 1.778 . . . . 0.0 110.598 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.76 164.77 51.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 170.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.43 162.03 36.61 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.321 2.014 . . . . 0.0 108.738 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 46.79 53.08 10.69 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.191 1.396 . . . . 0.0 111.932 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.25 22.03 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.095 -1.003 . . . . 0.0 113.023 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.63 160.36 9.11 Favored Glycine 0 CA--C 1.521 0.437 0 O-C-N 120.843 -1.161 . . . . 0.0 111.028 165.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 35' ' ' TYR . 9.9 tp -72.25 129.09 37.6 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.963 -1.316 . . . . 0.0 108.418 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -85.52 87.83 7.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.413 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -75.69 -166.62 0.58 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.302 0.641 . . . . 0.0 109.375 176.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.93 148.26 36.47 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 2.59 90.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.1 -1.389 . . . . 0.0 116.312 164.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -34.93 70.34 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.483 2.142 . . . . 0.0 110.107 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.06 17.51 22.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.685 1.594 . . . . 0.0 111.196 -172.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 t -57.16 109.78 0.72 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.55 0.99 46.73 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.631 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -79.02 66.63 4.51 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 120.538 2.169 . . . . 0.0 110.203 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.0 p -66.04 -6.61 13.48 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.652 1.981 . . . . 0.0 113.695 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.82 25.81 3.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.829 1.252 . . . . 0.0 110.887 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.734 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -70.8 135.19 47.98 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 171.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -137.6 -25.09 1.03 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.256 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.05 154.92 43.73 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.554 1.941 . . . . 0.0 110.88 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.45 147.7 27.18 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.32 2.248 . . . . 0.0 105.311 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.29 142.81 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' A' ' 58' ' ' TYR . 37.5 mt -121.12 116.19 24.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.858 0.863 . . . . 0.0 110.212 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.7 p -86.25 3.22 44.12 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.628 0.974 . . . . 0.0 113.628 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.93 162.17 23.92 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 120.802 -1.186 . . . . 0.0 110.931 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -110.61 3.25 19.21 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -164.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -152.6 144.66 16.7 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.119 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.53 -23.25 64.52 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.397 2.731 . . . . 0.0 112.87 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -60.95 -23.75 65.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.395 0.998 . . . . 0.0 112.143 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.84 4.87 17.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.134 0.973 . . . . 0.0 113.151 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.444 ' CE1' HD22 ' A' ' 50' ' ' LEU . 59.7 m-85 -134.9 170.58 15.65 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 126.8 2.04 . . . . 0.0 110.027 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.1 m -122.16 -176.56 3.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.147 1.379 . . . . 0.0 109.027 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . 174.72 -17.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.884 1.674 . . . . 0.0 113.02 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 47.35 -97.17 0.01 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 128.24 2.829 . . . . 0.0 111.349 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.27 14.78 1.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.233 1.413 . . . . 0.0 109.896 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.05 14.09 3.31 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 117.474 -1.736 . . . . 0.0 115.251 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.588 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 5.4 tt -44.22 -51.62 8.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.822 2.311 . . . . 0.0 111.874 -165.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -86.09 -7.36 58.65 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 116.975 -1.488 . . . . 0.0 114.823 -171.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.2 118.3 4.25 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.967 0.803 . . . . 0.0 111.11 -152.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.51 -9.28 38.14 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.823 1.677 . . . . 0.0 114.266 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.57 -174.38 3.11 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.147 1.474 . . . . 0.0 114.064 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -151.0 115.66 5.18 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 131.453 3.901 . . . . 0.0 103.749 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.734 ' HB2' HD22 ' A' ' 45' ' ' LEU . 46.8 p90 -147.91 -175.11 4.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.392 1.077 . . . . 0.0 109.972 174.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.7 tp -127.64 148.4 50.38 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.346 -1.471 . . . . 0.0 110.035 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.6 mt -110.72 136.87 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 127.036 2.134 . . . . 0.0 107.77 -173.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 33.7 m -123.43 122.62 38.73 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.994 2.117 . . . . 0.0 110.813 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.88 158.79 58.86 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 107.29 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -69.77 153.57 68.72 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.32 -32.54 73.31 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -27.03 66.65 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.39 0.541 . . . . 0.0 110.445 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -92.74 -7.82 45.55 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.167 -0.958 . . . . 0.0 111.857 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 tp -62.04 -55.94 24.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.104 1.775 . . . . 0.0 111.517 -162.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -65.72 -30.03 70.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.737 -0.602 . . . . 0.0 110.691 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -59.21 -31.58 69.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.178 1.391 . . . . 0.0 112.475 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -77.69 -41.5 37.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.342 0.974 . . . . 0.0 110.497 166.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -65.98 -27.06 67.86 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.756 -1.215 . . . . 0.0 113.506 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -77.12 -3.07 37.49 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.157 -0.965 . . . . 0.0 111.819 173.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.41 130.45 35.04 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 121.026 1.739 . . . . 0.0 107.902 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.67 -38.15 90.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.09 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 60' ' ' ALA . 1.5 t80 -71.42 -61.77 1.65 Allowed 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.601 0.637 . . . . 0.0 110.378 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -58.52 -9.1 1.45 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -43.32 -47.78 6.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.083 0.953 . . . . 0.0 111.908 163.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 t -61.11 -17.92 55.24 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.576 0.751 . . . . 0.0 111.272 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -113.14 5.61 17.14 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.614 1.966 . . . . 0.0 113.755 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.46 -24.95 65.64 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.946 1.248 . . . . 0.0 111.548 -171.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.09 -13.98 62.63 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -123.33 17.03 9.81 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.632 1.106 . . . . 0.0 111.546 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.2 mt -103.73 123.07 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 1.9 pt20 -130.01 166.04 29.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 126.553 1.941 . . . . 0.0 110.917 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 96' ' ' GLN . 55.4 Cg_endo -64.22 174.19 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.317 2.678 . . . . 0.0 112.006 169.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 mtm -96.3 170.7 9.06 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.74 1.616 . . . . 0.0 111.562 170.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -91.17 175.29 6.99 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.4 1.08 . . . . 0.0 110.279 162.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 130.047 3.339 . . . . 0.0 108.107 -160.256 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.912 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -57.93 148.76 24.7 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 118.843 1.321 . . . . 0.0 111.776 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 176.5 159.82 0.33 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 128.325 2.65 . . . . 0.0 108.312 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -92.34 163.92 13.7 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.604 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -113.55 16.92 21.36 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 117.575 -1.681 . . . . 0.0 113.989 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.8 86.01 0.55 Allowed Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 119.762 1.781 . . . . 0.0 108.872 173.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.11 78.95 2.13 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.78 2.986 . . . . 0.0 108.793 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.97 154.84 19.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 O-C-N 120.687 -1.258 . . . . 0.0 108.013 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.45 155.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 123.932 0.77 . . . . 0.0 109.189 165.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.4 -70.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 36.2 mtp -146.54 -51.98 0.22 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.245 1.418 . . . . 0.0 109.499 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -84.67 113.96 21.67 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.505 0.722 . . . . 0.0 109.695 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 27.2 mmtp -75.28 6.93 3.87 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -85.94 5.11 34.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -104.18 4.9 34.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -159.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -85.85 -57.28 3.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.364 0.984 . . . . 0.0 110.506 -165.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.47 85.21 0.28 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.019 2.528 . . . . 0.0 110.643 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.2 -17.72 0.02 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.934 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.04 114.9 28.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.378 1.589 . . . . 0.0 110.797 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 p -73.2 -0.66 14.95 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.597 -1.314 . . . . 0.0 114.173 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.84 -8.89 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 120.305 1.411 . . . . 0.0 110.8 -152.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.0 tt -65.16 99.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 127.637 2.375 . . . . 0.0 108.103 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -85.95 -10.0 55.91 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.739 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -141.43 134.98 29.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.286 0.948 . . . . 0.0 108.839 -172.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.03 122.55 49.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 168.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -83.09 141.17 32.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 160.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.7 143.31 32.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 124.147 0.979 . . . . 0.0 108.367 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -92.78 164.28 22.69 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 110.226 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.81 171.25 14.85 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.634 2.223 . . . . 0.0 110.007 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 48.68 35.39 6.19 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.601 1.96 . . . . 0.0 113.91 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.533 ' O ' ' HE3' ' A' ' 13' ' ' LYS 0.255 5.4 tt -131.53 63.34 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 122.634 1.207 . . . . 0.0 112.432 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.64 159.56 32.05 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.153 1.358 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.1 168.54 8.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.8 1.24 . . . . 0.0 111.671 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD13 HD13 ' A' ' 64' ' ' LEU . 37.1 mt -133.2 84.78 2.16 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 170.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -84.43 162.05 20.09 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.061 0.391 . . . . 0.0 110.726 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.18 126.03 26.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.436 0.636 . . . . 0.0 109.371 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.49 11.44 64.21 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.692 -1.06 . . . . 0.0 114.693 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -62.38 -32.94 73.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.22 2.01 . . . . 0.0 112.415 172.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -107.02 29.3 7.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.027 1.731 . . . . 0.0 110.996 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 t -66.12 102.83 0.87 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.06 12.78 48.32 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.828 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.09 63.37 1.8 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.78 1.79 . . . . 0.0 109.618 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 p -73.62 -12.51 60.77 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -158.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.42 13.8 19.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.857 1.208 . . . . 0.0 112.131 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.721 HD22 ' CB ' ' A' ' 70' ' ' PHE . 2.7 tt -65.32 117.59 8.09 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -126.94 -8.65 6.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -148.33 148.55 30.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.18 0.992 . . . . 0.0 112.282 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 tp -151.39 100.49 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.88 138.15 21.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 mt -123.48 129.85 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.051 0.94 . . . . 0.0 108.976 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 p -113.67 35.58 3.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.173 0.989 . . . . 0.0 111.409 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.62 139.9 11.35 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.1 4.13 21.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -163.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -151.75 144.49 16.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 120.64 -1.288 . . . . 0.0 109.423 -164.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -37.97 3.05 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.152 2.568 . . . . 0.0 113.241 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -74.95 -7.04 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.012 0.824 . . . . 0.0 112.095 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.08 -10.93 59.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.031 0.932 . . . . 0.0 112.237 165.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -97.71 173.11 7.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 123.263 1.506 . . . . 0.0 110.709 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 -164.39 1.08 Allowed 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 129.111 2.964 . . . . 0.0 106.869 169.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 77.05 142.64 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 130.223 3.409 . . . . 0.0 110.567 -169.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -170.91 -31.63 0.02 OUTLIER Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.214 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.5 -45.33 87.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.276 2.231 . . . . 0.0 110.235 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.44 71.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 118.554 -1.137 . . . . 0.0 112.248 -162.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.45 HD13 HD13 ' A' ' 34' ' ' LEU . 42.1 tp -44.63 -63.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.276 1.038 . . . . 0.0 110.766 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.6 -9.74 59.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 116.916 -1.516 . . . . 0.0 112.311 -164.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -45.29 112.36 0.44 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.954 1.302 . . . . 0.0 110.497 -157.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.08 -6.06 28.89 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.496 -1.169 . . . . 0.0 114.606 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.31 173.26 13.7 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.223 1.809 . . . . 0.0 110.73 168.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -140.48 81.91 1.83 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.167 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.721 ' CB ' HD22 ' A' ' 45' ' ' LEU . 24.8 p90 -95.26 -176.79 3.91 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.197 1.399 . . . . 0.0 109.023 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.85 157.86 28.86 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.969 1.307 . . . . 0.0 107.515 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.5 139.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.637 1.175 . . . . 0.0 108.814 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 38.9 m -123.26 135.36 54.21 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.533 1.133 . . . . 0.0 110.126 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -136.74 155.29 76.7 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 126.166 1.786 . . . . 0.0 107.036 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 153.71 71.22 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 121.536 1.584 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.09 -30.2 66.05 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.1 -29.69 69.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.322 1.049 . . . . 0.0 111.326 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.09 -11.63 22.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.33 1.052 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.0 tp -57.68 -52.06 66.97 Favored 'General case' 0 C--O 1.228 -0.055 0 O-C-N 121.108 -0.995 . . . . 0.0 110.45 -170.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -27.38 68.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -59.11 5.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.442 1.497 . . . . 0.0 109.551 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -63.01 -26.62 68.94 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.556 1.071 . . . . 0.0 111.414 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -17.17 61.45 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -103.26 -9.43 19.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.637 1.108 . . . . 0.0 113.612 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.97 151.27 26.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.489 1.116 . . . . 0.0 111.831 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.64 -50.74 72.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.014 -0.429 . . . . 0.0 111.679 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -82.94 -60.68 2.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 108.936 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -60.06 -15.63 24.63 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -43.96 -49.5 8.51 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 120.105 1.32 . . . . 0.0 112.98 164.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 t -57.19 -31.3 65.3 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -93.8 15.86 15.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.806 1.242 . . . . 0.0 112.658 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.71 65.69 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.016 -1.677 . . . . 0.0 112.18 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.44 38.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.112 0.965 . . . . 0.0 112.979 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -127.43 21.07 6.66 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 110.226 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.87 106.95 21.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 119.898 1.226 . . . . 0.0 108.739 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.62 164.86 26.03 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.088 1.755 . . . . 0.0 111.161 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.55 163.0 36.62 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.66 2.24 . . . . 0.0 112.211 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.7 mtt -75.78 176.82 7.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.859 1.264 . . . . 0.0 109.581 163.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -103.2 -166.66 1.29 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.133 1.373 . . . . 0.0 110.059 167.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.858 1.663 . . . . 0.0 107.999 -170.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.7 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 m -62.57 144.42 56.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.051 0.426 . . . . 0.0 110.796 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -147.14 36.93 0.93 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.612 1.165 . . . . 0.0 109.881 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -139.71 145.24 38.1 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.732 1.213 . . . . 0.0 108.541 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.452 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 129.29 74.66 0.16 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -66.64 165.28 25.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.239 0.615 . . . . 0.0 110.494 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.34 68.39 5.17 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.112 3.208 . . . . 0.0 109.816 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.54 146.79 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.755 1.222 . . . . 0.0 108.062 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.415 HG11 HG13 ' A' ' 27' ' ' VAL . 21.8 t -86.03 99.54 7.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.06 86.82 0.18 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 167.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.3 mtp 57.89 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 129.309 3.044 . . . . 0.0 118.241 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -110.44 97.07 6.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 121.69 2.041 . . . . 0.0 111.034 -171.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -73.16 28.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.921 1.288 . . . . 0.0 113.221 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.71 28.47 4.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.626 1.103 . . . . 0.0 111.671 -168.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.452 HD22 ' HA3' ' A' ' 5' ' ' GLY . 88.9 mt -125.1 1.94 7.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.11 1.364 . . . . 0.0 113.562 -171.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 18' ' ' GLY . 26.4 m-85 -91.67 -36.3 13.7 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.321 -0.862 . . . . 0.0 111.418 -162.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.53 14.65 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.458 2.303 . . . . 0.0 114.951 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 16' ' ' PHE . . . -114.58 -13.54 9.51 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 126.328 1.918 . . . . 0.0 113.848 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -120.86 107.13 12.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.215 2.007 . . . . 0.0 111.894 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.4 p -79.09 9.62 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.013 1.725 . . . . 0.0 114.355 -168.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.7 -4.36 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.146 -170.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.35 104.32 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -81.74 -15.62 53.75 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 117.954 -1.022 . . . . 0.0 111.13 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -143.44 126.03 15.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.002 0.921 . . . . 0.0 109.452 -162.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 45' ' ' LEU . 88.0 mt -133.15 103.98 6.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -175.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.4 m -75.03 139.77 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 166.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 9' ' ' VAL . 1.9 t -135.02 165.45 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.57 1.948 . . . . 0.0 108.024 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' HG22 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -125.08 165.87 23.57 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 108.992 176.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.65 162.52 41.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.928 1.752 . . . . 0.0 110.167 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 48.51 19.43 0.23 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.141 2.177 . . . . 0.0 114.549 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 28' ' ' GLN . 4.9 tp -95.06 55.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 119.895 -1.753 . . . . 0.0 110.758 -170.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.76 151.23 21.33 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 121.14 -0.975 . . . . 0.0 111.728 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.3 tp -70.44 138.47 51.24 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-O 121.769 0.795 . . . . 0.0 110.293 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.27 99.9 11.9 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 164.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -75.02 165.14 25.72 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 169.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.0 134.62 35.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.833 -1.167 . . . . 0.0 108.352 173.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.17 -0.07 71.58 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.928 1.252 . . . . 0.0 113.204 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -48.75 -44.03 38.23 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.457 2.303 . . . . 0.0 112.676 173.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -95.64 9.83 38.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.598 0.759 . . . . 0.0 112.668 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t -58.24 113.65 2.04 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.651 1.114 . . . . 0.0 109.861 -176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.54 -0.29 53.1 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.004 -1.442 . . . . 0.0 113.721 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.5 m -74.74 67.64 1.61 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.916 1.858 . . . . 0.0 109.284 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -75.17 10.85 1.35 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.389 1.876 . . . . 0.0 113.66 -168.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.32 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.113 0.965 . . . . 0.0 112.943 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.737 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -66.48 118.9 10.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.673 1.579 . . . . 0.0 109.68 -175.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -126.08 -11.59 6.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.313 0.645 . . . . 0.0 111.785 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.81 146.6 25.19 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 120.168 1.349 . . . . 0.0 111.322 -173.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -147.33 141.28 25.9 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.542 1.937 . . . . 0.0 106.417 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.25 141.27 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -175.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 48' ' ' LEU . 43.1 mt -122.74 103.87 8.94 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.487 1.115 . . . . 0.0 109.369 -170.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.8 p -77.53 39.24 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.456 1.502 . . . . 0.0 113.216 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.83 153.52 25.36 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 119.824 -1.798 . . . . 0.0 110.495 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -108.32 4.38 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -158.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.44 144.6 40.51 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.219 1.008 . . . . 0.0 111.37 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.28 -22.27 5.93 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.3 2.667 . . . . 0.0 115.383 -172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.9 m -64.95 -36.83 85.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.057 1.299 . . . . 0.0 109.822 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.81 7.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -126.54 128.42 46.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.373 1.069 . . . . 0.0 109.575 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 167.04 13.41 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.221 1.009 . . . . 0.0 110.817 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.88 167.67 16.56 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.117 2.167 . . . . 0.0 108.537 153.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.84 -177.45 40.97 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 158.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -51.76 -44.86 63.51 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.3 1.44 . . . . 0.0 109.847 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.26 82.09 0.3 Allowed Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 127.233 2.349 . . . . 0.0 109.738 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.8 tp -51.53 -63.47 1.12 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.16 0.984 . . . . 0.0 109.623 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.47 17.12 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.121 1.368 . . . . 0.0 112.165 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -55.26 127.18 28.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.797 0.726 . . . . 0.0 109.244 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.33 81.48 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.249 0.928 . . . . 0.0 113.762 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.54 -164.41 1.82 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.72 2.008 . . . . 0.0 107.402 170.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -167.73 99.37 0.48 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 167.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.737 ' CB ' HD22 ' A' ' 45' ' ' LEU . 19.6 p90 -131.52 168.81 17.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.022 1.329 . . . . 0.0 109.486 -168.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -98.18 152.82 18.96 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.147 1.379 . . . . 0.0 109.653 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.88 138.63 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 0.0 109.458 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -127.52 145.13 50.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.221 1.008 . . . . 0.0 110.014 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.12 158.77 74.95 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 108.58 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -67.17 148.85 81.53 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 CA-C-N 120.938 1.371 . . . . 0.0 110.229 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.4 -22.54 63.47 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -81.07 -22.85 38.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.022 1.329 . . . . 0.0 112.128 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -101.71 -1.58 32.2 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.151 1.38 . . . . 0.0 111.889 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.02 -47.39 83.19 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.769 -0.582 . . . . 0.0 112.019 -165.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.91 -43.67 78.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.443 0.297 . . . . 0.0 110.783 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -46.86 -55.0 8.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.19 1.396 . . . . 0.0 111.61 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -63.44 -41.47 98.66 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.012 0.824 . . . . 0.0 110.584 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -64.78 -16.09 62.55 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.312 -0.868 . . . . 0.0 112.475 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -101.11 15.55 28.35 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.262 1.825 . . . . 0.0 112.817 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.3 179.29 5.88 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.62 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -106.71 -29.33 9.64 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.609 1.964 . . . . 0.0 112.859 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.01 -56.2 2.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.772 0.829 . . . . 0.0 108.764 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -61.57 -10.71 8.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.743 -172.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.308 0.3 OUTLIER -43.89 -57.63 3.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.765 1.226 . . . . 0.0 113.373 168.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.6 t -69.86 -9.87 56.42 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.688 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -104.73 1.32 29.19 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.645 -1.285 . . . . 0.0 111.927 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -68.45 -3.86 12.85 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 119.671 -1.893 . . . . 0.0 112.585 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.82 -14.05 60.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.169 1.387 . . . . 0.0 112.375 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -127.78 34.96 4.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.203 1.401 . . . . 0.0 109.845 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 92' ' ' ALA . 63.2 mt -109.45 139.0 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.65 163.86 43.84 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.851 1.66 . . . . 0.0 110.127 166.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.92 149.04 91.49 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.86 1.707 . . . . 0.0 110.148 167.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ptp -77.96 160.05 28.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.641 1.177 . . . . 0.0 108.729 173.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.67 -168.55 2.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.876 1.67 . . . . 0.0 107.752 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 C--O 1.246 0.897 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.595 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -71.69 166.16 22.51 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.027 1.331 . . . . 0.0 108.472 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -154.47 39.38 0.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.111 0.964 . . . . 0.0 110.077 163.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.07 -179.24 7.94 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.727 1.611 . . . . 0.0 111.065 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.53 -88.32 0.07 OUTLIER Glycine 0 CA--C 1.521 0.464 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 168.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -133.25 156.2 80.1 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.976 1.311 . . . . 0.0 108.947 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.96 85.52 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.732 3.622 . . . . 0.0 107.298 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -150.1 147.32 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 120.448 -1.407 . . . . 0.0 107.92 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 t -78.8 101.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.43 -75.52 0.58 Allowed Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -51.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.379 1.872 . . . . 0.0 111.365 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -87.36 172.44 9.84 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -126.31 3.98 7.03 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.533 1.133 . . . . 0.0 113.939 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -83.38 -28.77 28.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.02 23.65 0.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.887 1.275 . . . . 0.0 113.733 -157.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.98 -47.34 5.57 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.088 -1.008 . . . . 0.0 110.57 -171.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.31 1.444 . . . . 0.0 108.054 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.61 -23.44 0.09 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.821 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -108.64 105.22 14.74 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.748 2.274 . . . . 0.0 111.56 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -68.81 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.908 2.483 . . . . 0.0 113.055 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.96 -9.28 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.884 1.274 . . . . 0.0 111.538 -163.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.2 tt -77.48 96.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 120.897 -1.127 . . . . 0.0 108.8 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.6 mtt85 -75.07 -16.12 60.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.18 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -149.19 134.81 18.64 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.601 0.761 . . . . 0.0 109.53 -168.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.4 114.13 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.0 m -89.82 137.72 32.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 t -130.77 121.37 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.935 1.694 . . . . 0.0 108.268 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -77.09 160.85 75.16 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.401 0.546 . . . . 0.0 110.798 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -75.49 159.9 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.723 2.282 . . . . 0.0 110.83 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 54.9 37.13 28.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.883 1.673 . . . . 0.0 113.007 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.292 3.7 tt -133.4 25.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.675 1.19 . . . . 0.0 112.205 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.61 159.3 8.15 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 127.132 2.301 . . . . 0.0 111.529 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.8 tp -71.96 126.15 29.03 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 124.306 1.042 . . . . 0.0 110.065 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.95 78.42 7.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -68.89 168.18 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.083 0.944 . . . . 0.0 111.548 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -75.54 137.42 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.59 -1.944 . . . . 0.0 108.667 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.34 3.4 90.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.101 0.858 . . . . 0.0 113.937 -174.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.1 ttp -59.77 -25.15 64.66 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 120.158 1.979 . . . . 0.0 113.364 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -114.4 15.69 17.9 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.848 1.259 . . . . 0.0 111.594 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.429 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 58.6 m -48.33 119.28 2.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.147 0.979 . . . . 0.0 111.371 175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.56 6.95 85.27 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.297 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.96 73.77 0.61 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.609 2.204 . . . . 0.0 107.092 163.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.6 p -65.31 -51.99 56.97 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.43 1.092 . . . . 0.0 111.532 -167.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.62 3.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.921 1.289 . . . . 0.0 113.957 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.2 tp -76.85 108.28 9.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.279 1.032 . . . . 0.0 110.129 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.62 -12.45 9.74 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.551 169.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -119.14 142.54 47.85 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 119.522 1.055 . . . . 0.0 113.236 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 49' ' ' ILE . 2.0 tm? -146.53 136.57 23.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.541 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.4 mp -133.94 137.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.2 113.75 22.0 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 p -83.97 0.38 48.2 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.33 179.05 41.96 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.216 0.912 . . . . 0.0 110.992 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.96 6.26 4.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.017 0.927 . . . . 0.0 112.63 -169.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -141.99 143.82 29.75 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.658 1.583 . . . . 0.0 107.721 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.53 -30.73 4.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.317 2.011 . . . . 0.0 112.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 m -77.07 -15.84 59.45 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 111.824 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.64 12.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.441 1.496 . . . . 0.0 112.804 165.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -124.33 168.55 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.252 1.021 . . . . 0.0 110.07 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -141.78 133.68 27.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.61 172.69 9.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.322 2.249 . . . . 0.0 106.388 172.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.73 -145.04 8.1 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 126.342 1.925 . . . . 0.0 109.361 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.01 -8.86 58.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.782 -0.834 . . . . 0.0 113.155 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.98 68.23 0.27 Allowed Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -170.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 tp -46.14 -44.02 15.44 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.204 1.402 . . . . 0.0 111.022 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -113.7 16.75 18.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.016 0.926 . . . . 0.0 111.419 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.67 146.24 52.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.861 0.755 . . . . 0.0 110.808 -173.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 76.47 -1.02 62.56 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.753 1.168 . . . . 0.0 113.825 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.27 -175.46 4.18 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 128.921 2.888 . . . . 0.0 107.456 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -156.56 94.49 1.48 Allowed 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.812 -1.18 . . . . 0.0 110.737 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -125.21 163.4 22.57 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.112 0.965 . . . . 0.0 111.134 -171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.68 152.39 18.5 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.668 1.587 . . . . 0.0 108.113 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.4 mt -122.08 101.61 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -167.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.2 m -87.78 138.05 31.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.365 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.16 155.28 72.62 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.42 1.888 . . . . 0.0 109.7 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.84 144.54 53.91 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 CA-C-N 121.432 1.547 . . . . 0.0 109.46 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -55.24 -32.78 62.57 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -67.33 -18.24 65.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.224 3.01 . . . . 0.0 112.159 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.46 -0.19 19.01 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.83 -1.168 . . . . 0.0 113.135 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 tp -62.7 -50.27 71.8 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.172 0.896 . . . . 0.0 111.351 -168.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.61 -43.21 99.28 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.8 -56.28 9.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.525 1.93 . . . . 0.0 111.795 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -70.61 -40.22 73.3 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.292 0.496 . . . . 0.0 109.744 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -62.7 -25.41 68.15 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 121.208 -0.933 . . . . 0.0 112.565 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -85.14 -13.69 49.38 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 125.275 1.43 . . . . 0.0 112.679 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.73 143.1 57.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.443 0.565 . . . . 0.0 111.553 -160.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.89 24.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.133 2.573 . . . . 0.0 113.439 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -67.32 0.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.983 2.513 . . . . 0.0 107.207 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -58.6 -16.96 18.19 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -167.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -44.08 -45.01 7.88 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.499 1.52 . . . . 0.0 113.775 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -69.36 -6.15 28.03 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.77 15.81 14.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.04 1.291 . . . . 0.0 111.567 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.66 66.55 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.48 -1.388 . . . . 0.0 110.707 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.28 3.28 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -127.29 4.74 6.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.878 1.217 . . . . 0.0 111.889 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.85 123.65 46.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -136.06 162.42 56.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.771 0.828 . . . . 0.0 111.508 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.75 149.16 91.43 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.315 2.677 . . . . 0.0 114.208 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.5 mtm -73.51 156.37 38.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.557 166.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -98.64 -178.02 3.85 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.061 2.144 . . . . 0.0 109.865 171.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.481 HE21 ' C ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 154.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -84.23 120.18 25.91 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.249 1.42 . . . . 0.0 110.238 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 47.45 51.91 13.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.29 1.036 . . . . 0.0 112.052 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -145.9 -174.22 4.36 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.157 1.783 . . . . 0.0 107.523 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.22 80.03 0.25 Allowed Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -116.94 85.75 18.33 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.558 1.543 . . . . 0.0 109.635 -175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -76.22 64.64 7.11 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.373 3.382 . . . . 0.0 110.639 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.34 165.42 30.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 108.791 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.503 HG22 HD12 ' A' ' 31' ' ' ILE 0.268 7.0 p -110.57 68.23 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 122.28 1.038 . . . . 0.0 109.826 -161.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.75 79.62 0.26 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 125.766 1.651 . . . . 0.0 109.791 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.2 10.07 1.57 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.786 2.034 . . . . 0.0 114.388 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.59 122.68 15.67 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.878 1.217 . . . . 0.0 110.225 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -105.29 90.94 3.58 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.391 1.476 . . . . 0.0 107.066 168.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -162.46 10.43 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 14' ' ' SER . 1.3 mp -131.67 1.28 4.02 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.782 -1.199 . . . . 0.0 113.053 -160.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -88.24 -36.66 16.61 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.664 -0.647 . . . . 0.0 111.573 -163.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 43.87 0.09 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.905 2.082 . . . . 0.0 112.255 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.82 -27.46 0.37 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.381 -1.233 . . . . 0.0 113.352 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -106.78 94.15 4.96 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.438 1.619 . . . . 0.0 110.63 -173.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.5 p -64.24 22.04 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 129.537 3.135 . . . . 0.0 115.107 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.29 7.56 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 O-C-N 119.861 -1.774 . . . . 0.0 110.074 -170.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.94 98.55 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.241 -1.537 . . . . 0.0 107.147 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -71.29 -26.36 62.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.744 172.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -136.79 120.72 17.57 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.432 0.56 . . . . 0.0 111.218 -160.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.6 mt -122.29 89.96 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 m -66.82 130.93 44.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 161.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 t -125.1 155.4 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.328 1.851 . . . . 0.0 107.047 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -119.59 159.66 45.21 Favored Pre-proline 0 N--CA 1.452 -0.368 0 C-N-CA 124.809 1.243 . . . . 0.0 107.864 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.1 152.98 51.68 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.733 1.622 . . . . 0.0 111.196 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 59.85 21.38 10.29 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.524 1.93 . . . . 0.0 113.849 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.503 HD12 HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -118.25 93.86 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 124.505 2.097 . . . . 0.0 107.198 176.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.49 138.62 5.21 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 127.27 2.367 . . . . 0.0 113.28 161.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -58.47 130.23 45.77 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 170.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mt -88.07 123.37 32.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -133.99 176.56 8.46 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.57 1.148 . . . . 0.0 109.407 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -72.42 152.07 42.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.545 1.164 . . . . 0.0 111.512 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.477 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 66.13 -3.67 3.07 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.085 1.326 . . . . 0.0 114.425 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.469 ' HE3' ' CZ ' ' A' ' 39' ' ' PHE . 3.6 tmm? -57.74 -32.56 67.56 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.805 . . . . 0.0 112.094 -170.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.469 ' CZ ' ' HE3' ' A' ' 38' ' ' MET . 59.7 m-85 -102.49 -5.92 23.48 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.406 1.482 . . . . 0.0 113.468 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 t -54.23 124.78 16.83 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.342 0.974 . . . . 0.0 110.974 -164.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.31 9.24 48.25 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.764 1.173 . . . . 0.0 112.784 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.7 p -69.85 74.19 0.43 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.951 1.7 . . . . 0.0 111.93 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -58.16 -7.83 0.93 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.49 0.23 5.6 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.609 -1.186 . . . . 0.0 113.5 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.35 123.34 24.44 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.5 1.955 . . . . 0.0 112.383 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.08 8.66 0.95 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -146.09 126.24 13.81 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.347 -1.471 . . . . 0.0 109.374 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 72' ' ' ILE . 2.3 tp -120.68 139.78 52.54 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.23 146.75 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 170.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.6 mt -121.86 136.33 54.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.384 1.474 . . . . 0.0 107.154 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 p -111.37 33.69 4.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.122 0.963 . . . . 0.0 111.246 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.85 161.66 20.22 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -113.75 4.17 15.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -157.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.99 147.81 19.46 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.466 1.03 . . . . 0.0 109.64 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.52 -27.51 70.04 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.042 3.161 . . . . 0.0 113.695 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 m -72.58 -13.24 61.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.36 7.17 4.6 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.061 -1.024 . . . . 0.0 112.125 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -139.89 179.45 6.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.162 2.185 . . . . 0.0 109.336 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -139.25 179.4 6.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.977 2.111 . . . . 0.0 108.625 172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -161.06 1.98 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.21 -108.14 0.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -150.69 38.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.747 1.619 . . . . 0.0 109.568 163.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.09 28.38 0.2 Allowed Glycine 0 C--O 1.225 -0.415 0 CA-C-O 118.043 -1.421 . . . . 0.0 114.285 -165.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 64' ' ' LEU . 7.2 tt -45.29 -41.97 9.23 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.55 1.675 . . . . 0.0 112.175 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -117.89 26.15 9.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.856 1.262 . . . . 0.0 112.071 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -58.55 141.64 51.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 110.151 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 -29.95 3.03 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.341 0.972 . . . . 0.0 112.389 -173.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.17 -179.82 4.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.269 1.828 . . . . 0.0 110.25 -175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -161.02 106.87 1.4 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.58 1.152 . . . . 0.0 107.973 165.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -139.13 167.27 22.43 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.245 1.418 . . . . 0.0 109.76 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.9 mt -89.92 141.93 28.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.949 1.299 . . . . 0.0 108.986 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.412 HG23 HD23 ' A' ' 48' ' ' LEU . 9.9 mt -90.19 138.12 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.627 1.971 . . . . 0.0 105.823 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.2 m -120.81 136.0 55.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.31 161.11 62.36 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 124.615 1.166 . . . . 0.0 107.997 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.04 147.7 84.68 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 CA-C-N 119.997 1.035 . . . . 0.0 110.425 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -50.34 -37.2 35.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.236 1.014 . . . . 0.0 112.6 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -31.93 59.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.797 -0.565 . . . . 0.0 110.482 -170.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.23 -5.84 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.926 1.29 . . . . 0.0 112.302 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.4 tp -56.14 -38.04 70.28 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.907 0.883 . . . . 0.0 112.12 -169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -69.8 -47.4 62.98 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.57 -0.706 . . . . 0.0 111.409 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -49.03 -53.28 20.8 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.136 1.774 . . . . 0.0 111.955 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -66.12 -42.6 88.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.288 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -57.1 -48.67 78.04 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.936 0.789 . . . . 0.0 111.657 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -68.87 -11.54 60.64 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.34 137.85 48.78 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.308 0.958 . . . . 0.0 111.218 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -61.4 -38.08 85.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.384 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.59 -66.73 0.66 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.369 1.068 . . . . 0.0 108.46 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -58.68 -23.17 58.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 117.563 -1.208 . . . . 0.0 112.232 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -44.7 -35.18 2.54 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -56.27 -41.1 75.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.085 0.402 . . . . 0.0 110.153 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -89.43 9.91 24.58 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 112.432 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -65.27 -22.06 66.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.083 -1.635 . . . . 0.0 112.393 -167.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.1 -19.16 64.17 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -113.43 5.27 16.66 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.891 0.769 . . . . 0.0 112.007 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 92' ' ' ALA . 29.9 mt -86.98 134.05 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.471 1.508 . . . . 0.0 109.271 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.42 166.44 19.94 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.694 1.998 . . . . 0.0 111.51 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.7 175.83 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.002 2.468 . . . . 0.0 112.599 169.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp -102.22 170.88 7.81 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.134 1.774 . . . . 0.0 109.39 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.47 -177.55 3.43 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.488 0.715 . . . . 0.0 110.678 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 . . . . . 0 C--O 1.246 0.885 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 161.553 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.632 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.8 m -153.1 88.64 1.32 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -120.34 51.47 1.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 127.446 2.299 . . . . 0.0 107.144 -170.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -167.69 100.37 0.48 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.52 90.64 0.08 OUTLIER Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -107.86 164.12 15.48 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.865 1.266 . . . . 0.0 110.71 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.44 67.65 7.72 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.979 3.119 . . . . 0.0 109.704 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.56 165.57 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 126.379 1.871 . . . . 0.0 107.948 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.676 HG23 ' CE ' ' A' ' 13' ' ' LYS . 2.1 p -93.48 95.79 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.12 -84.99 1.5 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.8 mtp -128.38 -56.79 1.23 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.197 1.799 . . . . 0.0 109.954 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 115.93 23.42 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.34 -0.85 . . . . 0.0 110.49 -163.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.676 ' CE ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -72.6 4.02 4.37 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -164.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.5 m -114.27 62.61 0.66 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.846 2.112 . . . . 0.0 112.33 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -133.9 4.47 3.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.402 1.081 . . . . 0.0 112.529 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.03 -55.96 3.25 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.443 1.497 . . . . 0.0 111.145 -167.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.28 92.57 0.04 OUTLIER 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 162.47 -6.04 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.199 -1.334 . . . . 0.0 112.988 -169.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -139.34 144.85 38.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.056 1.928 . . . . 0.0 112.525 161.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.1 p -115.65 16.34 16.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.44 2.296 . . . . 0.0 113.264 -159.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.72 14.02 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 127.81 2.444 . . . . 0.0 111.254 -168.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tt -95.43 85.22 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 O-C-N 119.887 -1.758 . . . . 0.0 108.464 -165.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -87.51 18.14 4.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.032 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.95 145.92 26.75 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -137.19 104.25 3.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 161.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -70.13 144.26 52.1 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 162.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.6 123.01 35.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.19 161.82 66.52 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.809 -0.557 . . . . 0.0 109.909 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.79 167.2 26.76 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.583 2.189 . . . . 0.0 111.285 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 45.09 42.68 6.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.365 2.266 . . . . 0.0 114.411 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 tt -141.42 2.17 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.417 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . 178.16 130.47 1.41 Allowed Glycine 0 C--N 1.336 0.561 0 O-C-N 120.056 -1.653 . . . . 0.0 112.546 174.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 tp -59.09 136.67 58.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 164.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.5 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 5.5 mt -100.64 75.08 1.71 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.205 1.002 . . . . 0.0 109.408 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -75.03 163.22 27.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.96 0.504 . . . . 0.0 111.63 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 10.6 p-10 -69.32 114.62 7.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.563 1.545 . . . . 0.0 110.517 175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.54 -5.75 24.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.297 1.427 . . . . 0.0 112.761 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' A' ' 34' ' ' LEU . 16.6 mtp -50.17 -54.0 23.84 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.952 1.301 . . . . 0.0 111.796 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -98.29 9.9 41.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.624 1.17 . . . . 0.0 111.497 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.403 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 11.6 t -66.76 112.28 4.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -174.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.34 -4.38 37.79 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 123.838 0.732 . . . . 0.0 112.598 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -76.58 72.63 3.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.331 1.565 . . . . 0.0 108.508 168.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 p -72.87 4.05 4.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.266 2.226 . . . . 0.0 113.189 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 49.89 1.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.215 1.806 . . . . 0.0 107.667 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.3 tp -122.67 105.34 10.0 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.32 -11.43 7.93 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.583 1.177 . . . . 0.0 114.159 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -129.98 124.2 32.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.537 HD21 HD21 ' A' ' 50' ' ' LEU . 2.4 tp -117.89 140.53 49.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.26 132.18 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.537 HD21 HD21 ' A' ' 48' ' ' LEU . 25.3 mt -110.92 113.85 26.73 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.481 0.713 . . . . 0.0 109.263 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.69 12.8 6.54 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.45 177.22 27.04 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -136.48 29.9 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.85 1.66 . . . . 0.0 109.261 -170.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -162.69 147.3 9.4 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.314 -0.866 . . . . 0.0 111.35 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.33 -42.84 9.35 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.706 2.938 . . . . 0.0 112.592 172.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.5 m -74.67 -15.31 60.81 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.377 -0.827 . . . . 0.0 112.759 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.79 -7.92 43.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.889 0.768 . . . . 0.0 113.06 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -110.41 -168.63 1.34 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.27 1.428 . . . . 0.0 109.579 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.9 m -145.62 172.69 12.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.552 1.541 . . . . 0.0 107.052 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.87 137.85 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.09 -165.39 11.96 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 156.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.57 -59.89 4.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.283 0.563 . . . . 0.0 109.536 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 36' ' ' ASP . . . -87.72 65.75 3.49 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 125.021 1.296 . . . . 0.0 111.45 -170.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.8 tp -45.07 -48.42 11.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.299 1.04 . . . . 0.0 110.719 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.94 36.69 2.78 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.567 -0.708 . . . . 0.0 111.108 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.66 121.2 12.2 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.445 -1.41 . . . . 0.0 110.029 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 83.73 10.18 81.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.08 171.89 13.45 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.674 1.237 . . . . 0.0 108.485 166.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -140.08 94.23 2.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 122.218 1.008 . . . . 0.0 108.299 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.59 165.04 16.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.272 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.8 mt -105.12 158.14 16.78 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.088 1.355 . . . . 0.0 109.051 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.78 101.39 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 127.089 2.155 . . . . 0.0 106.548 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.9 m -75.27 127.11 32.43 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.88 156.18 80.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 125.309 1.444 . . . . 0.0 107.116 172.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.59 143.16 67.48 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -51.61 -43.03 62.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.05 1.74 . . . . 0.0 110.568 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.91 -10.11 12.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.71 -4.66 12.16 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 125.139 1.376 . . . . 0.0 112.434 168.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.64 -59.1 5.93 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 121.286 1.857 . . . . 0.0 110.841 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.48 -18.05 61.71 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.457 0.646 . . . . 0.0 112.222 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -66.24 -45.06 81.96 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.462 2.305 . . . . 0.0 110.0 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -64.05 -49.91 70.47 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -56.27 -32.25 64.36 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.732 1.151 . . . . 0.0 113.947 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -80.69 2.27 26.65 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -64.13 167.04 6.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.393 1.092 . . . . 0.0 111.554 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.03 -45.61 60.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.746 0.818 . . . . 0.0 110.702 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -104.0 -47.93 4.04 Favored 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.048 0.939 . . . . 0.0 111.091 -162.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -55.03 -21.15 11.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.893 0.769 . . . . 0.0 112.188 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -46.15 -45.19 16.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.265 1.826 . . . . 0.0 113.099 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 t -64.56 -25.5 68.0 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.338 0.517 . . . . 0.0 110.297 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -94.28 9.34 38.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.24 1.816 . . . . 0.0 112.62 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -8.94 32.58 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.36 -1.463 . . . . 0.0 112.168 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.12 -18.62 59.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.471 1.032 . . . . 0.0 113.488 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -112.48 -4.3 14.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.593 1.088 . . . . 0.0 112.629 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.44 134.23 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.62 160.08 55.1 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.153 0.981 . . . . 0.0 111.031 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.17 164.12 26.48 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 111.963 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.1 mtt -83.71 -173.47 4.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.389 1.876 . . . . 0.0 111.645 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -137.8 179.92 6.14 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.203 2.601 . . . . 0.0 109.026 165.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 . . . . . 0 C--O 1.248 0.986 0 C-N-CA 125.928 1.691 . . . . 0.0 107.046 169.668 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.867 0 CA-C-O 120.122 -0.266 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -141.85 142.72 33.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.715 1.206 . . . . 0.0 110.456 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 45.59 45.5 10.79 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.79 1.636 . . . . 0.0 112.051 -166.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -147.29 147.77 30.73 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.516 -0.74 . . . . 0.0 109.517 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.16 71.67 0.32 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -170.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -130.49 78.0 74.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.003 2.121 . . . . 0.0 106.584 171.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.25 64.03 8.27 Favored 'Trans proline' 0 N--CA 1.458 -0.611 1 C-N-CA 126.484 4.789 . . . . 0.0 107.483 -171.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.96 140.75 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.534 1.134 . . . . 0.0 108.163 -164.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 27' ' ' VAL . 41.8 t -76.43 77.79 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.04 72.32 0.46 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.365 1.46 . . . . 0.0 110.086 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.39 9.49 2.02 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.467 1.907 . . . . 0.0 115.895 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -132.23 159.14 39.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.284 1.402 . . . . 0.0 109.374 158.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -138.46 31.92 2.32 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.392 1.477 . . . . 0.0 112.22 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.0 t -133.67 29.0 3.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.799 1.24 . . . . 0.0 110.882 175.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -115.4 2.72 13.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.161 1.785 . . . . 0.0 112.42 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -90.27 -41.07 11.77 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.967 -1.083 . . . . 0.0 110.926 -163.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.59 84.79 1.15 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.311 1.044 . . . . 0.0 109.759 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.06 -41.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -87.34 91.16 8.63 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.015 0.912 . . . . 0.0 112.37 -169.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.2 p -70.94 33.48 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 128.425 2.69 . . . . 0.0 114.589 -171.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.0 1.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 120.352 -1.468 . . . . 0.0 112.319 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -71.9 83.89 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-O 121.975 0.893 . . . . 0.0 111.473 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -79.37 4.31 15.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.797 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -153.29 138.28 17.23 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.1 1.36 . . . . 0.0 108.427 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -134.66 126.0 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 167.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.5 m -102.49 122.15 43.76 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 9' ' ' VAL . 2.3 t -112.12 112.49 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.96 1.304 . . . . 0.0 107.962 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -65.15 164.02 26.3 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.329 0.652 . . . . 0.0 110.491 167.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.24 154.97 68.98 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.216 1.944 . . . . 0.0 110.627 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 44.69 51.85 8.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.784 2.034 . . . . 0.0 113.109 171.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 tt -136.95 84.0 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 124.227 1.965 . . . . 0.0 107.808 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.82 149.48 0.11 Allowed Glycine 0 CA--C 1.525 0.682 1 C-N-CA 131.168 4.223 . . . . 0.0 113.014 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.86 HD21 ' HB3' ' A' ' 35' ' ' TYR 0.334 0.0 OUTLIER -64.81 155.33 34.29 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.792 -0.828 . . . . 0.0 110.195 170.789 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.534 ' H ' ' HB2' ' A' ' 59' ' ' SER . 5.0 mt -102.15 123.09 45.4 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 168.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.86 ' HB3' HD21 ' A' ' 33' ' ' LEU . 23.7 p90 -122.53 175.51 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 111.306 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.9 126.4 27.88 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.419 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.45 46.81 93.6 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 mtp -70.64 -34.24 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.815 1.246 . . . . 0.0 110.805 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -114.84 29.85 7.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.088 1.355 . . . . 0.0 110.655 -167.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.3 t -61.73 109.69 1.3 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.891 0.876 . . . . 0.0 110.53 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.79 12.88 55.03 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.978 -0.901 . . . . 0.0 113.462 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -78.2 73.82 4.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.392 1.596 . . . . 0.0 109.441 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 p -68.06 -3.17 9.36 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.971 2.508 . . . . 0.0 113.5 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.68 53.43 1.85 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.486 1.514 . . . . 0.0 107.889 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 tp -129.63 111.78 13.03 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.607 1.563 . . . . 0.0 107.882 174.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.77 8.95 3.06 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -137.3 152.7 50.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 O-C-N 120.878 -1.139 . . . . 0.0 110.503 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.8 tp -146.1 94.03 2.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.86 1.664 . . . . 0.0 107.169 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mp -82.71 141.52 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.6 mt -128.18 118.05 22.66 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 p -88.48 -4.53 58.6 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -167.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.8 154.31 20.56 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 119.064 0.847 . . . . 0.0 112.111 -167.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.31 -2.82 58.49 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.37 148.1 39.42 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 120.288 1.403 . . . . 0.0 111.868 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.91 -23.61 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.23 2.62 . . . . 0.0 113.803 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.2 t -73.69 -21.18 60.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.698 1.599 . . . . 0.0 110.869 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.26 6.27 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.263 1.825 . . . . 0.0 113.031 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -141.72 175.36 9.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.261 1.824 . . . . 0.0 111.001 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.534 ' HB2' ' H ' ' A' ' 34' ' ' LEU . 3.8 m -135.12 -171.95 2.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.42 2.688 . . . . 0.0 108.584 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 177.1 -13.56 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.393 1.477 . . . . 0.0 113.425 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.22 -100.24 0.51 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.588 1.566 . . . . 0.0 110.134 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -140.39 -13.16 1.02 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.372 1.069 . . . . 0.0 111.299 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.08 42.8 0.89 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 124.007 0.813 . . . . 0.0 111.343 -159.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -44.47 -55.56 4.97 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.216 1.406 . . . . 0.0 111.569 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -98.33 12.38 35.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.931 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -64.32 158.28 23.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.266 0.939 . . . . 0.0 110.17 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.8 6.52 51.71 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.894 1.235 . . . . 0.0 114.695 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.26 -163.84 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.318 2.247 . . . . 0.0 107.499 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -155.74 112.29 3.16 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 120.456 -1.403 . . . . 0.0 110.051 164.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -126.77 175.42 8.02 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.56 1.144 . . . . 0.0 112.774 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.2 tp -111.04 155.75 22.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.954 2.502 . . . . 0.0 108.553 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.9 mt -117.76 138.9 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.462 1.105 . . . . 0.0 108.206 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.8 m -126.93 130.7 50.62 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.556 1.542 . . . . 0.0 107.686 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 82' ' ' TYR . 34.6 m -131.74 160.18 68.66 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.18 144.54 69.33 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 N-CA-C 107.183 -1.891 . . . . 0.0 107.183 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -52.44 -29.99 27.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.53 0.732 . . . . 0.0 111.477 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.05 -33.08 73.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.022 1.329 . . . . 0.0 112.29 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -107.53 -3.82 19.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.584 1.154 . . . . 0.0 112.391 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.88 -46.4 74.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -75.47 -36.93 60.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.04 -52.5 42.53 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 109.799 172.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.476 ' CD2' HG11 ' A' ' 74' ' ' VAL . 3.2 m-85 -63.91 -42.03 97.51 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.868 0.867 . . . . 0.0 109.817 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 mtt-85 -67.01 -11.61 57.51 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -110.12 18.13 20.3 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.027 1.731 . . . . 0.0 110.707 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -79.53 159.43 26.9 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.757 -1.214 . . . . 0.0 112.036 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -81.71 -35.47 29.74 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.124 -0.985 . . . . 0.0 112.103 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -90.96 -54.21 4.06 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.606 -0.684 . . . . 0.0 109.225 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -69.54 -12.51 61.71 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -47.43 -35.5 8.55 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 121.27 1.85 . . . . 0.0 115.158 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -63.15 -41.41 99.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.116 0.871 . . . . 0.0 111.181 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -75.94 3.77 9.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.221 1.008 . . . . 0.0 112.35 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -63.85 -19.87 65.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 120.678 -1.263 . . . . 0.0 112.024 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.5 -5.94 6.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.742 -1.123 . . . . 0.0 113.626 173.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -133.41 12.61 4.16 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.369 1.44 . . . . 0.0 112.474 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 92' ' ' ALA . 54.3 mt -89.54 130.78 38.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -138.08 165.39 33.79 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 111.284 165.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 176.37 2.48 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.446 2.097 . . . . 0.0 111.36 168.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.3 ptp -109.36 154.15 22.95 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.731 1.613 . . . . 0.0 107.311 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.28 177.11 8.22 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.7 1.2 . . . . 0.0 109.698 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 115.977 -1.963 . . . . 0.0 111.344 -177.64 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.428 0 CA-C-O 121.403 0.446 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 p -152.38 177.12 10.92 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 129.416 3.086 . . . . 0.0 104.804 162.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -124.25 156.33 37.04 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.541 1.064 . . . . 0.0 111.341 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.39 168.36 12.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.977 1.711 . . . . 0.0 110.081 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.89 10.46 72.15 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 118.833 -0.982 . . . . 0.0 112.796 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -113.61 85.18 8.86 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.343 1.457 . . . . 0.0 110.65 -170.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.96 64.44 8.27 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.742 2.294 . . . . 0.0 110.397 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -134.67 165.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -169.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.06 70.07 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.381 -0.824 . . . . 0.0 108.796 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.99 69.51 0.51 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.1 mtp 58.42 13.8 2.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.679 1.992 . . . . 0.0 115.61 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.27 172.07 13.38 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.301 1.41 . . . . 0.0 109.899 157.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 13' ' ' LYS . 7.7 mmpt? -118.2 4.6 11.95 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.254 1.422 . . . . 0.0 113.422 -175.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -82.43 -23.93 34.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.395 1.452 . . . . 0.0 113.301 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.88 62.27 4.06 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.531 . . . . 0.0 111.999 -165.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -142.24 -49.06 0.36 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.686 -1.259 . . . . 0.0 112.13 -174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.77 66.06 2.0 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.476 1.11 . . . . 0.0 110.57 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 -34.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.587 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' O ' HG22 ' A' ' 22' ' ' ILE . 55.4 t30 -94.9 80.58 3.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.413 1.606 . . . . 0.0 112.297 -168.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.5 p -62.34 24.21 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 130.869 3.668 . . . . 0.0 116.511 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.36 -14.48 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 128.552 2.741 . . . . 0.0 110.947 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 19' ' ' ASN . 16.4 tt -62.51 99.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 119.348 0.976 . . . . 0.0 110.099 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -4.11 52.96 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.736 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -152.56 134.1 14.53 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 119.033 0.833 . . . . 0.0 112.163 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.5 108.88 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -81.0 146.53 30.63 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 166.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -139.65 115.0 8.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -66.5 164.2 34.06 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 118.202 0.455 . . . . 0.0 110.172 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.32 162.38 36.49 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.849 1.699 . . . . 0.0 110.848 173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 44.7 56.47 5.17 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.187 2.595 . . . . 0.0 112.693 169.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.5 tt -144.69 71.12 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 124.282 1.992 . . . . 0.0 109.37 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.46 170.81 42.4 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 126.988 2.232 . . . . 0.0 112.416 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.4 tp -83.84 133.71 34.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.901 1.28 . . . . 0.0 110.638 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.42 122.1 28.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 159.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -126.75 175.51 7.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.817 1.247 . . . . 0.0 109.35 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.42 156.14 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.829 0.851 . . . . 0.0 110.237 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 63.75 -1.01 2.69 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.737 2.113 . . . . 0.0 115.307 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -29.65 60.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.013 1.725 . . . . 0.0 112.643 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -110.56 18.45 19.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.795 1.238 . . . . 0.0 113.373 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 t -56.91 105.54 0.23 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.776 0.831 . . . . 0.0 111.577 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.43 23.47 39.95 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.128 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -72.37 76.96 1.02 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.743 1.772 . . . . 0.0 109.182 164.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -71.79 15.68 0.14 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.816 2.446 . . . . 0.0 114.243 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.41 4.39 1.98 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.759 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -68.37 119.85 13.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.394 0.997 . . . . 0.0 110.631 -169.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -122.25 -35.21 3.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.31 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -121.06 141.91 50.32 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 122.021 2.192 . . . . 0.0 113.178 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.7 tp -119.74 138.99 52.98 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.916 2.487 . . . . 0.0 104.561 161.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.05 140.59 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -115.44 151.38 34.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -119.47 5.14 11.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.487 0.715 . . . . 0.0 112.395 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.12 169.03 30.37 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 118.971 0.805 . . . . 0.0 111.828 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -124.39 15.69 8.96 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.59 152.7 42.2 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 120.641 -1.287 . . . . 0.0 108.632 163.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -3.32 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 124.526 3.484 . . . . 0.0 113.896 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 m -91.48 14.64 14.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.865 1.212 . . . . 0.0 112.495 161.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.59 -4.49 55.26 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.181 1.355 . . . . 0.0 113.497 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -129.07 174.74 9.27 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.987 1.715 . . . . 0.0 109.72 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -119.35 172.4 7.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.807 1.643 . . . . 0.0 108.316 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -174.06 118.81 0.25 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 127.977 2.511 . . . . 0.0 105.948 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.66 -178.91 5.27 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 125.817 1.675 . . . . 0.0 109.425 161.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.51 -38.82 88.74 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.452 1.101 . . . . 0.0 111.779 -162.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.21 81.79 0.29 Allowed Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 126.892 2.187 . . . . 0.0 107.832 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 tt -51.81 -47.06 64.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.544 1.172 . . . . 0.0 109.106 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -85.99 -7.0 58.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 117.573 -1.203 . . . . 0.0 114.157 -165.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -54.64 112.66 1.06 Allowed 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.684 0.615 . . . . 0.0 110.007 -159.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.38 -13.31 12.27 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.313 -1.271 . . . . 0.0 115.755 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -147.5 -172.43 4.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.014 1.407 . . . . 0.0 109.503 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -151.0 97.79 2.5 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.135 -0.978 . . . . 0.0 111.646 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.759 ' CB ' HD22 ' A' ' 45' ' ' LEU . 13.8 p90 -122.73 164.9 17.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 109.685 -174.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.5 149.0 21.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.375 1.87 . . . . 0.0 110.689 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 mt -105.26 126.34 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 m -112.78 140.15 47.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -133.39 160.21 69.53 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.075 1.35 . . . . 0.0 107.431 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.82 147.73 81.35 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.292 -1.465 . . . . 0.0 108.292 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.91 -30.21 32.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.964 0.506 . . . . 0.0 112.182 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -71.38 -25.58 62.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.871 1.268 . . . . 0.0 112.343 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.71 -3.28 46.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 113.049 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 tp -62.2 -50.09 73.19 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.358 -0.839 . . . . 0.0 113.216 -163.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -74.54 -37.85 62.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.805 0.842 . . . . 0.0 109.917 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -49.34 -52.81 25.69 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.529 1.132 . . . . 0.0 109.086 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -70.29 -30.22 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.09 0.556 . . . . 0.0 110.762 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -22.91 62.21 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.379 -0.826 . . . . 0.0 112.763 169.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -91.22 6.66 44.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.001 1.32 . . . . 0.0 112.175 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.98 159.73 24.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 120.807 1.64 . . . . 0.0 112.14 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -72.04 -43.73 64.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 120.768 -1.208 . . . . 0.0 110.978 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -95.36 -53.12 3.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.933 0.893 . . . . 0.0 110.22 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -61.86 -13.18 22.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.404 1.002 . . . . 0.0 113.415 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -48.64 -48.26 39.72 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.503 1.521 . . . . 0.0 114.743 164.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 t -52.04 -43.81 63.94 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.022 1.283 . . . . 0.0 110.171 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -80.38 6.7 11.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.435 1.094 . . . . 0.0 113.665 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.7 70.24 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.066 1.303 . . . . 0.0 111.533 -174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.1 -3.07 0.73 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.873 1.269 . . . . 0.0 114.239 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -135.89 12.49 3.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.194 1.398 . . . . 0.0 112.271 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.9 mt -98.02 131.09 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.676 1.125 . . . . 0.0 108.949 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.58 166.14 26.35 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.771 2.028 . . . . 0.0 111.737 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.2 154.16 69.47 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.134 1.89 . . . . 0.0 113.214 168.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.3 ptp -78.68 162.85 25.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.604 1.961 . . . . 0.0 109.515 173.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . 0.255 1.3 pt-20 -100.98 -167.96 1.5 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.832 0.853 . . . . 0.0 110.823 169.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 117.289 -1.338 . . . . 0.0 111.064 -166.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 CA-C-O 118.438 -1.201 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.85 123.49 7.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.164 1.386 . . . . 0.0 108.669 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -171.92 152.86 3.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.169 1.787 . . . . 0.0 108.336 176.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -88.08 40.77 0.96 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 122.415 1.102 . . . . 0.0 111.395 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.03 -41.44 2.76 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.687 1.613 . . . . 0.0 112.632 171.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.58 159.4 38.62 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 125.942 1.697 . . . . 0.0 108.59 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.19 100.83 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.385 2.057 . . . . 0.0 110.416 -171.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.29 165.78 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.242 1.417 . . . . 0.0 109.042 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 ' CE ' ' A' ' 13' ' ' LYS . 4.0 p -109.3 127.02 66.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 124.328 1.051 . . . . 0.0 111.806 -172.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.18 76.01 0.2 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.011 1.291 . . . . 0.0 110.018 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.4 mtm 63.19 -31.68 0.1 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.822 2.849 . . . . 0.0 115.99 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -44.39 43.39 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.746 1 C-N-CA 136.928 6.091 . . . . 0.0 118.52 169.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.629 ' CE ' HG23 ' A' ' 9' ' ' VAL . 3.1 mmtm -73.22 72.11 1.22 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 119.372 -2.08 . . . . 0.0 111.029 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.61 4.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.055 2.142 . . . . 0.0 112.266 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -108.06 -13.92 14.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.721 1.6 . . . . 0.0 113.096 -174.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CD1' ' SD ' ' A' ' 38' ' ' MET . 21.4 m-85 -69.4 -35.0 75.35 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.708 0.803 . . . . 0.0 111.777 -160.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 33.27 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.896 2.078 . . . . 0.0 112.827 168.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.62 -40.8 1.55 Allowed Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.5 -1.375 . . . . 0.0 112.37 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -102.37 157.28 17.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.924 1.362 . . . . 0.0 109.997 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 p -123.21 22.65 9.36 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.534 1.534 . . . . 0.0 110.671 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.05 16.79 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.13 1.772 . . . . 0.0 108.78 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tt -87.62 104.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 -107.65 9.59 29.23 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.168 1.787 . . . . 0.0 111.646 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -154.13 148.35 25.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 156.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.45 118.25 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -82.38 125.02 30.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 166.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 28' ' ' GLN . 1.8 t -119.24 164.45 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.442 ' H ' HG12 ' A' ' 27' ' ' VAL . 36.4 mt-30 -131.24 157.86 76.9 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -167.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 59.2 Cg_endo -70.7 157.07 59.59 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -177.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m120 46.73 37.72 5.01 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.179 1.791 . . . . 0.0 114.855 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.265 4.7 tt -117.12 18.65 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.242 . . . . 0.0 113.168 -174.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.62 149.56 5.68 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.59 1.566 . . . . 0.0 110.465 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 34' ' ' LEU . 1.4 tm? -65.82 130.23 42.54 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.574 ' N ' HD13 ' A' ' 33' ' ' LEU . 2.6 mt -79.44 78.01 5.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.66 1.184 . . . . 0.0 107.904 173.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HA ' HD12 ' A' ' 33' ' ' LEU . 3.3 p90 -75.36 168.63 19.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.833 0.825 . . . . 0.0 111.432 -162.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -74.56 98.08 3.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.512 0.725 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.77 -1.72 11.02 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.833 1.682 . . . . 0.0 113.815 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.465 ' SD ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 tmm? -59.24 -37.61 77.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.723 2.009 . . . . 0.0 113.431 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -103.68 11.88 35.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.042 1.337 . . . . 0.0 112.492 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 t -69.89 94.41 0.84 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -171.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.69 -6.65 6.19 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.157 -1.357 . . . . 0.0 113.478 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.2 m -74.63 70.54 1.84 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.652 2.226 . . . . 0.0 109.957 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p -67.83 -11.05 57.77 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.807 1.243 . . . . 0.0 114.326 -168.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.6 18.44 17.56 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.853 1.261 . . . . 0.0 111.714 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.756 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.2 tt -79.86 119.48 22.8 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 120.458 -1.401 . . . . 0.0 108.477 -173.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.82 -17.53 5.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.505 1.522 . . . . 0.0 112.447 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -152.02 150.15 29.65 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.175 2.19 . . . . 0.0 110.859 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.443 HD21 HD21 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -150.79 145.43 25.73 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 128.45 2.7 . . . . 0.0 104.451 178.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -131.29 141.38 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' A' ' 58' ' ' TYR . 94.9 mt -126.97 115.03 18.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.242 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.7 p -82.17 12.32 4.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.87 175.36 32.46 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.456 -1.402 . . . . 0.0 109.893 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -132.85 19.57 4.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.76 0.824 . . . . 0.0 110.982 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -160.88 144.81 10.12 Favored Pre-proline 0 N--CA 1.467 0.411 0 C-N-CA 125.029 1.332 . . . . 0.0 109.224 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.98 -25.03 44.88 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.01 2.473 . . . . 0.0 113.423 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 m -65.34 -11.67 44.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.346 0.658 . . . . 0.0 112.139 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 29' ' ' PRO . . . -79.52 -1.01 35.74 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.728 1.149 . . . . 0.0 112.869 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.47 ' CE2' HD22 ' A' ' 50' ' ' LEU . 83.9 m-85 -137.78 170.51 15.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 110.468 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.7 m -156.8 149.06 23.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.928 1.291 . . . . 0.0 109.59 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.21 158.3 44.41 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.231 2.213 . . . . 0.0 110.106 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.3 -166.23 42.0 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -65.67 -24.4 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.298 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.34 73.81 0.44 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.888 1.709 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.2 -40.75 5.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.642 1.577 . . . . 0.0 110.808 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.66 24.06 7.25 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.943 0.897 . . . . 0.0 111.415 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -51.53 121.93 7.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.144 0.884 . . . . 0.0 110.941 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.54 13.39 82.98 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.855 -0.969 . . . . 0.0 114.231 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.52 176.03 8.9 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.604 1.962 . . . . 0.0 108.178 162.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.61 76.27 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.08 -1.012 . . . . 0.0 110.159 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.756 ' HB2' HD22 ' A' ' 45' ' ' LEU . 18.8 p90 -119.83 171.06 8.68 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.391 1.076 . . . . 0.0 111.979 -165.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.4 tp -113.03 160.79 17.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.254 1.822 . . . . 0.0 110.303 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.8 mt -131.08 104.78 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 127.028 2.131 . . . . 0.0 110.016 -163.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.2 m -95.25 105.25 17.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.574 1.95 . . . . 0.0 113.334 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -113.22 156.14 43.45 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.702 1.201 . . . . 0.0 109.254 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.51 151.81 82.17 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 CA-C-N 121.585 1.602 . . . . 0.0 109.158 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.62 -31.24 66.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.781 0.832 . . . . 0.0 112.226 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -59.51 -33.17 71.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.333 1.453 . . . . 0.0 112.093 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.08 -6.52 38.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.499 -0.751 . . . . 0.0 111.978 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -61.9 -50.66 71.28 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.298 0.954 . . . . 0.0 111.663 -164.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.57 -30.65 46.88 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.688 -0.633 . . . . 0.0 111.078 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -50.32 -55.17 16.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.21 1.404 . . . . 0.0 109.242 168.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.25 -37.98 85.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.235 0.614 . . . . 0.0 111.054 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -68.12 -28.16 67.09 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 118.463 -0.78 . . . . 0.0 112.863 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.11 3.95 47.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.02 1.282 . . . . 0.0 113.291 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.36 148.36 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.738 0.815 . . . . 0.0 112.029 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -58.64 -42.77 89.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 112.815 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -102.88 -52.94 2.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.154 0.981 . . . . 0.0 109.731 -171.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -60.39 -12.25 8.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -44.28 -44.62 8.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 164.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.4 t -64.03 -46.35 84.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.358 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.98 6.37 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.111 -0.993 . . . . 0.0 112.812 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.11 68.3 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.663 -1.273 . . . . 0.0 111.181 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -19.04 15.32 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.008 0.923 . . . . 0.0 113.315 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -117.62 4.87 12.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.614 1.166 . . . . 0.0 112.673 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.5 mt -99.26 95.41 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -95.45 163.13 22.31 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.8 0.84 . . . . 0.0 109.245 173.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 96' ' ' GLN . 86.2 Cg_endo -69.48 166.57 26.79 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 168.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 9.6 mtm -86.82 172.96 9.72 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.127 1.371 . . . . 0.0 109.511 166.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -111.81 -164.96 0.95 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.283 2.233 . . . . 0.0 106.984 167.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--O 1.246 0.894 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 171.335 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.28 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 m -150.55 -166.85 2.65 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.39 2.676 . . . . 0.0 105.134 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.1 m170 57.81 37.93 27.15 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.962 0.905 . . . . 0.0 110.76 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.47 156.5 36.83 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.34 1.456 . . . . 0.0 108.297 170.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.96 81.94 0.44 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.011 1.291 . . . . 0.0 110.654 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HG3' HG23 ' A' ' 8' ' ' VAL . 43.8 tp10 -81.14 144.05 53.76 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.896 1.679 . . . . 0.0 108.491 172.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.27 64.57 8.45 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 124.211 3.274 . . . . 0.0 113.498 -171.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 6' ' ' GLU . 92.7 t -134.48 144.48 34.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 O-C-N 120.433 -1.417 . . . . 0.0 109.341 -170.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.927 HG13 ' HE3' ' A' ' 13' ' ' LYS . 16.6 t -77.71 94.15 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.66 84.25 0.22 Allowed Glycine 0 C--O 1.223 -0.554 0 N-CA-C 106.561 -2.616 . . . . 0.0 106.561 165.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 ttt 56.4 4.13 0.13 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 166.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -132.14 85.22 2.22 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.905 1.23 . . . . 0.0 111.51 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.927 ' HE3' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -74.81 73.49 2.09 Favored 'General case' 0 C--N 1.339 0.114 0 O-C-N 120.118 -1.614 . . . . 0.0 109.316 174.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -145.14 -16.98 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.558 1.143 . . . . 0.0 113.229 172.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.76 86.09 2.46 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 126.98 2.112 . . . . 0.0 107.817 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -142.01 -52.0 0.41 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.18 0.992 . . . . 0.0 112.047 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.92 87.17 1.01 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.22 1.808 . . . . 0.0 108.275 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 -41.59 0.05 OUTLIER Glycine 0 C--N 1.33 0.238 0 CA-C-O 118.488 -1.174 . . . . 0.0 112.535 -171.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -110.0 133.28 53.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.971 0.885 . . . . 0.0 109.909 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.7 p -101.28 6.3 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.094 1.758 . . . . 0.0 114.054 -155.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.76 17.81 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 110.666 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tt -97.92 90.57 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.86 -17.98 62.09 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.15 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -138.99 120.06 14.55 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.675 1.125 . . . . 0.0 108.786 -165.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.92 135.57 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.6 m -117.72 133.06 56.33 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG13 HG11 ' A' ' 9' ' ' VAL . 2.2 t -132.37 122.41 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.897 1.679 . . . . 0.0 109.195 -173.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 28' ' ' GLN . 6.4 mp0 -79.14 165.06 51.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -75.36 168.71 23.99 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.967 2.445 . . . . 0.0 111.922 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 50.0 34.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.964 2.106 . . . . 0.0 114.002 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.275 4.9 tt -138.47 27.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -171.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.58 162.59 9.17 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.43 0.538 . . . . 0.0 113.791 152.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.6 tp -80.77 121.13 25.54 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.873 0.869 . . . . 0.0 109.564 -177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -78.95 83.34 5.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -69.37 167.03 17.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.678 0.751 . . . . 0.0 111.447 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.2 124.91 25.55 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.817 1.247 . . . . 0.0 110.094 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.16 28.54 66.12 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.659 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 3.7 mtp -54.29 -35.04 62.17 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.2 1.5 . . . . 0.0 110.128 161.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.3 22.09 16.27 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.191 1.796 . . . . 0.0 111.807 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.419 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -67.34 121.22 15.26 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.484 -0.76 . . . . 0.0 110.415 179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.22 11.06 70.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.949 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.95 91.13 1.52 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.47 1.635 . . . . 0.0 108.485 171.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.25 -3.68 55.65 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.933 2.093 . . . . 0.0 113.677 -166.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.16 68.0 1.3 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 161.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.6 tp -121.17 109.93 15.57 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.634 1.173 . . . . 0.0 109.978 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -139.98 30.66 2.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 122.816 0.446 . . . . 0.0 112.103 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -157.02 147.54 21.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 119.874 -1.766 . . . . 0.0 110.196 169.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.657 HD12 HG23 ' A' ' 72' ' ' ILE . 2.1 tm? -134.41 150.22 50.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.195 1.798 . . . . 0.0 107.157 172.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.1 mp -137.62 145.4 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.7 mt -128.6 108.56 10.61 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.323 0.965 . . . . 0.0 111.775 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.284 9.5 t -93.44 57.43 2.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.082 1.353 . . . . 0.0 109.51 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.34 175.54 20.11 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.687 2.565 . . . . 0.0 107.95 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -132.17 6.39 4.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.616 0.766 . . . . 0.0 111.956 -165.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.1 144.11 19.27 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 119.658 1.117 . . . . 0.0 109.974 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -70.43 -30.06 19.76 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.899 2.399 . . . . 0.0 113.25 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 m -74.29 -18.29 60.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.711 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.5 15.12 0.19 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.373 1.469 . . . . 0.0 114.018 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -139.7 170.14 16.45 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.558 1.943 . . . . 0.0 108.077 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.0 m -138.0 165.49 26.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.391 1.077 . . . . 0.0 108.427 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.7 163.47 37.23 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.986 1.714 . . . . 0.0 106.931 162.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -154.06 27.17 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 164.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -23.04 65.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.582 0.753 . . . . 0.0 112.013 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 76.97 0.25 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -169.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.9 tp -45.58 -61.07 1.85 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.405 1.482 . . . . 0.0 110.824 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -90.46 16.81 8.21 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.979 1.312 . . . . 0.0 111.265 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -56.91 140.53 48.2 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.635 1.107 . . . . 0.0 109.348 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 40' ' ' SER . . . 87.15 -10.15 69.84 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.289 -0.728 . . . . 0.0 113.315 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.95 -174.31 3.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.212 1.805 . . . . 0.0 109.704 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -155.58 100.78 2.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.411 1.484 . . . . 0.0 108.283 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -138.1 171.32 14.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.43 1.492 . . . . 0.0 110.47 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.2 mt -101.81 151.71 21.74 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.203 1.401 . . . . 0.0 110.697 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.657 HG23 HD12 ' A' ' 48' ' ' LEU . 44.4 mt -106.79 104.4 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 126.53 1.932 . . . . 0.0 109.363 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.8 m -80.55 131.64 35.56 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.87 159.16 71.27 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 126.059 1.743 . . . . 0.0 108.311 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.35 157.7 49.3 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 121.459 1.557 . . . . 0.0 110.781 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -66.31 -24.72 66.59 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.15 -43.29 82.68 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.37 1.468 . . . . 0.0 110.396 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.09 -8.62 59.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.698 0.399 . . . . 0.0 111.269 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.41 -46.78 84.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.077 0.951 . . . . 0.0 111.24 -167.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.47 -29.81 59.71 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.548 -1.345 . . . . 0.0 110.495 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -59.07 5.83 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.615 1.566 . . . . 0.0 110.502 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -60.97 -39.65 90.41 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.92 0.782 . . . . 0.0 110.335 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 3.0 mtm180 -60.05 -39.27 85.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 121.896 -0.503 . . . . 0.0 110.121 -174.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -76.66 0.19 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.382 1.473 . . . . 0.0 113.685 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -71.57 173.02 8.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.993 1.27 . . . . 0.0 112.13 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -91.81 -21.25 20.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.837 1.655 . . . . 0.0 112.963 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 -56.53 2.4 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.915 1.286 . . . . 0.0 110.735 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -59.22 -11.42 3.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.324 1.9 pt20 -44.43 -62.31 1.22 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.683 2.393 . . . . 0.0 114.629 168.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -46.4 80.87 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.421 -0.799 . . . . 0.0 109.529 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -67.8 -6.6 22.1 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.093 -1.004 . . . . 0.0 113.477 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.54 61.46 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 119.973 -1.704 . . . . 0.0 112.171 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.5 57.57 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -124.33 -1.43 8.14 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.2 1.0 . . . . 0.0 112.465 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 82' ' ' TYR . 64.8 mt -85.14 134.31 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.52 164.91 33.68 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 126.282 1.833 . . . . 0.0 109.674 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.98 171.07 7.95 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.334 2.023 . . . . 0.0 112.814 174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtt -88.7 175.79 7.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 123.172 1.463 . . . . 0.0 109.897 168.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -123.19 170.19 10.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 156.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 127.602 2.361 . . . . 0.0 113.114 163.679 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 p -153.89 72.21 0.89 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -152.58 170.56 19.89 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.697 1.599 . . . . 0.0 109.116 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -85.16 109.97 18.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.61 51.49 0.03 OUTLIER Glycine 0 C--N 1.334 0.45 0 O-C-N 121.304 -0.872 . . . . 0.0 111.958 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -65.75 162.9 39.95 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.581 1.152 . . . . 0.0 111.577 170.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.33 72.0 4.33 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.369 3.379 . . . . 0.0 111.024 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -144.6 143.07 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.26 165.98 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.561 1.544 . . . . 0.0 111.331 165.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.16 -95.98 0.1 Allowed Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 104.002 -3.639 . . . . 0.0 104.002 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 mtt -141.41 27.08 1.92 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.246 1.023 . . . . 0.0 112.434 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -146.57 164.56 32.21 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.354 -0.841 . . . . 0.0 109.342 161.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -129.36 11.93 5.92 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -163.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.39 -16.82 30.08 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 122.403 2.365 . . . . 0.0 113.287 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.61 23.03 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.454 2.702 . . . . 0.0 114.877 -161.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -118.53 -33.71 4.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.4 -1.437 . . . . 0.0 111.298 -165.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.77 56.94 2.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.603 0.761 . . . . 0.0 110.002 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.97 -18.12 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 CA-C-O 117.77 -1.572 . . . . 0.0 115.974 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -119.95 147.73 44.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.808 . . . . 0.0 111.486 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -126.9 16.57 7.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 111.559 -155.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.81 29.41 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 126.104 1.762 . . . . 0.0 109.583 -166.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tt -113.87 98.5 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 126.706 2.002 . . . . 0.0 106.987 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 mtt85 -89.27 -9.62 49.94 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.071 -1.442 . . . . 0.0 111.144 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.97 135.75 36.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.626 1.557 . . . . 0.0 109.097 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 mt -138.94 102.76 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.2 m -90.78 94.55 9.72 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.44 127.37 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 120.209 -1.557 . . . . 0.0 110.223 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -79.6 162.67 62.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.656 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.83 164.83 31.19 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.922 2.415 . . . . 0.0 111.085 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 45.15 49.89 9.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.994 2.118 . . . . 0.0 112.015 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.91 -5.02 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.31 158.42 11.04 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 120.636 -1.29 . . . . 0.0 111.384 157.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD12 ' H ' ' A' ' 34' ' ' LEU . 36.5 tp -57.17 158.39 5.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 33' ' ' LEU . 4.9 mt -124.87 81.62 1.97 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.125 1.37 . . . . 0.0 109.494 172.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -70.19 174.68 5.25 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.616 -0.678 . . . . 0.0 112.189 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -73.24 131.1 41.57 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 120.631 -1.293 . . . . 0.0 109.736 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 66' ' ' ASP . . . 81.19 8.3 87.44 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 118.612 -1.105 . . . . 0.0 113.222 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -12.55 2.01 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.81 2.305 . . . . 0.0 113.038 175.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -122.05 11.5 10.25 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.36 1.464 . . . . 0.0 111.518 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.5 p -66.31 98.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.068 -1.02 . . . . 0.0 110.555 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.15 -6.35 6.8 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.107 1.337 . . . . 0.0 112.6 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 56.8 m -73.57 61.53 0.72 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.376 1.588 . . . . 0.0 111.381 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 p -72.19 25.81 0.05 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.998 1.719 . . . . 0.0 114.592 -171.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.92 17.02 2.3 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.528 -1.358 . . . . 0.0 111.796 161.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.773 HD22 ' HB2' ' A' ' 70' ' ' PHE . 1.3 tt -70.23 120.92 16.63 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.899 1.227 . . . . 0.0 109.193 -177.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.16 -17.46 4.31 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.133 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -144.63 152.78 40.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 120.881 1.673 . . . . 0.0 112.908 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.39 103.83 4.16 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 128.256 2.622 . . . . 0.0 104.39 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.29 142.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 58' ' ' TYR . 59.9 mt -117.11 146.38 43.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -119.6 28.12 8.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.602 0.761 . . . . 0.0 110.684 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.18 17.21 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.85 5.8 22.85 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.65 144.03 21.46 Favored Pre-proline 0 C--O 1.232 0.182 0 C-N-CA 124.83 1.252 . . . . 0.0 107.93 171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.06 -11.57 30.7 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.121 2.547 . . . . 0.0 113.691 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -59.55 -30.08 68.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.323 1.449 . . . . 0.0 111.057 167.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.76 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.881 1.272 . . . . 0.0 113.538 -166.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.477 ' CE2' HD22 ' A' ' 50' ' ' LEU . 86.0 m-85 -139.68 -175.93 4.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.271 1.829 . . . . 0.0 110.134 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 34' ' ' LEU . 8.3 t -144.42 172.74 12.52 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.881 2.072 . . . . 0.0 107.916 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.07 168.63 24.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.708 1.203 . . . . 0.0 108.295 161.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.0 -107.03 2.71 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -105.14 -21.41 13.27 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.186 0.594 . . . . 0.0 111.367 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.63 -136.36 3.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 105.408 -3.077 . . . . 0.0 105.408 152.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -160.37 -47.69 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.281 1.032 . . . . 0.0 110.971 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 12.42 28.79 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.249 -0.907 . . . . 0.0 112.526 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -58.97 145.93 39.88 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.473 1.109 . . . . 0.0 111.8 -165.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.03 -30.39 1.82 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.488 1.518 . . . . 0.0 112.778 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.67 -175.17 2.72 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 110.318 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -164.6 91.61 0.59 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.921 2.488 . . . . 0.0 106.371 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.773 ' HB2' HD22 ' A' ' 45' ' ' LEU . 24.4 p90 -134.09 172.65 12.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.595 1.958 . . . . 0.0 109.317 -172.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.15 157.46 16.98 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.809 -1.182 . . . . 0.0 110.887 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.3 mt -119.15 102.5 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.629 1.972 . . . . 0.0 106.358 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 m -99.35 110.41 22.92 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.86 1.664 . . . . 0.0 111.195 -175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.8 157.8 40.76 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.18 1.354 . . . . 0.0 110.34 -166.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -65.35 147.27 87.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 CA-C-N 120.385 1.173 . . . . 0.0 110.016 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.73 -37.49 71.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.899 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -38.86 89.47 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.606 -0.684 . . . . 0.0 110.138 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.2 -18.54 49.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.7 0.8 . . . . 0.0 112.475 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.0 tp -47.26 -53.49 13.25 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.329 1.451 . . . . 0.0 112.576 -166.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.1 -28.37 60.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.908 1.283 . . . . 0.0 109.629 169.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.98 -38.58 91.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.273 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -67.89 -31.93 72.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -84.25 9.83 11.94 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.65 163.47 21.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.518 1.054 . . . . 0.0 112.773 -169.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -88.12 -36.7 16.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.477 -0.764 . . . . 0.0 111.176 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -82.77 -66.55 0.88 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -68.6 -2.79 9.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.698 1.199 . . . . 0.0 114.172 -163.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.276 1.0 OUTLIER -43.76 -56.04 4.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.651 2.38 . . . . 0.0 112.666 174.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.447 HG23 ' CD2' ' A' ' 91' ' ' TYR . 5.9 t -52.75 -40.98 63.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.412 1.085 . . . . 0.0 111.183 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CD2' HG23 ' A' ' 90' ' ' THR . 97.2 m-85 -73.69 4.3 5.26 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.339 -0.851 . . . . 0.0 113.073 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -59.17 -26.48 64.82 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 119.71 -1.869 . . . . 0.0 112.097 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.55 -12.3 14.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -125.92 16.22 7.97 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.273 0.942 . . . . 0.0 110.188 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 92' ' ' ALA . 84.8 mt -99.27 122.03 50.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -132.73 165.61 35.2 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.59 1.556 . . . . 0.0 109.239 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.99 175.02 5.05 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.167 1.912 . . . . 0.0 112.072 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptp -101.22 165.23 11.39 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.842 1.657 . . . . 0.0 110.541 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.47 -174.44 4.04 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.206 1.403 . . . . 0.0 110.8 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 . . . . . 0 C--O 1.255 1.394 0 C-N-CA 129.019 2.928 . . . . 0.0 105.007 163.691 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.51 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.58 156.14 45.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.578 1.551 . . . . 0.0 108.25 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -163.3 175.31 11.02 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.299 1.84 . . . . 0.0 107.695 163.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -96.71 68.0 2.39 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -173.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -117.66 100.9 0.89 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 126.088 1.804 . . . . 0.0 109.441 -171.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.31 158.97 39.95 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.941 1.696 . . . . 0.0 108.919 170.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -80.86 64.78 8.93 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.955 3.77 . . . . 0.0 112.181 -163.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.64 158.28 31.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.58 1.952 . . . . 0.0 110.634 -165.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.672 HG13 ' CE ' ' A' ' 13' ' ' LYS . 36.7 t -80.9 67.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.977 1.311 . . . . 0.0 109.911 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.6 59.53 0.91 Allowed Glycine 0 C--N 1.332 0.353 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 69.82 -55.74 0.59 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.934 2.094 . . . . 0.0 114.016 -176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.26 106.9 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.548 1.539 . . . . 0.0 111.024 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.672 ' CE ' HG13 ' A' ' 9' ' ' VAL . 2.6 mmtm -94.36 81.27 3.97 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 119.612 -1.93 . . . . 0.0 108.169 166.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 p -168.19 -16.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.545 -162.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.14 8.23 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.073 0.851 . . . . 0.0 112.79 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.32 -64.21 0.92 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.945 1.298 . . . . 0.0 109.453 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.67 95.32 0.01 OUTLIER 'General case' 0 C--N 1.34 0.171 0 C-N-CA 127.203 2.201 . . . . 0.0 110.62 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.77 -42.82 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -81.51 112.7 18.98 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.279 0.54 . . . . 0.0 111.348 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.1 p -84.89 14.69 4.58 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.391 1.876 . . . . 0.0 112.559 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.62 46.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.687 1.595 . . . . 0.0 109.733 -170.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.28 86.59 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 O-C-N 120.922 -1.111 . . . . 0.0 108.88 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -68.82 -19.8 64.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.892 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -138.95 126.84 22.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.2 mt -130.69 90.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 m -64.69 141.37 58.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.74 159.55 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 128.079 2.552 . . . . 0.0 105.964 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' O ' HG22 ' A' ' 31' ' ' ILE . 3.1 mp0 -118.36 163.8 23.46 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.15 173.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.442 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . 61.5 Cg_endo -73.65 172.06 16.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.791 1.66 . . . . 0.0 110.883 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 51.42 27.39 3.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.33 1.852 . . . . 0.0 114.519 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 28' ' ' GLN . 5.2 tt -124.35 5.09 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 112.164 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.84 171.4 18.27 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.083 0.849 . . . . 0.0 112.692 164.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.4 tp -91.21 124.77 35.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.575 1.55 . . . . 0.0 107.402 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.21 104.64 11.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 168.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -107.97 175.49 5.46 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.756 1.222 . . . . 0.0 110.463 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.59 117.45 8.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.162 1.385 . . . . 0.0 111.168 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.74 40.76 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.217 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.4 mtp -61.23 -52.69 63.73 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.405 1.603 . . . . 0.0 108.557 156.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -90.11 22.46 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -168.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -47.77 123.91 6.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.46 10.58 86.15 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.339 -1.256 . . . . 0.0 114.358 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.9 m -75.91 67.74 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.904 2.352 . . . . 0.0 109.153 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -66.58 -26.23 67.01 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.115 2.166 . . . . 0.0 112.865 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.96 61.95 1.01 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.332 1.453 . . . . 0.0 108.455 172.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -109.29 129.69 55.51 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 165.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -125.97 -15.57 5.83 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.047 166.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -135.52 148.48 49.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 122.543 2.429 . . . . 0.0 114.122 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 70' ' ' PHE . 5.7 tp -137.77 92.17 2.65 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 128.788 2.835 . . . . 0.0 106.717 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.44 145.95 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -129.58 112.19 13.47 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.151 0.98 . . . . 0.0 108.634 -167.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.8 p -72.16 -6.18 40.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.606 1.093 . . . . 0.0 113.891 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 134.79 12.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.869 1.213 . . . . 0.0 110.583 -163.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.58 -14.64 60.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.926 1.29 . . . . 0.0 113.486 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.87 143.6 40.69 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 108.225 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.68 -36.45 41.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.531 2.154 . . . . 0.0 111.689 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.8 p -66.26 -12.8 58.54 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 29' ' ' PRO . . . -75.57 -6.75 51.87 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.37 1.068 . . . . 0.0 112.218 176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.95 177.59 4.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.748 2.019 . . . . 0.0 111.646 -174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -161.17 124.25 3.22 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.067 1.347 . . . . 0.0 109.383 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.37 1.62 2.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -164.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 45.4 -103.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 127.394 2.425 . . . . 0.0 113.321 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.96 -7.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.394 2.278 . . . . 0.0 111.275 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.2 25.92 3.8 Favored Glycine 0 C--N 1.336 0.572 0 O-C-N 121.127 -0.983 . . . . 0.0 112.889 -163.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.1 tp -47.18 -54.47 10.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.481 1.112 . . . . 0.0 110.704 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 74.79 0.95 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.13 125.4 44.41 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.94 -12.89 68.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.404 -170.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.21 172.02 17.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.139 2.176 . . . . 0.0 108.95 170.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -141.98 111.24 6.42 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 172.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.429 ' CB ' HD22 ' A' ' 45' ' ' LEU . 22.0 p90 -124.36 -178.79 4.22 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 128.308 2.643 . . . . 0.0 108.369 -173.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.24 154.03 27.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.569 -1.332 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.5 mt -116.89 131.4 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m -128.05 127.09 42.52 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.42 156.88 72.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 123.87 0.868 . . . . 0.0 108.851 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.1 153.28 78.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 120.856 1.037 . . . . 0.0 109.502 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.87 -33.15 70.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.03 -37.37 84.67 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.989 0.813 . . . . 0.0 110.316 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.94 -6.78 55.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.251 1.02 . . . . 0.0 111.527 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.5 -60.96 2.39 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.945 1.248 . . . . 0.0 112.386 -164.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.71 -36.0 79.68 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.447 0.699 . . . . 0.0 110.254 174.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.22 -57.52 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.984 1.714 . . . . 0.0 111.58 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -64.06 -42.76 96.9 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 124.912 1.285 . . . . 0.0 109.866 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -54.54 -39.39 67.63 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.149 -0.345 . . . . 0.0 110.791 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -81.02 8.07 9.34 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.419 1.487 . . . . 0.0 114.231 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.38 174.91 1.49 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 120.434 1.47 . . . . 0.0 110.989 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.96 -60.5 2.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.322 1.449 . . . . 0.0 111.455 163.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -78.92 -57.08 3.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.717 1.207 . . . . 0.0 109.774 -171.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -56.59 -17.17 7.66 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -44.59 -46.65 10.13 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 113.8 165.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 t -66.26 -31.83 72.89 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.676 -0.64 . . . . 0.0 110.518 -176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -83.35 4.72 26.13 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.389 -1.444 . . . . 0.0 112.283 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.58 5.03 2.63 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 120.219 -1.551 . . . . 0.0 112.466 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.81 -8.58 58.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.311 0.959 . . . . 0.0 112.524 167.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -138.65 14.1 2.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.665 1.12 . . . . 0.0 113.516 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.0 mt -91.7 138.97 18.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.51 164.52 39.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.183 -0.948 . . . . 0.0 109.681 165.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.91 164.4 27.34 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.131 1.887 . . . . 0.0 110.25 165.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.2 ptp -89.66 164.41 14.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.052 0.941 . . . . 0.0 109.873 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -153.29 172.89 16.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.707 1.203 . . . . 0.0 110.71 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.501 159.033 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.629 0 CA-C-O 119.167 -0.796 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.85 168.52 19.74 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 162.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -106.35 38.5 2.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.28 1.032 . . . . 0.0 110.945 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.4 164.13 39.14 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.509 -0.744 . . . . 0.0 109.854 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.06 78.37 1.41 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.13 0.871 . . . . 0.0 111.712 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -79.35 164.9 51.85 Favored Pre-proline 0 C--O 1.238 0.476 0 O-C-N 121.406 -1.055 . . . . 0.0 110.672 171.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 6' ' ' GLU . 62.6 Cg_endo -63.7 107.97 0.81 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.46 2.773 . . . . 0.0 107.369 161.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -152.68 164.57 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 122.183 0.992 . . . . 0.0 109.305 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.904 HG13 ' HE3' ' A' ' 13' ' ' LYS . 37.8 t -74.15 78.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 161.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.0 -167.27 32.81 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 152.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 -54.22 39.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.639 2.22 . . . . 0.0 113.308 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' C ' ' HZ3' ' A' ' 13' ' ' LYS . 20.6 t70 -89.71 114.33 25.97 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.787 -1.821 . . . . 0.0 109.297 -159.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.904 ' HE3' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -80.75 89.1 5.77 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.365 -1.459 . . . . 0.0 108.551 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 t -156.15 -2.45 0.13 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -125.96 25.62 6.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.693 1.133 . . . . 0.0 112.363 -151.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -103.37 -36.98 7.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.591 1.156 . . . . 0.0 111.872 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 28.89 0.05 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.744 1.618 . . . . 0.0 113.038 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.35 -21.7 4.7 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.027 -1.985 . . . . 0.0 113.41 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -126.73 118.17 24.17 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 121.409 2.605 . . . . 0.0 111.615 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.0 p -74.71 18.29 0.18 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.234 2.213 . . . . 0.0 113.72 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.45 6.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.322 1.419 . . . . 0.0 111.476 -158.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -92.62 94.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 O-C-N 120.555 -1.34 . . . . 0.0 107.541 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -75.81 -13.97 60.29 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.533 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -140.41 135.89 32.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.649 1.113 . . . . 0.0 109.995 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.38 90.49 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.498 1.119 . . . . 0.0 108.767 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.9 m -65.75 141.92 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 165.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 9' ' ' VAL . 3.3 t -136.34 167.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.016 1.327 . . . . 0.0 110.505 174.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -114.34 163.99 17.58 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.279 1.432 . . . . 0.0 110.486 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.7 153.78 72.58 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.691 2.261 . . . . 0.0 109.878 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.39 64.12 1.43 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.79 2.036 . . . . 0.0 111.679 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.273 0.2 OUTLIER -140.71 55.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 123.708 1.718 . . . . 0.0 109.558 -176.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.72 49.26 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 125.706 1.622 . . . . 0.0 112.543 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.6 tp -105.69 131.74 52.69 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 123.212 1.482 . . . . 0.0 112.745 -157.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 5.4 mp -84.37 67.11 9.73 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.674 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -65.47 162.52 17.75 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.214 1.007 . . . . 0.0 110.058 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -77.75 109.8 12.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.681 1.192 . . . . 0.0 109.249 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.73 6.78 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.024 1.773 . . . . 0.0 112.803 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.1 -33.51 26.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.372 1.869 . . . . 0.0 113.105 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -114.89 7.94 15.81 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.875 1.67 . . . . 0.0 113.558 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -62.75 101.84 0.29 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.657 1.117 . . . . 0.0 108.616 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.86 -2.85 10.89 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.162 0.887 . . . . 0.0 113.835 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.4 m -77.54 78.7 4.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.489 2.144 . . . . 0.0 109.474 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.5 p -69.97 -23.67 63.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 112.923 -172.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.39 45.15 2.36 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.728 1.211 . . . . 0.0 108.829 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 70' ' ' PHE . 3.0 tt -98.6 109.41 22.18 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -110.66 -22.37 11.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.26 150.45 39.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.472 1.033 . . . . 0.0 111.942 -171.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.52 142.45 24.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.958 2.503 . . . . 0.0 105.602 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.24 155.09 29.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.485 HD22 ' CE1' ' A' ' 58' ' ' TYR . 92.8 mt -128.08 127.84 43.82 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.5 172.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 p -88.52 38.27 0.86 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 110.076 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.83 159.52 24.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 125.102 1.335 . . . . 0.0 109.898 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -124.5 6.73 8.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.499 0.72 . . . . 0.0 112.482 -157.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -153.24 144.45 16.23 Favored Pre-proline 0 CA--C 1.535 0.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.64 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -66.49 -31.1 42.7 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.189 2.593 . . . . 0.0 113.059 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 m -76.22 -5.93 49.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.183 0.593 . . . . 0.0 112.044 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.99 3.16 27.62 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.171 0.896 . . . . 0.0 111.93 166.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.485 ' CE1' HD22 ' A' ' 50' ' ' LEU . 45.7 m-85 -133.7 165.62 24.52 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.87 1.319 . . . . 0.0 110.816 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -134.04 170.79 15.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.225 1.81 . . . . 0.0 108.818 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . . . -175.03 -177.56 1.09 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.997 3.719 . . . . 0.0 104.178 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.28 -145.91 5.34 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 0.2 21.89 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.803 -0.822 . . . . 0.0 113.015 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.99 74.47 0.11 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-O 119.481 -0.622 . . . . 0.0 111.832 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.483 HD23 ' C ' ' A' ' 64' ' ' LEU . 6.3 tt -44.44 -41.19 6.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.355 1.462 . . . . 0.0 109.098 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.443 ' NH1' ' H ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -125.33 34.75 4.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 126.009 1.724 . . . . 0.0 111.871 -173.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -52.26 121.14 6.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.966 0.803 . . . . 0.0 109.027 171.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.82 12.41 84.57 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.685 -1.064 . . . . 0.0 115.245 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 173.35 11.67 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.405 1.603 . . . . 0.0 109.85 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -157.43 95.16 1.44 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.782 ' HB2' HD22 ' A' ' 45' ' ' LEU . 37.8 p90 -131.62 168.9 16.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.157 1.383 . . . . 0.0 111.51 -173.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -104.27 146.08 29.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.21 1.004 . . . . 0.0 111.398 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 mt -114.68 128.44 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 127.717 2.407 . . . . 0.0 108.688 -172.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.72 109.55 14.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.159 1.784 . . . . 0.0 112.208 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.72 160.87 26.37 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.448 1.099 . . . . 0.0 108.896 -175.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.2 138.19 65.39 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 108.01 -1.573 . . . . 0.0 108.01 171.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.6 -31.18 56.57 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.26 -33.2 75.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 -175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.81 -2.73 58.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.238 1.415 . . . . 0.0 112.273 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.6 tp -61.97 -50.84 70.48 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 119.882 -1.761 . . . . 0.0 112.204 -166.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -65.28 -32.27 73.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.696 0.76 . . . . 0.0 111.039 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -57.27 -56.09 26.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.093 2.157 . . . . 0.0 110.419 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -60.87 -46.12 91.85 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.587 0.755 . . . . 0.0 110.587 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -58.54 -38.76 78.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.59 -0.96 22.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.911 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.56 164.88 6.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.212 1.369 . . . . 0.0 111.683 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.24 13.92 25.87 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.993 1.317 . . . . 0.0 113.162 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 60' ' ' ALA . 4.1 t80 -146.22 -59.25 0.31 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.843 2.057 . . . . 0.0 110.923 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -61.42 -9.05 4.74 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.931 1.241 . . . . 0.0 112.964 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.261 0.5 OUTLIER -43.38 -60.52 1.68 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.6 2.36 . . . . 0.0 114.177 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -50.85 37.07 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 109.849 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -71.02 -2.91 16.97 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.476 1.511 . . . . 0.0 113.285 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.93 -23.61 66.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.658 -1.276 . . . . 0.0 111.969 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.476 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . . . -61.0 -22.67 64.74 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.476 ' CE3' ' HB3' ' A' ' 93' ' ' ALA . 12.6 m-90 -116.41 10.45 14.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.296 1.438 . . . . 0.0 111.685 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.06 115.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.15 163.41 23.31 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.773 1.229 . . . . 0.0 109.872 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 164.34 34.37 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.171 1.914 . . . . 0.0 110.415 168.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.2 mtm -76.38 -171.44 1.79 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.251 2.22 . . . . 0.0 111.647 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -99.95 -177.01 3.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.708 2.003 . . . . 0.0 109.512 166.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 . . . . . 0 C--O 1.246 0.882 0 C-N-CA 128.093 2.557 . . . . 0.0 106.121 171.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.558 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -146.97 -167.96 2.91 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.769 0.827 . . . . 0.0 109.418 -170.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -135.86 48.62 2.18 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.025 1.73 . . . . 0.0 108.276 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -151.33 153.2 34.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.633 0.773 . . . . 0.0 109.439 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.59 4.24 0.18 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.926 1.25 . . . . 0.0 113.449 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -61.27 143.47 92.67 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 119.799 1.799 . . . . 0.0 107.815 168.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.41 66.49 8.44 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.781 3.654 . . . . 0.0 113.637 -171.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.86 139.74 47.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 121.154 -0.966 . . . . 0.0 110.463 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.52 123.6 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.165 0.586 . . . . 0.0 110.135 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.34 66.49 0.34 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.2 mmt 61.05 -55.43 0.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.425 2.69 . . . . 0.0 114.03 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -57.66 114.94 2.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 164.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 30.0 mmtp -104.02 88.55 3.04 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.38 1.072 . . . . 0.0 108.745 170.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -153.24 -14.94 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.176 0.99 . . . . 0.0 113.604 153.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.601 HD22 ' H ' ' A' ' 15' ' ' LEU . 1.7 mm? -65.55 -4.1 5.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -165.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -71.07 -51.29 26.05 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.571 1.148 . . . . 0.0 109.864 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.36 13.77 0.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.78 4.83 30.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 127.256 2.36 . . . . 0.0 112.708 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -132.4 161.29 34.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.125 1.463 . . . . 0.0 109.683 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 -3.73 10.4 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.155 1.782 . . . . 0.0 112.175 -163.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.0 0.66 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.39 . . . . 0.0 110.474 -160.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.9 tt -71.81 98.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.349 1.86 . . . . 0.0 109.138 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -78.79 -3.47 44.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 117.026 -1.464 . . . . 0.0 112.077 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -152.26 137.69 17.64 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 120.513 1.506 . . . . 0.0 111.344 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -143.72 102.32 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 108.28 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.1 m -85.59 95.75 9.43 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.11 147.79 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -108.99 163.85 16.04 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 124.838 1.255 . . . . 0.0 107.796 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.61 168.08 17.5 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.372 2.048 . . . . 0.0 109.004 174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 62.93 -7.13 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 167.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.466 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 5.9 tt -99.83 54.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 121.082 1.765 . . . . 0.0 112.803 -171.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.01 166.55 39.67 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 120.479 -1.388 . . . . 0.0 111.722 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.6 tp -76.12 165.88 24.28 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.527 1.931 . . . . 0.0 112.033 -171.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.9 73.94 0.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.029 0.831 . . . . 0.0 108.804 169.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -84.45 170.41 13.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.883 -169.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 150.77 41.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.343 1.068 . . . . 0.0 110.924 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.4 -2.55 37.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.268 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ptm -62.64 -11.25 15.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.866 1.833 . . . . 0.0 114.09 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.74 13.41 11.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.783 1.233 . . . . 0.0 111.829 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -66.96 96.88 0.45 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.456 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.2 -6.93 19.02 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.391 0.996 . . . . 0.0 112.901 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.9 m -73.66 68.8 1.24 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.026 1.413 . . . . 0.0 107.245 164.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -62.63 -55.08 30.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.51 58.01 3.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.377 -0.827 . . . . 0.0 109.002 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -114.84 121.14 42.34 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.233 1.813 . . . . 0.0 108.025 160.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -135.79 -5.24 2.2 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 177.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -124.87 153.12 43.1 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.636 -1.29 . . . . 0.0 110.821 176.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.46 131.02 11.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.66 144.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.6 mt -121.45 91.39 3.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 108.198 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 t -83.04 64.42 7.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.254 1.422 . . . . 0.0 110.213 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.3 150.49 18.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.059 1.314 . . . . 0.0 110.966 166.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -89.36 -20.41 24.05 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.988 1.315 . . . . 0.0 113.324 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.19 159.43 54.45 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 126.896 2.078 . . . . 0.0 107.155 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 81' ' ' ARG . 10.9 Cg_endo -74.1 -45.65 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.154 3.236 . . . . 0.0 111.851 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -61.7 -25.33 67.34 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -159.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.58 2.47 6.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.319 1.448 . . . . 0.0 113.084 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -105.78 156.02 18.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.339 1.456 . . . . 0.0 108.373 169.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -134.06 142.83 47.72 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 107.386 169.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.56 154.3 34.02 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.778 3.231 . . . . 0.0 106.849 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.98 -160.84 23.68 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 122.073 0.818 . . . . 0.0 111.797 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.04 2.15 4.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.006 1.322 . . . . 0.0 112.87 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.02 74.59 0.17 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 125.716 1.627 . . . . 0.0 109.726 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.98 -46.22 64.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.583 1.192 . . . . 0.0 109.484 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -106.07 37.8 2.18 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.776 1.63 . . . . 0.0 110.663 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 117.65 11.83 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 172.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.75 -11.68 38.49 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.262 0.934 . . . . 0.0 114.398 168.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 -178.3 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.785 1.634 . . . . 0.0 108.587 166.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -142.62 90.42 2.22 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -173.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -135.27 163.88 28.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.3 160.02 14.74 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.321 1.448 . . . . 0.0 109.664 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.45 89.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -171.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.2 m -78.79 155.9 29.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.407 -0.808 . . . . 0.0 111.031 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.78 160.83 37.19 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 125.479 1.512 . . . . 0.0 109.457 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.32 141.24 51.04 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 108.349 -1.443 . . . . 0.0 108.349 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -53.81 -31.76 50.25 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.416 1.086 . . . . 0.0 112.54 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -46.42 76.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.942 1.697 . . . . 0.0 110.475 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 81' ' ' ARG . . . -82.3 0.14 42.93 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.673 1.189 . . . . 0.0 112.248 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.5 -45.22 85.18 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.58 1.082 . . . . 0.0 112.419 -164.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.7 -44.44 90.25 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.686 0.795 . . . . 0.0 110.852 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.475 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -49.84 -53.18 27.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.97 1.308 . . . . 0.0 110.815 -171.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -66.53 -38.08 86.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.09 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -61.9 -18.0 58.65 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.437 1.017 . . . . 0.0 111.694 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -87.85 -15.26 37.26 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -71.65 130.21 40.61 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.319 1.872 . . . . 0.0 109.27 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -47.25 -39.25 13.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.656 1.182 . . . . 0.0 110.885 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -69.04 -74.21 0.13 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.4 1.08 . . . . 0.0 109.95 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -55.77 -22.96 26.95 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -44.67 -48.14 10.57 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -60.14 -43.59 95.6 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.691 0.678 . . . . 0.0 109.682 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.14 7.08 5.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.888 -1.133 . . . . 0.0 112.73 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 95' ' ' ILE . . . -62.68 -19.73 64.15 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 120.043 -1.661 . . . . 0.0 111.996 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.04 -18.75 37.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -121.01 7.94 10.39 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.234 1.013 . . . . 0.0 111.813 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 92' ' ' ALA . 92.3 mt -83.99 148.03 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.122 0.969 . . . . 0.0 108.995 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.33 165.3 17.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.982 1.713 . . . . 0.0 109.654 164.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.8 163.88 31.61 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.979 1.786 . . . . 0.0 112.299 174.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.2 ptp -82.17 -174.55 5.17 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 110.812 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.61 -170.0 2.15 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.258 2.223 . . . . 0.0 108.42 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 124.69 1.196 . . . . 0.0 107.773 176.474 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.29 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -168.57 1.15 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.394 1.092 . . . . 0.0 110.713 173.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -141.03 80.2 1.73 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.445 2.698 . . . . 0.0 105.205 173.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -166.9 166.67 15.37 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.312 0.645 . . . . 0.0 110.373 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.46 84.45 1.62 Allowed Glycine 0 C--N 1.331 0.291 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 163.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.82 161.15 80.75 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 160.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.38 70.99 5.39 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.648 3.565 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.04 146.56 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 120.764 -1.21 . . . . 0.0 109.701 -169.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.12 132.56 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.241 0.616 . . . . 0.0 110.261 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.79 82.54 0.15 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.471 ' H ' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER 48.2 28.88 1.68 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.805 1.642 . . . . 0.0 111.914 -175.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -147.9 122.42 9.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 31' ' ' ILE . 32.9 mmtp -106.32 94.98 5.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 162.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.68 19.73 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.943 1.697 . . . . 0.0 110.598 174.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.52 64.91 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.225 -1.547 . . . . 0.0 111.362 -167.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.0 -10.44 1.15 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.69 17.36 21.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.139 1.336 . . . . 0.0 112.483 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.6 -6.94 20.98 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.626 -168.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -138.43 105.17 5.36 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 120.354 2.077 . . . . 0.0 109.677 169.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.4 p -72.16 9.43 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -168.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.56 39.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 128.049 2.54 . . . . 0.0 109.442 -159.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.58 96.71 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 128.274 2.63 . . . . 0.0 106.557 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -78.83 -13.3 59.88 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.213 1.005 . . . . 0.0 111.557 -170.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.07 121.27 11.52 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.184 1.794 . . . . 0.0 107.143 -173.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.7 mt -111.39 103.41 15.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.0 m -72.71 143.41 48.05 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.77 159.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 127.308 2.243 . . . . 0.0 106.313 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.44 ' O ' HG22 ' A' ' 31' ' ' ILE . 4.5 pt20 -131.96 163.96 46.42 Favored Pre-proline 0 N--CA 1.451 -0.375 0 C-N-CA 124.033 0.933 . . . . 0.0 110.796 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.61 146.81 55.97 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 -171.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 51.31 66.08 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.09 2.156 . . . . 0.0 110.589 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.471 HD11 ' H ' ' A' ' 11' ' ' MET . 8.6 tp -133.88 40.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.877 1.271 . . . . 0.0 111.086 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.08 156.95 24.83 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 120.194 -1.566 . . . . 0.0 113.386 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.5 127.19 30.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 127.828 2.451 . . . . 0.0 111.015 -171.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.17 77.17 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -67.57 165.0 17.8 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.81 0.814 . . . . 0.0 110.302 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.96 144.26 33.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.963 -1.086 . . . . 0.0 110.333 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' A' ' 66' ' ' ASP . . . 85.84 5.62 83.59 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.718 0.675 . . . . 0.0 112.883 -178.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 mtp -54.81 -27.2 40.1 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.808 1.243 . . . . 0.0 112.849 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.67 20.53 4.24 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.627 1.171 . . . . 0.0 111.338 -162.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 t -65.44 115.86 6.13 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.88 56.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 76.0 m -68.02 74.81 0.21 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.971 1.385 . . . . 0.0 112.813 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.6 p -63.74 -31.23 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.289 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.57 63.87 0.71 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.178 1.354 . . . . 0.0 107.918 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -123.14 120.97 34.81 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.194 2.198 . . . . 0.0 106.804 162.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.5 ' N ' HD22 ' A' ' 45' ' ' LEU 0.307 1.2 pt-20 -131.44 -4.07 3.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.018 1.327 . . . . 0.0 114.382 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -144.63 157.99 43.97 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 122.491 1.139 . . . . 0.0 113.3 170.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 49' ' ' ILE . 1.7 tm? -140.65 141.04 35.09 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.378 3.071 . . . . 0.0 104.289 177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.527 ' N ' HD13 ' A' ' 48' ' ' LEU . 4.4 mp -135.28 142.33 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -173.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -128.07 104.69 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.687 1.195 . . . . 0.0 108.694 -169.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -79.28 37.22 0.32 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.577 0.751 . . . . 0.0 111.003 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.83 146.69 18.69 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -97.37 16.25 20.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.991 0.516 . . . . 0.0 111.434 -165.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.75 147.5 17.88 Favored Pre-proline 0 N--CA 1.445 -0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 110.157 -164.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.22 -41.62 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.647 2.898 . . . . 0.0 110.663 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -67.06 -22.21 65.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.575 1.55 . . . . 0.0 114.229 -169.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.37 4.79 10.0 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 112.158 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -122.62 172.7 8.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.708 1.242 . . . . 0.0 108.995 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.78 126.51 18.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.49 35.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.226 1.41 . . . . 0.0 107.478 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.3 -127.17 5.1 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.4 14.38 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.379 1.072 . . . . 0.0 111.859 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.45 82.86 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.7 tt -52.43 -50.96 61.54 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.52 40.95 1.28 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.473 1.109 . . . . 0.0 110.694 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 21.2 t70 -65.89 136.3 55.95 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 120.82 -1.175 . . . . 0.0 107.91 169.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.94 -10.85 60.55 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.776 -1.569 . . . . 0.0 114.865 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 -172.62 4.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.923 1.861 . . . . 0.0 109.444 175.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -134.76 80.18 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -94.38 167.88 11.24 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.48 149.95 28.84 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.281 1.033 . . . . 0.0 109.457 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -109.53 149.63 12.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.15 1.38 . . . . 0.0 107.926 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.1 m -129.87 130.61 45.44 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.343 1.457 . . . . 0.0 107.514 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.21 160.55 67.49 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.944 1.698 . . . . 0.0 108.395 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.55 147.75 90.35 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 120.377 1.17 . . . . 0.0 109.962 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.26 -28.12 67.8 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 -5.99 49.11 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.635 0.774 . . . . 0.0 112.053 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.15 -3.46 31.68 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.011 -1.055 . . . . 0.0 112.829 167.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.57 -36.59 81.22 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.359 0.982 . . . . 0.0 113.427 -161.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.57 -30.81 32.9 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.001 -1.062 . . . . 0.0 109.173 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.8 ttm105 -56.38 -60.27 3.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.729 1.211 . . . . 0.0 110.618 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 83' ' ' ARG . 1.2 p90 -54.87 -40.64 69.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.505 0.593 . . . . 0.0 110.939 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 1.3 mtp-105 -65.49 -19.85 66.1 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.883 -0.511 . . . . 0.0 111.433 -174.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -100.45 5.28 44.2 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.831 1.252 . . . . 0.0 111.655 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.02 162.7 21.53 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.707 1.139 . . . . 0.0 110.858 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.82 -43.83 64.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.306 -0.871 . . . . 0.0 111.346 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -95.42 -60.38 1.68 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.706 1.203 . . . . 0.0 109.926 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.78 -18.61 13.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.163 1.785 . . . . 0.0 113.936 -170.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -44.98 -42.97 8.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.316 1.446 . . . . 0.0 114.265 167.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 t -58.71 -37.96 77.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -85.59 10.92 11.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.395 1.478 . . . . 0.0 112.847 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.78 -0.69 7.53 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.497 -2.002 . . . . 0.0 112.729 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.82 -15.66 53.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.314 0.961 . . . . 0.0 113.451 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -118.11 0.35 11.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.4 92.87 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -168.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -99.35 163.14 19.19 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.371 1.068 . . . . 0.0 112.659 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.75 151.89 58.06 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.212 2.608 . . . . 0.0 112.067 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 mtm -71.15 179.84 2.66 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.855 1.662 . . . . 0.0 110.784 165.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.4 -177.2 3.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.167 1.387 . . . . 0.0 111.758 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 . . . . . 0 C--O 1.253 1.277 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 156.125 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.754 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.55 178.17 8.15 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.609 1.164 . . . . 0.0 110.351 -170.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -144.02 47.32 1.43 Allowed 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.527 0.731 . . . . 0.0 111.743 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -151.06 139.86 20.83 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -127.32 17.81 6.17 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.495 -1.169 . . . . 0.0 114.471 -169.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.3 85.46 0.74 Allowed Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 119.692 1.746 . . . . 0.0 110.853 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.36 73.5 2.72 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 123.097 2.532 . . . . 0.0 108.554 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.8 t -133.24 165.78 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.423 1.889 . . . . 0.0 108.359 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.762 HG13 ' CE ' ' A' ' 13' ' ' LYS . 11.5 t -100.1 66.87 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.049 1.74 . . . . 0.0 108.309 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.86 82.87 0.32 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 172.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.7 mmt 57.98 -58.38 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 130.229 3.411 . . . . 0.0 115.747 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -62.59 101.53 0.26 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.243 1.817 . . . . 0.0 111.413 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.762 ' CE ' HG13 ' A' ' 9' ' ' VAL . 2.0 mmtm -94.21 76.41 4.0 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 119.518 -1.989 . . . . 0.0 108.545 171.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.79 -9.02 0.72 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.434 1.094 . . . . 0.0 113.243 168.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 6.66 15.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -165.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CE2' HG22 ' A' ' 9' ' ' VAL . 13.9 m-85 -68.48 -43.89 75.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.139 1.336 . . . . 0.0 111.761 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.68 47.62 0.18 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.256 2.223 . . . . 0.0 112.973 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -133.16 -39.03 0.21 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-O 119.219 -0.767 . . . . 0.0 111.238 173.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -85.09 100.95 12.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.481 1.141 . . . . 0.0 110.878 -172.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -70.99 9.92 0.62 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.282 2.633 . . . . 0.0 113.88 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.19 55.02 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.892 1.277 . . . . 0.0 109.223 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -129.94 92.36 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.214 -0.928 . . . . 0.0 110.325 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 1.9 mmt85 -76.17 -15.26 60.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 117.044 -1.455 . . . . 0.0 112.019 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -137.36 135.62 37.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.569 1.077 . . . . 0.0 108.843 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -133.55 113.14 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.5 m -93.16 107.67 19.43 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.682 HG13 HG11 ' A' ' 9' ' ' VAL . 4.2 t -103.14 105.46 18.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.455 1.502 . . . . 0.0 108.386 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.509 ' HG3' HG21 ' A' ' 31' ' ' ILE . 6.3 pt20 -65.02 165.07 17.45 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.798 167.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 28' ' ' GLN . 57.5 Cg_endo -73.5 168.68 24.16 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.503 2.136 . . . . 0.0 110.15 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 46.67 39.21 6.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.91 1.684 . . . . 0.0 112.981 171.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.509 HG21 ' HG3' ' A' ' 28' ' ' GLN 0.304 5.2 tt -130.25 22.6 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 120.233 1.379 . . . . 0.0 112.386 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.53 164.33 11.72 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.007 0.813 . . . . 0.0 113.206 155.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.94 117.49 9.88 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 126.314 1.845 . . . . 0.0 111.54 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -74.55 95.56 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 164.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -76.29 173.79 10.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.147 0.979 . . . . 0.0 111.447 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.0 129.15 39.55 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.423 1.089 . . . . 0.0 113.004 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.62 25.18 74.01 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -45.17 -36.62 3.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.708 2.003 . . . . 0.0 113.321 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.22 13.62 20.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.07 1.748 . . . . 0.0 111.72 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -49.79 119.35 3.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.849 0.859 . . . . 0.0 111.935 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.5 20.99 79.41 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.598 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.8 m -71.91 78.67 0.89 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.3 p -76.02 -6.37 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.381 1.872 . . . . 0.0 112.305 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -135.48 72.9 1.45 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 162.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 39.4 tp -134.85 123.6 23.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 130.785 3.634 . . . . 0.0 109.036 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -143.03 -20.48 0.64 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -100.86 145.79 28.13 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 121.795 2.088 . . . . 0.0 111.163 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.35 150.38 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 166.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.65 138.18 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.7 mt -111.8 155.0 24.26 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 p -126.2 7.49 7.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.819 0.848 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.06 179.45 41.01 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -125.97 3.76 7.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.259 0.624 . . . . 0.0 111.768 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -147.65 144.17 18.91 Favored Pre-proline 0 N--CA 1.466 0.371 0 C-N-CA 124.6 1.16 . . . . 0.0 108.963 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.2 -27.3 16.82 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.768 2.312 . . . . 0.0 113.43 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.4 -14.67 63.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.827 1.251 . . . . 0.0 111.163 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.24 -2.96 23.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.699 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.93 165.33 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.76 1.624 . . . . 0.0 109.833 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 m -139.83 123.65 17.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 64' ' ' LEU . . . -126.93 -0.63 6.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.195 1.398 . . . . 0.0 113.0 -168.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.73 -97.81 0.23 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 126.831 2.158 . . . . 0.0 109.029 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -147.56 -9.6 0.42 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.007 1.723 . . . . 0.0 111.375 160.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.73 24.22 9.71 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.771 1.177 . . . . 0.0 114.04 -163.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.471 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 19.0 tp -44.46 -44.59 8.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.367 1.867 . . . . 0.0 114.092 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.83 58.57 1.64 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -164.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.05 153.15 26.03 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.29 -11.13 51.69 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 117.88 -1.511 . . . . 0.0 114.566 170.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.5 165.32 31.54 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.733 2.013 . . . . 0.0 107.946 162.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.93 86.47 2.41 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.32 1.048 . . . . 0.0 109.595 -168.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -112.18 174.82 5.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.892 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.67 154.09 39.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.092 2.957 . . . . 0.0 107.929 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.5 mt -117.03 107.92 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 126.207 1.803 . . . . 0.0 108.354 -163.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.12 151.63 36.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.728 161.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.07 161.72 51.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 126.236 1.814 . . . . 0.0 107.64 164.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.07 149.61 76.97 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 108.098 -1.539 . . . . 0.0 108.098 167.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.37 -33.09 41.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.832 0.853 . . . . 0.0 111.913 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -59.28 -42.82 92.13 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.714 1.605 . . . . 0.0 111.012 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 -7.22 56.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.688 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.7 tp -56.97 -55.18 37.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.822 1.192 . . . . 0.0 112.985 -164.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.53 -33.24 60.7 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.465 -0.772 . . . . 0.0 111.466 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -45.43 -51.62 11.21 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.791 2.036 . . . . 0.0 109.422 167.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.06 -43.43 92.3 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.233 1.013 . . . . 0.0 111.433 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.01 -19.71 65.75 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.255 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -103.09 18.8 20.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.174 1.352 . . . . 0.0 112.993 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.53 166.32 19.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.603 1.561 . . . . 0.0 111.775 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.37 -34.65 16.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.827 0.851 . . . . 0.0 111.514 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -92.04 -59.38 2.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -65.04 -12.42 50.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -170.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -44.15 -45.5 8.31 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.426 HG23 ' CD2' ' A' ' 91' ' ' TYR . 15.3 t -60.67 -43.95 97.06 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 125.623 1.569 . . . . 0.0 110.37 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.426 ' CD2' HG23 ' A' ' 90' ' ' THR . 97.3 m-85 -71.96 0.59 8.92 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.327 1.451 . . . . 0.0 112.811 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.32 71.06 Favored 'General case' 0 C--N 1.343 0.293 0 O-C-N 119.864 -1.773 . . . . 0.0 111.479 -172.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.65 5.07 1.56 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -125.1 7.77 7.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.907 1.683 . . . . 0.0 111.937 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.5 mt -102.89 116.2 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.933 1.242 . . . . 0.0 109.391 -173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.91 155.93 63.03 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 126.057 1.743 . . . . 0.0 111.037 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.37 146.71 40.4 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.978 3.119 . . . . 0.0 111.861 172.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 39.7 mtm -65.65 165.19 12.91 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.307 1.443 . . . . 0.0 112.151 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.08 -177.6 1.09 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.132 1.773 . . . . 0.0 110.375 160.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 . . . . . 0 C--O 1.245 0.842 0 C-N-CA 126.636 1.974 . . . . 0.0 105.871 178.106 . . . . . . . . 0 0 . 1 stop_ save_